{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Introduction\n",
    "This is my take on a Kaggle problem which was given to me as a recruitment test by Incubits Inc.\n",
    "# Personalized Medicine: Redefining Cancer Treatment\n",
    "The dataset was taken from a [Kaggle](https://www.kaggle.com/c/msk-redefining-cancer-treatment) competition.\n",
    "It consists of text documents serving as clinical evidence to classify genetic mutations of cancer tumors.\n",
    "Please check the competition page for more information.\n",
    "# Objective\n",
    "Classify cancer genetic mutations based on clinical evidence (text documents).\n",
    "# Data exploration\n",
    "First, I started by looking at the dataset to understand it's structure and gain some insights."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "from zipfile import ZipFile\n",
    "from os import path\n",
    "from itertools import islice\n",
    "import gc\n",
    "\n",
    "from imblearn.over_sampling import SMOTE\n",
    "from imblearn.under_sampling import ClusterCentroids, RandomUnderSampler\n",
    "from xgboost import XGBClassifier\n",
    "from sklearn.model_selection import cross_val_score, train_test_split, GridSearchCV\n",
    "from sklearn.linear_model import LogisticRegression\n",
    "from sklearn.metrics import classification_report, log_loss\n",
    "from sklearn.svm import SVC\n",
    "from sklearn.feature_extraction.text import CountVectorizer, TfidfTransformer\n",
    "from sklearn.ensemble import RandomForestClassifier\n",
    "from sklearn.preprocessing import LabelEncoder\n",
    "from sklearn.decomposition import PCA, TruncatedSVD\n",
    "from sklearn.manifold import TSNE\n",
    "from sklearn.pipeline import Pipeline\n",
    "from scikitplot.metrics import plot_confusion_matrix\n",
    "import nltk\n",
    "from nltk.stem.snowball import SnowballStemmer\n",
    "import numpy as np\n",
    "from scipy.sparse import save_npz, load_npz\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "from gensim.models import Doc2Vec\n",
    "import re\n",
    "import string\n",
    "from sklearn.naive_bayes import MultinomialNB\n",
    "from nltk.corpus import stopwords\n",
    "%matplotlib inline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Constats\n",
    "DATA_PATH = 'data/'\n",
    "TRAINING_TEXT_PATH = path.join(DATA_PATH, 'training_text')\n",
    "TRAINING_VARIANTS_PATH = path.join(DATA_PATH, 'training_variants')\n",
    "TEST_TEXT_PATH = path.join(DATA_PATH, 'test_text')\n",
    "TEST_VARIANTS_PATH = path.join(DATA_PATH, 'test_variants')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Extracting files and loading data\n",
    "Skip this if you have already extracted the data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Extracting training_text.zip\n",
      "Extracting training_variants.zip\n",
      "Extracting test_variants.zip\n",
      "Extracting test_text.zip\n",
      "Finished Extraction\n"
     ]
    }
   ],
   "source": [
    "files_to_extract = ['training_text.zip', 'training_variants.zip', 'test_variants.zip', 'test_text.zip']\n",
    "for filename in files_to_extract:\n",
    "    print('Extracting', filename)\n",
    "    zipfile = ZipFile(path.join(DATA_PATH, filename))\n",
    "    zipfile.extractall(DATA_PATH)\n",
    "    zipfile.close()\n",
    "print('Finished Extraction')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.set_option('display.max_colwidth', 150)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Gene</th>\n",
       "      <th>Variation</th>\n",
       "      <th>Class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>FAM58A</td>\n",
       "      <td>Truncating Mutations</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>CBL</td>\n",
       "      <td>W802*</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>CBL</td>\n",
       "      <td>Q249E</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>CBL</td>\n",
       "      <td>N454D</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>CBL</td>\n",
       "      <td>L399V</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   ID    Gene             Variation  Class\n",
       "0   0  FAM58A  Truncating Mutations      1\n",
       "1   1     CBL                 W802*      2\n",
       "2   2     CBL                 Q249E      2\n",
       "3   3     CBL                 N454D      3\n",
       "4   4     CBL                 L399V      4"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Training variants\n",
    "training_variants = pd.read_csv(TRAINING_VARIANTS_PATH)\n",
    "training_variants.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>Cyclin-dependent kinases (CDKs) regulate a variety of fundamental cellular processes. CDK10 stands out as one of the last orphan CDKs for which no...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Abstract Background  Non-small cell lung cancer (NSCLC) is a heterogeneous group of disorders with a number of genetic and proteomic alterations....</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>Abstract Background  Non-small cell lung cancer (NSCLC) is a heterogeneous group of disorders with a number of genetic and proteomic alterations....</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>Recent evidence has demonstrated that acquired uniparental disomy (aUPD) is a novel mechanism by which pathogenetic mutations in cancer may be red...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>Oncogenic mutations in the monomeric Casitas B-lineage lymphoma (Cbl) gene have been found in many tumors, but their significance remains largely ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   ID  \\\n",
       "0   0   \n",
       "1   1   \n",
       "2   2   \n",
       "3   3   \n",
       "4   4   \n",
       "\n",
       "                                                                                                                                                    Text  \n",
       "0  Cyclin-dependent kinases (CDKs) regulate a variety of fundamental cellular processes. CDK10 stands out as one of the last orphan CDKs for which no...  \n",
       "1   Abstract Background  Non-small cell lung cancer (NSCLC) is a heterogeneous group of disorders with a number of genetic and proteomic alterations....  \n",
       "2   Abstract Background  Non-small cell lung cancer (NSCLC) is a heterogeneous group of disorders with a number of genetic and proteomic alterations....  \n",
       "3  Recent evidence has demonstrated that acquired uniparental disomy (aUPD) is a novel mechanism by which pathogenetic mutations in cancer may be red...  \n",
       "4  Oncogenic mutations in the monomeric Casitas B-lineage lymphoma (Cbl) gene have been found in many tumors, but their significance remains largely ...  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Training text\n",
    "pd.set_option('display.max_colwidth', 150)\n",
    "training_text = pd.read_csv('data/training_text', sep='\\|\\|', engine='python', skiprows=1, names=['ID', 'Text'])\n",
    "training_text.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Sanity checking and basic statistics\n",
    "I checked how many samples I have in the dataset, and did some quick sanity checking to insure there are no missing values.\n",
    "I also calculated some basic statistics and plotted some interesting plots to help me undestand the data."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training variants counts:\n",
      "ID           3321\n",
      "Gene         3321\n",
      "Variation    3321\n",
      "Class        3321\n",
      "dtype: int64\n",
      "\n",
      "Missing values count: 0\n",
      "\n",
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 3321 entries, 0 to 3320\n",
      "Data columns (total 4 columns):\n",
      "ID           3321 non-null int64\n",
      "Gene         3321 non-null object\n",
      "Variation    3321 non-null object\n",
      "Class        3321 non-null int64\n",
      "dtypes: int64(2), object(2)\n",
      "memory usage: 103.9+ KB\n"
     ]
    }
   ],
   "source": [
    "print('Training variants counts:')\n",
    "print(training_variants.count())\n",
    "print('')\n",
    "print('Missing values count:', training_variants.isnull().sum().sum())\n",
    "print('')\n",
    "training_variants.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Gene</th>\n",
       "      <th>Variation</th>\n",
       "      <th>Class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>3321.000000</td>\n",
       "      <td>3321</td>\n",
       "      <td>3321</td>\n",
       "      <td>3321.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>unique</th>\n",
       "      <td>NaN</td>\n",
       "      <td>264</td>\n",
       "      <td>2996</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>top</th>\n",
       "      <td>NaN</td>\n",
       "      <td>BRCA1</td>\n",
       "      <td>Truncating Mutations</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>freq</th>\n",
       "      <td>NaN</td>\n",
       "      <td>264</td>\n",
       "      <td>93</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>1660.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4.365854</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>958.834449</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.309781</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>830.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>1660.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>2490.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>3320.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>9.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 ID   Gene             Variation        Class\n",
       "count   3321.000000   3321                  3321  3321.000000\n",
       "unique          NaN    264                  2996          NaN\n",
       "top             NaN  BRCA1  Truncating Mutations          NaN\n",
       "freq            NaN    264                    93          NaN\n",
       "mean    1660.000000    NaN                   NaN     4.365854\n",
       "std      958.834449    NaN                   NaN     2.309781\n",
       "min        0.000000    NaN                   NaN     1.000000\n",
       "25%      830.000000    NaN                   NaN     2.000000\n",
       "50%     1660.000000    NaN                   NaN     4.000000\n",
       "75%     2490.000000    NaN                   NaN     7.000000\n",
       "max     3320.000000    NaN                   NaN     9.000000"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "training_variants.describe(include='all')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training variants counts:\n",
      "ID      3321\n",
      "Text    3321\n",
      "dtype: int64\n",
      "\n",
      "Missing values count: 0\n",
      "\n",
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 3321 entries, 0 to 3320\n",
      "Data columns (total 2 columns):\n",
      "ID      3321 non-null int64\n",
      "Text    3321 non-null object\n",
      "dtypes: int64(1), object(1)\n",
      "memory usage: 52.0+ KB\n"
     ]
    }
   ],
   "source": [
    "print('Training variants counts:')\n",
    "print(training_text.count())\n",
    "print('')\n",
    "print('Missing values count:', training_text.isnull().sum().sum())\n",
    "print('')\n",
    "training_text.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>3321.000000</td>\n",
       "      <td>3321</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>unique</th>\n",
       "      <td>NaN</td>\n",
       "      <td>1921</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>top</th>\n",
       "      <td>NaN</td>\n",
       "      <td>The PTEN (phosphatase and tensin homolog) phosphatase is unique in mammals in terms of its tumor suppressor activity, exerted by dephosphorylation...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>freq</th>\n",
       "      <td>NaN</td>\n",
       "      <td>53</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>1660.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>958.834449</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>830.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>1660.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>2490.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>3320.000000</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 ID  \\\n",
       "count   3321.000000   \n",
       "unique          NaN   \n",
       "top             NaN   \n",
       "freq            NaN   \n",
       "mean    1660.000000   \n",
       "std      958.834449   \n",
       "min        0.000000   \n",
       "25%      830.000000   \n",
       "50%     1660.000000   \n",
       "75%     2490.000000   \n",
       "max     3320.000000   \n",
       "\n",
       "                                                                                                                                                         Text  \n",
       "count                                                                                                                                                    3321  \n",
       "unique                                                                                                                                                   1921  \n",
       "top     The PTEN (phosphatase and tensin homolog) phosphatase is unique in mammals in terms of its tumor suppressor activity, exerted by dephosphorylation...  \n",
       "freq                                                                                                                                                       53  \n",
       "mean                                                                                                                                                      NaN  \n",
       "std                                                                                                                                                       NaN  \n",
       "min                                                                                                                                                       NaN  \n",
       "25%                                                                                                                                                       NaN  \n",
       "50%                                                                                                                                                       NaN  \n",
       "75%                                                                                                                                                       NaN  \n",
       "max                                                                                                                                                       NaN  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "training_text.describe(include='all')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Plotting unique values counts of each variable (column)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Plotting the top 20 Gene counts and Variation counts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fea6277a320>"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAABIcAAAFNCAYAAACaOg/uAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nECYOAQAAAISJQwAAAABh4hAAAABA2AJDbgykjEFIhwAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fea72bcb5f8>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "training_variants['Gene'].value_counts()[:20].plot.bar(figsize=(20, 5), alpha=0.75, rot=45)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fea62830c50>"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAABIEAAAGRCAYAAADy2KP9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nIiIiIiIiImIA+D9QjjE/jq3hvgAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fea62780a58>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "training_variants['Variation'].value_counts()[:20].plot.bar(figsize=(20, 5), alpha=0.75, rot=45)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Note:\n",
    "The Genes and Variations distributions are very imbalanced in the dataset."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7fea606d2208>"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA3cAAAEvCAYAAADmcTilAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n/wtLcCuqaoQ51gAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fea627a1048>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "training_variants['Class'].value_counts().plot.bar(figsize=(15, 5))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Note:\n",
    "We can see from the plots that our data is very imbalanced. I'll have to take this in consideration in the modeling of the classifier. Having very few examples for some classes might prohibit the classifier from learning their features."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Text Length"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Min sentence length(words): 1\n",
      "Max sentence length(words): 76782\n",
      "Mean sentence length(words): 9551.11201445\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA4QAAAFACAYAAADkqLKwAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nCAEAACZKIAQAAJio/x+jC9VejpM9iwAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fea606b3b70>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "train_word_counts = training_text['Text'].apply(lambda x: len(x.split()))\n",
    "ax = train_word_counts.hist(bins=50, figsize=(15, 5))\n",
    "ax.set_xlabel(\"Text Length (words)\")\n",
    "ax.set_ylabel(\"Counts\")\n",
    "print('Min sentence length(words):', train_word_counts.min())\n",
    "print('Max sentence length(words):', train_word_counts.max())\n",
    "print('Mean sentence length(words):', train_word_counts.mean())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Max sentence length(characters): 523393\n",
      "Min sentence length(characters): 4\n",
      "Mean sentence length(characters): 63615.9713942\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA34AAAFACAYAAADjxq7gAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fea60467a58>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "train_char_counts = training_text['Text'].apply(len)\n",
    "ax = training_text['Text'].apply(len).hist(bins=50, figsize=(15, 5))\n",
    "ax.set_xlabel(\"Text Length (characters)\")\n",
    "ax.set_ylabel(\"Counts\")\n",
    "print('Max sentence length(characters):', train_char_counts.max())\n",
    "print('Min sentence length(characters):', train_char_counts.min())\n",
    "print('Mean sentence length(characters):', train_char_counts.mean())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Note:\n",
    "The _Text_ column contains very large documents, this will make it difficult to find a good representation for the documents."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Example text:\n",
      "\n",
      "KRAS mutations occur in one third of human cancers and cluster in several hotspots, with codons 12 and 13 being most commonly affected. It has been suggested that the position and type of amino acid exchange influence the transforming capacity of mutant KRAS proteins. We used MCF10A human mammary epithelial cells to establish isogenic cell lines that express different cancer-associated KRAS mutations (G12C, G12D, G12V, G13C, G13D, A18D, Q61H, K117N) at physiological or elevated levels, and investigated the biochemical and functional consequences of the different variants. The overall effects of low-expressing mutants were moderate compared to overexpressed variants, but allowed delineation of biological functions that were related to specific alleles rather than KRAS expression level. None of the mutations induced morphological changes, migratory abilities, or increased phosphorylation of ERK, PDK1, and AKT. KRAS-G12D, G12V, G13D, and K117N mediated EGF-independent proliferation, whereas anchorage-independent growth was primarily induced by K117N and Q61H. Both codon 13 mutations were associated with increased EGFR expression. Finally, global gene expression analysis of MCF10A-G13D versus MCF10A-G12D revealed distinct transcriptional changes. Together, we describe a useful resource for investigating the function of multiple KRAS mutations and provide insights into the differential effects of these variants in MCF10A cells.  Under physiological conditions, the small GTPase KRAS is activated in a controlled manner through the exchange of GDP for GTP upon binding of growth factors to their receptors, which then allows KRAS to bind and activate various effectors mediating a multitude of cellular effects. For example, the well-studied PI3K-PDK1-AKT, RAF-MEK-ERK, and TIAM1-RAC1 cascades regulate cell survival, cell proliferation, and cytoskeletal organization, respectively1.  Point mutations in the KRAS gene occur in approximately 30% of human cancers and are particularly common in adenocarcinomas of the pancreas, lung, and colon2. Thus far, mutant KRAS is considered an undruggable target3,4,5, although new approaches for blocking KRAS activity continue to be developed6,7, and serves as a predictor of non-responsiveness to molecularly targeted therapies such as EGFR inhibitors in lung and colon cancer8,9.  On the molecular level, KRAS mutations result in reduced intrinsic GTPase activity, which in turn leads to permanent activation of KRAS itself and downstream signalling pathways, thereby mediating malignant transformation. These single amino acid substitutions typically affect hotspots at codons 12 and 13. However, KRAS mutations also occur in codons 18, 61, 117, and 146 at low frequencies10. Of note, there is evidence that the type of KRAS mutation determines their biochemical activity and transforming capacity. For example, experiments with murine NIH/3T3 cells showed that codon 12 mutations protected from apoptosis and promoted anchorage-independent growth more strongly than codon 13 mutations11, and KRAS-K117N and A146T are associated with lower levels of GTP-bound RAS compared to G12D in transfected HEK293FT cells12. Of potential clinical relevance, patients with colorectal cancer harbouring G13D mutations were reported to respond better to anti-EGFR therapy compared to patients with G12D mutations13,14, but the biological basis for this observation is currently unclear.  We hypothesized that a systematic comparative analysis would greatly improve our understanding of the differential effects of diverse KRAS mutations on signalling pathways, cellular functions, and possibly clinical outcomes. Thus far, most in vitro studies have been performed in murine or human cell lines overexpressing the RAS mutants under investigation, which makes it difficult to assign specific biochemical or cellular effects to the respective mutation itself, since overexpression of wildtype (WT) KRAS also has transforming properties15. In addition, it remains elusive whether the specific amino acid that replaces glycine at positions 12 and 13 has an influence on the biological effects of mutant KRAS.  To address these questions, we generated isogenic MCF10A human mammary epithelial cell lines harbouring WT KRAS and eight different KRAS mutations that were all expressed at close-to-endogenous levels, and analysed these cell lines for KRAS activity, activation of downstream signalling pathways, and various cellular phenotypes including morphology, proliferation, anchorage-independent growth, and migratory properties. The different mutations clearly varied in their ability to mediate biochemical and cellular responses, and overall caused only moderate effects compared to oncogenic KRAS alleles expressed at supraphysiologic levels.  Go to: Results and Discussion Establishment of KRAS mutant MCF10A isogenic cell lines  To investigate the biochemical and functional consequences of different KRAS mutations, we chose the immortalised human mammary epithelial cell line MCF10A, since these cells are well characterised and represent a useful tool for assessing the transforming activity of oncogenes, such as RAS, ERBB2, and PLK416,17,18. We introduced the four most frequent KRAS mutations (G12D, G12V, G13D, G12C), which account for 83% of all KRAS mutations, KRAS-G13C as the second most common alteration of codon 13, three rare mutations (Q61H, A18D, K117N), and WT KRAS into MCF10A cells by lentiviral transduction (Figure 1a).  Figure 1 Figure 1 Generation of MCF10A isogenic cell lines harbouring various KRAS mutations. Six to eleven clones per cell line were obtained by seeding single cells in 96-well plates, and KRAS protein levels were compared to those of MCF10A cells transduced with an empty control vector (EV) (Figure S1). Clones with KRAS protein levels comparable to those of EV-transduced cells were selected, and side-by-side analysis by western blotting confirmed similar expression levels in all KRAS mutant clones and EV-transduced control cells (Figure 1b). In all clones, the presence of the respective KRAS mutation was confirmed by Sanger sequencing (data not shown).  To quantify the expression of the introduced cDNAs, we measured total (endogenous and exogenous) and endogenous KRAS mRNA levels by quantitative RT-PCR. In the KRAS mutant clones, we observed slightly increased levels of total KRAS mRNA with 1.5 to 3-fold higher expression compared to EV-transduced control cells (Figure 1c, left panel). For comparison, we analysed clones with substantially higher KRAS protein levels (Figure S1), resembling the high expression typically seen in, e.g., NIH/3T3 or HEK293 cells transduced or transfected with KRAS cDNAs that are often used in functional studies. KRAS mRNA expression in these cells was increased up to 60-fold compared to control cells, illustrating that forced expression of mutant cDNAs using viral vectors often results in supraphysiologic KRAS levels, which complicates assessment of the biochemical and functional consequences. Endogenous KRAS mRNA levels remained unchanged in both low and high-expressing clones, indicating that MCF10A cells did not downregulate endogenous KRAS as compensatory mechanism (Figure 1c, right panel).  GTPase activity of KRAS mutants  To characterise the different KRAS mutants, we first measured their activity by determining KRAS-GTP levels in pulldown experiments with the RAS-binding domain of RAF1 as bait in MCF10A cells starved overnight and either left untreated or stimulated with EGF for 10 minutes. Under starved conditions, we detected no GTP-bound KRAS in MCF10A cells expressing the different KRAS variants at low levels (data not shown). Following EGF stimulation, we observed minor, non-significant effects of the different KRAS variants on activated KRAS in low-expressing clones (Figure 2a). MCF10A cells expressing WT KRAS or the mutants G12D, G13D, and A18D showed similar KRAS-GTP levels as EV-transduced cells, pointing to unchanged GTPase activity. In contrast, the exchange of glycine (G) for cysteine (C) at codons 12 and 13 and valine (V) at codon 12 increased the level of GTP-bound KRAS up to 2-fold, indicating that the identity of the replacing amino acid determines the GTPase activity of oncogenic KRAS, with aspartic acid (D) having the least effect. Unexpectedly, cells expressing the rare mutations Q61H and K117N showed the highest levels of KRAS-GTP with a 5 to 6-fold increase compared to EV-transduced cells. These results reveal variable GTP binding properties among KRAS mutants, which may confer different biological functions.  Figure 2 Figure 2 GTPase activity and signal transduction properties of KRAS mutants. Signal transduction properties of KRAS mutants  To analyse the ability of KRAS mutants to activate downstream signalling pathways, we examined the phosphorylation of EGFR, ERK, RSK, PDK1, AKT, p53, and components of the mTOR-S6K1-RPS6 axis in starved and unstarved MCF10A clones (Figure 2b). The effects of different variants expressed at near-physiologic levels were overall surprisingly modest. Compared to MCF10A-EV and MCF10A-WT cells, none of the cell lines expressing mutant KRAS at low levels showed increased phosphorylation of ERK, PDK1, and AKT under starved or unstarved conditions (Figure 2c). As expected, phosphorylated ERK and AKT were readily detectable in MCF10A clones expressing mutant KRAS at high levels (Figure S2). Activation of the mTOR signalling cascade, as determined by phosphorylation of S6K1 and RPS6, was not observed under starvation, whereas addition of EGF to the low-expressing clones or cells overexpressing mutant KRAS resulted in pronounced phosphorylation of RPS6, most prominently in the context of KRAS-G13D and K117N (Figure 2c and S2). However, given the lack of PDK1 and AKT phosphorylation, activation of RPS6 was likely not induced by the PI3K-AKT-mTOR-S6K1 cascade. Instead, MCF10A-G13D cells showed increased RSK1 phosphorylation upon EGF stimulation, suggesting RSK1 as the kinase that phosphorylates RPS6 in this genetic context. In support of this hypothesis, it has been shown previously that RSK can phosphorylate RPS6 at S235 and S236 in response to serum, growth factors, and oncogenic RAS in an mTOR-independent manner19. Since we did not observe activated RSK1 in MCF10A-K117N cells, RPS6 phosphorylation is likely mediated by other signalling proteins in these cells.  Interestingly, we observed increased expression of total and phosphorylated EGFR in response to both codon 13 mutations in MCF10A cells cultured in regular growth medium, an effect that was also evident under starved conditions in MCF10A-G13D cells (Figure 2c). Furthermore, MCF10A-G13D cells displayed strong phosphorylation of p53 at serine 15, a site that is known to be phosphorylated by ATM, suggesting induction of DNA damage response signalling by G13D-mediated replicative stress20. The effects of KRAS-G13D on EGFR and p53 were strikingly different compared to mutations of codons 12, 18, 61, and 117, and could provide a biological explanation for the favourable clinical outcome of patients with G13D-positive colorectal cancer receiving anti-EGFR therapy compared to patients with codon 12 mutations13,14. For example, it is conceivable that higher EGFR levels provide a larger contact surface for therapeutic antibodies targeting EGFR, such as cetuximab and panitumumab, and that the activated senescence program predisposes EGFRhigh cells to death triggered by EGFR blockade. In accordance with this hypothesis, we observed increased sensitivity of MCF10A-G13D cells towards the EGFR inhibitors erlotinib and gefitinib compared to MCF10A-EV, G12D and K117N cells with 2 to 3-fold reduced IC50 values (Figure S3). To investigate this hypothesis further, correlating pretherapeutic EGFR and phospho-p53 levels with outcome in patients undergoing anti-EGFR therapy will be of interest.  Effects of KRAS mutants on cell morphology  We next examined whether the introduction of mutant KRAS into MCF10A cells induces changes in cell morphology. Subconfluent MCF10A cells grow as clusters, and cells display cell protrusions and lamellipodia at the edges under normal growth conditions16. This phenotype was not altered by any of the eight different KRAS mutations expressed at near-physiological levels (Figure 3a). In contrast, high levels of KRAS-G12D and G13D resulted in marked morphological changes, as the formation of cell clusters was disrupted and the cells showed a fibroblastic and spindle-like shape lacking epithelial polarisation (Figure 3a), a phenotype that is characteristic for epithelial-mesenchymal transition21.  Figure 3 Figure 3 Cellular effects of KRAS mutants. We also investigated the influence of EGF depletion on cell morphology according to KRAS mutation status. As in MCF10A-EV and MCF10A-WT cells, EGF withdrawal in MCF10A cells expressing low levels of mutant KRAS led to rounded cell clusters that completely lacked lamellipodia, and the cells assumed a cobblestone-like morphology similar to the changes observed under confluent growth conditions (Figure S4). In contrast, EGF depletion had less or no effect on the morphology of MCF10A cells overexpressing mutant KRAS, which appeared as single elongated cells with unaffected protrusions. These observations indicate that none of the KRAS mutations studied is able to induce morphological changes in MCF10A cells when expressed at physiological levels.  Effects of KRAS mutants on survival and proliferation  It is known that the withdrawal of medium additives is detrimental for the survival and proliferation of MCF10A cells22. Our experiments indicated that overexpression of mutant KRAS is able to rescue MCF10A cells from EGF depletion, whereas cells expressing KRAS mutations at physiological levels remain reliant on EGF supplementation. To further test this, we analysed the ability of different KRAS mutants to confer EGF-independent growth to MCF10A cells. Expression of the three most common KRAS mutations (G12D, G12V, G13D) or the rare K117N allele was associated with significantly increased proliferation compared to EV or WT controls, whereas the other variants were not able to compensate for EGF withdrawal (Figure 3b, right panel). When cultured in the presence of EGF, cells expressing G13C, G13D, K117N, and, to a lesser extent, codon 12 mutations, showed reduced proliferation. This finding might suggest that constitutive KRAS activity in combination with EGF leads to excessive stimulation of signalling pathways and enhanced oncogene-induced senescence, particularly in the context of KRAS-G13D and K117N. In accordance with this assumption, we found increased senescence, as measured by β-galactosidase staining, in MCF10A-G13D and K117N cells (and to a lesser extent MCF10A-Q61H, G12C, G12D, and G13C cells) compared to MCF10A-EV and WT cells grown in EGF-containing medium (Figure S5).  Effects of KRAS mutants on anchorage-independent growth  Next, we were interested in the impact of different KRAS mutations on anchorage-independent growth, an important characteristic of transformed epithelial cells. MCF10A cells exhibit several features of normal breast epithelium, including lack of colony formation in soft agar as a measure of anchorage-independent growth22. Compared to MCF10A clones overexpressing KRAS-G12D, G12V, and G13D, which gave very high colony numbers in soft agar, physiological expression of the different KRAS variants had only a weak effect on colony formation (Figure 3c). Whereas KRAS-G12D, G13C, G13D, and A18D did not confer anchorage-independent growth, slightly increased colony numbers were observed, in descending order, with cells expressing KRAS-K117N, Q61H, G12V, and G12C. This correlates with our observation that these clones exhibit the highest levels of GTP-bound KRAS (Figure 2a).  Effects of KRAS mutants on migration  Since enhanced cell migration is required for tumour cell invasion and metastasis, we examined the motility of EGF-deprived MCF10A clones in a monolayer wound healing assay. In contrast to MCF10A cells overexpressing KRAS-G12D, G12V, or G13D, which were able to close the wound almost entirely after 24 hours, none of the KRAS mutations expressed at physiological levels conferred increased migratory abilities compared to EV or WT controls (Figure 3d and S6). Similar to cells overexpressing mutant KRAS, EV-transduced control cells reduced the wound area by nearly 80% when EGF was added (Figure 3d and S6).  Transcriptional changes induced by KRAS mutants  To better understand the differential effects of KRAS-G12D versus G13D on signalling pathways, which might provide insights into the unequal clinical response to anti-EGFR therapy associated with these genotypes13,14, we used Illumina HumanHT-12 Expression BeadChips to profile gene expression in MCF10A-EV cells and MCF10A clones expressing physiological levels of WT KRAS, KRAS-G12D, and KRAS-G13D. Unsupervised hierarchical cluster analysis based on 2,487 genes demonstrated that WT KRAS-expressing cells were more similar to MCF10A-EV cells than cells expressing KRAS mutants, which clustered separately (Figure 4a). Notably, KRAS-G12D and KRAS-G13D-expressing cells exhibited distinct gene expression profiles that clearly separated them not only from EV-transduced cells and cells expressing WT KRAS, but also from each other.  Figure 4 Figure 4 Transcriptional changes induced by KRAS mutants. Class comparison analysis of control (KRAS-WT, KRAS-EV) versus KRAS mutant (KRAS-G12D, KRAS-G13D) samples demonstrated that both mutations caused widespread changes in the transcriptome of MCF10A cells. Using a 1.3-fold cutoff and a P value of 0.05, we found 939 genes to be significantly upregulated and 650 genes to be significantly downregulated (Table S1). To explore whether the transcriptional changes induced by KRAS-G12D and G13D in MCF10A cells were related to activated RAS signalling, we performed gene set enrichment analysis (GSEA) with the top 300 upregulated genes using the C6 oncogenic signatures collection of the Broad Institute Molecular Signatures Database (MSigDB; http://www.broadinstitute.org/gsea/msigdb/index.jsp). We identified several gene signatures derived from cells in which the RAS signalling pathway was activated through different stimuli, such as activation of ERBB2, EGFR, MEK, or KRAS itself (Figure 4b), again confirming the validity of our isogenic cell line models.  We next wanted to identify genes and pathways that are differentially regulated by KRAS-G12D and G13D. Class comparison analysis identified 1,207 significantly upregulated and 1,011 significantly downregulated genes in MCF10A-G13D cells versus MCF10A-G12D cells (Table S2). GSEA of the top 300 upregulated and the top 300 downregulated genes using the C2 curated gene sets of the MSigDB identified signatures from two independent studies that determined the gene expression profiles of luminal and basal/mesenchymal breast cancer23,24, in which KRAS-G13D was associated with the basal/mesenchymal subtype and KRAS-G12D with the luminal subtype (Figure 4c). Genes that were described to be upregulated in the basal subtype23 were highly expressed in MCF10A-G13D compared to MCF10A-G12D, including several cytokeratins (KRT6A, KRT6B, KRT16, KRT17), integrins (ITGA6, ITGB4), and others such as LAMB3, LAMC2, ANXA8, and COL17A1 (Table S2). Similarly, MCF10A-G13D cells showed high expression of genes upregulated in the closely related mesenchymal subtype23, including collagens (COL8A1), proteases (CTSC, PLAU, PLAUR, SERPINE1, SERPINE2), and others such as VIM and FN1 (Table S2). Although the basal subtype of breast cancer is associated with unfavourable clinical outcome25, it has been reported that breast basal-like cell lines are more sensitive to anti-EGFR treatment than luminal cell lines in vitro26. This differential sensitivity is reminiscent of the clinical behaviour of colorectal cancers harbouring KRAS-G13D versus G12D13,14 and suggests that KRAS-G13D induces distinct transcriptional and consequently biological changes that sensitise cancer cells of various tissue origin to anti-EGFR therapy.  In a second approach, we queried the STRING database (http://string-db.org) using the top 300 genes upregulated in MCF10A-G13D versus MCF10A-G12D cells to identify mutation-specific signalling networks. Of the 300 genes, 87 were clearly connected in one large cluster, suggesting activation of a distinct biological process (Figure 4d and Table S2). A search of the 87 genes against the Gene Ontology term “Biological Process” using the DAVID bioinformatics tool (http://david.abcc.ncifcrf.gov/home.jsp) revealed several processes that are associated with cytokine-induced cell migration (Figure 4e).  The top upregulated cytokine genes in MCF10A-G13D cells were CXCL1, IL1B, and IL8 with a more than 10-fold increase in transcription compared to MCF10A-G12D cells (Table S2). Cytokines have been implicated in RAS-driven cancer previously, as activated RAS positively regulates the expression of cytokines to induce autocrine and paracrine signals that promote tumourigenesis27. For example, CXCL1 (also known as Gro-1) was transcriptionally upregulated upon RAS activation and rendered essential for survival and malignant transformation in ovarian epithelial cells28. In a murine model of Kras-G12D-driven lung adenocarcinoma, the mouse homolog of IL8 was increased in lung tissue homogenates, and treatment of these mice with an antibody targeting Cxcr2, the receptor for Il8 and Cxcl1, significantly reduced lung tumour burden29. High expression of IL8 was also identified in human lung adenocarcinomas with mutant KRAS, and was associated with poor clinical outcome30. Furthermore, increased expression and secretion of IL8 was recently shown to be essential for the induction of protease-dependent invasion and metastasis of RAS mutant melanoma cells upon BRAF inhibition31. The involved proteases were MMP1, PLAU, and PLAUR31, of which the latter two were also upregulated in MCF10A-G13D cells (Table S2). Thus, while previous investigations into the effects of mutant KRAS on cytokine signalling have primarily focused on codon 12 mutations, reflecting the substantially higher prevalence of these alleles compared to mutations affecting other codons, our gene expression data suggest that the impact of KRAS-G13D is even more pronounced. However, there may be tissue-specific differences in the effects of various KRAS mutations on cytokine signalling as well as cell-extrinsic contributions from the tumour microenvironment in mouse models and human patients that are not accounted for by our in vitro experimental system.  Analysis of the entire complement of genes significantly upregulated in MCF10A-G13D versus MCF10A-G12D cells using the Ingenuity Pathway Analysis tool (http://www.ingenuity.com) confirmed several of the above mentioned cellular processes and signalling cascades (Figure 4f). For example, ILK signalling includes integrins, which are a component of the gene signature associated with the basal subtype of breast cancer that was identified through GSEA (Figure 4c); IL8 signalling was also identified by STRING analysis (Figure 4d and e); and activated p53 signalling was identified through detection of phosphorylated p53 by western blotting (Figure 2c).  Go to: Conclusions In summary, we established isogenic cell lines that allowed characterization of eight different KRAS mutations expressed at physiological levels. Our data support the conclusion that KRAS mutations affecting different codons have distinct effects on KRAS activity, signal transduction, transcriptional programs, and transforming capacity (Table 1). The overall effects in MCF10A cells were weaker than those of KRAS variants expressed at supraphysiological levels, which allowed discrimination of biological functions related to specific mutations rather than KRAS expression level. While none of the mutations tested induced obvious morphological changes or migratory abilities, clear differences were identified in the induction of EGF-independent proliferation and anchorage-independent growth. Finally, KRAS-G13D induced EGFR expression, senescence, and a distinct pattern of transcriptional changes that may help explain the improved response of patients with G13D-positive cancers to anti-EGFR therapies.  The three-dimensional structure of the complex between human H-Ras bound to  guanosine diphosphate and the guanosine triphosphatase (GTPase)-activating domain  of the human GTPase-activating protein p1 20GAP (GAP-334) in the presence of aluminum  fluoride was solved at a resolution of 2.5 angstroms. The structure shows the partly  hydrophilic and partly hydrophobic nature of the communication between the two mol-  ecules, which explains the sensitivity of the interaction toward both salts and lipids. An  arginine side chain (arginine-789) of GAP-334 is supplied into the active site of Ras to  neutralize developing charges in the transition state. The switch 11 region of Ras is  stabilized by GAP-334, thus allowing glutamine-61 of Ras, mutation of which activates  the oncogenic potential, to participate in catalysis. The structural arrangement in the  active site is consistent with a mostly associative mechanism of phosphoryl transfer and  provides an explanation for the activation of Ras by glycine-12 and glutamine-61 mu-  tations. Glycine-1 2 in the transition state mimic is within van der Waals distance of both  arginine-789 of GAP-334 and glutamine-61 of Ras, and even its mutation to alanine  would disturb the arrangements of residues in the transition state.  The Ras proteins H-, K-, and N-Ras are  central regulators of cellular signal transduc-  tion processes leading to cell growth and  differentiation. They are molecular switches  that in the resting cell are in the guanosine  diphosphate (GDP)-bound inactive state.  In response to receptor protein tyrosine ki-  nases or other growth factor-dependent  stimuli, these Ras proteins become activated  by binding guanosine triphosphate (GTP).  In the GTP-bound active state, they interact  with and activate downstream targets. GTP  hydrolysis mediated by Ras completes the  GTPase cycle (1).  The conformational state of Ras is reg-  ulated by two kinds of proteins, guanine  nucleotide exchange factors (GEFs) and  GTPase-activating proteins (GAPs) (2).  GEFs such as Sos or Cdc25 increase the  dissociation rate of guanine nucleotides, al-  K. Scheffzek, M. R. Ahmadian, L. Wiesmuller, A. Lau-  twein, F. Schmitz, and A. Wittinghofer are at the Max-  Planck-Institut for molekulare Physiologie, Abteilung  Strukturelle Biologie, Rheinlanddamm 201, 44139 Dort-  mund, Germany. W. Kabsch is at the Max-Planck-Institut  fOr medizinische Forschung, Jahnstrasse 29, 69120 Hei-  delberg, Germany.  *Present address: Heinrich Pette Institut for experimen-  telle Virologie und Immunologie an der Universitat Ham-  burg, Martinistrasse 52, 20251 Hamburg, Germany.  tPresent address: Chester Beatty Laboratories, Fulham  Road, London SW3 6JB, England.  tTo whom correspondence should be addressed. E-mail:  Alfred.Wittinghofer@mpi-dortmund.mpg.de  lowing GTP, which is more prevalent in the  cell, to bind Ras. GAPs inactivate Ras by  accelerating the slow intrinsic rate of GTP  hydrolysis by several orders of magnitude.  Five mammalian GAPs for Ras have been  described (2), including pI20GAP, the pro-  totype for this class of proteins (3), and  neurofibromin, the product of the type I  neurofibromatosis (NF1) gene (4, 5).  Oncogenic mutants of Ras are found in  about 25 to 30% of human tumors. They  have an impaired intrinsic GTPase and are  insensitive to GAPs, and thus are unable to  switch off the transmitted signal. Because of  the action of the negative regulator GAP,  wild-type Ras is found in the inactive GDP-  bound state in unstimulated cells, whereas  oncogenic Ras remains GTP-bound (1).  The mechanism by which GAPs acceler-  ate the GTPase reaction has been a matter  of debate (6, 7). In one model, Ras itself is  an efficient GTPase, and GAP induces the  attainment of a GTPase-competent con-  formation indirectly by catalyzing a rate-  limiting isomerization reaction. Conflicting  evidence for such an isomerization reaction  catalyzed by GAP has been presented (8). In  another model, the actual chemical cleavage  step is modified by GAP directly, most likely  by GAP supplying residues for GTP hydro-  lysis on Ras and thereby stabilizing the tran-  sition state of the reaction. In support of  this, RasGAPs (Ras-specific GAPs) have  been found to stabilize binding of aluminum  fluoride to RasGDP (9), forming a temary  complex that is believed to mimic the tran-  sition state of the GTPase reaction (10).  Stoichiometric amounts of GAP are needed  for this effect (9).  The catalytic fragment of p120GAP,  termed GAP-334, is a purely helical mole-  cule consisting of two domains, the larger of  which contains all residues conserved  among RasGAPs. On the basis of much  biochemical and genetic data, a model was  proposed of how Ras might interact with  GAP-334 (11). We now have solved the  crystal structure of the complex between  GAP-334 and RasGDP in the presence of  aluminum fluoride.  Structure of the RasRasGAP complex.  Crystals were obtained from solutions of  RasGDP and GAP-334 mixed with alumi-  num fluoride (12). We determined the  structure by the molecular replacement  Fig. 1. Stereo view of a segment of the 2Fo - Fc electron density map (contoured at 1 .2ou) covering the  active site region in the complex, with Ras in blue, GAP-334 in red, and waters in light blue.  www.sciencemag.org * SCIENCE * VOL. 277 * 18 JULY 1997 333 This content downloaded from 140.163.0.5 on Sun, 28 May 2017 23:37:08 UTC All use subject to http://about.jstor.org/terms  B  : P,-LeSop 1_  a3 ~ 88 De 25 IswII Ras  SW it \"t1G 11D  _ _ 0 45,,, /Z w > :N I~~~~VQA  S-2 1~~~~~~~~~~0  11 _ ll (<jSl~~~~~~~~ I _ = >m 1 1~~~~~~~~~~~~~5  Fig. 2. The complex between GAP-334 and Ras. (A) Ribbon representation  of the complex model drawn with Molscript (52) and Raster3D (53) according  to the assignment of secondary structure elements obtained with the pro-  gram DSSP (54). The extra and catalytic domains of GAP-334 are shown in  green and red (respectively), regions of GAP contacting Ras in light brown,  Ras in yellow, and GDP and AIF3 as ball-and-stick models. Regions involved  in the interface are labeled, Sw I and Sw 11 indicating the switch regions, C the  COOH-terminal, and N the NH2-terminal. (B) Schematic drawing with select-  ed interactions. Polar interactions between individual residues of GAP-334  and Ras are shown as red lines for interactions of side chains, and as red  arrows for contacts from side chain to main chain atoms, where the arrow-  head marks the residue contributing the main chain group. Yellow lines indi-  cate van der Waals or hydrophobic interactions. Some water molecules  (marked W) from the interface region are included. Residues belonging to the  interacting regions of Ras indicated in (A) are denoted with specified boxes, as  indicated. Interaction between Lys88 and Thr791 is shown by a dashed arrow,  because the electron density in this region is presently not of sufficient quality  to unambiguously define the contact. Amino acid abbreviations are in (55).  method using the coordinates of GAP-334  (11) and Ras (13) as search models. Both  rotation and translation functions, calculat-  ed with the program X-PLOR (14), showed  unique peaks for the GAP-334 and Ras  models. The electron density map based on  the phases derived from the GAP model  after rigid body refinement showed clear  density for the Ras molecule that was sub-  sequently adjusted manually in the map.  Rigid body and initial Powell minimization  resulted in an electron density map that  showed a strong peak for the bound nucle-  otide that was incorporated as GDP into  the complex model. After rebuilding of res-  idues 46 to 54 and 61 to 66 in Ras and of  residues 830 to 839 and 947 to 952 in  GAP-334, another round of positional re-  finement was done, yielding an R factor of  32% (Rfree = 37%). Local errors were cor-  rected by subsequent rounds of alternate  model building and positional and temper-  ature factor refinement, along with simulat-  ed annealing, including bulk solvent correc-  tion; water molecules were added in Fo - Fc  maps [programs 0 (15) and X-PLOR 3.8  (14)]. A maximum of electron density in  the position usually occupied by the ry-  phosphate present in all maps during refine-  ment was interpreted as aluminum fluoride.  From the outline in Fo - Fc maps it ap-  peared to be a trigonal AIF3 moiety rather  than a tetragonal AIF4-, as observed in the  structures of activated (x subunits of the  heterotrimeric guanine nucleotide-binding  proteins Gotil and Gott (10). Residues 981  to 990 are ill-defined in the electron density  and were modeled stereochemically. Our  model comprises residues 718 to 1037 of  GAP-334, residues 1 to 166 of H-Ras, GDP,  AIF3, Mg2+, and 35 water molecules. The  refinement is summarized in Table 1, and a  representative part of the electron density  map is shown in Fig. 1.  A ribbon representation and a schematic  drawing of the complex are shown in Fig. 2.  Table 1. Summary of crystallographic analysis.  Data collection  Resolution limit (A) 2.4  Total reflections (N) 35,339  Unique reflections (N) 15,811  Completeness (%) 81  Rsym (%)* 6.6  Search model  GAP-334(718-1042) H-Ras(1-1 66)  Molecular replacement  Resolution range (A) 15 to 4 15 to 4  01' 02' 03 rotationt (degrees) 18.6, 36.8, 256 31.6, 89.8, 250.2  x, y, z translationt 0.059, 0.0, 0.273 0.36, 0.0, 0.49  Refinement  Resolution (A) 30 to 2.5  Number of unique reflections 15,548  Rcryst (%)? 23.3  Rfree (%)11 32.3  rmsd bond length (A) 0.007  rmsd bond angles (degrees) 1.27  *Rsym = I|lhi - Ih|lllhi, where Ih; is the scaled intensity of the ith symmetry-related observation of reflection h and Ih is  the mean value. tEulerian angles Q1 02, 03, as defined in X-PLOR. tFractional coordinates x, y, z as obtained  by X-PLOR. = EhIF,h - EChI /h F where F and F are the observed and calculated structure factor  amplitudes for reflection h. IlValue of Rcryst for 10% randomly chosen reflections not included in the refinement.  334 SCIENCE * VOL. 277 * 18 JULY 1997 * www.sciencemag.org This content downloaded from 140.163.0.5 on Sun, 28 May 2017 23:37:08 UTC All use subject to http://about.jstor.org/terms  RESEARCH ARTICLES  The overall structures of GAP-334 and Ras  are similar to those of the isolated mole-  cules. The most significant differences are  seen in the switch II region of Ras and the  loop L6C of GAP-334. The values for the  root-mean-square deviation (rmsd) for su-  perimposition of corresponding Cax atoms  are 0.9 A for GAP-334 and 0.54 A for Ras,  using free GAP-334 (11) and Ras GppNHp  (13) for the comparison. The orientation of  the two proteins in the complex structure is  similar to that of our earlier docking model  [figure 4 in (11)]. Activated Ras binds in  the shallow groove of the central catalytic  domain GAPC of GAP-334, with the tip of  its triangular shape penetrating most deeply  into the groove. A large amount of solvent-  accessible surface area (3145 A2) becomes  buried in the interface during complex for-  mation (16). Consistent with numerous  mutational studies, residues of the phos-  phate-binding (P-) loop (residues 10 to 16),  switch regions I (30 to 37) and 11 (60 to 76),  and possibly helix (x3 (87 to 98) on Ras  (Fig. 2) participate in the interaction (17-  19). The switch regions of Ras have been  defined as the regions that change their  structure upon transition from the GTP- to  the GDP-bound state (20). On the GAP  side, helices x6c and x7c and loops Llc and  L6C are involved in the interaction with Ras  (Figs. 2 and 3). We call L1c the finger loop  because it points into the active site and  L6C the variable loop because its length is  variable in the structure-based alignment  (Fig. 3, see below). In contrast to the com-  plex of the Ras-related RaplAGppNHp  with the Ras-binding domain of the protein  kinase Raf, which shows many strong polar  hydrogen bonds and salt bridges between  the two proteins (21), the interface of the  RasRasGAP complex consists of weak van  der Waals interactions and a number of  polar interactions also involving several wa-  ter molecules. Because the affinity between  GAP-334 and RasGTP (5 ,uM) decreases  strongly with increasing salt concentration,  polar interactions appear to predominate in  the affinity of GAP-334 for Ras (22). The  structure suggests that the extra domain of  GAP-334, GAPex, is dispensable for Ras-  RasGAP interaction, consistent with studies  on neurofibromin that showed that a 230-  residue fragment corresponding to the cata-  lytic domain of GAP-334 (red/brown in Fig.  2A) is sufficient for GTPase activation (23).  Contact with the switch regions of Ras.  Switch I overlaps with the Ras effector  region (24). It interacts predominantly with  the central helices cx6c and x7c and with  the variable loop. Hydrophobic interactions  are formed by the invariant Leu902 and  Llc L2C  + 0+  764 KLESLLLCTLNDR EISMEDEATTLFRATTLASTLMEQYMK ATATQFVHHALKDSILKIMESKQS .... CELSPSKLEK.. hspl 20GAP  1251 HLLYQLLWNMFSK EVELADSMQTLFRGNSLASKIMTFCFK VYGATYLQKLLDPLLRIVITSSDWQHVSFEVDPTRLEPSE hsNF1  371 NKLVPFITAVADL DLKDTQDANAIFRGNSLATQCLTEMMK IVGGHYLKVTLKPVLDEICESSKS .... CEIDPVKLKE.. rnGAP1 m  163 NLAKEFLCDLIMK EVEKLDNDHLMFRGNTLATKAMESFMK LVADDYLDSTLSDFIKTVLQCEDS .... CEVDPQKLGNVS ceGAP  520 ERIAPIIKALADH EISHLTDPTTIFRGNTLVSKMMDEAMR LSGLHYLHQTLRPVLSQIVAEKKP.... CEIDPSKIKD.. dmGAP1  1571 NASHILVTELLKQ EIKRAARSDDILRRNSCATRALSLYTR SRGNKYLIKTLRPVLQGIVDNKES .... FEIDKMKPGS.. sciRAl  1717 NATHIVVAQLIKN EIEKSSRPTDILRRNSCATRSLSMLAR SKGNEYLIRTLQPLLKKIIQNRDF.... FEIEKLKPED.. scRA2  Block 1 A  - ~~~~~~~L3, L4, O  ____________________++ +  838 NEDVNTNLTHLLNILS ELVEKIFMASEILPPTLRYIYGCLQKSVQHKWPTNTTM RTR VVSGFVFLRLICPAILNPRMFN  1331 SLE. . ENQRNLLQMTE KFFHAIISSSSEFPPQLRSVCHCLYQVVSQRFPQNSIG ... AVGSAMFLRFINPAIVSPYEAG  GDNVESNKENLYYYVD KVFSAIVGSSVSCPTVMCDI FYSLRQMAAKRFPNNPHV QYS AVSSFVFLRFFAVAILSPHAFH  NSSLEKNRALLMRYVE VAWTKILNNVHQLPKNLRDVFSALRCRLEAQ. . NREAL ADT LISSSIFLRFLCPAILSPSLFN  RSAVDTNLHNLQDYVE RVFEAITKSADRCPKVLCQI FHDLRECAGEHFPSNREV RYS VVSGFIFLRFFAPAILGPKLFD  ENS. EKMLDLFEKYMT RLIDAITSSIDDFPIELVDICKTIYNAASVNFPEYAYI ... AVGSFVFLRFIGPALVSPDSEN  SDA. ERQIELFVKYMN ELLESISNSVSYFPPPLFYICQNIYKVACEKFPDHAII ... AAGSFVFLRFFCPALVSPDSEN  Block 2 A A Block 3A  L5 ~~~~~~~L6C: Variable loop  917 IIS DSPSPIAA RTLILVAKSVQNLAN ..LVEFGA ..... EPYMEGVNP ..FIKSNKHRMIM.FLDELGNVPELP 981  1405 ILD KKPPPRIE RGLKLMSKILQSIAN ..HVLFT .. !...... EEHMRPFND..FVKSNFDAARRFFLDIASDCPTSD 1469  LRP HYPDTQTV RTLTLISKTIQIIGN WGCQSRRKSRF .... KKSVMCEFLKM. FQEERYFTDVKKFLDEISSTETKE  LVS EYPSPTNA RNLTLIAKTLQNLAN ..FSKFGG ........ EPHMEFMNE ..FVDREWHRMKD.FLLRISSESKSG  LTT ERLDAQTS RTLTLISKTIQSLGN .LVSSRSSQQTC ... KEEFTVELYKK. FCTEQHVDAVKHFLEVISTPSHAS  III VTHAHD.R KPFITLAKVIQSLAN GRENIFKKDI .LVS. EEFLKTCSDKIFN .... FL...... SELCKIPTNN  IID ISHLSE.K RTFISLAKVIQNIAN GSEN.FSRWPALCSQKDFLKECS. DRIFR .......... FLAELCR.TDRT  Block 3B A  Fig. 3. Sequence alignment of the catalytic domain of RasGAPs from the indicated organisms, together  with secondary structure assignment according to the program DSSP (54). hs, Homo sapiens; rn,  Rattus norvegicus; ce, Caenorhabditis elegans; dm, Drosophila melanogaster; sc, Saccharomyces  cerevisiae; IRAl and IRA2 are yeast homologs of RasGAPs. Residues participating in catalysis are  marked as closed circles, residues involved in Ras-RasGAP interaction as crosses, and residues that  have been found mutated in neurofibromin from patients with type I neurofibromatosis and solid tumors  as closed triangles. Amino acid abbreviations are in (55).  Leu910 on cx6 of GAP and by Pro34, Jle36,  Tyr32, and Tyr64 of Ras (Figs. 2 and 4A).  These interactions are presumably the tar-  get of inhibitory lipids such as phosphatidic  acid and arachidonic acid (25, 26), the  latter of which inhibits the Ras-RasGAP  interaction in a partly competitive mode  with respect to RasGTP (27). The partly  hydrophobic nature of the interface might  also explain the finding that the oncogenic  mutation Gln61->Leu in Ras, although un-  able to hydrolyze GTP efficiently, has a  higher affinity than the wild type for either  GAP-334 or neurofibromin (26, 28-30),  and explain why apparently small perturba-  tions such as the mutation Leu902 ->Ile  strongly inhibit catalysis (29, 30).  Switch I contains five acidic residues,  Asp30, Glu31, Asp33, Glu37, and Asp38, that  create a negatively charged surface patch  used for interaction with effectors (21) and  with GAP-334 (Figs. 2 and 4, A and B).  Lysine-949, located on the tip of a conspic-  uously exposed part of loop L6c, points into  the highly negatively charged surface patch.  Whereas the side chains of Asp30, Glu31,  and Glu37 are not directly involved in the  interaction, Asp33 and Asp38 are oriented  toward Lys949, with only Asp33 making a  direct contact and Asp38 and Thr35 making  water-mediated polar contacts, which is  mostly consistent with mutational studies  (17, 26, 31).  From the invariant residues on helix  a7c, only Asn942 directly contacts Ras. It  forms a hydrogen bond with Asp33 of Ras,  and its own orientation is stabilized by the  carbonamide group of Gln938 (Figs. 2B and  4B). Lysine-935 forms an intramolecular  salt bridge with Glu950 in loop L6C, whose  carboxylate group also contacts the main  chain amide group of Ser39 of Ras (Fig. 4B).  Lysine-1423 in neurofibromin (Lys935 in  p120GAP) is mutated to Glu or Gln in neu-  rofibromas and solid tumors (32), and it is  thought to be important for catalysis be-  cause GAP activity is reduced in such mu-  tants, with conflicting results on its affinity  for Ras (32, 33). On the basis of the in-  tramolecular salt bridge between Lys935 and  Glu950, it appears unlikely that Lys935 is  directly involved in catalysis or binding.  One would postulate instead that most of its  mutations should destabilize the protein,  consistent with experimental findings on  the Lys1423->Met mutation in neurofibro-  min (34).  Two consecutive residues in loop L6C,  Lys949 and Glu950, form a bifurcated clamp  that fixes helix x7c and the effector loop of  Ras, and these residues appear to be of  crucial importance for complex formation  with Ras (Fig. 4B). We are proposing a  structure-based alignment (Fig. 3) where  the KB-motif (K is Lys and B is Glu) is  www.sciencemag.org * SCIENCE * VOL. 277 * 18 JULY 1997 335 This content downloaded from 140.163.0.5 on Sun, 28 May 2017 23:37:08 UTC All use subject to http://about.jstor.org/terms  Fig. 4. Details of the interac-  tion of Ras with GAP-334.  (A) Residues 32 to 39 from  the effector region of Ras,  with side chains shown as  ball-and-stick models (in  yellow), contact GAP-334  (ribbon colored red and light  brown as in Fig. 2A) in the  vicinity of helices a6c and  a7c. Selected side chains of  GAP-334 are shown as  ball-and-stick models with  Arg789 and Lys949 penetrat-  ing into the effector region  from opposite sides, similar  to the view in Fig. 1. Water  molecules are light brown  spheres. (B) Interaction of  helix Ha7c and the variable  loop including the KE-motif  of GAP-334 with part of the effector region in Ras, with water molecules in orange.  (C) Close approach of the finger loop of GAP-334 to loops Li (P-loop) and L4 of  Ras. In position 12 of Ras, normally glycine, an alanine side chain has been  introduced (gray) into the model to show that even small substitutions would be  within van der Waals distance (gray sphere) to Gln61 (NH2, blue sphere) and Arg789  (CO, red sphere). Glycine-1 3 is more remote from GAP-334.  situated in a loop of variable length (hence  the designation \"variable loop\") with al-  most complete conservation of this motif  and other residues. Point mutations in this  loop have consistently been identified as  mutants with increased affinity for Ras (33,  35) or as intragenic suppressors of Lys1423  mutations in genetic screens of neurofibro-  min: In one such mutation, Phe'434 close to  the KE-motif was mutated to Leu, and in  the other, Lys'436 of the KE-motif itself was  replaced by Arg (35).  Switch II comprises loop L4 and helix  (x2 in Ras. In contrast to the structures of  isolated Ras where L4 appears highly mo-  bile (13, 20, 36), this region is well defined  in the complex with GAP-334. Residues 61  to 63 are arranged in a short 310 helix  preceding ox2. Tyrosine-64 participates in  the formation of the hydrophobic interface  between Ras and GAP-334 and forms a  polar contact with the main chain carbonyl  group of Leu902, consistent with the obser-  vation that it can be mutated to Phe but  not to Glu without affecting Ras-RasGAP  interaction (17). Interactions between  Glu62 and Arg749 or between Glu63 and  Arg903 may contribute to the stabilization  of switch II. Glutamine-61 is essential for  GTP hydrolysis: Its mutation to any other  amino acid (except Glu) blocks Ras-medi-  ated GTP hydrolysis (18, 19, 26, 37, 38)  and leads to tumor formation. In Got pro-  teins in the GDP-AIF4- conformation, the  Gln61 homolog stabilizes the transition  state of the GTPase reaction (10), and a  similar role was suggested for Gln61 of Ras  (39). In the complex with GAP-334, Gln61  points toward the phosphate chain of the  nucleotide and is stabilized in its orienta-  tion by a hydrogen bond with the main  chain carbonyl group of the invariant  Arg789. The temperature factor distribution  shows a local minimum for the L4 region  (40), suggesting that binding of GAP to Ras  results in stabilization of switch II.  Structural basis for oncogenicity of  Gly12 mutants. Glycine-12 of the P-loop is  critical for oncogenic activation of Ras be-  cause any mutation of this residue [except  Gly'2-> Pro (G12P)] activates the oncogen-  ic potential of Ras (41). Ras(G12P), al-  though insensitive to GAP, does not have  transforming abilities, presumably because  its intrinsic rate of GTP hydrolysis is slight-  ly increased (6, 22, 42). No consistent ex-  planation has so far been put forward to  explain the defect in both the intrinsic and  GAP-accelerated GTP hydrolysis of Gly12  mutants, although some have more obvious  rearrangements of the active site (28, 43).  In the structure of the complex, Gly12 con-  tacts the loop L1c region of GAP-334. The  main chains approach each other, the clos-  est encounter being a van der Waals con-  tact between the Cot atom of Gly12 and the  main chain CO of Arg789 (Fig. 4C). This  mode of interaction imposes constraints on  the space that may be filled by amino acids  in position 12 of Ras and provides an ex-  planation for the block in GAP-accelerated  GTP hydrolysis. Although the interaction  with GAP has not been investigated for all  Gly12 mutants, it appears from the structure  that even replacement with alanine would  be highly unfavorable, leading to steric  clashes with the main chain of Arg789 and  with the side chain NH2 of Gln61 (31).  Glycine-12 mutants of Ras bind to GAP  with an affinity similar to that of the wild  type (38) without subsequent GTP hydro-  lysis. This suggests that the close neighbor-  hood of Arg789 and Gly12 is not as crucial  for the Ras-GTP-GAP ground state as for  the transition state.  The active site and catalytic mecha-  nism. GDP is bound in a mode similar to  that observed in isolated Ras GDP or  Ras-GppNHp complexes, with Mg2+  present in the expected position (13, 20).  336 SCIENCE * VOL. 277 * 18 JULY 1997 * www.sciencemag.org This content downloaded from 140.163.0.5 on Sun, 28 May 2017 23:37:08 UTC All use subject to http://about.jstor.org/terms  RESEARCH ARTICLES  Fig. 5. Structural (A)  * and schematic (B) view  of the active site, with  the important elements  of catalysis. (C) Super-  position of the active  site of Ga1 'GDP'AIFj  (10) (green) and the  Ras'GDP'AIF3'GAP-334  (light brown/red) com-  plexes (aligned by the G  domains).  B RAS--  2O' . 3 22 7 22  Om 2.1 .  S_r i7 Thr 36 i  The 3'-OH group of the ribose that is ex-  posed in isolated Ras is hydrogen bonded to  the hydroxyl group of Thr785. Aluminum  fluoride, modeled as AlF3, appears to be in  an orientation such that the fluoride ligands  contact Mg2+, Thr35 (NH), Lys16 (NH3+),  Gln6 (NH2), and most significantly for the  catalytic mechanism, the positively charged  guanidinium group of Arg789 (Fig. 5, A and  B). This residue in loop L1C is the postulat-  ed arginine finger (hence the designation  \"finger loop\"), which participates in catal-  ysis, consistent with mutational analysis  (31). It points into the active site, is addi-  tionally stabilized by interaction with  Thr785 (CO) (Fig. 5A), and communicates  with Lys949 of the KE-motif through two  water molecules, one of which contacts the  main chain carbonyl group of Glu3 . The  main chain CO of Arg789 forms a hydrogen  bond with the amide group of the Gln61  side chain. As in uncomplexed GAP-334,  the conformation of the finger loop appears  to be stabilized by the interaction of Arg903  with the main chain carbonyl oxygens of  Phe788, Arg789, and Ala790. Arginine-903,  from the most highly conserved FLR finger-  print regions of RasGAPs (901FLR903 in  pl20GAP), was found to be important for  catalysis (29); however, its conservative re-  placement by Lys results in only a small  reduction of GAP activity (30, 31). This  observation together with the structure sug-  gests an indirect role of Arg903 in catalysis,  whereby it stabilizes the position of the  crucial arginine.  In the structures of activated Gc-i and  Ga-t and of myosin, the putative transition  state mimics were identified as GDP-AlF4-  and adenosine diphosphate (ADP)-AIF4-,  respectively (10, 44). This difference is not  understood and may be clarified if higher  resolution data become available. AIF3 has  also been found in the transition-state mim-  ics of nucleoside di- and monophosphate  kinase structures (45), reflecting the ability  of aluminum fluoride to form trigonal-bipy-  ramidal complexes (46).  During phosphoryl transfer reactions, a  partial negative charge develops. If this is  on the -y-phosphate, the reaction is associa-  tive and goes through a pentavalent phos-  phorous intermediate. If the charge is on  the leaving group, which in the hydrolysis  of GTP is the P,y-bridging oxygen atom,  the mechanism is dissociative and shows a  metaphosphate-like transition state (7).  Proteins such as GAP could stabilize the  transition state by neutralizing these devel-  oping charges and thus catalyze the chem-  ical reaction. The intrinsic GTPase reac-  tion of Ras proceeds by means of substrate-  assisted catalysis in which the substrate  GTP itself acts as the general (or specific)  base (6), which would only be favorable in  the case of an associative mechanism (7).  The structure suggests a polar interaction  between the charged guanidinium group of  Arg789 and a fluoride ligand of aluminum  (Fig. 5, A and B). Because Al-F and P-O  bond lengths are very similar (46), and be-  cause an AIF3 trigonal base mimics the tri-  gonal base of the transferred phosphoryl  group, we assume that the observed geometry  in the active site is a close mimic of that of  the transition state (or intermediate) of the  GTPase reaction. We can identify one axial  ligand of the pentavalent aluminum as the  oxygen of the GDP leaving group, the sec-  ond being derived from the attacking nu-  cleophilic water. This water molecule  matches the site of Wat'75 found in the GTP  conformation of Ras (13) and is located  within hydrogen-bonding distance to the  carbonyl group of the Gln61 side and the  Thr35 main chains. On the basis of the ar-  guments put forward earlier (7) that residues  that neutralize charges on the -y-phosphate  would act anticatalytically in a dissociative  mechanism, and because Arg789 has its  strongest interaction with the fluoride ion  and a weaker one with the leaving group, the  arrangement of active site residues presently  seen would support a mostly associative  mechanism in the GTPase reaction.  The second major factor in the acceler-  ation of the Ras-GTPase reaction by GAP  appears to arise from the stabilization of the  switch II region, as postulated before (6,  10). It has been shown both by the crystal-  lographic analysis of Ras in the di- and  triphosphate form and by nuclear magnetic  resonance spectroscopy that the region  around loop L4 containing Gln61 is very  mobile with respect to the rest of the mol-  ecule (13, 20, 36). Glutamine-61 is invari-  ant in Ras-like GTP-binding proteins ex-  cept Rap. In the Ras-GAP-334 structure,  Gln61 contacts one of the fluoride ions and  the axial ligand derived from the nucleo-  philic water molecule, thereby contributing  to the stability of the transition state. It  gives an explanation why mutants of Gln61  have reduced GTPase activity and are on-  cogenic (18, 19, 26, 37, 38).  Comparison with Ga proteins. Com-  pared with Ras and other small GTP-  binding proteins, the a( subunits of hetero-  trimeric G proteins contain an extra helical  domain as an insertion into the G domain,  the topological domain responsible for the  biochemical properties of GTP-binding  proteins. The helical domain positions an  invariant arginine that appears to be criti-  cal for the GTPase reaction because its  www.sciencemag.org * SCIENCE * VOL. 277 * 18 JULY 1997 337 This content downloaded from 140.163.0.5 on Sun, 28 May 2017 23:37:08 UTC All use subject to http://about.jstor.org/terms  modification by cholera toxin reduces  the GTPase activity of Gas (47) and be-  cause its mutation in Gas or Gai renders  the proteins oncogenic (48). In the  Gr GDPAlF4j complex of both transdu-  cin and Gci1, this arginine contacts the  fluorides of AIF4J as well as the [3,ty-bridg-  ing oxygen and is thus involved in sta-  bilization of the transition state (10). From  the superimposition of the 0 domains of  RasGAP-334 and of Ga1 the transition  state mimics for the two GTPases look very  similar (Fig. 5C). The guanindinium groups  of the respective arginines are in a similar  position, although they point into the ac-  tive site from different directions. In Got,  the arginine, located in the linker connect-  ing the helical and the 0 domain, is sup-  plied in cis from the same molecule, where-  as in the RasRasGAP system it is supplied  in trans by RasGAP. The corresponding  glutamine residues are also in close proxim-  ity, confirming a similar role for these con-  served residues in the stabilization of the  transition state and their involvement in  oncogene formation (37, 48) .  Recently GAPs for GOL proteins, called  RGS (for regulator of 0 protein signaling),  have been described that increase the  GTPase' reaction rate and that have no  sequence homology to RasGAPs or other  GAPs for Ras-like proteins (49). Although  the maximal rate of GTP hydrolysis has not  been reported, it is estimated to be on the  same order of magnitude as the maximally  stimulated GTPase on Ras. Some RGS pro-  teins bind with higher affinity to the  GDP AlF4- complex of -Go proteins than  .to the guanosine 5'-O- (3 '-thiotriphos-  phate ) ( GTP-ty -S )-bound state, which in-  dicates that they act by stabilizing the tran-  sition state (50). The recent structure de-  termination of a complex of RGS4 with  Go11lGDPA1F4- (51 ) shows that RGS is a  purely helical protein that contacts the  switch residues of Gxi1, similar to RasGAP  contacting and stabilizing the switch re-  gions of Ras.  Ras-mediated GTP hydrolysis accelerat-  ed by RasGAP is required for physiological  control of a number of important signal  transduction processes. Indeed, oncogenic  mutants of Ras escape regulation by Ras-  GAP. The model of the Ras GDP AIF;  GAP-334 complex shows that GAP cata-  lyzes the GTPase reaction by stabilizing the  switch II region and by supplying a catalytic  residue. In addition, it provides an explana-  tion why mutations in both Gly12 and  GIn61 activate the transforming potential of  Ras: Both are in van der Waals distance  from each other and from GAP in the  .. .. ... .. .. . ... . ... .  of the communication between Ras and  transition state mimic. The structural view  GAP-334 may aid in the design of small  molecules with the capacity to induce GTP  hydrolysis on mutant oncogenic forms of  Ras found in human tumors. Together with  the biochemical data, it shows that for sig-  nal transduction to function properly, na-  ture has designed Ras to be an inefficient  GTPase, which can be induced to be an  efficient switch-off enzyme in the presence  of another signal transduction molecule The realization in the late 1970s that RAS harboured transforming properties that were bestowed by gain-of-function mutations shaped our view of the molecular biology of cancer. These studies spearheaded the discovery of many more genes the functions of which were altered in tumours, and gave rise to the concept that the progressive transition from a normal to a malignant phenotype reflects the successive accumulation of genetic alterations that each confer a unique capability that cancer cells need to acquire in order to evade homeostatic barriers. These capabilities, which more than a decade ago were dubbed by Hanahan and Weinberg as the hallmarks of cancer, encompass self-sufficiency in growth signals, insensitivity to growth-inhibitory signals, evasion of programmed cell death, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis1. To accommodate the emergence of additional cancer-associated pathologies this list has been increased to include additional hallmarks such as metabolic fitness and genomic plasticity2. Within this paradigm, the transforming function of oncogenic RAS has been initially attributed to its capacity to endow cells with sufficiency in growth signals. As our understanding of the tumorigenic process and its underlying mechanisms is evolving, it is becoming clear that the net cast by oncogenic RAS is much wider and captures many of the original, as well as some of the newly established, hallmarks of cancer. This Review discusses the ensemble of oncogenic RAS functions that fuel the tumorigenic process.  Oncogenic activation — themes and variations  In humans, three RAS genes encode four distinct but highly homologous ~21 kDa RAS proteins: HRAS, NRAS, KRAS4A and KRAS4B (KRAS4A and KRAS4B are alternative splice variants of the KRAS gene). Serving as transducers that couple cell surface receptors to intracellular effector pathways, RAS proteins cycle between 'on' and 'off' conformations that are conferred by the binding of GTP and GDP, respectively. Under physiological conditions, the transition between these two states is regulated by guanine nucleotide exchange factors (GEFs), which promote the activation of RAS proteins by stimulating GDP for GTP exchange, and by GTPase-activating proteins (GAPs), which accelerate RAS-mediated GTP hydrolysis. This inactivation of RAS activity by GAPs is the predominant target of the most common somatic mutations that are found in the oncogenic variants of RAS alleles. Accordingly, oncogenic mutations of Q61 impair the GTP hydrolysis reaction by interfering with the coordination of a water molecule that is required for the nucleophilic attack on the γ-phosphate3, 4. Similarly, oncogenic substitutions in residues G12 and G13 prevent the formation of van der Waals bonds between RAS and the GAP through steric hindrance and so perturb the proper orientation of the catalytic glutamine (Q61) in RAS, which results in the pronounced attenuation of GTP hydrolysis5. The outcome of these substitutions is the persistence of the GTP-bound state of RAS and, as a consequence, the incessant activation of a multitude of RAS-dependent downstream effector pathways.  Although not all RAS mutants are created equal, the extent to which specific mutations affect the biological behaviour of RAS remains to be established (Fig. 1). Studies carried out in patients with leukaemia and bladder cancers failed to identify a correlation between the occurrence of specific RAS mutations and the aggressiveness of the disease, suggesting that the different RAS mutations may lead to a common pathophysiologicalend point6, 7. Likewise, differences in the range of KRAS mutations observed in human tumours of the gastrointestinal tract seemingly reflect variations in the aetiology of RAS mutations as opposed to specific mutation-dependent disease characteristics8, 9, 10. By contrast, in colorectal and lung cancers, KRASG12V mutations have been associated with a worse prognosis than KRASG12D mutations, raising the possibility that particular amino acid substitutions might dictate specific transforming characteristics of oncogenic RAS alleles11, 12. In support of this idea, HRASG12V exhibits weaker GTPase activity and stronger binding to GTP than HRASG12D (Refs 13,14), and it is also more potent in cell culture-based transformation assays15. A new perspective on the issue of the contributions of particular amino acid substitutions to the in vivo transforming capabilities of RAS has been added by recent findings that have documented previously uncharacterized RAS mutations in colorectal tumours and leukaemias16, 17. In addition, certain RAS mutations may be associated with an altered response to therapy18. It thus seems that much remains to be learned about the link between sequence permutations and functional alterations of oncogenic forms of RAS.  Figure 1 | Frequency of mutations at G12, G13 and Q61 in RAS isoforms.  Figure 1 : Frequency of mutations at G12, G13 and Q61 in RAS isoforms. Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.comThe frequency of mutational substitution at G12, G13 or Q61 for a particular amino acid has been represented using pie charts. Percentages indicate the frequency with which a given residue is mutated within a particular isoform. Primary data source is the COSMIC database (see Further information). Full size figure and legend (67 KB) Figures and tables index Download high-resolution PowerPoint slide (105 KB)  Another unresolved question concerning the molecular principles of the oncogenic activation of RAS pertains to whether mutations in a particular RAS isoform dictate unique oncogenic outputs. This question has been predominantly instigated by the well-recognized non-random distribution pattern of activated isoforms of RAS among the range of cancer types19, 20. Thus, KRAS mutations are most frequently detected in colorectal tumours, lung carcinomas (mostly non-small-cell lung cancer (NSCLC)) and in pancreatic carcinomas; HRAS mutations are associated with tumours of the skin and of the head and neck; and NRAS mutations are common in haematopoietic malignancies (Table 1). Earlier attempts to delineate the functional diversity of different oncogenic RAS isoforms mainly relied on the use of ectopic overexpression approaches21. However, as it became apparent that the expression levels of oncogenic RAS impinge on the phenotypic outcome, more recent attempts have explored the possible functional importance of tissue type-dependent isoform segregation using knockout and knock-in mouse models of oncogenic RAS alleles22, 23, 24, 25, 26, 27 (Table 2). In a model where either Kras4b or Hras was expressed at endogenous levels from the Kras promoter, To et al.25 demonstrated that HRASQ61L was fully capable of substituting for KRASQ61L in carcinogen-induced lung tumorigenesis. Further-more, carcinogen-induced oncogenic mutations were found to target the Hras allele knocked into the Kras locus in a lung tumorigenesis model, as well as the endogenous Hras allele in a skin tumorigenesis model. These observations suggest that the selective predisposition of RAS isoforms to mutagenesis in a particular tissue reflects gene-specific regulatory elements rather than distinct functional outputs. Examining the roles of KRASG12D and NRASG12D in colonic tumorigenesis and haematological malignancies, Haigis et al.26 and Li et al.27 have reached a somewhat different conclusion. Using knock-in mouse models that do not rely on chemical carcinogenesis and that feature intact endogenous regulatory elements, they have found that, of the two isoforms, only KRASG12D was capable of inducing hyperproliferation and enhanced tumorigenesis when expressed in the crypts of the colonic epithelium and that it induced an aggressive as opposed to an indolent myeloproliferative disorder when expressed in haemato-poietic cells. In addition, germline mutations in KRAS and HRAS are associated with the acquisition of distinct developmental disorders (KRAS is associated with Noonan syndrome and cardio-facio-cutaneous syndrome, and HRAS is associated with Costello syndrome)28, 29, thus suggesting that mutations in specific isoforms might be selected in accordance with their capacity to deregulate cellular homeostasis in vivo. Notably, a substitution of HRAS for KRAS in a knock-in model rescues the embryonic lethality that is caused by the loss of KRAS4B, thus implying a functional overlap between the two isoforms when expressed from the wild-type allele30.  Table 1 | Frequency of RAS mutations in human cancer  Table 1 - Frequency of RAS mutations in human cancer Full table Figures and tables index Download high-resolution PowerPoint slide (150 KB)  Table 2 | Mouse models of oncogenic RAS activation  Table 2 - Mouse models of oncogenic RAS activation Full table Figures and tables index Download high-resolution PowerPoint slide (144 KB)  In summary, it seems that despite the remarkable progress made over the past three decades in understanding the mechanisms and outcomes of oncogenic RAS activation, fundamental issues concerning the role of distinct oncogenic RAS mutations and the contribution of different RAS isoforms to cancer aetiology remain. The recent emergence of sophisticated experimental tools to probe and to model oncogenic RAS-driven cancers clearly presents new opportunities to revisit these issues.  RAS and the transformed phenotype  Promotion of proliferation. The continual expansion of cancer cells relies on the erosion of the mechanisms that obligate cells to respond appropriately to mitogenic and anti-mitogenic factors that are present within the extracellular milieu. As RAS proteins are immediate arbitrators of mitogenic stimuli, it is perhaps not surprising that constitutive activation of RAS fuels cell proliferation (Fig. 2). Indeed, soon after the identification of RAS, pioneering studies revealed that overexpression of oncogenic HRAS is sufficient for driving the entry of G0 phase-arrested cells into the cell cycle in the absence of growth factors31, 32. Adding to its function as a transducer of growth factor signalling, active RAS can also enhance the proliferative capacity of cells by inducing the transcriptional upregulation of growth factors such as heparin-binding epidermal growth factor-like growth factor (HBEGF), transforming growth factor-α (TGFα) and amphiregulin (AREG)33, 34, 35. Another output of oncogenic RAS signalling that contributes to the aberrant proliferation is the alteration in expression of growth factor receptors33, 34. Additionally, oncogenic HRASG12V induces the upregulation of integrins that promote proliferation while downregulating the integrin subunits that could maintain cellular quiescence36, 37. On the opposing side of the proliferative balance, oncogenic RAS can directly interfere with anti-proliferative signals by inhibiting signalling from TGFβ38, 39, 40, 41, 42, 43.  Figure 2 | RAS effects on proliferation.  Figure 2 : RAS effects on proliferation. Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.comOncogenic RAS establishes independence from extracellular growth factors and growth inhibitors, thereby promoting exit from the G0 phase of the cell cycle, progression through G1 and entry into S phase. RAS induces the transcriptional upregulation of growth factors and interferes with transforming growth factor-β (TGFβ) signalling through inhibition of TGFβ receptor expression or downstream signalling by downregulating the expression of SMAD3, as well as the nuclear accumulation of SMAD2 and SMAD3. RAS also upregulates the levels of cyclin D1 and suppresses the cyclin-dependent kinase inhibitor (CDKI) p27. The newly synthesized cyclin D1 associates with and activates the cyclin-dependent kinases CDK4 and CDK6, leading to the phosphorylation of RB and the subsequent dissolution of the RB–E2F transcription factor complexes. Once released, E2F transcription factors transactivate several genes that are required for cell cycle progression, including cyclin E (CCNE) and cyclin A (CCNA) that induce transition through the G1/S checkpoint (not shown). Hyperproliferative cues from activation of the RAS oncogene can result in replicative stress leading to DNA damage. In response to DNA damage cells can activate the DNA damage checkpoints to transiently arrest and restore the integrity of the genome, enter a state of irreversible arrest (senescence) or undergo apoptosis. Inaccurate repair of DNA damage can lead to mutations and chromosome aberrations, thereby contributing to tumorigenesis. The asterisk represents the mutational activation of RAS. P, phosphorylation. Full size figure and legend (47 KB) Figures and tables index Download high-resolution PowerPoint slide (84 KB)  The panoply of proliferative signals generated by oncogenic RAS culminates with the upregulation of several transcription factors that are required for cell cycle entry and progression, including FOS, serum response factor (SRF), the leucine zipper protein JUN, the ETS domain-containing transcription factor ELK1, activating transcription factor 2 (ATF2) and nuclear factor-κB (NF-κB)44, 45, 46, 47, 48, 49. In turn, these factors trigger the expression of the G1 cyclin, cyclin D1 (Refs 50,51,52). Although initial studies attributed the stimulation of cyclin D1 transcription by oncogenic RAS to the activation of the RAF–MAPK pathway, it has become evident that additional levels of control are executed through RAS activation of PI3Ks, the RHO family GTPase RAC1, and the RAL-guanine nucleotide dissociation stimulator (GDS) family of GEFs50, 51, 53, 54, 55, 56, 57. In addition to stimulating cyclin D1 gene transcription, oncogenic HRASG12V also regulates the metabolic stability of the cyclin D1 protein through PI3K-dependent inhibition of glycogen synthase kinase 3β (GSK3β), which is the kinase that is responsible for the phosphorylation and the consequent ubiquitylation and proteasomal degradation of cyclin D1 (Ref. 58).  Given the central role of cyclin D1 in RAS-induced self-sufficiency in growth signals it is perhaps not surprising that cyclin D1 is a crucial determinant of RAS-induced transformation. As such, cyclin D1-deficient mice are resistant to developing mammary cancers and squamous tumours that are induced by the HRAS oncogene59, 60. Notably, dependency on cyclin D1 seems to be a unique property of RAS-induced tumours, as the absence of cyclin D1 had no effect on MYC- or WNT1-induced tumours. However, overexpression of cyclin D1 is not sufficient to transform cells without the activity of a cooperating oncogene, pointing to additional RAS-induced mechanisms to provoke a state of proliferative overdrive61, 62. Indeed, oncogenic RAS can promote cell cycle progression by deregulating anti-growth signalling pathways through the suppression of cyclin-dependent kinase inhibitors (CKIs), such as p27 and p21, which would otherwise associate with and inhibit cyclin-dependent kinases (CDKs). This suppressive effect is mediated by multiple RAS effector pathways and is exerted at the transcriptional, translational and post-translational levels42, 63, 64, 65, 66.  An inevitable consequence of the persistent mitogenic stimulation that is imposed by RAS is the initiation of replicative stress, which is marked by increased numbers of active DNA replication origins and collapsed replication forks, which ultimately leads to DNA damage and the activation of the DNA damage response (DDR)67, 68, 69, 70. Indeed, the presence of DNA damage in precancerous lesions has been reported in several cancers that harbour oncogenic RAS, such as cancers of the pancreas, colon and lung. The outcome of overworking the replicative machinery can vary depending on cellular and genetic context. In a cell that possesses the full complement of functional DNA damage checkpoints, the engagement of the DDR by oncogenic HRASG12V leads to an irreversible cell cycle arrest that is known as oncogene-induced senescence (OIS)67. Although OIS is a tumour-constraining response, its induction could contribute to the tumorigenic process by exerting a strong selective pressure in favour of cells in which crucial components of the DNA damage checkpoint have been lost (such as p53 and ARF (also known as p19))71. Conversely, in cells that are deficient in DNA damage checkpoints (through the loss of p53, for example) deregulated DNA replicative activity that is induced by oncogenic RAS results in the generation of chromosome aberrations such as dicentric chromosomes, acentric chromosomes and double-minute chromosomes, leading to the improper segregation of chromosomes and the consequent exclusion of chromosomes from daughter nuclei22, 72, 73, 74, 75. The documented capacity of oncogenic HRASG12V to induce accelerated transition through G2/M, to inhibit the activation of the G2 DNA damage checkpoint, as well as to induce defects in mitotic spindle checkpoints76, may also contribute to the genomic instability that is observed in RAS-driven cancers. With our understanding of genomic stress and its consequences in cancer initiation and progression still evolving, the contribution of oncogenic RAS to these processes will undoubtedly be an exciting avenue of cancer research in the coming years.  Suppression of apoptosis. Apoptotic cell death functions as a crucial defence mechanism against malignancy, and the corruption of the apoptotic machinery is a defining signature of cancer cells. A complex process, apoptosis is the result of balanced molecular actions that are initiated by a diverse range of signals, and it is regulated at several levels by both positive and negative modulators. Apoptotic cell death can be initiated extrinsically whereby extracellular cues such as growth factor withdrawal or matrix detachment induce the stimulation of death receptors, or it can be initiated intrinsically through the mitochondrion-mediated pathway, which is activated by cues such as DNA damage and nutrient deprivation. Although both the intrinsic and extrinsic signalling cascades converge at the point of caspase 3 activation, they are subject to different regulatory mechanisms, including the pro-apoptotic and anti-apoptotic members of the BCL-2 family acting on the mitochondrion-mediated pathway, the anti-apoptotic FADD-like molecule FLIP (also known as CFLAR) acting on the extrinsic pathway and the inhibitors of apoptosis (IAPs) acting on both pathways77. Oncogenic RAS-driven erosion of the apoptotic pathways and its contribution to cancer has been well documented77 (Fig. 3). For example, the elimination of inducible oncogenic HRASG12V expression results in the regression of melanomas accompanied by massive tumour cell apoptosis78. Additionally, withdrawal of doxycycline-inducible oncogenic KRASG12D expression from type II pneumocytes causes apoptosis and regression of both early proliferative lesions and lung cancers79.  Figure 3 | RAS effects on apoptosis.  Figure 3 : RAS effects on apoptosis. Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.comOncogenic RAS may have both pro-apoptotic and anti-apoptotic functions depending on the status of RAS effector pathways and the apoptotic machinery. In many cases oncogenic RAS signalling through the RAF pathway engages an apoptotic response that is mediated by p53. Also, signalling through the RAS effectors RASSF1, NORE1, mammalian STE20-like protein kinase 1 (MST1) and JUN N-terminal kinase (JNK) can lead to apoptotic death via the activation of caspase 3 and the pro-apoptotic proteins BCL-2-associated X protein (BAX) and BCL-2-homologous antagonist/killer 1 (BAK1). Acquisition of a tumorigenic phenotype is marked by the suppression of such mediators of RAS-induced apoptosis. In this context, the anti-apoptotic activity of RAS takes a stronghold. The anti-apoptotic function of oncogenic RAS is mediated by several effector pathways, including the RAS–PI3K effector pathway, which regulates the levels of pro-apoptotic protein BAK1 and inhibitors of apoptosis (IAPs), and the RAS–RAF pathway, which downregulates the pro-apoptotic transcriptional repressor prostate apoptosis response 4 (PAR4) while upregulating the anti-apoptotic proteins BCL-2 and apoptosis repressor with caspase recruitment domain (ARC). Both pathways have been implicated in phosphorylating and inactivating the pro-apoptotic protein BCL-2-associated agonist of cell death (BAD). The mechanism through which RAS induces the epigenetic silencing of the pro-apoptotic CD95 gene remains to be uncovered. The asterisk represents the mutational activation of RAS protein. P, phosphorylation. Full size figure and legend (37 KB) Figures and tables index Download high-resolution PowerPoint slide (74 KB)  Mechanistically, the PI3K and RAF pathways activated by oncogenic RAS can downregulate pro-apoptotic mediators or upregulate anti-apoptotic molecules. Thus, activation of PI3K leads to the downregulation of the pro-apoptotic protein BCL-2-homologous antagonist/killer 1 (BAK1), and augments levels of IAPs through the activation of NF-κB80, 81, 82, 83. RAF contributes to RAS-induced suppression of apoptosis by the downregulation of the pro-apoptotic transcriptional repressor prostate apoptosis response 4 (PAR4; also known as PAWR)84, 85, and the upregulation of the anti-apoptotic proteins BCL-2 and apoptosis repressor with caspase recruitment domain (ARC; also known as NOL3)86, 87. Additionally, both the RAS–PI3K–AKT and the RAS–RAF pathways have been shown to mediate the phosphorylation of the pro-apoptotic BCL-2 family member BCL-2-associated agonist of cell death (BAD) on serine 136 and serine 122. Phosphorylation of BAD in either site results in the preferential formation of an inactive complex with 14-3-3, and thereby prevents the heterodimerization with, and subsequent inactivation of, BCL-2 and BCL-XL88, 89. Recent findings also implicate oncogenic RAS-induced epigenetic silencing of the pro-apoptotic CD95 (also known as TNFRSF6) gene as a potential anti-apoptotic mechanism that is induced by RAS90, 91. The effector molecules operating downstream of RAS in this process remain to be elucidated.  In addition to its pro-survival function, cell type and context-specific oncogenic RAS signalling can also promote pro-apoptotic programmes92, 93. For example, the preferential activation of the RAS–RAF–MAPKK–MAPK pathway exacerbates apoptosis94, and HRASQ61L-mediated activation of JUN N-terminal kinase (JNK) signalling has also been associated with a pro-apoptotic role95, 96. Phosphorylation of oncogenic KRAS by protein kinase C (PKC) promotes translocation to the mitochondria and induces apoptosis in a BCL-XL-dependent manner97. Additional RAS-regulated molecules with a role in pro-apoptotic programmes include RASSF1 and NORE1 (also known as RASSF5)98. On overexpression, these proteins are found in a pre-existing complex with mammalian STE20-like protein kinase 1 (MST1; also known as STK4), which is an enhancer of caspase 3 activation, and co-transfection of oncogenic RAS results in increased binding of active RAS to this complex and increased apoptosis99, 100. There is an indication that such a pro-apoptotic function of RAS might be selected against in cancer, as the expression of either RASSF1 or RASSF5 in tumours is frequently suppressed either owing to promoter hypermethylation or — in the case of RASSF1 — owing to the deletion of the chromosomal region that contains the gene98, 101, 102, 103, 104, 105. Thus, although the context in which the pro-apoptotic capabilities of RAS are enacted remains unknown, it is the balance of pro-survival and pro-apoptotic signals that would ultimately determine whether the RAS-transformed cell will shift towards life or towards death. The sheer prevalence of oncogenic RAS in cancer is an indication that the pro-survival axis has a dominant role.  Metabolism. As a result of their high proliferative rates, cancer cells are crucially dependent on metabolic pathways that generate the building blocks that are needed to produce a new cell106. These unique metabolic needs were first described in the 1920s by Otto Warburg and are typified by an increase in glucose uptake and a shift from mitochondrial oxidative phosphorylation to aerobic glycolysis107, 108. Although the full ramifications of this metabolic phenotype are yet to be deciphered, it has been postulated that — although it is less efficient in generating ATP — the catabolism of glucose through glycolysis is highly effective in providing the macromolecular precursors that are necessary for the replication of biomass (such as nucleotides, amino acids and lipids)109.  Oncogenic RAS impinges on the metabolic reprogramming of cancer cells predominantly through the upregulation of hypoxia-inducible factor 1α (HIF1α), which forms the HIF transcription factor when bound to HIF1β (also known as ARNT), and is well recognized for its ability to stimulate a glycolytic shift. This is achieved through oncogenic RAS-induced concurrent activation of MAPK and PI3K effector pathways leading to the stimulation of mTOR activity and mTOR-mediated cap-dependent translation of HIF1α110, 111. RAS-dependent upregulation of HIF1α has been implicated in enhancing both the transport and the glycolytic capture of glucose, as well as its processing to biosynthetic intermediates. With respect to the transport and capture of glucose, oncogenic RAS increases the transcription of the glucose transporter GLUT1 (also known as SLC2A1), thus conferring cells with an increased capacity to take up glucose112, 113, 114, 115, 116, 117. With respect to the processing of biosynthetic intermediates, oncogenic RAS leads to an increase in the levels of key glycolytic enzymes, such as hexokinase, phosphofructokinase and lactate dehydrogenase117, 118, 119, 120, 121. Hence, oncogenic RAS directly contributes to metabolic reactions that promote the use of glucose as an anabolic substrate in generating building material for cellular growth106 (Fig. 4). Whether this contribution is solely attributable to the upregulation of HIF1α by oncogenic RAS or whether it might involve other RAS targets remains to be established.  Figure 4 | Effect of RAS on energy metabolism in cancer cells: generating macromolecular precursors.  Figure 4 : Effect of RAS on energy metabolism in cancer cells: generating macromolecular precursors. Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.comERK and PI3K signalling downstream of oncogenic RAS converge to activate mTOR by inhibiting its negative regulators tuberin (TSC2) and liver kinase B1 (LKB1)–AMP-activated protein kinase (AMPK)116. TSC2 can be directly phosphorylated by both ERK and ERK-activated ribosomal protein S6 kinase (RSK) on S664 and S1798, respectively, as well as by AKT (on S939 and T1362), and, likewise, RAF–ERK1 or RAF–ERK2 signalling disrupts the LKB1–AMPK checkpoint200, 201, 202, 203, 204. This leads to mTOR–eukaryotic translation initiation factor 4 (eIF4)-dependent translation of hypoxia-inducible factor 1α (HIF1α). Activated RAS can also result in the transcriptional upregulation of HIF1A. Increased levels of HIF1α augment multiple steps in glycolytic metabolism (shown in blue). The upregulation of hexokinase (HK) facilitates the conversion of glucose to glucose-6-phosphate, a glycolytic intermediate that is used in pentose phosphate pathway-dependent nucleotide synthesis205. Higher levels of phosphofructokinase (PFK) lead to an enhanced glycolytic flux and the production of pyruvate, which, in conjunction with the oncogenic RAS-dependent increase in lactose dehydrogenase (LDH) levels, can allow glycolysis to persist by regenerating NAD+, a necessary cofactor for glycolytic reactions109, 120, 121. In addition, some of the pyruvate can enter the tricarboxylic acid (TCA) cycle where its conversion to citrate generates intermediates that are necessary for the synthesis of fatty acids and non-essential amino acids205. The asterisk represents the mutational activation of RAS. GLUT1, glucose transporter 1. Full size figure and legend (64 KB) Figures and tables index Download high-resolution PowerPoint slide (102 KB)  Another avenue through which oncogenic RAS interfaces with cellular metabolism is by affecting autophagy — a process of self-consumption that generates energy, as well as building blocks that are necessary for cellular survival, and that supports organelle homeostasis122. Although autophagy has been shown to have both tumour-suppressive and tumour-promoting qualities, recent studies have implicated oncogenic RAS in the upregulation of the autophagic processes, resulting in the upkeep of mitochondria, an increase in glycolytic rate and cellular viability, and ultimately supporting tumour growth in vivo123, 124, 125. Such dependency requires essential autophagy genes such as ATG5 and ATG7, as well as the autophagy cargo receptor p62 (Ref. 125). With the rapid expansion of the field of cancer metabolism, we are likely to encounter an increasing number of molecular interactions that link metabolic nodes to oncogenic RAS signalling.  Remodelling the microenvironment. For decades RAS has been the prime example of a potent cell-autonomous oncogene. It is, however, becoming increasingly evident that the effects of oncogenic RAS stretch further to include non-cell-autonomous changes in the cellular microenvironment that have essential roles in tumour initiation and progression. A prime example of such an effect is the induction of the outgrowth of new blood vessels, or angiogenesis, which allows cells within the evolving tumour to accommodate the physiological need for an adequate supply of oxygen and nutrients126, 127. The mechanisms by which RAS activation initiates and sustains pro-angiogenic processes are complex and impinge on the modulation of levels of endothelial growth factors and also increase local inflammation and stromal remodelling128, 129, 130 (Fig. 5).  Figure 5 | RAS and angiogenesis.  Figure 5 : RAS and angiogenesis. Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.coma | The induction of pro-angiogenic growth factors (vascular endothelial growth factor A (VEGFA) and fibroblast growth factor 2 (FGF2)) by RAS in neoplastic cells is shown. RAS enhances the transcription of VEGFA by recruiting transcription factors such as SP1, SP2, AP2 and ETS to the VEGFA promoter. RAS also increases the stability of VEGFA mRNA and augments its translation206, 207, 208, 209, 210, 211, 212, 213. The RAS–JUN N-terminal kinase (JNK) signalling axis is responsible for upregulating the transcription of prostaglandin-endoperoxide synthase 2 (PTGS2), which encodes COX2, by activating JUN, a component of the AP1 transcription complex, whereas the RAS–ERK1 and ERK2 pathway contributes to COX2 expression through the phosphorylation of CCAAT/enhancer binding protein-β (C/EBPβ) and ETS transcription factors such as PEA3 (Refs 214,215,216,217. Expression of COX2, in turn, increases the levels of VEGFA produced by RAS-transformed cells. b | The release of proteases by neoplastic cells cleaves components of the extracellular matrix (ECM) and releases VEGFA and FGF2, which are trapped in the ECM. Expression of proteases urokinase-type plasminogen activator (uPA), matrix metalloproteinase 2 (MMP2) and MMP9 in RAS-transformed cells is increased by the combined effects of ETS transcription factors (activated by the RAF–ERK pathway) and JUN (activated by the RAC–JNK pathway) binding to the promoters of PEA3–AP1 sites, as well as enhanced translation of polysome-associated MMP9 mRNA144, 218, 219. Stimulation of uPA expression is also dependent on RAS-mediated activation of RAL GTPase220, 221. This induces neo-proliferation and sprouting of microvessels towards the tumour site. c | The recruitment of macrophages by neoplastic cells (through RAS-induced nuclear factor-κB (NF-κB)-dependent production of the cytokines interleukin-6 (IL-6) and IL-8) and subsequent promotion of endothelial proliferation and sprouting by newly recruited macrophages is shown. Full size figure and legend (143 KB) Figures and tables index Download high-resolution PowerPoint slide (182 KB)  Vascular endothelial growth factor A (VEGFA), which is a key player in the induction of endothelial cell proliferation and the sprouting of new blood vessels, is a well-recognized target of oncogenic RAS. In fact, the disruption of either KRASG12V or KRASG13D expression and the subsequent reduction in VEGFA levels leads to diminished tumour growth127, 131. Oncogenic RAS-mediated upregulation of VEGFA involves the activation of multiple signalling cascades that eventually culminate in the stabilization of the pro-angiogenic transcription factor HIF1α, boosting its transactivation potential at the VEGFA promoter132, 133, 134, 135. There is also another pathway by which RAS can upregulate VEGFA: via the pro-angiogenic enzyme cyclooxygenase 2 (COX2), which, through the production of prostaglandins, leads to the enhancement of the cyclic AMP-dependent transcription of VEGFA129. COX2 can also increase the levels of a plethora of other endothelial growth factors, such as basic fibroblast growth factor (bFGF; also known as FGF2) and platelet-derived growth factor (PDGF), and is required for integrin-mediated endothelial cell spreading and migration136, 137.  Oncogenic HRASG12V-mediated production of pro-inflammatory cytokines has emerged as another contributor to the induction of angiogenesis130. Several cytokines have been implicated in this response, including interleukin-8 (IL-8), IL-6 and GRO1 (also known as CXCL1), and their RAS-dependent upregulation is predominantly mediated by the activation of signalling pathways that impinge on the transcriptional machinery controlling their expression130, 138. Once produced, the pro-inflammatory cytokines recruit immune cells, such as neutrophils and macrophages, which produce angiogenic growth factors138, 139, 140.  Cancer cells and the pro-angiogenic growth factors that they produce are often physically trapped by the extensive network of the extracellular matrix (ECM). Hence, the modification of the surrounding ECM is necessary both for the growth factors to reach the target endothelium and for the migration of the newly generated endothelium into the tumour129, 141, 142. Oncogenic HRASG12V-mediated upregulation of matrix metalloproteinase 2 (MMP2), MMP9 and urokinase-type plasminogen activator (uPA) has been shown to be instrumental in removing the physical confines of the basement membrane, with upregulation of uPA especially important in potentiating endothelial cell migration and vessel sprouting129, 143, 144, 145, 146, 147, 148. Oncogenic RAS can also promote the angiogenic process by restricting the expression of negative regulators of neo-vascularization, such as thrombospondin 1 (TSP1; also known as THBS1) and TSP2 (also known as THBS2), in tumour cells149, 150. These extracellular glycoproteins interact with components of the ECM to restrict the availability of endothelial growth factors and chemokines to the vascular system. In addition, they directly affect the viability of endothelial cells151, 152. Overall, the role of oncogenic RAS in the development of tumour vasculature represents a compendium of cell-autonomous and non-cell-autonomous functions that are engaged together to activate the pro-angiogenic programme.  Evasion of the immune response. The emergence of a tumour in spite of an immune system that in principle should be able to recognize it as a foreign entity raises the question of how a cancer cell evades such surveillance. Thus far, two mechanisms by which oncogenic RAS can subvert antitumour immunity have surfaced.  First, oncogenic activation of RAS reduces the surface expression of antigen-presenting major histocompatibility complexes (MHC) on cancer cells, and such downregulation results in decreased immunogenicity of the RAS-transformed cells153, 154, 155, 156, 157. The oncogenic RAS-mediated downregulation of MHC was shown to be independent of the promoter activity at MHC loci, suggesting that defects in the components of antigen-processing machinery could be responsible for the compromised antigenic peptide transport and loading154, 158, 159. Indeed, transformation by RAS reduced the levels and functionality of the antigen peptide transporters TAP1 and TAP2 and proteasome subunits LMP2 (also known as PSMB9) and LMP7 (also known as PSMB8), resulting in decreased MHC expression160, 161.  Second, data from human cancers and transgenic mouse models indicate that RAS-driven cancers possess the capacity to overcome host-protecting adaptive immune responses162. Thus, although T cells specific for the mutated RAS antigens can be found in patients with melanoma, pancreatic and colon cancers, they are often anergic and so inactive towards the tumour158, 163, 164, 165, 166. This concept is supported by recent experimental evidence from a mouse model of oncogenic KRASG12D-induced lung cancer, demonstrating that the initial immune response becomes substantially attenuated, eventually leading to a full escape from immune surveillance167. One possible mechanism by which oncogenic RAS expression may lead to a compromised antitumour immune response is through the recruitment of immunosuppressive regulatory T cells (TRegs) and myeloid-derived suppressor cells (MDSCs) to the tumour site168, 169. The potential importance of this mode of immune modulation for the tumorigenic process is suggested by the observation that TRegs are required for cancer formation in the mouse model of KRASG12V-initiated lung tumorigenesis170. Whether RAS-transformed cells influence the immune response through direct recruitment of immunosuppressive cells or in conjunction with the induction of an inflammatory response remains to be elucidated171, 172.  Metastasis. Among the most threatening aspects of an evolving tumour is the acquisition of metastatic properties, whereby the cancer cells spread to the surrounding and distant organs. Many metastatic tumours (such as lung, pancreas and colon tumours) contain RAS mutations. This fact, along with the demonstration that oncogenic mutants of RAS could confer metastatic properties to mouse cells in culture, served as a foundation for a large body of work that aimed to understand the role of oncogenic RAS in metastatic tumour spread. Although far from complete, the picture that has emerged so far implicates RAS in multiple cellular processes that endow cells with metastatic potential.  The initial step in the metastatic cascade is the establishment of local tumour cell invasion, a process that relies on the ability of tumour cells to break away from the primary tumour. Oncogenic RAS contributes to this process by inducing alterations in cell–cell and cell–matrix interactions and the acquisition of a migratory phenotype. The perturbation of cell–cell contacts by oncogenic RAS is accomplished through the targeting of the molecular machinery that maintains intercellular adhesion junctions, which includes the calcium-dependent E-cadherin receptor and its associated cytoplasmic protein β-catenin173, 174, 175, 176. Thus, the expression of oncogenic RAS reduces the levels of E-cadherin through the upregulation of the E-cadherin transcriptional repressors SNAIL (also known as SNAI1) and SLUG (also known as SNAI2), the stimulation of E-cadherin proteolytic degradation and the induction of E-cadherin promoter methylation177, 178, 179. RAS activation has also been shown to induce the destabilization of E-cadherin–β-catenin complexes and the relocalization of β-catenin174, 180, 181, 182. Along with the weakening of cell–cell interactions, oncogenic RAS expression reduces attachments to the ECM by downregulating integrin subunits (such as integrin α5β1) that facilitate the maintenance of stable adhesion complexes183, 184, 185, 186, 187. Finally, oncogenic RAS directly contributes to the enhanced motility of cancer cells by affecting pronounced changes in the polymerization, organization and contraction of actin; the polymerization and/or stability of microtubules; and the transcriptional regulation of mitogenic gene products188. Collectively, these changes establish the front–rear asymmetry that is required for cell migration.  Progression through the metastatic process requires the cancer cell to leave the confines of the primary tumour and to enter the blood or lymphatic system (intravasation). Crucial for the execution of this step is the capacity to invade through the physical barrier that is imposed by the basement membrane. The link between oncogenic RAS expression and the acquisition of the invasive phenotype has been attributed to alterations in cellular activities that control ECM degradation. Specifically, signalling pathways that are downstream of constitutively activated RAS can increase the expression and/or activity of various ECM proteases and in parallel can decrease the expression of protease inhibitors. Oncogenic RAS is also thought to contribute to the capacity of tumour cells to migrate through the circulatory system by protecting them from matrix deprivation-induced apoptosis, or anoikis77, 80, 127, 174, 189, 190, 191.  Given the multitude of cellular activities on which tumour metastasis relies, it is not surprising that oncogenic RAS promotes this aspect of the transformed phenotype by engaging a diverse and broad platform of effector mechanisms. RAS-dependent signalling pathways that have been demonstrated to have an essential role in metastatic progression include the RAS–MAPK, RAS–PI3K, RAS–RAL GTPase and RAS–RHO GTPase pathways182, 188. Each of these pathways can promote the metastatic process at multiple steps. For example, the activation of RHO GTPases leads to concurrent alterations in cell adhesion and cell motility. In addition, the identity of RAS-dependent signals that promote metastasis has been shown to vary substantially depending on tissue type and genetic background192, 193, 194, 195, 196. Furthermore, in some settings, the induction of metastasis is the product of cooperation between oncogenic RAS and other metastasis-promoting pathways, such as the TGFβ pathway177, 197. Thus, defining the precise modes by which RAS-responsive pathways affect metastatic capacity awaits an improved understanding of the context-dependent outcome of their coordinated activation.  The road ahead  As research on oncogenic RAS is entering its fourth decade, the information it has generated thus far serves as a rich and instructive backdrop for the challenges and opportunities that lie ahead. A unifying concept that emerges from the large number of genetic, biochemical and cell biological studies is that the oncogenic potential of RAS manifests in a context-dependent manner. Thus, the subcellular, cellular and tissue environments within which oncogenic RAS operates crucially determine its functional output. In addition, depending on the genetic landscape of an individual cell, different RAS-dependent oncogenic activities might become more or less important during tumour evolution. Although the task of developing a mechanistic understanding of how these determinants dictate a specific pathological outcome may seem daunting, the outpouring over the past few years of highly refined experimental tools to address these questions holds promise for considerable advances.  At the subcellular level, RAS proteins have been shown to reside in distinct compartments within the cell, with each compartment eliciting differential signalling outputs that may control various aspects of oncogenic transformation198, 199. Recent advancements in the development of multi-parameter fluorescent reporters and biosensors, along with improved access to high-sensitivity real-time imaging techniques, should provide important insights into the spatiotemporal coordination of oncogenic RAS signalling in live cells. At the cellular and tissue level, our capacity to probe the in vivo ramifications of the expression of oncogenic RAS has been continuously improving owing to an ever-growing collection of sophisticated genetically engineered mouse models that feature activating mutations in RAS. By affording tissue- and cell-specific expression in a time-controlled and reversible manner, these models often recapitulate the genetic and biological evolution of human cancers. As such, their future use could not only augment the understanding of the crucial mediators of RAS-driven oncogenesis but could also be instrumental in testing and developing novel targeting strategies directed at RAS. Finally, signalling networks that are triggered by oncogenic RAS within the cell are complex and highly dynamic. Computational approaches that are designed to model how the integration of multi-pathway networks determines their biological output will clearly be an area of intense investigation in the years to come. Equipped with these tools we might be in a unique position to translate major advances in basic research on the RAS oncogenes into meaningful clinical benefits. The Ras signaling pathway controls important cellular responses to growth factors, and somatic mutations in RAS genes and other components of the Ras pathway, such as PTPN11 (encoding the protein-tyrosine phosphatase SHP-2) and BRAF, are found in human malignancies. Ras proteins are guanosine nucleotide-binding proteins that cycle between active guanosine triphosphate (GTP)-bound and inactive guanosine diphosphate (GDP)-bound conformations. Neoplasia-associated Ras mutations frequently affect amino acids G12, G13, or Q61 and decrease the intrinsic guanosine triphosphatase (GTPase) activity by ten- to twentyfold. The GTPase activity is crucial for Ras inactivation by hydrolysis and release of a phosphate group from Ras·GTP to produce Ras·GDP. We and others have recently discovered germline mutations in the KRAS gene in individuals diagnosed with Noonan and cardio–facio–cutaneous (CFC) syndrome, two clinically overlapping disorders characterized by short stature, distinct facial anomalies, heart defects, and other abnormalities. Noonan syndrome-associated mutations V14I and T58I K-Ras activate Ras but have milder biochemical effects than somatic mutations encountered in cancers, offering an explanation why these K-Ras lesions are tolerated during embryonic development. Together with recent findings of BRAF, MEK1, and MEK2 mutations in CFC syndrome and HRAS mutations in Costello syndrome, another clinically related disorder, it has now become clear that Noonan-like features (short stature, relative macrocephaly, facial anomalies, learning difficulties) that are found in these three related disorders are a result of constitutive activation of the Ras–Raf–extracellular signal-regulated and mitogen-activated protein kinase pathway.  Keywords: Noonan syndrome, Cardio–facio–cutaneous syndrome, Costello syndrome, Neurofibromatosis type 1, Ras signaling Go to: RAS genes The three human RAS genes, KRAS (isoforms A and B), NRAS, and HRAS (isoforms 1 and 2), encode small, highly conserved guanosine triphosphatases (GTPases) that relay growth signals to a number of effector proteins to control fundamental cellular pathways (reviewed in [1]). Ras proteins act as molecular switches by cycling between an active guanosine triphosphate (GTP)-bound and an inactive guanosine diphosphate (GDP)-bound state. Stimulated growth factor receptors recruit a number of adaptor proteins that activate guanosine nucleotide exchange factors (GEFs) to remove guanine nucleotides from Ras. Ras is then activated by binding to GTP, which is present at a tenfold higher concentration than GDP. In the GTP-bound state, the two switch regions of Ras (switch I and II) change their conformation. This conformational switch allows Ras to bind and activate Ras effector proteins such as Raf-1. The “on” position is turned “off” by an intrinsic GTPase activity, which hydrolyses and releases a phosphate group from Ras·GTP to produce Ras·GDP. The conformational transition of the switch I and II regions that is associated with this reaction disrupts the interaction between Ras and its effectors. The intrinsic GTPase activity of Ras is slow and accelerated about 105-fold by GTPase activating proteins (GAPs), such as neurofibromin or p120 GAP. These GAPs mediate Ras·GTP hydrolysis by inserting an arginine residue (arginine finger) into the phosphate-binding pocket of Ras (reviewed in [2, 3]; Fig. 1).  Fig. 1 Fig. 1 Ras cycles between an active GTP-bound and an inactive GDP-bound conformation. In the active state, the two switch regions, switch I and II, change their conformation allowing Ras to activate effector proteins. The intrinsic GTPase hydrolyzes a phosphate ... For several decades, it has been well recognized that RAS genes are frequently mutated in human cancers (reviewed in [4]). These mutations predominantly lead to amino acid substitutions at residues G12, G13, or Q61 and lock Ras in the active GTP-bound state by diminishing the intrinsic Ras GTPase activity and/or by causing resistance to GAPs. These mutations were long believed to occur only as somatic events, and in a mouse model system, widespread expression of endogenous K-RasG12D leads to embryonic death [5]. The highest incidence of RAS mutations are found in adenocarcinomas of the pancreas (90%), the colon (50%), and the lung (30%), in thyroid tumors (50%), and in myeloid leukemia (30%) [4].  Go to: Noonan syndrome and related disorders Noonan syndrome (NS; MIM 163950) is an autosomal dominant disorder characterized by short stature, distinct facial anomalies (Fig. 2), a typical spectrum of congenital heart defects, including pulmonic stenosis, hypertrophic cardiomyopathy, and septal defects, and developmental delays (reviewed [6]). The disorder occurs in approximately 1 out of 2,000 individuals and shares many features with the much less common disorders of Costello syndrome (CS), cardio–facio–cutaneous (CFC) syndrome, and lentigines, electrocardiographic conduction defects, ocular hypertelorism, pulmonary stenosis, abnormalities of the genitals; retarded growth resulting in short stature, and deafness (LEOPARD) syndrome (LS) [6]. Patients with these disorders have in common Noonan-like facial features, a similar spectrum of cardiac anomalies, delayed growth, and—to a variable degree—developmental retardation, which is stronger in patients with CS or CFC. In addition, each of these disorders is characterized by unique phenotypic patterns: (1) CS patients have nasal papillomata, loose skin, and a strong predisposition to tumors (mainly rhabdomyosarcoma) [7]; (2) CFC patients have ectodermal abnormalities with sparse curly hair, sparse, or absent eyelashes [8]; and (3) LS patients have multiple lentigines typically emerging during adolescence [6]. NS and LS may be familial with an autosomal dominant inheritance pattern (except for rare instances of NS where rare recessive inheritance has been suspected [9]), but most cases of these disorders and virtually all of the more severe conditions, CFC and CS, occur sporadically, suggesting dominant new mutations. Until recently, the genetic basis for these disorders was unknown. It was not clear whether they represented genetically distinct entities or if they were different (allelic) variants of a common disorder. By linkage analysis in families with NS, the disorder was mapped to chromosome 12q24 [10], and subsequently, it has been shown that approximately 50% of patients with NS carry germline mutations in PTPN11 [11]. The PTPN11 gene encodes for tyrosine-protein phosphatase (SHP-2), a phosphatase that relays growth signals from activated growth factor receptors to other signaling molecules, including Ras (reviewed in [12]). Most PTPN11 mutations are predicted to disrupt the auto-inhibition of the catalytic phosphatase domain (PTPase) by the N-terminal src-homology 2 (N-SH2) domain thereby promoting the active conformation of the protein [12]. PTPN11 mutations were not found in patients with CS or CFC syndromes (reviewed in [6]). However, specific mutations in the same gene were uncovered in patients with LS [13]. Surprisingly, in contrast to NS, LS mutants are catalytically defective and may act as dominant negative mutations [14, 15]. Molecular modeling and biochemical studies suggest that LS mutations disrupt the SHP-2 catalytic domain to result in open, inactive forms of SHP-2. Thus, the pathogenesis of LS and NS is distinct. It is unknown why the clinical phenotypes of LS and NS are similar although the underlying mutations have opposite biochemical effects. There are several possible explanations for this paradox. These are discussed in detail by Kontaridis et al. [14]: (1) The NS and LS phenotypes potentially result from differential effects of mutant SHP-2 on different receptor tyrosine kinase pathways at distinct developmental times. For example, recent work by others suggests that the main effect of NS mutants is to enhance epithelial–mesenchymal transformation/mesenchymal cell proliferation by increasing ErbB2/3 (and/or ErbB3/4) signaling. By contrast, LS mutants antagonize HB-EGF/ErbB1 signaling at later times [14]; (2) Other phenotypes common to NS and LS such as facial abnormalities and short stature might involve defective migration and/or differentiation, which might result from increased or decreased signaling involving the same pathway; (3) Yet, undetermined or poorly understood functions of SHP-2 might underlie pathogenesis of one or both of these disorders [14].  Fig. 2 Fig. 2 a Craniofacial phenotype of young children with NS, CFC, and CS aged between 10 and 18 months. Their genotypes are PTPN11 G503R, BRAF K499E, and HRAS G13C, respectively. Note the similarities of facial features, including hypertelorism, broad ... Go to: The Noonan gene PTPN11 also acts as oncogene One of the myeloid malignancies that has been found to be particularly related to perturbed Ras signaling is juvenile myelomonocytic leukemia (JMML), a myeloproliferative disorder (MPD) of early childhood [16], in which mutations occur in NRAS or KRAS (∼25%) or in NF1 (clinical diagnosis of neurofibromatosis type 1 in ∼11%) [17–19]. In a murine model, somatic activation of K-Ras in hematopoietic cells initiates a rapidly fatal MPD modeling JMML [20, 21]. Despite a low annual incidence estimated at 1–2 per million, JMML has attracted many clinical and basic researchers because of the severe and often lethal clinical course and the association with NS [22] and neurofibromatosis type 1 (NF1; MIM 162200; reviewed in [19]). Shortly after the discovery of PTPN11 mutations in individuals with NS, specific germline PTPN11 alterations were identified in young children with NS who developed a JMML-like disorder within the first few weeks of birth (NS/JMML) [23, 24], and somatic PTPN11 mutations were subsequently uncovered in JMML cells from 35% of children with non-syndromic JMML [23–25]. Somatic PTPN11 mutations also occur in B-cell precursor acute lymphoblastic leukemia [26] and rarely other malignancies [27]. Somatic mutations observed in patients with JMML differ from those mutations found in patients with NS/JMML and from those detected in patients with NS alone. In sporadic JMML, the most common mutation predicts an E76K substitution. This mutation has never been found in patients with NS (N308D most common) or NS/JMML (T73I most common) [6, 25]. In elegant functional experiments, several groups have shown that somatic PTPN11 mutations associated with sporadic JMML exhibit stronger biochemical and biological effects than germline PTPN11 mutations, leading to the concept that only milder SHP-2 activation may be tolerated during embryonic development [28–30]. The situation is too complex however to be explained by a simple model of strong activating somatic vs less activating germline mutations alone. Enzymatic, structural, and mathematical modeling analyses show that these mutants can affect basal activation, SH2 domain-phosphopeptide affinity, and/or substrate specificity to varying degrees, and there is no absolute correlation between the mutants’ extents of basal activation and the diseases they induce [31]. A murine knock-in Ptpn11D61G/+ model of NS has been constructed, revealing that endocardial cushions of these mice have increased activation of extracellular signal-regulated kinase [32]. This finding suggests that the phenotype exhibited by PTPN11 mutations is mediated through hyperactive Ras signaling.  Go to: Neurofibromatosis type 1 JMML is also associated with NF1 (MIM 162200), an autosomal dominant disorder that occurs in 1 of 4,000 births and is characterized by pigmentary anomalies (multiple café-au-lait spots) and a predisposition to benign and malignant tumors of mainly neurogenic origin. The disorder is caused by mutations in the NF1 tumor suppressor gene, which encodes the RasGAP neurofibromin. The incidence of JMML is increased approximately 200-fold in children with NF1 (reviewed in [33]). Loss of the normal NF1 allele (LOH, loss of heterozygosity) is common in JMML cells from children with NF1 [34, 35], and this results in severely deregulated Ras signaling and causes aberrant growth of hematopoietic progenitor colonies in vitro [36]. In addition, adoptive transfer of homozygous Nf1 mutant fetal liver cells or somatic inactivation of a conditional mutant Nf1 allele in hematopoietic cells induces a JMML-like MPD in mice [37, 38]. Remarkably, many NF1 patients have mild features reminiscent of NS [39], and some may even develop a mixed phenotype, which has prompted the definition of neurofibromatosis–NS (NFNS; MIM 601321) as a separate entity. Most patients who are diagnosed with this condition harbor NF1 mutations without an obvious genotype–phenotype correlation [40].  Go to: Additional genes mutated in Noonan syndrome To date, the identification of additional NS genes was hampered by the fact that the vast majority of PTPN11 mutation-negative NS-patients represent sporadic cases [41], rendering genetic linkage studies impossible. However, recent findings by our group and others identified germline mutations in components of the Ras signaling pathway in individuals with NS or related syndromes [42–46]. We systematically screened patients with NS and CFC for RAS mutations after having discovered a novel de novo germline KRAS mutation in a patient with NS/JMML [42]. The mutation c.173C>T (p.T58I) detected in the index patient affects a highly conserved amino acid residue of K-Ras flanking the switch II region (amino acids 59–67) of the protein. De novo KRAS mutations were identified in 4 of 174 sporadic cases with NS previously excluded for PTPN11 mutations. All germline KRAS mutations were novel and not known to occur in human cancer. NS-associated KRAS alleles included recurrent mutations, V14I and D153V. The latter was confirmed in patients with more severe phenotypes [44, 46]. Analogous to the dual role of PTPN11 as both oncogene and developmental gene, this discovery led to the hypothesis that activating KRAS mutations do not only act as oncogenes; aberrant K-Ras can also cause developmental disorders when mutations—probably conferring relatively mild effects—emerge in the germline. To prove our hypothesis, we studied the functional properties of V14I and T58I K-Ras [42] and found both NS-associated mutants V14I and T58I to have intermediate biochemical (e.g., ability to hydrolyze Ras·GTP) and biological properties (e.g., growth behavior in response to growth factors after retroviral transfection) when compared with wild-type K-Ras and the oncogenic mutant K-Ras G12D [42].  The two aforementioned mutations, V14I and T58I, are located adjacent to amino acid residues that are typically altered in cancer (G12, G13, or Q61). They locate to regions of Ras that are known to be involved in GTP binding. By contrast, in a subset of NS patients, KRAS mutations lead to substitutions in protein regions not obviously involved in GTP binding (e.g., D153V K-Ras), indicating the existence of previously unappreciated mechanisms of Ras activation. Carta et al. [46] performed a structural analysis on the two K-Ras mutants, V152G and D153V, that these investigators identified in two patients with severe NS. Their computer-based analysis indicated that both mutations disturb the conformation of the guanine ring-binding pocket favoring the active GTP-bound conformation by increasing the guanine nucleotide dissociation rate. Additionally, these residues are predicted to be important for binding the RasGEF son of sevenless (SOS) [47]. In the meantime, we have detected a number of additional KRAS mutations associated with NS (Q22R, P34L, P34Q, I36M), all of which affect highly conserved amino acid residues and are assumed to confer (mild) gain of function [48]. In this study on additional 236 PTPN11-negative NS patients, we detected KRAS mutations in seven individuals [48], thus confirming that KRAS accounts for less than 5% of NS cases.  Go to: Genes mutated in cardio–facio–cutaneous syndrome In our initial study, we also discovered a novel K-Ras mutation, K-Ras P34R, in 1 of 12 patients with CFC syndrome [42]. This mutation is now known to be located in another mutational hotspot associated with NS [48]. A P34R H-Ras lesion has been previously characterized by Stone et al. [49]. These investigators employed a mutagenesis strategy during which they found that H-Ras P34R binds to GTP in vivo. In vitro, H-Ras P34R is not stimulated by GAPs [49]. Considering the highly conserved G-domain structure of Ras proteins, the P34R K-Ras mutation presumably has very similar (if not identical) biochemical properties. The presence of K-Ras mutations in CFC syndrome was confirmed by Niihori et al. [44] who analyzed DNA specimens from 43 individuals with CFC syndrome and found two KRAS germline mutations (G60R and D153V) in three patients. Notably, the D153V K-Ras mutation also has been described in patients with NS [42, 46, 48]. In a more recent study, we identified additional K-Ras mutations in individuals with CFC or NS/CFC including Q22E and F156I. The observations that mutations, such as K-Ras F156I, may be associated with an overlap of NS and CFC suggest that there is not a very strict genotype–phenotype correlation [48]. Simultaneous to the finding of mutated K-Ras in CFC, Niihori et al. identified BRAF germline mutations in 16 of 43 CFC patients [36]. At the same time, another group found BRAF germline mutations in 18 of 23 CFC patients and MEK1 or MEK2 germline mutations in 3 of the remaining 5 CFC patients studied [45]. Like PTPN11 and RAS, BRAF is a known oncogene, and somatic mutations are frequently found in cancer [50].  Go to: The molecular basis of Costello syndrome Shortly before germline KRAS mutations were described in patients with NS and CFC, HRAS germline mutations were reported to cause CS [43]. Later, other investigators also detected these mutations in the majority (∼90%) of CS patients studied [51–53]. Surprisingly, these germline lesions affect the same amino acid residues of H-Ras that are also mutated in cancer. The observation that activating oncogenic H-Ras mutations affecting codons G12 or G13 are tolerated in the germline, whereas oncogenic K-Ras mutations affecting these residues are not, underscores the notion that although H-Ras and K-Ras are structurally highly similar, they play different roles during embryonic development. Knockout studies have shown that only K-Ras is essential for embryonic development, whereas N-Ras and H-Ras are not [54]. Different phenotypes exhibited by mutations in various Ras isoforms may be due to heterogenous expression patterns of these proteins. Additionally, various Ras isoforms undergo different processing, e.g., de/repalmitoylation kinetics that regulate subcellular localization and activity of Ras isoforms [55, 56]. Although the vast majority of patients with CS harbor HRAS mutations, very recent studies have indicated that a CS phenotype may occasionally be associated with specific mutations of BRAF [57] or KRAS [48]. It remains to be determined if these patients also have the increased risk of neoplasia, which is typical of CS. Therefore, we doubt it is useful to classify these patients with mutations in Ras pathway genes other that HRAS as CS.  Go to: Neuro–cardio–facial–cutaneous syndrome The molecular explanation of how different germline K-Ras or H-Ras mutations cause a wide spectrum of different phenotypes is still largely unknown. Activating germline K-Ras mutations may be associated with the broadest spectrum of clinical manifestations [42, 44, 46]. However, these syndromes are not just a less or more severe expression of essentially the same disorder. Therefore, it is conceivable that the different RAS mutations associated with divergent phenotypes do not only vary quantitatively in their degree of constitutive activation. Unique lesions may also have different qualitative effects on downstream signaling pathways. Additionally, modifier loci may play a role. Recently, the term ‘neuro–cardio–facial–cutaneous’ (NCFC) syndrome [58] was coined to illustrate that clinically overlapping disorders of the NS spectrum, including NF1, NS, CS, LS, and CFC syndrome, are caused by mutations in components of the Ras signaling pathway (Fig. 3). We speculate that the phenotypic variability between these disorder results from (1) different expression patterns of affected genes/isoforms and (2) variable mechanisms by which certain mutants interact with downstream effectors or regulatory proteins; these mutants therefore perturb Ras signaling in varying degrees. Further research is required to determine the basis of genotype–phenotype correlations in NS and related disorders.  Fig. 3 Fig. 3 The Ras signaling pathway relays growth signals from activated growth factor receptors to the nucleus. Somatic mutations in several molecules of the pathway have been implicated in cancer. It is now recognized that germline mutations of identical molecules ... Go to: Neurofibromatosis Noonan syndrome and NS-like features in neurofibromatosis The rapidly increasing knowledge of the Ras signaling pathway and its relation to developmental disorders of the NS spectrum suggests that Noonan-like features are the clinical correlate of any genetic abnormality occurring in the germline and leading to a generalized mild deregulation of the Ras signaling cascade(s) during embryonic development. The new insights gained by recent research in this field may explain the phenotypic similarities between individuals with NF1 and NS. In addition to the well-known symptoms defining NF1, namely multiple café-au-lait spots and cutaneous neurofibromas, patients with NF1 are known to exhibit NS features, including relative short stature, relative macrocephaly, mild facial anomalies, thorax deformities, and learning difficulties. NFNS probably just represents the extreme end of a highly variable expression of these features [59]. Although the association of NF1 and NS was described in one family with independently segregating mutations in NF1 and PTPN11 [60], this double chance event is not the causative mechanism in many other patients with NF1 and NS-like features. The majority of patients with the NFNS phenotype have been found to harbor NF1 mutations, some of which also occur in patients with “pure” NF1 [40, 59]. We propose that the NS-like features that are often present in patients with NF1 are potentially due to NF1 haploinsufficiency leading to decreased inactivation of Ras·GTP. This might cause mild constitutional deregulation of Ras signaling, which may occasionally reach a level that leads to a NF1-NS phenotype. Frequently, patients with NF1 have mild features of NS. These may be explained by a mild activation of Ras, which is due to loss-of-function of one NF1 allele. Unknown genetic modifiers may play a role. Malignant cells arising in patients with NF1 somatically loose the wild-type NF1 allele. This second somatic hit ablates the GAP function of neurofibromin resulting in strongly enhanced Ras signaling (Fig. 4).  Fig. 4 Fig. 4 Model illustrating the molecular basis of how Ras signaling may be increased in patients with neurofibromatosis type 1 leading to Noonan-like feature in these patients. Although only one NF1 allele is inactive in the germline, tumors of patients with ... Go to: Work in progress Although the vast majority of cases with CFC and CS are explained by mutations in KRAS, BRAF, MEK1, MEK2, and HRAS, the underlying genetic defect in 50% of NS and 10–30% of CFC cases remains unknown. Based on the assumption that the NS phenotype results from hyperactive Ras signaling, we and others are currently screening DNA specimens from patients for mutations in genes encoding for other components, including negative regulators, of the Ras pathway. Analogous to PTPN11 and KRAS, currently unknown genes of the Ras pathway mutated in NS are presumably playing double roles in both development and oncogenesis. Mutations in BRAF and MEK1/2 have been excluded as major NS genes (M.Z., unpublished data).  It will be of interest to study how the different expression patterns of various RAS genes and isoforms influence clinical phenotypes when these genes/isoforms are mutated in the germline. It will be crucial to elucidate the structural mechanisms to understand how these new lesions perturb signaling on a molecular level. Characterization of the biological consequences of these mutations will be largely improved by the construction of murine knock-in models.  Somatic gain-of-function mutations in members of the RAS subfamily of small guanosine triphosphatases are found in > 30% of all human cancers. We recently described a syndrome of chronic nonmalignant lymphadenopathy, splenomegaly, and autoimmunity associated with a mutation in NRAS affecting hematopoietic cells, and initially we classified the disease as a variant of the autoimmune lymphoproliferative syndrome. Here, we demonstrate that somatic mutations in the related KRAS gene can also be associated with a nonmalignant syndrome of autoimmunity and breakdown of leukocyte homeostasis. The activating KRAS mutation impaired cytokine withdrawal–induced T-cell apoptosis through the suppression of the proapoptotic protein BCL-2 interacting mediator of cell death and facilitated proliferation through p27kip1 down-regulation. These defects could be corrected in vitro by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1 or phosphatidyl inositol-3 kinase inhibition. We suggest the use of the term RAS-associated autoimmune leukoproliferative disease to differentiate this disorder from autoimmune lymphoproliferative syndrome.  Go to: Introduction The autoimmune lymphoproliferative syndrome (ALPS) is characterized by childhood onset chronic lymphadenopathy, splenomegaly, multilineage cytopenias secondary to sequestration and autoimmune destruction, and an increased risk of B-cell lymphoma.1 Laboratory findings include polyclonal hypergammaglobulinemia and expansion of a unique population of circulating T-cell receptor αβ+B220+CD4−CD8− T (αβ+-DNT) lymphocytes.2,3 Most patients with ALPS harbor heterozygous autosomal-dominant germline mutations in FAS, with somatic FAS mutations representing the second most common genetic cause.4–7 Germline mutations in the genes encoding FAS ligand and caspase 10 have been identified in a small minority of patients.8–12 In our cohort, approximately one-third of the patients with ALPS have an undetermined genetic basis. In addition, there is a group of genetically undetermined ALPS-like patients without αβ+-DNT cell elevation.  We recently reported one person among these latter patients with a syndrome of lymphoproliferation, autoimmunity, and minimally increased αβ+-DNT cells caused by a somatic mutation in the NRAS gene, resulting in defective lymphocyte apoptosis.13 Here, we demonstrate that somatic mutations in the homologous KRAS gene can also be associated with a syndrome consisting of autoimmune phenomena and dysregulated leukocyte homeostasis, with normal αβ+-DNT cells. The activating KRAS mutation, like the previously described NRAS mutation, impaired intrinsic T-cell apoptosis through the suppression of the proapoptotic protein BCL-2 interacting mediator of cell death (BIM) and facilitated cellular proliferation by repression of p27kip1.  Go to: Methods Cells and treatments  All patients were studied at the National Institutes of Health (NIH) under protocols approved by the institutional review board (93-I-0063 and 95-I-0066). DNA sequencing, apoptosis assays, immunoblotting, and active RAS pull down were performed as previously described.13  Plasmids and transfection  The plasmids pCEFL-KZ-AU5-KRAS-wt and pCEFL-KZ-AU5-KRAS-V12 were kindly provided by Silvio Gutkind (National Institute of Dental and Craniofacial Research, NIH). AU5-tagged KRAS G13C plasmid was constructed by site-directed mutagenesis with the use of the QuickChange kit (Stratagene) according the manufacturer's instructions. Transient transfections in human 293T and Jurkat cells were performed with the TransIT-LT1 reagent (MirusBio) and Lonza solution V kit (Lonza), respectively. Assays were performed 48 hours after transfection.  Go to: Results and discussion Somatic gain-of-function KRAS mutation in 2 patients with ALPS-like symptoms  To identify novel genes linked to persistent lymphadenopathy, splenomegaly, and autoimmunity, we sequenced patients with ALPS-like syndromes for candidate genes and identified activating KRAS mutations in 2 patients. Patient 1 showed a c.37G > T, p.G13C mutation, present in lymphoid and myeloid cell types (Figure 1A) but not in heart tissue (data not shown). Patient 2 showed a c.35G > A, p.G12D mutation in peripheral blood mononuclear cells but not in buccal swab cells (Figure 1B). This indicated a somatic origin probably at the hematopoietic stem cell level. No mutations in FAS, NRAS, or HRAS were detected in either patient. Gain of function for G13C was confirmed in patient 1 by the increased amount of active RAS present in cells after transfection with a plasmid-encoding mutant G13C versus wild-type KRAS (supplemental Figure 1, available on the Blood Web site; see the Supplemental Materials link at the top of the online article). KRAS G12D is already described to produce a gain of function.14  Figure 1 Figure 1 Gain-of-function somatic KRAS mutations. (A) Cell subsets were sorted by flow cytometry and used for DNA sequencing; (B) Peripheral blood mononuclear cells (PBMCs) were lysed and used for DNA sequencing; a buccal swab was also sequenced to rule out a ... Clinical history and laboratory findings  Patient 1. This white female patient had a history of lymphadenopathy and splenomegaly first noted at 4 years of age at the time of a tonsillectomy and adenoidectomy for recurrent upper respiratory tract infections. Splenomegaly, autoimmune hemolytic anemia, and thrombocytopenia (Evan syndrome) were diagnosed at follow-up. She was evaluated at the NIH at 9 years of age and was found to have positive serology for several autoantibodies and polyclonal hypergammaglobulinemia as well as persistent splenomegaly and lymphadenopathy (supplemental Table 1). Flow cytometry did not show the hallmark elevation of αβ+-DNTs seen in ALPS but did document B-cell lymphocytosis and monocytosis (supplemental Table 1). Lymph node biopsy showed plasmacytosis but no paracortical infiltration by αβ+-DNTs (supplemental Figure 2). The patient had a history of recurrent infections, including bronchitis, otitis media (several episodes), cellulitis, lymphadenitis, and pneumonia (one episode each), without documentation of an infectious agent. She died at the age of 13 after an episode of fever followed 48 hours later by acute loss of consciousness and cardiac arrest at home. Autopsy studies could not determine the cause of death but ruled out malignancy.  Patient 2. This patient is a white female of Italian ancestry who was first noted to have splenomegaly with neutropenia, monocytosis, reticulocytosis, thrombocytopenia, and hyperuricemia when evaluated for a routine respiratory tract infection with facial rash at 5 years of age. Serologies were positive for Parvovirus B19 and Epstein-Barr virus, and the findings were attributed to acute viral infection, with hematologic parameters returning to near normal levels 5 months later. The patient remained well with the exception of periodic, painful, erythematous bilateral swelling of the ankles progressing to ecchymosis over a short period, which occurred once to twice yearly and was associated with swimming and beach activities. After an abrupt increase in the frequency and severity of these symptoms at 7 years of age, the patient was referred for further evaluation and was found to have pancytopenia, massive splenomegaly with bulky intra-abdominal and inguinal lymphadenopathy, marked hypergammaglobulinemia, and anticardiolipin and anti-β2-glycoprotein-I antibodies. Bone marrow examination showed only a hyperreactive state. Hematologic malignancy and lysosomal storage diseases were excluded. A diagnosis of Evan syndrome was considered on the basis of the presence of antineutrophil and antiplatelet antibodies. She had normal cognitive and motor development throughout these episodes. Weight and height were normal at birth, decreasing progressively to ∼ 3 percentile currently. She continues to the present with rash of the lower extremities presumed to represent a vasculopathy secondary to antiphospholipid syndrome, but she is otherwise well.  KRAS mutation impaired lymphocyte apoptosis and increased proliferation  We evaluated lymphocyte apoptosis and proliferation in samples from patient 1 and found that the KRAS G13C mutation did not impair FAS-mediated apoptosis but induced resistance to apoptosis triggered by interleukin-2 (IL-2) withdrawal of activated T lymphocytes (Figure 2A-B). Because BIM, a proapoptotic protein of the BCL-2 family, is the main mediator of this form of apoptosis,15 we checked the patient's cells and found markedly reduced BIM levels compared with healthy controls or patients with ALPS-FAS (Figure 2C). These findings are reminiscent of our previous work that described a patient with a mutation in NRAS.13 We speculate that low BIM levels underlie the accumulation of B cells and monocytes in these patients, given the critical role for this protein in leukocyte homeostasis in murine models.15  Figure 2 Figure 2 Functional evaluation of patient 1 lymphocytes. Activated peripheral blood mononuclear cells (PBMCs) from normal volunteers (NL), a patient with an inactivating FAS mutation (FAS mut), a patient with a gain-of-function somatic NRAS mutation (NRAS mut), ... Apoptosis resistance in patient 1 was at least partially mediated by downstream extracellular signal-regulated kinase (ERK) and phosphatidyl inositol-3 kinase hyperactivation, because the addition of mitogen-activated protein kinase/ERK kinase 1 (PD98059; 20μM) or phosphatidyl inositol-3 kinase (LY294002; 10μM) inhibitors almost completely abrogated the apoptotic defect in vitro (Figure 2D).16 Myeloid cells from patients with somatic KRAS mutations associated with juvenile myelomonocytic leukemia, unlike normal myeloid cells, expand in the presence of low concentrations of granulocyte-macrophage colony-stimulating factor.17 We hypothesized that a similar phenomenon could occur in this patient's cells and cultured activated primary lymphocytes under limiting IL-2 concentrations and demonstrated increased proliferation compared with controls (Figure 2E). This was linked to low levels of the cell cycle inhibitor protein p27kip1 in primary cells and transfected cell lines, as previously described for cancer cells (Figure 2F).18,19  Because missense mutations at certain RAS codons, including 12, 13, and 61, are known prevent interactions with guanosine triphosphatase (GTPase)–activating proteins and thus greatly decrease GTP hydrolysis, resulting in constitutively active RAS,20 it is reasonable to speculate that the KRAS G12D mutation in patient 2 also impairs apoptosis and proliferation. Moreover, the G12V control showed repressed p27kip1 levels.  Spectrum of clinical manifestations associated with somatic RAS mutations  KRAS is a member of the p21 small GTPase family of proteins that also includes HRAS and NRAS. Germline RAS mutations are associated with specific developmental disorders, including Noonan, Costello, and cardio-facio-cutaneous syndromes.21 Somatic RAS mutations are seen in > 30% of all human cancers.16 In the hematopoietic system, somatic KRAS and NRAS mutations are commonly observed in aggressive tumors such as multiple myeloma or juvenile myelomonocytic leukemia.22  This report and our previous work13 suggest that activating somatic mutations in NRAS or KRAS can be associated with a nonmalignant hematologic syndrome, which we refer to as RAS-associated autoimmune leukoproliferative disease (RALD).23 The factors determining which patients with somatic RAS mutations develop hematologic malignancy versus RALD are unknown, but a previous report also showed that patients with somatic NRAS or KRAS mutations could follow a more benign clinical course.24  The clinical entity described here seems distinct from ALPS in several respects: the characteristic αβ+-DNT cells are present at normal levels or only marginally elevated in the peripheral blood and absent in lymph nodes; there is no defect in the FAS pathway of apoptosis; biomarkers typically associated with ALPS, such as IL-10 and sFASL25,26 are normal; and monocytosis, reminiscent of juvenile myelomonocytic leukemia, was seen in all the patients evaluated to date (supplemental Table 2).  We suggest that RALD should be considered in the differential diagnosis of patients with autoimmune cytopenias, monocytosis, and lymphoid organ expansion. These patients may in the future benefit from therapies directed at blocking ERK and/or RAS that are under development as cancer therapeutics.\n"
     ]
    }
   ],
   "source": [
    "print('Example text:')\n",
    "print('')\n",
    "print(training_text.sample(1)['Text'].values[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Longest text:\n",
      "\n",
      "Activation of the phosphoinositide 3-kinase (PI3K) pathway has been implicated in the pathogenesis of a variety of cancers. Recently, mutations in the gene encoding the p110α catalytic subunit of PI3K (PIK3CA) have been identified in several human cancers. The mutations primarily result in single amino acid substitutions, with >85% of the mutations in either exon 9 or 20. Multiple studies have shown that these mutations are observed in 18% to 40% of breast cancers. However, the phenotypic effects of these PIK3CA mutations have not been examined in breast epithelial cells. Herein, we examine the activity of the two most common variants, E545K and H1047R, in the MCF-10A immortalized breast epithelial cell line. Both variants display higher PI3K activity than wild-type p110α yet remain sensitive to pharmacologic PI3K inhibition. In addition, expression of p110α mutants in mammary epithelial cells induces multiple phenotypic alterations characteristic of breast tumor cells, including anchorage-independent proliferation in soft agar, growth factor–independent proliferation, and protection from anoikis. Expression of these mutant p110α isoforms also confers increased resistance to paclitaxel and induces abnormal mammary acinar morphogenesis in three-dimensional basement membrane cultures. Together, these data support the notion that the cancer-associated mutations in PIK3CA may significantly contribute to breast cancer pathogenesis and represent attractive targets for therapeutic inhibition.  Introduction  The phosphoinositide 3-kinase (PI3K) family of lipid kinases is implicated in oncogenesis in many different cellular paradigms ( 1). Type 1a PI3Ks are composed of a heterodimer with a p85 regulatory subunit and a p110 catalytic subunit ( 2). Stimulation of cells by a variety of extracellular signals activates PI3K by recruitment to specific phosphotyrosine residues on signaling molecules via the two SH2 domains of the p85 subunit. This interaction results in increased catalytic activity and localizes PI3K to the site of its membrane-bound phosphatidylinositol substrates to generate phosphatidylinositol-3,4-bisphosphate [PI(3,4)P2] and phosphatidylinositol-3,4,5-trisphosphate [PI(3,4,5)P3]. These lipid second messengers then activate downstream pathways involved in many fundamental cellular processes, including proliferation, cell survival, motility, and cell growth ( 2). The PI3K pathway is negatively regulated by the PTEN phosphatase, which removes the 3-phosphate from PI(3,4)P2 and PI(3,4,5)P3, turning off the signaling cascade ( 3).  Dysregulation of the PI3K pathway is implicated in many cancers. Loss-of-function mutations in PTEN result in hyperactivity of the PI3K pathway. Such mutations are found in a variety of cancers, including breast, lung, prostate, endometrial, melanoma, glioblastoma, and lymphoma ( 4). Germ line mutations in PTEN are found in several genetic syndromes, such as Cowden disease, which predisposes patients to breast, thyroid, and other cancers ( 3). The serine/threonine kinase Akt/protein kinase B (PKB), a downstream target of PI3K activation, was initially identified as a retroviral oncogene that leads to its constitutive activation ( 5) and is amplified or up-regulated in gastric ( 6), pancreatic ( 7), and ovarian and breast ( 8, 9) cancers. Recently, oncogenic somatic mutations in the gene encoding the p85 regulatory subunit have been identified in colon and ovarian cancers in which a short deletion leads to constitutive PI3K activation ( 10). Amplification of the gene encoding the p110α subunit of PI3K (PIK3CA) occurs in ovarian ( 11), cervical ( 12, 13), head and neck ( 14), non–small cell lung ( 15), and esophageal ( 16) cancers. However, no such amplification has been identified in breast cancer ( 11).  Recently, somatic mutations in PIK3CA were identified in colon, brain, gastric, breast, and lung cancers ( 17). Several subsequent studies reported that 18% to 40% of breast cancer samples harbor mutations in PIK3CA ( 18– 22). Although >25 mutations in PIK3CA were identified, the majority lie in two hotspot regions, including the central helical domain encoded by exon 9 and the COOH-terminal kinase domain encoded by exon 20. The two most common mutations led to amino acid changes of E545K in the helical domain and H1047R in the kinase domain. This raised the intriguing possibility that such mutations may result in increased PI3K activity in vivo. Indeed, overexpression of the H1047R mutant in NIH3T3 cells resulted in increased in vitro PI3K activity ( 17). Additionally, overexpression of these PI3K mutants in chicken embryo fibroblasts and NIH3T3 cells resulted in increased PI3K activity and transformation ( 23, 24).  The high frequency of PIK3CA mutations reported in breast cancer suggests that they may play an important role in breast cancer pathogenesis. We therefore sought to examine the phenotypic alterations induced by stable expression of these cancer-associated PI3K mutants in nontransformed mammary epithelial cells. We report here that mammary epithelial cells harboring either of the two most common PIK3CA mutations, E545K and H1047R, display constitutive activation of Akt and phenotypes that model certain hallmarks of cancer, including anchorage-independent growth in soft agar, protection from anoikis, and growth factor–independent growth. In addition, expression of these mutations induces abnormal acinar formation using a three-dimensional mammary morphogenesis model and results in increased resistance to chemotherapy.  Materials and Methods  Cell lines and cell culture. MCF-10A cells were obtained from American Type Culture Collection (Manassas, VA) and cultured as described ( 25) in growth medium containing DMEM/F-12 (Invitrogen, Carlsbad, CA) supplemented with 5% donor horse serum (HS), 20 ng/mL epidermal growth factor (EGF), 10 μg/mL insulin, 100 μg/mL hydrocortisone, 1 ng/mL cholera toxin, 50 units/mL penicillin, and 50 mg/mL streptomycin. Where indicated, cells were cultured in starvation medium (growth medium lacking EGF and insulin). MCF-10A cells expressing the p110α variants were generated by retroviral gene transfer. Hemagglutinin (HA)–tagged bovine PIK3CA cDNA was subcloned into the pDNR-Dual vector (Clontech, Mountain View, CA), and site-directed mutagenesis (Quick Change, Stratagene, La Jolla, CA) was used to generate the E545K and H1047R variants (primers available upon request). All variant cDNAs were shuttled into the JP1520 retroviral vector ( 26) 6 using the BD Creator System (Clontech). Vesicular stomatitis virus–pseudotyped retroviruses were generated as described previously ( 27) and used to infect MCF-10A cells. Stable populations were obtained by selection with 2 μg/mL puromycin (Sigma-Aldrich, St. Louis, MO).  Immunoblots. Cell lysates were prepared in NP40 lysis buffer [50 mmol/L Tris (pH 7.6), 150 mmol/L NaCl, 1% NP40, 10% glycerol] supplemented with leupeptin (2 μg/mL), aprotinin (2 μg/mL), phenylmethylsulfonyl fluoride (PMSF; 1 mmol/L), NaF (50 mmol/L), and Na3VO4 (1 mmol/L). Lysates were cleared by centrifugation at 16,000 × g for 15 minutes at 4°C and the supernatant was used for all subsequent procedures. Lysates were separated by SDS-PAGE and transferred to either nitrocellulose or polyvinylidene difluoride membranes. Immunoblotting was done according to the antibody manufacturers' recommendations using enhanced chemiluminescence. Antibodies used for immunoblotting were HA.11 (Covance, Berkeley, CA); anti-p-Akt (S473), anti-p70S6K (T389), anti-S6, anti-eIF4e, anti-p110α, and anti-p-Erk (Cell Signaling, Beverly, MA); and anti-Erk, anti-Akt1, and anti-p85 (Upstate Biotechnology, Lake Placid, NY). In preliminary experiments, we noted that in MCF-10A cells the addition of insulin to the starvation medium had no effect on p-Akt or p-Erk levels. For simplicity, unless specifically noted in the text, we used starvation medium lacking both EGF and insulin. Cells were cultured in starvation medium for 24 hours or for the indicated time before lysis and stimulated for 10 minutes with full growth medium containing EGF and insulin as indicated. LY294002 and rapamycin (Calbiochem, San Diego, CA) in DMSO were added to cells 1 hour before lysis as indicated.  Phosphoinositide 3-kinase assay. The assay was done as described previously with minor modifications ( 28). Briefly, MCF-10A cells were lysed with lysis buffer [25 mmol/L Tris-HCl (pH 7.4), 150 mmol/L NaCl, 1% NP40, 1 mmol/L EDTA, 20 mmol/L NaF, 10 mmol/L NaPPi, 50 mmol/L DTT, 1 mmol/L Na3VO4, 1 mmol/L PMSF, 4 μg/mL each of leupeptin, aprotinin, and pepstatin]. The lysate was clarified by centrifugation, and PI3K was immunoprecipitated overnight at 4°C with anti-HA antibody. The immunoprecipitate was captured on protein G-Sepharose beads and washed thrice with immunoprecipitation wash buffer [25 mmol/L Tris-HCl (pH 7.4), 150 mmol/L NaCl, 1% NP40, 1 mmol/L EDTA, 20 mmol/L NaF, 10 mmol/L NaPPi, 50 mmol/L β-glycerophosphate] and thrice with kinase assay buffer [20 mmol/L Tris-HCl (pH 7.4), 100 mmol/L NaCl, 0.5 mmol/L EGTA]. The immunoprecipitated PI3K was preincubated with a lipid substrate mix of phosphatidylserine and phosphatidylinositol [in 30 mmol/L HEPES (pH 7.4), 1 mmol/L EGTA] at room temperature for 10 minutes. Kinase reaction was initiated with the addition of [γ-32P]ATP [in 30 mmol/L HEPES (pH 7.4), 10 mmol/L MgCl2, 0.5 mmol/L ATP] and allowed to proceed for 10 minutes at room temperature before termination with 4 mol/L HCl. The phospholipid products were extracted with methanol/CHCl3 (1:1). The organic fraction contained the phospholipids that were separated by TLC with 2 mol/L acetic acid/n-propyl alcohol (35:65) as solvent. Phospholipid signal was quantified using a PhosphoImager screen. For experiments assessing inhibition by LY294002 in vitro, the inhibitor was added to the lipid mix to yield the final indicated concentrations.  Growth curves and fluorescence-activated cell sorting. MCF-10A cells were seeded in triplicate at 25 × 103 per well in 12-well plates on day 0 in growth medium lacking EGF. Cells were trypsinized and counted with a hemacytometer on days 1, 4, 7, and 10. Fresh medium was changed on the same days. For cell cycle analysis by fluorescence-activated cell sorting (FACS), cells were seeded at 500,000 per 10-cm plate in growth medium for 24 hours and then changed to either fresh growth medium or growth medium lacking EGF for another 24 hours. Cells were harvested by incubating the cells at 37°C in PBS with 2.5 mmol/L EDTA for 30 minutes. Following EDTA treatment, the cells were fixed in 80% ethanol for 15 minutes at 4°C. After fixation, the cells were washed with PBS containing 1% goat serum and stained at 37°C for 1 hour in propidium iodide/RNase A solution (PBS with 2.5 mmol/L EDTA, 10 μg/mL propidium iodide, 0.25 mg/mL RNase A). Flow cytometry was done to determine DNA content using a BD Biosciences FACSCalibur, and data were analyzed using CellQuest (BD Biosciences, San Jose, CA).  Colony formation in soft agar assay. To assess anchorage-independent growth, triplicate samples of 5 × 104 cells from each MCF-10A-derived cell line were mixed 4:1 (v/v) with 2.0% agarose in MCF-10A growth medium for a final concentration of 0.4% agarose. The cell mixture was plated on top of a solidified layer of 0.5% agarose in growth medium. Cells were fed every 6 to 7 days with growth medium containing 0.4% agarose. Cells were stained with 0.02% iodonitrotetrazolium chloride (Sigma-Aldrich) and photographed after 21 days. Colonies in the entire well were counted using a dissecting microscope and colonies larger than 50 μm were included.  Anoikis assay. Detachment-induced cell death was assayed essentially as described ( 29). Six-well tissue culture plates were coated with 6 mg/mL poly-HEMA in 95% ethanol, incubated at 37°C for several days until dry, and rinsed with PBS. MCF-10A cells were then plated at 400,000 per well in 2 mL growth medium for 42 hours. Cells were collected and washed with PBS. Apoptosis was measured using a Cell Death Detection ELISA kit according to the manufacturer's instructions (Roche Diagnostics, Mannheim, Germany). Cells were lysed in 600 μL lysis buffer supplied with the kit and 20-μL lysate was used in the assay. Absorbance at 405 nm was measured and is reported with arbitrary units. In parallel, 2 × 106 cells were plated in poly-HEMA-coated 10-cm plates for 42 hours, lysed, and analyzed by Western blot as described above.  Morphogenesis assay. The three-dimensional culture of MCF-10A cells on basement membrane was carried out as described previously ( 25, 30). Briefly, 5 × 103 cells were resuspended in modified growth medium containing 2% Matrigel (BD Biosciences), 2% HS, and 5 ng/mL EGF plus all other additives and seeded on top of a layer of growth factor–reduced Matrigel. Medium was exchanged every 4 days. Rapamycin (20 nmol/L) was added to cultures as indicated on day 2 of three-dimensional culture and exchanged every 4 days thereafter. Photographs of representative fields were taken on day 6.  Cell viability assay. MCF-10A cells were seeded in 96-well plates at 104 per well in 100 μL growth medium and allowed to adhere overnight. The next day, paclitaxel was added by 2-fold serial dilutions. After 24 hours, cell viability was quantified by MTS assay using the CellTiter 96 Aqueous kit (Promega, Madison, WI) according to the manufacturer's instructions. Untreated wells of each cell line were used as the control for calculation of percent viability. Wells were plated in at least triplicate for each experiment.  Results  Cancer-associated mutations in PIK3CA promote constitutive activation of Akt in mammary epithelial cells. To determine whether cancer-associated PIK3CA mutations promote growth factor–independent activation of the PI3K pathway in human mammary epithelial cells, we generated vectors encoding HA epitope–tagged p110α variants containing each of the two most common amino acid substitutions found in breast cancer, E545K and H1047R. Stable pools of MCF-10A mammary epithelial cells expressing either variant were generated by retroviral infection, and the activation of Akt/PKB was monitored by analyzing phosphorylation at S473. After 24 hours of growth factor (EGF and insulin) withdrawal, there was a significant loss of S473 phosphorylation (p-Akt) in MCF-10A cells expressing wild-type (WT) p110α and control MCF-10A cells compared with cells maintained in growth medium ( Fig. 1A ). In contrast, cells expressing mutant p110α maintained p-Akt in the absence of growth factors. When maintained in growth medium, the level of basal p-Akt was greater in the mutant p110α cell lines than in WT p110α or control cells ( Fig. 1A). On acute growth factor stimulation, all cell lines displayed increased p-Akt. There was no difference in expression levels of p85 between control and mutant cell lines. Cells harboring PIK3CA mutations also displayed slightly increased p-Erk levels after growth factor withdrawal ( Fig. 1A). However, the p-Erk levels promoted by the PIK3CA mutations in the absence of growth factors were lower than those observed when cells were cultured in normal growth medium.  Figure 1. Download figureOpen in new tabDownload powerpoint Figure 1. Constitutive activation of the PI3K pathway in mammary epithelial cells expressing p110α mutants. A, MCF-10A cells expressing WT or mutant (H1047R and E545K) HA-tagged p110α or vector control (C) were seeded in growth medium for 24 hours and then cultured in starvation medium (-) or growth medium (G), which contains 20 ng/mL EGF and 10 μg/mL insulin, for an additional 24 hours, lysed, and immunoblotted with the indicated antibodies. As a control, after 24 hours in starvation medium, cells were stimulated for 10 minutes with growth medium (+). B, cell lines as above were deprived of EGF and insulin for 24 hours and then stimulated for 10 minutes with increasing concentrations of EGF as indicated. Lysates were immunoblotted as indicated. C, cell lines were seeded in six-well plates in growth medium overnight, and growth medium was replaced with starvation medium lacking EGF and insulin for the indicated time points. Lysates were immunoblotted with antibodies as indicated. To further evaluate the sensitivity of the mutant p110α isoforms to growth factor stimulation, a dose-response curve was generated using increasing concentrations of EGF ( Fig. 1B). In p110α mutant-expressing cells, the basal level of p-Akt was near maximal, whereas in control and WT-expressing cells, 0.05 to 0.5 ng/mL EGF were necessary to achieve a similar relative activation ( Fig. 1B; data not shown). In addition, the basal p-Akt in the mutant-expressing cells was greater than the maximal p-Akt in controls. Together, these results show that p110α harboring the mutations found in breast cancer functionally activate the PI3K/Akt pathway in mammary epithelial cells in an EGF- and insulin-independent manner.  To investigate the kinetics of the Akt regulation following growth factor withdrawal, we analyzed lysates collected over a time course of EGF and insulin withdrawal from the various cell lines ( Fig. 1C). Four hours after growth factor withdrawal, control and WT cells display maximally reduced levels of p-Akt, whereas the E545K and H1047R cells have persistent p-Akt. Cells expressing the mutant p110α continue to sustain abundant levels of p-Akt for at least 48 hours after growth factor withdrawal. In addition, on growth factor withdrawal, the time course of dephosphorylation of the S6 ribosomal protein target of p70S6 kinase was slightly delayed ( Fig. 1C). A similar delay in dephosphorylation of Erk was observed ( Fig. 1C), in agreement with the slight enhancement of p-Erk levels observed in Fig. 1A. The evidence that sustained activation of Akt does not lead to maintenance of p70S6K activation suggests that Akt-independent modes of regulation of the mammalian target of rapamycin (mTOR) pathway are dominant in these conditions.  After 24 to 48 hours of EGF withdrawal, the relative expression level of the recombinant p110α increased, with the mutants increasing to a greater extent than the WT ( Fig. 1C). This is consistent with the expression level observed in Fig. 1A after 24 hours of growth factor withdrawal (compare - and G in Fig. 1A, top). Immunoblotting with anti-p110α antibodies shows that the expression of total p110α was equivalent in the WT and mutant cell lines when cultured in normal growth medium. The p110α antibody is a monoclonal antibody raised against amino acids 100 to 300 of human p110α, which is identical to bovine p110α, except for three amino acids, and seems to recognize the endogenous human and the recombinant bovine proteins approximately equally. 7 Thus, it seems that although there are equivalent levels of total p110α and p85 in the WT and mutant cell lines, on growth factor withdrawal, the mutant p110α comprises more of the total p110α. The PIK3CA cDNA is under control of the cytomegalovirus promoter in the retroviral vector, which may account for the relative increase in expression of the recombinant p110α compared with the endogenous p110α. The data above temporally dissociate the apparent induction of mutant p110α at 24 to 48 hours of growth factor withdrawal from the increased level of p-Akt present at 4 hours of withdrawal. Therefore, the increased activation of the PI3K pathway is unlikely to be explained by the slight relative increase observed in p110α after growth factor withdrawal.  The PIK3CA mutations confer increased in vitro phosphoinositide 3-kinase activity and are sensitive to pharmacologic phosphoinositide 3-kinase inhibition. To test whether introduction of the cancer-associated mutations into PIK3CA causes an increase in PI3K activity, lysates from the MCF-10A cells grown in the absence of growth factors for 24 hours were immunoprecipitated with anti-HA antibodies, and in vitro PI3K assays were done. The PI3K activity of the H1047R and E545K mutant proteins was 2.5- to 3.5-fold higher than WT ( Fig. 2A ). Notably, the amount of the p85 regulatory subunit of PI3K that coimmunoprecipitated with p110α was similar between mutant and WT cell lines. This shows that the PIK3CA mutations increase the intrinsic kinase activity of PI3K and further suggests that the difference in PI3K activity noted above is not due to quantitative differences in binding to p85. It does not exclude, however, that qualitative differences in protein interactions or conformations exist.  Figure 2. Download figureOpen in new tabDownload powerpoint Figure 2. Increased in vitro PI3K activity of mutant p110α and inhibition by LY294002. A, MCF-10A cells as in Fig. 1A were lysed and p110α was immunoprecipitated with HA antibodies. Immunoprecipitates were split in half and one half was immunoblotted with anti-HA and anti-p85 as indicated (top two). The other half was subjected to in vitro PI3K assays that were quantified by PhosphoImager analysis and the data are plotted as arbitrary units (bottom two). Samples from each cell line were prepared and analyzed in duplicate. Representative of three independent experiments. B, cell lines as in (A) were lysed and immunoprecipitated as in (A). Increasing levels of the PI3K inhibitor LY294002 (LY) were added directly to the in vitro reaction at the indicated concentration, and PI3K assays were done as in (A). C, cell lines as in (A) were cultured in starvation medium for 24 hours. Cells were then either left in control starvation medium (C) or incubated for 1 hour in starvation medium containing 20 nmol/L rapamycin (R) or 20 μmol/L LY294002 (L). After 1 hour, cells were either lysed directly (-) or stimulated with growth medium (+) containing the indicated inhibitor for 10 minutes and lysed. Lysates were immunoblotted with the indicated antibodies. Several pharmacologic inhibitors of the PI3K family have been developed, including the fungal metabolite wortmannin and the structurally unrelated molecule LY294002, and additional PI3K inhibitors are in preclinical development ( 31). Increasing doses of LY294002 inhibited the in vitro PI3K activity of the mutant and WT isoforms similarly ( Fig. 2B). Although the mutant p110α isoforms had greater baseline activity than untreated WT control, activity was inhibited to a similar degree ( Fig. 2B; data not shown). To further examine whether the PI3K pathway was inhibited by LY294002 in cells, the MCF-10A cells were incubated in starvation medium overnight and analyzed for p-Akt after LY294002 treatment. In the absence of LY294002, the H1047R and E545K mutants displayed higher basal p-Akt compared with control and WT cells ( Fig. 2C). After LY294002 treatment, the mutant cell lines lost detectable p-Akt, thereby showing that pharmacologic inhibition of cancer-associated mutant p110α results in decreased p-Akt. Furthermore, stimulation of cells for 10 minutes with EGF-induced p-Akt in all cell lines, and this induction was also blocked by LY294002. As expected, treatment of cells with the mTOR inhibitor rapamycin did not affect p-Akt. The mutant cell lines showed small but reproducible basal phosphorylation of p70S6K (pp70), which was inhibited by rapamycin and LY294002. Rapamycin and LY294002 did effectively inhibit phosphorylation of p70S6K on EGF stimulation. Together, these results show that the PI3K mutants have increased PI3K enzymatic activity, which is inhibited in vitro and in vivo by pharmacologic inhibitors of PI3K. Furthermore, rapamycin remains an effective inhibitor of the PI3K pathway downstream of mTOR. This may be important given that PIK3CA mutations are present in a significant percentage of breast cancer and rapamycin, and its analogues are currently in clinical trials assessing their efficacy as antitumor agents alone and in combination with other agents.  Mutant p110α expression permits epidermal growth factor–independent growth. Growth factor–independent proliferation is a common feature of transformed cells and is considered one of the hallmarks of cancer ( 32). MCF-10A cells are not transformed and their proliferation requires EGF in the growth medium. This requirement can be overcome by exogenous expression of several oncogenes, such as activated colony-stimulating factor receptor (CSF-1R; ref. 33), activated mitogen-activated protein kinase/extracellular signal-regulated kinase kinase ( 34), Ras, and Raf. 8 We tested whether expression of the activated PI3K mutants in MCF-10A cells was sufficient for EGF-independent growth. Each of the two mutant PI3K-expressing cell lines was able to proliferate in the absence of EGF, whereas the WT and control cells were not ( Fig. 3A ). In the cell lines harboring mutant PIK3CA, there was no difference in proliferation relative to WT-expressing cells when EGF was maintained in the growth medium (data not shown). To confirm this observation, the fraction of cells in the S phase of the cell cycle was determined by FACS analysis in the presence of EGF or after 24 hours of EGF withdrawal. In the absence of EGF, the PI3K mutant cells showed a 2-fold increase in the percentage of S phase cells compared with control and WT cells ( Fig. 3B). As expected, there was no difference between mutant and WT cells grown in the presence of EGF ( Fig. 3B). Together, these results show that expression of the cancer-associated, constitutively active PI3K mutants is sufficient to allow for EGF-independent monolayer growth of MCF-10A cells.  Figure 3. Download figureOpen in new tabDownload powerpoint Figure 3. Effects of PIK3CA mutations on growth factor–independent cell growth. A, MCF-10A cells as in Fig. 1A were seeded in 12-well plates at 25 × 103 per well in growth medium lacking EGF on day 0 and cell numbers were plotted for each day indicated. Each experiment was done with triplicate wells. Points, mean; bars, SD. Representative experiment. B, cells were seeded at 5 × 105 per 10-cm plate overnight. Medium was then exchanged with fresh growth medium (+EGF) or growth medium lacking (-EGF) for 24 hours. Cells were then collected, fixed, and analyzed by FACS to determine the percentage of cells in the S phase of the cell cycle. Cancer-associated mutations in PIK3CA induce anchorage-independent survival and proliferation. The ability of cells to form colonies in soft agar is a property of transformed cells that best correlates with in vivo tumorigenicity ( 35). Each of the mutant PI3K cell lines formed colonies in soft agar, but neither control MCF-10A cells nor cells expressing WT PI3K were able to do so ( Fig. 4A ). The mutants were equivalent in their ability to form colonies ( Fig. 4A). Therefore, the cancer-associated mutations in PI3K are able to induce anchorage-independent proliferation in mammary epithelial cells.  Figure 4. Download figureOpen in new tabDownload powerpoint Figure 4. Effects of PIK3CA mutations on anchorage-independent proliferation and survival. A, soft agar colony formation. MCF-10A cells as in Fig. 1A were plated as described in Materials and Methods. Columns, mean of a representative experiment done in triplicate wells; bars, SD. Bar, 1 mm. B, anoikis. Cell lines were cultured in suspension in poly-HEMA-coated plates for 42 hours as described in Materials and Methods. Apoptosis was measured using a colorimetric ELISA assay to detect histone release. Results are plotted as arbitrary units of absorbance at 405 nm. Greater absorbance indicates greater apoptosis and histone release. Columns, mean of a representative experiment done in triplicate; bars, SD. Immunoblotting was done on a second set of suspended cells prepared in parallel to assess the level of p-Akt (S473). A common feature of malignant transformation is the ability to evade apoptotic cell death signals ( 32). Epithelial cells and endothelial cells require extracellular matrix attachment for cell survival and undergo apoptosis when detached from the matrix through a process called anoikis ( 36). Malignant cells are often resistant to anoikis, and activation of the PI3K pathway has been shown to contribute to the survival of transformed cells after detachment ( 37). Activation of Akt has been shown to protect MCF-10A cells from anoikis ( 29, 38). Expression of the PI3K mutants in MCF-10A cells resulted in a 2-fold reduction in anoikis compared with control cells ( Fig. 4B). However, expression of WT p110α failed to provide any protection. Protection from anoikis correlated with persistent p-Akt in the mutant p110α cell lines compared with control or WT ( Fig. 4B), showing that the activated p110α mutants continued to signal through the Akt pathway in suspension.  Altered three-dimensional acinar morphogenesis induced by the PIK3CA mutations. Mammary epithelial cells form acinar-like structures consisting of an outer layer of polarized, growth-arrested epithelial cells surrounding a hollow lumen and basal deposition of basement membrane components when plated within a reconstituted basement membrane gel ( 25, 39). Our laboratory has shown previously the utility of this model system to study the phenotypes induced by oncogenes, such as ErbB2, CSF-1R, and Akt ( 30, 33, 34). Inducible activation of ErbB2 homodimers in this model results in generation of multiacinar structures with constitutively proliferating cells that fill the hollow lumens ( 30). Inducible activation of Akt results in large, partially filled, misshapen acini and this phenotype was effectively inhibited by the mTOR inhibitor rapamycin ( 34). These distorted epithelial structures are reminiscent of the aberration in glandular structures commonly observed in premalignant, noninvasive tumors.  When cultured in Matrigel, MCF-10A cells expressing the active PI3K mutants formed large, highly proliferative, abnormal structures that did not invade into the surrounding matrix ( Fig. 5 ). In contrast, WT cells formed acini similar to control cells ( Fig. 5). Treatment with rapamycin prevented the abnormal acinar morphogenesis, suggesting that the Akt/mTOR pathway is necessary for the full phenotypic effect of the activated PI3K in this model system ( Fig. 5). This result is in agreement with previous data from our laboratory showing that rapamycin prevented abnormal morphogenesis induced by activated Akt ( 34).  Figure 5. Download figureOpen in new tabDownload powerpoint Figure 5. Effects of PIK3CA mutations on mammary acinar morphogenesis. MCF-10A cells as in Fig. 1A were cultured on a bed of Matrigel as described in Materials and Methods. Rapamycin (20 nmol/L; +Rap) was added (bottom) to culture medium on day 1 and maintained in culture medium. Representative bright-field images of acini taken on day 6. Bar, 100 μm. PIK3CA mutations confer resistance to chemotherapy. A growing body of evidence supports a role for the PI3K pathway in mediating resistance to traditional and targeted chemotherapies ( 40– 45). We determined whether MCF-10A cells expressing the active PI3K mutants were more resistant to paclitaxel than control or WT cells. After 24 hours of exposure to varying concentrations of paclitaxel, cells expressing the active PI3K mutants had increased viability compared with control or WT cells ( Fig. 6 ). The IC50 of control cells was ∼8 nmol/L, whereas the IC50 for cells expressing activated PI3K was not reached at this time point for paclitaxel doses up to 128 nmol/L. These results support the hypothesis that somatic mutation of PIK3CA may represent another mechanism by which cancer cells develop resistance to chemotherapy and further support that inhibiting the PI3K pathway may restore chemotherapy sensitivity.  Figure 6. Download figureOpen in new tabDownload powerpoint Figure 6. Effect of PIK3CA mutations on paclitaxel sensitivity. MCF-10A cells as in Fig. 1A were seeded at 10 × 103 per well in 96-well plates overnight. Two-fold serial dilutions of paclitaxel from 128 to 0.25 nmol/L were added at the indicated doses, and 24 hours later, cell viability was determined by MTS assay. Results are presented as the % viability of each cell line at the indicated paclitaxel dose compared with untreated cells. Points, mean of three independent experiments; bars, SD. Discussion  In this study, we have evaluated the phenotypic alterations in MCF-10A mammary epithelial cells induced by expression of the recently discovered PIK3CA mutations. Our findings support the involvement of these mutations in breast tumor pathogenesis based on their ability to induce colonies in soft agar and hyperproliferative, abnormal acini in three-dimensional culture, protect from anoikis, promote growth factor–independent proliferation, and confer resistance to chemotherapy. In addition, our results indicate that these mutations promote increased PI3K activity and PI3K/Akt signaling in the absence of growth factors.  The compiled data from several studies indicate that ∼25% to 30% of breast cancers harbor mutations in PIK3CA ( 17– 22). The two most frequent mutations result in amino acid substitutions at H1047R and E545K, the two mutations used in our investigations. Interestingly, alterations leading to loss of PTEN expression are rarely observed in the same tumors as those containing PIK3CA mutations ( 21). This may be expected because either event results in increased 3-phosphoinositide levels. Thus, either loss of PTEN expression or PIK3CA mutation likely occurs in ∼50% to 75% of breast cancers, underscoring the importance of the PI3K pathway in breast cancer and making it the most commonly mutated pathway in breast cancer known to date. The data in this article strengthen conclusions from previous studies that the cancer-associated PIK3CA mutations ( 17, 23, 24, 46) or membrane targeting of p110α ( 47) confer oncogenic activity to this key regulatory protein and this study is the first to show that expression of the two most frequently mutated variants of PIK3CA are sufficient to transform mammary epithelial cells. Thus, inhibitors that specifically target PI3K may be particularly effective for the treatment of breast cancers harboring these mutations.  Expression of the activated p110α isoforms in MCF-10A cells promoted EGF-independent cell proliferation in monolayer culture. In contrast, MCF-10A cells expressing activated Akt are dependent on EGF for monolayer growth ( 34). This suggests that activating mutations of PI3K induce additional Akt-independent signaling pathways that are necessary for EGF-independent monolayer growth. This is consistent with previous observations that human mammary epithelial cells immortalized with hTERT and LT can proliferate in medium with reduced growth factors on expression of either myr-p110α alone or activated Akt and Rac together ( 47). However, activated Akt alone was not able to support growth under the same conditions.  When cultured in Matrigel, MCF-10A cells expressing mutant p110α are able to form large disorganized structures and escape the controls that normally limit their proliferation in acinar structures. In contrast to their behavior in monolayer culture, cells expressing mutant p110α were unable to proliferate in Matrigel in the absence of EGF. 9 A similar EGF dependence for three-dimensional growth was observed in cells expressing activated Akt, and the EGF requirement in those cells could be overcome by coexpression of the proliferative oncogenes human papillomavirus E7 or cyclin D1 ( 34). Therefore, activation of the PI3K pathway at the level of PI3K itself provides a sufficient proliferative signal to allow for monolayer growth in the absence of EGF, but the proliferative signal is not strong enough to overcome the constraints imposed in the three-dimensional morphogenesis system. Importantly, rapamycin inhibited the abnormal morphogenesis induced by activated PI3K but did not prevent the development of normal acinar structures. This suggests that the mTOR pathway is required for mediating the abnormal morphogenesis induced by activated PI3K but not normal morphogenesis. This supports the idea that inhibition of mTOR by rapamycin or its analogues may be a viable strategy in patients harboring mutations in PIK3CA.  A variety of chemotherapeutic agents converge on a common final pathway leading to apoptotic cell death. Activation of the PI3K pathway has been shown to enhance the survival of breast cancer cells in response to such agents and contribute to chemotherapy resistance ( 38, 40, 42, 48, 49). Here, we used a cell viability assay to show that mammary epithelial cells expressing the activated p110α isoforms found in breast cancer were more resistant to paclitaxel chemotherapy than control cells. The PI3K pathway may lead to increased resistance to paclitaxel by several mechanisms. Akt activation leads to phosphorylation of the proapoptotic protein BAD, thereby preventing its association with BCL-XL, resulting in reduced apoptosis following paclitaxel treatment in ovarian carcinoma cells ( 50). Furthermore, activation of PI3K has been shown to induce expression and activation of MDR-1 and MRP-1 in breast and prostate cancer cell lines ( 43, 51), possibly contributing to paclitaxel resistance. Recent data also suggest that regulation of glycogen synthase kinase 3β downstream of Akt may also contribute to paclitaxel sensitivity ( 52). Further work to elucidate the mechanisms by which the PI3K pathway may contribute to chemotherapy resistance may have important implications for clinical trials combining traditional chemotherapies with novel agents, particularly in patients harboring activated PI3K mutations. If the presence of PIK3CA mutations in breast cancer patients correlates with increased resistance to chemotherapy, then agents that target the PI3K/Akt pathway may be particularly useful to restore sensitivity in these patients. Indeed, recent preclinical data support the rationale of combining rapamycin with paclitaxel in breast cancer cell lines ( 53).  While this article was in preparation, Samuels et al. reported findings regarding the function of the PIK3CA mutations in colon cancer cell lines ( 46). In their study, they evaluated two colon cancer cell lines that harbor oncogenic PIK3CA mutations and, using gene targeting inactivation techniques, isolated clones of these cell lines that had either WT PIK3CA or mutant PIK3CA. The clones with the mutant PIK3CA had increased levels of p-Akt and p-FKHRL. In the absence of serum, the mutant clones formed more colonies in soft agar and showed greater proliferation in monolayer culture. Our investigations are indeed complementary and, together with the experiments in chicken embryo fibroblasts ( 23) and NIH3T3 cells ( 24), provide compelling evidence that mutant PIK3CA confers an oncogenic stimulus. Whereas our studies reveal that expression of these p110α mutants in nontransformed, mammary epithelial cells confers an oncogenic phenotype, their study shows that inactivation of the mutant PIK3CA oncogene renders a cancer cell line less transforming in the absence of serum.  What is the mechanism of action by which these mutations promote oncogenic phenotypes? Our studies reveal that immunoprecipitated PI3K containing the mutant p110α subunits have increased in vitro lipid kinase activity compared with WT PI3K ( Fig. 2). These findings agree with other published reports ( 17, 23, 24). We also observe increased levels of p-Akt in growth factor–starved MCF-10A cells harboring PIK3CA mutations, a finding also observed by others when these mutants were expressed in fibroblasts. Thus, these mutant p110α subunits seem to result in constitutive activation of PI3K, which likely accounts for its oncogenic phenotype.  However, the molecular mechanisms by which these mutations promote increased PI3K activation remain unknown. Although one study reported that rare PIK3CA mutations in the p85-binding domain resulted in a decreased association with p85, this does not seem to be the case with the common H1047R and E545K mutations ( Fig. 2). Because the total amount of PI3K holoenzyme in a cell is often limited by the available p110, it is possible that the mutations could increase PI3K signaling by promoting increased levels of p110α. However, we found no increase in the half-life of the mutant compared with WT p110α (data not shown) and the levels of total p85 and p110α were similar in MCF-10A cells expressing WT and mutant PI3K ( Fig. 1C). Additionally, as mentioned above, the mutants have increased PI3K activity in vitro ( Fig. 2), suggesting that the mutations lead to a structural or conformational alteration that leads to increased activity of the PI3K holoenzyme.  A recent study showed that mutation of the p85 regulatory subunit of PI3K can confer oncogenic capacity to this adaptor protein. Truncation of p85 has been observed in ovarian and colon cancers. These p85 mutations are believed to promote transformation via constitutive activation of PI3K ( 10). Interestingly, a recent report showed that a deletion mutant of p85 truncated at position 571 (p65), near the end of the inter-SH2 (iSH2) domain, increases PI3K activity ( 54). Using heteronuclear nuclear magnetic resonance spectroscopy, the authors show that the COOH-terminal end of the iSH2 domain (581-593) is closely associated with the NH2-terminal SH2 (NSH2) domain of p85. The NSH2 domain of p85 negatively regulates PI3K activity ( 55) and thus is thought to maintain PI3K in a low activity state until the NSH2 domain engages phosphotyrosine-containing proteins. The authors therefore conclude that p65 loses the packing interaction between the iSH2 domain and the NSH2 domain, thereby relieving the NSH2 inhibition of PI3K resulting in increased PI3K activity. The authors further suggest that the PIK3CA mutations, specifically E545K, may abrogate the interaction between the p85 NSH2 domain and p110α, thereby leading to increased PI3K activity. Thus, it is interesting to speculate that these PIK3CA mutations may qualitatively affect p85/p110 interactions to promote increased PI3K activity. Understanding the molecular mechanisms by which these mutations promote increased PI3K activity may facilitate the rational design of p110α inhibitors specific for the cancer-associated mutant p110α.  In summary, we have shown that expression of the recently identified mutations in PIK3CA in mammary epithelial cells results in constitutive PI3K activation and induces multiple phenotypic alterations characteristic of breast tumor cells, including anchorage-independent proliferation in soft agar, growth factor–independent proliferation, and protection from anoikis. Expression of these mutations also confers increased resistance to paclitaxel and induces abnormal mammary acinar morphogenesis in three-dimensional basement membrane cultures. Together, these data support the notion that the cancer-associated mutations in PIK3CA may significantly contribute to breast cancer pathogenesis and represent attractive targets for therapeutic inhibition.  To generate mice with inducible expression of human p110alpha H1047R, we injected a DNA segment consisting of seven direct repeats of the tetracycline operator (Tet-op) sequence, followed by human PIK3CA complementary DNA encoding the H1047R mutation and the SV40 polyadenosine tail into FVB/N fertilized eggs as previously described2, 3. Ten Tet-op-PIK3CA founders were identified and then crossed to clara cell secretory protein (CCSP)-reverse tetracycline transactivator protein (rtTA) mice (in which expression of rtTA is specifically targeted to type II alveolar epithelial cells4) to generate inducible, double-transgenic mouse cohorts harboring both the activator and the responder transgenes4, 5. The Tet-op-PIK3CA copy numbers from the two most commonly used founders (13 and 121) were determined by quantitative real-time PCR (Supplementary Fig. 1a online).  To induce expression of p110-alpha H1047R in mouse lung epithelial cells, we administered doxycycline chow to double-transgenic mice from each of the founder lines, monitored them for labored breathing and imaged dyspneic mice with magnetic resonance imaging (MRI) to identify abnormalities. Three founder lines (13, 121 and 3011) had labored breathing and MRI images consistent with lung tumors after 12, 26 and 60 weeks, respectively (data not shown). These mice were killed, and gross inspection revealed multiple small tumor nodules. Histological analyses revealed mixed adenocarcinomas with bronchioloalveolar features (Fig. 1a). As founder line 13 showed the shortest latency period, it was used for subsequent experiments.  Figure 1: Development of a Tet-inducible PIK3CA H1047R mouse model of lung tumorigenesis.  Figure 1 : Development of a Tet-inducible PIK3CA H1047R mouse model of lung tumorigenesis. (a) Histological analyses of lungs derived from inducible Tet-op-PIK3CA H1047R–CCSP-rtTA (line 13) double-transgenic mice. Lungs from mice not induced with doxycycline (no doxy) or those from mice induced for 6 and 14 weeks are shown. Adenocarcinoma is present in the lungs of mice induced with doxycycline after 6 and 14 weeks. Scale bars: top, 200 muM and bottom, 50 muM. (b) Rapid disappearance of lung tumors after withdrawal of doxycycline. MRI images of PIK3CA H1047R–CCSP-rtTA double-transgenic mice placed on a doxycycline diet for 12 weeks to induce tumor formation and then taken off doxycycline and re-imaged 1, 2 and 3 weeks later. Representative examples are shown. Scale bars, 4.5 mm. (c) Histological analysis of lungs after doxycycline withdrawal. PIK3CA H1047R–CCSP-rtTA double-transgenic mice were placed on a doxycycline diet until tumors were confirmed by MRI. Doxycycline was then withdrawn from the diets, the mice were killed and their lungs were examined histologically. Shown are the histology sections from two different mice after doxycycline withdrawal for 1 and 3 weeks. Scale bars: top, 200 muM; bottom, 50 muM.  Full size image (102 KB)  The inducibility of the PIK3CA mutant transgene expression in the lung was evaluated at the RNA level by RT-PCR. PIK3CA H1047R expression was readily observed after 12 weeks of doxycycline administration (Supplementary Fig. 1b). Doxycycline withdrawal led to a loss of mutant PIK3CA expression (Supplementary Fig. 1b). We observed expression of mutant p110-alpha protein in PI3K immunoprecipitations only from the double-transgenic mice induced with doxycycline (Supplementary Fig. 1c). Of note, expression of the transgene did not substantially increase total p110-alpha protein expression (Supplementary Fig. 1c). This is expected, as p110-alpha that is not bound to p85 is unstable, and any p110-alpha expressed in excess of p85 is rapidly degraded6, 7, 8.  Withdrawal of doxycycline led to rapid and marked tumor regression, thereby demonstrating that these established lung tumors require continual expression of p110-alpha H1047R (Fig. 1b). After doxycycline withdrawal, histological examination showed focal pulmonary fibrosis and scarring and no evidence of cancer (Fig. 1c). Of note, complete tumor regression was also observed in the other founder line (121) that was examined for reversibility (Supplementary Fig. 2 online). Thus, these lung tumors require continual p110-alpha H1047R expression for their maintenance.  To inhibit PI3K signaling in vivo, we treated mice with NVP-BEZ235, a potent dual pan–PI3K-mTOR inhibitor currently under clinical development (Supplementary Fig. 3a online)9. This drug blocks the kinase activity of all four p110 isoforms and mutant p110-alpha H1047R with similar potencies9. To identify a dose that adequately blocks PI3K in lung tissue, we treated control mice with one dose in the range of 30 mg kg-1 to 52.5 mg kg-1 and harvested the lungs either 3 h or 8 h later. At most of the dose levels examined, NVP-BEZ235 induced suppression of PI3K signaling, as indicated by a decrease in phosphorylated Akt (P-Akt) at both Ser473 and Thr308 (Supplementary Fig. 3b). Akt is a serine-threonine kinase that is phosphorylated and activated in response to PI3K signaling. We then evaluated whether this compound could inhibit PI3K signaling in the lung tumors induced by the p110-alpha H1047R mutant. One oral treatment of 35 mg kg-1 NVP-BEZ235 led to substantial suppression of Akt, ribosomal protein S6 and 4E-binding protein-1 phosphorylation in these mouse tumors (Fig. 2a and Supplementary Methods online).  Figure 2: NVP-BEZ235 downregulates PI3K signaling in p110-alpha H1047R–induced lung tumors and leads to rapid tumor regression.  Figure 2 : NVP-BEZ235 downregulates PI3K signaling in p110-|[alpha]| H1047R|[ndash]|induced lung tumors and leads to rapid tumor regression. (a) Immunohistochemical staining showing the phosphorylation state of proteins in the PI3K signaling pathway. Tet-op-PIK3CA H1047R–CCSP-rtTA tumors were induced in mice by a doxycycline diet (verified by MRI). Mice with established tumors were treated with one dose of NVP-BEZ235 (35 mg kg-1), and the lungs were harvested 8 h later. Sections were stained with the indicated antibodies. No primary was used as a control. 4-E-BP1, 4E-binding protein-1. Scale bar, 50 muM. (b) CT scans (top) and PET scans (bottom) of Tet-op-PIK3CA H1047R–CCSP-rtTA double-transgenic mice treated with doxycycline until tumors developed and then treated with NVP-BEZ235 35mg kg-1 per day for 4 d. Red arrows on the CT scans indicate tumor. H, heart. Scale bar, 5 mm. (c) H&E staining showing the histological effects of NVP-BEZ235 on the p110-alpha H1047R–driven lung tumors. Tet-op-PIK3CA H1047R–CCSP-rtTA double-transgenic mice were treated with doxycycline until they developed tumors (confirmed by MRI). Mice with established tumors were treated with NVP-BEZ235 35 mg kg-1 for 3 d (left and middle) or 2 d (right), and the lungs were examined histologically. Scale bars: top, 200 muM; bottom, 50 muM. (d,e) Tet-op-PIK3CA H1047R–CCSP-rtTA mice with established tumors were treated with either placebo, 35 mg kg-1 NVP-BEZ235 or 6 mg kg-1 rapamycin daily for 2 weeks. (d) A representative MRI is shown before and after treatment for each group. Scale bar, 4.5 mm. (e) The average tumor volumes of three mice in each treatment group after 2 weeks are shown relative to pretreatment tumor volumes. Values are means plusminus s.d. (P < 0.05 BEZ235 versus placebo).  Full size image (191 KB)  We next evaluated the clinical efficacy of NVP-BEZ235 against p110-alpha H1047R–induced mouse lung tumors. Tumor responses were assessed by MRI, positron emission tomography–computed tomography (PET-CT) scans and histological analyses. Doxycycline was administered to double-transgenic mice, and MRI screening identified mice with established tumors before the initiation of treatment. We observed that 4 d of treatment with NVP-BEZ235 at 35 mg kg-1 d-1 led to a substantial reduction in the 18fluorodeoxyglucose (18FDG) avidity of the tumor, as measured by PET imaging, and also led to a marked decrease in their size, as judged by CT (Fig. 2b and Supplementary Movie 1 online for three-dimensional reconstruction PET images). These data support the notion that 18FDG-PET imaging may be a major pharmacodynamic marker for efficacy of PI3K inhibitors in the clinic. Histopathological analysis after short-term treatments showed decreased cellularity and increased interstitial thickening within the residual tumor nodule, with no evidence of adenocarcinoma (Fig. 2c).  Because NVP-BEZ235 is a dual PI3K-mTOR inhibitor, we determined whether the effects of this compound were due to its inhibition of TOR complex-1 (TORC1) (mTOR-Raptor). Therefore, we treated mice with established PIK3CA-mutated tumors with rapamycin. Treatment with rapamycin effectively blocked TORC1 in these tumors, as evidenced by a loss of S6 phosphorylation (Supplementary Fig. 4 online). However, unlike NVP-BEZ235, rapamycin did not shrink these tumors (Figs. 2d, e). These findings suggest that the activity of NVP-BEZ235 in these tumors is not solely due to TORC1 inhibition.  A recent study revealed that p110-alpha is required for lung tumorigenesis in the LA2 Kras G12D mouse model10. This is a model of mutant Kras lung cancers in which a silenced Kras G12D mutant allele is activated by spontaneous homologous recombination at a low frequency, resulting in lung adenocarcinomas11. In that study, mice were generated in which the endogenous Pik3ca gene was mutated in the Ras binding domain. This mutation abrogated the ability of Kras G12D to induce lung tumors. Using a different genetic approach, we also observed that loss of PI3K signaling hindered Kras–induced lung tumorigenesis. We crossed the Lox-Stop-Lox (LSL) Kras G12D mice to mice with genetic deletion of the p85 PI3K regulatory subunits (encoded by Pik3r1 and Pik3r2). We previously used p85 knockouts to genetically ablate PI3K signaling in different tumor models12. The experiments were performed on a Pik3r2-/- background, and the Pik3r1 allele was flanked by flox sites. Inhaled adenoviral Cre leads to both the deletion of Pik3r1 and activation of Kras G12D. We observed that loss of both Pik3r1 alleles inhibited tumorigenesis (Fig. 3a). Of note, these genetic experiments evaluate the role of PI3K in mutant Kras-induced tumor development. To more closely mirror clinical treatment of individuals with cancer, we evaluated whether PI3K signaling is necessary for the maintenance of established Kras-driven tumors. We used both the tetracycline-inducible Tet-op-Kras G12D transgenic model4 as well as the LSL Kras G12D mouse model to induce lung tumors. After tumors developed, the mice were treated with NVP-BEZ235. In contrast to the lung cancers induced by p110-alpha H1047R, those derived from Kras G12D did not shrink in response to single-agent NVP-BEZ235, as indicated by PET-CT or MRI images (Fig. 3b, c and Supplementary Fig. 5a online). However, NVP-BEZ235 decreased Akt phosphorylation in these lungs, as determined by western blot (Fig. 3d) and immunohistochemical analyses (described below). These results suggest that PI3K may be required for Kras-induced tumorigenesis but may be less crucial for tumor maintenance. Indeed, this concept may reconcile our results with another recent study that showed that a different PI3K inhibitor, PX-866, blocked both the development of new Kras G12D–induced tumors and inhibited growth of the Kras G12D–driven atypical adenomatous hyperplasias and early adenoma13. Although both the Kras tumor model mouse strains and the p110-alpha H1047R tumor model mouse strain are on similar mixed genetic backgrounds, it remains conceivable that subtle differences in genetic background may have affected their responsiveness to PI3K inhibitors. However, the data with the Kras tumor models clearly underscore the notion that blocking tumorigenesis is not equivalent to treating a cancer that is already established.  Figure 3: PI3K signaling is needed for Kras-induced tumorigenesis but not tumor maintenance.  Figure 3 : PI3K signaling is needed for Kras-induced tumorigenesis but not tumor maintenance. (a) The average number of tumors per mouse in LSL Kras G12D; Pik3r2-/- mice, either Pik3r1+/+ (n = 7), Pik3r1flox/+ (n = 9) or Pik3r1flox/flex (n = 5), treated with adenoviral Cre to induce lung tumors development. Fifteen weeks after adenoviral Cre inhalation, mice were killed and tumor numbers were determined. (b,c) Tet-op–Kras mice were induced to develop lung tumors with doxycycline and then treated with 35 mg kg-1 NVP-BEZ235 for 2 weeks. (b) A PET-CT scan before and after one week of therapy is shown. Scale bar, 5 mm. (c) Axial MRI images from two representative mice. Scale bar, 4.5 mm. (d) Western blot analysis evaluating the effect of NVP-BEZ235 on P-Akt. Tet-op–Kras G12D–CCSP-rtTA mice were induced to develop lung tumors with doxycycline and then were treated with one dose of NVP-BEZ235 35 mg kg-1. Lungs were harvested 6 h later and probed for P-Akt (Ser473) and total Akt.  Full size image (121 KB)  Recently, it has become evident that cancers respond markedly to therapies targeting receptor tyrosine kinases when inhibition of the receptor tyrosine kinase leads to loss of both PI3K and extracellular signal–related kinase signaling14, 15, 16, 17. To recapitulate this effect in the Kras–mutant lung tumors, we treated the mice with a combination of PI3K and MEK inhibitors. Whereas treatment of the Kras-mutant mice with the MEK inhibitor, ARRY-142886 (ref. 18), led to only modest tumor regression, the combination led to marked synergistic tumor regression (Fig. 4a, b), and pathological analyses at the completion of treatment revealed only scant remnants of tumor nodules (Supplementary Fig. 5b). After 2 d of the combination treatment, there was marked downregulation of PI3K, extracellular signal–related kinase and downstream signaling as indicated by western blot analyses and immunohistochemistry (Fig. 4c, d). Of note, we invariably detected low-level P-Akt staining in the Kras G12D mouse nodules that was lost upon treatment of the mouse with NVP-BEZ235 (Fig. 4d).  Figure 4: Combined PI3K and MEK inhibition shrinks Kras G12D induced lung tumors.  Figure 4 : Combined PI3K and MEK inhibition shrinks Kras G12D induced lung tumors. (a,b) LSL Kras G12D mice were induced to develop tumors by adenoviral Cre inhalation. After the establishment of sizeable tumors (determined by MRI), mice were treated with either placebo, 35 mg kg-1 NVP-BEZ235 once daily, 25 mg kg-1 ARRY-142886 twice daily or 35 mg kg-1 NVP-BEZ235 once daily and 25 mg kg-1 ARRY-142886 once daily for two weeks. (a) Representative axial MRIs of the chest are shown. Scale bar, 4.5 mm. (b) The average tumor volumes of three mice in each treatment group after 2 weeks are shown relative to pretreatment tumor volumes. P < 0.05, BEZ235 + ARRY versus each of the other three treatment groups. (c,d) Mice were treated as in a for 1.5 d. Six hours after their dose on day 2 of treatment, the mice were killed. (c) Western blot analysis using the indicated antibodies of one lung that had been snap-frozen in liquid nitrogen. (d) Immunohistochemistry assessment with the indicated antibodies of the other lung (fixed in formalin). Microscopy was performed at two magnifications for the P-Akt immunohistochemistry. Scale bar for the high-magnification P-Akt images, 25 muM. Scale bar for all other images, 100 muM. H&E stains of the nodules examined by immunohistochemistry are shown in Supplementary Figure 6 online.  Full size image (240 KB)  KRAS-mutated lung cancers remain a huge cancer problem, as they comprise 20–30% of non–small cell lung cancers. Currently, there are no effective targeted therapies for this subset of cancers. In fact, the presence of KRAS mutations only serves to identify those cancers that are likely not to respond to targeted therapies. The data in this study clearly show that the combination of PI3K and MEK inhibitors may be a very potent combination for such cancers. We hope this study spurs efforts to combine these classes of inhibitors for KRAS-mutated cancers.  There is not yet sufficient clinical data to determine whether PI3K inhibitors will be powerful therapeutic agents as single-agent cancer therapies for patients or whether they will be effective only when combined with other targeted therapies. However, it is tempting to speculate that cancers that harbor activating mutations in PIK3CA or loss of PTEN may be particularly sensitive to PI3K inhibitors. Although this study suggests that cancers with PIK3CA mutations may respond to PI3K inhibitors, human cancers with PIK3CA mutations often harbor other known oncogenic mutations such as mutations in KRAS (colon cancers) and HER2 (encoding human epidermal growth factor-2) amplification (breast cancer)19, 20, 21. These concomitant oncogenic genetic changes may affect the tumors' responsiveness to PI3K inhibitors and, possibly, may necessitate combinations of treatments, as was the case for effective treatment of the Kras-mutated mouse lung cancers.  top of page Methods  Plasmids for transgenic mice. We purchased human PI3KCA from OpenBiosystems and introduced the H1047R point mutation with the QuickChange kit from Stratagene, following the manufacturer's instructions. We cloned the gene encoding PI3KCA H1047R into the BamHI and HindIII site of pTRE-tight (Clontech), resulting in plasmid pTRE-tight-H1047R. We gel-purified the XhoI-released fragment from pTRE-tight-H1047R for pronuclei injection at the transgenic core facility at Dana-Farber Cancer Institute.  Mouse cohorts. We crossed Tet-op-PI3KCA H1047R mice to CCSP-rtTA mice (generously provided by J. Whitsett). We gave the double-transgenic mice (Tet-op-PI3KCA H1047R and CCSP-rtTA) a doxycycline diet (c11300-2000i, Researchdiets) beginning at 22 d of age. We used MRI to determine tumor burden as previously described2. Tet-op-Kras mice were generously provided by H. Varmus. LSL Kras G12D mice were kindly provided by T. Jacks. All of the mice used in these studies were of mixed genetic backgrounds (mostly B6 and FVB), and treatment studies were performed on littermate controls. We housed all mice in the pathogen-free environment at the Harvard School of Public Health. We handled the mice in strict accord with good animal practice, as defined by the Center for Animal Resources and Comparative Medicine (ARCM) at Harvard Medical School, and all mouse work was done with ARCM approval.  Cancer therapy using inhibitors. We reconstituted the dual PI3K-mTOR inhibitor, NVP-BEZ235-AN (Novartis Institutes for Biomedical Research), in one volume of N-methyl-2-pyrrolidone (69118, Fluka) and then added nine volumes of PEG300 (81160, Fluka). We gave the mice the dosages indicated in the figure legends by oral gavage. The dosage indicates the amount of the free base. We purchased the MEK inhibitor ARRY-142886 (AZD6244) from commercial sources (Otava Chemicals) and reconstituted it in 0.5% methyl cellulose (Fluka) and 0.4% polysorbate (Tween 80; Fluka) and administered it at the dosages indicated in the figure legends by oral gavage. We prepared rapamycin stock solution at a concentration of 50mg ml-1 in 100% ethanol, diluted it to 1 mg ml-1 immediately before use with 5% polyethylene glycol 400 (vol/vol) and 5% Tween 80 (vol/vol), mixed it thoroughly and then administered it by intraperitoneal injection at the dosages indicated in the figure legends. After treatment, we analyzed mice by MRI and PET-CT at different time points to determine the change in tumor burden. Sectioning was performed by the Department of Pathology at Brigham and Women's Hospital.  Positron emission tomography–computed tomography scans. We imaged the mice with a Siemens Inveon PET-CT scanner 1 h after injection of approximately 500 muCi of 18FDG. We performed the PET scan first. The PET scanner was set to finish after 600 million events were recorded. List mode files were rebinned in three dimensions, and the subsequent sinograms were reconstructed using filtered back projection for quantification. Certain images were also reconstructed using two-dimensional ordered subset expectation maximization for better visualization. Immediately after the PET scan, we acquired the CT scan. We set the X-ray source to a voltage and current of 70 kVp and 500 muA, respectively, and we positioned it relative to the charge-coupled device detector camera and mouse such that the effective pixel size was 59.73 mum isotropically. We monitored the mouse's breathing rate with a BioVet (M2M Imaging), and we used the breathing signal to gate the CT. We acquired 360 projections with an exposure time of 320 ms. All projection data were reconstructed using filtered backprojection. The images were interpolated bilinearly and filtered with a Shepp-Logan filter for higher resolution.  Magnetic resonance imaging and tumor volume measurement. We performed MRI measurements as described previously2. Briefly, we made the measurements with a 4.7T Bruker Avance horizontal bore system equipped with a 200-mm inner diameter gradient set capable of 30 G cm-1 gradient strength or with a 7T Bruker Pharmascan system. We anesthetized the mice with 1% isoflurane in an oxygen-air mixture. We monitored the respiratory and cardiac rates of the mice with Biotrig Software (4.7T) or an SA Instruments monitoring device (Stony Brook, for 7T system). We imaged the mice on the 4.7T system with rapid acquisition with relaxation enhancement (RARE) sequence (repetition time (TR) = 2000 ms; effective echo time (TE) effect = 25 ms) in the coronal and axial planes with a 1-mm slice thickness and with the number of slices sufficient to cover the entire lungs and with a matrix size of 128 times 128 and field of view of 2.5 times 2.5 cm2. With the same geometry as described above, we also imaged the mice with a gradient echo fast imaging sequence (TR = 180 ms, TE = 2.2 ms) with respiratory and cardiac gating in both the coronal and the axial planes. For images acquired on the 7T system, we performed RARE sequences after the intravenous administration of 0.3 mmol kg-1 gadolinium–diethylenetriamine penta-acetic acid (Gd-DTPA; Magnevist) in both coronal and axial planes with TR = 600 ms, TE = 15.3 ms, FOV 5.4 times 4.0 cm, matrix size 256 times 192, slice thickness 1.0 mm, 12 number of excitations, for a voxel size of 0.2 times 0.2 times 1.0 mm. Using the RARE sequence scans, we performed volume measurements of the tumors using in-house custom software.  Statistical analyses. We compared tumor volumes of mice treated with different therapies using a two-sided Student's exact t-test. A P value of less than 0.05 was considered statistically significant. Lung cancer is the leading cause of cancer-related mortality worldwide, leading to an estimated 1.4 million deaths in 2010 (ref. 1). The discovery of recurrent mutations in the epidermal growth factor receptor (EGFR) kinase, as well as fusions involving anaplastic lymphoma kinase (ALK), has led to a marked change in the treatment of patients with lung adenocarcinoma, the most common type of lung cancer2, 3, 4, 5. More recent data have suggested that targeting mutations in BRAF, AKT1, ERBB2 and PIK3CA and fusions that involve ROS1 and RET may also be successful6, 7. Unfortunately, activating mutations in EGFR and ALK fusions are typically not present in the second most common type of lung cancer, lung squamous cell carcinoma (SQCC)8, and targeted agents developed for lung adenocarcinoma are largely ineffective against lung SQCC.Although no comprehensive genomic analysis of lung SQCCs has been reported, single-platform studies have identified regions of somatic copy number alterations in lung SQCCs, including amplification of SOX2, PDGFRA and FGFR1 and/or WHSC1L1 and deletion of CDKN2A9, 10. DNA sequencing studies of lung SQCCs have reported recurrent mutations in several genes, including TP53, NFE2L2, KEAP1, BAI3, FBXW7, GRM8, MUC16, RUNX1T1, STK11 and ERBB4 (refs 11, 12). DDR2 mutations and FGFR1 amplification have been nominated as therapeutic targets13, 14, 15.We have conducted a comprehensive study of lung SQCCs from a large cohort of patients as part of The Cancer Genome Atlas (TCGA) project. The twin aims are to characterize the genomic and epigenomic landscape of lung SQCC and to identify potential opportunities for therapy. We report an integrated analysis based on DNA copy number, somatic exonic mutations, messenger RNA sequencing, mRNA expression and promoter methylation for 178 histopathologically reviewed lung SQCCs, in addition to whole genome sequencing (WGS) of 19 samples and microRNA sequencing of 159 samples (Supplementary Table 1.1). Demographic and clinical data and results of the genomic analyses can be downloaded from the TCGA data portal (https://tcga-data.nci.nih.gov/docs/publications/lusc_2012/).Samples and clinical dataAbstract• Introduction• Samples and clinical data• Somatic DNA alterations• Somatically altered pathways• mRNA expression profiling and subtype classification• Analysis of the CDKN2A locus• Therapeutic targets• Discussion• Methods• References• Acknowledgements• Author information• Supplementary information• CommentsTumour samples were obtained from 178 patients with previously untreated stage I–IV lung SQCC. Germline DNA was obtained from adjacent, histologically normal tissues resected at the time of surgery (n = 137) or from peripheral blood (n = 41). All patients provided written informed consent to conduct genomic studies in accordance with local Institutional Review Boards. The demographic characteristics are described in Supplementary Table 1.2. The median follow-up for the cohort was 15.8 months, and 60% of patients were alive at the time of the last follow-up (data updated in November 2011). Ninety-six per cent of the patients had a history of tobacco use, similar to previous reports for North American patients with lung SQCC16. DNA and RNA were extracted from patient specimens and measured by several genomic assays, which included standard quality-control assessments (Supplementary Methods, sections 2–8). A committee of experts in lung cancer pathology performed a further review of all samples to confirm the histological subtype (Supplementary Fig. 1.1 and Supplementary Methods, section 1).Somatic DNA alterationsAbstract• Introduction• Samples and clinical data• Somatic DNA alterations• Somatically altered pathways• mRNA expression profiling and subtype classification• Analysis of the CDKN2A locus• Therapeutic targets• Discussion• Methods• References• Acknowledgements• Author information• Supplementary information• CommentsThe lung SQCCs analysed in this study display a large number and variety of DNA alterations, with a mean of 360 exonic mutations, 323 altered copy number segments and 165 genomic rearrangements per tumour.Copy number alterations were analysed using several platforms. Analysis of single nucleotide polymorphism (SNP) 6.0 array data across the set of 178 lung SQCCs identified a high rate of copy number alteration (mean of 323 segments) when compared with other TCGA projects (as of 1 February 2012), including ovarian cancer (477 segments)17, glioblastoma multiforme (282 segments)18, colorectal carcinoma (213 segments), breast carcinoma (282 segments) and renal cell carcinoma (156 segments) (P < 1 × 10−15 by Fisher’s exact test). These segments gave rise to regions of both focal and broad somatic copy number alterations (SCNAs), with a mean of 47 focal and 23 broad events per tumour (broad events defined as ≥50% of the length of the chromosome arm). There was strong concordance between the three independent copy number assays for all regions of SCNA (Supplementary Figs 2.1–2.4).At the level of whole chromosome arm SCNAs, lung SQCCs exhibit many similarities to 205 cases of lung adenocarcinoma analysed by TCGA (Supplementary Fig. 2.1a). The most notable difference between these cancers is selective amplification of chromosome 3q in lung SQCC, as has been reported9, 19. Using the SNP 6.0 array platform and GISTIC 2.0 (refs 20, 21), we identified regions of significant copy number alteration (Supplementary Methods, section 2). There were 50 peaks of significant amplification or deletion (Q < 0.05), several of which included SCNAs previously seen in lung SQCCs including SOX2, PDGFRA and/or KIT, EGFR, FGFR1 and/or WHSC1L1, CCND1 and CDKN2A9, 10, 19 (Supplementary Fig. 2.1b and Supplementary Data 2.1 and 2.2). Other peaks defined regions of SCNA reported for the first time, including amplifications of chromosomal segments containing NFE2L2, MYC, CDK6, MDM2, BCL2L1 and EYS and deletions of FOXP1, PTEN and NF1 (Supplementary Fig. 2.1b).Whole exome sequencing of 178 lung SQCCs and matched germline DNA targeted 193,094 exons from 18,863 genes. The mean sequencing coverage across targeted bases was 121×, with 83% of target bases above 30× coverage. We identified a total of 48,690 non-silent mutations with a mean of 228 non-silent and 360 total exonic mutations per tumour, corresponding to a mean somatic mutation rate of 8.1 mutations per megabase (Mb) and median of 8.4 per Mb. That rate is higher than rates observed in other TCGA projects including acute myelogenous leukaemia (0.56 per Mb), breast carcinoma (1.0 per Mb), ovarian cancer17 (2.1 per Mb), glioblastoma multiforme18 (2.3 per Mb) and colorectal carcinoma (3.2 per Mb) (data as of 1 February 2012, P < 2.2 × 10−16 by t-test or Wilcoxon’s rank sum test for lung SQCC versus all others). In lung SQCC, CpG transitions and transversions were the most commonly observed mutation types, with mean rates of 9.9 and 10.7 per sequenced megabase of CpG context, respectively, for a total mutation rate of 20.6 per Mb. At non-CpG sites, transversions at C:G sites were more common than transitions (7.3 versus 2.9 per Mb; total = 10.2 per Mb) and more common than transversions or transitions at A:T sites (1.5 versus 1.3 per Mb; total = 2.8 per Mb).Significantly mutated genes were identified using a modified version of the MutSig algorithm (Supplementary Methods, section 3)22, 23. We identified 10 genes with a false discovery rate (FDR) Q value < 0.1 (Supplementary Table 3.1): TP53, CDKN2A, PTEN, PIK3CA, KEAP1, MLL2, HLA-A, NFE2L2, NOTCH1 and RB1, all of which demonstrated robust evidence of gene expression as defined by reads per kilobase of exon model per million mapped reads (RPKM) > 1 (Fig. 1). TP53 mutation was observed in 81% of samples by automated analysis; visual review of sequencing reads identified a further 9% of samples with potential mutations in regions of sub-optimal coverage or in samples with low purity. Most observed mutations in NOTCH1 (8 out of 17) were truncating alterations, suggesting loss-of-function, as has recently been reported for head and neck SQCCs22, 24. Mutations in HLA-A were also almost exclusively nonsense or splice site events (7 out of 8).Figure 1: Significantly mutated genes in lung SQCC.Significantly mutated genes in lung SQCC.Significantly mutated genes (Q value < 0.1) identified by exome sequencing are listed vertically by Q value. The percentage of lung SQCC samples with a mutation detected by automated calling is noted at the left. Samples displayed as columns, with the overall number of mutations plotted at the top, and samples are arranged to emphasize mutual exclusivity among mutations. Syn., synonymous.Full size image (81 KB)Download PowerPoint slide (462K)Figures indexNextTo increase our statistical power to detect mutated genes in the setting of the observed high background mutation rate, we performed a secondary MutSig analysis only considering genes previously observed to be mutated in cancer according to the COSMIC database. This yielded 12 other genes with FDR < 0.1: FAM123B (also known as WTX), HRAS, FBXW7, SMARCA4, NF1, SMAD4, EGFR, APC, TSC1, BRAF, TNFAIP3 and CREBBP (Supplementary Table 3.1). Both the spectrum and the frequency of EGFR mutations differed from those seen in lung adenocarcinomas. The two most common alterations in lung adenocarcinoma, Leu858Arg and inframe deletions in exon 19, were absent, whereas two Leu861Gln mutations were detected in EGFR.As described in Supplementary Fig. 3.1, we verified somatic mutations by performing an independent hybrid-recapture of 76 genes in all samples. A total of 1,289 mutations were assayed, and we achieved satisfactory coverage to have power to verify at 1,283 positions. We validated 1,235 mutations (96.2%) (Supplementary Fig. 3.1 and Supplementary Methods, section 3). We also verified mutation calls using WGS and RNA sequencing data with similar results (Supplementary Figs 3.1, 4.3 and Supplementary Methods, sections 3 and 4).WGS was performed for 19 tumour/normal pairs with a mean computed coverage of 54×. A mean of 165 somatic rearrangements was found per lung SQCC tumour pair (Supplementary Fig. 3.2), a value in excess of that reported for WGS studies of other tumour types including colorectal carcinoma (75)25, prostate carcinoma (108)26, multiple myeloma (21)23 and breast cancer (90)27. Although most inframe coding fusions detected in WGS were validated by RNA sequencing, no recurrent rearrangements predicted to generate fusion proteins were identified (Supplementary Data 3.1 and 4.1).Somatically altered pathwaysAbstract• Introduction• Samples and clinical data• Somatic DNA alterations• Somatically altered pathways• mRNA expression profiling and subtype classification• Analysis of the CDKN2A locus• Therapeutic targets• Discussion• Methods• References• Acknowledgements• Author information• Supplementary information• CommentsMany of the somatic alterations we have identified in lung SQCCs seem to be drivers of pathways important to the initiation or progression of the cancer. Specifically, genes involved in the oxidative stress response and squamous differentiation were frequently altered by mutation or SCNA. We observed mutations and copy number alterations of NFE2L2 and KEAP1 and/or deletion or mutation of CUL3 in 34% of cases (Fig. 2). NFE2L2 and KEAP1 code for proteins that bind to each other, have been shown to regulate the cell response to oxidative damage, chemo- and radiotherapy, and are somatically altered in a variety of cancer types28, 29. We found mutations in NFE2L2 almost exclusively in one of two KEAP1 interaction motifs, DLG or ETGE. Mutations in KEAP1 and CUL3 showed a pattern consistent with loss-of-function and were mutually exclusive with mutations in NFE2L2 (Figs 1c and 2). PARADIGM SHIFT30 analysis predicts that mutations in NFE2L2 and KEAP1 exert a considerable functional effect (Supplementary Fig. 7.C.1, 7.C.2 and Supplementary Methods, section 7).Figure 2: Somatically altered pathways in squamous cell lung cancer.Somatically altered pathways in squamous cell lung cancer.Left, alterations in oxidative stress response pathway genes as defined by somatic mutation, copy number alteration or up- or downregulation. Frequencies of alteration are expressed as a percentage of all cases, with background in red for activated genes and blue for inactivated genes. Right, alterations in genes that regulate squamous differentiation, as defined in the left panel.Full size image (76 KB)Download PowerPoint slide (458K)PreviousFigures indexNextWe also found alterations in genes with known roles in squamous cell differentiation in 44% of samples, including overexpression and amplification of SOX2 and TP63, loss-of-function mutations in NOTCH1, NOTCH2 and ASCL4 and focal deletions in FOXP1 (Fig. 2). Although NOTCH1 has been well characterized as an oncogene in haematological cancers31, NOTCH1 and NOTCH2 truncating mutations have been reported in cutaneous SQCCs and lung SQCCs32. Truncating mutations in ASCL4 are the first to be reported in human cancer and may have a lineage role given the requirement for ASCL1 for survival of small-cell lung cancer cells33. Alterations in NOTCH1, NOTCH2 and ASCL4 were mutually exclusive and exhibited minimal overlap with amplification of TP63 and/or SOX2 (Fig. 2), suggesting that aberrations in those modulators of squamous cell differentiation have overlapping functional consequences.mRNA expression profiling and subtype classificationAbstract• Introduction• Samples and clinical data• Somatic DNA alterations• Somatically altered pathways• mRNA expression profiling and subtype classification• Analysis of the CDKN2A locus• Therapeutic targets• Discussion• Methods• References• Acknowledgements• Author information• Supplementary information• CommentsWhole-transcriptome expression profiles were generated by RNA sequencing for the entire cohort and by microarrays for a 121-sample subset. Of 20,502 genes analysed, the mean RNA coverage indices were 19× and 6,420 RPKM (Supplementary Fig. 4.1 and Supplementary Methods, section 4). Previously reported lung SQCC gene expression-subtype signatures34 were applied to both of the expression platforms, yielding four subtypes designated as classical (36%), basal (25%), secretory (24%) and primitive (15%). The concordance of subtypes between the two platforms was high (94% agreement) (Supplementary Fig. 4.2). Considerable correlations were found between the expression subtypes and genomic alterations in copy number, mutation and methylation (Fig. 3). The classical subtype was characterized by alterations in KEAP1, NFE2L2 and PTEN, as well as pronounced hypermethylation and chromosomal instability. The 3q26 amplicon was present in all of the subtypes, but it was most characteristic of the classical subtype, which also showed the greatest overexpression of three known oncogenes on 3q: SOX2, TP63 and PIK3CA. RNA sequencing data suggested that high expression levels of TP63, in samples with and without amplification of TP63, were associated with dominant expression of the deltaN isoform (also called p40), which lacks the amino-terminal transactivation domain, compared with the longer isoform, called tap63 (89% of tumours overexpressed deltaN compared with tap63; P < 2.2 × 10−16). The short deltaN isoform is thought to function as an oncogene35, 36, and its expression was most enriched in the classical subtype. By contrast, the primitive expression subtype more commonly exhibited RB1 and PTEN alterations, and the basal expression subtype showed NF1 alterations (Fig. 3). Amplification of FGFR1 and WHSC1L1 was anticorrelated with the classical subtype and specifically with NFE2L2 or KEAP1 mutated samples. Although CDKN2A alterations are common in lung SQCCs, they are not associated with any particular expression subtype (Fig. 3).Figure 3: Gene expression subtypes integrated with genomic alterations.Gene expression subtypes integrated with genomic alterations.Tumours are displayed as columns, grouped by gene expression subtype. Subtypes were compared by Kruskal–Wallis tests for continuous features and by Fisher’s exact tests for categorical features. Displayed features showed significant association with gene expression subtype (P < 0.05), except for CDKN2A alterations. deltaN percentage represents transcript isoform usage between the TP63 isoforms, deltaN and tap63, as determined by RNA sequencing. Chromosomal instability (CIN) is defined by the mean of the absolute values of chromosome arm copy numbers (CN) from the GISTIC23, 24 output. Absolute values are used so that amplification and deletion alterations are counted equally. Hypermethylation scores and iCluster assignments are described in Supplementary Figs 6.1 and 7.A1, respectively. CIN, methylation, gene expression and deltaN values were standardized for display using z-score transformation. Expr., expression; mut., mutation; WT, wild type.Full size image (135 KB)Download PowerPoint slide (516K)PreviousFigures indexNextIndependent clustering of miRNA and methylation data indicated association with expression subtypes. The highest overall methylation was seen in the classical subtype (Fig. 3, Supplementary Figs 5.1 and 6.1, Supplementary Methods, sections 5 and 6, Supplementary Data 6.1 and 6.2 and Supplementary Table 5.1). Integrative clustering (iCluster)37 of mRNA, miRNA, methylation, SCNA and mutation data demonstrated concordance with the mRNA expression subtypes and associated alterations (Fig. 3, Supplementary Fig. 7.A.1 and Supplementary Methods, section 7). Independent correlation of somatic mutations, copy number alterations and gene expression signatures revealed notable subtype associations with alterations in the TP53, PI3K, RB1 and NFE2L2/KEAP1 pathways (Supplementary Fig. 7.B.1 and Supplementary Methods, section 7).Analysis of the CDKN2A locusAbstract• Introduction• Samples and clinical data• Somatic DNA alterations• Somatically altered pathways• mRNA expression profiling and subtype classification• Analysis of the CDKN2A locus• Therapeutic targets• Discussion• Methods• References• Acknowledgements• Author information• Supplementary information• CommentsIntegrated multiplatform analyses showed that CDKN2A, a known tumour suppressor gene in lung SQCC38 that encodes the p16INK4A and p14ARF proteins, is inactivated in 72% of cases of lung SQCC (Fig. 4a and Supplementary Data 7.1)—by epigenetic silencing by methylation (21%), inactivating mutation (18%), exon 1β skipping (4%) and homozygous deletion (29%).Figure 4: Multi-faceted characterization of mechanisms of CDKN2A loss.Multi-faceted characterization of mechanisms of CDKN2A loss.a, Schematic view of the exon structure of CDKN2A demonstrating the types of alterations identified in the study. The locations of point mutation are denoted by black and green circles. b, CDKN2A expression (y axis) versus CDKN2A copy number (x axis). Samples are represented by circles and colour-coded by specific type of CDKN2A alteration. Del., deletion; het., heterozygous; homoz., homozygous. c, Diagram of the KIAA1797-p16INK4 fusion identified by WGS. ORF, open reading frame. d, CDKN2A alterations and expression levels (binary) in each sample.Full size image (109 KB)Download PowerPoint slide (490K)PreviousFigures indexNextAnalysis of mRNA expression across the CDKN2A locus revealed four distinct patterns of expression: complete absence of both p16INK4 and ARF (33%); expression of high levels of both p16INK4 and ARF (31%); high expression of ARF and absence of p16INK4 (31%); or expression of a transcript that represents a splicing of exon 1β from ARF with the shared exon 3 of ARF and p16INK4, generating a premature stop codon (4%) (Supplementary Fig. 4.4). Almost all of the cases completely lacking p16INK4 and ARF expression showed homozygous deletion (Fig. 4b and Supplementary Data 7.1). In one case, p16INK4 expression was detected but analysis of WGS data demonstrated an intergenic fusion event that resulted in detectable transcription between exon 1α p16INK4 and exon 18 of KIAA1797 (Fig. 4b, c). Interestingly, combined analysis of WGS and RNA sequencing data identified tumour suppressor gene inactivation by intra- or interchromosomal rearrangement in PTEN, NOTCH1, ARID1A, CTNNA2, VHL and NF1, in eight further cases (Supplementary Data 3.1 and 4.1).In addition to homozygous deletion, there are frequent mutational events in CDKN2A (Fig. 4b and Supplementary Data 7.1). These account for 45% of the 56 cases with high p16INK4 and ARF expression. Furthermore, methylation of the exon 1α promoter accounts for many other cases of CDKN2A inactivation (70% of lung SQCCs with ARF expression in the absence of detectable p16INK4). Seven other tumours in the high-ARF/low-INK4A group had documented mutations of INK4A, primarily nonsense mutations, suggesting nonsense-mediated decay as a mechanism. Of the 28% of tumours without CDKN2A alterations, RB1 mutations were identified in eight cases and CDK6 amplification in one case (Fig. 4d).Therapeutic targetsAbstract• Introduction• Samples and clinical data• Somatic DNA alterations• Somatically altered pathways• mRNA expression profiling and subtype classification• Analysis of the CDKN2A locus• Therapeutic targets• Discussion• Methods• References• Acknowledgements• Author information• Supplementary information• CommentsMolecularly targeted agents are now commonly used in patients with adenocarcinoma of the lung, whereas no effective targeted agents have been developed specifically for lung SQCCs13. We analysed our genomic data for evidence of the two common genomic alterations in adenocarcinomas of the lung: EGFR and KRAS mutations. Only one sample had a KRAS codon 61 mutation, and there were no exon 19 deletions or Leu858Arg mutations in EGFR. However, amplifications of EGFR were found in 7% of cases, as were two instances of the Leu861Gln EGFR mutation, which confers sensitivity to erlotinib and gefitinib39.The presence of new potential therapeutic targets in lung SQCC was suggested by the observation that 96% (171 out of 178) of tumours contain one or more mutations in tyrosine kinases, serine/threonine kinases, phosphatidylinositol-3-OH kinase (PI(3)K) catalytic and regulatory subunits, nuclear hormone receptors, G-protein-coupled receptors, proteases and tyrosine phosphatases (Supplementary Fig. 7.D.1a and Supplementary Data 7.2 and 7.3). From 50 to 77% of the mutations were predicted to have a medium or high functional effect as determined by the mutation assessor score40 (Supplementary Fig. 7.D.1a), and 39% of tyrosine and 42% of serine/threonine kinase mutations were located in the kinase domain. Many of the alterations were in known oncogenes and tumour suppressors, as defined in the COSMIC database (Supplementary Data 7.3).We selected potential therapeutic targets based on several features, including (1) availability of a US Food and Drug Administration (FDA)-approved targeted therapeutic agent or one under study in current clinical trials (Supplementary Data 7.2); (2) confirmation of the altered allele in RNA sequencing; and (3) the mutation assessor score40. Using those criteria, we identified 114 cases with somatic alteration of a potentially targetable gene (64%) (Supplementary Fig. 7.D.1b and Supplementary Data 7.4). Among these, we identified three families of tyrosine kinases, the erythroblastic leukaemia viral oncogene homologues (ERBBs), fibroblast growth factor receptors (FGFRs) and Janus kinases (JAKs), all of which were found to be mutated and/or amplified41. As discussed for EGFR, the mutational spectra in these potential therapeutic targets differed from those in lung adenocarcinoma (Supplementary Fig. 7.D.2)42.To complement a gene-centred search for potential therapeutic targets, we analysed core cellular pathways known to represent potential therapeutic vulnerabilities: PI(3)K/AKT, receptor tyrosine kinase (RTK) and RAS. Analysis of the 178 lung SQCCs revealed alteration in at least one of those pathways in 69% of samples after restriction of the analysis to mutations confirmed by RNA sequencing and to amplifications associated with overexpression of the target gene (Fig. 5). Mutational events that have been curated in COSMIC are also shown in Supplementary Fig. 7D.2, as is the distribution of mutations, amplifications and overexpression of the genes depicted in Fig. 5. (A summary of all samples and their significant mutations and copy number alterations, including alterations in Fig. 5, is shown in Supplementary Data 7.5.) Specifically, one of the components of the PI(3)K/AKT pathway was altered in 47% of tumours and RTK signalling probably affected by events such as EGFR amplification, BRAF mutation or FGFR amplification or mutation in 26% of tumours (Fig. 5 and Supplementary Fig. 7.D.3). Alterations in the PI(3)K/AKT pathway genes were mutually exclusive with EGFR alterations as identified by MEMo43 (Supplementary Fig. 7.D.4.). Although the dependence of lung SQCC on many of these individual alterations remains to be defined functionally, this analysis suggests new areas for potential therapeutic development in this cancer.Figure 5: Alterations in targetable oncogenic pathways in lung SQCCs.Alterations in targetable oncogenic pathways in lung SQCCs.Pathway diagram showing the percentage of samples with alterations in the PI(3)K/RTK/RAS pathways. Alterations are defined by somatic mutations, homozygous deletions, high-level, focal amplifications, and, in some cases, by significant up- or downregulation of gene expression (AKT3, FGFR1, PTEN).Full size image (115 KB)Download PowerPoint slide (496K)PreviousFigures indexDiscussionAbstract• Introduction• Samples and clinical data• Somatic DNA alterations• Somatically altered pathways• mRNA expression profiling and subtype classification• Analysis of the CDKN2A locus• Therapeutic targets• Discussion• Methods• References• Acknowledgements• Author information• Supplementary information• CommentsLung SQCCs are characterized by a high overall mutation rate of 8.1 mutations per megabase and marked genomic complexity. Similar to high-grade serous ovarian carcinoma17, almost all lung SQCCs display somatic mutation of TP53. There were also frequent alterations in the following pathways: CDKN2A/RB1, NFE2L2/KEAP1/CUL3, PI3K/AKT and SOX2/TP63/NOTCH1 pathways, providing evidence of common dysfunction in cell cycle control, response to oxidative stress, apoptotic signalling and/or squamous cell differentiation. Pathway alterations clustered according to expression-subtype in many cases, suggesting that those subtypes have a biological basis.A role for somatic mutation in the cancer hallmark of avoiding immune destruction44 is suggested by the presence of inactivating mutations in the HLA-A gene. Somatic loss-of-function alterations of HLA-A have not been reported previously in genomic studies of lung cancer. Given the recently reported efficacy of anti-programmed death 1 (PD1)45 and anti-cytotoxic T-lymphocyte antigen 4 (CTLA4) antibodies in non-small-cell lung cancer46, these HLA-A mutations suggest a possible role for genotypic selection of patients for immunotherapies.Targeted kinase inhibitors have been successfully used for the treatment of lung adenocarcinoma but minimally so in lung SQCC. The observations reported here suggest that a detailed understanding of the possible targets in lung SQCCs may identify targeted therapeutic approaches. Whereas EGFR and KRAS mutations, the two most common oncogenic aberrations in lung adenocarcinoma, are extremely rare in lung SQCC, alterations in the FGFR kinase family are common. Lung SQCCs also share many alterations in common with head and neck squamous cell carcinomas without evidence of human papilloma virus infection, including mutation in PIK3CA, PTEN, TP53, CDKN2A, NOTCH1 and HRAS22, 24, suggesting that the biology of these two diseases may be similar.The current study has identified a potentially targetable gene or pathway alteration in most lung SQCC samples studied. The data presented here can help to organize efforts to analyse lung SQCC clinical tumour specimens for a panel of specific, actionable mutations to select patients for appropriately targeted clinical trials. These data could thereby help to facilitate effective personalized therapy for this deadly disease.MethodsAbstract• Introduction• Samples and clinical data• Somatic DNA alterations• Somatically altered pathways• mRNA expression profiling and subtype classification• Analysis of the CDKN2A locus• Therapeutic targets• Discussion• Methods• References• Acknowledgements• Author information• Supplementary information• CommentsAll specimens were obtained from patients with appropriate consent from the relevant Institutional Review Board. DNA and RNA were collected from samples using the Allprep kit (Qiagen). We used commercial technology for capture and sequencing of exomes from tumour DNA and normal DNA and whole-genome shotgun sequencing. Significantly mutated genes were identified by comparing them with expectation models based on the exact measured rates of specific sequence lesions. GISTIC23, 24 analysis of the circular-binary-segmented Affymetrix SNP 6.0 copy number data was used to identify recurrent amplification and deletion peaks. Consensus clustering approaches were used to analyse mRNA, miRNA and methylation subtypes using previous approaches20, 21, 34, 38, 41, 44. There have long been indications of a role for PI3K (phosphatidylinositol 3-kinase) in cancer pathogenesis. Experimental data document a requirement for deregulation of both transcription and translation in PI3K-mediated oncogenic transformation. The recent discoveries of cancer-specific mutations in PIK3CA, the gene that encodes the catalytic subunit p110α of PI3K, have heightened the interest in the oncogenic potential of this lipid kinase and have made p110α an ideal drug target. Phosphatidylinositol 3-kinases (PI3Ks) phosphorylate phosphatidylinositol and its phosphorylated derivatives at the 3′ position of the inositol ring, generating second messengers that control cellular activities and properties including proliferation, survival, motility and morphology — mutations in PI3K function disrupt these processes1–10. PI3K proteins form a family that is divided into three classes that differ in structure, substrate preference, tissue distribution, mechanism of activation and, ultimately, in function11–15 (FIG. 1). In regulating proliferation and in tumorigenesis, the most important PI3K proteins are those that belong to class IA — the catalytic subunit p110α and its associated regulatory subunit p85. In quiescent cells, p85 binds to p110α, stabilizing p110α and inactivating its kinase activity. Upon growth factor stimulation, the SH2 DOMAINS (Roussarcoma-oncogene homology-2 domains) of p85 bind to phosphorylated tyrosine in YxxM motifs in receptor tyrosine kinases or their substrate adaptor proteins. This binding relieves the inhibition of p110α and mediates recruitment of the catalytic subunit to the plasma membrane16. PI3K activity is further augmented by the interaction between p110α and the GTP-bound form of the RAS oncoprotein17,18. The high-affinity substrate of p110α is phosphatidylinositol 4,5-bisphosphate (PIP2 ). This is phosphorylated to become phosphatidylinositol 3,4,5-trisphosphate (PIP3 ), which then recruits proteins that contain a PLECKSTRIN HOMOLOGY DOMAIN to cellular membranes19. Among these are the serine-threonine kinase AKT, as well as its activating kinases PDK1 (3-phosphoinositide-dependent kinase 1) and possibly PDK2. The identity of the latter has remained controversial. Potential candidates for PDK2 include PDK1, AKT, integrin-linked kinase (ILK), DNA-dependent protein kinase (DNA-PK) and the Rictor–TOR (target of rapamycin) complex20–24. Recruitment of these kinases by PIP3  results in the activation of AKT by phosphorylation at T308 and S473. Activated AKT is the predominant and essential mediator for the regulation of both growth and proliferation by PI3K. PIP3  is also a substrate of the phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10), which dephosphorylates PIP3  to generate PIP2 . PTEN is a negative regulator of PI3K signalling and functions as a tumour suppressor25,26. Genetic inactivation of PTEN occurs in numerous human tumours and results in a constitutive upregulation of PI3K signals27–30. Wild-type p110α is not oncogenic, but its growth-regulatory functions confer a potential for oncogenicity that can be activated by simple genetic changes. These include retroviral transduction, point mutations, gene amplification, overexpression and NATURE REVIEWS | CANCER VOLUME 5 | DECEMBER 2005 | 921 REVIEWS © 2005 Nature Publishing Group Catalytic Adaptor Regulation Lipid substrate specificity Class Subunits Structural features of catalytic subunits Adaptorbinding domain RBD C2 domain Helical domain Catalytic domain p110α,β,δ p85α p55α p50α p85β p55γ Receptor tyrosine kinases and RAS (p110β is also regulated by G-protein-coupled receptors) PIP2 PIP PI p110γ p101 p84 G-protein-coupled receptors and RAS PIP2 PIP PI A B Vps34p analogues p150 Constitutive? PI PI3K-C2α,β,γ ? Receptor tyrosine kinases? G-protein-coupled receptors? PIP2 PI I II III Coiled-coil domain PX domain C2 domain Proline-rich domain the acquisition of sequences that localize the protein to cellular membranes. The avian PIK3CA gene and the mouse Akt gene have both been identified as oncogenes in retroviruses31–33. Oncogenic forms of p110α and AKT are constitutively present in the cell membrane where they have high levels of kinase activity34,35. Mutations in the regulatory subunit of PI3K, p85, have been identified in transformed cell lines and in human tumour samples36–40. The mutant forms of p85 induce constitutive activation of PI3K–AKT signalling36,38–40. Expression of mutant p85 in mice induces a lymphoproliferative disorder and solid tumours36,37. The gain of function in PI3K–AKT signalling, which is characteristic of experimental transformation in cell culture and of many human tumours, affects the synthetic activities of the cell at the transcriptional and translational levels (FIG. 2). PI3K and transcription PI3K–AKT signals control several growth-regulatory transcription factors. Two prominent examples are the forkhead box (FOXO) proteins and nuclear factor κΒ (NFκB). The FOXO transcription factors, which are a subclass of the much larger FOX protein family, encompass FOXO1 (FKHR), FOXO3A (FKHRL1), FOXO4 (AFX) and FOXO6 REF. 41. FOX proteins bind to DNA as monomers with a highly conserved domain that is referred to as the forkhead or winged helix domain that also serves as the defining structural feature of the protein family. The FOXO proteins control the pace of the cell cycle, as well as apoptosis, DNA repair and protection from oxidative damage42,43. Their activities are regulated by post-translational modifications that include phosphorylation by several kinases, acetylation and ubiquitylation. These Summary • Phosphatidylinositol 3-kinases (PI3Ks) are lipid kinases that generate second messengers that govern cellular activities and properties including proliferation, survival, motility and morphology. • PIK3CA, the gene that encodes the catalytic subunit p110α of PI3K, is frequently mutated in human solid tumours. • Cancer-specific mutations are clustered in the helical and the kinase domains of p110α. The amino-acid residues E542, E545 and H1047 are prominent mutational hot spots. • The mutations in the p110α hot spots induce a gain of enzymatic function and confer oncogenic activity both in vitro and in vivo. • The oncogenicity of PI3K is the result of interactions with transcriptional and translational controls. Figure 1 | PI3Ks constitute a family of enzymes that is divided into three classes. The figure summarizes the domain organization and defining criteria of the three phosphatidylinositol 3-kinase (PI3K) classes. The catalytic subunit of class I enzymes (p110α, β, δ and γ) contains an adaptor-binding domain, a RAS-binding domain (RBD), a C2 (protein-kinase-C homology-2) domain, a helical domain and a catalytic domain. Class IA enzymes are constitutively associated with an adaptor subunit to form a heterodimeric complex. There are three genes that encode at least five different adaptor subunits, all of which can bind to phosphorylated tyrosine in YxxM motifs through their SH2 (Rous-sarcoma-oncoprotein homology-2) domains. The only member of class IB is p110γ, which associates with the p101 regulatory subunit or the recently identified p84 adaptor subunit. Class I enzymes are regulated by receptor tyrosine kinases and RAS, and have lipid substrates that include phosphatidylinositol-bisphosphates (PIP2 ), phosphatidylinositol phosphate (PIP) and phosphatidylinositol (PI). Class II enzymes are comprised of a PI3K-C2α, β and γ domains. They lack an adaptor-binding site but possess carboxy-terminal phox (PX) and C2 domains that could mediate binding to phosphoinositides that have been phosphorylated at position D3 and other membrane lipids. Class II enzyme substrates include PIP2 , PIP and PI. Although their adaptor subunits have not been identified, class II enzymes are believed to be regulated by receptor tyrosine kinases and G-protein coupled receptors. Class III enzymes comprise analogues of the yeast Vps34p PI3K subunit and a p150 adaptor subunit, and accept only PI as a substrate. They are believed to be constitutively active, and all isoforms of class I PI3K also possess an intrinsic protein kinase activity. 922 | DECEMBER 2005 | VOLUME 5 www.nature.com/reviews/cancer REVIEWS © 2005 Nature Publishing Group PIP2 PIP3 PIP3 PIP3 PI3K PDK PTEN GSK3β MDM2 IKK MIZ1 FOXO S6K 4EBP S6 4E NFκB p53 c-MYC AP1 β-catenin Translation Transcription TSC RHEB TOR HIF1α AKT modifications determine the cellular localization and, ultimately, the fate and functions of FOXO proteins — nuclear FOXO proteins act as transcriptional regulators whereas cytoplasmic FOXO proteins are transcriptionally silent and are subject to proteasomal degradation. Nuclear FOXO proteins activate several distinct transcriptional programmes. One of these leads to G1 arrest through increased expression of the cyclin-dependent kinase inhibitors p27kip1 and p21cip1, and reduced expression of cyclin D1 and cyclin D2 REFS 4447. AKT terminates these activities by initiating nuclear export of FOXO proteins. It phosphorylates FOXO at three conserved residues48–52, thereby masking the nuclear localization signal, interfering with DNA-binding, disrupting the association with the co-activator p300–CBP (CREB-binding protein) and mediating the interaction with 14-3-3 proteins and the exportin CRM1 REFS 49,5358. The result is inhibition of FOXO nuclear functions and removal of FOXO from the nucleus. FOXO that has been exported from the nucleus as a result of AKT-dependent phosphorylation is rapidly degraded59–62. The phosphorylation by AKT not only triggers nuclear export of FOXO but it also creates a binding site for the ubiquitin ligase S-phase kinase-associated protein 2 (SKP2, a suppressor of a cyclin-dependent-kinase-inhibitor proteolysis defect), which then marks FOXO for proteasomal degradation60. This radical elimination of transcriptionally active FOXO is a key feature of cells that have been transformed by oncogenic PI3K or AKT — in these cells, levels of FOXO are dramatically reduced and the growth-regulatory activity of FOXO is suspended59. FOXO activity also influences other signalling pathways — in a complex with SMAD, FOXO regulates p21cip1 gene expression during TGF signalling, and FOXO3a is inactivated by the NFκB pathway45, 63. Whereas FOXO is inactivated by AKT signalling, the transcription factor NFκB is activated. In human cancer cells, NFκB positively regulates cell survival, proliferation, chemoresistance, angiogenesis, cellular invasion and oncogenesis64–66. NFκB is negatively regulated by the inhibitor IκB, which anchors NFκB in the cytoplasm. Positive regulation of NFκB occurs through IκB kinases (IKKs), which phosphorylate IκB and mark it for proteasomal degradation. Released from IκB, NFκB travels into the nucleus and forms a functional transcriptional unit with its dimerization partner, REL-A, which is also known as p65 REFS 64,65. AKT stimulates the transcriptional activity of NFκB by three distinct modes, all of which require IKK function. First, AKT interacts with the IKK complex, phosphorylates the α subunit and increases IKK activity67,68. Next, AKT indirectly stimulates IKK activity through the mitogen-activated protein kinase kinase kinase COT69. Finally, AKT targets the transactivation domain of REL-A, increasing NFκB activity70–72. In specific cellular settings, the transcriptional activity of NFκB is required for oncogenic transformation by PI3K–AKT signalling. For example, disruption of the nuclear activity of NFκB with peptide antagonists of its nuclear localization signal, or with non-degradable forms of IκB, inhibits oncogenic transformation and cell proliferation, and induces apoptosis in pancreatic cancer cells73,74. NFκB activation by PI3K–AKT can also Figure 2 | PI3K–AKT signalling affects translation and transcription. The lipid kinase phosphatidylinositol 3-kinase (PI3K) phosphorylates phosphatidylinositol-bisphosphates (PIP2 ), generating phosphatidylinositol-trisphosphates (PIP3 ), which recruit the serine-threonine kinase AKT and 3-phosphoinositide-dependent kinase (PDK) to the plasma membrane. Phosphorylation by PDK activates AKT. The signal branches at the level of AKT, regulating downstream proteins that control translation and transcription. During translation, AKT signalling stimulates protein synthesis by activating the ribosomal protein S6 and the translational initiation factor 4E. Stimulation of these translational regulators is indirect and involves the signalling molecules TSC (tuberous sclerosis complex), RHEB (RAS homologue enriched in brain) and TOR (target of rapamycin). TSC is a heterodimeric complex consisting of TSC1 (also known as hamartin) and TSC2 (also known as tuberin) and functions as a GTPase-activating protein for the small GTPase RHEB155–159. TSC2 is directly phosphorylated and inactivated by AKT, which leads to increased RHEB activity155,160. In the GTP-bound state, RHEB activates TOR, presumably by direct interaction161. TOR then mediates phosphorylation of S6K and 4EBP (4E-binding protein), thereby stimulating the former and inactivating the latter, leading to increased S6 and 4E activity. During transcription, AKT affects numerous transcription factors, the control of which is either direct or indirect. Direct targets are the forkhead box proteins, FOXO, and the cell cycle inhibitor, MIZ1, both of which are inhibited upon AKT-mediated phosphorylation. AKT-dependent regulation of p53, nuclear factor κB (NFκB), c-MYC, activator protein 1 (AP1) and β-catenin is indirect and also independent of TOR. However, TOR does regulate the transcriptional activity of the hypoxiainducible factor HIF1α162,163. GSK3β, glycogen synthase kinase 3β; IKK, IκB kinase; MDM2, murine double minute; PDK, 3-phosphoinositide-dependent kinase; PTEN, phosphatase and tensin homologue deleted on chromosome 10. NATURE REVIEWS | CANCER VOLUME 5 | DECEMBER 2005 | 923 REVIEWS © 2005 Nature Publishing Group MACROLIDE A group of antibiotics that are produced by various strains of Streptomyces and have a complex macrocyclic structure. POL I AND POL IIIDEPENDENT TRANSCRIPTION Class I RNA polymerases synthesize all ribosomal RNAs except the 5S ribosomal RNA; class III RNA polymerases transcribe transfer RNA genes and the gene that encodes the 5S ribosomal RNA. mRNA CAP STRUCTURE The 5ʹ end of virtually all mRNAs is protected by a ‘cap’ with the chemical structure m7 GpppN (where m7 G represents 7-methylguanylate, p represents a phosphate group and N represents any base). result in a positive auto-feedback loop — NFκB signalling indirectly represses transcription of the PTEN gene and therefore amplifies the PI3K signal75,76. Other transcriptional regulators whose activities are affected by PI3K–AKT signalling include MIZ1 (Mycinteracting zinc-finger protein 1), p53, AP1 (activator protein 1), c-MYC, β-catenin and HIF1α (hypoxia inducible factor 1α). The exact roles of these proteins during PI3K-mediated oncogenesis are currently unknown, but they have all been linked to oncogenic transformation. AKT phosphorylates and thereby inactivates the cell-cycle inhibitor MIZ1 REF. 77, and also suppresses p53 activity by a mechanism that involves MDM2 (murine double minute)78,79. By contrast, the activities of AP1, c-MYC and β-catenin are increased by AKT. These targets are negatively controlled by GSK3β (glycogen synthase kinase 3β), which is inactivated by AKT-mediated phosphorylation80–87. In cancer cell lines that upregulate PI3K signalling, levels of HIF1 are increased, and the gene targets of this transcriptional regulator (for example, vascular endothelial growth factor) are activated88. PI3K and protein synthesis The key evidence that links protein synthesis to PI3K-mediated growth signals comes from studies with rapamycin and its target, TOR. Rapamycin is a MACROLIDE antibiotic that interacts with a small cellular protein FKBP12 (FK506-binding protein 12)89,90. The rapamycin–FKBP12 complex binds to the kinase TOR, interfering with the TOR-Raptor (regulatory associated protein of TOR) connection and blocking the phosphorylation of TOR–Raptor targets91–96. TOR has multiple and diverse functions, including the control of protein synthesis97. It stimulates POL I AND POL IIIDEPENDENT TRANSCRIPTION, thereby regulating the abundance of the components that make up the protein-synthesizing machinery of the cell98–102. The activities of Pol I and of Pol III have long-term effects, but TOR also regulates protein synthesis on a shorter timescale by inducing the phosphorylation of S6K (p70 S6 kinase) and of the 4EBP (translation initiation factor 4E-binding protein) family of proteins97,103. S6K is a positive regulator of protein synthesis and cell size104–107. Its mechanism of action is not fully understood; recent experiments have challenged previously proposed models in which S6K controls the translation of mRNAs that contain a 5′-terminal oligopyrimidine tract adjacent to the mRNA CAP STRUC TURE108,109. The 4EBP proteins are negative regulators of protein synthesis. They interact with the cap-binding protein 4E and thereby prevent the formation of the 4F translational initiation complex, which depends on the availability of 4E110. The phosphorylation of 4EBP by TOR breaks the attachment to 4E, allowing 4E to build a functional initiation complex and recruit the scaffolding protein 4G and the RNA helicase 4A111–113. TOR signals to its targets, S6K and 4EBP, through interaction with a binding partner, Raptor114,115. The function of Raptor in this process depends on a specific motif in the target proteins, named the TOS (TOR signalling) motif116–118 (FIG. 2). The oncogenic activities of PI3K and of AKT are exquisitely sensitive to rapamycin. Low concentrations of the drug completely prevent transformation that is induced by oncogenic versions of PI3K and of AKT in cell culture119. However, rapamycin does not inhibit transformation that is induced by other oncoproteins, although some, such as SRC, are sensitive to rapamycin in combination with inhibitors of MAP kinase signalling119,120. Sensitivity of tumours to rapamycin is also seen in animal model systems121,122. PTEN-deficient mice develop spontaneous cancers that show constitutive gain of function in PI3K–AKT signalling. The tumours respond to treatment with the rapamycin derivative CCI-779, which shows that TOR activity is essential for PI3K-dependent oncogenesis. In PI3Ktransformed or AKT-transformed cells, S6K and 4EBP are constitutively phosphorylated, indicating activation of the former and inactivation of the latter119. This constitutive phosphorylation is sensitive to rapamycin, and is therefore TOR-dependent119. The correlation between TOR-dependent intervention in protein synthesis and PI3K-induced oncogenic transformation is complemented by data on another regulator of protein synthesis, the mRNAbinding protein YB-1 (Y box-binding protein 1)123–126. YB-1 is transcriptionally downregulated in PI3Ktransformed and AKT-transformed cells127. Vectormediated expression of YB-1 in normal cells induces specific resistance to transformation by PI3K or AKT but does not affect transforming activities of other oncoproteins127. YB-1 acts downstream of TOR, as the phosphorylation levels of the TOR targets S6K and 4EBP are not changed in YB-1-overexpressing cells127. A deletion analysis of YB-1 shows that interference with PI3K-induced and AKT-induced transformation is correlated with the ability of YB-1 to inhibit cap-dependent protein synthesis128. All interfering YB-1 mutants also bind to mRNA, including the cap structure, and are localized in the cytoplasm128. The data on YB-1 provide an independent line of evidence for an essential role of protein synthesis in PI3Kinduced and AKT-induced transformation. It is likely that this role does not extend to protein synthesis in general but is restricted to the efficient translation of specific mRNAs. Table 1 | Aberrant PI3K-signalling in human cancers Component Type of alteration References p110α Gain of function by amplification, overexpression or somatic mutation 1–10,143,144,164–166 p85 Gain of function by mutation 36–40 PTEN Loss of function by mutation or transcriptional downregulation 27–29,158,167 AKT Gain of function by amplification, overexpression or increased phosphorylation 144,167–170 AKT, serine-threonine kinase that is a homologue of thymoma viral oncoprotein; p110α, catalytic subunit of phosphotidylinositol 3-kinase (PI3K); p85, regulatory subunit of PI3K; PTEN, phosphatase and tensin homologue deleted on chromosome 10. 924 | DECEMBER 2005 | VOLUME 5 www.nature.com/reviews/cancer REVIEWS © 2005 Nature Publishing Group R38 Q60 R88 P104 G106 R108 E110 K111 G118 G122 P124 N345 D350 C378 S405 E418 C420 E453 P539 E542 E545 Q661 H701 K733 C901 F909 S1008 P1011 Y1021 T1025 E1035 M1043 N1044 A1046 H1047 G1049 H1065 1.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.8 0.4 0.4 3.8 9.8 0.4 0.4 0.4 0.4 0.4 0.8 0.8 7.1 0.2 0.2 0.2 0.2 0.3 0.2 0.2 1.2 0.2 0.3 3.6 6.2 0.3 0.2 0.2 0.2 0.2 0.2 14.8 0.2 0.1 0.1 0.1 0.5 3.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 1.5 0.1 0.1 0.13 0.04 0.13 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.13 0.04 0.04 0.04 0.04 0.39 0.09 0.13 1.63 4.76 0.04 0.13 0.04 0.09 0.09 0.04 0.04 0.13 0.17 0.04 0.21 0.04 0.04 5.48 0.09 0.04 p85 RBD C2 Helical Kinase Mutated residue Colon Breast Others Total Total 32.3 29.3 6.5 15.1 p110α Frequency of mutation (%) Q546 2.6 0.2 0.2 0.47 Microarray analysis of polysomal RNA samples have shown a differential effect of PI3K, AKT and rapamycin treatment on the expression of specific mRNAs129– 131. These included mRNAs with lower translational fitness, presumably due to highly structured, complex 5′-untranslated regions. Efficient translation of such mRNAs is dependent on high levels of active 4E, which recruits an RNA helicase that can unwind 5′-mRNA structures to facilitate ribosome scanning132. Numerous mRNAs that code for growth factors, oncoproteins and cell cycle regulators have highly structured 5′-untranslated regions, making their efficient translation dependent on the abundance of 4E132. We conclude that deregulation of protein synthesis is necessary for PI3K- induced and AKT-induced transformation, but it might not be sufficient, as there are no reports that show oncogenic transformation by TOR or the TOR activator, RHEB (RAS homologue enriched in brain). The effects of AKT on transcriptional regulators are also essential features of the transformation process — transcriptional and translational deregulation are both necessary and complement each other. In addition to deregulating transcription and protein synthesis, oncogenic PI3K also affects cell replication and survival by post-translational modification of proteins. Examples of these effects that are outside the scope of this review are the AKT-induced phosphorylation and inactivation of the cyclin-dependent kinase inhibitors p21cip1 and p27kip1, as well as of the pro-apoptotic proteins BAD (BCL2-anatagonist of cell death) and caspase 9 REFS 133140. PI3K as a drug target Genetic aberrations that lead to a gain in PI3K signalling are commonly observed in human cancers TABLE 1. The recent sequencing of cancer cell genomes has revealed point mutations in PIK3CA1–10. These mutations occur at significant frequencies in several types of solid tumours (FIG. 3). They are observed in colon as well as in breast and hepatocellular carcinomas. The mutations in PIK3CA in human tumours are somatic, cancer-specific and heterozygous. They are mostly missense mutations; no truncating or nonsense mutations have been identified, but a few cases of in-frame deletions and insertions have been detected1,3,5. Rare cases of double mutations, in which two amino-acid residues are altered, have also been reported5,8. In breast carcinoma, mutations in PIK3CA and loss of PTEN function are almost always mutually exclusive8 . However, mutations in PIK3CA are often correlated with overexpression of ERBB2 (also known as HER2/ NEU), indicating that gains of function in these two signalling components could have a synergistic effect in counteracting PTEN8 . The most important attribute of the cancerspecific mutations in PIK3CA is a non-random distribution along the coding sequence (FIG. 3). This non-randomness is indicative of selection for mutations that confer a proliferative advantage, which act as dominant oncoproteins. The majority of the mutations map to three sites — E542 and E545 in the helical domain and H1047 in the kinase domain of p110α (FIG. 3). E542 and E545 are commonly changed to lysine, whereas H1047 is frequently substituted with arginine. At all three sites, the mutations cause a gain of enzymatic function1,141. The three mutant Figure 3 | Point mutations in PIK3CA observed in human tumours. Analyses of the phosphatidylinositol 3-kinase PIK3CA gene in human tumour samples have identified somatic point mutations that affect a total of 38 residues1–10. Mutations other than point mutations have not been included in the figure. The mutations localize to various domains of the p110α primary structure as indicated. ‘Hot-spot’ mutations that occur at high frequency are confined to residues E542, E545 and H1047 and are highlighted in orange. Overall frequencies of mutation have been determined for cancers of the colon (266 samples)1,3, breast (580 samples)1–3,5,6,8 and others, which include liver (73 samples)5 , brain (382 samples)1,4,10, stomach (291 samples)1,5,7, lung (253 samples)1,5 and ovary (489 samples)3,6,9, with a total of 2,334 tumour samples. Protein domains have been determined using NCBI tools. C2, protein-kinase-C homology-2 domain; p85, p85-binding domain; RBD, RAS-binding domain. NATURE REVIEWS | CANCER VOLUME 5 | DECEMBER 2005 | 925 REVIEWS © 2005 Nature Publishing Group proteins also induce oncogenic transformation when expressed in primary chicken-embryo fibroblasts and in NIH 3T3 cells141,142. AKT signalling is constitutively activated in the mutant-transformed cells, as indicated by high levels of phosphorylated AKT and of its downstream targets S6K and 4EBP141,142. The oncogenic transformation that is induced by the three mutant p110α proteins is inhibited by rapamycin, indicating that TOR and TOR-dependent protein synthesis are essential components of the transformation process141. Mutations in p110α and other mechanisms of activating PI3K signalling appear to be mutually exclusive. In ovarian cancer, mutations in p110α are confined almost exclusively to tumours that do not show amplification of the PIK3CA gene3 . Since amplification of PIK3CA is common in ovarian cancers, mutations in p110α are rare in these tumours3, 9, 143. Likewise, in gastric tumours, the incidence of PIK3CA amplification far exceeds that of mutations in PIK3CA5,7,144. By contrast, tumours that lack PIK3CA amplification, such as in breast cancer or colorectal cancer, more frequently harbour mutations in p110α3, 6. The mechanisms by which the mutations in p110α induce a gain of function remain to be determined. In the absence of structural data for p110α, it is nevertheless possible to model the catalytic and helical domains of the molecule using the published crystal structure of the homologous p110γ isoform145 (FIG. 1). In this model, the two most prevalent mutations in the helical domain, E542K and E545K, map to the surface of the protein6,146. Both mutations cause an electrostatic charge reversal from negative to positive that could change the ability of the protein to interact with regulatory proteins. Although deletion mapping has defined separate binding regions for the regulatory subunit p85 and for RAS that lie in the amino-terminus of p110α, the data do not rule out an extended interaction of p85 or RAS with this helical domain. The p85 subunit can function as a negative regulator of p110α, and reduction of p85 binding by the E542K or E545K mutations could increase p110α enzymatic activity147. There is also the possibility that these mutations disrupt the ability of p110α to interact with a still unknown regulatory protein. Another possible explanation for the gain of function that is induced by the mutations in the helical domain is that these cause a change in enzyme conformation. These mutations could affect the C2 (protein-kinase-C homology-2) domain and thereby increase the affinity of that domain for lipid membranes. The third of the prevalent mutations, H1047R, is located near the activation loop in the catalytic domain. It is likely that it affects specificity or affinity of p110α towards the lipid substrate of PI3K. Mutated kinases are ideal drug targets — especially when mutated forms of these proteins are only expressed in tumour cells and result in a gain of function. Studies of patients with non-small-cell lung cancer have shown that tumours that express mutant forms of the receptor tyrosine kinase EGFR (epidermal growth factor receptor) are more responsive to EGFR inhibitors such as erlotinib and gefitinib, compared with tumours that express wild-type EGFR148–150. Therapy with these inhibitors increased survival times of patients with tumours that express EGFR151. A rough estimate that is based on the published frequencies of tumour-specific mutations in PI3K indicates that the number of newly diagnosed patients with cancer who carry one of the ‘hot spot’ mutations in PI3K (described in FIG. 3), is in excess of 10,000 per year in the United States and there are many more worldwide. Specific inhibitors of mutant forms of PI3K could therefore have a significant therapeutic effect. The feasibility of generating mutant-specific PI3K inhibitors has not been established. However, recent advances in the design and assembly of bivalent enzyme inhibitors indicate that compounds with the requisite specificity and potency could be within reach.  Mutations in the gene encoding the p110α subunit of PI3K (PIK3CA) that result in enhanced PI3K activity are frequently observed in human cancers. To better understand the role of mutant PIK3CA in the initiation or progression of tumorigenesis, we generated mice in which a PIK3CA mutation commonly detected in human cancers (the H1047R mutation) could be conditionally knocked into the endogenous Pik3ca locus. Activation of this mutation in the mouse ovary revealed that alone, Pik3caH1047R induced premalignant hyperplasia of the ovarian surface epithelium but no tumors. Concomitantly, we analyzed several human ovarian cancers and found PIK3CA mutations coexistent with KRAS and/or PTEN mutations, raising the possibility that a secondary defect in a co-regulator of PI3K activity may be required for mutant PIK3CA to promote transformation. Consistent with this notion, we found that Pik3caH1047R mutation plus Pten deletion in the mouse ovary led to the development of ovarian serous adenocarcinomas and granulosa cell tumors. Both mutational events were required for early, robust Akt activation. Pharmacological inhibition of PI3K/mTOR in these mice delayed tumor growth and prolonged survival. These results demonstrate that the Pik3caH1047R mutation with loss of Pten is enough to promote ovarian cell transformation and that we have developed a model system for studying possible therapies.  Go to: Introduction In human cancers, somatic mutations in PIK3CA commonly target specific hot spots in the helical (E542 and E545) and kinase (H1047) domains (1, 2), resulting in enhanced lipid kinase activity and upregulation of downstream signaling events such as phosphorylation of Akt (3). Activation of Akt is observed in up to 70% of ovarian cancers (4) due to a variety of causes, including PIK3CA mutations (8%–12%) or amplification (3%–8%) and/or PTEN loss (27%) or mutations (3–8%) (1, 5–10). Loss of Pten (11, 12) or overexpression of activated PI3K in the mouse ovarian surface epithelium (OSE) (13) do not lead to tumor formation; however, the ability of mutant Pik3ca to initiate tumorigenesis or drive tumor progression has not been established. Here we describe an animal model that allows us to study the effects of the Pik3caH1047R mutation in the physiologically relevant context of a somatic, heterozygous Pik3ca mutation expressed at endogenous levels in otherwise normal cells and tissues.  Go to: Results and Discussion We analyzed 87 human ovarian cancers for changes in PI3K pathway genes PIK3CA, PIK3R1 (encoding the PI3K p85 regulatory subunit), PTEN, and also in KRAS, which interacts with PI3K to mediate its activity (refs. 14, 15, and Supplemental Table 1; supplemental material available online with this article; doi: 10.1172/JCI59309DS1). We found 37% of samples exhibited genetic aberrations in one of these genes. Notably, 4 (40%) of the 10 patients who had PIK3CA mutations also exhibited PIK3R1, PTEN, and/or KRAS mutations. Analysis of 34 ovarian cancer cell lines found 3 (IGROv1, TOV21G, and MCAS) had coexisting PIK3CA mutation with PTEN and/or KRAS aberrations (Supplemental Table 1). Consistent with this, studies in endometrioid ovarian (11), breast, endometrial, and colon cancers (16) have identified tumors with coexistent PIK3CA and PTEN mutations. Neither the role of endogenous levels of mutant PIK3CA nor the cooperative nature of PIK3CA and PTEN mutations has been evaluated in vivo.  To address this, we used what we believe to be a novel exon-switch strategy to generate a mutant mouse harboring a germline Pik3ca allele with a conditional H1047R mutation. We inserted loxP sites flanking exon 20 of Pik3ca and downstream placed a tandem copy of exon 20 containing a CAT→AGG change in codon 1047 (Figure (Figure1A1A and Supplemental Figures 1 and 2). Adenoviral Cre–mediated (AdCre-mediated) recombination leads to replacement of wild-type with mutant exon 20, resulting in p110α-H1047R protein expression at endogenous levels in otherwise normal cells, thus accurately reproducing the scenario of a naturally occurring mutation. The presence of the conditional allele did not affect development (Supplemental Table 2). Using murine embryonic fibroblasts (MEFs), we confirmed the knock-in of the Pik3caH1047R mutation after AdCre infection in vitro (Supplemental Figures 3 and 4). Pik3caH1047R resulted in elevated p-Akt and p–ribosomal protein S6 (p-Rps6) levels, increased PI3K activity, enhanced proliferation, and reduced apoptosis (Figure (Figure1,1, B–E). We have thus generated a model system in which the biological effects of Pik3caH1047R expression can be examined both in vivo and in vitro.  Figure 1 Figure 1 Pik3caH1047R results in increased PI3K activity and functional changes in MEFs. Combining this mouse with a Cre-inducible knockout of Pten (17), we investigated whether two genetic hits affecting PI3K regulation (Pik3caH1047R and Pten loss) are sufficient to promote tumorigenesis in the ovary. We induced the Pik3caH1047R mutation and/or deleted Pten in the left ovary by intrabursal AdCre delivery, which targets recombination to the OSE, granulosa cells of the ovarian follicles, and ovarian bursal cells (refs. 11, 12, 18, 19, and Supplemental Figure 5).  At 8 weeks after AdCre infection, OSE of Pik3caH1047R mice showed mild, focal papillary serous hyperplasia, and Pik3caH1047RPtendel/del mice showed marked hyperplasia (Figure (Figure2A).2A). p-Akt T308 and p-Akt S473 staining was strongest and located at the membrane in the OSE of double Pik3caH1047RPtendel/del mutants (Figure (Figure2A). 2A).  Figure 2 Figure 2 Pik3caH1047R and Pten deletion leads to robust p-Akt T308 and p-Akt S473 levels in OSE. Over 1 year of observation, no wild-type or single mutant mice developed tumors. Pik3caH1047R, Pik3caH1047RPtendel/WT, and Ptendel/del mice developed serous papillary hyperplasia of the OSE (Figure (Figure2B,2B, Supplemental Figure 6, and Table Table1),1), coincident with an increase in p-Akt T308 and p-Akt S473 compared with equivalent OSE at 8 weeks after AdCre infection. The degree of the hyperplasia varied between mice and was highest in the Pik3caH1047R and Pik3caH1047RPtendel/WT compared with the Ptendel/del mice, suggesting that alone, Pik3caH1047R more potently promotes proliferative changes compared with Pten loss. In some Pik3caH1047R mice, the hyperplasia resembled epithelial proliferation seen in the borderline (low malignant potential) subtype of human ovarian serous carcinoma. In 2 mice, we observed microinvasion of the ovarian stroma, indicating that the epithelial proliferation was neoplastic despite the absence of definitive cytological evidence of malignancy. The inability of Pik3caH1047R to induce ovarian tumorigenesis differs from transgenic mouse models of Pik3caH1047R inducing lung and breast (20–23) tumors, but these models are driven by overexpressed Pik3caH1047R rather than mutation of the endogenous gene, as occurs in human tumors. Possibly, the ovary could be less susceptible to transformation via a single mutation compared with other tissue types. Studies are underway to examine the role of this mutation in the lung, breast, and gastrointestinal tract.  Table 1 Table 1 Pik3caH1047R or Pten deletion in the ovary induces serous papillary hyperplasia and together can cooperate to induce serous adenocarcinomas or granulosa cell tumors In contrast to the single mutant mice, all Pik3caH1047RPtendel/del mice developed ovarian masses, necessitating sacrifice with a median latency of 16 weeks (Figure (Figure2B2B and Figure Figure3,3, A and B). Macroscopic analyses at autopsy revealed that many Pik3caH1047RPtendel/del mice developed hemorrhagic ascites, and some showed intraperitoneal masses on the peritoneal wall and diaphragm. No distant metastases were evident macroscopically. Histological examination confirmed malignancy in 15 of 18 ovarian masses, consisting of ovarian serous adenocarcinomas (Figure (Figure3,3, D and E), ovarian granulosa cell tumors (Figure (Figure3,3, I–K), and a single ovarian luteoma (Table (Table1).1). Three mice had collision tumors composed of different histological cancer types within the same mass. Serous carcinomas exhibited high abundance and membrane localization of p-Akt S473, p-Akt T308 (Figure (Figure2B2B and Figure Figure3F),3F), cytoplasmic p-Rps6 (Figure (Figure3G),3G), and keratin (Figure (Figure3H).3H). Granulosa cell tumors were positive for inhibin (Figure (Figure3K).3K). Expression of the Pik3caH1047R mutant and loss of PTEN protein were confirmed in tumors (Figure (Figure22 and Supplemental Figure 7). Consistent with these findings, recent genomic analysis of high-grade serous ovarian cancers shows that while PIK3CA amplification and mutations are rare events in this subtype, upregulation of the pathway is seen in 45% of cases (24).  Figure 3 Figure 3 Pik3caH1047R and Ptendel/del cooperate to promote tumorigenesis in mouse ovary. Additionally, 13 of the 15 (86.7%) Pik3caH1047RPtendel/del mice showed variable degrees of fibrous and/or smooth muscle hyperplasia, which formed irregular or solid masses of desmoplastic stroma or resulted in bursal wall thickening by actin-positive smooth muscle (data not shown). This phenotypic heterogeneity demonstrates that combined Pik3caH1047R mutation and Pten loss can cooperate to potently promote proliferation or transformation in several cell types, including OSE, ovarian granulosa cells, fibroblasts, and smooth muscle cells following AdCre infection.  We compared PI3K/Akt/mTOR pathway signaling in Pik3caH1047RPtendel/del tumor lysates with that in other mouse ovarian cancer models: KrasG12DPtendel/del and ApcS580/S580Ptendel/del (refs. 11, 12, and Figure Figure3L).3L). Pik3caH1047RPtendel/del and KrasG12DPtendel/del tumors exhibited equivalent pathway signaling to multiple substrate proteins. While ApcS580/S580Ptendel/del tumors showed equivalent p-Pdk1 and p-Rps6 levels, they showed relatively low levels of p-Akt and its substrates. This suggests that cooperating mutations — Pten loss and Kras or Pik3ca mutation, but not Apc mutation — are required to robustly activate Akt and its direct targets.  These mutations may cooperate because both Pik3caH1047R kinase activity and loss of PTEN’s phosphatase activity are necessary to reach a threshold of PIP3 levels required for transformation. Alternatively, since PTEN has additional, PI3K-independent tumor-suppressive functions (25), its loss may promote tumorigenesis via these additional mechanisms. Finally, both mutations may be required to overcome negative feedback loops that could be activated as a result of only one of these genetic events.  To examine whether established Pik3caH1047RPtendel/del tumors remained dependant on PI3K pathway activity for tumor maintenance, we utilized an ATP-competitive PI3K/mTOR inhibitor, PF04691502, currently in phase I clinical trials (26, 27). Treatment of Pik3caH1047RPtendel/del mice commenced 10 weeks following AdCre exposure (Figure (Figure3M),3M), and tumor progression was monitored by ultrasound (Supplemental Figure 8). Early response was characterized by cytostasis, which significantly lengthened median survival time (Figure (Figure3M),3M), indicating a continued dependence on PI3K and/or mTOR for tumorigenesis in this model. Interestingly, tumors eventually regrew despite continuous PI3K/mTOR inhibition with PF04691502. This suggests that patients with PIK3CAH1047R mutations and loss of PTEN could be initially responsive to PI3K/mTOR inhibition, but that resistance is likely to develop. This model has the potential to provide a crucial new system for examining resistance mechanisms to PI3K pathway inhibitors and for testing novel therapeutics targeting the PI3K pathway alone or in combination with other therapies.  In summary, study of the Pik3caH1047R mouse model described herein has demonstrated that Pik3ca mutation requires a second hit to initiate tumorigenesis in the ovary. We found that mutations in PI3K regulatory proteins co-occur in human ovarian tumors with PIK3CA mutations and demonstrate that in vivo, Pik3caH1047R and loss of Pten is sufficient to promote ovarian cell transformation.  Go to: Methods Generation of Pik3caLat-H1047R mice.  Pik3caLat-H1047R mice were generated by homologous recombination in embryonic stem cells (Ozgene). The targeting construct, detailed in Supplemental Figure 1, was assembled from C57BL/6 genomic DNA and cloned into the Ozgene F_PacI_Neo vector containing a PGK-neomycin cassette flanked by FLP recombinase target (FRT) sequences. The targeting vector was electroporated into 129S1/Sv-derived W9.5 ES cells. Targeted ES cells were injected into C57BL/6 blasto­cysts and chimeras crossed with C57BL/6 mice. The PGK-neomycin cassette was deleted by crossing with C57BL/6 ACTB-FLPe mice.  AdCre recombination in the ovary.  Cells in the ovarian bursa were infected with AdCre, a gift from Walter Thomas (Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia) as described previously (18); details are provided in Supplemental Methods. Endpoints were excessive tumor burden (>1.5 cm3), severe abdominal distension, or signs of severe illness (hunching, ruffled fur, or loss of responsiveness).  Mouse cohorts.  Ptendel/del mice (c;129S4-Ptentm1Hwu/J) were from The Jackson Laboratory. All Pik3caH1047RPtendel/del mice were maintained on a mixed (C57BL/6; BALB/c; 129S4) background, and littermates were used where possible. Pik3caH1047R refers to heterozygotes. KrasG12DPtendel/del and APC580S/580SPtendel/del ovarian tumor samples were generated using APC580S (a gift from Tetsuo Noda, Department of Cell Biology, Cancer Institute, Toshima-ku, Tokyo, Japan; ref. 28) and KrasG12D (MMHCC, ref. 29) mice.  Histology and protein analysis.  Tumors were formalin fixed, and immuno­histochemistry was performed as described previously (27). For Western blotting, tumors were snap frozen and lysed in RIPA buffer. Antibodies are detailed in Supplemental Methods.  In vivo therapy.  Mice received vehicle (0.5% methylcellulose) or 10 mg/kg PF04691502 orally, daily. Ovary volume was monitored by ultrasound imaging (Vevo 770, Visualsonics). Endpoints were as above or weight loss of greater than 20%.  Statistics.  Statistical analyses were performed using a 2-tailed Student’s t test or log-rank (Mantel-Cox) Kaplan-Meier survival test. P values less than 0.05 were considered statistically significant.  Study approval.  Animal experiments followed the National Health and Medical Research Council (NHMRC) Australian Code of Practice for the Care and Use of Animals for Scientific Purposes and were approved by the PMCC ethics committee.  The PIK3CA gene, coding for the catalytic subunit p110α of class IA phosphatidylinositol 3-kinases (PI3Ks), is frequently mutated in human cancer. Mutated p110α proteins show a gain of enzymatic function in vitro and are oncogenic in cell culture. Here, we show that three prevalent mutants of p110α, E542K, E545K, and H1047R, are oncogenic in vivo. They induce tumors in the chorioallantoic membrane of the chicken embryo and cause hemangiosarcomas in the animal. These tumors are marked by increased angiogenesis and an activation of the Akt pathway. The target of rapamycin inhibitor RAD001 blocks tumor growth induced by the H1047R p110α mutant. The in vivo oncogenicity of PIK3CA mutants in an avian species strongly suggests a critical role for these mutated proteins in human malignancies.  Keywords: chorioallantoic membrane, hemangiosarcoma, phosphatidylinositol 3-kinase, p110 The PIK3CA gene codes for the catalytic subunit p110α of class IA phosphatidylinositol 3-kinases (PI3Ks) (reviewed in refs. 1-3). PIK3CA is the cellular homolog of the retroviral v-p3k oncogene and is amplified in ovarian and cervical cancer (4-6). Genomic profiling of human cancers revealed the presence of somatic, heterozygous point mutations in PIK3CA (7-16). These mutations occur in ≈30% of all breast and colon cancers and are less frequent in cancers of the brain, stomach, liver, and ovary. The mutations are nonrandomly distributed over the primary structure of p110α and cluster to regions in the p85-binding domain, the C2 domain, the helical domain, and the C terminus of the catalytic domain. The sites most frequently affected by mutation are the residues E542 and E545 in the helical domain and H1047 in the catalytic domain. The glutamates at position 542 and 545 are commonly changed to lysines, and H1047 is often replaced by arginine. The cancer-specific point mutations of p110α confer a gain of function resulting in increased lipid kinase activity (15, 17-19). Expression of p110α mutants activates the Akt-signaling pathway in the absence of growth factors and induces oncogenic cellular transformation of chicken embryo fibroblasts (CEFs) and of NIH 3T3 cells (17, 18). The transformation by p110α mutants is sensitive to rapamycin, suggesting that the target of rapamycin (TOR) and downstream effector molecules of TOR are crucial components of the oncogenic process (18).  Here, we provide evidence for the oncogenicity of p110α E542K, E545K, and H1047R in vivo and identify the PIK3CA mutants as oncoproteins. These mutants induce angiogenesis and malignant cell growth in the chorioallantoic membrane (CAM) of the chicken embryo and cause hemangiosarcomas in young chickens. The rapamycin derivative RAD001 interferes with H1047R-induced tumor formation, in agreement with observations made in cell culture and in murine tumor systems that depend on increased PI3K function (18, 20, 21).  Go to: RESULTS p110α Mutant Proteins Induce Neoplastic Cell Growth in the Chicken CAM. To explore the oncogenic effects of cancer-specific p110α mutations in vivo, we used the CAM of the chicken embryo as an in vivo tumor model. The CAM is a vascularized membrane located underneath the shell membrane, engulfing the chicken embryo, and is commonly used to measure angiogenesis and oncogenesis (22, 23). We inoculated the CAMs of 9-day-old chicken embryos with CEFs transformed by p110α mutant proteins E542K, E545K, and H1047R. CEFs stably transfected with wild-type p110α or empty replication-competent retroviral avian sarcoma-leukosis virus long-term repeat with splice acceptor (RCAS) vector served as nontransforming controls, and cells expressing the highly oncogenic protein myr-p110α, which contains an N-terminal myristylation signal, were used as a positive control (24). CEFs transfected with RCAS constructs release infectious viruses that harbor the RCAS genome plus insert and thus spread expression of the RCAS construct to neighboring cells. CAMs treated with E542K, E545K, and H1047R display increased vascularization and the formation of neoplastic nodules (Fig. 1). Areas that show abnormal cell growth are marked by strongly elevated angiogenesis. The positive control myr-p110α induces angiogenesis and neoplastic cell growth similar to the p110α mutants, in agreement with a previous report (23). Histological analysis of the H1047R tumor reveals hemangiosarcoma-like characteristics that closely resemble those observed in tumors induced by myr-p110α (Fig. 2). Large areas of polymorphic cells and multiple enlarged blood channels with a complete disruption of endothelial linings are common features. The tumor sections are dotted with frequent metaphases, and some of these are highly abnormal. The areas of hyperplasia on CAMs inoculated with the E542K or E545K mutants do not show hemangiosarcoma-like features in hematoxylin- and eosin-stained sections but nevertheless represent foci of abnormal cell growth (data not shown). In contrast, cells transfected with empty RCAS or wild-type p110α fail to induce angiogenesis or aberrant cell growth on the CAM, in agreement with previous observations in cell culture, suggesting that mere overexpression of p110α is insufficient for oncogenesis (18, 24).  Fig. 1. Fig. 1. Neoplastic cell growth and angiogenesis induced by p110α mutants in the CAM of the chicken embryo. CAMs of 9-day-old chicken embryos were each inoculated with 106 CEFs stably expressing p110α mutant proteins, myr-p110α, wild-type ... Fig. 2. Fig. 2. Histology of tumors in the CAM. Three-micrometer cuts of membranes shown in Fig. 1 were stained with hematoxylin and eosin. Micrographs were taken by using the ×4 objective (Left) and the ×40 objective (Right). The corresponding area of ... p110α Mutant Proteins Cause Tumors in the Animal. Data from in vitro studies and CAM assays indicate that the mutant proteins p110α E542K, E545K, and H1047R promote aberrant cell growth and may therefore cause tumors in the animal. To test this possibility, we s.c. injected CEFs transformed by the p110α mutants into the wing web of newly hatched chickens and monitored the animals for the following 27 days. Cells transfected with myr-p110α or empty RCAS vector were used as controls. Expression and the integrity of p110α, as well as retroviral Gag proteins on the day of injection were verified by Western blot analysis (Fig. 3B). Animals injected with any of the three p110α mutants developed tumors at the site of injection (Fig. 3A). Control animals treated with cells expressing the empty vector RCAS remained negative, and all animals injected with myr-p110α-expressing cells developed tumors. The growth rates of mutant-induced tumors varied, with the p110α H1047R protein as the most potent carcinogen. The mutants also differed in their frequencies of tumor induction, depending on whether the mutation occurred in the helical or in the catalytic domain of the p110α protein. Eighty percent of animals treated with H1047R (four of five) developed tumors, whereas E542K or E545K caused tumors at a frequency of 50% (four of eight). The difference in tumor incidence and growth cannot be explained by expression levels of individual p110α proteins, because cells used for injections show similar expression levels of E542K, E545K, and H1047R (Fig. 3B). These results suggest that the H1047R mutation in the catalytic domain is more potent than the E542K and E545K mutations in the helical domain, in accordance with data obtained from CAM assays and focus-formation assays (18). Histological analysis showed that all tumors induced by p110α mutant proteins were highly hemorrhagic and contained areas of polymorphic and neoplastic cells, similar to tumors caused by myr-p110α and to tumors of the CAM (Fig. 4). All tumors also show a high degree of angiogenesis. The H1047R-induced tumors classify as hemangiosarcomas; tumors caused by the helical domain mutations E542K and E545K were diagnosed as either hemangiomas or hemangiosarcomas.  Fig. 3. Fig. 3. Tumor growth induced by p110α mutants in chickens. (A) CEFs (106) stably transfected with p110α mutants, myr-p110α, or empty RCAS were injected into the wing web of newly hatched chickens (day 0). Tumor growth was monitored for ... Fig. 4. Fig. 4. Histology of a H1047R tumor. Tumor tissue and the corresponding tissue of an animal that was injected with RCAS-transfected cells were dissected and fixed in paraffin. Three-micrometer sections were stained with hematoxylin and eosin and photographed ... Activation of Akt Signaling in Mutant-Induced Tumors. Previous studies demonstrated that somatic mutations in PIK3CA constitute gain-of-function mutations, transmitting signals to downstream effector molecules independently of growth factors (18). To investigate whether tumors derived from H1047R show an activation of the PI3K pathway, we extracted total protein from tumors and probed for Akt and glycogen synthase kinase 3β (GSK-3β) with phospho-specific antibodies (Fig. 5). All tumors tested showed increased levels of phosphorylated Akt relative to the corresponding control tissues from the untreated wing of the same animal. Phosphorylation of Akt tightly correlates with elevated expression of p110α H1047R (data not shown). In most samples, GSK-3β is hyperphosphorylated at the Akt-specific target site, providing further evidence for an up-regulation of Akt signaling. These in vivo data are in agreement with results from experiments in cell culture and establish the oncogenicity of the p110α mutants and their activating effect on the Akt-signaling pathway.  Fig. 5. Fig. 5. Activation of Akt signaling in tumors induced by H1047R. Tumors of animals injected with H1047R-expressing cells (T) and corresponding control tissue of the untreated wing (C) were used for the extraction of protein lysates. Fifty micrograms of total ... Inhibition of H1047R-Dependent Tumor Growth by RAD001. Cancers induced by deregulation of the PI3K pathway depend on the TOR kinase and are exquisitely sensitive to the TOR inhibitor rapamycin and its derivatives (20, 21). Tissue culture experiments demonstrated that cellular transformation induced by p110α mutants is similarly inhibited by rapamycin (18). Therefore, TOR may also be necessary in mutant-induced tumor formation in the animal. To test this hypothesis, we determined tumor growth in the presence of the rapamycin derivative RAD001 [everolimus, 40-O-(2-hydroxyethyl)rapamycin] (Novartis Pharma, Basel). We injected CEFs expressing p110α H1047R into 10 2-day-old chickens and treated 5 animals with RAD001 and 5 animals with placebo. RAD001 or placebo was administered orally at 10 mg/kg per day by gavage feeding and did not cause any toxicity, because animals were healthy and continually gained in size and body weight. Medication began on the day of injection and continued for the following 17 days. Animals on placebo rapidly developed tumors, and the onset as well as the growth rate of tumors was comparable to the ones in the previous experiments (Figs. ​(Figs.3A3A and ​and6A).6A). Tumor formation in animals treated with RAD001, however, was largely suppressed. During RAD001 treatment, three of five animals developed small colorless nodules that showed no signs of angiogenesis. Upon removal of the drug, these nodules quickly became hemorrhagic and rapidly increased in size, suggesting that continuous administration of RAD001 is required to inhibit tumor growth and angiogenesis. Because the incidence of tumor development induced by p110α H1047R is not 100%, we medicated a second group of animals, all of which had developed ≈3-mm tumors before therapy (Fig. 6B). Similar to the data shown in Fig. 6A, RAD001 treatment led to an initial regression of tumors with a concomitant loss of excess vascularization. Prolonged RAD001 treatment resulted in a stable disease with no increase or decrease of H1047R-induced tumors. Once therapy was terminated, however, all tumors became hemorrhagic and resumed growth at a pace comparable to animals on placebo.  Fig. 6. Fig. 6. Inhibition of H1047R-induced tumor growth by RAD001 therapy. (A) Ten 2-day-old chickens were injected with 106 CEF stably expressing H1047R (day 0) and medicated daily with 10 mg/kg RAD001 or placebo. On day 17, RAD001 treatment was terminated. (B) A ... Go to: DISCUSSION The mutants of p110α tested in this study are cancer-specific, show enzymatic gain of function, and induce oncogenic transformation in cell culture (18). The data presented here extend the oncogenic potential of these mutants to animals. The E542K, E545K, and H1047R mutants map to mutational hot spots of the PIK3CA gene. This nonrandom distribution suggests that the mutations confer a selective advantage to the cell and is in accord with the interpretation that they contribute to the neoplastic phenotype of the cancer cell. The in vivo oncogenicity of the mutants adds strong support to this idea.  A mutant protein becomes an attractive target for cancer therapy when it combines the following four properties: (i) The occurrence of the protein is restricted to cancer tissue. (ii)Ithas a specific enzymatic activity. (iii) The enzymatic activity shows a gain of function compared with the wild-type enzyme. (iv) The mutant protein plays a causative role in the disease process. All four qualities are found in the p110α mutants. In these respects, the p110α mutants are similar to other exceptional cancer targets such as BCR-ABL, a fusion protein kinase that plays a causative role in chronic myeloid leukemia and has been targeted by the small molecule inhibitor imatinib with unequalled success in the clinic (25, 26).  The molecular mechanisms by which the mutants gain enzymatic function and hence acquire oncogenic potential are not known. The mutations could affect binding to the enzyme substrate or to a regulatory protein, or they could enhance the stability of the protein or affect the release from an intramolecular inhibitory interaction. The mutations could induce major conformational changes or locally confined structural alterations. Structural analysis and studies with small molecule inhibitors will provide answers to these questions.  Overexpression of the wild-type p110α protein from the retroviral vector RCAS can lead to oncogenic transformation in cell culture (18, 24). These rare oncogenic events derive from the use of the RCAS vector that expresses the p110α insert from actively replicating retroviral genomes. In the course of viral replication, the insert can become spontaneously fused to viral Gag sequences, generating a chimeric protein that, by virtue of its Gag region, has a constitutive membrane address and strong oncogenic potential. In all transformed cell foci induced by wild-type p110α, the lipid kinase is fused to viral Gag (18, 24). This tendency of the RCAS vector to generate oncogenic fusion proteins raises the possibility that the tumors developing after injection of mutant p110α-producing cells are caused not by the mutants themselves but by RCAS-generated Gag-p110α fusions. We have probed several tumor lysates for Gag fusions yet were unable to detect such chimeric proteins (data not shown). These results show that tumor induction by p110α mutants is not an artifact of the vector system and that the mutant proteins are oncogenic on their own. This conclusion is also supported by the rapidity of tumor induction, which is comparable to that of the highly oncogenic myristylated p110α and unlike the protracted process of oncogenic transformation associated with Gag-p110α fusions.  The tumors induced by mutant p110α proteins on the CAM and in the animal are highly hemorrhagic, and this phenotype appears to be linked to the activation of the Akt/TOR signaling pathway. We have shown previously that PI3K-Akt signaling is essential for angiogenesis (23). The growth of the tumors is effectively inhibited by the rapamycin-like inhibitor RAD001, suggesting an essential role for TOR in tumorigenesis. RAD001 treatment also leads to a complete regression of the hemorrhagic phenotype. This result is in accord with observations in mouse models, demonstrating that tumor development in these animals is suppressed by RAD001 with a concomitant decrease in angiogenesis (27). The angiogenic activity of p110α mutants may be mediated, at least in part, by hypoxia-inducible factor 1α (HIF-1α), which transcriptionally stimulates the expression of vascular endothelial growth factor (VEGF) (23). HIF-1α is regulated by TOR, and, therefore, suppression of angiogenesis by RAD001 could be a consequence of HIF-1α inactivation through inhibition of TOR (28, 29).  Avian cells appear to be highly sensitive to oncogenic transformation induced by gain-of-function PI3K, and this quality makes them exceptionally suitable for investigations on small molecule inhibitors of PI3K. There are evidently species-specific differences in the sensitivity to oncogenic signals. Human cells are notoriously difficult to transform in culture, requiring multiple genetic changes (30). However, the basic growth-regulatory machineries of all vertebrate cells appear to be identical. The induction of tumors by PI3K mutants in an avian species therefore reflects an oncogenic potential that is probably also active in human cells but for full expression may require additional factors.  Go to: MATERIALS AND METHODS Cell Culture and DNA Transfection. Fertilized chicken eggs (White Leghorn) were obtained from SPAFAS (Preston, CT). Primary CEFs were prepared as described in ref. 31. For stable transfections, 3 × 106 CEFs were transfected with 5 μg of RCAS vectors by DMSO shock (32). The RCAS constructs encoding chicken p110α, myr-p110α, E542K, E545K, and H1047R are described elsewhere (18, 24). Expression of p110α proteins was verified by Western blot analysis before in vivo studies.  CAM Assays. CAM assays were performed by following a published protocol (22, 23). Briefly, fertilized chicken eggs (White Leghorn) obtained from McIntyre Poultry & Fertile Eggs (Lakeside, CA) were incubated at 37.5°C with 70% humidity for 9 days. Eggs were candled to confirm embryo growth and to locate vascularized areas of the CAM. Two holes were drilled, one into the air-sack at the bottom of the eggs, another one at the lateral end above the blood vessels, penetrating through the outer shell membrane without injuring the CAM. The CAM was dropped by applying suction to the air-sack, exposing an ≈3-cm× 4-cm area of the CAM. CAMs were inoculated with 106 CEFs stably transfected with RCAS constructs encoding E542K, E545K, H1047R, myr-p110α, wild-type p110α, or empty vector. Eggs were sealed and incubated for another 9 days. Exposed areas of CAMs were dissected, washed with PBS, photographed, and prepared for histology. Three-micrometer sections of tissues embedded in paraffin were stained by hematoxylin and eosin by following standard protocols.  Animal Studies. Left wing webs of 1- to 2-day-old chickens (White Leghorn) were injected with 106 CEF stably transfected with empty RCAS or RCAS constructs encoding p110α proteins. Right wing webs were left untreated. Tumor growth was monitored 2-4 times a week. Animals with tumors larger than 10 mm in diameter were killed. Tumors and control tissues were isolated, documented by photography, and either used for the preparation of protein lysates or fixed in paraffin for histology. RAD001 solution (2% wt/wt) and placebo were obtained from Novartis Pharma. RAD001 was administered orally by gavage feeding at 10 mg/kg per day in 5% glucose. Placebo was given accordingly in 5% glucose. During medication, the body weight of animals was determined daily to evaluate potential side effects.  Western Blot Analysis. CEFs were grown to confluence, rinsed with PBS, and lysed in protein lysis buffer containing 1% Nonidet P-40, 10% glycerol, 20 mM Tris (pH 7.9), 150 mM NaCl, 1 mM MgCl2, 1 mM PMSF, 50 mM NaF, 1 mM DTT, 50 mM β-glycerophosphate, 1 mM Na3VO4, and 1× protease inhibitor mixture (Roche, Gipf-Oberfrick, Switzerland). Thirty micrograms of total protein was separated on a denaturing Tris-acetate/3-8% polyacrylamide gradient gel (Invitrogen), transferred onto a nitrocellulose membrane, and probed with polyclonal anti-p110α antibodies (Santa Cruz Biotechnology) and monoclonal anti-Gagp19 antibodies, kindly provided by Volker Vogt (Cornell University, Ithaca, NY). Blots were probed with monoclonal anti-tubulin immunoglobulins (ICN) to confirm equal loading. For the generation of tumor protein lysates, tumors were trimmed and ground in erythrocyte lysis buffer (ELB) containing 154 mM NH4Cl, 10 mM KHCO3, and 0.1 mM EDTA by using the large pestle of a Kontes tissue grinder. Samples were incubated on ice for 15 min to ensure lysis of erythrocytes and centrifuged for 10 min at 390 × g. Pellets were washed with ELB and centrifuged as described above. Finally, tissue pellets were suspended in tumor lysis buffer (1% Triton X-100/20 mM Tris, pH 7.9/150 mM NaCl/2 mM EDTA/1 mM Na3VO4/40 mM NaF/1× protease inhibitor mixture) and ground thoroughly, completely homogenizing the tissue. Protein lysates were incubated on ice for 30 min and cleared from debris by centrifugation at 16,450 × g for 15 min. Preparation of lysates from tissues of the corresponding control wings was performed accordingly. Fifty micrograms each of tumor protein lysates and control lysates were subjected to Western blot analyses by either Tris-acetate SDS/3-8% PAGE or Tris-glycine SDS/10% PAGE and probed with the following primary antibodies from Cell Signaling Technology (Beverly, MA): anti-Akt, anti-phospho-Akt (Ser-473), anti-GSK-3β, and anti-phospho-GSK-3β (Ser-9). Large-scale sequencing efforts are uncovering the complexity of cancer genomes, which are comprised of causal “driver” mutations that promote tumor progression along with many more pathologically-neutral “passenger” events. The majority of mutations, both in known cancer drivers and uncharacterized genes, are generally of low occurrence, highlighting the need to functionally annotate the long tail of infrequent mutations present in heterogeneous cancers. Here we describe a mutation assessment pipeline enabled by high-throughput engineering of molecularly-barcoded gene variant expression clones identified by tumor sequencing. We first used this platform to functionally assess tail mutations observed in PIK3CA, which encodes the catalytic subunit alpha of the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) frequently mutated in cancer. Orthogonal screening for PIK3CA variant activity using in vitro and in vivo cell growth and transformation assays differentiated driver from passenger mutations, revealing that PIK3CA variant activity correlates imperfectly with its mutation frequency across breast cancer populations. While PIK3CA mutations with frequencies above 5% were significantly more oncogenic than wild-type in all assays, mutations occurring at 0.07 – 5.0% included those with and without oncogenic activities that ranged from weak to strong in at least one assay. Proteomic profiling coupled with therapeutic sensitivity assays on PIK3CA variant-expressing cell models revealed variant-specific activation of PI3K signaling as well as other pathways that include the MEK1/2 module of Mitogen-Activated Protein (MAP) Kinase pathway. Our data indicate that cancer treatments will need to increasingly consider the functional relevance of specific mutations in driver genes rather than considering all mutations in drivers as equivalent.  Keywords: Cancer genomics, functional screens, mutagenesis, molecular barcoding, breast cancer, PIK3CA Go to: INTRODUCTION Next generation sequencing (NGS) provides a powerful tool for elucidating the genetic underpinnings of tumor initiation and progression. A central goal of large-scale projects such as The Cancer Genome Atlas (TCGA) is to catalog the genomic landscape of diverse cancers while illuminating new diagnostic biomarkers and therapeutic targets. Such efforts have confirmed recurrent signature mutations in cancer driver genes that include KRAS, NRAS, BRAF, PIK3CA, EGFR, TP53, and PTEN among others. Knowledge on the functional impact of these events, efforts toward developing therapies targeting their activity and plummeting sequencing costs have prompted healthcare providers to incorporate NGS into the clinic to facilitate diagnostic and therapeutic decisions. As we continue in the era of precision medicine, physicians will have increased access to patient tumor genomes, ultimately providing a means to subtype disease, provide rational use of molecular-guided therapies and monitor disease progression. Mainstream cancer protocols assign patients to a particular treatment regimen based predominately on their diagnosed cancer, yet modernized approaches call for choosing therapeutics based on the underlying mutations in each individual patient’s tumor.  While much is known about the function and clinical impact of recurrent “hotspot” mutations in genes including those listed above, less is known about which and how the more abundant, low-frequency mutations contribute to tumor progression. This is true for not only mutations in under-described or novel genes, but also rare “tail mutations” in well-studied cancer genes often mutated at hotspot positions. For example, the p110α catalytic subunit of the phosphatidylinositol 3-kinase (PI3K) encoded by PIK3CA represents the most commonly mutationally-activated gene in the cancer genome (1). In breast cancer, the most frequent PIK3CA mutations lead to protein residue changes at positions E542, E545 and H1047, comprising approximately 78% of all PIK3CA mutations observed in breast tumors (2,3). The high frequency of these hotspot mutations has prompted much investigation into their functional impact, thus it is well-established that they lead to gain-of-function PI3K activity, downstream signaling through the AKT/mTOR pathway and robust in vitro and in vivo transformation phenotypes (4–7). As a result, much focus has been placed on developing PI3K pathway inhibitors that are at varying stages of clinical testing in several cancer types.  In addition to these PIK3CA hotspot mutations, the sequencing of greater numbers of tumors is revealing numerous tail mutations existing outside the hotspot locations. While some efforts have been made to functionally characterize PIK3CA tail mutations [e.g., (8–11)], their growing number among tumor NGS datasets requires flexible approaches to characterize the functional impact of large numbers of mutant variants. This is true not only for PIK3CA, but also for other cancer genes with increasing numbers of identified mutations afforded by greater NGS sequencing depths. Recent studies demonstrate the need for comprehensive functional testing of cancer gene variants. For example, mutations in isocitrate dehydrogenase (IDH1 and IDH2), which occur in low-grade gliomas and secondary high-grade gliomas, inhibit the enzyme’s ability to catalyze conversion of isocitrate to alpha-ketoglutarate while conferring a neomorphic activity for reduction of α-ketoglutarate to d-2-hydroxyglutaric acid (2-HG) (12). 2-HG is proposed to function as an oncogenic metabolite by inducing hypermethylation of histones and DNA (13), thus much work is focused on developing effective inhibitors of mutant IDH1/2. Similar to studies on IDH1/2, a recent examination of mutant isoforms of PIK3R1, which encodes the p85α regulatory subunit of PI3K, revealed novel activity for cancer-associated variants (14). Unlike other mutations in PIK3R1 that function to activate PI3K activity, truncating variants at positions R34 and L370 confer unexpected neomorphic activation of JNK pathway and response to JNK inhibitors resulting from the mutant proteins’ mislocalization to the nucleus (14).  The development of driver prediction algorithms provides one means to detect oncogenic mutations in silico, though the success of these tools has been limited without validation and iterative improvement using functional screening approaches. However, experimental annotation of rare mutations is difficult given their large number, examination of which requires robust pipelines permitting scalable gene variant construction and cancer context-specific screening for activity. Here we describe a mutation assessment pipeline first used to functionally annotate tail mutations within PIK3CA discovered in breast cancer. We employ High-Throughput Mutagenesis and Molecular Barcoding (HiTMMoB) technology to construct an allelic series of PIK3CA variants, each uniquely barcoded with a molecular DNA tag allowing individual and pooled examination in vitro and in vivo to identify mutations exhibiting gain-of-function cancer activity. Expanding our analysis of the PIK3CA allelic series to functional proteomics through use of Reverse Phase Protein Arrays provided a comprehensive view of variant-induced changes to key cancer signaling pathways, dependence on which was validated by cell-based inhibitor assays. Our data indicate that many but not all PIK3CA variants similarly activate the PI3K signaling pathway, and furthermore that subsets of PIK3CA variants also trigger activation of the MAPK pathway as well as evoke cell invasion activity. When applied more broadly to other oncogenes and tumor suppressor genes, functional assessment of low-frequency mutations by use of HiTMMoB and comprehensive phenotyping will allow scalable characterization of gene variant activity with potential clinical outcomes.  Go to: MATERIALS AND METHODS Bioinformatic genetic analysis  The Catalogue of Somatic Mutations in Cancer (COSMIC; http://cancer.sanger.ac.uk/cosmic, queried 12/18/2014). We applied the following algorithms: SIFT (15), PolyPhen (16), MutationAssessor (17), VEST (18), CHASM (19), MutationTaster (20), Condel (21), and CanDrA (22). Exome Aggregation Consortium database (ExAC; Exome Aggregation Consortium Cohort; http://exac.broadinstitute.org, 05/05/2015) was queried to determine the germline population allele frequency of PIK3CA variants in global human populations. All variants are reported relative to PIK3CA NM_006218.2 and NP_006209.2.  Cell culture  MCF10A cells were obtained from the American Type Tissue Collection (ATCC) and HMLER cells were provided by S. Mani (MD Anderson Cancer Institute). MCF10A and HMLER cells were cultured in MEGM medium without antibiotics and serum. MCF10A cells were supplemented with 100ng/ml cholera toxin (Sigma). Ba/F3 cells were grown in RPMI medium supplemented with 5% Fetal Bovine Serum. Parental Ba/F3 cells were grown in the presence of IL3 at 5 ng/ml. Stable Ba/F3 cells expressing PIK3CA variants were always grown without IL3. MCF10A cells and HMLER cells were fingerprinted prior to use on 10/14/2014 and 4/21/2015, respectively, by the MD Anderson Cancer Center Characterized Cell Line Core using STR testing platform. Ba/F3 is a mouse-originated cell line, thus STR testing could not be performed.  Immunoblot analysis  Cells were lysed using RIPA buffer (Sigma) containing Protease Inhibitor Cocktail (Sigma) with phosphatase inhibitors (Calbiochem) for separation on NuPAGE-Bis-Tris gels (Life Technologies) and blotting onto PVDF membrane. The following antibodies were used for immunoblotting: p110alpha (Cell Signaling), phospho-MEK1/2 (Cell Signaling), phospho-p38 (Cell Signaling), phospho-S6K (Cell Signaling), phospho-S6 (Cell Signaling), phospho-AKT (Cell Signaling), phospho-PRAS40 (Cell Signaling), Vinculin (Santa Cruz).  RPPA analysis  RPPA method has been described previously (23). Cells were plated as singlets and treated growth medium without insulin and EGF for 60 hours and then lysed with RPPA lysis buffer. Then, lysate concentrations were adjusted and the lysates were mixed with SDS sample buffer.  Cloning  Site-directed mutagenesis was based on modified application of megaprimer PCR (24). For barcoding, a set of barcode entry clones was constructed by annealing in vitro complimentary DNA oligonucleotides containing 24 nt barcodes flanked by T3/T7 sequences and attB2r/B4 sites. Annealed oligonucleotides were subsequently recombined into modified pDONR223 by BP recombination, leading to entry clones whose barcodes were flanked with attR2/L4 for multi-fragment recombineering (with ORF entry clone or mutagenesis PCR) into pLenti6 V5/Dest BC that contains attR1 and attR4 recombination sites. STBL3 (Life Technologies) bacteria were heat-shock-transformed with the BP/LR reaction mixtures for vector propagation.  Stable cell lines  Lentivirus was produced using standard virus packaging vectors and virus protocols. For MCF10A and HMLER transduction, cells were infected twice with 10–12 hour periods in the presence of 8 μg/ml polybrene before blasticidin selection (10 μg/ml). Ba/F3 cells were spin-infected for 2 hours at 300g and then incubated at 37ΰC for 10 hours before refreshing the regular medium with 1:10000 diluted IL3 concentrations.  Survival assays  MCF10A cells were trypsinized and 300 or 1200 cells were seeded in 96-well opaque plates for No Insulin and No Insulin-No EGF assays, respectively, in quadruplicates with corresponding medium conditions. Cell viability was measured after 5 days for No Insulin assay and 10 days for No Insulin-No EGF assay with Cell Titer Glo (Promega) following manufacturer’s instructions. Ba/F3 IL-less survival assays were performed by removing medium after viral infection and culturing cells in low IL3 medium (1:10000 dilution) in duplicates. Cell viability was measured after 7 days.  Drug sensitivity assays  Drug experiments for MCF10A cells were done in No Insulin-No EGF condition with 1000 cells in 96-well white plates (PerkinElmer). Drugs were added at the specified concentrations the next day after seeding the cells. For Ba/F3 cells, drugs were tested in the presence or absence of IL3 and drugs were added the same day. Cell viability was measured 3 days after adding drugs with Cell Titer Glo for both cell types. All inhibitors were purchased from Selleck.  In vitro cell invasion and anchorage independent growth assays  Cell invasion assays and anchorage-independent growth assays were performed as described previously (25). Colonies were stained with 0.05% iodonitrotetrazolium chloride (Sigma) and counted after scanning with a flatbed scanner. All data were assessed by two-tailed t-test calculation using Prism 6 (Graphpad).  Animal studies  All studies using mice were performed in accordance with our IACUC-approved animal protocol at Baylor College of Medicine. 8X105 HMLER cells transduced with GFP, PIK3CAWT, PIK3CAE545K or PIK3CAH1047R were re-suspended in a 1:1 solution of Hank’s balanced salts and Matrigel (BD Bioscience) and then subcutaneously injected into female nude animals (Harlan, Indianapolis, IN) as described previously (25). For PIK3CA variant competition assays,1X105 cells from each of the HMLER cell lines expressing GFP, PIK3CAWT, eight PIK3CA constructs with silent mutations and twenty rare PIK3CA mutants were pooled and injected subcutaneously as above. Tumor volumes were calculated by following formula: Length × Width2/2  Barcode sequencing  Genomic DNA was extracted from pool of HMLER cells that were injected (Input) and 3 individual tumor cores (output) for triplicate and duplicate, respectively, PCR reactions to amplify the barcode pools present within each sample using Platinum Super Mix (Life Technologies) and flanking primers common to each barcode: 5′-CAATTAACCCTCACTAAAGG and 5′-CCGCCACTGTGCTGGATA). Amplification parameters were as follows: 1 × [94°C-4′]; 35 × [94°C-1′, 60°C-1′, 68-1′]; 1 × [68°C-10′]. Each replicate PCR amplicon (211 nt) was purified for PGM library preparation where each amplicon was ligated to unique Ion Xpress Barcode Adaptors for PGM sequencing (318 V2 Chip) following the manufacture’s recommendations. Raw data were concatenated into one ‘reference’ file and indexed using BWA for alignment of barcode sequences (with parameters “-l7 -t12 -N -n3”) for counting the occurrence of each barcode. For 2D barcode representation graph, total reads of barcodes in all tumors were averaged for each barcode and their ratio to total number of barcode reads in all tumors were plotted. Barcode enrichment for individual tumors was assessed by quantitating the number of occurrences for each barcode sequence as a ratio to total number of barcode reads in each sample. Standard deviations were calculated for triplicate and duplicate reactions for input and output samples, respectively, and plotted as error bars on the barcode enrichment graphs.  Go to: RESULTS Selection and construction of PIK3CA tail mutations  Interrogation of the Catalogue of Somatic Mutations in Cancer (COSMIC) revealed 3,096 somatic DNA aberrations in PIK3CA residing in breast cancer tumors and tumor-derived cell lines (Supplementary Table S1). The majority of these somatic events were nucleotide missense substitutions (3,063; 98.9%), and the remaining aberrations consisted of small insertions/deletions (0.68%), silent (0.29%) and nonsense substitutions (0.032%). Given the high recurrence of PIK3CA missense mutations corresponding to alterations at amino acid residues E545 (21.5%) and H1047 (57.3%), the 3,063 missense mutations encompassed only 106 variants that resulted in a single amino acid change at 75 of the 1068 residues of the encoded PIK3CA protein, p110alpha. In order to assess the functional impact of rare PIK3CA mutations, we selected 25 representative variants whose breast cancer COSMIC frequencies ranged 0.07% (present in two specimens) to 10.9% (present in 334 specimens), as well as the E545K and H1047R hotspot mutations that represent 18.5% and 51.0% of PIK3CA mutations, respectively (Fig. 1A). The 27 mutations chosen for functional annotation targeted a total of 16 amino acid residues positioned within or proximal to the p85 binding, C2, Helical and Kinase domains of p110alpha (Fig. 1A). It is noteworthy that one selected somatic mutation, T1025T, is a synonymous change residing distal to the kinase domain with breast cancer COSMIC frequency 0.1%.  Figure 1 Figure 1 PIK3CA variant selection and mutation assessment platform Our selection of PIK3CA mutations was based on an unbiased analysis of breast cancer COSMIC data. In order to gain initial insight into the potential impact of these mutations, we evaluated the 26 missense mutations by 9 computational algorithms designed to predict the functional impact of mutations on protein function (Supplementary Table S2). We observed a general disagreement among the prediction algorithms, though each PIK3CA missense variant was predicted to have functional consequence by at least 4 of the 9 algorithms used. For example, there was a general consensus among algorithms that hotspot mutation E545K would result in a deleterious, possibly damaging alteration considered to be a disease-causing driver event. In contrast, hotspot mutation H1047R was considered a deleterious, disease-causing driver event by some algorithms yet neutral or benign by others. Likewise, I31M, which was identified in only two (0.07%) COSMIC samples with mutant PIK3CA, was determined to be a neutral, benign event by some algorithms yet others identified I31M as a driver mutation with a high likelihood of being a disease-causing event. The inconsistencies observed across these prediction algorithms further illustrate the need for functional examination of individual mutations within bona fide cancer drivers.  We next employed HiTMMoB to engineer mutations into the PIK3CA open reading frame (ORF) using megaprimer-based mutagenesis (26), followed by recombination-based cloning of mutant PCR products into Gateway (Life Technologies)-compatible destination vectors that enable ORF virus production for expression in mammalian cells (see Methods). Our multi-fragment recombineering cloning strategy (Fig. 1B) also permits rapid simultaneous tagging of individual ORF clones with unique 24-nucleotide DNA “barcodes”. The addition of barcodes (BCs) permits ORF pooling and tracking, as each BC serves as surrogate identifier for its associated ORF. We applied these cloning strategies to engineer wild-type, the selected 27 mutations and an additional 9 silent mutation controls (e.g., E545E and H1047H; Supplementary Table S3). HiTMMoB achieved 62.4% mutation efficiency per reaction (Supplementary Table S3), permitting clonal isolation and full sequence confirmation of individual mutant ORFs after picking an average of 3 colonies per each mutagenesis reaction. In total, we successfully constructed all 37 barcoded PIK3CA ORF clones in a single pass for functional assessment using our mutation assessment pipeline (Fig. 1C).  PIK3CA tail mutations promote Ba/F3 survival  Many studies have characterized the phenotypic consequence of expressing PIK3CA hotspot variants, and some effort has been made to rare PIK3CA mutant effects on kinase activity and transformation of chicken and mouse fibroblast models among others [e.g., (8–11); Supplementary Table S4]. In addition to malignant transformation, activating mutations in oncogenes such as PIK3CA are known to promote sustained proliferation and survival in the absence of growth factors. We modeled these hallmarks of cancer by entering our PIK3CA allelic series into assays to assess growth factor-free survival. We first employed the Ba/F3 murine, IL3-dependent pro-B cell model (27) used by us (14,28) and others to screen for the ability of driver genes to induce cell survival and proliferation. Ba/F3 cells die in the absence of exogenous IL3; therefore, we quantitated cell growth as a measure of “transfer of driver addiction” from IL3 to PIK3CA variant ORFs and controls following IL3 removal from growth medium. For example, expression of hotspot mutant ORFs PIK3CAH1047R and KRASG12D promote robust Ba/F3 cell proliferation in the absence of IL3 compared to undetectable growth by cells expressing green fluorescent protein (eGFP; negative control) or wild-type PIK3CA at 7 days following removal of IL3 (Fig. 2A). Analysis of PIK3CA variants in Ba/F3 confirmed potency for PIK3CAH1047R as well as a >40-fold increase in growth-promoting activity for high-frequency (>5.0%) PIK3CA mutations E542K, E545K, H1047L and H1047R (Fig. 2B). In contrast, cells expressing wild-type PIK3CA or silent controls (E542E, E545E, H1047H) proliferated similar to parental Ba/F3 cells and those expressing eGFP and mCherry (Fig. 2B). Of the remaining 23 low-frequency variants (<5.0% of PIK3CA mutations in COSMIC breast cancer data), 19 promoted Ba/F3 survival and proliferation at a range of 2.1- to 36-fold over the mean of negative controls (parental, eGFP, mCherry, silent mutations). Nine of 12 driver events with a COSMIC frequency less than 0.5% (represented ≤ 11 of 3,096 PIK3CA mutations; E542V, Q546E, N1044K, M1043V, Q546P, E545Q, P539R, H1047Y and E453K) exhibited a significant >5-fold impact on Ba/F3 IL3-indendent survival despite their low frequency, indicating that ultra-rare PIK3CA mutations can provide driver activity. Spearman’s correlation analysis of these data revealed that the fold-change increase in Ba/F3 growth significantly correlated (r=0.83, p=3.6E-08) with increasing COSMIC frequency of PIK3CA variants; however, this correlation is imperfect as some low-frequency mutations were more active than more common events (e.g., Q546E and Q546P). This correlation was not entirely due to hot-spot mutations PIK3CAE545K and PIK3CAH1047R (69.5% combined COSMIC frequency), as the Spearman’s p-value remained significant (r=0.79, p=1.2E-06) following removal of the E545K and H1047R datasets from the Spearman’s analysis. Four PIK3CA variants (H701P, I31M, T1025T and A1020V) exhibited no activity in Ba/F3, which suggests that these events may represent true passenger mutations as assessed under the conditions and driver sensitivity of this assay.  Figure 2 Figure 2 PIK3CA tail mutations promote growth factor-free survival As a means of providing orthogonal evidence for the notion of driver versus passenger mutation, we determined the allele frequencies of the 27 engineered and functionally vetted variants in across global human populations. The ExAC database contains exome data generated from the germlines of 60,000 adults representing Europe, Africa, Asia, and America. Notably, our analyses revealed that PIK3CA c.C3075T (p.T1025T), is a high frequency variant in the human germline ranging from as high as 13% of South Asians to a low of 0.2% of East Asians. This finding is consistent with our experimental evidence for T1025T being a passenger mutation. The only other tested variants observed in ExAC were c.A3140G (p.H1047R), c.A3140T (p.H1047L), c.G1633A (p.E545K), each of which were observed in only one chromosome out of 120,000. We found no indication that the remaining three inactive variants (H701P, I31M and A1020V) represented common germline variants, which further illustrates the need to for functional evaluation of all variants of unknown significance for a given disease-associated gene.  PIK3CA tail mutations promote growth factor-free survival of breast epithelial cells  While serving as a tractable cell model for generalized evaluation of driver activity, Ba/F3 cells may not provide the optimal cell lineage context for analysis of breast cancer-specific mutations and may only detect a subset of oncogenic events. To examine this further, we assessed PIK3CA variant activity using normal MCF10A breast epithelial cells widely used to assess the oncogenic impact of breast cancer drivers. MCF10A cell growth is dependent on insulin and epidermal growth factor [EGF; Supplementary Fig. S1A], which are both potent activators of signaling pathways activated in diverse cancer types. MCF10A cells stably expressing PIK3CAH1047R exhibited a 6.0- and 8.2-fold increase in cell growth in culture medium lacking insulin (p<0.0001) and medium lacking insulin and EGF (p<0.0001), respectively, whereas wild-type- and PIK3CAT1025T-expressing control cells did not exhibit a growth advantage under matched-normalized conditions (Fig. 2C). In contrast, no growth difference was observed between the cell lines when propagated in medium fully supplemented with insulin and EGF (Fig. 2C). Expanding this analysis to the PIK3CA allelic series confirmed potent growth-promoting activity for H1047R (16.5-fold, p<0.0001) and E545K (10.8-fold, p<0.0001) hotspot mutations in the absence of insulin and EGF relative to the mean of all negative controls (Fig. 2D). The remaining PIK3CA variants performed similar to our findings using Ba/F3, exhibiting a 2.3- to 9.0-fold range increase in MCF10A growth that correlated, albeit imperfectly, with each variant’s frequency in COSMIC (with hotspot data: r=0.75, p=3.0E-06; without hotspot data: r=0.68, p=7.3E-05) whereas cells expressing wild-type PIK3CA and silent controls proliferated similar to parental and eGFP-expressing MCF10A cells (Fig. 2D). PIK3CA variants H701P, I31M, T1025T and A1020V did not provide a cell growth advantage in MCF10A, which is consistent with results using Ba/F3, further suggesting they may represent passenger mutations. Moreover, our data indicate that PIK3CAG1049R (COSMIC frequency = 0.5% or 16 of 3,096 PIK3CA mutations) activity was greater than all other low-frequency variants, exhibiting a 9.0-fold change increase in MCF10A growth similar to the PIK3CAE545K mutation with COSMIC frequency of 18.5%. On the other hand, expression of PIK3CAM1043I and PIK3CAK111N provided no growth advantage to MCF10A cells in the absence of insulin and EGF despite exhibiting driver activity in Ba/F3 cells. Assaying MCF10A growth in the presence of EGF (No insulin) revealed growth-promoting activity for the M1043I and K111N variants but not H701P, I31M, T1025T and A1020V (Supplementary Fig. S1B), suggesting that the observed MCF10A and Ba/F3 discordance for PIK3CAM1043I and PIK3CAK111N might be due either to increased assay stringency upon combined removal of insulin and EGF conditions or specific insulin pathway dependencies for these two variants.  PIK3CA tail mutations drive malignant transformation  Assaying the ability of oncogene expression to promote colony formation in semi-solid culture medium is widely used to assay for anchorage-independence, a hallmark of cell transformation (29). Therefore, we next entered the PIK3CA allelic series into MCF10A soft agar colony formation assays to determine each variant’s ability to promote cell transformation in vitro. Similar to as reported by others (5), stable expression of both PIK3CAH1047R and PIK3CAE545K led to a significant increase in colony formation (9.5- and 9-fold, respectively, p<0.0001; Fig. 3A) compared to wild-type PIK3CA-expressing and parental control cells. Expanding the colony formation assay to the PIK3CA allelic series revealed potent activity for high-frequency mutations E545K and H1047R (average 11.8-fold increase over negative controls, p<0.0001) and a range of activities (2.3-fold to 11.5-fold) for PIK3CA variants (Fig. 3B; Spearman’s correlation analysis with COSMIC frequencies with hotspot data: r=0.67, p=6.3E-05; without hotspot data: r=0.59, p=8.6E-04). PIK3CA variants H701P, I31M, T1025T and A1020V did not promote colony formation, which is consistent with their inactivity in the growth factor-free survival assays using Ba/F3 and MCF10A (Fig. 2). We also did not observe colony-forming activity for PIK3CA variants N345I, M1043I and P539R, which exhibited very weak activity in the growth factor-free survival assays (Fig. 2), a discordant result potentially due to the increased biological stringency of the colony transformation assay. As noted for MCF10A growth factor-free survival (Fig. 2D), the low-frequency G1049R variant promoted colony formation similar to the hotspot mutations E545K and H1047R, further supporting the notion that this mutation is a rare but strong oncogenic PIK3CA mutation.  Figure 3 Figure 3 PIK3CA tail mutations promote in vitro cell transformation and oncogenic tumor growth (A–B) We next sought to evaluate the oncogenic activity of rare PIK3CA variants by performing xenograft tumorigenesis assays in mice. We chose to evaluate tumor driving activity by modeling our PIK3CA allelic series into primary human mammary epithelial cells (HMECs) having undergone sequential retroviral-mediated expression of the telomerase catalytic subunit, SV40 large T and small t antigens and H-RasV12 [HMLER cells, (30)]. HMLER cells are primed for tumorigenesis and do not form tumors unless H-RasV12 levels are substantially high, suggesting they require more cooperating events to drive tumor formation (30,31). Consistent with this notion, stable expression of hotspot variants PIK3CAH1047R and PIK3CAE545K robustly drive tumor growth by HMLER when implanted subcutaneously into athymic mice, whereas control cells stable expressing eGFP or wild-type PIK3CA fail to drive frank tumorigenesis (Fig. 3C). Based on this finding we next performed a competitive tumorigenesis assay whereby equal numbers of HMLER cell populations, each engineered to express an individual barcoded PIK3CA variant ORF (COSMIC frequency ≤ 0.5%), along with an additional 10 control cell populations (barcoded ORFs encoding eGFP, wild-type PIK3CA and 8 PIK3CA silent mutation controls) were implanted into a cohort of 15 athymic mice. We reasoned that highly oncogenic PIK3CA variants would be positively enriched in tumor tissue over weak variants or those providing no transforming potential. Based on this precept, we employed NGS (Fig. 3D) barcode enrichment analysis to quantitate the number of barcode sequencing reads in tumor (i.e., “output”; 3 tumor cores per 7 tumors and technical replicates for each sample) and injected cells (i.e., “input”; 2 input replicates), followed by comparing the number of individual barcode reads between populations as a ratio of each barcode to the total number barcode reads per sample. Analysis of all tumor cores (Supplementary Table S5) indicated high concordance with the MCF10A colony formation data (Fig. 3B), revealing PIK3CAG1049R as the most significantly-enriched, rare PIK3CA ORF across all tumors (44.2% of all tumor barcode reads; Fig. 3E). We observed less enrichment for N345l, E542V, Q546E/R/K/P and H1047Y (average 7.1%), which is consistent with their relatively weaker colony-formation activity (Fig. 3B) compared to G1049R. At the individual tumor level (representative tumor T7 cores 1–3 shown in Fig. 3F), we observed a range of heterogeneous variant complexities in the backdrop of high PIK3CAG1049R enrichment.  Characterization of PIK3CA pathway activation through functional proteomics  PIK3CA encodes the 110α is catalytic subunit of PI3K, and highly oncogenic mutations in PIK3CA such as H1047R and E545K result in ligand-independent activation of the PI3K/AKT/mTOR signaling pathway (32). In order to determine whether rare PIK3CA variants similarly activate PI3K signaling, we examined the phosphorylation levels of key pathway intermediates AKT, PRAS40, and S6. Immunoblot analysis of growth factor-deprived MCF10A cells expressing hotspot variants PIK3CAH1047R and PIK3CAE545K confirmed robust activation of PI3K/AKT/mTOR compared to parental MCF10A cells and those expressing wild-type PIK3CA and PIK3CAT1025T (Fig. 4A). As observed in the phenotypic profiling studies (Figs. 2–3), expression of the rare but highly active variant PIK3CAG1049R led to greater pathway activation compared to phenotypically weaker mutations that include K111N, M1043I, E453K and E542V (Fig. 4A). Consistent with these observations, MCF10A cells expressing variants H1047R, E545K, G1049R and other activating PIK3CA alleles (Q546K, N345K, H1047L, E542K) were significantly more sensitive to PI3K pathway inhibition (PI3K/mTOR inhibitor, BEZ235; PI3Kα inhibitor, BYL719; AKT inhibitor, MK2206) compared to parental cells and cells expressing wild-type or PIK3CAT1025T (Fig. 4B). These data suggest that patients whose tumors harbor rare, activating PIK3CA variants may benefit from therapeutic intervention similar to those carrying hotspot mutations.  Figure 4 Figure 4 PIK3CA tail mutations differentially activate cancer signaling pathways and sensitize cells to pathway inhibitors To expand our analyses of pathways activated by PIK3CA variant clones, we next applied Reverse Protein Phase Array (RPPA) technology (33) to MCF10A cell lysates to catalog PIK3CA effects on expression or phosphorylation of 214 cancer-related proteins. In total, we analyzed 32 lysates extracted from growth factor-restricted MCF10A cells expressing all 24 missense mutation variants and 8 controls (parental, 2x eGFP, wild-type PIK3CA, and 4 silent mutations). RPPA analysis revealed that expression of activating PIK3CA variants leads to a significant shift in diverse cancer-related pathways beyond changes directly associated with PI3K/AKT/mTOR signaling (Fig. 4C and Supplementary Fig. S2), a finding consistent with a recent global analysis of gene expression and metabolomics of PIK3CAH1047R-expressing MCF10A cells (34). RPPA confirmed significant activation of the PI3K/AKT/mTOR signaling axis and downstream effectors (Fig. 4C; p<0.05). In addition, activating PIK3CA variant-expressing cells exhibited robust phosphorylation or up-regulation of cell cycle proteins (e.g., phospho-Rb, CyclinB1 and FOXM1) and down-regulation of the p27KIP1 cell cycle inhibitor, phospho-ATM(S1981), phospho-Chk1(S345) and phospho-Chk2(T68), which are indicative of evasion of growth suppression and activated replication, both hallmarks of cancer consistent with the known role of PI3K pathway in cancer (7,35–38).  In addition to PI3K signaling, RPPA analysis also revealed significant (p<0.05) up-regulation of phospho-HER2 and phospho-EGFR (Fig. 4C and Supplementary Fig. S2), which are receptor tyrosine kinases (RTKs) positioned upstream of PI3K and often targeted for activation in cancer. Our finding of HER2 and EGFR activation suggests the presence of positive feedback loop, indicating these RTKs may represent therapeutic liabilities in PIK3CA-activated cells. To examine this further, we treated PIK3CA-expressing MCF10A cell lines with HER2 and EFGR inhibitors Lapatinib and Neratinib. Consistent with our signaling observations made by RPPA, MCF10A cells expressing activated PIK3CA variants were significantly more sensitive to inhibition compared to parental cells and cells expressing wild-type or PIK3CAT1025T(Fig. 4D). RPPA analysis also indicated PIK3CA-dependent MEK1/2 activation (phosphorylation) and down-regulation of p38 and JNK (Fig. 4C and Supplementary Fig. S2; p<0.05), which was also confirmed by immunoblotting analysis with available antibodies (Fig. 4E). Therefore, we performed a similar drug sensitivity screen as in Figure 4B using Trametinib, a potent inhibitor of the MEK1/2 positioned in the mitogen activated protein kinase (MAPK) pathway (39). Unlike treatment with p38 and JNK inhibitors VX-702 and JNK-IN-8 (40,41), respectively, Trametinib inhibited cell growth by MCF10A cells expressing activated PIK3CA variants H1047R, E545K, G1049R, Q546K, N345K, H1047L, E542K) compared to parental cells and cells expressing wild-type or PIK3CAT1025T (Fig. 4F). We confirmed these results using a subset of activating PIK3CA variants (H1047R, Q546K, G1049R, N345K, E545K) expressed in Ba/F3 under conditions of PIK3CA addiction (-IL3), and parallel counter screens on these cells re-addicted to IL3 in place of PIK3CA relieved the inhibitory growth effect by Trametinib (Fig. 4F). These data suggest crosstalk between PI3K and MAPK MEK1/2 module but not the p38/JNK module of MAPK pathway, which has been suggested elsewhere (42).  A previous study reported a role for PIK3CAH1047R in promoting epithelial-mesenchymal transition (EMT) and cell invasion, an obligate step during tumor metastasis, through activation of PI3K pathway (43). Consistent with this report, overexpression of activated PIK3CA variants led to striking morphological changes such as a cell spreading phenotype that often correlates with invasiveness, disrupting the typical “cobblestone” appearance of primary epithelial cells such as MCF10A (Fig. 5A). Moreover, our RPPA analysis (Fig. 4C, Supplementary Figure S2) revealed a significant increase in the expression of Rab25, Claudin-7, Caveolin and phospho-Myosin-IIa reported by others to represent molecular markers of cell invasion (44–47). To determine whether expression of PIK3CA variants is sufficient to promote cell invasion, we examined the invasiveness of MCF10A cells using transmembrane chambers coated with Matrigel (BD Biosciences). Stable expression of both PIK3CAH1047R and PIK3CAE545K hotspot variants led to a robust increase in cell invasion (9.6- and 10.6-fold, respectively, p<0.0001) compared to parental cells and those expressing wild-type or PIK3CAT1025T (Fig. 5B–C). PIK3CAE542V-and PIK3CAE453K-expressing cells did not provide pro-invasion activity consistent with their weak driver activity across the other phenotyping platforms used (Figs. 2–3) whereas the remaining 7 variants examined enhanced invasion at range of 2.5- to 7.8-fold over the mean of negative controls (Fig. 5B) in a manner consistent with signaling assessed by RPPA (Fig. 4C).  Figure 5 Figure 5 Oncogenic PIK3CA variants induce invasive phenotypes in breast epithelial cells Go to: DISCUSSION Recent developments in NGS technology are enabling full cataloguing of genomic alterations residing within cancer genomes at record pace and lower costs, revealing numerous potential targets and therapeutic approaches for the treatment of cancer. However, translation of NGS-based discoveries is hampered by the slower development of functional genomics approaches aimed at characterizing newly discovered “uncommon” aberrations and their impact on therapeutic response. In this study, we attempted to narrow this gap by designing scalable screening tools for constructing and examining rare gene variants. Our comprehensive mutation assessment platform integrates an in-house developed, high-throughput mutagenesis and barcoding technology with a phenotype screening to rapidly interrogate each variant for cancer-relevant activities. Our results provided key insights on correlation between rare events of PIK3CA and their oncogenic potentials as well as novel implications for cancer therapy. The scalability and success of our approaches toward discovering rare, activating cancer mutations suggests this platform may applied to other cancer types to screen for novel cancer-causing aberrations following tissue-specific modifications of the models employed.  We first used our platform to examine an allelic series of the PIK3CA gene, a well-known oncogene often targeted by mutagenesis in cancer. Some attempts have been made to catalogue the consequences of expressing rare PIK3CA mutant alleles [e.g., (8–11). However, such studies employ varying expression systems and diverse cell models that lack tissue specificity for the study of PIK3CA variants identified in breast cancer, which collectively make it difficult to compare PIK3CA variant driver activity across those studies. In addition to Ba/F3 cells, which provide a generalized “sensor” model to detect driver activity, we also employed normal MCF10A breast cells as well as primary HMECs to provide lineage specificity. Our results revealed that 21 out of 25 (84%) rare PIK3CA mutations (COSMIC frequencies ranging <0.1–10%) were oncogenic. Interestingly, the power of PIK3CA variant activity correlated significantly with their frequency in breast cancer, albeit not perfectly (Fig. 6). Of note, mutations that were present on the same residues had different phenotypic activity correlated with their frequencies. While higher frequency mutation on a given residue showed a stronger phenotype, rare mutations of the same residue exhibited weaker activity (see Fig. 6 for mutations of N345, E542, E545, Q546 and H1047). Q546 mutations were all similar to each other in terms of activity in our phenotyping assays, which is consistent with their comparable frequencies. One intriguing result from our screening platform was that even though G1049R mutation is a rare (~0.5%) aberration, it demonstrated strong driver activity in 4 out of 5 assays used in our platform and exhibited activity levels similar to the E542K variant with 20-fold higher frequency (10.8%; Fig. 6). Further studies need to address why this strong event is present at low frequencies in breast cancer.  Figure 6 Figure 6 PIK3CA tail mutation activity summary Deconvoluting the alterations at a molecular level triggered by expression of PIK3CA variants revealed expected consequences as well as novel deregulation of cancer pathways. Consistent with the previous data, oncogenic PIK3CA variants also deregulated transcription and translation pathways and led to activated cell cycle and down-regulation of stress/inflammation markers (48) in accordance with mechanistic alterations caused by other oncogenes. Proteomics analysis and our observation of phenotypic changes in 2-D cultures of PIK3CA variant-expressing cells also suggested that oncogenic PIK3CA alleles drive invasiveness, which was confirmed with increased invasion potential in transwell chambers. In addition, active PIK3CA mutations hyper-activated PI3K pathway and rendered cells sensitive to inhibitors targeting PI3K pathway as expected. However, we also observed activation of MAPK pathway, a commonly deregulated growth regulating cancer pathway, suggesting a strong positive cross-talk between PI3K and MAPK signaling. PIK3CA variants led to hyper-activation of EGFR, HER2 receptors and MEK1/2 modulators, and as a result, cells expressing PIK3CA variants were sensitized to inhibitors of these already known cancer targets. Our findings imply that patients that are positive for PIK3CA variants might benefit from combinatorial treatment options targeting both PI3K and MAPK pathways.  It has been suggested before that based on the affected domains, PIK3CA variants induce gain-of-function by different mechanisms (49–51). Our results in this study informed us on alterations and therapeutic liabilities that are common to all active PIK3CA variants; however, as a next step, it would be intriguing to study the potential mechanistic differences between PIK3CA alleles categorizing them into different classes with their corresponding unique drug liabilities. This would take precision medicine one step further from “gene specific” targeting to “mutation specific” approach in hopes of more efficient therapeutic options.  More than 25% of breast cancers harbor somatic mutations in the PIK3CA-encoded p110α catalytic subunit of PI3K1, 2, 3, 4. These mutations usually occur in the helical region (E545K and E542K) or the kinase domain (H1047R) of p110α; H1047R is the most common mutation (>50% of cases). Several experimental models have demonstrated that these tumor-associated PIK3CA mutations lead to constitutive p110α activation and oncogenic transformation5, 6, 7, 8, 9, making the PIK3CA oncogene a target for cancer therapy.  To study the effects of mutational activation of PI3K on breast tumorigenesis in vivo and to identify potential mechanisms of resistance to PI3K inhibition, we generated a transgenic mouse line expressing human PIK3CAH1047R in which transgene expression is under the control of a tetracycline-inducible promoter (TetO). PIK3CAH1047R expression is coupled with a luciferase reporter allowing transgene expression to be followed in vivo (Fig. 1a). To drive mammary-specific expression of PIK3CAH1047R, we crossed two TetO-PIK3CAH1047R founders (HR-2239 and HR-2251) to a previously described MMTV-rtTA (MTB) line10. The resulting bitransgenic MTB/TetO-PIK3CAH1047R mice were designated iPIK3CAH1047R. Quantitative RT-PCR analyses of mammary tissues isolated from bitransgenic females showed that doxycycline treatment led to a substantial increase in PIK3CAH1047R expression and luciferase reporter activity, whereas endogenous mouse Pik3ca expression remained unaffected (Supplementary Fig. 1a,b). As mice derived from both iPIK3CAH1047R founder lines showed comparable mammary gland-specific and doxycycline-dependent transgene expression, we used the MTB/HR-2239 line for all subsequent experiments.  Figure 1: Mammary gland–specific expression of PIK3CAH1047R induces mammary tumors. Mammary gland-specific expression of PIK3CAH1047R induces mammary tumors. (a) Generation of a transgenic mouse model expressing hemagglutinin (HA)-tagged human PIK3CAH1047R under the control of TetO. The expression of PIK3CAH1047R is coupled through an internal ribosomal entry site (IRES) with downstream expression of luciferase. These mice were crossed with MMTV-rtTA (MTB) mice to generate bitransgenic iPIK3CAH1047R animals to drive the expression of HA-PIK3CAH1047R in mammary glands. Bottom, bioluminescence imaging of iPIK3CAH1047R mice maintained with or without doxycycline (Dox). (b) Tumor-free survival curve for iPIK3CAH1047R mice maintained on doxycycline (n = 81, median tumor-free survival 208 d), and three groups of control mice (blue line): MTB (n = 12) and TetO-PIK3CAH1047R (n = 10) mice maintained with doxycycline, and iPIK3CAH1047R (n = 14) mice maintained without doxycycline. (c) Representative H&E-stained sections of primary mammary tumors from iPIK3CAH1047R mice subjected to chronic doxycycline treatment. Scale bars, 25 μm. (d) Representative images of immunohistochemistry for p-AKT (Ser473) and p-S6RP (Ser235 and Ser236) carried out on tumors isolated from iPIK3CAH1047R mice maintained on doxycycline (Dox on) or 6 d after doxycycline withdrawal (Dox off). Scale bars, 50 μm. (e) Representative images of immunohistochemistry for Ki67 or TUNEL carried out on tumors isolated from iPIK3CAH1047R mice maintained on doxycycline (Dox on) or 3 d after doxycycline withdrawal (Dox off). Scale bars, 50 μm. Data are means ± s.e.m. (n = 6). *P < 0.005 (Student's t test).  Full size image (91 KB) Figures index Next To determine whether expression of PIK3CAH1047R can initiate transformation of mammary epithelium, we analyzed mammary glands isolated from iPIK3CAH1047R females treated with doxycycline for 4 weeks. Histological examination showed increased mammary ductal side-branching and enlarged focal nodular structures filled with hyperproliferative cells characteristic of early neoplastic lesions (Supplementary Fig. 2a,b). Immunohistochemical analyses showed strong phospho-AKT (p-AKT) signals in proliferating epithelial cells in the mammary glands of doxycycline-treated mice (Supplementary Fig. 2c), indicating activation of PI3K signaling in response to the induction of PIK3CAH1047R. Consistent with the phenotype noted above, chronic doxycycline induction of the PIK3CAH1047R transgene in bitransgenic mice led to the development of mammary tumors with 95% penetrance and a mean latency of 7 months (Fig. 1b). These primary tumors had heterogeneous pathological phenotypes, including adenocarcinomas and adenosquamous carcinomas (Fig. 1c and Supplementary Table 1). In contrast, we observed no tumors in any of the control groups over the same time period (Fig. 1b). Thus, sustained induction of oncogenic PIK3CA expression leads to mammary tumor formation.  To examine whether established tumors required continued PIK3CAH1047R expression to maintain their malignant state, we withdrew doxycycline from a cohort of tumor-bearing mice. All tumors regressed during the first week after doxycycline removal. We confirmed the suppression of PIK3CAH1047R expression after doxycycline withdrawal by RT-PCR in primary tumors (Supplementary Fig. 3). Immunohistochemical analyses showed markedly lower abundance of both p-Akt and phospho-S6 ribosomal protein (p-S6RP) in tumors from which doxycycline was withdrawn as compared with those maintained on doxycycline (Fig. 1d). Moreover, although we detected a robust Ki67 signal in tumors maintained on doxycycline, there were significantly fewer proliferating cells after doxycycline withdrawal (Fig. 1e). Conversely, whereas we detected only a few apoptotic cells in tumors on doxycycline, we observed substantially more TUNEL-positive cells in tumors after doxycycline removal (Fig. 1e). These data indicate that reduced cellular proliferation and increased apoptosis are responsible for the initial phase of tumor regression after downregulation of oncogenic PIK3CA.  To determine whether the continued inactivation of oncogenic p110αH1047R led to sustained regression of mammary carcinomas initiated by the expression of PIK3CAH1047R, we followed a large cohort of tumors after doxycycline withdrawal for up to 6 months. We found that one-third of tumors (45 of 135, 33%) rapidly and completely regressed to a nonpalpable state within 1–2 months after doxycycline withdrawal with no regrowth (Fig. 2a and Supplementary Fig. 4a), indicating that these tumors remained dependent on p110αH1047R for their maintenance. Although a small fraction of tumors (4 of 135, 3%) regressed partially and did not resume growth after doxycycline removal, about two-thirds of tumors (86 of 135, 64%) partially regressed but then resumed growth without doxycycline (Fig. 2a and Supplementary Fig. 4b). We confirmed that all recurrent tumors showed sustained downregulation of the PIK3CAH1047R transgene and its protein product (Fig. 2b). Thus, PIK3CAH1047R-initiated mammary tumors frequently did not regress completely upon PIK3CAH1047R inactivation and recurred in a PIK3CAH1047R-independent manner.  Figure 2: Tumor responses to doxycycline withdrawal. Tumor responses to doxycycline withdrawal. (a) Response of primary tumors (135 primary tumors derived from 107 tumor-bearing bitransgenic mice; 81 mice carried one tumor, 21 mice bore two tumors and 4 mice had three tumors) to doxycycline withdrawal. (b) Western blot analyses of HA-p110αH1047R, p-Akt and p-S6RP in six recurrent tumors (RCT) without doxycycline and their matched primary tumors (PMT) maintained on doxycycline. Mammary gland tissues from uninduced iPIK3CAH1047R mice were controls. (c) Responses of recurrent tumor transplants to GDC-0941 or vehicle treatment. Data are means ± s.e.m. (n = 6). *P < 0.001 (Student's t test).  Full size image (79 KB) Previous Figures index Next We next examined whether the PI3K pathway remained active in recurrent tumors, thus compensating for the loss of PIK3CAH1047R expression. Western blot analyses of six paired primary and recurrent tumors showed that, although the phosphorylation levels of both AKT and S6RP were robust in all six primary tumors maintained on doxycycline, these signals were maintained in three recurrent tumors but were substantially lower in the other three (Fig. 2b). We then transplanted these six recurrent tumors into the mammary fat pads of athymic mice, and treated the tumor-bearing recipients with GDC-0941, a pan-Class I PI3K inhibitor currently in clinical trials11, 12. Three recurrent tumors (RCT-D782, RCT-E565 and RCT-E302), all of which retained high abundance of both p-AKT and p-S6RP, were sensitive to GDC-0941 treatment (Fig. 2c). In contrast, the three recurrent tumors (RCT-E473, RCT-D419 and RCT-C658), which showed lower p-AKT and p-S6RP abundance, were resistant to GDC-0941 (Fig. 2c). These data suggest that some recurrent tumors escaped addiction to the oncogenic PIK3CA but remained dependent on the PI3K pathway, whereas others acquired the ability to grow independently of both the PIK3CA oncogene and the PI3K pathway.  To search for genomic aberrations associated with this recurrence, we carried out mouse single nucleotide polymorphism (SNP) array analyses of six recurrent tumors. A GDC-0941-sensitive tumor, RCT-E565, had a narrow amplification region encompassing Met (Fig. 3a) and also harbored a single-copy loss of the tumor suppressor gene Cdkn2a (Supplementary Fig. 5a). Notably, two of three tumors that were resistant to GDC-0941 had a common amplification on chromosome 15 spanning 1.48 megabases (chromosome 15:61,271,320–62,750,432), which contains the coding sequence for a single gene, Myc (Fig. 3b and Supplementary Fig. 6). In addition to Myc amplification, RCT-C658 also carried an amplification encompassing the Mdm2 oncogene (Supplementary Fig. 5b). Further analyses of c-Met, c-Myc and Mdm2 in a large collection of recurrent tumors showed that these oncogenes were upregulated in various fractions of recurrent tumors (Supplementary Figs. 7–12 and Supplementary Table 2). These data demonstrate that several of the most common gain- or loss-of-function genetic events in human cancers were recapitulated in this mouse tumor model.  Figure 3: Genetic alterations associated with PIK3CAH1047R-independent tumor recurrence. Genetic alterations associated with PIK3CAH1047R-independent tumor recurrence. (a,b) Mouse SNP6.0 array analyses of six recurrent tumors identified an amplification region encompassing Met in RCT-E565 (a) and a common focal amplification at the Myc locus in RCT-D419 and RCT-C658 tumors (b). (c) Western blot analyses of p-Akt (Ser473) and p-S6RP (Ser235 and Ser236) in two RCT-E565 transplanted tumors treated with vehicle or PF02341066. Samples were isolated 4 h after the last dose from mice treated with PF02341066 for 3 d. (d) Responses of RCT-E565 transplanted tumors in athymic mice to PF02341066 or vehicle. Data are means ± s.e.m. (each group, n = 6). *P < 0.005, **P < 0.001 (Student's t test).  Full size image (73 KB) Previous Figures index Next Because c-Met is a receptor tyrosine kinase that activates the PI3K pathway via ERBB3 and GAB1 (refs. 13,14), we tested whether Met amplification contributes to greater PI3K activity and tumor growth in the absence of PIK3CAH1047R expression. We confirmed that the RCT-E565 tumor, but not its parental primary tumor PMT-E565, had elevated c-Met mRNA and protein expression (Supplementary Fig. 13). We then treated mice bearing RCT-E565 tumor transplants with PF02341066, a c-Met inhibitor currently in clinical development15. PF02341066 abrogated both p-Akt and p-S6RP signals as well as tumor growth (Fig. 3c,d). These results suggest that c-Met elevation is a mechanism underlying the growth of recurrent tumors that have escaped oncogenic PIK3CA addiction but remain dependent on the PI3K pathway.  Because two of three GDC-0941-insensitive recurrent tumors featured Myc amplification (Fig. 3b) and overexpression (Supplementary Fig. 14), and as c-Myc functions downstream of the PI3K pathway16, we hypothesized that c-Myc elevation might contribute to the recurrence of tumors that were resistant to PI3K inhibition. Further analyses of c-Myc for DNA copy number and both mRNA and protein expression in a large cohort of recurrent tumors (Supplementary Figs. 7–10) showed that c-Myc elevation frequently occurs in recurrent tumors after sustained PIK3CAH1047R inactivation. To test whether c-Myc elevation contributes to tumor recurrence in a PI3K pathway–independent manner, we examined the effects of Myc knockdown by shRNAs (sh-Myc1 and sh-Myc2) on the growth of recurrent tumors transplanted in the mammary fat pads of immunodeficient mice. Knockdown of Myc led to markedly lower tumor incidence and longer time to tumor onset (Fig. 4a,b). Conversely, enforced expression of c-Myc or c-MycT58A, a more stable version of c-Myc17, rendered otherwise PIK3CAH1047R-dependent tumors able to grow without doxycycline (Fig. 4c–e). Moreover, these c-Myc- or c-MycT58A-expressing tumors were resistant to GDC-0941 treatment (Fig. 4f and Supplementary Fig. 15). Together, these data suggest that c-Myc elevation renders tumors free of addiction to PIK3CAH1047R and provides resistance to PI3K inhibition.  Figure 4: Elevation of c-Myc drives mammary tumors to become independent of PIK3CAH1047R and resistant to PI3K inhibition. Elevation of c-Myc drives mammary tumors to become independent of PIK3CAH1047R and resistant to PI3K inhibition. (a) shRNA knockdown of c-Myc in primary tumor cells isolated from RCT-D419. Western blot analysis of c-Myc in RCT-D419 parental cells or cells infected with indicated lentiviral shRNAs. Vinculin, loading control. (b) RCT-D419 cells expressing sh-Luc, sh-Myc1 or sh-Myc2 were transplanted into NOD-SCID mice and tumor formation was monitored. P < 0.001 (log-rank test). (c) Western blot analysis of ectopically expressed c-Myc or c-MycT58A in D777 tumor cells isolated from a PIK3CAH1047R-dependent primary tumor maintained on doxycycline. (d) Bioluminescence imaging of tumor establishment in NOD-SCID mice transplanted with D777 cells expressing vector, c-MycT58A or c-Myc. Mice were maintained on doxycycline to sustain PIK3CAH1047R expression. (e) Responses of tumors established by D777 cells expressing control vector, c-Myc or c-MycT58A to doxycycline withdrawal. Data are means ± s.e.m. (n = 6). (f) Mice bearing D777-MycT58A tumors were treated with either GDC-0941 or vehicle and tumor growth was monitored. Data are means ± s.e.m. (n = 6). (g) Schematic summarizing three outcomes of PIK3CAH1047R-initiated tumors after inactivation of PIK3CAH1047R expression.  Full size image (47 KB) Previous Figures index In our model, PIK3CAH1047R-induced tumors have three potential outcomes in response to PI3K inhibition (Fig. 4g). For tumors that escape oncogene addiction and recur, c-Myc elevation represents a potential resistance mechanism with respect to current PI3K-targeted therapies in clinical trials. To explore whether PIK3CA mutations and c-MYC elevation coexist in human breast cancer, we analyzed several breast cancer data sets containing both PIK3CA mutation status and MYC copy number or expression data18, 19, 20, 21. Among these cohorts, we found that substantial fractions of PIK3CA mutation–positive tumors have increased MYC copy numbers as well as mRNA and c-MYC protein levels22, 23 (Supplementary Fig. 16 and Supplementary Table 3). Taken together, our findings suggest that aberrant elevation of c-MYC is a potential mechanism by which tumors develop resistance to PI3K inhibition, and thus combination therapies targeting both PI3K and c-MYC may be necessary to circumvent resistance to PI3K-targeted therapy.  Methods Main• Methods• Accession codes• References• Acknowledgments• Author information• Supplementary information Transgenic mice. We cloned human PIK3CAH1047R into the BamHI site of pTRE2 (Clontech) and inserted an IRES-firefly luciferase sequence downstream of PIK3CAH1047R to generate the TetO-PIK3CAH1047R-IRES-luciferase plasmid. We linearized the plasmid and gel-purified the released fragment for injection into fertilized oocytes from superovulated FVB mice at the transgenic core facility at Brigham and Women's Hospital, Boston. We crossed TetO-PIK3CAH1047R mice with MMTV-rtTA (MTB) mice (provided by L. Chodosh, University of Pennsylvania School of Medicine) to produce mice with inducible PIK3CAH1047R transgene expression in mammary glands (iPIK3CAH1047R). We administered iPIK3CAH1047R mice with doxycycline in their drinking water (2 mg ml−1). We carried out all mouse experiments in accordance with protocols approved by the Institutional Animal Care and Use Committees of Dana-Farber Cancer Institute and Harvard Medical School.  Bioluminescence imaging. We anesthetized mice with ketamine and xylazine and administered D-luciferin (Promega) intraperitoneally to monitor luciferase gene expression in vivo. We analyzed images with KODAK Molecular Imaging Software (version 4.5.0b6 SE).  Western blotting. We prepared lysates for mammary glands, mammary tumors or tumor cells in ice-cold RIPA buffer (Sigma-Aldrich) containing protease inhibitor cocktail (Roche). We cleared lysates by centrifugation before subjecting them to separation on SDS-PAGE and carried out western blot assays as described5 with antibodies to p-AKT (Ser473 or Thr308), AKT, p-S6RP (Ser235 and Ser236), S6RP and c-Met (Cell Signaling Technology), c-Myc (Santa Cruz Biotechnology) and vinculin (Sigma-Aldrich). We used immunofluorescently labeled antibody to mouse IgG (Rockland Immunochemicals) and antibody to rabbit IgG (Molecular Probes) to visualize western blots on an Odyssey scanner (Li-Cor).  Histology and immunohistochemistry. We fixed tumors in formalin overnight before paraffin embedding. Paraffin blocks were sectioned and stained with H&E at the Dana-Farber/Harvard Cancer Center Rodent Histopathology Core. We carried out immunohistochemistry using the antibodies Ki67 (Vector), p-Akt (Ser473) (Invitrogen) and p-S6RP (Cell Signaling). We carried out TUNEL assays using the ApoTag Plus Peroxidase in situ TUNEL Apoptosis Kit (Millipore) according to the manufacturer's instructions.  Mouse SNP analyses. We isolated genomic DNA from mammary tissues or tumors using the Allprep DNA/RNA Kit (Qiagen). SNP array analyses with Mouse Diversity Genotyping Arrays (Affymetrix) were carried out at the Microarray Core at Dana-Farber Cancer Institute. The SNP data were analyzed using a SNP microarray copy number application24 in the software suite dChip (http://biosun1.harvard.edu/complab/dchip/) to compare positions of copy difference between a normal tissue sample from the inbred strain of mouse used in this study and each of the tumor samples from the same inbred strain.  Tumor cell culture and viral transduction. We isolated tumors and dissociated them into single cells as described25 with the exception that the cells were cultured in DMEM/F12 supplemented with 0.5% (vol/vol) FBS and 10 ng ml−1 epidermal growth factor and doxycycline (2 μg ml−1). We produced retrovirus or lentivirus and infected cells according to the methods described26, 27. Infected cells were selected in culture medium plus puromycin (0.5 μg ml−1) for 2 d. Cells were passaged no more than twice before being used for injection or further analysis. The retroviral vectors used in this study were MSCV-PIG (Puro IRES GFP; used as control vector, Addgene plasmid 18751), MSCV-MYC-T58A (Addgene plasmid 20076) and MSCV-MYC (derived from MSCV-MYC-T58A by site-directed mutagenesis; Stratagene). The lentiviral shRNA constructs sh-Luc, shMyc-1 (TRCN 42513) and shMyc-2 (TRCN 42517) were obtained from the RNAi consortium (Broad Institute).  Tumor transplantation and in vivo treatment studies. For tumor grafting, we injected 2–5 × 105 tumor cells into the inguinal mammary glands of recipient mice (NcrNu or NOD-SCID females, 10–12 week old, Taconic). GDC-0941 was purchased from Sai Advantium Pharma and was reconstituted in 0.5% (wt/vol) methylcellulose (Sigma) and 0.2% (vol/vol) Tween 80 (Sigma) and administered by oral gavage (120 mg kg−1 d−1). PF02341066 (Selleck Chemicals) was administered via oral gavage at doses of 25 or 50 mg kg−1 d−1 in water. Tumor volumes were measured twice a week with calipers and calculated using the following formula: tumor volume = (length × width2)/2 (ref. 28).  Statistical analyses. We analyzed mammary tumor-free survival using Kaplan-Meier log-rank test. We analyzed quantitative results by two-tailed unpaired Student's t test. P < 0.05 was considered statistically significant.  ABSTRACT Germline mutations in the BRCAJ tumor suppressor gene are thought to be the most common cause of hereditary ovarian cancer. The aim of this study was to explore further the role of BRCA1 alterations in the development of ovarian cancers. We sought to determine whether somatic BRCA1 mutations are ever present in ovarian cancers and whether mutation is always accompanied by loss of the wild-type allele. The entire coding region and intronic splice sites of BRCA1 were sequenced using genomic DNA samples from 103 unselected ovarian cancers. Thirteen clearly deleterious BRCA1 mutations and two variants of uncertain significance were found. Blood DNA was available in all but two cases and demonstrated that 4 of 13 mutations and both variants of uncertain significance were germline alterations, whereas in seven cases the mutation was a somatic change present only in the cancer. Using four microsatellite markers, loss of heterozygosity at the BRCAJ locus was found in all 15 ovarian cancers with BRCA1 sequence alterations, compared with only 58% of ovarian cancers that did not have BRCA1 mutations. BRCA1-associated ovarian cancers were characterized by serous histology and moderate histological grade. These data confirm prior reports suggesting that germline mutations in BRCA1 are present in about 5% of women with ovarian cancer. In addition, somatic mutations in BRCA1 occur in the development of some sporadic cases. The finding that both germline and somatic BRCA1 mutations are accompanied by loss of heterozygosity, suggests that loss of this tumor suppressor gene is a critical event in the development of these cancers. Received 4/22/98; revised 6/29/98; accepted 7/14/98. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with I 8 U.S.C. Section 1 734 solely to indicate this fact. C To whom requests for reprints should be addressed, at Division of Gynecologic Oncology, Duke University Medical Center, Box 3079, Durham, NC 21 170. INTRODUCTION Germline mutations in the BRCAJ gene are thought to be the most common cause of hereditary ovarian cancer. In one large study in the United Kingdom, it was estimated that about 5% of women with epithelial ovarian cancer carry mutations in BRCAI (I). The fraction of ovarian cancers attributable to germline BRCAI mutations may vary significantly between populations due to founder effects, however (2). In Ashkenazi Jews, it seems that about 20-30% of ovarian cancer cases arise in BRCA1 carriers (3, 4). Although loss of heterozygosity at the BRCAI locus frequently occurs in sporadic ovarian cancers (5-7), it remains uncertain whether somatic mutations in BRCA1 play a role in their development. At the time of the identification of BRCA1 in 1994, Futreal et a!. (8) completely sequenced BRCA1 in 12 ovarian and 32 breast cancers that had allele loss at this locus. Four BRCA1 mutations were found, but all of these mutations also were present in the germline. Subsequently, Merajver et a!. (9) found somatic mutations in BRCA1 in 4 of 47 unselected ovarian cancers, and Hosking et a!. ( 10) found one case with a somatic mutation among 17 ovarian cancers with allele loss at BRCA 1 ; but more recent studies in which larger numbers of ovarian cancer were screened failed to identify somatic mutations (7, 8). To determine the fraction of ovarian cancers in eastern North Carolina that are attributable to germline BRCA1 mutations and whether somatic mutations occur in the development of sporadic ovarian cancers, we performed DNA sequencing of the entire coding region and intronic splice sites using genomic DNA samples from 103 unselected snap-frozen epithelial ovarian cancers. In cases in which mutations were found, the corresponding blood DNA was examined to see if the mutation also was present in the germline. Before the identification of BRCA1, it had been reported that cancers in families demonstrating linkage to chromosome l7q21, invariably had lost the wild-type allele (1 1). This was interpreted as consistent with the hypothesis that BRCA 1 acts as a tumor suppressor gene. In the present study, we performed loss of heterozygosity analysis on tumors known to harbor BRCA 1 mutations to address more definitively the issue of whether mutations always are accompanied by loss of the wild-type allele. MATERIALS AND METHODS Ovarian Cancers. The 103 snap-frozen ovarian cancers used were from women who had undergone surgery for epithehal ovarian cancer at Duke University between 1991 and 1996. The study group included 90 Whites, 1 1 African-Americans, and 2 Native Americans. The median age at diagnosis of the patients in this study was 64 years. Cancers were selected without knowledge of the age at ovarian cancer onset, history of prior breast cancer, or family history of cancer. In most cases, peripheral WBCs also had been obtained. Patients signed conResearch.  Downloaded from clincancerres.aacrjournals.org on June 2, 2017. © 1998 American Association for Cancer Type Age Race Exon or intron Table 1 BRCA1 sequence variants in lO3unselectedDuke ovarian cancers Germline mutations 49 W intr5 39 W 11 46 B 48 W Other cancer Family history cancer Histology/grade 19 5296de14 Breast I I 2576delC Germline variants of uncertain significance 40 W 2 44 W 11 Serous/2 Serous/2 Serous/3 Serous/2 W W B W W W WW W Bilateral breast Sister, breast Mother, “pelvic cancer” intr2 1111 5 II11 11 11 11 IVS2+1 G>T 2569delG 2388delG C61G Q1420X R1835X 2388delG 2O8OinsA E730X Endometrium Aunt, breast 2434 BRCA1 Mutations in Ovarian Cancer Somatic mutations 49 7264 63 61 59 6170 56 Polymorphisms 1468 1803 2252 2369 56 White I 1 83 White 1 1 72 White 11 66 White 11 Mutation IVS5-l IT>G 3875dei4 D173G G1788V A1641T R1347G Sl5 121 R1347G Endometrium Sister, breast Sister, ovarian Father, stomach Aunt, breast Father, stomach Sister, breast Sister, breast Sister, ovarian Two brothers. colon Grandfather, prostate Brother, lymphoma Father, leukemia/lung Serous/2 Serous/2 Serous/2 Serous/2 Endometrioidl2 Serous/2\u0001 Serous/2” Serous/3 Serous/l Serous/3 Serous/2 Endometrioid/3 Serous/2 Endometrioidl2 Endometrioid/2 (a Presumed somatic mutations (germline DNA not available for analysis). sent forms permitting the use of tissue and blood. Medical records were reviewed to collect relevant demographic and clinical information. All of the histology had been reviewed by gynecological pathologists at our institution. BRCA1 Sequence Analysis. The entire coding region and intronic splice sites of the BRCAJ gene were sequenced using genomic DNA isolated from 103 snap-frozen ovarian cancers. Sequence analysis of BRCA 1 was performed at Myriad Genetic Laboratories. Briefly, exons 2-24 of the BRCAJ gene were amplified using 35 pairs of PCR primers designed to avoid common polymorphisms that might inhibit equal amplification of both alleles. Dye primer sequencing was performed using fluorescent energy transfer primers (Amersham Life Science, Inc., Cleveland, OH), the mutant Taq polymerase F667Y, and a thermal stable pyrophosphatase (both from Perkin-Elmer Corp., Norwalk, CT). Sequencing reaction products were electrophoresed and detected using a Perkin-Elmer Applied Biosystems 377 sequencing gel. Analyses of sequence data were performed using software developed by Myriad Genetic Laboratories, Inc. All analyses demonstrating mutations were repeated for verification, and the appropriate segment of the BRCA 1 gene was sequenced in the corresponding WBC DNA. BRCA1 Loss of Heterozygosity. DNA was isolated as prescribed by Puregene (Gentra, Minneapolis, MN), and four microsatellite markers at the BRCAJ locus were analyzed in paired normal/cancer DNA. PCR reactions were performed using 100 ng of DNA, 1 msi dNTP, 0.5 pg of primer, and 0.5 unit of AmpliTaq Gold in standard buffer with a total volume of 20 p.1. Primers for markers flanking the BRCAI locus are: THRA1-AC (CTGCGC1TFGCACTATFGGG)/THRA l-TG (CGGGCAGCATAGCATFGCCT) and 658 (AGTCCTGTAGACAAAACCTG)1705 (CAG1TFCATACCAAGUCCF). Primers intragenic to BRCAJ include: 175 1322R (CTAGCCTGGGCAACAAACGA)/17S l322F(GCAGGAAGCAGGAATGGAAC) and 855R (ACACAGACTFGTCCTACTGCC)/855F (GGATGGCCT1TTAGAAAGTGG). The PCR reaction involved an initial denaturation step, 95#{176}C/12mm, followed by 32 cycles of 94#{176}C/l mm, 57#{176}C/imm, and 72#{176}C/lmm. Reactions were then incubated at 72#{176}C/Smm and stored at 4#{176}C.The presence of the correct-sized PCR products was confirmed by electrophoresis on 2.5% agarose gels. For PCR-2, 3 p.1 of PCR-l product was added to 1 mM CTP, 1 mr\u0001i UP, 1 m\u0001i GTP, and 0.1 msi AlP, 0.5 p.Ci of [a-32P]dATP, 0.5 p.g of primer, and 0.5 unit of Taq polymerase (Life Technologies, Inc.). PCR was initiated with a denaturation step of 95#{176}C/Smm, 35 cycles of 95#{176}C145 s, 60#{176}C/45s, 72#{176}C/l mm, and then 72#{176}C/Smm. Products were run on a 5% polyacrylamide gel in Tris-borate EDTA buffer and visualized by autoradiography. RESULTS Clearly deleterious mutations in BRCA1 were found in 13 of 103 ovarian cancers (Table 1). Two variants of uncertain significance and four probable polymorphisms also were detected. Among the clearly deleterious mutations, 10 involved changes that predict a truncated protein product (7 frameshift, 3 nonsense). In addition, one missense mutation was found (C61G). This mutation, which disrupts a critical cysteine residue Research. Downloaded from clincancerres.aacrjournals.org on June 2, 2017. © 1998 American Association for Cancer Clinical Cancer Research 2435 in the zinc finger domain, has been reported previously (12). Two significant intronic splice site missense mutations were found. The mutation seen in intron 5 has been shown previously to represent a significant change that results in a splice variant encoding a truncated protein product (12). Similarly, the intron 2 mutation would be predicted to result in a truncated product or unstable mRNA transcript. WBC DNA was available in 1 1 of 13 cases in which a clearly deleterious mutation was found. In four of these cases, the identical mutation was identified in the germline. All of these women developed ovarian cancer before age 50 and had a family history of breast or breast and ovarian cancer (Table 1). In seven cases, the BRCA 1 mutation present in the cancer was not found in the corresponding blood DNA and presumably arose as a somatic event. The median age at onset in these seven women was in the early 60s, and none had a first-degree relative with breast and/or ovarian cancer. In two cases in which blood DNA was not available, the patients also had a later age at onset and lacked a family history of cancer. These also were classified as probable somatic mutations. In addition, missense variants of uncertain significance were seen in two women and both were found in the germline. The D173G change, which was seen in a woman who developed ovarian cancer at age 40, results in substitution of an uncharged (glycine) for a charged (aspartic acid) amino acid. Although this may represent a disease causing mutation, it has not previously been reported. The G1788V mutation, in which valine is substituted for glycine, was seen in a woman with a prior history of bilateral breast cancer who developed ovarian cancer at age 44. In addition, she had a sister who developed breast cancer. Although this is not a striking sequence variant, neither is it a reported polymorphism. Overall, there were four definite and two probable germline BRCAI mutations (6%) and seven defmite and two probable somatic mutations (9%). Loss of heterozygosity at one or more BRCA 1 microsatellite markers was found in all 15 ovarian cancers with BRCA1 sequence alterations. In contrast, only 1 1 of 19 (58%) ovarian cancers that were completely sequenced and found to have wild-type BRCA1 had loss of heterozygosity at or near the BRCAJ locus. Examples of ovarian cancers in which there is loss or retention of the wild-type BRCAJ allele are demonstrated in Fig. 1 . In all cases, analysis of the chromosome l7q BRCA1 markers and microsatellite markers D16S767, Dl9S6Ol , and D3S 1763 revealed identical-sized alleles in the paired normal/ cancer DNAs confirming the identity of these samples. There was no evidence of microsatellite instability. We examined the relationship between the status of the BRCAI gene and clinical features of ovarian cancers (Table 2). Because the two germline BRCA1 variants of uncertain significance occurred in women with early onset ovarian cancer, we considered them significant mutations for the purpose of this analysis. The median age of those with germline BRCA1 mutations (45 years) was younger than that of cases with somatic mutations (61 years) and cases not associated with BRCAI mutations (64 years). All but one of the BRCA1-associated ovarian cancers were serous and all were stage III/IV, but they were less likely to be poorly differentiated (20%) relative to cases without mutations (45%). There was no difference between cases with germline mutations and those with somatic Mutant WT 1 2 3 4 5 NTNT NTNT NT 17S1322 Fig. 1 Loss of heterozygosity at the BRCAJ locus is seen in ovarian cancers with BRCAI mutations (Lanes 1-4), whereas the ovarian cancer lacking a BRCAI mutation (Lane 5) does not have loss of heterozygosity. mutations with respect to stage or grade. Finally, BRCA1- associated ovarian cancers were about 3-fold more likely to have undergone a negative second-look laparotomy (Table 2). DISCUSSION In a study from the United Kingdom in which blood cell DNA was screened using single-stranded conformation and heteroduplex analysis, 3% of 375 women with ovarian cancer were found to carry germline BRCA 1 mutations ( 1 ). Because some mutations may be missed using these techniques, it was estimated that the true frequency of mutations probably was about 5%, but could be as high as 8%. The present study is the first in which the entire coding region and intronic splice sites of the BRCA I gene were sequenced in a large group of unselected ovarian cancers. Using this more sensitive detection strategy, we found clearly deleterious germline mutations in 4% of cases and 2% of cases with germline variants of uncertain significance that may represent deleterious mutations. Thus, the fraction of ovarian cancer cases attributable to germline BRCA1 mutations in eastern North Carolina is similar to that estimated for the population studied in the United Kingdom. Our estimate that approximately 5% of ovarian cancer is attributable to inherited BRCA1 mutations likely represents a reasonable estimate for other areas of the United States as well, because the distribution of racial and clinical features in the study population was relatively representative. One possibly significant difference between our study and the general population is the absence of Ashkenazi Jewish women, who have a much higher incidence of germline BRCA1 mutations (20- 30%; Refs. 3 and 4). This group is underrepresented in eastern North Carolina and none of the women in this study are known to be of Ashkenazi descent. Because only 2-3% of American women are of Ashkenazi heritage, even if they had been represented in our study in proportion to the United States population, the overall incidence of germline BRCA 1 mutations would only be predicted to rise by 1-2%. Research. Downloaded from clincancerres.aacrjournals.org on June 2, 2017. © 1998 American Association for Cancer 2436 BRCAI Mutations in Ovarian Cancer Table 2 Relationship between BRCA1 and clinical features of ovarian cancers BRCAI mutation no/total (%) F” RaceWhite 11/90(12%) NS African-American 2/11 (18%) Native American 0/2 Age of onset \u000150 7/19 (37%) 0.006 >50 8/84(10%) Family history of breast/ovarian cancer No 9/75 (12%) 0.35 Yes 6/28(21%) First-degree relative with breast/ovarian cancer No 11/90(12%) 0.09 Yes 4/13(31%) Histology Serous 14/80 (I8%) 0.18 Endometrioid 1/7 (14%) Mucinous 0/4 Clear cell 0/4 Undifferentiated 0/8 GradeBorderline 0/5 0.09 Well 1/4(25%) Moderate I 1/52 (2 1%) Poor 3/42 (7%) Stage I/Il 0/14 0.12 III/IV 15/89(17%) Second-look Negative 6/18(33%) 0.07 Microscopic 1/9 (11%) Positive 3/26 (12%) Not done 5/48 (10%) a Fisher’s exact test. We also cannot exclude the possibility that BRCA1 is inactivated in some women with ovarian cancer by other genetic mechanisms. Although it is unlikely that we missed mutations in the BRCA 1 coding sequence or splice sites, it has been documented that regulatory mutations affecting the promoter can occur and these would not be detected using DNA sequencing (13). In addition, large genomic deletions in BRCA1 have been reported that are not detectable with the conventional PCRbased DNA sequencing mutation detection techniques (14). Additional studies in the United States population are needed to determine whether these other types of mutations contribute significantly to the development of any ovarian cancers. Initially, two small studies reported somatic mutations in BRCA1 in about 10% of 54 ovarian cancers (9, 10). Larger studies published subsequently did not confirm this finding, however. Although BRCA1 mutations were seen in 7 of 1 15 and 4 of 76 ovarian cancers, all of the mutations were also present in the germline, and it was concluded that somatic mutations rarely occur (7, 8). Similarly, somatic mutations in BRCA1 have not been described in breast cancers (8, 13). In the present study, sequencing of the BRCA 1 gene in 103 ovarian cancers revealed mutations in at least 7, and possibly 9, cases that were present in the cancer but not in paired normal WBC DNA. The frequency of somatic BRCA1 mutations in the present study (7-9%) is similar to that reported in the two earlier small studies (10%; Refs. 9 and 10). In contrast to women with germline BRCA1 mutations whose median age at ovarian cancer diagnosis was in the mid- 405, the median age of women with somatic mutations was about 60 years. This is consistent with the “multi-hit” theory of carcinogenesis in which several genetic alterations are requisite for tumorigenesis. Women with an inherited mutation in BRCA1 have a head start along this pathway and develop ovarian cancer at an earlier age, but additional genetic alterations must occur for malignant transformation to take place. In this regard, other genetic alterations have been demonstrated in BRCA1-associated breast cancers (15). In addition, it has been suggested that BRCA1 may be involved in DNA recombination and repair pathways (1 6). Thus, mutations in this gene may serve not only as the first hit in the transformation process, but also to accelerate the rate of accumulation of alterations in other cancer causing genes. Before the identification of BRCA 1 , it had been anticipated that somatic mutations in BRCA 1 would be common in ovarian cancers, because more than half of these cancers exhibit loss of heterozygosity on chromosome l7q (5-7). In a previous study from our group, loss of heterozygosity on chromosome 17q was seen in 64 of 120 (53%) cases (5). In 56 cases with allele loss, all informative markers on 1 7q were lost whereas focal losses were seen in only 8 cases. In the present study, we found that loss of the wild-type BRCAJ allele invariably accompanied both germline and somatic BRCA1 mutations in 15 cases, whereas in a control group of 19 ovarian cancers lacking mutations 58% were found to have 17q allele loss similar to our prior study (5). Loss of the wild-type allele also was found in all eight breast and ovarian cancers that developed in women with germline BRCA1 mutations in a Japanese study (17) and in six ovarian cancers in a study from the United States (7). These data are supportive of the hypothesis that loss of BRCA1 function occurs by way of the classic tumor suppressor paradigm with mutation of one copy and deletion of the other. In summarizing four prior hospital-based studies (1, 7, 17, 18) and the present study, 94% (59 of 63 cases) of BRCA1- associated ovarian cancers have been serous. Although this is the most commonly observed histological type of epithelial ovarian cancer, it generally accounts for only about one-half to two-thirds of cases. In view of the consistency of these reports, it now seems reasonably certain that serous histology is a hallmark of ovarian cancers with BRCA1 mutations. Rubin et a!. (19) found that survival of 43 BRCAI carriers with advanced ovarian cancer in a collaborative study in the United States was markedly better than that of carefully matched sporadic cases. Actuarial median 5-year survival was 77 months in carriers and 29 months in noncarriers. Similarly, a Japanese group reported 79% survival in 13 stage III BRCA1- associated ovarian cancers treated with cisplatin-containing regimens, compared with 30% in matched controls (20). The present study suggests that BRCA 1-associated ovarian cancers have a more favorable phenotype regardless of whether the mutation is germline or sporadic. Although all of the BRCA1-associated cases in this report were advanced stage, they were half as likely to be poorly differentiated and twice as likely to have a pathoResearch.  Downloaded from clincancerres.aacrjournals.org on June 2, 2017. © 1998 American Association for Cancer Clinical Cancer Research 2437 logically negative second-look operation after completion of primary chemotherapy, compared with cases without BRCA1 mutations. In contrast, a recent population-based study from Sweden noted an initial survival advantage in BRCA1-associated cases, but this did not persist over time (21). None of the studies performed to date have been optimally designed to assess survival and have included only small numbers of cases, however. Previous studies have demonstrated associations between alterations in the p.53 (22) and HER-2/neu (23) genes and high-risk clinical features and poor outcome. Thus, it would not be surprising if other genetic alterations, such as BRCA1 mutation, are associated with a more favorable clinical phenotype in ovarian cancer. Adenocarcinoma of the lung is the leading cause of cancer death worldwide. Here we report molecular profiling of 230 resected lung adenocarcinomas using messenger RNA, microRNA and DNA sequencing integrated with copy number, methylation and proteomic analyses. High rates of somatic mutation were seen (mean 8.9 mutations per megabase). Eighteen genes were statistically significantly mutated, including RIT1 activating mutations and newly described loss-of-function MGA mutations which are mutually exclusive with focal MYC amplification. EGFR mutations were more frequent in female patients, whereas mutations in RBM10 were more common in males. Aberrations in NF1, MET, ERBB2 and RIT1 occurred in 13% of cases and were enriched in samples otherwise lacking an activated oncogene, suggesting a driver role for these events in certain tumours. DNA and mRNA sequence from the same tumour highlighted splicing alterations driven by somatic genomic changes, including exon 14 skipping in MET mRNA in 4% of cases. MAPK and PI(3)K pathway activity, when measured at the protein level, was explained by known mutations in only a fraction of cases, suggesting additional, unexplained mechanisms of pathway activation. These data establish a foundation for classification and further investigations of lung adenocarcinoma molecular pathogenesis.  Lung cancer is the most common cause of global cancer-related mortality, leading to over a million deaths each year and adenocarcinoma is its most common histological type. Smoking is the major cause of lung adenocarcinoma but, as smoking rates decrease, proportionally more cases occur in never-smokers (defined as less than 100 cigarettes in a life-time). Recently, molecularly targeted therapies have dramatically improved treatment for patients whose tumours harbour somatically activated oncogenessuch as mutant EGFR1 or translocated ALK, RET, orROS1 (refs 2–4). Mutant BRAF and ERBB2 (ref. 5) are also investigational targets. However, mostlung adenocarcinomas either lack an identifiable driver oncogene, or harbour mutations in KRAS and are therefore still treated with conventional chemotherapy. Tumour suppressor gene abnormalities, such as those in TP53 (ref. 6), STK11 (ref. 7), CDKN2A8, KEAP1 (ref. 9), and SMARCA4 (ref. 10) are also common but are not currently clinically actionable. Finally, lung adenocarcinoma shows high rates of somatic mutation and genomic rearrangement, challenging identification of all but the most frequent driver gene alterations because of a large burden of passenger events per tumour genome11–13. Our efforts focused on comprehensive, multiplatform analysis of lung adenocarcinoma, with attention towards pathobiology and clinically actionable events.  Go to: Clinical samples and histopathologic data We analysed tumour and matched normal material from 230 previously untreated lung adenocarcinoma patients who provided informed consent (Supplementary Table 1). All major histologic types of lung adenocarcinoma were represented: 5% lepidic, 33% acinar, 9% papillary, 14% micropapillary, 25% solid, 4% invasive mucinous, 0.4% colloid and 8% unclassifiable adenocarcinoma (Supplementary Fig. 1)14. Median follow-up was 19 months, and 163 patients were alive at the time of last follow-up. Eighty-one percent of patients reported pastor present smoking. Supplementary Table 2 summarizes demographics. DNA, RNA and protein were extracted from specimens and quality-control assessments were performed as described previously15. Supplementary Table 3 summarizes molecular estimates of tumour cellularity16.  Go to: Somatically acquired DNA alterations We performed whole-exome sequencing (WES) on tumour and germ-line DNA, with a mean coverage of 97.6× and 95.8×, respectively, as performed previously17. The mean somatic mutation rate across the TCGA cohort was 8.87 mutations per megabase (Mb) of DNA (range: 0.5–48, median: 5.78). The non-synonymous mutation rate was 6.86 per Mb. MutSig2CV18 identified significantly mutated genes among our 230 cases along with 182 similarly-sequenced, previously reported lung adenocarcinomas12. Analysis of these 412 tumour/normal pairs highlighted 18 statistically significant mutated genes (Fig. 1 a shows co-mutation plot of TCGA samples (n =230), Supplementary Fig. 2 shows co-mutation plot of all samples used in the statistical analysis (n =412) and Supplementary Table 4 contains complete MutSig2CV results, which also appear on the TCGA Data Portal along with many associated data files (https://tcga-data.nci.nih.gov/docs/publications/luad_2014/). TP53 was commonly mutated (46%). Mutations in KRAS (33%) were mutually exclusive with those in EGFR (14%). BRAF was also commonly mutated (10%), as were PIK3CA (7%), MET (7%) and the small GTPase gene, RIT1 (2%). Mutations in tumour suppressor genes including STK11 (17%), KEAP1 (17%), NF1 (11%), RB1 (4%) and CDKN2A (4%) were observed. Mutations in chromatin modifying genes SETD2(9%), ARID1A(7%) and SMARCA4 (6%) and the RNA splicing genes RBM10 (8%) and U2AF1 (3%) were also common. Recurrent mutations in the MGA gene (which encodes a Max-interacting protein on the MYC pathway19) occurred in 8% of samples. Loss-of-function (frameshift and nonsense) mutations in MGA were mutually exclusive with focal MYC amplification (Fisher’s exact test P =0.04), suggesting a hitherto unappreciated potential mechanism of MYC pathway activation. Coding single nucleotide variants and indel variants were verified by resequencing at a rate of 99% and 100%, respectively (Supplementary Fig. 3a, Supplementary Table 5). Tumour purity was not associated with the presence of false negatives identified in the validation data (P =0.31; Supplementary Fig. 3b).  Figure 1 Figure 1 Somatic mutations in lung adenocarcinoma Past or present smoking associated with cytosine to adenine (C >A) nucleotide transversions as previously described both in individual genes and genome-wide12,13. C >A nucleotide transversion fraction showed two peaks; this fraction correlated with total mutation count (R2 =0.30) and inversely correlated with cytosine to thymine (C >T) transition frequency (R2 =0.75) (Supplementary Fig. 4). We classified each sample (Supplementary Methods) into one of two groups named transversion-high (TH, n =269), and transversion-low (TL, n =144). The transversion-high group was strongly associated with past or present smoking (P < 2.2 ×10−16), consistent with previous reports13. The transversion-high and transversion-low patient cohorts harboured different gene mutations. Whereas KRAS mutations were significantly enriched in the transversion-highcohort (P=2.1×10−13), EGFR mutations were significantly enriched in the transversion-low group (P =3.3 ×10−6). PIK3CA and RB1 mutations were likewise enriched in transversion-low tumours (P <0.05). Additionally, the transversion-low tumours were specifically enriched for in-frame insertions in EGFR and ERBB2 (ref. 5) and for frameshift indels in RB1 (Fig. 1b). RB1 is commonly mutated in small-cell lung carcinoma (SCLC). We found RB1 mutations in transversion-low adenocarcinomas were enriched for frameshift indels versus single nucleotide substitutions compared to SCLC (P <0.05)20,21 suggesting a mutational mechanism in transversion-low adenocarcinoma that is probably distinct from smoking in SCLC.  Gender is correlated with mutation patterns in lung adenocarcinoma22. Only a fraction of significantly mutated genes from the complete set reported in this study (Fig. 1a) were enriched in men or women (Fig. 1c). EGFR mutations were enriched in tumours from the female cohort (P =0.03) whereas loss-of-function mutations within RBM10, an RNA-binding protein located on the X chromosome23 were enriched in tumours from men (P =0.002). When examining the transversion-high group, 16 out of 21 RBM10 mutations were observed in males (P =0.003, Fisher’s exact test).  Somatic copy number alterations were very similar to those previously reported for lung adenocarcinoma24 (Supplementary Fig. 5, Supplementary Table 6). Significant amplifications included NKX2-1, TERT, MDM2, KRAS, EGFR, MET, CCNE1, CCND1, TERC and MECOM (Supplementary Table 6), as previously described24, 8q24 near MYC, and a novel peak containing CCND3 (Supplementary Table 6). The CDKN2A locus was the most significant deletion (Supplementary Table 6). Supplementary Table 7 summarizes molecular and clinical characteristics by sample. Low-pass whole-genome sequencing on a subset (n =93) of the samples revealed an average of 36 gene–gene and gene–inter-gene rearrangements per tumour. Chromothripsis25 occurred in six of the 93 samples (6%) (Supplementary Fig. 6, Supplementary Table 8). Low-pass whole genome sequencing-detected rearrangements appear in Supplementary Table 9.  Go to: Description of aberrant RNA transcripts Gene fusions, splice site mutations or mutations in genes encoding splicing factors promote or sustain the malignant phenotype by generating aberrant RNA transcripts. Combining DNA with mRNA sequencing enabled us to catalogue aberrant RNA transcripts and, in many cases, to identify the DNA-encoded mechanism for the aberration. Seventy-five per cent of somatic mutations identified by WES were present in the RNA transcriptome when the locus in question was expressed (minimum 5×) (Supplementary Fig. 7a) similar to prior analyses15. Previously identified fusions involving ALK (3/230 cases), ROS1 (4/230) and RET (2/230) (Fig. 2a, Supplementary Table 10), all occurred in transversion-low tumours (P =1.85 × 10−4, Fisher’s exact test).  Figure 2 Figure 2 Aberrant RNA transcripts in lung adenocarcinoma associated with somatic DNA translocation or mutation MET activation can occur by exon 14 skipping, which results in a stabilized protein26. Ten tumours had somatic MET DNA alterations with MET exon 14 skipping in RNA. In nine of these samples, a 5′ or 3′ splice site mutation or deletion was identified27. MET exon 14 skipping was also found in the setting of a MET Y1003* stop codon mutation (Fig. 2b, Supplementary Fig. 8a). The codon affected by the Y1003* mutation is predicted to disrupt multiple splicing enhancer sequences, but the mechanism of skipping remains unknown in this case.  S34F mutations in U2AF1 have recently been reported in lung adenocarcinoma12 but their contribution to oncogenesis remains unknown. Eight samples harboured U2AF1S34F. We identified 129 splicing events strongly associated with U2AF1S34F mutation, consistent with the role of U2AF1 in 3′-splice site selection28. Cassette exons and alternative 3′ splice sites were most commonly affected (Fig. 2c, Supplementary Table 11)29. Among these events, alternative splicing of the CTNNB1 protooncogene was strongly associated with U2AF1 mutations (Supplementary Fig. 8b). Thus, concurrent analysis of DNA and RNA enabled delineation of both cis and trans mechanisms governing RNA processing in lung adenocarcinoma.  Go to: Candidate driver genes The receptor tyrosine kinase (RTK)/RAS/RAF pathway is frequently mutated in lung adenocarcinoma. Striking therapeutic responses are often achieved when mutant pathway components are successfully inhibited. Sixty-two percent (143/230) of tumours harboured known activating mutations in known driver oncogenes, as defined by others30. Cancer-associated mutations in KRAS (32%, n =74), EGFR (11%, n =26) and BRAF (7%, n =16) were common. Additional, previously uncharacterized KRAS, EGFR and BRAF mutations were observed, but were not classified as driver oncogenes for the purposes of our analyses (see Supplementary Fig. 9a for depiction of all mutations of known and unknown significance); explaining the differing mutation frequencies in each gene between this analysis and the overall mutational analysis described above. We also identified known activating ERBB2 in-frame insertion and point mutations (n =5)6, as well as mutations in MAP2K1 (n =2), NRAS and HRAS (n =1 each). RNA sequencing revealed the aforementioned MET exon 14 skipping (n =10) and fusions involving ROS1 (n =4), ALK (n =3) and RET (n =2). We considered these tumours collectively as oncogene-positive, as they harboured a known activating RTK/RAS/ RAF pathway somatic event. DNA amplification events were not considered to be driver events before the comparisons described below.  We sought to nominate previously unrecognized genomic events that might activate this critical pathway in the 38% of samples without a RTK/RAS/RAF oncogene mutation. Tumour cellularity did not differ between oncogene-negative and oncogene-positive samples (Supplementary Fig. 9b). Analysis of copy number alterations using GISTIC31 identified unique focal ERBB2 and MET amplifications in the oncogene-negative subset (Fig. 3a, Supplementary Table 6); amplifications in other wild-type proto-oncogenes, including KRAS and EGFR, were not significantly different between the two groups.  Figure 3 Figure 3 Identification of novel candidate driver genes We next analysed WES data independently in the oncogene-negative and oncogene-positive subsets. We found that TP53, KEAP1, NF1 and RIT1 mutations were significantly enriched in oncogene-negative tumours (P <0.01; Fig. 3b, Supplementary Table 12). NF1 mutations have previously been reported in lung adenocarcinoma11, but this is the first study, to our knowledge, capable of identifying all classes of loss-of-function NF1 defects and to statistically demonstrate that NF1 mutations, as well as KEAP1 and TP53 mutations are enriched in the oncogene-negative subset of lung adenocarcinomas (Fig. 3c). All RIT1 mutations occurred in the oncogene-negative subset and clustered around residue Q79 (homologous to Q61 in the switch II region of RAS genes). These mutations transform NIH3T3 cells and activate MAPK and PI(3)K signalling32, supporting a driver role for mutant RIT1 in 2% of lung adenocarcinomas. This analysis increases the rate at which putative somatic lung adenocarcinoma driver events can be identified within the RTK/RAS/RAF pathway to 76% (Fig. 3d).  Go to: Recurrent alterations in key pathways Recurrent aberrations in multiple key pathways and processes characterize lung adenocarcinoma (Fig. 4a). Among these were RTK/RAS/ RAF pathway activation (76% of cases), PI(3)K-mTOR pathway activation (25%), p53 pathway alteration (63%), alteration of cell cycle regulators (64%, Supplementary Fig. 10), alteration of oxidative stress pathways (22%, Supplementary Fig. 11), and mutation of various chromatin and RNA splicing factors (49%).  Figure 4 Figure 4 Pathway alterations in lung adenocarcinoma We then examined the phenotypic sequelae of some key genomic events in the tumours in which they occurred. Reverse-phase protein arrays provided proteomic and phosphoproteomic phenotypic evidence of pathway activity. Antibodies on this platform are listed in Supplementary Table 13. This analysis suggested that DNA sequencing did not identify all samples with phosphoprotein evidence of activation of a given signalling pathway. For example, whereas KRAS-mutant lung adenocarcinomas had higher levels of phosphorylated MAPK than KRAS wild-type tumours had on average, many KRAS wild-type tumours displayed significant MAPK pathway activation (Fig. 4b, Supplementary Fig. 10). The multiple mechanisms by which lung adenocarcinomas achieve MAPK activation suggest additional, still undetected RTK/RAS/ RAF pathway alterations. Similarly, we found significant activation of mTOR and its effectors (p70S6kinase, S6, 4E-BP1) in a substantial fraction of the tumours (Fig. 4c). Analysis of mutations in PIK3CA and STK11, STK11 protein levels, and AMPK and AKT phosphorylation33 led to the identification of three major mTOR patterns in lung adenocarcinoma: (1) tumours with minimal or basal mTOR pathway activation, (2) tumours showing higher mTOR activity accompanied by either STK11-inactivating mutation or combined low STK11 expression and low AMPK activation and (3) tumours showing high mTOR activity accompanied by either phosphorylated AKT activation, PIK3CA mutation, or both. As with MAPK, many tumours lack an obvious underlying genomic alteration to explain their apparent mTOR activation.  Go to: Molecular subtypes of lung adenocarcinoma Broad transcriptional and epigenetic profiling can reveal downstream consequences of driver mutations, provide clinically relevant classification and offer insight into tumours lacking clear drivers. Prior unsupervised analyses of lung adenocarcinoma gene expression have used varying nomenclature for transcriptional subtypes of the disease34–37. To coordinate naming of the transcriptional subtypes with the histopathological38, anatomic and mutational classifications of lung adenocarcinoma, we propose an updated nomenclature: the terminal respiratory unit (TRU, formerly bronchioid), the proximal-inflammatory (PI, formerly squamoid), and the proximal-proliferative (PP, formerly magnoid)39 transcriptional subtypes (Fig. 5a). Previously reported associations of expression signatures with pathways and clinical outcomes34,36,39 were observed (Supplementary Fig. 7b) and integration with multi-analyte data revealed statistically significant genomic alterations associated with these transcriptional subtypes. The PP subtype was enriched for mutation of KRAS, along with inactivation of the STK11 tumour suppressor gene by chromosomal loss, inactivating mutation, and reduced gene expression. In contrast, the PI subtype was characterized by solid histopathology and co-mutation of NF1 and TP53. Finally, the TRU subtype harboured the majority of the EGFR-mutated tumours as well as the kinase fusion expressing tumours. TRU subtype membership was prognostically favourable, as seen previously34 (Supplementary Fig. 7c). Finally, the subtypes exhibited different mutation rates, transition frequencies, genomic ploidy profiles, patterns of large-scale aberration, and differed in their association with smoking history (Fig. 5a). Unsupervised clustering of miRNA sequencing-derived or reverse phase protein array (RPPA)-derived data also revealed significant heterogeneity, partially overlapping with the mRNA-based subtypes, as demonstrated in Supplementary Figs 12 and 13.  Figure 5 Figure 5 Integrative analysis Mutations in chromatin-modifying genes (for example, SMARCA4, ARID1A and SETD2) suggest a major role for chromatin maintenance in lung adenocarcinoma. To examine chromatin states in an unbiased manner, we selected the most variable DNA methylation-specific probes in CpG island promoter regions and clustered them by methylation intensity (Supplementary Table 14). This analysis divided samples into two distinct subsets: a significantly altered CpG island methylator phenotype-high (CIMP-H(igh)) cluster and a more normal-like CIMP-L(ow) group, with a third set of samples occupying an intermediate level of methylation at CIMP sites (Fig. 5b). Our results confirm a prior report40 and provide additional insights into this epigenetic program. CIMP-H tumours often showed DNA hypermethylation of several key genes: CDKN2A, GATA2, GATA4, GATA5, HIC1, HOXA9, HOXD13, RASSF1, SFRP1, SOX17 and WIF1 among others (Supplementary Fig. 14). WNT pathway genes are significantly over-represented in this list (P value =0.0015) suggesting that this is a key pathway with an important driving role within this subtype. MYC overexpression was significantly associated with the CIMP-H phenotype as well (P =0.003).  Although we did not find significant correlations between global DNA methylation patterns and individual mutations in chromatin remodelling genes, there was an intriguing association between SETD2 mutation and CDKN2A methylation. Tumours with low CDKN2A expression due to methylation (rather than due to mutation or deletion) had lower ploidy, fewer overall mutations (Fig. 5c) and were significantly enriched for SETD2 mutation, suggesting an important role for this chromatin-modifying gene in the development of certain tumours.  Integrative clustering41 of copy number, DNA methylation and mRNA expression data found six clusters (Fig. 5c). Tumour ploidy and mutation rate are higher in clusters 1–3 than in clusters 4–6. Clusters 1–3 frequently harbour TP53 mutations and are enriched for the two proximal transcriptional subtypes. Fisher’s combined probability tests revealed significant copy number associated gene expression changes on 3q in cluster one, 8q in cluster two, and chromosome 7 and 15q in cluster three (Supplementary Fig. 15). The low ploidy and low mutation rate clusters four and five contain many TRU samples, whereas tumours in cluster 6 have comparatively lower tumour cellularity, and few other distinguishing molecular features. Significant copy number-associated gene expression changes are observed on 6q in cluster four and 19p in cluster five. The CIMP-H tumours divided into a high ploidy, high mutation rate, proximal-inflammatory CIMP-H group (cluster 3) and a low ploidy, low mutation rate, TRU-associated CIMP-H group (cluster 4), suggesting that the CIMP phenotype in lung adenocarcinoma can occur in markedly different genomic and transcriptional contexts. Furthermore, cluster four is enriched for CDKN2A methylation and SETD2 mutations, suggesting an interaction between somatic mutation of SETD2andderegulated chromatin maintenance in this subtype. Finally, cluster membership was significantly associated with mutations in TP53, EGFR and STK11 (Supplementary Fig. 15, Supplementary Table 6).  Go to: Conclusions We assessed the mutation profiles, structural rearrangements, copy number alterations, DNA methylation, mRNA, miRNA and protein expression of 230 lung adenocarcinomas. In recent years, the treatment of lung adenocarcinoma has been advanced by the development of multiple therapies targeted against alterations in the RTK/RAS/RAF pathway. We nominate amplifications in MET and ERBB2 as well as mutations of NF1 and RIT1 as driver events specifically in otherwise oncogene-negative lung adenocarcinomas. This analysis increases the fraction of lung adenocarcinoma cases with somatic evidence of RTK/RAS/RAF activation from 62% to 76%. While all lung adenocarcinomas may activate this pathway by some mechanism, only a subset show tonic pathway activation at the protein level, suggesting both diversity between tumours with seemingly similar activating events and as yet undescribed mechanisms of pathway activation. Therefore, the current study expands the range of possible targetable alterations within the RTK/RAS/RAF pathway in general and suggests increased implementation of MET and ERBB2/HER2 inhibitors in particular. Our discovery of inactivating mutations of MGA further underscores the importance of the MYC pathway in lung adenocarcinoma.  This study further implicates both chromatin modifications and splicing alterations in lung adenocarcinoma through the integration of DNA, transcriptome and methylome analysis. We identified alternative splicing due to both splicing factor mutations in trans and mutation of splice sites in cis, the latter leading to activation of the MET gene by exon 14 skipping. Cluster analysis separated tumours based on single-gene driver events as well as large-scale aberrations, emphasizing lung adenocarcinoma’s molecular heterogeneity and combinatorial alterations, including the identification of coincident SETD2 mutations and CDKN2A methylation in a subset of CIMP-H tumours, providing evidence of a somatic event associated with a genome-wide methylation phenotype. These studies provide new knowledge by illuminating modes of genomic alteration, highlighting previously unappreciated altered genes, and enabling further refinement in sub-classification for the improved personalization of treatment for this deadly disease.  Class IA phosphoinositide 3-kinases (PI3Ks) transduce growth factor signalling by phosphorylating phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) to produce PtdIns(3,4,5)P3 on the plasma membrane. Recruitment to membrane receptors and enzyme activation are coordinated by engagement of the p85 SH2 domains to regions bearing phosphorylated ‘YXXM’ motifs on activated receptor tyrosine kinases (RTKs) or RTK-associated adaptors (Backer et al., 1992; Carpenter et al., 1993). PtdIns(3,4,5)P3 serves as docking sites for downstream signalling molecules that harbour pleckstrin homology domains. Central among these are PDK1 and PKB/AKT, which orchestrate signalling cascades promoting cell growth, proliferation, survival, metabolism and migration (Manning and Cantley, 2007; Franke, 2008; Bayascas, 2010). Cellular levels of PtdIns(3,4,5)P3 are tightly regulated. PTEN downregulates p110 signalling by removing the 3′-phosphate of PtdIns(3,4,5)P3 (Carracedo and Pandolfi, 2008). Upregulation of PI3K signalling, through amplification or gain-of-function mutations of RTKs, p110α and AKTs, as well as loss of PTEN function and expression, occurs frequently in human cancers (Yuan and Cantley, 2008; Chalhoub and Baker, 2009).  Uniquely among the four class I PI3K isoforms that produce PtdIns(3,4,5)P3, p110α has been identified with activating cancer-linked somatic mutations (Samuels et al., 2004). Over 80% of the missense mutations cluster in two ‘hotspots’ commonly represented by E545K in the helical domain and H1047R in the kinase domain. Both display transforming activities in cell culture (Zhao et al., 2005; Gymnopoulos et al., 2007). The ability to initiate tumourigenesis in transgenic mouse models has been demonstrated for the H1047R mutant (Engelman et al., 2008; Adams et al., 2011; Meyer et al., 2011).  Crystal structures of p110α/85α complexes have provided molecular details of p85-mediated inhibition (Huang et al., 2007; Mandelker et al., 2009), revealing that many activating mutations, including ones occurring at low frequencies (Ikenoue et al., 2005; Gymnopoulos et al., 2007; Oda et al., 2008; Zhang et al., 2008; Jaiswal et al., 2009; Rudd et al., 2011), are located in inter-domain contact sites. These sites include the inhibitory interfaces between the p110α C2/helical/kinase domains and the p85α N-terminal SH2 domain (nSH2; Miled et al., 2007; Mandelker et al., 2009), and between the p110α C2 domain and the p85α-inter-SH2 (iSH2) domain (Wu et al., 2009). Phosphopeptide binding to nSH2 competes with its inhibitory interaction with p110, constituting the dominant activation mechanism for p110α, and E545K mimics this activation (Yu et al., 1998; Miled et al., 2007; Mandelker et al., 2009). As p110α adaptor-binding domain (ABD) binds to p85α-iSH2 tightly, the often-mutated interface between adaptor-binding domain and the kinase domain can be viewed as an extension of the p85 inhibitory network. Mutations in the kinase C-terminal region do not appear to interfere with p85 inhibition, as p85α cSH2 does not have an inhibitory role in p110α regulation (Yu et al., 1998), although it does for p110β and p110δ via direct contact with this region (Burke et al., 2011; Zhang et al., 2011).  Some of the cancer-linked mutations confer a positive charge, such as C420R and H1047R in p110α, and have been suggested to enhance membrane binding (Gymnopoulos et al., 2007; Mandelker et al., 2009). However, direct membrane-binding measurements are lacking. A common assumption is that these mutations directly facilitate electrostatic interaction with phospholipid headgroups. However, this has limited applicability to other activating mutations, notably H1047L. The E545K and H1047R mutants were first reported to have similar biological activities, in terms of promoting cell growth and resisting apoptosis under growth factor limiting conditions (Samuels et al., 2005). More recent studies showed that they can have differential functional outcomes, in terms of chemotactic and metastatic phenotypes (Pang et al., 2009) and transforming potential (Chakrabarty et al., 2010) of isogenic human breast cancer cells. Transforming ability of chicken embryonic fibroblasts differs between the E545K and the H1047R mutants, invoking the suggestion that these two mutants operate via different activation mechanisms (Zhao and Vogt, 2008).  Previously, the E545K and H1047R mutants were found to be more active than the wild-type (WT) enzyme, but their similar affinities for ATP did not explain the differences in lipid kinase activities (Carson et al., 2008). Here, we investigated the premise that enhanced lipid binding forms a general mechanism for p110 activation, particularly regarding cancer mutations. We dissected the structural elements important for lipid binding. Our results show that p85α nSH2, a key regulatory element for p110α lipid kinase activity, controls access of the catalytic subunit lipid-binding sites to membrane. We examined a set of p110α/p85α cancer-linked mutants of diverse structural and chemical types, and find a strong correlation linking their elevated lipid kinase activities to their lipid-binding levels. We present a crystal structure of WT p110α/p85α-iSH2 in complex with an inhibitor. Its structural features in the kinase domain resemble those of the H1047R mutant (Mandelker et al., 2009), instead of the WT apo structure (Huang et al., 2007). We also noted unusual structural features of the kinase C-terminal tail and tested their function. We observe global conformational changes that might be of relevance to allosteric regulation of p110α, and provide a structural context to understand the functional data presented here.  Top of page Results Structure of a WT p110α/p85α-iSH2 complex A crystal structure of mouse WT p110α in complex with human p85α-niSH2 fragment and the p110β/p110δ-selective inhibitor PIK-108 has been determined and refined to 3.5 Å (Rwork/Rfree=0.184/0.228; acronyms of p110α and p85α domain structures and mutations are illustrated in Figure 1). Details of crystallographic statistics are provided in Supplementary Table S1. Although other compounds that inhibit p110α more specifically were surveyed for co-crystallization, the p110β/δ-selective PIK-108 produced the best crystals. As in the structure of human WT p110α/p85α-iSH2 (Huang et al., 2007), the nSH2 of the p85α-niSH2 fragment is not observed in the electron density map. The high salt concentration in the crystallization cocktail might have competed off nSH2 binding to p110α. As such, our structure represents an alternative view of p110α not constrained by nSH2 binding. Unlike previous structures of p110α/p85α complexes, our structure shows clear electron density for the entire activation loop (Figure 2a). However, key conserved activation loop residues, K942 and R949, previously identified to be important for p110γ recognizing the substrate PtdIns(4,5)P2 headgroup (Pirola et al., 2001), point away from the ATP-binding site (Figure 2d). Hence, although structure of a p110α/p85α-iSH2 complex should mimic an RTK-activated state (see below), the observed conformation of this loop does not appear to be compatible with positioning the lipid headgroup for phosphoryl transfer. The activation loop is also involved in crystal contacts (Supplementary Figure S1), which likely influenced the conformation that we observe. Figure 1. Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author Schematics of p110α and p85α domain structures. Substitution and deletion mutants used in this study are illustrated. Sequence alignment display was prepared with Jalview (Waterhouse et al., 2009). Basic residues in the activation loop (which binds the lipid substrate headgroup) and hydrophobic residues in the C-terminal tail are highlighted. ABD, adaptor-binding domain; RBD, Ras-binding domain.  Full figure and legend (158K)  Figure 2. Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author Structure of the kinase domain in WT p110α/p85α-iSH2 complexed with the inhibitor PIK-108. (a–c) Omit maps (contoured at 3.5 s). The σA-weighted Fo-Fc electron density maps were calculated separately with the activation loop and the C-terminal tail omitted from the refined model (a). PIK-108 binding sites in the ATP-binding pocket of the kinase domain (b) and a novel site in the kinase C-lobe (c). PIK-108-interacting residues (less than or equal to3.8 Å inter-atomic distances) are shown as stick models. (d) Functional elements in the kinase domain. (e) Kinase domain of p110γ catalytic core, shown for comparison with respect to secondary structure in the C-terminal tail. Note the interactions between the conserved W1086 in helix kα12 and the conserved catalytic residues DRH.  Full figure and legend (314K)  PIK-108 belongs to the class of propeller-shaped PI3K inhibitors. In our structure, the PIK-108 phenyl substituent occupies what has been coined the ‘specificity pocket’, which is gated by the P-loop M772, in the kinase ATP-binding site (Figure 2b). Opening of this pocket by propeller-shaped compounds appears to be more favourable in p110δ than in other p110 isotypes (Berndt et al., 2010). This could be the reason for the PIK-108 selectivity for p110β and p110δ. There is also complete density for what we interpret as a second PIK-108, snuggling in a hydrophobic pocket in the kinase C-lobe, surrounded by helices kα6–8, kα11 (hereafter all p110 secondary structure nomenclature is according to that of p110γ (Walker et al., 1999)) and the C-terminal end of the activation loop (Figure 2c). This pocket is partially occupied by the activation loop residues 954–956 (or their equivalents) in other p110 structures. The presence of the compound in this induced pocket may have contributed to the ordering of the activation loop, which is involved in crystal packing, and might explain why this crystal form is specific to PIK-108, out of 20 tested p110-selective inhibitors.  The kinase C-terminal region of p110α exhibits intrinsic flexibility Our structure is for the WT p110α, but the kinase C-terminal tail more closely resembles those in the structures of the oncogenic mutant H1047R p110α/p85α-niSH2 (Mandelker et al., 2009), than those in the WT apo p110α/p85α-iSH2 structure (Huang et al., 2007). In the WT apo p110α/p85α-iSH2 structure, helix kα11 is complete to residue 1048, and the rest of the C-terminal sequence is largely disordered (Huang et al., 2007). The kinase C-terminal tail in our structure adopts an extended conformation from residue 1045 to 1061, with the last helical turn of kα11 appearing to be distorted (Figure 2a). A striking feature in this region is the WIF motif (1057–1059), whose side chains stack against each other (Figure 2d). This motif is conserved as a triplet of hydrophobic residues in class I and class II PI3Ks, with W1057 being invariant in class I p110 (Figure 1). The equivalent ‘WFL’ (1086–1088) in p110γ is part of helix kα12 (Figure 2e), which corresponds to residues 1050–1061 in p110α. Helix kα12 also exists in the crystal structures of p110β and Vps34 (Miller et al., 2010; Zhang et al., 2011). This C-terminal region in our structure, and also in the H1047R p110α/p85α-niSH2 structures, is involved in crystal packing with the Ras-binding domain of a symmetry-related molecule (Supplementary Figure S1). Therefore, the conformations of the C-terminal tail among the current p110α structures appear to be dictated by the crystalline environments. It is likely fortuitous that the Ras-binding domain and the kinase domain pack against each other in different crystal forms of p110α. We would not ascribe any functional significance to these crystal contacts, particularly with regard to Ras activation. Deletion of helix kα12 in Vps34, p110β and p110δ abrogated lipid kinase activity and lipid binding (Miller et al., 2010; Burke et al., 2011; Zhang et al., 2011). This region is also of functional importance for p110α (see below). Deletion of kα12 in Vps34 and in p110β resulted in increased intrinsic ATPase activity in the absence of lipid substrate (Miller et al., 2010; Zhang et al., 2011), an observation replicated by deletion of residues 1051–1068 in p110α (Supplementary Figure S2, Δcterm mutant). Interactions between helix kα12 and the catalytic loop (illustrated for p110γ in Figure 2e) were suggested to shield the conserved catalytic DRH motif from performing futile ATP hydrolysis (Miller et al., 2010; Zhang et al., 2011). These interactions are not observed in the current p110α crystal structures, suggesting that in solution p110α could also have a helix kα12, similar to p110γ, p110β and Vps34. The extended conformations observed in current crystal structures of p110α suggest an intrinsic flexibility in this region.  Correlation of lipid kinase activity with lipid binding To test whether lipid binding forms the basis of p110 activation, we compared lipid kinase with lipid-binding activities for three sets of p110α/p85α complexes: SH2 deletions in p85α, engineered mutations in the p110α kinase domain and cancer-linked mutations in both p110α and p85α (Figure 3). We evaluated activation by RTK phosphopeptide for all complexes using the doubly tyrosine-phosphorylated peptide (pY2-peptide) derived from platelet-derived growth factor receptor-β (PDGFR-β). We used liposomes of defined compositions generally mimicking that of plasma membranes (Narayan and Lemmon, 2006). The substrate PtdIns(4,5)P2 was used at 2% (close to the physiological concentration), and the anionic lipid phosphatidylserine (PS) was tested at two concentrations, 10% and 20%. Cancer-linked mutations and nSH2 deletion in p85α severely suppressed expression of p110/p85 in insect cells. To obtain sufficient materials for lipid-binding analyses, we produced activating p110α/p85α proteins in the catalytically dead (CD) background, bearing the D915N mutation in the catalytic DRH motif of p110α. Figure 3. Figure 3 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author Lipid kinase and lipid-binding activities. (a–c) Structural views of the mutant positions in our WT p110α/p85α-iSH2 complex. A global view is shown in b, with Cα atoms of the mutated residues displayed as pink spheres. Detailed views of mutant positions at the C2 domain/iSH2 interface and the helical domain (a) and in the kinase C-lobe (c). (a) The C2 C420 contacts the iSH2 P568, and the iSH2 N564 contacts the C2 N345 (N345K is a cancer-linked mutant, not analysed in this study). (d) Schematics of the surface plasmon resonance (SPR) lipid-binding experiment. Liposome vesicles are captured via the lipophilic groups attached to the dextran matrix on the flow cells. (e) Example (C420R/nic + pY2-peptide) of a steady-state binding sensogram before (left) and after (right) signal subtraction from Fc1. (f, i) Lipid kinase activities. The initial rates of PtdIns(3,4,5)P3 production were measured with fixed substrate concentration (50 μm PtdIns(4,5)P2 and 100 μm ATP) using liposomes of the indicated compositions. No lipid kinase activity was detected for the lipid kinase-dead mutants, which were active in hydrolysing ATP in the absence of lipid substrate. (g, h, j) Lipid binding measured by SPR. Binding levels were compared at identical protein concentration in each set (g, j: 500 nm, h: 1 μm). Averaged binding levels of the lipid kinase-dead mutants on Fc1, ~35 RU, were taken as the estimated bulk contribution, that is, refractive index change due to the presence of proteins in the buffer (h). Data in f–j represent the mean±s.d. of two to three independent experiments. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PIP2, PtdIns(4,5)P2; PIP3, PtdIns(3,4,5)P3; pY2, pY2-peptide with two pYXXM motifs from platelet-derived growth factor receptor-β (PDGFR-β).  Full figure and legend (355K)  We employed surface plasmon resonance to measure lipid binding (schematics shown in Figures 3d and e). We examined the electrostatic and the hydrophobic components of lipid binding explicitly, as both are important properties for many membrane-binding proteins (Cho and Stahelin, 2005; Lemmon, 2008). We immobilized liposomes of different compositions in each of the four serially connected flow cells on the sensor chip. Flow cell one (Fc1) of the chip contained only neutral lipids phosphatidylcholine, phosphatidylethanolamine and cholesterol, whereas Fc2, Fc3 and Fc4 contained additionally negatively charged lipids PS (Fc2) or PS with PtdIns(4,5)P2 (Fc3 and Fc4). As such, Fc1-subtracted signals represent the electrostatic component of binding. We attribute any binding signals on Fc1 that are significantly above background (estimated as the averaged signal on Fc1 produced by the lipid kinase-dead mutants) to be the hydrophobic component of lipid binding.  p85α nSH2, but not cSH2, regulates both lipid kinase activity and membrane binding of p110α The nSH2 has a dominant role in regulating the lipid kinase activity of p110α. The basal activities of p110α/p85α-nicSH2 and p110α/p85α-niSH2 complexes are very low using liposome substrate mimicking physiological concentrations of PS and PtdIns(4,5)P2. Activation, whether by binding of RTK phosphopeptide to nSH2-containing complexes or by nSH2 deletion, increases the activity by 25- to 50-fold (Figure 3f). Qualitatively, our results recapitulate those of previous studies performed with pure PtdIns as substrate (Yu et al., 1998). Correspondingly, RTK phosphopeptide binding to nSH2-containing complexes induces lipid binding (Figure 3g). Binding of RTK phosphopeptide to cSH2 does not affect either the kinase activity or membrane binding (Figures 3f and g). Total negative charge on the liposomes positively influenced lipid binding. Liposome compositions differing by 10% in PS confer up to twofold increases in lipid-binding levels. Hence, it appears that for p110α, the nSH2-p110α inhibitory contact, which is relieved by phosphopeptide binding, suppresses the basal lipid kinase activity by inhibiting membrane binding. Both kinase activation loop and C-terminal tail are necessary for binding to anionic lipids Using PtdIns(4,5)P2-containing liposomes, no kinase activity could be detected for three engineered kinase domain mutants: (1) the activation loop mutant R949D, (2) the kinase helix kα12 deletion mutant (Δcterm) nor (3) a helix kα12 triple mutant with much reduced hydrophobicity (WIF-AAA(1057–1059)), with protein concentration as high as 500 nm and incubation time up to an hour. These mutants, however, are catalytically active in terms of intrinsic ATPase activity (Supplementary Figure S2). In lipid-binding experiments, correspondingly, the R949D mutant showed much reduced binding to anionic lipids (Figure 3h). The same result was observed for K942Q (data not shown). These results are consistent with the observation that mutations removing the positive charges of the equivalent residues in p110γ prevent PtdIns(4,5)P2, but not PtdIns or PtdIns4P, from acting as a substrate (Pirola et al., 2001). The kinase C-terminal mutants, Δcterm and WIF-AAA, did not show any detectable binding to anionic lipids at concentration up to 1 μm. This establishes the WIF motif as a key determinant for lipid binding in the C-terminal region. These results indicate that there are at least two lipid-binding sites in the kinase domain: one is in the polybasic activation loop, electrostatic in nature, and the other in the C-terminal region, hydrophobic in nature. Effects of cancer-linked mutations in p110α/p85α on lipid binding To gain a broader view of the effects of cancer-linked mutations, we studied seven mutations that have previously been characterized to be activating (Ikenoue et al., 2005; Gymnopoulos et al., 2007; Zhang et al., 2008; Jaiswal et al., 2009). They cover three structurally distinct regions (Figures 3a–c), namely, the C2–iSH2 interface (p110α C420R and p85α-N564D), the helical-nSH2 interface (p110α E545K) and the kinase domain (M1043I, H1047L, H1047R and G1049R), and represent different chemical property changes. Overall, there is a strong correlation between lipid kinase activity and lipid binding (Figures 3i and j, total lipid binding on Fc4 is shown in Supplementary Figure S3), underscoring enhanced lipid binding as a general mechanism for cancer-linked activating mutations. All mutants have increased basal activity, and other than E545K, can be significantly further activated by phosphopeptide binding. This affirms that the C2–iSH2 inhibitory contact site does not function identically to the nSH2 inhibitory site, which includes both C2 and helical domains in the crystal structure (Mandelker et al., 2009). The degree of activation is enhanced by increase in negative charges on the liposomes. Both anionic lipids PS and PtdIns(4,5)P2 enhance lipid binding.  There is a pattern correlating the location of the mutations with their hydrophobic component of lipid binding (Figure 3j): non-kinase domain mutants (C420R, E545K and p85α-N564D) display high levels of hydrophobic interaction with neutral lipids in the basal state, whereas the kinase C-terminal mutants require phosphopeptide activation to achieve the same level of hydrophobic binding. We will consider the two groups separately.  Despite their different chemical properties, the kinase domain mutants, H1047L, H1047R and G1049R, exhibit similarly high levels of hydrophobic binding to neutral lipids, and electrostatic binding to PS/PtdIns(4,5)P2-containing lipids upon phosphopeptide activation. These binding levels are a few folds higher than those of the activated WT enzyme. We have shown that the kinase helix kα12 constitutes a lipid-binding site. It is likely that helix kα11 and the kα11–kα12 ‘elbow’, on which these mutations reside, is an extension of the same site.  For non-kinase domain mutants, the nature of the effects of hydrophobicity is not immediately obvious. Disruption of the C2–iSH2 (C420R and p85α-N564D) or the C2/helical-nSH2 contacts (E545K) could expose hydrophobic regions in the C2 domain that are normally inaccessible to lipid binding. The iSH2 N564 forms polar contacts with the C2 N345, which is in the C2β1–β2 loop. The C2 C420, which is in the C2β5–β6 loop, forms van der Waals contacts with iSH2 P568 (Figure 3a). These two C2 loops in p110α are equivalent to the lipid-binding loops in the C2 domains of PKCα, which binds to PS (Guerrero-Valero et al., 2009), and of cPLA2, which binds to phosphatidylcholine (Perisic et al., 1999; Stahelin et al., 2003). Superposition of the PKCα C2 structure, which has a bound short acyl-chain PS molecule (PDB ID: 1dsy), onto the C2 domain of our p110α/p85α-iSH2 structure reveals that both N564D and C420R would be compatible with accessing phospholipid headgroups (Supplementary Figure S4a). This interpretation would account for the observed increase in electrostatic interaction with anionic lipids (Figure 3j).  Global conformational change in p110α accompanies nSH2 disengagement The p85α nSH2 does not contact the lipid-binding elements in the kinase C-lobe (Figure 4a) but appears to control their access to membrane (Figures 3f–j). This suggests the activation mechanism by nSH2 to be allosteric. By performing structural alignments on the iSH2 of p110α/p85α structures, we observe a global conformational difference between those lacking the inhibitory contacts with nSH2 (as represented by the WT p110α/p85α-iSH2 structures) and those with the nSH2 interactions (as represented by the H1047R p110α/p85α-niSH2 structures; Figures 4b and c). Viewing down the iSH2 coiled-coil axis from the nSH2 side, the p110α subunit rotates clockwise from the state with an ordered nSH2 to the state lacking the nSH2 (Figure 4c). The adaptor-binding domain and the C2, which are anchored on the iSH2, form the pivot points of the movement (Figure 4d). The movement appears to be transmitted from the helical domain to the Ras-binding domain and the kinase C-lobe, which exhibit the greatest degree of displacement (Figure 4d). This global conformational change suggests how nSH2 disengagement from p110α could allosterically cause local conformational change in the kinase C-lobe that might impact on activity. This is noteworthy considering that our WT p110α/p85α-iSH2/PIK-108 structure and the apo WT p110α/p85α-iSH2 structure experience very different crystal packing environments but superimpose well (Figure 4b). Figure 4. Figure 4 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author Global conformational change in p110α. (a) Spatial relationship between the nSH2 inhibitory contact site and the lipid-binding elements in the kinase C-lobe. (b, c) Pairwise superposition of the p110α/p85α structures was performed by aligning the main-chain atoms of p85α-iSH2 domain. Structures without p85α nSH2 represent the ‘activated’ form, the p110α/p85α-niSH2 structure represents the ‘inhibited’ form. The arrow indicates the direction of p110α domain movement around the p85α-iSH2 coiled-coil axis. (d) Representation of the r.m.s.d. calculated between main-chain atoms of the superposed p110α subunits shown in c, as projected on the coordinates of 2rd0. To assist domain recognition, the lower panel shows the enzyme in the same orientation but coloured by domains. ABD, adaptor-binding domain; RBD, Ras-binding domain.  Full figure and legend (365K)  Activation of all class IA PI3Ks by phosphopeptide increases lipid binding Activation of p110β/p85α-nicSH2 and p110δ/p85α-nicSH2 complexes by phosphopeptide also induces lipid binding (Figure 5a). This is in agreement with the recent report for p110δ in a complex with full-length p85α (Burke et al., 2011). The relative contributions of electrostatic and hydrophobic components of binding differ among the three p110 isoforms, probably reflecting their sequence variability in the key lipid-binding sites (Figure 1). In the primary sequences, the equivalent of H1047 in p110α is a Leu in p110β and p110δ. For PS/PtdIns(4,5)P2-containing liposomes, the total lipid-binding level of activated H1047L p110α is a few fold higher than those of activated p110β and p110δ (Figure 5b). These results indicate that there is more than this hotspot position that differentiates the lipid-binding capabilities among the three p110 isoforms. Figure 5. Figure 5 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author Lipid-binding activities of class IA PI3Ks. (a) Comparison of the three isoforms (protein concentration=1 μm). (b) Comparison of total lipid binding of the three isoforms with the p110α H1047L mutant (protein concentration=0.5 μm). The data represent the mean±s.d. of two independent experiments.  Full figure and legend (77K)  Top of page Discussion We have directly demonstrated that phosphopeptide-induced lipid binding underlies the activation mechanism for WT p110α/p85α. For most cancer-linked mutants of p110α/p85α, both basal and phosphopeptide-induced membrane binding is enhanced. For WT p110α, the primary lipid-binding sites reside in the kinase domain, comprising the polybasic activation loop and hydrophobic elements in the C-terminal tail. We have identified activating cancer-linked mutants in the kinase C-terminal tail (H1047L, H1047R and G1049R) as well as mutants affecting the C2–iSH2 interaction (C420R and p85α-N564D) that enhance intrinsic lipid binding. Our binding data and structural analysis support the dual roles of C420R and N564D in disrupting C2–iSH2 contact and enhancing lipid binding. It is likely that this occurs via direct interactions between the C2 and/or the iSH2 domains with membranes. This additional membrane-binding site could both enhance total lipid binding and influence the choice of the membrane used by the WT enzyme or by particular p110α/p85α mutants in a cellular context.  Our data indicate that the inhibitory contact formed between the nSH2 and p110α C2/helical/kinase domains suppresses the basal kinase activity by inhibiting membrane binding. This is consistent with previous biochemical results for enzyme activity (Yu et al., 1998), in that the p85α nSH2, but not the cSH2, has a principal role in regulating the activity of p110α. Mechanistically, we postulate that relieving the nSH2 inhibitory contact from p110α could result in a concerted conformational change propagating from the helical domain to the kinase C-lobe, as suggested by our structural comparison of activated and inhibited forms of p110α/p85α (Figure 4). This might trigger the activation loop and the C-terminal region to adopt lipid-binding competent conformations. The polybasic activation loop both facilitates long-range electrostatic attraction to anionic lipids and positions the PtdIns(4,5)P2 headgroup to the bound ATP for phosphoryl transfer. As the ATP-binding pocket is recessed in the kinase domain, partial membrane penetration by the C-terminal region would facilitate approach of the ATP γ-phosphate to the inositol ring of PtdIns(4,5)P2 (Figure 6).  Figure 6. Figure 6 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author Summary and modelling of membrane binding. The grey line approximates the putative membrane surface and is drawn collinear with the phosphate in the PS and PI in the Ins(1,4,5)P3 (IP3). Positions of PS, IP3 and ATP are derived from the following structures: 1dsy (Verdaguer et al., 1999), 1w2c (Gonzalez et al., 2004) and 1e8x (Walker et al., 1999). Details of how PS, IP3 and ATP were docked and modelling of the kinase C-terminal helices are illustrated in Supplementary Figure S4. The Cα atoms of the labelled residues are represented in spheres. For clarity, the kinase domain N-lobe is coloured red in the right panel only, and the helical domain is green on the left panel only. Type I activating cancer-linked mutations that are shown or predicted to relieve the p85α adaptor-binding domain-mediated inhibition are highlighted in orange (the mutations that we predict would be type I, but have not been tested are underlined). The type II mutants, which are RTK hyperactivatable, are highlighted in pink. Note that docking of PS is solely for the purpose of approximating the lipid-binding site in the p110α C2 domain, and does not imply that this domain binds PS specifically.  Full figure and legend (204K)  We have demonstrated that binding of activated p110/p85α to lipid membrane has both an electrostatic and a hydrophobic component. Basic residues in the activation loop contribute to the electrostatic component. The C-terminal tail is clearly important for membrane interaction, but its contribution is complex. Surface plasmon resonance measurements show that mutating the hydrophobic WIF motif to ‘AAA’ abolishes measurable electrostatic interactions with anionic lipids. Conversely, the activated H1047L, H1047R and G1049R mutants increase both hydrophobic and electrostatic interactions with lipids. These observations attest to the importance of cooperation between the electrostatic and the hydrophobic membrane-binding elements in p110α/p85α, as seen for other membrane-binding proteins (Cho and Stahelin, 2005). Our data also elucidate the influence of lipid composition on lipid kinase activities for both WT and mutant p110/p85 complexes (Mandelker et al., 2009).  Our structure reveals an alternative, small-molecule binding site in the kinase C-lobe. Current inhibitors for class I PI3K are all ATP-competitive compounds (Marone et al., 2008). This induced binding pocket might be exploited to develop a novel class of inhibitors that are not ATP competitive but could interfere with membrane binding. Although we could not detect any inhibition of lipid binding with PIK-108 (up to 50 μm for the CD_E545K mutant, assayed in the same manner described in Figures 3i and j, data not shown), it might be that compounds with enhanced affinity for this site could act as PI3K inhibitors. An example of a membrane-binding inhibitor that is in clinical trials is perifosine, an alkylphospholipid that targets the PH domain of AKT (Gills and Dennis, 2009).  It appears that the p110α and p85α mutations can be classified as two basic types: (1) those that relieve p85-mediated inhibition and (2) those that lead to additional lipid-binding capability (Figure 6). Type I mutations upregulate kinase activity by unmasking the intrinsic lipid-binding potential of WT p110α/p85α. These mutants have elevated basal activities, and binding of RTK phosphopeptides does not significantly enhance their activities beyond that of activated WT enzyme. We have shown that the hotspot mutant E545K belongs to this class, in accordance with previous work (Miled et al., 2007; Carson et al., 2008). Several other activating mutations that are distant from the putative membrane interface, such as R38C/H, R88Q, P539R, and deletion of residues 449–455 in the C2β7–β8 loop (Ikenoue et al., 2005; Oda et al., 2008; Rudd et al., 2011), could also belong to this class (Figure 6). Type II mutations are still subjected to p85α nSH2-mediated inhibition. We and others have shown that H1047R belongs to this type, which can be significantly activated by a phosphorylated RTK peptide (this study) or the adaptor protein IRS (Carson et al., 2008). Although basal activities of type II mutants are higher than that of WT enzyme, their maximal lipid-binding and kinase activities achieved by RTK phosphopeptide binding greatly exceed than those of the activated WT enzyme (three- to sevenfold with our experimental setup).  Our in vitro results imply that the biological outputs of the type II mutants can be greatly augmented by growth factor/RTK signalling. This notion is supported by reports that compared the E545K with H1047R mutants in cells. Human cancer cell lines bearing helical domain mutations showed lower AKT phosphorylation level and AKT-dependent signalling than cell lines bearing kinase domain mutations coupled with either HER2 amplification or epidermal growth factor receptor hyperactivation (Vasudevan et al., 2009). H1047R, but not E545K, was found to enhance HER2-mediated transformation of breast cancer cells via autocrine proliferative stimulation (Chakrabarty et al., 2010). Therefore, cancers with the type II mutations might be better treated by co-inhibition of p110α and RTKs, because these mutants strongly depend on RTK stimulation to reach a critical threshold of membrane binding/activity necessary for transformation. For E545K to achieve a similar level of transforming activity as H1047R in chicken embryonic fibroblasts, it required additionally Ras binding (Zhao and Vogt, 2008). It is likely that Ras could increase recruitment of p110α to lipid membrane. Cancers with type I mutations, such as E545K, might be better treated by co-inhibition of the p110α and the Ras pathway, because these mutants could be more dependent on ‘topping up’ by Ras to achieve the membrane binding threshold necessary for transformation. Type I and type II mutants could also confer distinct functional significance during different stages of cancer biology. For example, the E545K mutant was found to have a stronger metastatic phenotype than the H1047R mutant in tumour xenograft models using isogenic, human breast cancer cells (Pang et al., 2009). The ability to induce tumour formation thus far has been demonstrated only for the H1047R mutant, but not yet for the E545K mutant, in engineered mouse models of cancers (Engelman et al., 2008; Adams et al., 2011; Meyer et al., 2011).  Both growth factor independence and growth factor signalling manipulation are traits that enable cancer cells to sustain proliferative signalling (Witsch et al., 2010; Hanahan and Weinberg, 2011). Investigating the influence of upstream RTK signalling could elucidate the yet unclear roles of the different PI3K mutations in cancer initiation, progression and maintenance, and in identifying suitable biomarkers for cancer therapy targeting the PI3K pathway (Engelman, 2009).  Top of page Materials and methods Plasmids Details of expression constructs for p110α, p110β, p110δ (all mouse), p85α (mouse, except for the ‘ni’ fragment which is human) and Grp1-PH (human) are provided in Supplementary materials and methods. Domain boundaries of p85α fragments are shown in Figure 1. Protein expression and purification All p110/p85 complexes were co-expressed in Sf9 insect cells. The N-terminal His6 tag on p110α was kept for proteins used for crystallization but was cleaved off for those used for functional analyses. GST–Grp1-PH was expressed in Escherichia coli. Details of expression and purification are described in Supplementary materials and methods. Crystallization and structure determination The complex of His6-(TEV)-tagged mouse p110α with human p85α-niSH2 was co-crystallized with PIK-108. The crystals diffracted to 3.5 Å, and belong to the space group I222 with one heterodimer per asymmetric unit. The human apo WT p110α/p85α-iSH2 structure ((Huang et al., 2007), PDB ID: 2rd0) was used as the search model for molecular replacement. Details of crystallization and structure determination are described in Supplementary materials and methods. Crystallographic statistics are presented in Supplementary Table S1. All structural graphics were prepared with PyMOL (http://www.pymol.org). Lipid kinase activity assay Liposomes comprising phosphatidylcholine/phosphatidylethanolamine/PS/PtdIns(4,5)P2/cholesterol were in mol% ratios of either 38:25:20:2:15 or 38:35:10:2:15. PtdIns(3,4,5)P3 production was measured by a modified fluorescence polarization assay (Echelon Biosciences, Salt Lake City, UT, USA), originally developed for use with diC8-PtdIns(4,5)P2 as a substrate (Drees et al., 2003). Reactions were carried out at room temperature (25 °C) in 384-well microtitre plates. A 10-μl reaction consisted of 50 μm PtdIns(4,5)P2 in 2.5 mm liposomes, p110/p85 (500 nm for non-activated WT p110α/p85α-nicSH2, 5 nm for the rest), 100 μm ATP, 1 mm MgCl2 and with or without 1 μm pY2-peptide. The reactions were quenched with 5 μl buffer containing 20 mm Hepes (pH 7.5), 150 mm NaCl, 20 mm EDTA and 400 nm GST–Grp1-PH, followed by addition of 5 μl of 40 nm TAMRA-Ins(1,3,4,5)P4 in HNT buffer. The plates were read in a PHERAstar spectrofluorometer (BMG Labtech, Ortenberg, Germany) using the FP/540-20/590-20/590-20 optical module. Standard curves were performed with diC8-PtdIns(3,4,5)P3 with or without pY2-peptide. Only a minor difference due to presence of pY2-peptide was observed under our assay condition, which is different from that published previously (Carson et al., 2008). Surface plasmon resonance measurement of lipid binding Liposome-binding experiments were performed at 25 °C on a BIAcore2000, using the L1 sensor chip (GE Healthcare, Chalfont St Giles, UK). HNT was used as the running buffer. Liposomes comprising phosphatidylcholine/phosphatidylethanolamine/PS/PtdIns(4,5)P2/cholesterol were in mol% ratios of either 60:25:0:0:15 (Fc1), 50:25:10:0:15 (Fc2), 48:25:10:2:15 (Fc3) or 38:25:20:2:15 (Fc4). Liposomes (0.1–0.2 mm) were injected into each flow cell at 5 μl/min flow rate to achieve ~3400 RU immobilization level. This was followed by two injections of 0.2 m Na2CO3 to remove loosely bound liposomes. Chicken egg white albumin (0.2 mg/ml) was injected over the flow cells to mask any residual hydrophobic surface not covered by the liposomes, followed by multiple injections of 0.2 m Na2CO3 to stabilize the baseline. Steady-state binding was measured by injecting p110/p85 complexes (concentration at either 500 nm or 1 μm) at 2 μl/min flow rate for 5 min. Each measurement was followed by injections of 0.2 m Na2CO3 to regenerate the liposome surface. Independent experiments were carried out with freshly immobilized liposomes after stripping the sensor surface sequentially with 0.1 N NaOH, isopropanol:0.1 N NaOH (2:3) and 6 m guanidine HCl. The phosphoinositide 3-kinase (PI3K) signaling pathway is one of the most frequently mutated pathways in cancer. One common and direct mechanism by which the PI3K pathway is activated in breast, endometrial, colorectal, urinary tract, thyroid, and ovarian cancer is through gain-of-function mutations in PIK3CA (1–3). PIK3CA mutations are particularly important in human breast cancer, with activated alleles detected in 25% to 30% of tumors (4–7). These mutations have been found in ductal carcinoma in situ, suggesting that they play a role in breast tumor initiation (8–10). In addition, they are present at high frequency in estrogen receptor α (ERα)-positive, Her2/Neu+ and triple-negative breast tumors (TNT), suggesting an important role for mutant PIK3CA in etiology of multiple breast tumor subtypes (4). Metaplastic breast cancers have the highest percentage of PIK3CA mutations (11). Importantly, PIK3CA mutations can induce p53-dependent growth inhibition (12) and mutations in both genes occur together in some human breast tumors (13, 14).  PIK3CA point mutations occur most often within 2 hotspots: the helix and kinase domains (1). H1047R mutations in the kinase domain account for approximately 40% of breast cancer PIK3CA mutant alleles (4). This mutant shows elevated kinase activity (15–17) and is capable of transforming cells in culture (18), including mammary epithelial cells (19, 20). Despite the high frequency, and hence importance of this allele in breast cancer, there is no animal model to test for its role in transformation of mammary epithelium. Here, we describe generation of a Cre-mediated system to conditionally express Pik3ca alleles in mouse tissues, and use of this system to test for induction of mammary tumor formation by Pik3caH1047R. We report that ectopic expression of Pik3caH1047R, but not Pik3cawt, induced mammary tumors at high frequency. Furthermore, we have used the knock-in system to test for cooperation between Pik3ca and p53 (3), showing that deletion of p53 enhances tumor formation and alters the spectrum of mammary tumor subtypes that form in our Pik3caH1047R model.  Materials and Methods  Generation of transgenic mice  Shuttle vectors containing either wild-type or H1047R mutant Pik3ca were subcloned into the pROSA26PA gene-targeting vector (21, 22). pR26-Pik3ca plasmids were linearized with KpnI (Fig. 1) and electroporated into mouse embryonic stem cells (mESC). G418-resistant clones were isolated, expanded, and screened by Southern blot (probing for the 3′ recombination junction—see following text) and PCR [amplifying across the 5′ recombination junction, forward primer (FP) 5′-CGCCTAAAGAAGAGGCTGTG-3′, reverse primer (RP) 5′-GAAAGACCGCGAAGAGTTTG-3′]. Targeted clones were transiently transfected (Fugene6, Roche 11815091001) with Cre or control vector (pCAGGS-Cre-IRES-puro; pCAGGS-FlpE-IRES-puro; ref. 23). RNA was harvested (RNeasy, Qiagen 74104) and RT-PCR performed (SuperScript II, Invitrogen 18064022) by using FP in R26 exon 1 (5′-CTAGGTAGGGGATCGGGACTCT-3′) and a RP in Pik3ca cDNA (5′-AATTTCTCGATTGAGGATCTTTTCT-3′). Cre-inducible mESC lines were used for morula aggregation in the Toronto Centre for Phenogenomics (TCP).  Figure 1. Download figureOpen in new tabDownload powerpoint Figure 1. R26-Pik3caH1047R;MMTV-Cre mice develop tumors in the mammary gland, skin, and lymphocytic tissue. A, conditional knock-in mice were generated by recombining mouse Pik3ca cDNAs (preceded by a loxP-flanked transcriptional stop cassette) into the R26 locus (22). B, lin− mammary epithelium from R26-Pik3ca;MMTV-Cre mice expressed their respective transgene, whereas cells from Cre− littermates did not. C, Kaplan–Meier survival curves for R26-Pik3caH1047R;MMTV-Cre female mice. D, cause of death data for R26-Pik3caH1047R;MMTV-CrelineA (left) and R26-Pik3caH1047R;MMTV-CreNLST (right) mice. “Other” includes mice that died without obvious tumors (e.g., with dystocia) or mice that could not be examined because of decomposition. MGT, mammary gland tumors; L/T, lymphoma/thymoma; ST, skin tumors. Southern blot analysis  A standard Southern blot protocol was used. Genomic DNA (10 μg) was digested with EcoRV/SstI. An approximately 940 bp probe on the 3′ side of the targeted insertion site (CTTGAAAGTGGAGTAACTAC to TCAGAAGCTTTGAACTAGAA in the R26 locus) was 32P-labeled, using the Random Primers DNA Labeling System (Invitrogen 18187013). This probe binds an 11 kb fragment in nontargeted R26, and a 9 kb fragment if the R26 locus is correctly targeted.  Mouse colony maintenance  Mice were housed at TCP according to guidelines from the Canadian Council on Animal Care (CCAC). Cre strains were genotyped by using FP 5′-TCGCGATTATCTTCTATATCTTCAG-3′, RP 5′-GCTCGACCAGTTTAGTTACCC-3′. R26-Pik3ca mice were genotyped by using primers previously published (22). Multiparous females had 3 litters. p53loxP/+ conditional mutant mice (FVB.129-Trp53tm1Brn–MMHCC 01XC2; for simplicity, this strain is labeled throughout as p53f/+; ref. 24) were obtained from the Mouse Models of Human Cancer Consortium and genotyped by PCR (FP 5′-CACAAAAACAGGTTAAACCCAG-′, RP 5′-AGCACATAGGAGGCAGAGAC-3′). p53 deletion was confirmed by using FP 5′-CACAAAAACAGGTTAAACCCAG-3′, RP 5′-GAAGACAGAAAAGGGGAGGG-3′ to amplify a 612 bp fragment (24).  RT-PCR on lin− mammary epithelium  Mammary glands from young virgin mice were minced and digested in collagenase/hyaluronidase (Stem Cell Technologies 07912) for 4 hours (37°C). Mammary epithelial (lineage-depleted; lin−) cells were isolated by using the EasySep kit (StemCell Technologies 19757). RT-PCR was performed as outlined earlier in the text.  Tumor collection  Mice were humanely sacrificed at endpoint, and mammary tumors dissected. Humane endpoint was based on criteria outlined by the CCAC (tumor volume = 1.7 cm3, tumor mass = 5% of body weight, or ulcerated tumor). Part of each tumor was fixed in 10% formalin and embedded in paraffin. The remaining tumor was divided into small samples and snap frozen.  Western blots  Tumors and control glands were lysed by using a TissueRuptor homogenizer (Qiagen 9001271) in lysis buffer (ProteoJET Lysis Reagent, Fermentas K0301; PhosSTOP, Roche 04906837001; protease inhibitor, Roche 11836170001). Protein lysates (150 μg) were analyzed using a standard Western blot protocol. Primary antibodies were incubated overnight and secondary antibodies for 1 hour, both at room temperature. Western blots were quantified using AlphaImager software (Cell Biosciences) and normalized with respect to β-actin expression. Antibodies (used at recommended dilutions) are as follows: AktpT308 (Cell Signaling CS2965), AktpS473 (Cell Signaling CS927), PTEN (Cell Signaling CS9559), c-JunpS73 (Cell Signaling CS3270), SGK3pS486 (SantaCruz sc33044), ERα (SantaCruz sc71064), Atf3 (SantaCruz sc188), β-catenin (BDTL 610154), carbonic anhydrase IX (CAIX; R&D Systems AF2344), β-actin (abCam ab8226), goat anti-rabbit IgG-HRP (SantaCruz sc2004), goat anti-mouse IgG-HRP (SantaCruz sc2005), donkey anti-goat IgG-HRP (SantaCruz sc2020).  Histology and immunohistochemistry  Five-micrometer paraffin sections were either stained with hematoxylin and eosin, or subjected to antigen retrieval in a decloaking chamber (Biocare Medical; SetPoint1 = 125°C, 5 minutes; SetPoint2 = 90°C, 10 seconds), using epitope-retrieval solution (Biocare Medical BD1000G1 or RV1000G1). Slides were mounted into a Tecan FreedomEvo liquid-handling robot.  Immunohistochemistry: endogenous peroxidases were quenched in 3% H2O2/methanol (15 minutes, room temperature), then VectaStain ABC kits (Vector Laboratories) were used (PK-6101, PK-4002, PK-6105). Antibodies were incubated for 30 minutes at room temperature. 3,3′-Diaminobenzidine (DAB) substrate kit (Vector Laboratories SK-4100) was used for staining and slides were counterstained in hematoxylin (10 seconds).  Immunofluorescence: slides were blocked for 30 minutes (DakoCytomation X0909). Primary antibodies were incubated overnight (4°C), secondary antibodies were incubated for 1 hour (room temperature). Slides were mounted with fluorescence mounting medium (DakoCytomation S3023) containing 4′,6-diamidino-2-phenylindole (DAPI).  Antibodies (used at recommended dilutions) are as follows: Gata3 (ProteinTech 10417–1-AP), Cytokeratin 5 (Covance PRB-160P), ERα (SantaCruz sc542), Ki67 (BioCare Medical CRM326), Cytokeratin 8 (Fitzgerald 10R-C177AX), Cytokeratin 14 (Panomics E2624), Cytokeratin 10 (Covance PRB-159P), vimentin (Vim; SantaCruz sc32322), desmin (Des; DakoCytomation M0760), N-cadherin (N-Cad; Novus NB200–592), AlexaFluor488 anti-mouse (Invitrogen A21202), AlexaFluor594 anti-rabbit (Invitrogen A21442).  TUNEL  Five-micrometer paraffin sections were immersed in 2.5 μg/mL proteinaseK (2 minutes). Endogenous peroxidases were quenched via 3% H2O2 (15 minutes). Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) was performed by using terminal deoxynucleotidyl transferase (Fermentas EP0161) and biotin-16-UTP (Roche 11093070910). Signal was amplified (ABC, Vector Laboratories PK-6100) and developed (DAB Kit, Vector Laboratories SK-4100); sections were counterstained with methyl green.  Image capture  Images were captured with an AxioCam HRm digital camera (Zeiss) by using AxioVision (release 4.6.3) software.  Results  Generation of a Cre-inducible Pik3ca mammary tumor model  To test for the ability of Pik3caH1047R or wild-type Pik3ca (Pik3cawt) to induce mammary tumors, we used the Cre-conditional ROSA26 (R26) knock-in system, whereby Cre-mediated deletion of loxP-flanked transcriptional stop sequences allows for tissue-specific expression of either allele (Fig. 1A; refs.21, 22). mESC were targeted and screened to identify clones with Cre-inducible transgene expression (Supplementary Fig. 1). Cre-responsive mESC clones were then used to generate chimeric mice, and germline transmission of each knock-in allele confirmed. R26-Pik3caH1047R and R26-Pik3cawt mice were mated with MMTV-Cre mice, which express Cre-recombinase in mammary epithelium. Two different strains of MMTV-Cre were used: MMTV-CrelineA, which expresses Cre recombinase in mammary epithelium at high efficiency and also in skin and lymphocytes (25); MMTV-CreNLST, which is less efficient but more mammary restricted in its expression (Supplementary Fig. 2; refs. 26, 27). Mammary-inducible transgene expression was observed in R26-Pik3ca;MMTV-Cre mice but not in Cre-negative littermates (Fig. 1B).  Female R26-Pik3caH1047R;MMTV-Cre mice from both Cre lines showed reduced survival (Fig. 1C; Supplementary Table 1; note, males were not studied). Some animals died abruptly, whereas most were sacrificed at humane endpoint due to lethargy and impaired breathing or solid tumor growth. Decreased survival was not because of Pik3ca overexpression as R26-Pik3cawt;MMTV-Cre mice remained healthy (Fig. 1C). R26-Pik3caH1047R;MMTV-Cre mice started developing mammary tumors at 5 months of age. Mammary tumors were observed in both virgin and multiparous mice using either MMTV-Cre strain. R26-Pik3caH1047R;MMTV-CrelineA mice reached endpoint more rapidly than R26-Pik3caH1047R;MMTV-CreNLST mice (Fig. 1C). In addition, R26-Pik3caH1047R;MMTV-CrelineA mice reached endpoint with a more diverse set of tumor types. 69% of NLST mice and 42% of line A mice and had palpable mammary tumors at endpoint (Fig. 1D). For this reason, we used MMTV-CreNLST transgenics for subsequent studies. Development of lymphoma/thymoma, skin, and other nonmammary tumors was attributed to Cre expression in other tissues (25). Interestingly, survival of R26-Pik3caH1047R mice, without Cre, was reduced in comparison with MMTV-Cre controls (Fig. 1C; Supplementary Table 1; P < 1×10−6). This was due to development of blood vessel lesions in some R26-Pik3caH1047R animals (data not shown), potentially through spontaneous activation of Pik3caH1047R expression in endothelial cells (28).  Pik3ca and p53 mutations cooperate in vivo  To test for cooperation between Pik3ca and p53, we mated R26-Pik3caH1047R;MMTV-CreNLST mice with Cre-conditional p53 mutants (24). Most R26-Pik3caH1047R;p53f/f;MMTV-CreNLST mice died early with lymphoma/thymoma (Fig. 2A). On autopsy, some had small mammary tumors (Fig. 2C, left). Lymphoma/thymoma occurred at a much lower rate in R26-Pik3caH1047R;p53f/+;MMTV-CreNLST p53 heterozygous mice, which also showed significantly reduced survival as compared with R26-Pik3caH1047R;MMTV-CreNLST, p53f/+;MMTV-CreNLST, and Cre-negative control mice (Fig. 2A; Supplementary Table 2). To test whether Pik3ca and p53 show an additive or synergistic interaction, we simulated a Kaplan–Meier survival curve by combining single-mutant cohorts, such that as any R26-Pik3caH1047R;MMTV-CreNLST or p53f/+;MMTV-CreNLST mouse reached endpoint, it was scored as an event within one cohort. R26-Pik3caH1047R;p53f/+;MMTV-CreNLST double-mutant mice showed significantly decreased survival (P = 2.79×10−5) compared with this hypothetical cohort indicating synergy between Pik3caH1047R and p53 gene loss. Synergistic interaction was also evident when considering only mice that reached endpoint from mammary tumors (Supplementary Fig. 3). p53 deletion was observed in R26-Pik3caH1047R;p53f/+;MMTV-CreNLST and p53f/+;MMTV-CreNLST tumors (Fig. 2B). Ninety-two percent of p53f/+;MMTV-CreNLST and 80% of R26-Pik3caH1047R;p53f/+;MMTV-CreNLST mice had mammary tumors (Fig. 2C). Many mice had mammary tumors in more than one gland. These were treated as distinct lesions.  Histologic analysis revealed that mammary tumors from R26-Pik3caH1047R;MMTV-CreNLST mice were typically either adenosquamous carcinoma or adenomyoepithioma (Fig. 3A; Supplementary Fig. 4). Adenosquamous tumors contained cystic regions composed of laminar keratin lined with squamous epithelium and adjacent glandular elements. Some tumors had squamous nodules or necrosis, and several had invasive margins. Expansile tumors were also observed. Adenomyoepitheliomas contained a mixture of glandular epithelium and interstitial fusiform cells with abundant polar cytoplasm. These myoepithelial stromal cells represented 10% to 80% of the tumor. Isolated lung metastasis were observed in rare R26-Pik3caH1047R;MMTV-CreNLST mice (data not shown). Mammary tumors from p53f/+;MMTV-CreNLST mice were either spindle/epithelial-mesenchymal transition (EMT) type or poorly differentiated adenocarcinoma as previously reported (Fig. 3B; Supplementary Fig. 4; refs. 29–31). Spindle tumor cells had fusiform nuclei and polar cytoplasm. Swirling patterns and necrotic areas were observed. Poorly differentiated adenocarcinomas were composed of solid sheets of cells with little tissue architecture and some necrosis. Cells had large, pleomorphic nuclei and dark staining cytoplasm. Interestingly, mammary tumors that formed in R26-Pik3caH1047R;p53f/+;MMTV-CreNLST double-mutant mice were typically either spindle/EMT or adenosquamous carcinoma (Fig. 3C; Supplementary Fig. 4). Radial scar and poorly differentiated adenocarcinomas were also observed, although at a lower frequency (Fig. 3C; Supplementary Fig. 4). Radial scar tumors were small and had a stellate outline composed of dense connective tissue and a center with distorted neoplastic glands. Gross metastasic lesions were not observed in R26-Pik3caH1047R;p53f/+;MMTV-CreNLST mice (data not shown).  Figure 2. Download figureOpen in new tabDownload powerpoint Figure 2. Pik3caH1047R and p53 deletion show cooperation in mice. A, Kaplan–Meier survival curves. B, p53 deletion in tumor DNA was confirmed via PCR (diagnostic 612bp fragment). C, cause of death data for R26-Pik3caH1047R;p53f/f;MMTV-CreNLST (left), p53f/+;MMTV-CreNLST (middle), and R26-Pik3caH1047R;p53f/+;MMTV-CreNLST (right) mice. Figure 3. Download figureOpen in new tabDownload powerpoint Figure 3. Mammary tumor pathology in R26-Pik3caH1047R;p53f;MMTV-CreNLST mice. A, mammary tumors in R26-Pik3caH1047R;MMTV-CreNLST mice are mostly adenomyoepitheliomas (AME; left) or adenosquamous carcinomas (ASC; middle). B, p53f/+;MMTV-CreNLST mice develop mammary spindle cell tumors (left) or poorly differentiated adenocarcinomas (PDA; middle). C, R26-Pik3caH1047R;p53f/+;MMTV-CreNLST mice develop mostly spindle cell tumors (left) or ASCs (middle). Some developed radial scar (RS) or PDAs (right). Scale bars, 50 μm. Akt activation in Pik3caH1047R and p53 mutant mammary tumors  To test for PI3K pathway activation, lysates from representative tumors were analyzed for Akt phosphorylation, and for expression of PTEN and phospho-c-Jun (S73). Western blot signals were normalized to β-actin protein expression, and compared with levels in mammary lysates from a non–tumor-bearing 74-week-old R26-Pik3caH1047R virgin female. Adenosquamous carcinomas from R26-Pik3caH1047R;MMTV-CreNLST mice showed elevated accumulation of phospho-AktS473, PTEN, and phospho-c-JunS73 (Fig. 4). Adenosquamous carcinomas from R26-Pik3caH1047R;p53f/+;MMTV-CreNLST showed increased PTEN and phospho-c-JunS73 expression. Surprisingly, however, no change in phospho-Akt was observed in these tumors. The reason for this is not clear, perhaps representing a change in PI3K signaling such as a reduced dependence on Akt activation (32). Alternatively, the wild-type sample used for normalization in this experiment was whole mammary gland lysate. This tissue contains a large amount of insulin-responsive fat, and may show higher basal levels of Akt activation than mammary epithelium. We therefore tested additional adenosquamous tumors from R26-Pik3caH1047R;MMTV-Cre mice for phospho-Akt and used lin− mammary epithelium as control. Indeed, phospho-AktT308 and phospho-AktS473 were significantly elevated in 12 adenosquamous carcinomas from R26-Pik3caH1047R;MMTV-Cre mice (Supplementary Fig. 5).  Figure 4. Download figureOpen in new tabDownload powerpoint Figure 4. Akt activation in mammary tumors from Pik3caH1047R model mice. A, Western blot analysis of PI3K-pathway components and phospho-c-Jun. B, Western blot signals were quantified and normalized with respect to β-actin. Mean fold increase compared with mammary lysate from a control mouse was calculated after normalization. Bars, group mean values; error bars, ±SE; asterisks, significant increase in expression (1-sided 1-sample t test; α = 0.05; *, P < 0.05 and **, P < 0.1). Yellow dashed line, protein expression in a normal mammary gland. Elevated levels of phospho-AktT308 and phospho-AktS473 were observed in lysates from adenomyoepithelioma lesions in R26-Pik3caH1047R;MMTV-CreNLST mice and in lysates from R26-Pik3caH1047R;p53f/+;MMTV-CreNLST spindle/EMT tumors. Interestingly, elevated levels of phospho-AktT308 and phospho-AktS473 were also seen in lysates from spindle/EMT and in poorly differentiated adenocarcinomas from p53f/+;MMTV-CreNLST mice. Elevated levels of PTEN expression and of phospho-c-Jun accumulation were observed in each mammary tumor type studied. In the case of PTEN, this is likely a result of PI3K pathway–induced phosphorylation and stabilization of PTEN, a negative feedback loop which functions to decrease PIP3 levels (33). Also, increased phospho-c-Jun is associated with elevated PI3K pathway activation (34). Finally, it has been suggested that activation of other PDK1 substrate kinases, such as SGK3, may play an important role downstream of PIK3CA gene mutation in breast cancer (32). We therefore analyzed SGK3 phosphorylation in these tumors. Phospho-SGK3S486 was not elevated in any of the tumor types analyzed (Supplementary Fig. 6).  Pik3caH1047R mice form multiple mammary tumor subtypes  PIK3CA gene mutations are found in ERα-positive, HER2/Neu-positive, and TNT cancers (4–7). To further define mammary tumor subtype in our Pik3ca model, we stained representative tumors for expression of luminal and basal cell cytokeratin, cytokeratin 8 (K8) and cytokeratin 14 (K14), respectively (Fig. 5; Supplementary Fig. 7). Glandular regions of R26-Pik3caH1047R;MMTV-CreNLST adenosquamous carcinomas contained cells expressing either cytokeratin. Mammary architecture was maintained in glandular regions, in that K14+ cells surrounded layers of K8+ cells (Fig. 5A, middle). K8+ cells in these regions also expressed Gata3, albeit at a level lower than in adjacent normal glands (data not shown; ref. 35). The glandular epithelium in R26-Pik3caH1047R;MMTV-CreNLST adenomyoepitheliomas also stained positive for both cytokeratin (Fig. 5A, right). K14+ expression was noted in interstitial fusiform cells surrounding glandular type structures (data not shown). Spindle tumors from p53f/+;MMTV-CreNLST mice had few K8- or K14-positive cells (Fig. 5B, left). In contrast, cells in poorly differentiated adenocarcinomas from p53f/+;MMTV-CreNLST mice were mostly either K14+ (Fig. 5B, middle) or K8+ (Fig. 5B, right). Some double-negative regions and regions with double-positive cells were also observed (data not shown). Adenosquamous carcinomas from R26-Pik3caH1047R;MMTV-CreNLST and R26-Pik3caH1047R;p53f/+;MMTV-CreNLST mice showed the same staining pattern (Fig. 5C, left). Similarly, K14 and K8 staining in spindle/EMT (Fig. 5C, middle) and poorly differentiated adenocarcinomas (Fig. 5C, right) from R26-Pik3caH1047R;p53f/+;MMTV-CreNLST and p53f/+;MMTV-CreNLST mice was indistinguishable (note, right panel of Fig. 5C shows a tumor region with many K14+/K8+ double-positive cells; such regions were also frequently observed in poorly differentiated adenocarcinomas from p53f/+;MMTV-CreNLST mice as described earlier). K5 immunostaining closely matched with that observed for K14 in each case (data not shown).  Figure 5. Download figureOpen in new tabDownload powerpoint Figure 5. Expression of luminal and basal differentiation markers and ERα in Pik3caH1047R model mammary tumors. A, normal mammary ducts (left) express K14 and K8. Glandular regions of ASC (middle) or AME (right) from R26-Pik3caH1047R;MMTV-CreNLST mice. B, spindle cell tumor (left) and PDA (middle right) from p53f/+;MMTV-CreNLST mice. C, glandular region of ASC (left), spindle cell tumor (middle), and PDA (right) from R26-Pik3caH1047R;p53f/+;MMTV-CreNLST mice. D, immunohistochemistry for ERα in R26-Pik3caH1047R;MMTV-CreNLST ASCs (top left, top middle) and AMEs (top right) compared with normal mammary epithelium (inset). Western blot analysis for ERα (bottom left). Western signals were quantified as described earlier (bottom right). Bars, sample mean; error bars: ±SE; asterisks, significant increase (1-sided 1-sample t test; α = 0.05; *, P < 0.05 and **, P < 0.1). White scale bars, 40 μm; black scale bars, 20 μm. Yellow dashed line, protein expression in a normal mammary gland. ERα expression was noted in R26-Pik3caH1047R;MMTV-CreNLST (Fig. 5D) and R26-Pik3caH1047R;p53f/+;MMTV-CreNLST (data not shown) adenosquamous carcinomas, although nuclear staining appeared reduced in most tumor cells as compared with that observed in normal ducts (Fig. 5D, inset). R26-Pik3caH1047R;MMTV-CreNLST adenomyoepitheliomas also contained nuclear ERα+ cells (Fig. 5D, right). In contrast, less signal was observed in other tumor types. To better quantify ERα expression, Western blot analysis was performed on tumor lysates (Fig. 5D, bottom). Adenosquamous carcinomas (from R26-Pik3caH1047R;MMTV-CreNLST and R26-Pik3caH1047R;p53f/+;MMTV-CreNLST) as well as adenomyoepitheliomas from R26-Pik3caH1047R;MMTV-CreNLST mice expressed similar levels of ERα as in the control gland. In contrast, ERα expression was decreased in p53f/+;MMTV-CreNLST poorly differentiated carcinomas, R26-Pik3caH1047R;p53f/+;MMTV-CreNLST spindle/EMT tumors and trended toward decreased expression in p53f/+;MMTV-CreNLST spindle/EMT tumors (Fig. 5D).  Next, we stained for the EMT marker N-Cad and, in some tumors, for Des or Vim (Fig. 6; Supplementary Fig. 8; refs. 27, 36, 37). R26-Pik3caH1047R;MMTV-CreNLST adenosquamous carcinomas had scattered N-Cad+ cells and Vim+ cells in squamous regions (Fig. 6A). R26-Pik3caH1047R;MMTV-CreNLST adenomyoepitheliomas had many N-Cad+ cells and some Des+ cells in nonglandular regions (Fig. 6B). In contrast, N-Cad+ cells were observed throughout spindle/EMT tumors from p53f/+;MMTV-CreNLST and R26-Pik3caH1047R;p53f/+;MMTV-CreNLST mice (Fig. 6C, left). Both also had rare Des+ cells. Adenosquamous carcinomas from R26-Pik3caH1047R;p53f/+;MMTV-CreNLST animals had some N-Cad+, but no Des+ cells. Finally, poorly differentiated adenocarcinomas from p53f/+;MMTV-CreNLST mice showed no evidence of EMT. Adenosquamous carcinomas from R26-Pik3caH1047R;MMTV-CreNLST single or Pik3caH1047R;p53f/+;MMTV-CreNLST double-mutant mice also contained cells expressing a marker of differentiated squamous epithelium, cytokeratin 10 (K10). K10+ cells were typically found lining keratinized cysts (Fig. 6C, right; Supplementary Fig. 8). Atf3 has been implicated in squamous cell carcinoma (38) and accumulated to widely variable levels in our mammary tumors. For example, some R26-Pik3caH1047R;MMTV-CreNLST tumors (adenosquamous carcinomas and adenomyoepitheliomas) and some p53f/+;MMTV-CreNLST poorly differentiated carcinomas expressed Atf3. Expression was not observed in other tumor types (Supplementary Fig. 9). Mammary tumors of all genotypes appeared less bloody than MMTV-Wnt1 control tumors. This was typically associated with less vasculature and, in most cases, with elevated expression of carbonic anhydrase CAIX, an indirect marker of hypoxia (Supplementary Fig. 9; ref. 39). Interestingly, elevated β-catenin levels, comparable with levels in MMTV-Wnt1 tumors, were observed in both major tumor types from R26-Pik3caH1047R;MMTV-CreNLST mice and in poorly differentiated adenocarcinomas in p53f/+;MMTV-CreNLST mice, suggesting that Wnt signaling may be activated in each case (Supplementary Fig. 9).  Figure 6. Download figureOpen in new tabDownload powerpoint Figure 6. EMT in mammary tumors from Pik3caH1047R model mice. A, R26-Pik3caH1047R;MMTV-CreNLST adenosquamous carcinomas express N-Cad (left) and Vim (right). B, R26-Pik3caH1047R;MMTV-CreNLST adenomyoepitheliomas express N-Cad (left) and Des (right). C, spindle tumors express N-Cad (left); adenosquamous carcinomas express K10 (right). Scale bars, 40 μm. To quantify cell proliferation and apoptosis in each tumor type, we performed Ki67 immunohistochemistry and TUNEL analysis, respectively (Table 1; Supplementary Table 3). Each tumor type examined had very low levels of TUNEL-positive nuclei (<1% in all cases). This result is not surprising given that PI3K pathway activation and p53 gene deletion are both associated with enhanced cell survival. In contrast, the percentage of Ki67-positive nuclei varied with genotype and tumor type. Mammary tumors from R26-Pik3caH1047R;MMTV-CreNLST mice had the highest proportion of Ki67-positive nuclei, whereas p53f/+;MMTV-CreNLST tumors had the lowest. In tumor type analysis, adenosquamous carcinomas had the highest Ki67 index whereas poorly differentiated carcinomas had the lowest.  View inlineView popup Table 1. Ki67 and TUNEL data for R26-Pik3caH1047R;p53f;MMTV-CreNLST mouse mammary tumors Discussion  PIK3CA is commonly mutated in human breast cancer. The PIK3CA locus is also amplified in some breast cancers (6, 40, 41). To test for initiation of mammary tumor formation by PIK3CA alleles we generated syngeneic R26-Pik3caH1047R and R26-Pik3cawt knock-in mice. Each strain carried a Cre-inducible allele of mouse Pik3ca, and each was crossed to MMTV-Cre mice to activate expression within mammary epithelium. Starting at 5 months, R26-Pik3caH1047R;MMTV-Cre females developed mammary tumors at a high frequency. Importantly, R26-Pik3cawt;MMTV-Cre mice did not. Thus, low-level ectopic expression of p110αH1047R, but not p110αwt, is sufficient to initiate mammary tumor formation in mice. This result is consistent with identification of H1047R mutations in premalignant lesions (8–10). We did not observe any gross abnormalities in glands of young R26-Pik3caH1047R;MMTV-CreNLST mice, likely because of inefficient Cre-deletion in this line. It will be important to define early responses to PIK3CAH1047R gene activation in our model, perhaps using line A or through ex vivo, Cre-induced, gene activation and transplantation.  PIK3CA mutations occur in all major subtypes of human breast cancer (4–7, 11). Our mouse model of Pik3caH1047R-induced breast cancer develops adenosquamous carcinoma and adenomyoepithelioma of the mammary gland at high frequency. Both tumor types were ERα+. Both also contained luminal and myoepithelial keratin-positive cells, suggesting that the cell of origin had bilineage potential. As PIK3CA and TP53 are the 2 most commonly mutated genes in human breast cancer, and mutations in both occur together in many tumors, we tested for cooperation between these genes in our model. Indeed, we observed reduced survival of R26-Pik3caH1047R;p53f;MMTV-CreNLST double-mutant animals. Cooperation between Pik3caH1047R and p53 loss-of-function mutation is in contrast to the situation observed in MMTV-myrPik3ca mice, in which mammary tumor formation is enhanced by expression of CDK4R24C but not by deletion of one p53 allele (42). In our model, apoptosis was very low in all of the tumors analyzed. In contrast, the proliferation rate varied significantly from one tumor type to another, tracking more closely with tumor type than with genotype. Thus, the observed cooperation between pik3caH1047R and p53 loss-of-function mutation is not at the level of apoptosis or proliferation. Indeed, data presented in Figures 2A and 3C indicate that pik3caH1047R and p53 mutations cooperate in mammary tumor initiation and interact to control mammary tumor type. In total, on wild-type and p53 mutant backgrounds, we observed 5 distinct types of mammary tumors in our PIK3CA model: adenosquamous carcinoma, adenomyoepithelialomas, spindle/EMT tumors, poorly differentiated adenocarcinomas, and radial scar type lesions. Although some of these tumor types are quite rare in humans, poorly differentiated adenocarcinomas are common, as are spindle/EMT tumors (Basal B tumors in humans). In addition, adenosquamous carcinomas are metaplastic, a tumor type in humans with a high frequency of PIK3CA mutations (11). This result is consistent with the wide spectrum of human breast cancers found to have PIK3CA mutations. In addition, our diverse collection of tumors includes ERα+ tumors and TNT-type tumors. This result contrasts with tumor models using Neu, Wnt, Myc, or Polyoma middle T, each of which induce a very specific mammary tumor type in mice (43).  We tested for PI3K pathway activation in major mammary tumor types that developed in our PIK3CAH1047R model mice. To this end we analyzed Akt phosphorylation, which was elevated in each tumor type. The modest level of Akt activation noted was somewhat surprising, although this was related to the use of whole mammary gland control tissue rather than lin− mammary epithelium for normalization (Supplementary Fig. 5). In any case, Akt-independent transformation has been noted in some breast tumors with a PIK3CA mutation (32), and other PDK1 substrates are thought to play a role in this case. Indeed, transgenic mice expressing activated alleles of Akt1 from the MMTV LTR do not form mammary tumors, highlighting the importance of other PI3K pathways in breast cancer (44, 45). Future studies will be required to define the importance of specific PIP3-responsive kinases and pathways in our Pik3caH1047R model.  By using the Cre-conditional knock-in system, we can compare mammary tumor formation in response to distinct alleles of Pik3ca, each expressed at precisely the same level and in the same cell types. For example, we can now directly compare mammary tumors in our R26-Pik3caH1047R model with tumor formation in mice expressing helical domain mutants of Pik3ca. As our system is Cre-inducible, we can also compare mammary tumor formation in R26-Pik3caH1047R;MMTV-CreNLST mice and in Ptenf/f;MMTV-CreNLST mice, in which PI3K pathway activation will occur in the same cell of origin but through a distinct mechanism. The importance of cell of origin can now be probed in our system as transgenic mice are available to activate Pik3ca alleles in luminal committed cells (WAP-Cre) and in bipotential cells expressing cytokeratin 14 (K14-Cre). Finally, this model can be used to identify genetic and cellular events associated with progression/metastasis, to screen for novel therapeutic targets in Pik3caH1047R mammary tumor cells ex vivo and to develop preclinical data on PI3K pathway inhibitors for treatment of breast cancer.  Human epidermal growth factor receptor 2 (HER2; ERBB2) amplification and phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA) mutations often co-occur in breast cancer. Aberrant activation of the phosphatidylinositol 3-kinase (PI3K) pathway has been shown to correlate with a diminished response to HER2-directed therapies. We generated a mouse model of HER2-overexpressing (HER2+), PIK3CAH1047R-mutant breast cancer. Mice expressing both human HER2 and mutant PIK3CA in the mammary epithelium developed tumors with shorter latencies compared with mice expressing either oncogene alone. HER2 and mutant PIK3CA also cooperated to promote lung metastases. By microarray analysis, HER2-driven tumors clustered with luminal breast cancers, whereas mutant PIK3CA tumors were associated with claudin-low breast cancers. PIK3CA and HER2+/PIK3CA tumors expressed elevated transcripts encoding markers of epithelial-to-mesenchymal transition and stem cells. Cells from HER2+/PIK3CA tumors more efficiently formed mammospheres and lung metastases. Finally, HER2+/PIK3CA tumors were resistant to trastuzumab alone and in combination with lapatinib or pertuzumab. Both drug resistance and enhanced mammosphere formation were reversed by treatment with a PI3K inhibitor. In sum, PIK3CAH1047R accelerates HER2-mediated breast epithelial transformation and metastatic progression, alters the intrinsic phenotype of HER2-overexpressing cancers, and generates resistance to approved combinations of anti-HER2 therapies.  The human epidermal growth factor receptor 2 (HER2) oncogene, which encodes the HER2 receptor tyrosine kinase, is amplified in 20% of breast cancers (1). HER2 activation triggers signal transduction through oncogenic signaling pathways, such as the PI3K–Akt survival pathway, which is arguably the most commonly mutated pathway in human cancer. In breast cancer, hyperactivation of the PI3K pathway can occur through a number of mechanisms, including activating mutations in phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA, the gene encoding the p110α catalytic subunit) (2). More than 80% of PIK3CA mutations occur in two “hot spots”: E452K and E545K (exon 9) in the helical domain and H1047R (exon 20) in the kinase domain. The PI3K–Akt survival pathway has attracted considerable interest as a target for therapeutic intervention. Indeed, PI3K inhibitors are currently in clinical trials for the treatment of breast and other cancers (2).  Approximately 40% of HER2+ breast cancers harbor activating mutations in PIK3CA (3), consistent with the notion that these two oncogenes have nonoverlapping functions and may cooperate to promote tumor growth. In addition, mutant PIK3CA enhances HER2-mediated transformation of MCF10A breast epithelial cells in vitro (4). Trastuzumab, an antibody directed against the ectodomain of HER2, pertuzumab, an antibody that blocks dimerization of HER2 with other ERBB receptors, and lapatinib, an ATP-competitive tyrosine kinase inhibitor of EGFR and HER2, are approved for the treatment of patients with HER2-overexpressing breast cancer. However, both de novo and acquired resistance to anti-HER2 therapies are not uncommon (5). Several studies suggest that PIK3CA mutations confer resistance to these therapies (6–8), but confirmation of a causal association between aberrant activation of the PI3K pathway and resistance to HER2-directed therapies in the clinic is still missing.  To further study the role of PIK3CA mutations in HER2+ breast cancer, we generated a genetically engineered mouse model expressing human HER2 and PIK3CAH1047R, the most common PIK3CA mutation found in human breast cancers. We used this model to determine whether HER2 and PIK3CAH1047R cooperate to promote mammary tumor formation and progression and whether mutant PI3K promotes innate resistance to anti-HER2 therapies in a defined genetic background.  Go to: RESULTS HER2 and Mutant PIK3CA Induce Distinct Premalignant Changes in the Mammary Gland. To generate a mouse model of human HER2+/PIK3CA-mutant breast cancer, we crossed mice bearing three transgenes (Fig. S1A). MMTV-HER2 drives high levels of human HER2 in the mammary epithelium, resulting in tumor formation (9). MMTV-rtTA, together with TetOp-HA-PIK3CAH1047R-IRES-luciferase, allows for the doxycycline (DOX)-inducible expression of mutant PI3K in the mammary gland (10). For simplicity, we refer to mice bearing all three oncogenes as HER2+PIK3CA; mice expressing either oncogene alone are referred to as HER2 or PIK3CA. Starting at 4 wk of age, female mice were treated with DOX in their drinking water. DOX-induced expression of luciferase in the mammary glands was observed within 1 wk (Fig. S1B). Luciferase expression was not detected in the absence of DOX, or in MMTV-HER2.rtTA mice treated with DOX (Fig. S1B).  We asked first if the HER2 and PIK3CAH1047R transgene products synergistically transformed mammary epithelial cells. We performed whole mount staining of mammary glands from 12-wk-old virgin transgenic mice and found that expression of HER2 increased ductal side branching, whereas mutant PI3K increased growth of lobuloalveolar structures (Fig. S2A). The combined expression of both HER2 and PI3KH1047R resulted in a combination of both phenotypes, such that side branching and lobulo-alveolar growth were markedly increased. Immunohistochemistry (IHC) showed elevated levels of the PI3K target p-AKT and the proliferation marker Ki67 in oncogene-expressing glands (Fig. S2 A–C). Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining indicated higher rates of apoptosis in PIK3CA-expressing mammary glands relative to wild type (Fig. S2D). However, the differences in Ki67 and TUNEL staining between the three oncogene-expressing models were not statistically significant.  HER2 and Mutant PIK3CA Accelerate Mammary Tumor Formation and Lung Metastases. We next treated mice expressing HER2 alone, PIK3CA alone, or both oncogenes with DOX beginning at 4 wk of age, and serially palpated mammary glands to detect tumor formation. In the absence of DOX, rtTA.PIK3CA mice failed to develop tumors up to 500 d of follow-up (Fig. 1A). HER2-expressing mice (HER2.rtTA or HER2.PIK3CA +DOX, or uninduced HER2.rtTA.PIK3CA –DOX) formed tumors with a median latency of 368 d (∼12 mo). PIK3CA mice formed tumors with a median latency of 149 d (∼5 mo), whereas HER2+PIK3CA mice did so at 76 d (∼2.5 mo) postinduction. This latency period was significantly shorter than that seen in mice expressing either oncogene alone (P = 0.0012 vs. PIK3CA; P < 0.0001 vs. HER2; log-rank test; Fig. 1A). When corrected for age at time of killing, the HER2+PIK3CA mice developed significantly more tumors per mouse, and carried a larger tumor burden, measured as total tumor volume and tumors per mouse (Fig. S3 A and B). In addition, HER2+PIK3CA tumors grew faster than tumors expressing only PIK3CA (Fig. S3C). Suggestive of faster growth outpacing tumor angiogenesis, HER2+PIK3CA tumors and lung metastases were frequently hemorrhagic (Fig. S3 D–G).  Fig. 1. Fig. 1. HER2 and mutant PIK3CA cooperate to promote mammary tumor formation and metastasis. (A) Female mice of the indicated genotypes were continuously administered DOX or vehicle control beginning at 4 wk of age. Mice were palpated twice weekly for the presence ... HER2+PIK3CA tumors expressed both HER2 and HA-tagged p110α by Western blot analysis (Fig. 1B). PIK3CA tumors also expressed elevated levels of p-AKT and its substrate p-PRAS40, suggesting that the PI3K pathway is highly activated in these tumors. All tumors exhibited elevated p-S6 compared with control mammary glands. Although HER2-expressing tumors exhibited elevated p-HER3, the HER2+PIK3CA tumors showed reduced expression of total HER3 in comparison, consistent with PI3K-mediated feedback repression of HER3 transcription (11–13).  We next determined if human HER2 and HA-p110αH1047R were coexpressed within the same cells in HER2+PIK3CA tumors. We performed immunofluorescence (IF) of mouse mammary tumors using trastuzumab as the primary antibody, followed by a fluorescently conjugated anti-human secondary antibody. Trastuzumab only recognizes human HER2 and not mouse erbb2. We costained with an HA antibody to detect HA-p110αH1047R. We observed heterogeneous expression of both transgenes in primary tumors; surprisingly, not all tumor cells coexpressed both oncogene products as measure by IF (Fig. 1C). In contrast, detectable coexpression was significantly higher in lung metastases (Fig. 1 C and D), suggesting that high coexpression of both oncogenes selects for tumor cells with an increased capacity to metastasize.  We further studied the metastatic phenotype of the mammary tumors. Lung metastases were rare in our original cohort, probably because these mice were killed when total tumor burden reached ∼1,500 mm3. Therefore, we injected cells isolated from HER2, PIK3CA, or HER2+PIK3CA tumors in the tail vein of nude mice. HER2+PIK3CA tumor cells formed significantly more lung metastases than cells from tumors expressing either oncogene alone (Fig. 1E). The HER2+PIK3CA lung metastases were also significantly larger (Fig. 1F and Fig. S3 H–J). These data suggest that HER2 and PI3KH1047R strongly cooperate to promote metastatic colonization and growth.  Mutant PIK3CA Confers Features of Epithelial-to-Mesenchymal Transition and Stem-Like Cells. We next examined the histopathological features of tumors expressing HER2, mutant PI3K, or both. HER2-expressing tumors were histologically homogeneous, consisting mostly of solid adenocarcinomas. By IHC, they expressed luminal cytokeratin 18 but were negative for the basal markers p63 and cytokeratin 14 (Fig. S4A). In accordance with previous studies (10), PIK3CA tumors exhibited heterogeneous cancer histologies, including a large proportion of metaplastic carcinomas. HER2+PIK3CA tumors were also heterogeneous, although the histological spectrum was distinct from PIK3CA-only tumors (Fig. S4 A and B). Like the PIK3CA tumors, the HER2+PIK3CA tumors expressed basal and luminal markers (Fig. S4A), suggesting that these tumors may arise from pluripotent progenitor cells and/or that mutant PI3K enhances tumor cell plasticity.  Next, we analyzed gene expression using microarrays. Mammary tumors from each genotype (HER2, PIK3CA, or HER2+PIK3CA) contained distinct clusters of genes, further suggesting that HER2+PIK3CA tumors are phenotypically distinct (Fig. S5A). Tumors from HER2 mice treated with or without DOX exhibited similar gene expression patterns. Microarray data were used to determine whether these mouse tumors are associated with a particular subtype of human breast cancer. We derived a gene signature for each of our models by identifying differentially expressed genes in comparison with a large series of mouse models of breast cancer (14, 15). The average of each signature was scored in the UNC337 dataset (Fig. 2A) (16) and the combined 855 dataset (Fig. 2B) (17) of human breast tumors. Like the MMTV-Neu model, the MMTV-HER2 signature was enriched in the luminal breast cancer subtype (Fig. 2) (14). In both datasets, the PIK3CA and HER2+PIK3CA signatures were most strongly associated with the claudin-low breast cancer subtype (Fig. 2).  Fig. 2. Fig. 2. Gene expression profiles of PIK3CA and HER2+PIK3CA tumors resemble the claudin-low subtype of human breast cancer. RNA isolated from mouse mammary tumors of the indicated genotypes was hybridized to Agilent 4 × 180 k mouse microarrays. Gene signatures ... Claudin-low breast cancer is a subtype of triple-negative breast cancer characterized by poor differentiation, elevated expression of markers of an epithelial-to-mesenchymal transition (EMT) and enrichment for cancer stem cells (CSCs). This subtype also shares similarities with metaplastic breast cancer (16, 18), consistent with our histological findings. In agreement, gene set analysis (GSA) showed that gene sets associated with EMT, metastasis, spherical vs. adherent growth, and metaplastic breast carcinoma, were elevated in the PIK3CA and HER2+PIK3CA expression profiles (Table S1 and Fig. S5B). We then used a recently described metric to calculate a “differentiation score” (D score) (16), with high scores representing a likeness to mature luminal cells, intermediate scores to luminal progenitor cells, and low scores to adult mammary stem cells. Whereas the HER2 tumors were more similar to mature luminal cells, PIK3CA tumors had intermediate d scores on average (Fig. S6C), suggesting that cells from PIK3CA tumors are most similar to luminal progenitors (16).  To further test the association of PIK3CA tumors with the claudin-low subtype, we examined our microarray data for expression of luminal and EMT markers and putative markers of mammary stem-like cells. Fig. 3A shows that expression of the luminal markers Xbp1, Erbb3, and Spdef were reduced in the PIK3CA and HER2+PIK3CA tumors relative to the HER2 tumors. In addition, the EMT markers Snai1 (Snail), Snai2 (Slug), Twist1, Twist2, Vim (Vimentin), Cdh2 (N-cadherin), and Sparc were elevated in PIK3CA and HER2+PIK3CA tumors (Fig. 3B). Finally, expression of CSC markers, including Bmi1, Itgb1 (CD29), Procr, Thy1, and the Notch ligands Jag1 and Jag2 (19–21) were significantly up-regulated in PIK3CA and HER2+PIK3CA tumors (Fig. 3C). Consistent with these results, protein levels of the epithelial cell marker E-cadherin were reduced in HER2+PIK3CA tumors relative to HER2 tumors (Fig. 3D). Further, IHC staining of Vimentin and Snail/Slug was elevated in HER2+PIK3CA tumors and lung metastases relative to corresponding tissues from HER2 transgenics (Fig. S7 A–C). These results suggest that mutant PIK3CA induces mammary tumors with EMT and stem-like features.  Fig. 3. Fig. 3. Expression of EMT and CSC markers is increased in PIK3CA and HER2+PIK3CA tumors, whereas expression of luminal markers is reduced. (A–C) Relative gene expression of luminal breast cancer markers (A), EMT markers (B), or CSC markers (C) was quantified ... To further address if mutant PIK3CA tumors are enriched with CSCs, we harvested primary tumor cells and performed mammosphere-forming assays. This method is used to measure the tumor-initiating capacity of cancer cells. HER2+PIK3CA mammosphere cultures retained luciferase expression only in the presence of DOX (Fig. S8). DOX-treated cells from HER2+PIK3CA tumors formed significantly more and larger mammospheres than DOX-minus cells or cells from tumors expressing only HER2 (Fig. 4 A and B). The pan-PI3K inhibitor BKM120 (22) markedly decreased the ability of HER2+PIK3CA cells to form mammospheres, whereas trastuzumab had no effect on mammosphere formation (Fig. 4C), further suggesting that aberrant PI3K activity is associated with CSC characteristics.  Fig. 4. Fig. 4. Induction of PI3KH1047R promotes mammosphere formation. (A) Mammospheres were imaged using the 10× objective of an Olympus CK40 microscope. (Scale bar, 100 µm.) (B) Total mammosphere volume from each well was quantified using Gelcount ... Mutant PIK3CA Confers Innate Resistance to Trastuzumab and Combinations of Anti-HER2 Therapies. We transplanted tumors from HER2 or HER2+PIK3CA mice into recipient nude mice; once tumors reached a volume of ≥200 mm3, mice were treated with PBS or trastuzumab. Treatment with trastuzumab inhibited growth of HER2-induced but not HER2+PIK3CA tumor transplants (Fig. 5 A and B). We next determined whether these tumors responded to BKM120, which has currently completed phase I studies in patients with cancer (23). Treatment with BKM120 inhibited tumor growth but did not induce tumor regressions. The combination of trastuzumab and BKM120 was moderately superior to single-agent BKM120, suggesting that inhibition of both oncogenes is required to inhibit tumor growth in this bitransgenic model (Fig. 5C).  Fig. 5. Fig. 5. HER2+PIK3CA tumors are resistant to trastuzumab, but respond to the combination of trastuzumab + BKM120. (A and B) Nude mice were transplanted with HER2-expressing (A) or HER2+PIK3CA (B) cells harvested from transgenic tumors. When tumors reached ≥200 ... We next examined pharmacodynamic biomarkers of target inactivation by Western blot analysis of tumor lysates and IHC of formalin-fixed, paraffin embedded (FFPE) tumor sections. BKM120 strongly inhibited p-AKTS473 and more modestly blocked p-AKTT308 following 18 d of treatment, whereas trastuzumab alone failed to inhibit p-AKT, p-S6, p-HER3, or p-ERK in HER2+PIK3CA tumors (Fig. 5D and Fig. S9). In addition, the combination of BKM120 and trastuzumab decreased vimentin expression, although E-cadherin and N-cadherin levels were unchanged (Fig. 5D). HER2+PIK3CA tumors treated with BKM120 displayed up-regulation of p-HER3Y1289 and p-ERK, consistent with relief of PI3K-driven negative repression of HER3 transcription/expression and ERK signaling (11–13, 24). However, the up-regulation of pERK did not rescue the inhibition of p-S6. Total HER2 and HA-PI3K levels remained unchanged with treatment.  We finally examined whether mutant PIK3CA also conferred resistance to currently approved anti-HER2 combinations, specifically trastuzumab/lapatinib and trastuzumab/pertuzumab (25–27). HER2+PIK3CA tumors failed to respond to these combinations (Fig. 6A). However, the combination of trastuzumab + pertuzumab + BKM120 inhibited tumor growth better than BKM120 alone. There was also a trend toward better inhibition with trastuzumab + lapatinib + BKM120, but this was not statistically significant. Likewise, dual HER2 blockade also failed to inhibit p-AKT or p-S6 (Fig. 6B). The addition of pertuzumab reduced BKM120-induced up-regulation of p-HER3, but not p-ERK. Lapatinib + trastuzumab also failed to prevent BKM120-induced p-ERK, suggesting that dual HER2 blockade does not prevent feedback compensation upon inhibition of PI3K in these tumors. Whether the addition of MEK inhibitors will improve the efficacy of the BKM120-containing combination will require additional investigation.  Fig. 6. Fig. 6. HER2+PIK3CA tumors are resistant to dual blockade of HER2. (A) Mice with established HER2+PIK3CA tumor transplants were randomized to receive vehicle control, BKM120, trastuzumab + lapatinib ± BKM120 (T + L ± B), or trastuzumab + pertuzumab ... Go to: DISCUSSION Resistance to current anti-HER2 therapies is a major hurdle in the eradication of HER2+ breast cancer. Several studies have suggested aberrant activation of the PI3K pathway as a mechanism of resistance to anti-HER2 therapies, although confirmation in the clinic is still unclear. Herein, we uniquely characterized a genetically engineered mouse mammary tumor model harboring both (human) HER2 and mutant PIK3CA. We showed that coexpression of both oncogenes in the mouse mammary gland accelerated tumor formation with an average tumor latency of just 2.5 mo following DOX induction. These tumors were histologically heterogeneous, exhibited features of EMT and stem-like cells, and displayed a high metastatic propensity. HER2+PIK3CA tumors also were resistant to trastuzumab as a single agent and in combination with lapatinib or with pertuzumab. Drug resistance was partially reversed by the PI3K inhibitor BKM120. We propose that this conditional mouse model will be a useful tool for testing novel drugs and combinations for the treatment of HER2+/PIK3CA-mutant breast cancer.  HER2 and PI3KH1047R cooperated to promote transformation of the mammary epithelium, cancer establishment, and metastasis. The mechanism by which these two oncogenes cooperate in this setting is unclear. Whereas it is possible that HER2 overexpression may further enhance the activity of mutant PI3K, we did not observe an increase in phosphorylation of AKT or downstream targets in the HER2+PIK3CA mammary glands or tumors compared with tumors expressing PIK3CA alone (Figs. 1B and and2B).2B). HER2 is also capable of activating the MAPK pathway. Whereas p-ERK levels were low in HER2 tumors, they were elevated in HER2+PIK3CA tumors (Fig. 2B). However, p-ERK levels were also high in untransformed mammary glands, so the significance of elevated MAPK signaling in these tumors is unclear. Table S2 presents a list of genes that are differentially expressed in the HER2+PIK3CA tumors compared with the tumors expressing either oncogene alone; some of these genes may account for the increased tumorigenicity observed in this model.  The histopathological heterogeneity observed in the PIK3CA tumors is consistent with other mouse models of PI3K-induced breast cancer (28), including PIK3CAH1047R knock-in models (29, 30). This heterogeneity also reflects the fact that although PIK3CA mutations are enriched in the luminal A subtype, they are found across all subtypes of human breast cancer (3). Interestingly, ∼40% of the tumors in our PIK3CA mouse model were classified as metaplastic carcinomas, consistent with the high rate of PIK3CA mutations (∼50%) found in human metaplastic carcinomas (18). This suggests that PIK3CA-induced tumors may be useful models for the study of this rare form of breast cancer. The link with metaplastic breast carcinoma is further strengthened by the finding that the PIK3CA-driven tumors were associated with the claudin-low subtype of breast cancer, because claudin-low and metaplastic breast carcinomas exhibit similar gene expression patterns (16, 18). Furthermore, we found that the PIK3CA and HER2+PIK3CA tumors displayed high expression of EMT and stem cell markers and that induction of PIK3CA promoted mammosphere formation. These data are in agreement with in vitro studies that have implicated the PI3K pathway in EMT (31, 32) and stem cell maintenance in breast cancer (33–35). Therefore, the association between PIK3CA mutations and the claudin-low subtype of breast cancer, as well as EMT and stem-like features, suggests that HER2+ breast cancers harboring PIK3CA mutations will exhibit a more virulent behavior than HER2+ tumors with wild-type PIK3CA.  Several mechanisms may explain why mutational activation of PI3K promotes resistance to therapeutic inhibitors of HER2 in our model system. First, HER2 blockade did not affect p-AKT levels in the HER2+PIK3CA tumors (Fig. 6B), suggesting that it can no longer inhibit PI3K signaling in the presence of mutant PIK3CA. In agreement, a recent study showed that the PI3K H1047R mutation enhanced lipid binding, basal catalytic activity, and interaction with the plasma membrane (36) and hence may be insensitive to dual blockade of HER2 upstream. The receptor-independent strong catalytic activity of PI3K H1047R is further supported in our studies by the lack of response of the bigenic tumors to trastuzumab/lapatinib and transtuzumab/pertuzumab. Second, HER2+PIK3CA tumors displayed heterogeneous, nonoverlapping expression of HER2 and HA-PI3K transgenes (Fig. 1C); presumably trastuzumab would not inhibit HER2-negative, HA-PI3K–expressing cancer cells within these heterogeneous tumors. However, we do not believe that this contributes to trastuzumab resistance in our model, because treatment with trastuzumab did not affect HA-PI3K or HER2 expression (Fig. 5D). Third, both EMT and CSCs may play a role in trastuzumab resistance. The EMT transcription factors Snail and Slug, both transcriptionally up-regulated in our HER2+PIK3CA tumors (Fig. 3B), were recently shown to confer resistance to trastuzumab in HER2+ cells (37). CSCs may be less sensitive to trastuzumab than their more differentiated counterparts (38), and long-term trastuzumab treatment has been shown to enrich for CSCs that display an EMT phenotype (39). Indeed, mutant PIK3CA-containing tumors were associated with increased stem cell characteristics, such as the ability to form mammospheres in nonadherent conditions (Fig. 4); trastuzumab did not inhibit the mammosphere-forming capacity of HER2+PIK3CA cells (Fig. 4C). Finally, the elevated PI3K activity may counteract the trastuzumab-induced immune response required for an antitumor effect (39). One limitation of our mouse model is that it may not accurately recapitulate the genomic complexity of human tumors, so these studies should be complemented by future experiments using patient-derived xenografts. It is possible that a combination of multiple mechanisms contribute to the decreased sensitivity of HER2+/PIK3CA-mutant tumors to HER2 inhibitors.  In summary, HER2 and mutant PI3K cooperate to promote mammary tumor establishment and metastatic progression. These tumors are resistant to trastuzumab and combinations of direct inhibitors of HER2. Addition of a PI3K inhibitor reversed resistance in these tumors, suggesting that combining anti-HER2 therapies with PI3K inhibitors may be beneficial for the clinical treatment of HER2+/PIK3CA-mutant breast cancers. We speculate the addition of MEK inhibitors to this combination may prevent feedback compensation (Fig. 5D) and potentially eliminate these tumors. We propose that the mouse model presented here will be a valuable tool to investigate the underlying biology of HER2+/PI3K-mutant breast cancers and for preclinical testing of therapeutic strategies against this subtype of breast cancer.  The Cancer Genome Atlas profiled 279 head and neck squamous cell carcinomas (HNSCCs) to provide a comprehensive landscape of somatic genomic alterations. We find that human papillomavirus-associated (HPV) tumors are dominated by helicase domain mutations of the oncogene PIK3CA, novel alterations involving loss of TRAF3, and amplification of the cell cycle gene E2F1. Smoking-related HNSCCs demonstrate near universal loss of TP53 mutations and CDKN2A with frequent copy number alterations including a novel amplification of 11q22. A subgroup of oral cavity tumors with favorable clinical outcomes displayed infrequent CNAs in conjunction with activating mutations of HRAS or PIK3CA, coupled with inactivating mutations of CASP8, NOTCH1 and wild-type TP53. Other distinct subgroups harbored novel loss of function alterations of the chromatin modifier NSD1, Wnt pathway genes AJUBA and FAT1, and activation of oxidative stress factor NFE2L2, mainly in laryngeal tumors. Therapeutic candidate alterations were identified in the majority of HNSCC's.  Go to: Introduction HNSCCs impact ~600,000 patients per year worldwide 1. They are characterized by phenotypic, etiologic, biologic, and clinical heterogeneity. Smoking is implicated in the rise of HNSCC in developing countries, while the role of HPV is emerging as an important factor in the rise of oropharyngeal tumors affecting non-smokers in developed countries 2. Despite surgery, radiation, and chemotherapy, approximately half of all patients will die of the disease. Risk stratification for HNSCC is by anatomic site, stage, and histologic characteristics of the tumor. Except for HPV status, numerous molecular and clinical risk factors that have been investigated have limited clinical utility.  Published genome-wide profiling studies of HNSCC3,4 are limited to single platforms. To generate an integrated genomic annotation of molecular alterations in HNSCC, The Cancer Genome Atlas (TCGA) has undertaken a comprehensive multi-platform characterization of 500 tumors with the a priori hypothesis of detecting somatic variants present in at least 5% of samples. Here, we report the results for analyses from the first 279 patients with complete data.  Samples and Clinical Data  The cohort is comprised primarily of tumors from the oral cavity (n=172/279, 62%), oropharynx (n=33/279, 12%), and laryngeal sites (n=72/279, 26%) (Section S1, Table S1.1, Data File S1.1). Most patients were male (n=203/279, 73%) and heavy smokers (mean pack years = 51). Samples were classified as HPV positive using an empiric definition of >1000 mapped RNA-Seq reads, primarily aligning to viral genes E6 and E7 (Section S1.2, Figure S1.1). The HPV status by mapping of RNA-Seq reads was concordant with the genomic, sequencing, and molecular data and indicated that 36 tumors were HPV(+) and 243 HPV(−). (Section S1.2, Figure S1.1, Data File S1.2). Of 33 oropharyngeal tumors 64% were positive for HPV, compared to 6% of 246 non-oropharyngeal tumors. Molecular HPV signatures were identified using miRNA, DNA methylation, gene expression, and somatic nucleotide substitutions (Section S1.2, Figures S1.1-S1.3). HPV(+) tumors exhibited infrequent mutations in TP53 or genetic alterations in CDKN2A. We evaluated outcome by site, stage, HPV status, molecular subtypes, and putative biomarkers (Section S1.3, Figure S1.4-5). HPV(+) and interestingly patients with HPV(−), TP53 wild-type tumors demonstrated favorable outcomes compared to TP53 mutants and 11q13/CCND1 amplified tumors.  DNA and RNA Structural Alterations  Most tumors demonstrated copy number alterations (CNAs) including losses of 3p and 8p, and gains of 3q, 5p, and 8q chromosomal regions (Figures 1A and S2.1, Section S2) resembling lung squamous cell carcinomas (LUSCs) 5 (Figure 1A , S2.1, S2.2). HNSCC genomes showed high instability with a mean of 141 altered CNAs (amplifications or deletions) from microarray data and 62 structural aberrations (chromosomal fusions) per tumor by “high coverage” whole genome sequencing (n=29) (Section S2.2). We observed 39 regions of recurrent copy number (CN) loss and 23 regions of recurrent CN gain (q < 0.1, Data File S2.1,2). Both HPV(+) and (-) tumors harbored recurrent focal amplifications for 3q26/28, a region involving squamous lineage transcription factors TP63 and SOX2 and the oncogene PIK3CA (Figures 1B, S2.3).  Figure 1 Figure 1 A. Copy number alterations by anatomic site and HPV status for squamous cancers. Lung squamous cell carcinoma (LUSC, n = 358), cervical squamous cell carcinoma (CESC, n = 114). B. Unsupervised analysis of copy number alteration of HNSCC (n = 279) with ... HPV(+) tumors were distinguished by novel recurrent deletions (n=5/36, 14%) and truncating mutations (n=3/36, 8%) of TNF receptor-associated factor 3 (TRAF3) gene loss (Figure S2.3,4, Data File S2.1). TRAF3 is implicated in innate and acquired anti-viral responses 6 including Epstein-Barr, HPV, and HIV 7-9 while loss promotes aberrant NF-κB signaling 10. While TRAF3 inactivation has been reported in hematologic malignancies and nasopharyngeal carcinoma 11,12, this is the first evidence linking TRAF3 to HPV-associated carcinomas. HPV(+) tumors were also notable for focal amplification of E2F1 and an intact 9p21.3 region containing the CDKN2A gene commonly deleted in HPV(−) tumors.  HPV(−) tumors featured novel co-amplifications of 11q13 (CCND1, FADD, and CTTN) and 11q22 (BIRC2, YAP1) which also harbor genes implicated in cell death/NF-κB and Hippo pathways. HPV(−) tumors featured novel focal deletions in the Nuclear Set Domain gene (NSD1) and tumor suppressor genes (e.g. FAT1, NOTCH1, SMAD4, and CDKN2A; Figure S2.3). Recurrent focal amplifications in receptor tyrosine kinases (e.g. EGFR, ERBB2 and FGFR1) also predominated in HPV(−) tumors. Interestingly, unsupervised clustering analysis of CNAs identified a mutually exclusive subset of predominantly oral cavity tumors with reduced CNAs, a pattern recently described in cancer as “M” class (tumors driven by mutation rather than CNA) (Figure 1B) 13. This subset in particular harbored a novel 3 gene pattern of activating mutations in HRAS, frequently with inactivating CASP8 mutations, and wild type TP53. We confirmed a previously reported favorable clinical outcome in tumors with few CNAs 14. The three gene constellation of wild type TP53 with mutant HRAS and CASP8 suggested an alternative tumorigenesis pathway involving RAS and/or alterations in cell death/NF-κB 15. Unsupervised analysis also suggested that clustering was a function of chromosome 7 amplification (including the EGFR locus) in a manner that largely excluded HPV(+) tumors.  To detect additional structural alterations, we interrogated whole genome and RNA-Seq data (Section S3, Data File S3.1, Figure S3.1). Known fusion oncogenes reported in solid tumors including those involving the ALK, ROS, or RET genes were not observed in HNSCC. Previously reported FGFR3-TACC3 fusions 5 were present in two HPV(+) tumors (Figure S3.2). Only one of 279 patients showed evidence of the vIII isoform of EGFR, previously described in HNSCC (Figure S3.3) 16. While our investigation did not identify additional novel oncogenic fusions, several tumors demonstrated exon 1 of EGFR or FGFR3 fused to non-recurrent partners, suggesting potential promoter swaps for the partner genes (Data File S3.1). A low prevalence of an alternate MET transcript with skipped exon 14 was identified in two HPV(−) tumors (Figure S3.4); this finding was reported to be an activating event in non-small cell lung cancer 17. Structural alterations (homozygous deletions, intra- and inter-chromosomal fusions) were more commonly associated with loss of function in tumor suppressor genes, most prominently CDKN2A (Figure S3.5-6), followed by TP53, RB1, NOTCH1, and FAT1 (Figures S3.7-S3.9) than protein coding fusion events. RNA-Seq data (Data File S3.3) demonstrated evidence of alterative splicing in genes not previously described in HNSCC including kallikrein 12 (KLK12) (Figure S3.11), as well as genes such as TP63 with known importance in HNSCC (Figure S3.12).  By DNA analysis, most HPV(+) tumors demonstrated clear evidence of host genome integration, usually in a single genomic location per sample and almost always in association with amplifications of the host genome (Figure S3.10, Data File S3.2). Interrogation of RNA transcripts confirmed transcription across the viral-human integration locus. However, none of the genes involved were recurrent which suggests a single driver mechanism related to HPV integration. Similarly, none of the integration sites involved the MYC gene as reported in HPV(+) cell lines18.  Somatic Mutations  Whole exome sequencing identified somatically mutated genes, many located in regions of CNAs and annotated in the COSMIC database (Figure 2) 19. The mean sequencing coverage across targeted bases was 95X, with 82% of target bases above 30X coverage. In 279 samples, 12,159 synonymous somatic variants, 37,061 non-synonymous somatic variants, and 2,579 germline single base substitutions from dbSNP 20 were detected (Section S4). Targeted re-sequencing of 394 unique regions (Figure S4.1) validated 99% of mutations. Interrogation of RNA for expression of the mutated alleles confirmed the variant in 86% of cases (S3.2, Figure S3.1). In contrast to prior reports, the mutation rates did not differ by HPV status, although transversions at CpG sites were more frequent in HPV(−) tumors and a predominance of TpCmutations were noted in HPV(+) cases (Figure S1.1) 3. Mutations were statistically enriched in 11 genes (Figure 2). Among inactivating mutations (premature termination of the protein by nonsense, frameshift, or splice site mutations), four genes segregated exclusively or predominantly in HPV(−) tumors. Two were associated with cell cycle and survival (CDKN2A (p<0.01) and TP53 (p<0.01)) and two were linked to Wnt/β-catenin signaling (FAT1 (p<0.01) and AJUBA (p=0.14)) 21,22. We observed TP53 mutation among HPV(−) samples at rates higher (86%) than have been previously reported 23, while only 1 of 36 HPV(+) cases had a non-synonymous TP53 mutation. Previously unreported somatic mutations and deletions of AJUBA were primarily 5’ inactivating events and clustered missense mutations in the functional LIM domain (Figure S4.2). AJUBA is a centrosomal protein that regulates cell division, vertebrate ciliogenesis, and left-right axis determination 24. Additionally, AJUBA is subject to EGFR-RAS-MAPK-dependent phosphorylation and implicated in Hippo growth and regeneration pathways conserved from Drosophila to mammals 25,26, in ATR-mediated DNA damage response, 27 and tumor invasion and migration 28.  Figure 2 Figure 2 Significantly mutated genes in HNSCC. Genes (rows) with significantly mutated genes (MutSigCV q <0.1) ordered by q-value; additional genes with trends towards significance are also shown. Samples (columns, n = 279) are arranged to emphasize mutual ... A frequently mutated novel gene, the nuclear receptor binding SET domain protein 1 (NSD1), was identified in 33 HNSCCs. Alterations included inactivating mutations (n=29) and focal homozygous deletions (n=4). NSD1 is a Histone H3K36 methyltransferase, similar to SETD2, which is frequently mutated in the clear cell variant of renal cell carcinoma, and associated with DNA hypomethylation 29. Germline carriers of inactivating mutations in NSD1 are associated with craniofacial abnormalities (Sotos syndrome), and malignancies including squamous carcinoma, implicating NSD1 as a tumor suppressor gene 30. Interestingly, NSD1 functions as an oncogene when fused to nucleoporin-98 (NUP98) t(5;11)(q35;p15.5) in hematologic cancers with elevated H3K36me3 levels at HOXA genes and accompanying transcriptional activation 31. Translocations involving other dedicated H3K36 methyltransferase genes including WHSC1 / MMSET / NSD2 are reported in 20% of multiple myelomas. In contrast NSD1 loss has been associated with sporadic non-melanoma skin cancers 32. Significant inactivating mutations were found in genes linked to squamous differentiation including in NOTCH1 (19%), and other non-significant (NS) family members (NOTCH2 9%, and NOTCH3 5%, q>0.1, NS), and the TP63 target gene ZNF750 (4%, q>0.1, NS) which falls in a significantly deleted peak at 17q25.3. The analysis identified additional mutations including TRAF3, RB1, NFE2L2, among others with q-values <1(NS). The frequently mutated apoptosis gene CASP8 displayed clustered missense and other inactivating mutations in the first death effector, intron, and caspase peptidase domains. Statistically significant mutations in KMT2D (aka MLL2) and HLAA could contribute to defective immunosurveillance. Of known oncogenes, only PIK3CA achieved (q <0.01) statistical significance. Approximately one-fourth of the mutated PIK3CA cases displayed concurrent amplification, with an additional 20% of tumors containing focal amplification without evidence of mutation. Seventy-three percent of PIK3CA mutations localized to E542K, E545K, and H1047R/L hotspots that promote activation, with the remaining mutations of uncertain function. Recurrent activating mutations of HRAS in the GTPase domain in residues 11-13 approached statistical significance (q=0.2).  We extended our unsupervised genome-wide analysis of significantly mutated genes as well as genes reported in COSMIC to a subgroup analysis by anatomic sites, tumor vs. normal status, HPV status, and four previously validated gene expression subtypes (Section S5, Figures S5.1-4, Data File S4.1, 5.1-4) 33,34 Additional mutations included TRAF3, RB1, NFE2L2, among others with q-values <1, and we observed statistical evidence for mutations of HRAS (q=0 in COSMIC subset) and other genes. Sporadic inactivating mutations and deletions of TGFBR2 were identified primarily in oral cavity tumors, consistent with its role in promoting squamous tumorigenesis in mouse models 35. Investigating COSMIC database mutations focused attention on the significant deletion peak at 4q31.3 containing the gene FBXW7, a ubiquitin ligase targeting cyclin E and NOTCH genes, in which we identified mutations that included recurrent R505G/L substitutions (n=14). Genes with at least one identical mutation previously reported in COSMIC include SCN9A, CHEK2, PTCH1, and PIK3R1. We further focused on somatic alterations and protein expression that represent plausible therapeutic targets (Figure 3) (Section S6, Figures S6.1,2, Data File S6.1,2, Section S7).  Figure 3 Figure 3 Candidate therapeutic targets and driver oncogenic events. Alteration events for key genes are displayed by sample (n = 279). TSG, tumor suppressor gene. Integrated Genome Analysis and Pathways  Correlative genetic alteration analysis identified numerous pairwise significant findings (Section S7, Figure S7.1). In particular, co-amplification of 11q13 harboring CCND1, FADD, and CTTN and a narrow segment of 11q22 harboring the genes with equal evidence for YAP1 and BIRC2 was further characterized (Figure S7.2). Chromosome 11q22 was focally but rarely amplified in the absence of co-amplification of 11q13. This novel finding suggests that the selection pressure for this co-amplification stems from BIRC2's interaction with FADD and the caspase cascade that inhibits cell death. Interestingly, the vast majority of tumors with the 11q13 amplification had large deletions in the telomeric region of 11q22 including other genes known to be important in cell death in cancer including ATM and the caspases 1, 4, 5, and 12. 11q13 amplification was anti-correlated with CASP8 mutations, suggesting an alternate function of CASP8 and FADD in cell death/NF-κB activation 36.  We investigated whether clinical factors, single gene alterations and statistically significant pairwise gene correlations (Figure S7.1, Data File S7.1) might segregate previously defined molecular subtypes and/or anatomic sub-sites (Data File S5.1-4). We confirmed reported gene expression subtypes (Atypical (24%), Mesenchymal (27%), Basal (31%), and Classical (18%)), and assessed the subtypes for enrichment of somatic alterations (Data File S7.1) 33,34. Notably, TP53 mutation, CDKN2A loss of function, chromosome 3q amplification, alteration of oxidative stress genes (KEAP1, NFE2L2, or CUL3), heavy smoking history (Table S1.1), and larynx sub-site co-occurred in the majority of Classical subtype tumors (Figure 4A, Section S7.2), similar to LUSC (Figure S5.1, 2)5. Collectively, these findings suggest that the NFE2L2 oxidative stress pathway is a tobacco-related signature across anatomic tumor sites. In contrast, the Basal subtype demonstrated inactivation of NOTCH1 with intact oxidative stress signaling and fewer alterations of chromosome 3q. Analysis of the 3q locus highlighted a dramatic relative decrease of SOX2 expression in Basal tumors relative to all other HNSCC and tumor adjacent normal samples (Figure S5.4) supporting the interaction of transcription factors SOX2, TP63, NFE2L2, and NOTCH1 as driving differences between expression subtypes. Additionally, the Basal subtype included most tumors with the HRAS-CASP8 co-mutation and the majority of co-amplified 11q13/q22 tumors. These findings along with HRAS mutations implicate disrupted cell death as a major alteration in this subtype (Figure S7.2) 37. The Atypical subtype was characterized by a lack of chromosome 7 amplifications (Figure S5.3), enrichment of HPV(+) tumors with activating mutations in exon 9 of the PIK3CA helicase domain. In contrast, the Mesenchymal subtype showed high levels of alteration in innate immunity genes, in particular high NK cell marker CD56 expression and a low frequency of HLA class I mutations (Figure S7.3). Among the significantly mutated genes, TP53 (p<0.001), CASP8 (p=0.01), NSD1 (p=0.01), and CDKN2A (0.06) were the most differentially mutated across anatomic sites (Data File S4.1). The majority of CASP8 mutations (22/24, 92%) were in oral cavity tumors, while TP53, NSD1, and CDKN2A demonstrated decreased mutation rates in oropharyngeal tumors relative to other sites.  Figure 4 Figure 4 Integrated analysis of genomic alterations. Samples (n = 279) are displayed in columns and grouped by (A) gene expression subtype or (B) methylation subtype. Unadjusted two-sided Fisher's exact test p-values assess the association of each genomic alteration. ... Unsupervised analysis of gene expression by HPV status and of reverse phase protein arrays (RPPA, Section S6), DNA methylation (Section S8), and miRNA platforms (Section S9, Table S9.1, Figure S7.4-9, Data File S7.1) showed high correlation across platforms (p<0.01, Figure 4, S7.9, Data File S7.2) and coordinated alterations of genes including the epithelial-mesenchymal transition (EMT) signature (Figures S7.4, S7.7,8) 38. However, within the broader cross-platform agreement, individual unsupervised clustering of miRNA, RPPA, and DNA methylation data provided insight into the association of molecular subtypes with single gene alterations. The most striking example was the detection of a hypomethylation and loss of function mutations of NSD1, and wild type NOTCH1 in Atypical and Classical gene expression subtypes (Figure 4B, Table S7.1).  Supervised analyses detected genomic features (miRNA, gene expression, and DNA methylation) associated with anatomic site (Figure S5.5-8, Data File S5.1-4). A supervised integrated analysis identified target genes that are inversely regulated by miRNAs in HNSCC (Section S7.4). Among these miRNA-mRNA networks, let-7c-5p and miR-100-5p exhibited a correlation between low copy number and expression. Let-7c-5p and miR-100-5p were decreased in tumors compared to normal (Figure S7.10). For these miRNAs, deletion was highly associated with increased expression of target genes, including the cell cycle regulator CDK6, transcription factor E2F1 39 mitosis regulator PLK1 40, and transcription factor HMGA2 (Figures S7.10, Tables S7.2, 3) 41.  Integrative bioinformatics analysis identified a limited number of pathways targeted by frequent genome alterations (Figure 5; Section S7, Figure S7.11-15, Data File S7.3). Among receptor tyrosine kinases, EGFR/ERBB2 or FGFR1/3 alterations are the most frequent. Among downstream targets of the RTK/RAS/PI3K pathway, PIK3CA dominates with occasional HRAS and PTEN alterations. Further downstream, nearly every tumor has alteration of genes governing the cell cycle. The tumor suppressors TP53, CDKN2A, oncogenes CCND1, MYC, and the newly identified miR let-7c, are most often altered in HPV(−) tumors, while viral E6/7 and E2F1 predominate in HPV(+) cases. In addition, we report frequent alterations in genes involved in cell death, NF-κB-mediated survival, or immunity pathways 15,36. Co-amplification of FADD+/−BIRC2, or CASP8+/−HRAS mutations define exclusive HPV(−) subsets, while TRAF3 loss characterizes an HPV(+) subset. These alterations along with PIK3CA and TP63 converge upon NF-κB transcription factors that promote cell survival, migration, inflammation and angiogenesis 42,43. Additionally, TRAF3 and/or HLA loss are implicated in deregulation of innate antiviral and adaptive anti-tumor immunity 44,45. Further alterations of NOTCH, TP63, and other genes in HPV(−) tumors (FAT1, AJUBA) recently linked functionally to beta-catenin (CTNNB1) are also detected 21,22,46. Finally, we highlight a previously underappreciated role for a key transcription factor regulator of oxidative stress, NFE2L2, and its protein complex partners CUL3 and KEAP1 in HPV(−) HNSCC.  Figure 5 Figure 5 Deregulation of signaling pathways and transcription factors. Key affected pathways, components, and inferred functions, are summarized in the main text and Section S7 for n = 279 samples. The frequency (%) of genetic alterations for HPV(−)and ... Go to: Conclusion The TCGA study represents the most comprehensive integrative genomic analysis of HNSCC. Loss of TRAF3, activating mutations of PIK3CA, and amplification of E2F1 in HPV(+) oropharyngeal cancers point to aberrant activation of NF-κB, other oncogenic pathways, and cell cycle, as critical in the pathogenesis and development of new targeted therapies for these tumors. In HPV(−) HNSCC mutually exclusive subsets harboring amplicons on 11q with CCND1, FADD, BIRC2 and YAP1, or concurrent mutations of CASP8 with HRAS, also target cell cycle, death, NF-κB and other oncogenic pathways. Recent studies predict that the inactivation of AJUBA, as well as FAT1 and NOTCH1 may converge to uncheck Wnt/β−catenin signaling, implicated in deregulation of cell polarity and differentiation. The 3q amplicon found in both HPV(+) and (-) HNSCC includes transcription factors TP63, SOX2 and signal molecule PIK3CA, which are also implicated in homeostasis of epithelial stem cells and differentiation. Among these, the biologic function and agents targeting BIRCs, PI3K, Wnt/β−catenin and NOTCH are under investigation. Collectively, these findings provide new insights into HNSCC and suggest that shared and unique alterations might be leveraged to accelerate progress in prevention and therapy across tumor types.   Introduction In 2004, Samuels et al. reported the results of the analysis of the sequences of all known lipid kinase genes in 35 colorectal cancers. PIK3CA, which encodes the p110α catalytic subunit of PI3Kα, was the only gene that showed somatic (i.e., tumor-specific) mutations [1]. Extension of this analysis to PIK3CA in 199 additional colorectal cancers revealed mutations in 32 % of the tumors (74 out of 199 tumors). In contrast, in 76 premalignant colorectal tumors only two mutations were found; both these tumors were very advanced tubulovillous adenomas. These observations were interpreted as indicating that PIK3CA mutations generally arise late in tumorigenesis, just before or coincident with invasion. In the same study, mutations PIK3CA mutations were also identified in several other tumor types, including those of the breast, brain, stomach, and lung. Subsequent studies have identified similar mutations in these and many other tumor types [2, 3]. Over 1500 such mutations are now recorded in a principle cancer mutation database[4].  The PIK3CA gene codes for p110α, the major catalytic subunit of PI3Kα. This subunit is composed of five domains: an adaptor-binding domain (ABD), a Ras-binding domain (RBD), a C2 domain, a helical domain, and a kinase domain [5–8]. The complete enzyme also contains one of several regulatory subunits of similar size and function. The regulatory subunits, such as p85α, also contain five domains: an SH3 domain, a GAP domain, an N-terminal SH2 (nSH2) domain, an inter-SH2 domain (iSH2), and a C-terminal SH2 domain (cSH2) [9, 10]. The iSH2 domain is responsible, in part, for binding the catalytic domain, while the nSH2 and cSH2 domains mediate the interactions between PI3Kα and the tyrosine kinase receptors that activate it.  Of the five p110α domains, mutations were initially found in the Adaptor Binding Domain (ABD), C2, helical domain, and the kinase domain. No mutations were found in the Ras binding domain. A large percentage of mutations (~75%) occurred in two clusters—one in the helical domain and the other in the kinase domain [1]. Mutations have since been identified in 140 of the 1068 residues of PIK3CA. While some of these mutations are rare, others are commonly observed. The residues with the highest number of observed mutations, so-called “hotspots” are His1047 in the kinase domain (470 occurrences) and Glu545, Glu542 and Gln546 (362, 193, and 51 reported occurrences, respectively).  Samuels et al. also showed that the H1047R mutation resulted in a small but significant increase in enzymatic activity with respect to the wild type [1]. Subsequently, it was determined that two additional high frequency mutations, E542K and E545K, also increased enzymatic activity [11]. The increase in activity produced by the mutations was similar in magnitude to the increase that is observed when PI3Kα is activated by its physiological effectors, including phosphorylated tyrosine kinase receptors and their substrates [12]. These data were interpreted as indicating that the observed mutations of p110α result in a constitutively activated enzyme, which in turn regulates cellular pathways that contribute to several aspects of tumor growth. These considerations made PI3Kα an ideal target for the development of chemotherapeutic agents.  PI3Kα is only one of several PI3K enzymes that are central to numerous aspects of metabolism and cell growth. Because of the potential toxicity associated with such pleiotropic enzymes, chemotherapeutic agents that target PI3Kα must be at least isoform-specific, preferentially inhibiting the PI3Kα isoform over the others. The ideal agent would of course be one that inhibited mutant PI3Kα but not normal (wild type or wt) forms of the enzyme. Structural information is crucial for this type of development.  The structure of a major portion of the complete PI3Kα, determined by x-ray diffraction, provided the first look at the overall subunit organization of the enzyme as well as the positions of mutations within the 3-dimensional structure [7]. This structure contains many of the portions of the enzyme most important for the regulation of enzymatic activity and for understanding the effects of common mutations: the complete p110α and two domains of the regulatory subunit p85, viz., nSH2 and iSH2. Of the four regions of p85, iSH2 is absolutely required for binding to p110 and nSH2 is the domain most directly involved in PI3K regulation [13]. The iSH2 domain is a long coiled-coil that protects the large subunit from degradation by cellular proteases [14]. The nSH2 domain has an inhibitory effect on the kinase activity, but this inhibition is relieved when the domain binds to a phosphorylated tyrosine from an activated upstream protein [12]. In this regard, activation of PI3Kα is, in reality, removal of the inhibition by nSH2.  In addition, the same portion of the oncogenic H1047R mutant of PI3Ka was determined as the free enzyme and in complex with the covalent inhibitor wortmannin [15].  Go to: Description of the Structure The p110α/niSH2 complex [7] is a large sail-boat shaped molecule with a narrow cross section (~80 Å, Fig. 1) [7]. The base is approximately 100 Å and its height 100 Å. The p110 portion forms the “sail” while the iSH2 of p85 constitutes the “hull” (Fig. 1a). Four of the p110 domains are arranged roughly along the top edge of p85, with the RBD at the top of the molecule. The base of the p110 subunit has the ABD at one end and the kinase domain at the other but permits a direct interaction between these two domains. The helical and C2 domain are closer to the center of the structure, at one side of the kinase domain along the narrow thickness of the subunit.  Figure 1 Figure 1 Structure of the p110α/niSH2 heterodimer. (A) Ribbon diagram of the p110α/niSH2 heterodimer. For p110α, ABD is colored navy blue, RBD is turquoise, C2 is green, helical is red and kinase is purple. p85α iSH2 is yellow; ... The ABD (residues 1–108) and the RBD (residues 191–291) domains interact with the kinase domain over a large surface area. They both fold with α/β topologies and are connected to each other by an 81 residue linker (109–190) that contains two helices.  A short helix and a long coil (residues 292–329) connects the RBD to the C2 domain (residues 330 to 480), which folds as a β-sandwich composed of two four-stranded antiparallel β-sheets. C2 interacts not only with the helical and kinase p110 domains but also with the iSH2 domain of p85: H-bonds between Asp560 and Asn564 of iSH2 to Asn345 of C2 form the major interaction sites. The topology of the C2 domain of the p110 domains in class I PI3K enzymes appears to be highly conserved despite the fact that this domain has lower sequence homology than the other four domains (27% identity between α and γ). The differences between the C2 domains of p110α and p110γ are concentrated in the loops connecting the β-strands and includes insertions/deletions: the loop spanning residues 406 to 424, for example, is ten residues shorter in p110α than in p110γ (Fig. 2). Differences in conformation between the loops of the two isoforms may be a consequence of the interaction of the C2 domain of p110α with the iSH2 domain of the regulatory subunit p85 (p85 is not the regulatory subunit of p110γ). Importantly, the conformation that the loops adopt in p110γ makes it impossible for the iSH2 coiled-coil to fit in a position equivalent to that of the p110α/niSH2 complex.  Figure 2 Figure 2 Structural alignment and overlap of human p110α/niSH2 heterodimer (PDB id 2RD0) and wild boar p110γ (PDB id 1E8X)in relationship to the iSH2 domain of p110α. (A) Ribbon diagram of the p110α/niSH2 C2 (green) and p110γ ... The helical domain is connected through a linker (residues 481 to 524) to the C2 domain and through another linker (residues 525 to 696) to the kinase domain (Fig. 1). The kinase domain (residues 696 to 1068) folds as an α/β structure composed of two subdomains separated by a cleft that harbors the catalytic site of the enzyme, in an arrangement reminiscent of other kinases. This similarity allows assignment of the catalytic and the activation loops of p110α to residues 912 to 920 and 933 to 957. The structure of this domain is conserved among Class I PI3Ks (rmsd between p110α and p110γ for 288 Cα atoms is 1.8 Å), especially for residues surrounding the binding pocket. The largest differences occur in the the helices spanning residues 856 to 865, a region that lines the ATP binding site, as well as in residues 1032 to 1048 (rmsd 3.2 Å), a region that contains two positions that are mutated with high frequency in cancers, (Fig. 2b). The ATP binding site was identified by aligning the structure of the kinase domain of p110α with that of the same domain in the structure of the complex of p110γ with ATP. The high degree of similarity between the two structures in this region allowed an unambiguous localization of the ATP.  Go to: Association with the lipid membrane Although PI3Ks are not integral membrane proteins, their substrate, PIP2 is mainly found as a plasma membrane component. To gain access to their substrates, PI3Ks must be recruited to the plasma membrane. The C2 domain within the p110 sequence is thought to provide a locus for the association of PI3Ks with membranes. In PI3Kα, iSH2 binds between the C2 domain and the rest of the p110 in such a way that if C2 and the kinase domain interact with the membrane, iSH2 must also interact (Fig. 3). In this arrangement, iSH2 would provide a large contact surface lined with positively charged residues lysines 447, 448, 480, 530, 532, 551, and 561, and arginines 461, 465, 472, 480, 523, 534, 543, and 544 (Fig. 3c). Residues 723 to 729 and 863 to 867 of the kinase domain, which includes positively charged residues Lys 723, Lys729, Lys 863, and Lys867 complete this surface. Arg349, Lys410, Arg412, Lys413, and Lys416 of the C2 domain of p110 may also interact with the membrane.  Figure 3 Figure 3 Model of the association of the p110α/niSH2 heterodimer with the lipid membrane. (A) Model of the lipid membrane with a ribbon diagram of the p110α/niSH2 structure. A black box highlights the loops that move in the mutant structure. (B) ... Go to: Cancer-specific mutations The cancer-associated mutations that have been identified in the ABD, C2, helical and kinase domains of p110α were believed to act through unrelated mechanisms [16, 17] but these hypotheses were difficult to interpret in the absence of structural information. The structure of the p110α/niSH2 suggest specific mechanisms through which these mutations increase kinase activity [7, 18, 19].  As the ABD domain was known to interact with p85, ABD mutations Arg38Cys, Arg38His and Arg88Gln were initially thought to disrupt the interaction between ABD and iSH2. However, the structure of the complex between ABD and iSH2 showed that these mutations are not located at the interface between the two domains [20]. In the structure of the p110α/niSH2 heterodimer, Arg38 and Arg88 are located at a contact surface between the ABD and the kinase domains, at hydrogen bonding distance (<3.2 Å) of Gln738, Asp743, and Asp746 of the N-terminal lobe of the kinase domain (Fig. 4a and 4b). Thus, mutations of Arg38 and Arg88 are likely to disrupt these interactions, resulting in a conformational change of the kinase domain that alters enzymatic activity.  Figure 4 Figure 4 Somatic mutations of p110α identified in human cancers localize to domain interfaces. (A) Location of representative mutations within p110α and niSH2. Amino acids mutated in cancers are shown as CPK models and framed with a black box. ... Before the determination of the structure of the p110α/niSH2 complex, the C2 domain was considered to be the main locus of interaction of PI3K with the membrane. Not surprisingly, mutations in the C2 domain were thought to change the affinity of p110α for the lipid membrane [19]. In the structure of the complex however, Asn345, which is mutated to Lys in some cancers, is within hydrogen bonding distance (2.8 Å and 3.0 Å) of Asn564 and Asp560 of iSH2, suggesting that mutation of Asn345 would disrupt the interaction of the C2 domain with iSH2, (Fig. 4a and 4c). This mutation may alter the regulatory effect of p85 on p110α rather than disrupt the interaction between p110α with the membrane. Another mutation identified in cancers, Glu453Gln, is also located at the interface between C2 and iSH2, Fig. 4d. A recently identified mutation (Cys378Arg) most likely increases the positive charge of the surface proposed to interact with the membrane, as it is contiguous with the surface of the iSH2 domain (Fig. 4c and 4d).  The two residues of the helical domain that are most frequently mutated in cancers are Glu542 and Glu545 (Fig. 4e). In the majority of cases, these two residues are mutated to Lys, causing a charge reversal. These residues as well as the less frequently mutated Gln546 are located on an exposed region of the helical domain (Fig. 4e). Biochemical studies suggested that they interact with Lys379 and Arg340 of the p85 nSH2 domain and that this interaction inhibited the activity of the catalytic subunit [20]. Though nSH2 was included in the wild type p110α/niSH2 protein complex, it was not highly ordered in the crystal. However, in the crystal structure of the same construct carrying the H1047R mutation, the nSH2 domain was clearly visible [15]. In this structure, the nSH2 is located close to the interface between the kinase and the helical domain, in a manner that allows it to interact with both domains as well with the C2 domain of p110α. Biochemical experiments showed that mutations at residues 542, 545, and 546 abrogate the inhibitory effect of nSH2 [20]. The structure suggests a mechanism through which the mutations may have this effect: they could modify the interaction of nSH2 with the helical and the kinase domains in a manner similar to that achieved by binding of the phosphotyrosine residue of physiological activators to nSH2. Other examples of somatic mutations at the interface between domains are provided by those at His701 of the kinase domain and Gln661 at the helical domain (Fig 4f).  His1047 in the kinase domain is another hot spot for somatic mutations in cancer and is associated with an unfavorable clinical prognosis breast cancers [21–23]. It is interesting that His1047 is mutated to Arg in the majority of cases, yet arginine is normally present at the homologous position in human p110γ (Fig. 4g). In the structure of the p110α/niSH2 p85 complex of the wild type enzyme, His 1047 is located within a helix of the C-terminal lobe of the kinase domain and is close to the C-terminal end of the activation loop, making a hydrogen bond with the main chain carbonyl of Leu956 within the activation loop. In the structure of the H1047R mutant with and without wortmannin [15], (Fig. 5), the orientation of the arginine side chain of residue 1047 is perpendicular to that of the histidine residue in the wild type. In this orientation, Arg 1047 occupies a crevice in the kinase domain and points toward the membrane (Fig. 4g). Additional effects of this mutation include ordering of the C-terminal residues of p110α 1050 to 1062, which were disordered in the wild type (Fig. 3a). The new orientation of this loop places some of its residues directly on the surface that was proposed to interact with the membrane (Fig. 3b). The conformation of another loop (residues 864–874) that also interacts with the membrane assumes different conformations in the wild type and the mutant (Fig. 3a, b). Taken together, these changes suggest that the gain of function that results from the H1047R is a result of stronger interaction of the mutant with the membrane that, in turn, provides increased accessibility to the PIP2 substrate. This mode of increasing enzymatic activity is compatible with the observation that binding to a cognate phosporylated peptide further increases the activity of this mutant [11]. Another less frequently observed mutation, Met1043IIe, is located on the same helix and may exert its effect through changes in the activation loop (Fig. 4g).  Figure 5 Figure 5 Wortmannin bound to the p110α H1047R/niSH2. The kinase domain is shown as purple ribbons with the wortmaninn carbons in yellow. The covalent bond between K802 and wormannin is shown as a thicker line to distinguish it from other bonds. Residues ... In addition to mutations in p110α, mutations in p85α have been observed, particularly in brain tumors [2, 3]. Residues Asn564 and Asp560 of iSH2, which make H-bonds with Asn345, were found to be mutated. These iSH2 mutations probably affect PI3K activity by the same mechanism proposed above for the Asn345 mutations, i.e., by disrupting the interaction between the iSH2 and C2 domains.  Most other mutations in p85α have involved truncations or deletions starting at or near residue 571 (Fig. 6). In particular, a truncation mutant known as p65, that lacks all amino acids C-terminal to residue 571 leads to constitutively activated PI3Kα activity [24]. It is possible, that residues 581–593 constrain the location of the inhibitory nSH2 domain and that the deletion removes this constraint. Based on the crystal structure of p110/niSH2, however, an alternative possibility appears more likely: truncation at residue 571 might destabilize the iSH2 coiled-coil around residues 560 and 564 that make an important contact with Asn345 of the C2 domain (Fig. 6). Thus, the effect of this truncation may also be equivalent to that of the Asn345 mutation discussed above.  Figure 6 Figure 6 Somatic mutations of p850α identified in human cancers. (A) Modeled structure of nSH2 domain shown as a surface in relation to C2, iSH2 and helical domains. Single mutations observed in the iSH2 are shown as stick and ball representations (Lys ... Another intriguing mutation identified in p85α is Gly376Arg. Residue 376 is within the nSH2 domain in a tightly packed volume at the interface between nSH2 and the C2 domain of p110α. It forms a close contact with Glu365 of C2 and substitution of the glycine at residue 376 with a bulky positively, charged arginine residue would disrupt this contact.  In sum, most of the p85α mutations described to date, whether they be subtle point mutations or large deletions, appear to disrupt the interaction between nSH2 and iSH2 and the C2 domain of p110α, thereby relieving inhibition of the kinase domain by nSH2.  Go to: Summary and Conclusions PI3Kα is mutated in many cancers and biochemical analyses have shown that they often result constitutively activated enzymes. Some mutants, such as H1047R, can be further activated by tyrosine phosphorylated peptides derived from their physiological effectors. The increased PI3Kα activity of the mutants activate downstream processes that control cell growth, survival, apoptosis, differentiation, motility, migration, and adhesion. Structural information on PI3Kα has provided an initial look at possible mechanisms through which the oncogenic mutations may result in enzyme activation. Most commonly, mutations occur at the interfaces between p110α domains or between p110α and p85 domains, disrupting the negative regulatory influences that results from the interfacial contacts. Other mutations, such as H1047R, may affect the activity of PI3Kα by changing the interaction of the protein with the membrane. Small-cell lung cancer (SCLC) is an exceptionally aggressive disease with poor prognosis. Here, we obtained exome, transcriptome and copy-number alteration data from approximately 53 samples consisting of 36 primary human SCLC and normal tissue pairs and 17 matched SCLC and lymphoblastoid cell lines. We also obtained data for 4 primary tumors and 23 SCLC cell lines. We identified 22 significantly mutated genes in SCLC, including genes encoding kinases, G protein–coupled receptors and chromatin-modifying proteins. We found that several members of the SOX family of genes were mutated in SCLC. We also found SOX2 amplification in ~27% of the samples. Suppression of SOX2 using shRNAs blocked proliferation of SOX2-amplified SCLC lines. RNA sequencing identified multiple fusion transcripts and a recurrent RLF-MYCL1 fusion. Silencing of MYCL1 in SCLC cell lines that had the RLF-MYCL1 fusion decreased cell proliferation. These data provide an in-depth view of the spectrum of genomic alterations in SCLC and identify several potential targets for therapeutic intervention.  Lung cancer is the leading cause of cancer mortality in the United States, where it is responsible for over 160,000 deaths annually1. Approximately 10–15% of the new lung cancer cases diagnosed each year are SCLC2. The genomic landscape of SCLC is of particular interest compared to those of other solid tumors, given the unique biological characteristics of this tumor type3. SCLC is an exceptionally aggressive malignancy with a high proliferative index and an unusually strong predilection for early metastasis.  Previous efforts to characterize the genetic alterations present in SCLC tumors identified high prevalence of inactivating mutations in TP53 (75–90%)4, RB1 (60–90%)5,6 and PTEN (2–4%)7, rare activating mutations in PIK3CA, EGFR and KRAS8–10, amplification of MYC family members, EGFR and BCL2, and loss of RASSF1A, PTEN and FHIT6,11.  A better understanding of the genomic changes in this cancer will be essential to developing new therapeutics. To this end, we have applied next-generation sequencing technologies to characterize multiple exomes and a single genome of primary SCLC, as well as exomes of SCLC cell lines, together with genome-wide copy-number analysis and whole-transcriptome sequencing.  Specifically, we characterized 80 human SCLCs, including 36 primary SCLC human tumor and adjacent normal sample pairs and 17 paired SCLC cell lines and their patient-matched lymphoblastoid cell lines, as well as 4 primary SCLC tumors and 23 SCLC cell lines without matched normal controls (Supplementary Table 1). We sequenced and analyzed the complete genome of one SCLC tumor–normal tissue pair.  Exome capture, sequencing and analysis of 42 SCLC tumor–normal tissue pairs identified 26,406 somatic mutations. Approximately 30% (7,977) of these mutations were protein altering (Fig. 1a and Supplementary Table 2). The somatic mutations identified included 7,154 missense, 536 nonsense, 12 stop loss, 243 essential splice site, 32 protein-altering insertion and/or deletion (indel), 2,674 synonymous, 11,460 intronic and 4,295 other types (Fig. 1a and Supplementary Tables 3 and 4). Comparison of the protein-altering changes identified in this study with those reported in the Catalogue of Somatic Mutations in Cancer (COSMIC)12 showed that 98% (7,824/7,977) of these variations are newly identified somatic changes. Nineteen percent of the protein-altering somatic mutations reported were validated using RNA sequencing (RNA-seq) data or mass spectrometry genotyping, with a validation rate of 91% (Supplementary Table 3). We confirmed the effect of several splice-site mutations using RNA-seq data (Supplementary Table 3). We validated all of the indels reported using Sanger sequencing (Supplementary Table 4). One sample represented a distinct profile, with 2,953 mutations (757 validated protein-altering variants; Fig. 1a and Supplementary Table 3). Given the exceptionally high number of mutations in this sample, we excluded it from our calculations of the background mutation rate. Excluding the hypermutated sample, the SCLC tumors had an average of 175 protein-altering single-nucleotide variants (range 31–388) with a mean nonsynonymous mutation rate of 5.5 mutations per megabase (Fig. 1a). This is comparable to the 92 protein-altering variants observed in the previously sequenced genome of a single SCLC cell line13.  Figure 1 Figure 1 SCLC somatic mutations Analysis of the base-level transitions and transversions showed that G-to-T transversions were predominant, followed in prevalence by G-to-A and A-to-G transitions (Fig. 1b), both at the exome (Fig. 1c) and whole-genome (Fig. 1d,e and Supplementary Fig. 1) levels. This pattern is consistent with demonstrated effects of tobacco smoke carcinogens on DNA13.  In assessing the whole-genome data for an SCLC tumor–normal tissue pair, we found 59,784 somatic mutations, of which 286 were protein-altering changes (256 missense, 19 nonsense, 11 essential splice site, 77 synonymous, 13,924 intronic and 45,497 others). The average whole-genome mutation rate was 21.34 mutations per mega-base (Fig. 1d). Previously, 22,910 somatic variants were reported for the NCI-H209 SCLC cell line13.  Our mutation analysis identified protein-altering somatic single-nucleotide variants in 5,179 genes, including 4,775 genes that were mutated in the non-hypermutated SCLC sample set. Frequently mutated classes included genes encoding kinases, G protein–coupled receptors and chromatin-modifying proteins. To further understand the impact of the mutations on gene function, we applied SIFT14, Polyphen15 and Condel16 and found that ~53% of the somatic mutations identified are likely to have functional consequences according to at least two of the three methods (Supplementary Table 3). In contrast, only approximately 17% of germline variants identified in the normal samples are predicted by these methods to have a functional impact (Supplementary Fig. 2).  To further assess the relevance of mutated genes, we applied a q-score metric17 to rank significantly mutated cancer-associated genes. We identified 22 significantly mutated genes in SCLC (q score ≥ 1; false discovery rate ≤ 10%; Supplementary Table 5). These genes included TP53 and RB1 and several genes that have not previously been reported as mutated in SCLC (Fig. 2a and Supplementary Table 5). To further confirm the relevance of the 22 genes, we assessed the mutation frequency for these genes using exome data from a set of 21 additional samples (Supplementary Table 6). We found a significant correlation between the mutation frequencies of the 22 genes in the initial sample set and the validation cohort (P = 1.16 × 10−5, r2 = 0.63; Supplementary Table 7). In addition, we found that 42 genes that were mutated in our primary tumor samples (Supplementary Table 8) were also previously reported to be mutated in the genome of the NCI-H209 SCLC cell line13.  Figure 2 Figure 2 Significantly mutated genes in SCLC Mutational hotspots are indicative of genes that are relevant to cancer. In this study, we have identified 17 genes with 18 hotspot mutations (Supplementary Table 9). By comparing our mutations with those reported in COSMIC12 and a large-scale colon cancer mutation screen18, we identified an additional 150 hotspot mutations in 116 genes (Supplementary Table 9). Besides known hotspots in TP53, RB1, PIK3CA, CDKN2A and PTEN, several new hotspot mutations were identified. These included genes encoding Ras family regulators (RAB37, RASGRF1 and RASGRF2), chromatin-modifying enzymes or transcriptional regulators (EP300, DMBX1, MLL2, MED12L, TRRAP and RUNX1T1), ionotropic glutamate receptor (GRID1), kinases (STK38, LRRK2, PRKD3 and CDK14), protein phosphatases (PTPRD and PPEF2) and G protein–coupled receptors (GPR55, GPR113 and GPR133). Further, three of the genes with the top q scores—RUNX1T1, CDYL and RIMS2—contained a hotspot mutation.  In addition to the hotspots, we found mutations clustering in particular gene families and pathways (Supplementary Table 10). Evidence of clustering was found in genes in the phosphatidylinositol 3-kinase (PI3K) pathway (PIK3CA, AKT1–3, MTOR, RPS6KA2 and RPS6KA6), the mediator complex (MED12, MED12L, MED13, MED13L, MED15, MED24, MED25, MED27 and MED29), Notch and Hedgehog family members (NOTCH1, NOTCH2, NOTCH3 and SMO), glutamate receptor family members (GRIA1, GRIA2, GRIA3, GRIA4, GRIND1, GRID2 and GRM1–3, GRM 5, GRM 7 and GRM 8), SOX family members (SOX3, SOX4, SOX5, SOX6, SOX9, SOX11, SOX14 and SOX17; Fig. 2b) and DNA repair and/or checkpoint pathway genes (ATM, ATR, CHEK1 and CHEK2). The mutations in SOX family members were mutually exclusive (Supplementary Fig. 3). In contrast to non–small-cell lung cancer (NSCLC)12, we did not observe any SCLC samples with a KRAS mutation. Among the receptor tyrosine kinase genes, we identified mutations in FLT1, FLT4, KDR and KIT and members of the Ephrin family (EPHA1–7 and EPHB4). Notably, the KIT mutation affecting codon 761 has previously been reported in mast cell activation disorder and is likely an activating change19 (Supplementary Fig. 4).  Chromosomal copy-number analysis of 56 SCLC samples identified recurrent copy gains and losses (Supplementary Tables 11 and 12). Genes with copy-number loss included the previously reported RB1, RASSF1 and FHIT (Fig. 3) and several genes not previously known to be altered in SCLC, including KIF2A and CNTN3 (refs. 6,20). Among the genes with recurrent copy-number gain, we confirmed previously reported amplifications involving MYC, SOX4 and KIT (Fig. 3a, Supplementary Fig. 4b and Supplementary Table 11)6,20,21.  Figure 3 Figure 3 SOX2 is amplified in SCLC and drives proliferation In addition, we identified high levels of amplification (copy number of ≥4) of SOX2 in ~27% (15/56) of the SCLC samples (Fig. 3b). RNA-seq data showed that the majority of the SCLC samples, including those with SOX2 amplification, had higher SOX2 expression compared to adjacent normal samples (Fig. 3c). We further examined the expression of SOX2 by immunohistochemistry (IHC) and copy-number change by FISH in an independent cohort of 110 primary SCLC tumor samples (Fig. 4a,b). Expression of SOX2 was strongly correlated with increased gene copy number and with clinical stage (Fig. 4c,d).  Figure 4 Figure 4 SOX2 gene amplification and protein expression in SCLC To further assess the relevance of SOX2 in SCLC, we analyzed a panel of SCLC cell lines for SOX2 protein expression and gene copy number (Supplementary Fig. 5). Among these cell lines, H446 and H720 both had strong SOX2 protein expression, and H720 was found to have elevated gene copy number. SOX2 has previously been implicated in the maintenance of proliferative potential and stem cell function22–25. To test whether H446 and H720 were dependent on SOX2 for continued growth and proliferation, we stably transduced them with lentiviruses carrying either a doxycycline-inducible SOX2-targeting short hairpin RNA (shRNA) or a scrambled control shRNA. Induction of SOX2 shRNA in both H446 and H720 resulted in lower amounts of SOX2 protein and reduced cell proliferation (Fig. 3d,e). Previously, amplification of SOX2 and its role as an oncogene have been reported in lung and esophageal squamous cell carcinoma26. Our findings further support the idea of SOX2 as a genuine SCLC driver gene.  Analysis of RNA-seq data obtained from SCLC samples for fusion transcripts identified 41 gene fusions, including 4 recurrent fusions (Supplementary Table 13). A majority of the predicted gene fusions were intrachromosomal (83%, 34/41). All of the gene fusions reported were verified and confirmed to be somatic by RT-PCR Supplementary Table 13). A fusion involving RLF and MYCL1 (Supplementary Fig. 6a) was found in one primary SCLC tumor and four SCLC cell lines (H889, HCC33, H1092 and COR-L47). RLF and MYCL1 are ~259 kb apart and are encoded by opposing strands. The observed fusion requires an inversion event that brings exon 1 of RLF in frame with MYCL1, leading to the expression of a fusion protein composed of the first 79 amino acids of RLF and a MYCL1 protein lacking its first 27 amino acids, thereby generating a 446-residue fusion protein. The clinical sample that had the RLF-MYCL1 fusion also overexpressed MYCL1. This fusion has previously been noted27, but its role as an oncogene in SCLC has not been established. We found that small interfering RNA (siRNA)-mediated targeting of MYCL1 in H1092 and CORL47 fusion-positive cells effectively reduced the proliferation of these cells, strongly suggesting a functional role for MYCL1 in SCLC (Supplementary Fig. 6).  Multiple gene fusions involving kinase genes have recently been shown to be activating28. We identified four such fusions—NPEPPS-EPHA6, SKP1-CDKL3, NEK4-SFMBT1 and ZAK-RAPGEF4—that are predicted by sequence to result in functional fusion proteins (Fig. 5 and Supplementary Figs. 7–9). The roles of these fusion products in cancer remain to be elucidated.  Figure 5 Figure 5 Kinase fusions In this study, we have identified multiple new recurrent somatic mutations in SCLC, including multiple mutations and copy-number alterations in SOX gene family members. The potential role of SOX family members in SCLC is further emphasized here by the identification of SOX2 amplification and overexpression in approximately a quarter of the SCLC samples analyzed. SOX proteins have an important role in diverse biological processes, including cell type specification. Among the SOX family members, SOX2 in particular is a key factor in the maintenance of pluripotency and self-renewal of stem cells23. Aberrant SOX2 expression has also been implicated in reprogramming mature cells to acquired pluripotency24. Its expression in mouse fibroblasts, together with FoxG1, has been shown to generate self-renewing neural precursor cells25. Conditional deletion of Sox2 in mice indicates its critical role in lung development22. Conversely, overexpression of SOX2 in lung epithelial cells has been shown to promote tumorigenesis29.  Notably, conditional induction of SOX2 in lung epithelial cells is also known to increase the number of neural progenitor cells30. SCLCs are tumors with neuroendocrine features. SOX2 protein overexpression has previously been noted in high-grade SCLC31, and immunoreactive antibodies against SOX2 have been detected in sera from SCLC patients32. These observations, together with the frequent amplifications identified here, imply that SOX2 has an important role as a putative lineage-survival oncogene in SCLC. This suggestion is further supported by the correlation of SOX2 expression with SCLC stage and the role of SOX2 expression in maintaining SCLC proliferation.  The recurrent nature of the RLF-MYCL1 fusion and its functional relevance provide additional opportunities for therapeutic intervention in SCLC. Recently, oncogenic kinase gene fusions have become a major focus of interest in the therapeutic targeting of NSCLC33–35. Understanding the role of tumor-specific in-frame kinase fusion transcripts identified in SCLC in this study may provide promising opportunities for targeted therapy development.  Go to: ONLINE METHODS Samples, DNA and RNA preparations  In this study, we have characterized 80 human SCLCs, including 36 primary SCLC human tumor and adjacent normal sample pairs and 17 paired SCLC cell lines and their patient-matched lymphoblastoid lines, as well as 4 primary SCLC tumors and 23 SCLC cell lines without matched normal controls (Supplementary Table 1).  Patient-matched fresh-frozen primary SCLC tumors and normal tissue samples were obtained from commercial sources or the Johns Hopkins tissue repository (Supplementary Table 1). All samples used in the study had appropriate IRB approval and informed consent from study participants. All tumor and normal tissues were subjected to review by a pathologist to confirm diagnosis and tumor content. The Qiagen AllPrep DNA/RNA kit was used to prepare DNA and RNA.  Exome capture and sequencing  We analyzed the exomes of 42 SCLC samples (30 primary tumor–normal tissue pairs and 12 paired cell lines) and their patient-matched normal samples to assess their mutational burden. We also obtained exome data for an additional 21 SCLC samples that included 5 primary SCLC tumors and 16 SCLC cell lines (Supplementary Table 1). Exome capture was performed using the Agilent SureSelect Human All Exome kit (38 Mb or 50 Mb). The SureSelect 50 Mb kit includes all of the capture probes from the 38 Mb kit plus some additional content derived from CCDS, GENCODE and RefSeq. Exome capture libraries were sequenced by HiSeq 2000 (Illumina) to generate 2 × 75-bp paired-end data (Supplementary Table 1). Targeted mean coverage of 80× and 162× with 96% and 92% of bases covered at ≥10× was achieved for 38 Mb and 50 Mb exome libraries, respectively (Supplementary Table 2).  RNA-seq  We obtained RNA-seq data for 55 samples (24 primary tumor–normal tissue pairs, 7 primary tumors, 2 adjacent normal samples and 22 SCLC cell lines) using the TruSeq RNA Sample Preparation kit (Illumina). Libraries were multiplexed two per lane and sequenced on HiSeq 2000 to obtain at least ~30 million paired-end (2 × 75-bp) reads per sample.  Sequence data processing  All sequencing reads were evaluated for quality using the Bioconductor ShortRead package36. Sample identity was confirmed by comparing data derived from exome sequencing and RNA-seq against Illumina 2.5 M array data as described18.  Variant calling and validation  Sequencing reads were mapped to the UCSC human reference genome (GRCh37/hg19) using Burrows-Wheeler Aligner (BWA) software37 set to default parameters. Local realignment, duplicate marking and raw variant calling were performed as described previously38. Known germline variations represented in dbSNP Build 131 (ref. 39) but not represented in COSMIC v56 (ref. 12) were filtered out. Variations present in the tumor sample but absent in matched normal tissue were predicted to be somatic. Predicted somatic variations were additionally filtered to include only positions with a minimum of 10× coverage in both the tumor and matched normal tissue, as well as an observed variant allele frequency of <3% in the matched normal tissue and a significant difference in variant allele counts, as determined using Fisher’s exact test. To control for possible low-level tumor contamination in adjacent normal tissue, the allele frequency cutoff was expanded to 5% if a gene was significantly mutated, allowing for an additional 11 variants to be included. We performed whole-genome sequencing of the 1 hypermutated sample and only report the 755 protein-altering variants that were found in both the exome and whole-genome data for this sample. This sample was excluded from background mutation rate calculations. For unpaired samples, in addition to dbSNP, variants were filtered against normal variants from this data set, as well as normal variants from a published colon data set18. In addition, data from 2,500 normal exomes in the National Heart, Lung, and Blood Institute (NHLBI) Exome Sequencing Project was used to filter out variants and hotspot mutations. To evaluate the performance of the variant calling algorithm, we randomly selected 594 protein-altering variants and validated them using Sequenom, as described previously17. Of these variants, 91% (539) were validated as somatic. All variants that were invalidated were removed from the final set. Variants that were also validated by RNA-seq are labeled as VALIDATED: RNA-Seq to show confirmed expression of the variant (Supplementary Table 3). Indels were called using the GATK Indel Genotyper Version 2 (ref. 28). Indel validation was performed as described in a recent study18. The effects of all nonsynonymous somatic mutations on gene function were predicted using SIFT14, PolyPhen15 and Condel16. All variants were annotated using Ensembl (release 59).  Mutational significance  We evaluated the mutational significance of genes using a previously described method17, with the addition of an expression filter, as mutation rates are known to vary with expression level13,40. The hypermutated sample was excluded from analysis so that it did not affect the background mutation rate. Because of the variability in background mutation, the uniform background mutation rate used to assess the significance of mutation in cancer-associated genes is at times lower than the actual mutation rate in some regions, resulting in false positive candidates, such as the olfactory genes, seeming to be significantly mutated cancer-associated genes. To address this, a recent study used an RNA-seq–based expression filter to focus on expressed genes, thereby potentially filtering out genes that are expressed at very low levels or are not expressed at all41. In this study, we classified average gene expression on the basis of RNA-seq data into tertiles (high, medium and low) and used this information to remove low expressors that would otherwise be identified as significantly mutated cancer-associated genes.  Whole-genome, RNA-seq and pathway analysis  Whole-genome analysis, RNA-seq–based expression assessment and pathway-level analysis were performed as described previously18.  SNP array data generation and analysis  Illumina HumanOmni2.5_4v1 arrays were used to assay 56 samples (36 primary tumor–normal pairs, 15 SCLC cell line–normal pairs, 1 SCLC cell line and 4 unpaired primary tumors) for genotype, DNA copy number and loss of heterozygosity (LOH) at ~2.5 million SNP positions. These samples all passed our quality control metrics for sample identity and data quality. A subset of 2,295,239 high-quality SNPs was selected for all analyses.  After making modifications to permit use with Illumina array data, we applied the PICNIC42 algorithm to estimate total copy number, allele-specific copy number and LOH, as described recently18. Recurrent genomic regions with DNA copy gain and loss were identified using GISTIC, version 2.0 (ref. 43).  Fusion detection and validation  Fusion identification and validation were performed as has been recently described18.  Cell lines and culture conditions  All cell lines used in the study, except where noted, were cultured in RPMI 1640 supplemented with 10% FBS. H446 and H720 were cultured in RPMI 1640 with 10% tetracycline-free FBS (Hyclone, R10). Cell line identity for lines used to assess SOX2 copy number was confirmed by short tandem repeat (STR) profiling using the StemElite ID System (Promega). HCC33, HCC2433, H289, H2141, H2107, H209, H1963, H1672, H1607, H1450, H1339, H1184, H2171, HCC1772, HCC970, H128 and H2195 SCLC cell lines, their patient-matched lymphoblastoid lines and their culture conditions have been described previously44–46 (Supplementary Table 1). Additional SCLC cell lines were obtained from the American Type Culture Collection (ATCC).  Doxycycline-inducible shRNA-expressing cell lines and protein blotting  Scrambled or SOX2-targeting (TRC Clone TRCN0000003253) shRNAs were cloned as annealed oligonucleotides (Sigma) into Tet-pLKO-puro (Addgene plasmid 21915) digested with AgeI and EcoRI according to published protocols47,48. Sequence-verified clones were used to produce lentiviral particles according to TRC protocols. Lentiviral supernatants were used to infect cultured H446 or H720 cells in R10 medium at low multiplicity of infection in the presence of 8 µg/ml polybrene for 16 h. After incubation, medium was replaced with fresh R10, and cells were cultured for an additional 24 h before being selected and maintained in 500 ng/ml puromycin. The optimal doxycycline dose for inducible knockdown was determined to be 2 µg/ml, which was the minimum dose that resulted in maximal knockdown of SOX2 after 96 h. The effect of SOX2 knockdown on the amount of SOX2 protein was assessed by protein blot using antibody to SOX2 (Cell Signaling Technology 27485) or GAPDH (Santa Cruz Biotechnology, sc-25778) horseradish peroxidase (HRP)-conjugated secondary antibodies, followed by signal detection with chemiluminescence (GE Healthcare Life Sciences).  Cell viability and proliferation assays  Stable cell lines were plated in quad-ruplicate at a density of 1 × 103 cells per well in opaque 96-well plates in the presence or absence of 2 µg/ml doxycycline. Cells were plated in replicate plates for each time point tested. ATP content was measured as an indicator of metabolically active cells using the CellTiter-Glo Luminescent Cell Viability Assay (Promega) read on a SpectraMax M2e plate reader in luminescence mode (Molecular Devices). Viability was normalized between cell lines at 48 h to correct for differences in the initial number of cells plated in each group. All experiments were repeated a minimum of three times with similar results, and one representative experiment is shown.  Analysis of copy-number variation in SCLC cell lines  SOX2 copy number was assessed by quantitative RT-PCR using TaqMan Copy Number Assays (Hs02719379_cn) on a StepOnePlus Real-Time PCR System (Applied Biosystems). RPPH1 served as the reference gene (Applied Biosystems). Copy-number calls relative to normal human genomic DNA (Promega) were made with CopyCaller v2.0 (Applied Biosystems).  Tissue microarrays  SCLC tissue microarrays were obtained from US Biomax (LC703, LC802a, LC1009 and LC10010a) for IHC and FISH as fresh-cut slides. The four tissue microarrays contain replicate cores and a small set of overlapping cases. For analysis, missing or inconclusive cores were removed, and the replicate or overlapping case core with the highest percentage of tumor area was used for analysis, yielding 110 unique SCLC cases and 15 normal lung cases. Histological diagnosis with SCLC was confirmed by an attending pathologist.  Immunohistochemistry  IHC for SOX2 was performed on the tissue microarrays using a Leica Bond-III automated slide stainer (Leica Microsystems). The 4-µm sections were deparaffinized and subjected to antigen retrieval with Cell Conditioning Solution (high pH CC1 standard, Ventana Medical Systems) for 60 min. Sections were then incubated for 44 min with rabbit monoclonal antibody to SOX2 (1:100 dilution; clone SP76, Cellmarque). Reactions were developed through biotin-free, polymer detection (Ultra-view, Ventana Medical Systems) according to the manufacturer’s instructions.  Scoring was performed on each sample. Nuclear labeling was scored by intensity (no (0), weak (1), moderate (2) or strong (3)) and for extent (expressed as the percentage of nuclei that were positive). Results were expressed by assigning a composite IHC score that was calculated by multiplying the intensity score by the percentage of nuclei with positive staining, with a maximum value of 300.  FISH analysis  FISH was performed on the tissue microarrays. The BAC clone RP11-459K6 containing a human DNA insert from the genomic region of SOX2 (previously validated by PCR) was used for preparation of the SOX2 FISH probe. The SOX2 probe was validated for chromosome mapping and quality of hybridization in the human lymphoblastoid cell line AG09391 (Coriell Institute).  One slide of each tissue microarray was subjected to a two-color FISH assay using a mixture of the SOX2 probe (red) and a commercially available probe for the chromosome 3 centromere (Kreatech) (green). The steps before hybridization were performed using the Zymed Spot-Light Tissue Pretreatment kit (Invitrogen) according to the manufacturer’s instructions.  Analysis was performed on an epifluorescence microscope using single interference filter sets for blue (DAPI), green (FITC) and red (Texas red). For each interference filter, monochromatic images were acquired and merged using CytoVision (Leica Microsystems). Tumor cells were scored for copy-number signals of SOX2 in 30–50 cells. In this analysis, a scoring system was proposed to identify increased levels of copy number per cell. Scores were assigned on a scale from 1–6 (according to pattern of copy-number gain, median per-cell change): 1 (no, 1–2), 2 (low, 2–3), 3 (moderate, 3–4), 4 (high, 4–5), 5 (very high, >5), 6 (gene amplification, gene clusters).  MYCL1 knockdown studies  The SCLC cell lines, NCI-H1092, CORL47 and NCI-H2171 were transfected with siRNA pools targeting MYCL1 (Dharmacon) or with a non-targeting control siRNA (Dharmacon) following a reverse transfection protocol. The cells were incubated at 37 °C for 5 d after transfection and were subjected to a cell viability assay using the CellTiter-Glo kit (Promega).  MYCL1 (Hs00420495_m1) and GAPDH (Hs00266705_g1) TaqMan probes and primers were obtained from Life Technologies and were used to assess knockdown according to the manufacturer’s instructions. Data were analyzed using the ΔΔCT method by normalizing to GAPDH and mock-transfected controls. TaqMan reactions were performed in duplicate to obtain a mean value and s.d. P values were calculated by t test. Oncogenic mutations in PIK3CA, which encodes the phosphoinositide-3-kinase (PI3K) catalytic subunit p110α, occur in ∼25% of human breast cancers. In this study, we report the development of a knock-in mouse model for breast cancer where the endogenous Pik3ca allele was modified to allow tissue-specific conditional expression of a frequently found Pik3caH1047R (Pik3cae20H1047R) mutant allele. We found that activation of the latent Pik3caH1047R allele resulted in breast tumors with multiple histological types. Whole-exome analysis of the Pik3caH1047R-driven mammary tumors identified multiple mutations, including Trp53 mutations that appeared spontaneously during the development of adenocarinoma and spindle cell tumors. Further, we used this model to test the efficacy of GDC-0941, a PI3K inhibitor, in clinical development, and showed that the tumors respond to PI3K inhibition.  Keywords: Pik3ca, H1047R, knock-in, mammary gland, Trp53, exome sequencing Go to: Introduction The class-IA phosphoinositide-3-kinase (PI3K) catalytic subunits, p110α, p110β and p110δ, occur as an obligate heterodimer in complex with p85α-, p55α-, p50α-, p85β- or p55γ-regulatory subunits.1, 2, 3 In normal cells, PI3Ks are maintained in a basal inactive state and become active following growth factor stimulation and cell-surface-receptor engagement. Activated PI3Ks phosphorylate and convert phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-trisphosphate (PIP3). Elevated cellular PIP3 levels promote the activation of PI3K effectors, which in turn regulate a number of cellular processes, including cell growth, proliferation and survival.1, 2, 3  Frequent somatic mutations in PIK3CA, the gene that encodes p110α, have been reported in colorectal, breast and liver cancers.4, 5, 6 The majority of the reported p110α mutations occur in three hotspots—two (E542K and E545K) in the helical domain and one (H1047R) in the kinase domain.7, 8 These hotspot mutations result in an oncogenic p110α capable of constitutively activating downstream signaling.8 Further, the p110α mutants when expressed in cells can lead to cellular transformation and support tumor formation in xenograft models.4, 9, 10, 11, 12  Genetically engineered mouse models (GEMMs) of human cancer serve as an important resource for understanding tumor initiation and progression.13 GEMMs have also been used to test therapeutics and develop treatment strategies.14 Studies aimed at understanding oncogenic transformation by mutant Pik3ca have primarily used cell-based systems, xenograft models and conditional transgenic models.4, 10, 11, 12, 15, 16, 17, 18 Given the high frequency of PIK3CA mutations and ongoing efforts to develop small-molecule inhibitors, a knock-in mouse model that can express endogenous levels of mutant Pik3ca from its native promoter and genomic architecture would be a valuable tool to study tumor initiation, progression and treatment. Also, such a model would lend itself to identification of lesions that cooperate with mutant Pik3ca during tumor development. With this in mind, we generated a GEMM where we have modified the endogenous Pik3ca allele by placing a dormant copy of an oncogenic mutant Pik3ca exon 20, encoding H1047R, adjacent to the wild-type coding exon 20. Prior to activation of the dormant mutant allele, the engineered mice expressed the modified wild-type Pik3ca (Pik3cae20mwt) allele. However, upon Cre-mediated recombination, the mutant Pik3cae20H1047R allele was conditionally activated in the mouse mammary glands, leading to its expression and tumorigenesis.  Although next-generation sequencing has enabled basepair-level characterization of human tumors as they evolve and progress,19, 20 mouse models of cancer provide a defined experimentally tractable system that allows systematic sampling and characterization of tumors as they evolve. In an effort to characterize the tumors at the sequence level, we performed whole-exome capture and sequencing of tumors, and identified the emergence of spontaneous Trp53 mutations as a potential cooperating event in spindle cell tumor and adenocarcinoma formation. We further report additional somatic mutations and copy-number aberrations in breast tumors from this model. In addition to molecular characterization, we tested the ability of a PI3K small-molecule inhibitor for efficacy and show that the tumors respond to inhibitor treatment.  Go to: Results Engineering conditionally activatable Pik3caH1047R mice  To study the role of Pik3ca mutations in tumor initiation, development and progression, we have engineered a mouse capable of conditionally expressing the mutant Pik3ca H1047R allele driven by its native promoter. The engineered mouse, Pik3cae20mwt, has a wild-type Pik3ca exon 20 that was modified to contain flanking loxP sites. The modified wild-type exon is followed by a transcriptional stop cassette and a copy of Pik3ca exon 20 encoding an H1047R mutation (Figures 1a–d). A targeting vector (Figure 1b) was used to modify the endogenous Pik3ca locus in mouse embryonic stem (ES) cells. Two independent ES cell clones containing the appropriate modification, identified by Southern blotting (Figures 1f and g), were used to generate chimeric mice that showed germline transmission of the Pik3cae20mwt allele. Intercrosses involving heterozygous Pik3cae20mwt/+ mice resulted in progenies with the appropriate genotypes at expected Mendelian ratios (Supplementary Table 1). Unlike the embryonic lethality observed in Pik3ca−/−-null mice,21 prior to Cre-mediated recombination, we found that the homozygous Pik3cae20mwt/e20mwt animals were born at the expected Mendelian frequency (Supplementary Table 1), indicating that the modified Pik3cae20mwt functioned analogous to the wild-type Pik3ca allele.  Figure 1 Figure 1 Generation of Pik3cae20H1047R conditionally activatable knock-in allele. (a–d) Genomic locus encoding Pik3ca locus (a); targeting construct (b); targeted allele (c); targeted locus in the ES after removal of the neomycin cassette (d); and Pik3ca ... Mammary gland-specific expression of Pik3cae20H1047R allele  As PIK3CA is mutated in over 25% of human breast cancers9 we tested the role of Pik3caH1047R in breast tumorigenesis by breeding the Pik3cae20mwt mouse to an MMTV-Cre transgenic mouse.22, 23 The MMTV-Cre strain expresses P1 Cre recombinase under the control of a mammary gland-permissive MMTV-LTR promoter, allowing recombination and expression of Pik3cae20H1047R. We confirmed the expression of the Pik3cae20H1047R mutant allele and the wild-type Pik3ca allele by sequencing the cDNA corresponding to the Pik3ca mRNA extracted from the mammary glands of the Pik3cae20H1047R/+ mouse (Figure 1h). In contrast, RNA extracted from kidney showed the expression of only wild-type Pik3ca from the Pik3cae20mwt allele (Figure 1i), confirming mammary-specific expression of the mutant Pik3cae20H1047R allele.  Expression of Pik3cae20H1047R leads to enhanced mammary branch morphogenesis  Previous studies have shown that expression of oncogenes or loss of tumor suppressors, such as Pten, affects branching and morphogenesis of mouse mammary glands.17, 24, 25 Hence, we studied the effect of expression of Pik3cae20H1047R on mammary gland development using whole-mount staining. At 12 weeks, Pik3cae20H1047R/+ mutant mammary glands showed precocious lobulo-alveolar development and hyper-branched ductal structures compared to control mammary glands (Supplementary Figures 1a–d). We found that there was a ∼2-fold increase in ductal branch points in mutant animals (n=6) as compared with the control group (MMTV-Cre (n=3), P=0.003; Pik3cae20mwt/+ (n=4), P=0.001; Supplementary Figure 1e). By 50 weeks, the Pik3cae20H1047R/+ mutant mammary glands showed a feathery, hyper-branched morphology compared with the control mammary glands (Supplementary Figures 1f and g). Further, histological sections of the Pik3cae20H1047R/+ mutant mammary glands showed evidence of tumor nodules at 50 weeks of age (Supplementary Figures 1h and i). This is similar to the mammary branching morphogenesis defects reported in previous studies involving Pten conditional null mice and other mammary-specific transgenic models with PI3K pathway activation.17, 24  Pik3cae20H1047R expression promotes mammary tumorigenesis  Female Pik3cae20H1047R/+, Pik3cae20mwt/+ and MMTV-Cre mice were aged to see if they develop mammary tumors. We found that the Pik3cae20H1047R/+ animals developed mammary gland tumors (Figures 2a–c), with a median tumor-free survival of 478.5 days. The majority of the animals developed tumors in the thoracic mammary glands (#1, 2, 3, 6 7 and 8), whereas some developed tumors in the inguino-abdominal mammary glands (#4, 5, 9 and 10), and a few developed tumors in both thoracic and inguino-abdominal mammary glands. In contrast to Pik3cae20H1047R/+, the control Pik3cae20mwt/+ and MMTV-Cre animals remained tumor-free for the duration of the study. The mammary gland tumor phenotype with a similar latency was also observed in Pik3cae20H1047R/+ mice derived from a second independent targeted ES clone (line 2; Figure 2c), further confirming the specificity of the Pik3cae20H1047R expression-driven tumor phenotype.  Figure 2 Figure 2 Pik3cae20H1047R/+ mice develop mammary tumors. (a, b) Mouse bearing tumor in the abdominal mammary (a) and thoracic mammary (b) glands. The white arrowheads indicate the location of the tumors. (c) Kaplan–Meier plot depicting tumor-free ... MMTV-LTR promoter drives gene expression in both virgin and lactating mammary glands.22 Given this, we compared tumor incidence in nulliparous and multiparous mice, and found that latency was significantly shortened from 492 to 465 days (P=0.0002) in multiparous Pik3cae20H1047R/+ mice as compared with nulliparous Pik3cae20H1047R/+ animals (Supplementary Figure 2), suggesting that pregnancy-related mammary gland changes potentially contribute to accelerated tumorigenesis. Alternatively, during pregnancy, an increase in progenitor cells undergoing Cre-mediated Pik3ca activation may contribute to the accelerated tumorigenesis observed.26  Although the MMTV-LTR promoter directs Cre expression starting at day 6 after birth in mammary epithelial cells primarily, it is also known to drive expression in salivary glands and male seminal vesicles.23 In performing histological analysis of salivary glands from mice bearing mammary tumors and seminal vesicles from males aged between 35 and 41 weeks, we found no evidence of tumors (Supplementary Figures 3a and b). However, morphologically the seminal vesicles were larger in Pik3cae20H1047R/+ mice as compared with the control animals. Histological analysis of seminal vesicle cross-sections indicated an increase in seminal vesicle fluid secretion leading to ductal distention and enlargement (Supplementary Figures 3c and d). However, this did not affect the breeding and fertility of Pik3cae20H1047R/+ males.  Histology and signaling activation in Pik3cae20H1047R-driven tumors  We performed histological analysis of Pik3cae20H1047R/+ tumors to understand its pathological features and found that the majority of the tumors showed features consistent with fibroadenoma (76.9% (20/26)) (Figure 2d), whereas a few showed histopathological features of adenocarcinoma (15.4% (4/26)) (Figures 2e and f) or spindle cell neoplasia (7.7% (2/26)) (Figure 2g).  To further characterize tumors, we tested the PI3K pathway activation status of the histologically distinct tumor types. In all tumors types, we observed elevated pAKT and pS6-kinase (Figure 2h), both downstream from PI3K, indicative of constitutive activation of the pathway in these tumors.  In an effort to further understand the mammary tumor types observed, we studied the expression of basal cytokeratin 5 (CK5), luminal cytokeratin 18 (CK18), estrogen receptor (ER), progesterone receptor (PR) and a mesenchymal marker, vimentin, in them (Figure 3). While we found fibroadenomas and adenocarcinomas to be CK5+, CK18+, ER+ and PR+, the spindle cell tumors were ER−/PR− (Figure 3o) and CK5− (data not shown). Interestingly, this is reminiscent of the ER− and PR− status reported for human mammary spindle cell tumors.27, 28 In addition, the spindle cell tumors were CK18+/vimentin+ (Figures 3n and p), indicating that the cells are undergoing epithelial–mesenchymal transition (EMT).  Figure 3 Figure 3 Immunofluorescence staining of Pik3cae20H1047R mammary tumors. (a–p) Serial sections of a fibroadenoma (a–d), two adenocarcinomas (e–h and i–l) and a spindle cell tumor (m–p) stained with H&E (a, e, i, ... Genomic analysis of Pik3cae20H1047R-driven mammary tumors  Prior to performing genomic analysis of Pik3caH1047R mammary tumors, given the long latency for tumor formation, we first tested whether tumor explants derived from mammary tumors would grow as xenografts in SCID mice. The majority of fibroadenomas, adenocarcinomas and spindle cell tumors that we tested formed tumors. Interestingly, the histology of some xenograft tumors derived from fibroadenoma explants showed features of adenocarcinoma, indicating that fibroadenomas are likely benign and that only a subset of cells with tumorigenic potential within the original explants contributed to the development of tumors upon passage (Supplementary Figures 4a and b). However, the spindle cell tumor explants maintained their histological features during passage (Supplementary Figures 4c and d).  We performed microarray-based gene expression analyses of different mammary tumor subtypes and control mammary glands to further understand their molecular characteristics. Hierarchical clustering of expression data using markers for epithelial cells, stem cells and EMT29, 30 showed that primary fibroadenomas, adenocarcinomas and tumors derived from passaging the explants from these tumor types clustered together, indicating a common origin and a shared set of gene expression changes (Figure 4a). In contrast to the spindle cell type, both primary and passaged tumors, clustered together showing features of EMT, suggests a distinct cellular origin or is reflective of a distinct set of cooperating mutations in this tumor type (Figure 4a).  Figure 4 Figure 4 Expression profile and genomic aberrations in Pik3cae20H1047R-driven mammary tumors. (a) Heatmap derived by hierarchical clustering of the histologically distinct mammary tumor types using the expression level for the set of genes indicated. Mammary tumors ... Whole-exome capture and sequencing have been applied in identifying somatic mutations in the coding regions of genomes.31 In order to understand the emergence of secondary mutations in the various mammary tumor types observed in our model, we performed whole-exome capture and sequencing of a select set of samples (Supplementary Table 2). Besides the presence of the engineered Pik3ca H1047R mutation, the tumors also contained several additional somatic changes (Supplementary Table 3 and Supplementary Figure 5). We found that the fibroadenomas had a low level of somatic mutations (between 2 and 13), followed by adenocarcinomas (between 4 and 61 mutations) and spindle cell tumors (between 44 and 88 mutations). Notably, we found the Trp53 I192N mutation in an adenocarcinoma and an R245H mutation in a spindle cell tumor. The R245H mutation is equivalent of R248H TP53 hotspot mutation found in human cancers.32 Additionally, to understand the prevalence of the Trp53 mutation in the oncogenic Pik3ca-driven mouse tumors, we sequenced the coding exons of Trp53 in an independent spindle cell tumor and identified an A135V mutation (Figure 4b, and Supplementary Tables 3 and 5). All Trp53 mutations identified in this study occur in the DNA-binding domain and are known to impair Trp53 function and have been reported in human cancers.32, 33, 34 Further, the Trp53 mutation and the majority of the mutations identified in the primary spindle cell tumor were also found in the explant-derived tumors following passage, indicating that the primary spindle tumor was likely genetically less heterogeneous (Supplementary Figure 5). As observed in the spindle cell tumors, the majority of the mutations present in the primary adenocarcinoma were also present in the tumors derived following transplantation and passaging (Supplementary Figure 5). Analysis of the effect of protein-altering somatic changes using SIFT35 and/or PolyPhen36 identified 39 mutations, including those in Plk1, Tssk2 and Smg1 kinases, to have a functional effect suggesting that some of these may act as drivers (Supplementary Table 3 and Supplementary Figure 5). Interestingly, SMG1 mutations have been reported previously in human breast cancer.37  In addition to whole-exome mutational analysis, we profiled the tumors on CGH arrays to understand chromosomal copy-number alteration. We found that both fibroadenomas and adenocarcinomas showed few regions of copy-number aberrations (Supplementary Table 4). In contrast to fibroadenomas and adenocarcinomas, we found several regions with copy-number alterations in spindle cell tumor samples when compared with normal mammary glands (Supplementary Table 4 and Supplementary Figures 6s and 7a). Spindle cell tumors are also characterized by two regions of chromosomal loss that fall within chromosomes 11 and 12, both of which contain several coding genes. In particular, deletion in chromosome 11 resulted in loss of Nf1 (Supplementary Figure 7) and is consistent with its downregulated expression (log2 ratio of −2.09; P=8.338e−05; Figure 4a), suggesting that the Ras–MAPK pathway might also be engaged in these tumors.  Pik3cae20H1047R/+ mammary tumors respond to PI3K inhibitor  Engineered mouse models provide an ideal platform for candidate drug testing in a preclinical setting.14 As the mice in this study develop mammary tumors after a long latency, we used our explant-derived tumor model to test its utility in assessing drug efficacy. Explants derived from spindle cell tumors with Trp53 mutation were implanted subcutaneously near the mammary fat pad and treated with a PI3K inhibitor, GDC-0941,38, 39 once the tumors had reached a volume of 200–300 mm3. Tumor-bearing mice were treated in four groups of nine animals each with 50, 100 and 150 mg/kg GDC-0941 or a vehicle. We found that animals treated with GDC-0941 showed the highest tumor growth inhibition (TGI) of 85% at 150 mg/kg, although TGI was also observed at the other tested doses compared with vehicle treatment (Figure 5a), indicating that these tumors were still dependent on the mutant Pik3ca signaling for their growth. Further, log-rank tests of these data regarding time to progression showed that all the drug treatment groups showed a statistically significant difference when compared with the vehicle-treated animals at all the doses tested (P<0.0001 at 150 mg/kg; Supplementary Figure 8). Consistent with the TGI observed, tumors from mice treated with GDC-0941 showed a significant decrease in pAKT and pS6 at least up to 10 h following treatment (Figure 5b), confirming the contribution of PI3K inhibition in tumor growth inhibition.  Figure 5 Figure 5 In vivo antitumor activity of PI3K inhibitor. (a) Pik3ca e20H1047R mammary tumor explants grown as xenografts respond to treatment with GDC-0941. 35, 41 and 85% on the graph represent %TGI with respect to control (n=9) for each of the ... Go to: Discussion GEMMs of cancer are invaluable for understanding tumor initiation, progression and therapy evaluation.40 In addition, application of next-generation sequencing technologies to these models can provide valuable information on the molecular aberrations that arise during the evolution of tumors. Here we describe a conditionally activatable Pik3caH1047R mouse model of breast cancer and show that these mice develop mammary tumors of multiple histological types, including fibroadenomas, adenocarcinomas and spindle cell neoplasia. We found that the fibroadenomas and adenocarcinomas were positive for hormone receptors and cytokeratins (CK5+/CK18+), indicating they are epithelial and myoepithelial in origin. By contrast, the spindle cell tumors, whereas being positive for cytokeratin 18, were distinct in that they were ER/PR-negative but vimentin-positive. This is reminiscent of human mammary spindle cell tumors.27, 28  PIK3CA mutations are observed in multiple human breast cancer subtypes, including of hormone receptor-positive (HR+), Her2+ triple-negative (TN) and metaplastic types.41 This is consistent with the multiple histological types observed in our breast cancer model and other published transgenic Pik3caH1047R breast tumor models.16, 17, 18 However, the latency of breast tumor development in our model is longer compared with these studies where the Pik3caH1047R mutant cDNA was expressed under the control of either an ROSA26 locus promoter (median survival ∼140 days in line A; >500 days in line NLST)16 or a chicken β-actin promoter (average latency 214±22.6 days)17, 24, 25 following activation of its expression using MMTV-Cre or induction of expression from a tetracycline-inducible promoter (average latency 210 days).16, 17, 18 This likely reflects the fact that our knock-in model expresses the mutant Pik3ca allele from its endogenous promoter present in its native genomic configuration and hence more closely mimics the PIK3CAH1047R-driven tumorigenesis observed in human tumors.  The advent of next-generation sequencing technology has allowed comprehensive characterization of cancers at the sequence level.42 In applying next-generation sequencing technology, we have characterized tumors derived from our mouse model to understand additional hits required for breast tumor development following expression of the Pik3caH1047R mutant allele. Among several candidate secondary hits that may cooperate with Pik3caH1047R, we report the occurrence of Trp53 mutations in two spindle cell tumors and one adenocarcinoma sample. All three Trp53 mutations, R245H, A135V and I192N (equivalent to human TP53 mutations R248H, A138V and I195N), observed in this study occur in human cancers.32, 33, 34 TP53 and PIK3CA mutations co-occur in human breast cancer.43 Recently, loss of Trp53 has been shown to accelerate tumorigenesis in an oncogenic Pik3ca transgenic mouse breast tumor model.16 The spontaneous emergence of Trp53 mutations in our tumor model mimics the cooperative TP53 lesions observed in human breast cancer. Hence, our mouse model will be ideal to study therapeutic intervention strategies for Pik3ca-driven mammary tumors. In line with this, we demonstrate the utility of our model in testing the efficacy of GDC-0941, a PI3K inhibitor, in a subset of mammary tumor with EMT features. A previous report studied the efficacy of NVP-BEZ235, a dual pan-PI3K/mTOR inhibitor, in a Pik3caH1047R transgenic lung tumor model.15 However, given that PIK3CA mutations are more frequent in human breast cancers, our model can serve as a genetically defined system to test the efficacy of PI3K inhibitors in breast cancer and potentially help to develop treatment regimens for clinical drug testing. Also, the model can be used to understand the development of resistance to targeted therapeutics. In this context, it remains to be seen whether the c-Myc-mediated mechanism of resistance, recently reported in a transgenic oncogenic Pik3ca mammary tumor model, has a role in our model system.16, 17, 18  Besides its utility in studying mammary tumorigenesis, this model can be used to study other cancers where PIK3CA mutations have been observed, by activating the mutant Pik3ca allele using an appropriate tissue-specific Cre line. In conjunction with next-generation sequencing technologies, our model can be used to discover and understand additional driver mutations that cooperate with mutant Pik3ca in other tumor types. Given that PI3K pathway activation has been implicated in resistance to therapy,44 the Pik3caH1047R mice can also be used to model drug resistance and study therapeutic strategies to overcome resistance.  Because of increasing rates of oral infection with human papillomavirus (HPV), the incidence of oropharyngeal squamous cell carcinoma (OPSCC) has been rapidly increasing.1 Patients with HPV-related cancers tend to present at a younger age and experience markedly improved survival compared with patients with smoking- and alcohol-related head and neck cancers.1 Given that these younger patients with HPV-positive tumors are likely to survive their cancer and have to cope with the adverse effects of therapy for decades, optimizing the posttreatment quality of life for patients with OPSCC has become one of the most important issues in head and neck oncology. Many institutions favor cisplatin-based concurrent chemoradiation for high-risk OPSCC.2 However, this combined-modality treatment has notable acute and late toxic effects including dysphagia, mucositis, xerostomia, fibrosis, osteoradionecrosis, neutropenia, neurotoxicity, nephrotoxicity, and ototoxicity.3 Thus, alternative treatment options are needed to decrease toxic effects while maintaining high cure rates.  Two large-scale whole-exome sequencing studies of head and neck cancer have recently defined the genetic makeup of head and neck squamous cell cancer (HNSCC).4,5 These multi-institutional efforts revealed that the mutational landscape of HNSCC is dominated by alterations in tumor suppressors including TP53, CDKN2A, and NOTCH1, NOTCH2, and NOTCH3, while activating mutations in oncogenes were observed at a very low frequency including HRAS (5%) and PIK3CA (8%).4,5 This low frequency of activating mutations in oncogenes is disappointing from a therapeutic perspective because activated oncogene products can potentially be targeted with inactivating small molecule drugs. However, effective strategies to replace lost tumor suppressor function are lacking. A small cohort of the patients in the 2 studies were HPV positive: 4 of 32 patients in the study by Agrawal et al4 (2011) and 11 of 74 patients in the study by Stransky et al5 (2011). Stransky et al5 noted a total of 6 PIK3CA mutations in all subjects (both HPV positive and HPV negative), but a much higher proportion (albeit in a small total number of subjects) were found in the HPV-positive patients (3 of 11 [27%]) vs the HPV negative patients (3 of 63 [5%]). The aim of this study was to confirm whether activating mutations in PIK3CA are, in fact, frequent in HPV-positive HNSCC because this mutated oncogene represents a potential therapeutic target.  Methods Study population Study approval was obtained from the University of Western Ontario Research Ethics Board. A retrospective search of the London Regional Cancer Program (LRCP) pathology database was performed to identify patients diagnosed as having OPSCC from 2003 to 2009. Patient eligibility required (1) a histologically confirmed diagnosis of squamous cell carcinoma, (2) no history of head and neck cancer, and (3) the availability of a pretreatment primary site biopsy specimen for analysis. Patient data were extracted from a retrospective medical chart review, including age at diagnosis, use of tobacco and alcohol, American Joint Committee on Cancer TNM stage, treatment regimen, and posttreatment follow-up information.  Quantitative polymerase chain reaction Deparaffinization, DNA extraction, and detection of high-risk HPV types by multiplex quantitative polymerase chain reaction (qPCR) was performed as described previously.6 Standard curves were produced from 10-fold serial dilutions of CaSki cell genomic DNA. CaSki cell DNA was used as a positive control for HPV16, and HeLa cell genomic DNA was used as the HPV18 control.  Detection of pik3ca mutations by conventional pcr Tumor DNA was tested with primers flanking the known PIK3CA hot spots at codons 542, 545, and 1047 (Table 1). The PCR reactions (20 μL) were prepared using 0.2 μL of patient template DNA and amplified with Phusion DNA polymerase (Fisher Scientific) following a hot start (98°C for 30 seconds, followed by 37 cycles at 98°C for 10 seconds, 62°C for 10 seconds, and 72°C for 30 seconds to amplify the 542 and 545 regions and 98°C for 30 seconds, and followed by 37 cycles at 98°C for 10 seconds, 47°C for 10 seconds, and 72°C for 30 seconds to amplify the 1047 region). Amplified products were resolved on agarose gel, 1%. Bands of interest were extracted from agarose gel slices, purified on columns (Bio Basic), and Sanger sequenced using both forward and reverse primers. Samples with identified mutations were confirmed by repeated PCR and sequencing.  Statistical analysis Statistical analysis was performed with the R system (R Foundation for Statistical Computing). For all analyses, P ≤ .05 was considered statistically significant. Patient variables were compared using the Fisher exact test.  Results Pik3ca activating mutations are common in hpv-positive opscc Of the 87 patients, 46 were positive for HPV (53%), of which 44 were positive for type 16 and 2 were positive for type 18. A total of 17 PIK3CA mutations were noted in the 87 patients for a frequency of 19.5%. In all cases, the mutation represented a transversion. At codon 542 and 545, there was a substitution from a guanine to an adenine resulting in a nonsynonymous substitution resulting in a change from a glutamic acid (E) to a lysine (K). At codon 1047, the transversion occurred when an adenine changed to a guanine. Again, this resulted in a nonsynonymous change from a histidine (H) to an arginine (R) (examples of the Sanger sequencing results are shown in the Figure). The specific mutations observed are outlined in Table 2. PIK3CA mutations were noted in 13 of 46 HPV-positive patients (28%) and in 4 of 41 HPV-negative patients (10%), which was statistically significant (P = .03). There was a difference in the codon distribution of the mutations between the HPV-positive and negative patients, with the HPV-positive patients more likely to harbor mutations at codons 542 and 545 (12 of 13 mutations), while 3 of 4 PIK3CA mutations in the HPV-negative tumors occurred at codon 1047 (Table 2; P = .009).  Pik3ca mutations were associated with decreased tobacco use Patient demographics, tumor stage, and tobacco and alcohol use were correlated with PIK3CA mutation status for the entire cohort and for HPV-positive and negative tumors separately (Table 3). Activating PIK3CA mutations were associated with less tobacco use (P = .01), and there was a trend toward fewer PIK3CA mutations in heavy drinkers (P = .09).  Discussion Two high-impact companion publications reported the mutational landscape of head and neck squamous cell carcinoma (HNSCC) using whole-exome sequencing.4,5 These studies provided new insights into the genetic underpinnings of the disease and highlighted the high frequency of mutations in tumor suppressors TP53, CDKN2A, NOTCH1, NOTCH2, and NOTCH3. Somewhat disappointingly, there was a very low incidence of activating mutations in oncogenes. Of the few observed, PIK3CA and HRAS mutations were the most frequent, comprising 8% and 5% of the samples, respectively. The ideal result would have been a frequent mutation in a targetable oncogene such as the frequent mutations in BRAF observed in approximately 50% of malignant melanomas, which are targetable with BRAF inhibitors.7  However, both studies included only a small number of HPV-positive patients, who represent a rapidly increasing fraction of contemporary head and neck oncology. A close examination of the data in the study by Stransky et al5 revealed that the frequency of PIK3CA mutations were not equally distributed. Of the 63 HPV-negative tumors, 3 (5%) harbored PIK3CA mutations, while 3 of 11 HPV-positive tumors (27%) contained mutations. The study by Agrawal et al4 demonstrated PIK3CA mutations in 1 of 4 HPV-positive tumors and 2 of 28 HPV-negative tumors.4 Combining these 2 high-impact studies; there were PIK3CA mutations in 4 of 15 HPV-positive samples (25%) and 5 of 91 HPV-negative samples, which was significant (P = .02, Fisher exact test). Other groups have assessed PIK3CA status by PCR in head and neck tumors without regard to HPV status and revealed low rates of mutations.8,9 Kozaki et al8 (2006) evaluated 108 oral cancers and found a mutation frequency of 7%. Murugan et al9 (2008) studied 37 head and neck cancers from a variety of sites and found mutations in only 5%. In contrast to these studies, which largely included sites that are generally not HPV related, we specifically focused our efforts on the oropharynx in view of the findings of exome sequencing studies.4,5 Our study confirms that activating mutations are indeed more frequent in HPV-positive tumors with a comparable frequency to the exome sequencing studies (28%). When we pooled our results with the exome sequencing studies, the findings were significant (17 of 61 HPV-positive tumors and 9 of 133 HPV-negative tumors; P < .001, Fisher exact test). This finding, in addition to the fact that PIK3CA is frequently amplified in HNSCC,10 provides significant evidence that PIK3CA represents an important therapeutic target particularly in HPV-positive disease.  We chose to examine only the known hot spots at codons 542, 545, and 1047 outlined in the COSMIC database (http://www.sanger.ac.uk/perl/genetics/CGP/cosmic?action=bygene&ln=PIK3CA&start=1&end=1069 &coords=AA:AA) and that are well described to be oncogenic and accounted for 5 of 6 mutations noted by Stransky et al.5 The nonsynonymous mutations resulting in the changes E542K and E545K are located within exon 9 in the helical domain of PIK3CA, whereas H1047R is encoded within exon 20 and is part of the kinase domain. The probable mechanism for the oncogenicity of the E542K and E545K mutations is the disruption of an inhibitory charge-charge interaction between PIK3CA and the N-terminal SH2 domain of the p85 regulatory subunit.11 In contrast, the H1047R mutation increases binding affinity of PIK3CA for the negatively charged phosphatidylinositol substrate.11  Genome-wide analysis has shown that mutations are twice as frequent in HPV-negative than in HPV-positive tumors (4.83 vs 2.28 mutations per megabase pair, respectively).5 In strong contrast, our results show that the PIK3CA gene exhibited a higher number of mutations in the HPV-positive population. This observation suggests that either HPV cancers frequently require activation of the PIK3CA pathway to progress or that an HPV-specific mechanism leads to genetic instability in this gene. Although the connection between HPV and PIK3CA has not been specifically studied in head and neck cancer, Henken et al12 observed overexpression of PIK3CA in HPV-transformed human foreskin keratinocytes. Reduction of PIK3CA activity in these human foreskin keratinocytes resulted in reduced cellular viability, migration, and anchorage-independent growth.12 These results suggest that this pathway is critical for HPV-related oncogenesis and that these cells are “addicted” to activated PIK3CA. Further study is needed to better characterize the mechanistic roles by which PIK3CA contributes to HPV-positive head and neck cancers.  Our results also demonstrate a strong correlation between increased PIK3CA mutations and decreased exposure to tobacco. This observation is unexpected because increased mutation rates, particularly guanine to thymine (G→T) transversions in non-CpG sites, have been documented in patients with a heavy tobacco history.5 Thus, one might have predicted a decreased frequency of PIK3CA mutations in individuals with decreased tobacco consumption. Similar to our observations with PIK3CA, an increased frequency of activating mutations in epidermal growth factor receptor has been reported in non–small cell lung cancers from nonsmokers than from smokers.13 The mechanisms responsible for this phenomenon remain unknown.  The observation that HPV-positive patients tend to be younger, healthier, nonsmokers, and nondrinkers who experience markedly improved survival compared with their HPV-negative counterparts is now well described.1 Given that these young patients have a high likelihood of surviving their disease, their posttreatment quality of life becomes of paramount importance. Cisplatin-based chemoradiation is highly effective, particularly in the HPV-positive patient population. Most patients have very good functional outcomes after chemoradiation. However, a subset of patients experience severe acute and late toxic effects including hearing loss, neuropathy, renal failure, dysphagia requiring long-term gastrostomy tube dependence, and osteoradionecrosis that can have deleterious effects on patient quality of life.3 Thus, there is a great deal of interest in equally effective therapies with fewer adverse effects. However, therapy still fails in 10% to 20% of HPV-positive patients, with failure occurring because of distant metastases in approximately half.14,15 New treatment options are needed for these patients as well. Targeting the PIK3CA pathway is one strategy that may improve outcomes in HNSCC for patients with tumors harboring PIK3CA mutations. Phosphoinositide 3-kinase can be treated with pan-inhibitors, or PIK3CA can be targeted with agents specific to the catalytic 110α subunit.11 Alternate approaches include inhibiting downstream pathway members AKT and mammalian target of rapamycin (mTOR). There are numerous phase 2 trials testing these strategies in other cancers.11 In addition, 2 studies testing PX-866, a pan-PI3K inhibitor, in the metastatic setting combined with either cetuximab or docetaxel are under way for HNSCC and other solid tumors.16,17 Neither of these studies require the presence of an activating PIK3CA mutation as a criterion for entry into the study. This, combined with the low failure rate of HPV-positive patients (and thus low numbers of patients likely to enrolled compared with HPV-negative patients), and the confounding presence of another simultaneously administered chemotherapy agent make it unlikely that either will provide clear information about the role of this agent in HPV-positive HNSCC. Given the high incidence of activating PIK3CA mutations in HPV-positive HNSCC, a specific trial targeting only recurrent or metastatic HPV-positive patients harboring PIK3CA mutations is warranted.  In conclusion, activating PIK3CA mutations occur at a high frequency in HPV-positive oropharyngeal cancer, offering the possibility for personalized therapy with PIK3CA pathway inhibitors to improve outcomes in this rapidly expanding population of patients. Further work is necessary to understand the mechanism of interaction between PIK3CA and HPV. We performed an integrated genomic, transcriptomic, and proteomic characterization of 373 endometrial carcinomas using array- and sequencing-based technologies. Uterine serous tumors and ~25% of high-grade endometrioid tumors have extensive copy number alterations, few DNA methylation changes, low ER/PR levels, and frequent TP53 mutations. Most endometrioid tumors have few copy number alterations or TP53 mutations but frequent mutations in PTEN, CTNNB1, PIK3CA, ARID1A, KRAS and novel mutations in the SWI/SNF gene ARID5B. A subset of endometrioid tumors we identified had a dramatically increased transversion mutation frequency, and newly identified hotspot mutations in POLE. Our results classified endometrial cancers into four categories: POLE ultramutated, microsatellite instability hypermutated, copy number low, and copy number high. Uterine serous carcinomas share genomic features with ovarian serous and basal-like breast carcinomas. We demonstrated that the genomic features of endometrial carcinomas permit a reclassification that may impact post-surgical adjuvant treatment for women with aggressive tumors.  Endometrial cancer arises from the lining of the uterus. It is the fourth most common malignancy among women in the United States, with an estimated 47,000 new cases and 8,000 deaths in 2012.1 Most patients present with low-grade, early-stage disease. The majority of patients with more aggressive, high-grade tumors who have disease spread beyond the uterus will progress within 1 year.2,3 Endometrial cancers have been broadly classified into two groups.4 Type I endometrioid tumors are linked to estrogen excess, obesity, hormone-receptor positivity, and favorable prognosis compared with type II, primarily serous, tumors that are more common in older, non-obese women and have worse outcome. Early-stage endometrioid cancers are often treated with adjuvant radiotherapy, whereas serous tumors are treated with chemotherapy, similar to advanced-stage cancers of either histologic subtype. Therefore, proper subtype classification is critical for selecting appropriate adjuvant therapy.  Several prior reports suggest that PTEN mutations occur early in the neoplastic process of Type I tumors and co-exist frequently with other mutations in the PI3K/AKT pathway.5,6 Other commonly mutated genes in Type I tumors include FGFR2, ARID1A, CTNNB1, PIK3CA, PIK3R1, and KRAS.7–9 Microsatellite instability (MSI) is found in approximately one-third of Type I tumors but is infrequent in Type II tumors.10 TP53, PIK3CA, and PPP2R1A mutations are frequent in Type II tumors.11,12 Most of these studies have been limited to DNA sequencing only with samples of heterogeneous histologic subtypes and tumor grades. We present a comprehensive, multiplatform analysis of 373 endometrial carcinomas including low-grade endometrioid, high-grade endometrioid, and serous carcinomas. This integrated analysis provides key molecular insights into tumor classification, which may have direct impact on treatment recommendations for patients, and provides opportunities for genome-guided clinical trials and drug development.  Go to: Results Tumor samples and corresponding germline DNA were collected from 373 patients, including 307 endometrioid and 66 serous (53) or mixed histology (13) cases. Local institutional review boards approved all tissue acquisition. The clinical and pathologic characteristics of the samples generally reflect a cross-section of individuals with recurrent endometrial cancer (Supplementary Table 1.1).2,3 The median follow-up of the cohort was 32 months (range, 1–195 months); 21% of the patients have recurred, and 11% have died. Comprehensive molecular analyses were performed at independent centers using six genomic or proteomic platforms (Supplementary Table 1.2). MSI testing performed on all samples using seven repeat loci (Supplementary Table 1.3) found MSI in 40% of endometrioid tumors and 2% of serous tumors.  Somatic copy number alterations  Somatic copy number alterations (SCNAs) were assessed in 363 endometrial carcinomas. Unsupervised hierarchical clustering grouped the tumors into four clusters (Fig. 1a). The first three copy number clusters were composed almost exclusively (97%) of endometrioid tumors without significant differences in tumor grades. Cluster 1 tumors were nearly devoid of broad SCNAs, averaging less than 0.5% genome alteration, with no significant recurrent events. Cluster 1 tumors also had significantly elevated non-synonymous mutation rates compared to all others (median 7.2 × 10−6 vs. 1.7 × 10−6 mutations per megabase (Mb), P<0.001). Copy number clusters 2 and 3 consisted mainly of endometrioid tumors, distinguished by more frequent 1q amplification in cluster 3 than cluster 2 (100% of cluster 3 tumors vs. 33% of cluster 2 tumors) and worse progression-free survival (PFS, P=0.003, log-rank vs. clusters 1 and 2; Fig. 1b).  Figure 1 Figure 1 Somatic copy number alterations in endometrial carcinomas Most of the serous (50 of 53 [94%]) and mixed histology tumors (8 of 13 [62%]) clustered with 36 (12%) of the 289 endometrioid tumors, including 24% of grade 3 and 5% of grade 1 or 2, into copy number cluster 4; a single group characterized by a very high degree of copy-number alterations (Supplementary Fig. 2.1; focal SCNAs with FDR < 0.15, and Supplementary Data File 2.1). Cluster 4 tumors were characterized by significantly recurrent previously reported focal amplifications of the oncogenes MYC (8q24.12), ERBB2 (17q12), and CCNE1 (19q12),13 and by SCNAs previously unreported in endometrial cancers including those containing FGFR3 (4p16.3) and SOX17 (8q11.23). Cluster 4 tumors also had frequent TP53 mutations (90%), little MSI (6%), and fewer PTEN mutations (11%) than other endometrioid tumors (84%). Overall, these findings suggest that a subset of endometrial tumors contain distinct patterns of SCNAs and mutations that do not correlate with traditional tumor histology or grade.  As expected, tumors in the ‘serous-like’ cluster (cluster 4) had significantly worse PFS than tumors in the endometrioid cluster groups (P=0.003, log-rank, Fig. 1b). Potential therapeutically relevant SCNAs included the cluster 2 15q26.2 focal amplification, which contained IGF1R; and cluster 4 amplifications of ERBB2, FGFR1, FGFR3, and LRP1B deletion, which was recently associated with resistance to liposomal doxorubicin in serous ovarian cancer.14  Exome sequence analysis  We sequenced the exomes of 248 tumor/normal pairs. Based on a combination of somatic nucleotide substitutions, MSI, and SCNA, the endometrial tumors were classified into four groups (Fig. 2a and b): 1) an ultra-mutated group with unusually high mutation rates (232×10−6 mutations/Mb) and a unique nucleotide change spectrum; 2) a hypermutated group (18×10−6 mutations/Mb) of MSI tumors, most with MLH1 promoter methylation; 3) a group with lower mutation frequency (2.9×10−6 mutations/Mb) and most of the microsatellite stable (MSS) endometrioid cancers; and 4) a group that consists primarily of serous-like cancers with extensive SCNA (copy-number cluster 4) and a low mutation rate (2.3×10−6 mutations/Mb). The ultra-mutated group consisted of 17 (7%) tumors exemplified by an increased C→A transversion frequency, all with mutations in the exonuclease domain of POLE, and an improved progression-free survival (Fig. 2a and 2c). POLE is a catalytic subunit of DNA polymerase epsilon involved in nuclear DNA replication and repair. We identified hotspot mutations in POLE at P286R and V411L present in 13 (76%) of the 17 ultramutated samples. Significantly mutated genes (SMGs) identified at low False Discovery Rates (Q) in this subset included PTEN (at 94% with Q=0), PIK3R1 (65%, Q=8.3×10−7), PIK3CA (71%, Q=9.1×10−5), FBXW7 (82%, Q=1.4×10−4), KRAS (53%, Q=9.2×10−4), and POLE (100%, Q=4.2×10−3). Mutation rates in POLE mutant endometrial and previously reported ultramutated colorectal tumors exceed that found in any other lineage including lung cancer and melanoma.15–17 Germline susceptibility variants have been reported in POLE (L424V) and POLD1 (S478N), but were not found in our endometrial normal exome-seq reads.18  Figure 2 Figure 2 Mutation spectra across endometrial carcinomas The MSI endometrioid tumors had a mutation frequency approximately 10-fold greater than MSS endometrioid tumors, few SCNAs, frame-shift deletions in RPL22, frequent non-synonymous KRAS mutations, and few mutations in FBXW7, CTNNB1, PPP2R1A, and TP53. The MSS, copy number low, endometrioid tumors had an unusually high frequency of CTNNB1 mutations (52%); the only gene with a higher mutation frequency than the MSI samples. The copy number high group contained all of the remaining serous cases and one-quarter of the grade 3 endometrioid cases. Most of these tumors had TP53 mutations and a high frequency of FBXW7 (22%, Q=0) and PPP2R1A (22%, Q=1.7×10−16) mutations, previously reported as common in uterine serous but not endometrioid carcinomas. Thus, a subset of high-grade endometrioid tumors had similar SCNAs and mutation spectra as uterine serous carcinomas, suggesting these patients might benefit from treatment approaches that parallel those for serous tumors.  There were 48 genes with differential mutation frequencies across the four groups (Fig. 2d, Supplementary Data File S3.1). ARID5B, a member of the same AT-rich interaction domain (ARID) family as ARID1A, was more frequently mutated in MSI (23.1%), than in either MSS endometrioid (5.6%) or high SCNA serous tumors (0%), a novel finding for endometrial cancer. Frame-shifting RPL22 indels near a homopolymer at Lys15 were almost exclusively found in the MSI group (36.9%). The TP53 mutation frequency (>90%) in serous tumors differentiates them from the endometrioid subtypes (11.4%). However, many (10 of 20; 50%) endometrioid tumors with a non-silent TP53 mutation also had non-silent mutations in PTEN, compared to only 1 of 39 (2.6%) serous tumors with TP53 non-silent mutations. Though TP53 mutations are not restricted to serous tumors, the co-existing PTEN mutations in the endometrioid cases suggest a distinct tumorigenic mechanism.  Comparisons of 66 SMGs between traditional histologic subtypes are provided (Supplementary Methods S3) and SMGs across other subcohorts can be found in Supplementary Data File S3.2. The spectrum of PIK3CA and PTEN mutations in endometrial cancer also differs from other solid tumors (Supplementary Methods S3). Integrated analysis may be useful for identifying histologically misclassified cases. For example, a single serous case was identified without a TP53 mutation or extensive SCNA and with a KRAS mutation and high mutation rate. Upon re-review of the histologic section, the case was deemed consistent with a grade 3 endometrioid tumor demonstrating how molecular analysis could reclassify tumor histology and potentially impact treatment decisions.  Multiplatform subtype classifications  All of the endometrial tumors were examined for mRNA expression (n=333), protein expression (n=293), miRNA expression (n=367), and DNA methylation (n=373) (Supplementary Methods S4–S7). Unsupervised k-means clustering of mRNA expression from RNA sequencing identified three robust clusters termed ‘mitotic’, ‘hormonal’, and ‘immunoreactive’ (Supplementary Fig. 4.1) that were significantly correlated with the four integrated clusters; POLE, MSI, CN low and CN high (P<0.0001). Supervised analysis identified signature genes of the POLE cluster (n = 17) mostly involved in cellular metabolism (Fig. 3a). Among the few signature genes in the MSI cluster was decreased MLH1 mRNA expression likely due to its promoter methylation. Elevated progesterone receptor (PGR) expression was noted in the CN low cluster, suggesting responsiveness to hormonal therapy. The CN high cluster, which included most serous and serous-like endometrioid tumors, exhibited the greatest transcriptional activity exemplified by increased cell cycle deregulation (e.g. CCNE1, PIK3CA, MYC, and CDKN2A) and TP53 mutation (Supplementary Figs. 4.2 and 4.3). This is consistent with reports that elevated CDKN2A can distinguish serous from endometrioid carcinomas.19 Approximately 85% of cases in the CN high cluster shared membership with the ‘mitotic’ mRNA subtype.  Figure 3 Figure 3 Gene expression across integrated subtypes in endometrial carcinomas Supervised clustering of the RPPA expression data was consistent with loss of function for many of the mutated genes (Fig. 3b). TP53 was frequently mutated in the CN high group (P=2.5×10−27) and its protein expression was also elevated, suggesting these mutations are associated with increased expression. By contrast, PTEN (P=2.8×10−19) and ARID1A (P=1.2×10−6) had high mutation rates in the remaining groups, but their expression was decreased, suggesting inactivating mutations in both genes. The CN high group also had decreased levels of phospho-AKT, consistent with down regulation of the AKT pathway. The CN low group had elevated RAD50 expression, which is associated with DNA repair, explaining some of the differences between the CN high and CN low groups. The POLE group had high expression of ASNS and CCNB1, whereas the MSI tumors had both high phospho-AKT and low PTEN expression.  Unsupervised clustering of DNA methylation data generated from Illumina Infinium DNA methylation arrays revealed four unique subtypes (MC1-4) that support the four integrative clusters. A heavily methylated subtype (MC1) reminiscent of the CpG island methylator phenotype (CIMP) phenotype described in colon cancers and glioblastomas,20–22 was associated with the MSI subtype and attributable to promoter hypermethylation of MLH1. A serous-like cluster (MC3) with minimal DNA methylation changes was composed primarily of serous tumors and some endometrioid tumors (Supplementary Fig. 7.1) and contained most of the CN high tumors.  Integrative clustering using the iCluster framework returned two major clusters split primarily on serous and endometrioid histology highlighting TP53 mutations, lack of PTEN mutation and encompassing almost exclusively CN high tumors (Supplementary Fig. 8.1).23 We developed a new clustering algorithm, called SuperCluster, to derive overall subtypes based on sample cluster memberships across all data types (Supplementary Fig. 9.1). SuperCluster identified 4 clusters that generally confirmed the contributions of individual platforms to the overall integrated clusters. No major batch effects were identified for any platform (Supplementary Methods S10).  Structural Aberrations  To identify somatic chromosomal aberrations, we performed low-pass, paired-end, whole-genome sequencing on 106 tumors with matched normals. We found recurrent translocations involving genes in several pathways including WNT, EGFR-RAS-MAPK, PI3K, Protein Kinase A, RB and apoptosis. The most frequent translocations (5/106) involved a member of the BCL family (BCL2, BCL7, BCL9 and BCL2L11). Four of these were confirmed by identification of the translocation junction point and two were also confirmed by RNA-Seq. In all cases the translocations result in in-frame fusions and predicted to result in activation or increased expression of the BCL family members (Supplementary Fig. 3.2). Translocations involving members of the BCL family leading to reduced apoptosis have been described in other tumor types24 and our results suggest that similar mechanisms may be operative here.  Pathway alterations  Multiple platform data were integrated to identify recurrently altered pathways in the four endometrial cancer integrated subgroups. Because of the high background mutation rate and small sample size, we excluded the POLE subgroup from this analysis. Considering all recurrently mutated, homozygously deleted, and amplified genes, we used MEMo25 to identify gene networks with mutually exclusive alteration patterns in each subgroup. The most significant module was found in the CN low group and contained CTNNB1, KRAS, and SOX17 (Fig. 4a). The very strong mutual exclusivity between mutations in these three genes suggests that alternative mechanisms activate WNT signaling in endometrioid endometrial cancer. Activating KRAS mutations have been shown to increase the stability of beta-catenin via GSK3beta leading to an alternative mechanism of beta-catenin activation to APC degradation.26 SOX17, which mediates proteasomal degradation of beta-catenin,27,28 is mutated exclusively in the CN low group (8%) at recurrent positions (A96G and S403I) not previously described. Other genes with mutually exclusive alteration patterns in this module were FBXW7, FGFR2, and ERBB2.29 ERBB2 was focally amplified with protein overexpression in 25% of the serous or serous-like tumors, suggesting a potential role for HER2 targeted inhibitors. A small clinical trial of trastuzumab found no activity in endometrial carcinoma, but accrued few HER2 FISH-amplified serous carcinomas.30  Figure 4 Figure 4 Pathway alterations in endometrial carcinomas PIK3CA and PIK3R1 mutations were frequent and showed a strong tendency for mutual exclusivity in all subgroups, but unlike other tumor types, they co-occurred with PTEN mutations in the MSI and CN low subgroups as previously reported (Fig. 4b).5,9 The CN high subgroup showed mutual exclusivity between alterations of all three genes. Overall, 93% of endometrioid tumors had mutations that suggested potential for targeted therapy with PI3K/AKT pathway inhibitors.  Consensus clustering of copy number, mRNA expression, and pathway interaction data for 324 samples yielded 5 PARADIGM clusters with distinct pathway activation patterns (Fig. 4c, Supplementary Methods, S11).31 Paradigm cluster 1 had the lowest level of MYC pathway activation and highest level of WNT pathway activation, consistent with its composition of CN low cases having frequent CTNNB1 mutations. PARADIGM cluster 3 was composed predominantly of the CN high cases with relatively high MYC/Max but low ER/FOXA1 signaling and p53 activity. Only TP53 truncation and not missense mutations were implicated as loss-of-function mutations, suggesting different classes of p53 mutations may have distinct signaling consequences. Paradigm cluster 5 was enriched for hormone receptor expression.  Comparison to ovarian and breast cancers  The clinical and pathologic features of uterine serous carcinoma and high-grade serous ovarian carcinoma (HGSOC) are quite similar. HGSOC shares many similar molecular features with basal-like breast carcinoma.32 Focal SCNA patterns were similar between these three tumor subtypes and unsupervised clustering identified relatedness (Fig. 5a, Supplementary Fig. 12.1). Supervised analysis of transcriptome datasets showed high correlation between tumor subtypes (Supplementary Fig. 12.2). The MC3 DNA methylation subtype with minimal DNA methylation changes also was similar to basal-like breast and HGSOCs (Supplementary Fig. 12.3). High frequency of TP53 mutations is shared across these tumor subtypes (uterine serous, 91%; ovarian serous, 96%; basal-like breast, 84%),33,34 as is the very low frequency of PTEN mutations (uterine serous carcinoma, 2%; HGSOC, 1%; basal-like breast carcinoma, 1%). Differences include a higher frequency of FBXW7, PPP2R1A, and PIK3CA mutations in uterine serous compared to basal-like breast and HGSOCs (Fig. 5b). We show that uterine serous carcinomas share many molecular features with both HGSOC and basal-like breast carcinomas, despite more frequent mutations, suggesting new opportunities for overlapping treatment paradigms.  Figure 5 Figure 5 Genomic relationships between endometrial serous, ovarian serous, and basal-like breast carcinomas Go to: Discussion This integrated genomic and proteomic analysis of 373 endometrial cancers provides insights into disease biology and diagnostic classification that could have immediate therapeutic application. Our analysis identified four novel groups of tumors based on integrated genomic data, including a novel POLE subtype in ~10% of endometrioid tumors. Ultra-high somatic mutation frequency, MSS, and common, newly identified hotspot mutations in the exonuclease domain of POLE characterize this subtype. SCNAs add a layer of resolution, revealing that most endometrioid tumors have few SCNAs, most serous and serous-like tumors exhibit extensive SCNAs, and the extent of SCNA roughly correlates with PFS.  Endometrial cancer has more frequent mutations in the PI3K/AKT pathway than any other tumor type studied by TCGA to-date. Endometrioid endometrial carcinomas share many characteristics with colorectal carcinoma including a high frequency of MSI (40% and 11%, respectively), POLE mutations (7% and 3%, respectively) leading to ultrahigh mutation rates, and frequent activation of WNT/CTNNB1 signaling; yet endometrial carcinomas have novel exclusivity of KRAS and CTNNB1 mutation and a distinct mechanism of pathway activation. Uterine serous carcinomas share many similar characteristics with basal-like breast and HGSOCs; three tumor types with a high frequency non-silent TP53 mutations and extensive SCNA. However, the high frequency of PIK3CA, FBXW7, PPP2R1A, and ARID1A mutations in uterine serous carcinoma are not found in basal-like breast and HGSOCs. The frequency of mutations in PIK3CA, FBXW7, and PPP2R1A was ~30% higher than in a recently reported study of 76 uterine serous carcinomas,11 but similar to another study.12 Uterine serous carcinomas have ERBB2 amplification in 27% of tumors and PIK3CA mutations in 42%, which provide translational opportunities for targeted therapeutics.  Early stage Type I endometrioid tumors are often treated with adjuvant radiotherapy, while similarly staged Type II serous tumors are treated with chemotherapy. High-grade serous and endometrioid endometrial carcinomas are difficult to correctly subtype, and intra-observer concordance among specialty pathologists is low.7,34–36 Our molecular characterization data demonstrate that ~25% of tumors classified as high-grade endometrioid by pathologists have a molecular phenotype similar to uterine serous carcinoma, including frequent TP53 mutations and extensive SCNA. The compelling similarities between this subset of endometrioid tumors and uterine serous carcinomas suggest that genomic-based classification may lead to improved management of these patients. Clinicians should carefully consider treating copy number altered endometrioid patients with chemotherapy rather than adjuvant radiotherapy and formally test such hypotheses in prospective clinical trials. Further, the marked molecular differences between endometrioid and serous-like tumors suggest that these tumors warrant separate clinical trials to develop the independent treatment paradigms that have improved outcomes in other tumor types, such as breast cancer.  Fifteen rare cancer-derived mutants of PIK3CA, the gene coding for the catalytic subunit p110α of phosphatidylinositol 3-kinase (PI3K), were examined for their biological and biochemical properties. Fourteen of these mutants show a gain of function: they induce rapamycin-sensitive oncogenic transformation of chicken embryo fibroblasts, constitutively activate Akt and TOR-mediated signaling, and show enhanced lipid kinase activity. Mapping of these mutants on a partial structural model of p110α suggests three groups of mutants, defined by their location in distinct functional domains of the protein. We hypothesize that each of these three groups induces a gain of PI3K function by a different molecular mechanism. Mutants in the C2 domain increase the positive surface charge of this domain and therefore may enhance the recruitment of p110α to cellular membranes. Mutants in the helical domain map to a contiguous surface of the protein and may affect the interaction with other protein(s). Mutants in the kinase domain are located near the hinge of the activation loop. They may alter the position and mobility of the activation loop. Arbitrarily introduced mutations that have no detectable phenotype map either to the interior of the protein or are positioned on a surface region that lies opposite to the exposed surfaces containing gain-of-function mutants. Engineered mutants that exchange acidic or neutral residues for basic residues on the critical surfaces show a gain of function.  Keywords: molecular model, phosphatidylinositol 3-kinase, lipid membrane, protein–protein interaction, activation loop The catalytic subunit p110α of class I phosphatidylinositol 3-kinase (PI3K) is frequently mutated in cancer (1–5). The incidence of these cancer-specific point mutations varies with the tissue of origin and is particularly high in mammary and colorectal cancers (1, 2, 6–12). A conspicuous feature of the p110α mutations is their specific location in the gene of p110α: almost 80% of these mutations map to one of three hot spots in the p110α coding sequence (1). Two of the hot spot mutations are located in the helical domain of p110α at residue positions E542K and E545K, and the third hot spot (residue H1047R) is located in the C-terminal portion of the kinase domain. Besides these frequently occurring hot spot mutations, numerous rare, cancer-specific mutations have also been identified in p110α (1, 3, 7, 8, 10, 11). These rare mutations are widely distributed over the entire coding sequence of p110α. It has been assumed that the prevalence of hot spot mutations reflects the strong selective growth advantage that these mutants provide to the cell. This suggestion is supported by the fact that all three hot spot mutations confer in vitro and in vivo oncogenicity on p110α (13–18). A corollary of this interpretation is that the rare mutants would not offer a comparable growth advantage and may therefore show either no phenotype or a loss of function. Consequently, they may be of no relevance to the oncogenic process. We studied 15 of these rare cancer-specific mutants of p110α and found that 14 show gain of function, inducing oncogenic transformation in primary cultures of chicken embryo fibroblasts (CEF), constitutive signaling to Akt, cellular homolog of the oncogene carried by the Akt8 murine retrovirus, and TOR and elevated lipid kinase levels. These observations suggest that even the rare mutants reflect positive selection, most likely by providing a significant growth advantage to the cell. Such growth-promoting activity suggests participation of rare mutations in the cancer process. A map of p110α point mutations on a homology model of the protein suggests the existence of three categories of mutants, defined by the structural and functional domains in which they are located. The data are in accord with the proposal that the three categories of mutants induce a gain of PI3K function through three distinct molecular mechanisms.  Go to: RESULTS Rare Cancer-Derived Mutants of p110α Induce Oncogenic Transformation in CEF. We chose 15 rare mutants of p110α that had been identified in diverse human cancers and analyzed their biological and biochemical properties (R38H, K111N, N345K, C420R, P539R, E545A, E545G, Q546K, Q546P, H710P, T1025S, M1043I, M1043V, H1047L, and H1047Y). Fig. 1 shows a map of the mutations, illustrating their wide dispersion over the primary sequence of the protein. The mutants were expressed in CEF with the RCAS retroviral vector. Fourteen of the 15 mutants induced oncogenic transformation of the avian cells, as evidenced by focus formation (Fig. 2) and by the ability to propagate and form colonies in agar suspension (not shown). The efficiencies of transformation (EOT), expressed as number of foci per nanogram of DNA, were characteristic of individual mutants, extending from 1.7 to 4.6. Based on specific EOT, these mutants can be further classified into three groups: a class of weak transformers (EOT <2.0), a class of intermediate transformers (EOT 2.0–3.0), and a class of strong transformers (EOT 3.0–4.0) (Table 1 and Fig. 2). For comparison, the EOT of the hot spot mutations is >4.0 foci/ng. One specific cancer-derived mutant, H701P, failed to induce oncogenic transformation when expressed in CEF (Fig. 2). EOTs represent the efficiencies with which individual transforming events are initiated. In addition, the transformed cell foci induced by different mutant groups differ in size (Fig. 2). Focus size reflects the rate of cell replication; EOTs are correlated with the replication rates of the transformed cells, and strong transformers not only initiate transformation more efficiently, they also induce increased rates of cell growth.  Fig. 1. Fig. 1. A map and frequency distributions of the three hot spot mutations of the 15 rare mutations and of eight arbitrary mutations investigated in this study (catalog of Somatic Mutations in Cancer, www.sanger.ac.uk/genetics/CGP/cosmic). Hot spot mutations are ... Fig. 2. Fig. 2. The EOT of primary CEF by mutants of p110α. The EOT (foci per nanogram of DNA) sets the hot spot mutations apart from the rare mutations and suggests the existence of three categories of rare mutations. Shown are transformation induced by a hot ... Table 1. Table 1. Mutants of p110α grouped by oncogenic potency Rare Cancer-Derived Mutants of p110α Signal Constitutively Through Akt. The canonical signaling sequence initiated by PI3K proceeds through Akt, the tuberous sclerosis complex (TSC) proteins TSC1 and TSC2, the Ras-related GTPase Rheb to the TOR kinase (19). Two important downstream targets of TOR are S6K and 4E-BP. Determining the relative levels of phosphorylation of Akt, S6K, and 4EBP in the absence of growth factors assesses the constitutive activity of cellular PI3K signaling. We have probed the status of PI3K signaling in mutant-transfected cells by using Akt and S6K as indicators. All rare mutants that induce oncogenic transformation in cell culture also constitutively activate the downstream signaling cascade as suggested by the phosphorylation of Akt and S6K in the absence of growth factors (Fig. 3). Consistent with this signaling cascade, transformation by the rare mutants is also rapamycin-sensitive [supporting information (SI) Fig. 8]. The single nontransforming mutant (H701P), as well as the wild-type p110α, do not activate signaling under these conditions. The H701P mutation is located at the N terminus of an α-helix in the N-terminal region of the kinase domain, far from the active site and from the gain-of-function mutations.  Fig. 3. Fig. 3. Western blots comparing the phosphorylation levels of Akt and S6K that are induced in CEF by mutant and wild-type p110α. Hot spot mutants are marked with ▿, and strongly transforming rare mutants are marked with ◆. ∗ marks ... Rare Mutants with a Gain of Function in Oncogenicity and Signaling Also Show Elevated Lipid Kinase Activity in Vitro. p110α proteins with specific amino acid substitutions that map to one of the cancer-specific mutational hot spots (E542K, E545K, and H1047R) show increased lipid kinase activity in vitro (1, 13, 14, 20). We have analyzed the lipid kinase activities of the 15 rare cancer-derived mutations and compared them to those of several nononcogenic mutants of p110α (SI Fig. 9). These results show that all rare gain-of-function mutants have elevated lipid kinase activity and that oncogenicity and constitutive signaling in mutants of p110α are roughly correlated with increased enzymatic activity in vitro.  Arbitrary Mutations Introduced into p110α Do Not Result in Oncogenicity, Constitutive Signaling, or Elevated Enzyme Activity. Because almost all of the cancer-derived mutants of p110α show a gain of function, it was conceivable that wild-type p110α occurs predominantly in an inactive conformation, and that even nontargeted mutations would frequently trigger the transition to the active conformation. We therefore introduced random single amino acid substitutions at five different sites in the p110α coding sequence (E52K, E116K, P217K, G912R, and D1016G). The mutated proteins were expressed with the RCAS vector and tested in CEF for oncogenicity and constitutive signaling through Akt. They were also assayed for lipid kinase activity in vitro. None of these random mutants caused transformation in cell culture or generated a signal in the absence of growth factors (Fig. 4). Moreover, their lipid kinase activities are significantly lower than those of the gain-of-function mutants (SI Fig. 9).  Fig. 4. Fig. 4. Random mutations without phenotype. (A) Five constructs with mutations in arbitrary sites of p110α (P217K, G912R, D1016G, E52K, and E116K) fail to induce oncogenic transformation. The mutant proteins were expressed with the RCAS vector in primary ... Gain-of-function Mutations of p110α Map to the Surface of the Protein. Although the 3D structure of p110α has not yet been determined, it is possible to use the known structure of the related p110γ isoform to build a partial model of p110α based on sequence homology between the two isoforms (14, 21–23). We have mapped the gain-of-function mutations and the nontransforming, arbitrary mutations shown in Fig. 1 on this homology model (Fig. 5). This model and the nature of the amino acid substitutions provide the following picture: (i) the gain-of-function mutations are grouped in three separate functional domains, the C2 domain, the helical domain and the kinase domain; (ii) two mutations in the C2 domain (N345K and C420R) are located in surface loops that were predicted to be part of the membrane binding region of p110α (21); (iii) three mutation sites in the helical domain (E542, E545, and Q546) are clustered on an exposed face of this domain that could interact with another protein. Similar to the C2 domain mutations, most helical domain mutations insert a basic residue, frequently a lysine (E542K, E545K, and Q546K), making it tempting to speculate that this region may also interact with the cellular membrane. The other mutation site in the helical domain, P539, is located in a loop that packs against the kinase domain in the model. This mutation may perturb the packing of the helical domain with the kinase domain or it may be more exposed in the actual structure. (iv) Five of the kinase domain mutations (M1043I, M1043V, H1047L, H1047Y, and H1047R) and one engineered mutation (D1045K; see below) pack against the hinge region of the activation loop. These mutations may lock the activation loop in the “on” position. The other mutation site (T1025) packs against the base of the catalytic loop and may affect the activity of the enzyme. The two nontransforming kinase domain mutations (Q1033K and D1017G) are completely solvent-exposed and are located far away from the active site (SI Fig. 10). Two of the other nontransforming mutations (H701P and P217K) are located on the opposite site of the molecule, away from the surface regions containing the gain-of-function mutations. A sixth kinase domain mutation (G912R), although located at base of the catalytic loop and near the T1025S mutations, has no phenotype, but may affect the stability of the protein. Together, these observations suggest three main mechanisms for the gain of function in p110α: (i) enhanced binding of the C2 domain to membrane phospholipids, (ii) modified binding of the helical domain to an unknown component or to a membrane, and (iii) increased catalytic activity through interaction with the activation or catalytic loops. The most potent of the kinase domain mutations, H1047R, is located near the hinge region of the activation loop and could affect both the position and the mobility of the activation loop (Fig. 6).  Fig. 5. Fig. 5. Ribbon and molecular surface representation of p110α, showing the locations of gain-of-function mutations on the homology model. The domains of p110α are colored as follows: C2 domain, blue; helical domain, green; N-terminal region of ... Fig. 6. Fig. 6. Ribbon diagram focused on the catalytic domain of p110α mutant residues. Labeling and color code are as in Fig. 5. The model illustrates the position of H1047R hotspot mutation in proximity to the hinge region of the activation loop and suggests ... Some Engineered Mutations That Increase the Positive Surface Charge of p110α Show a Gain of Function. The map of the mutants on the partial protein model suggests that increasing the positive surface charge of p110α could lead to a gain of function. We tested this possibility by generating three point mutations that aim to introduce a positively charged amino acid to the surface of p110α. Two of these mutants (D1045K and E579K) showed a gain of function as judged by their ability to transform cells (Fig. 7A). The efficiencies of transformation achieved by these mutants were low (E576K EOT = 0.65, D1046K EOT = 1.6), and they did not significantly increase the phosphorylation level of Akt (Fig. 7B). E576K is located at the edge of a helical domain surface patch that includes E542, E545, and Q546 and could also affect the interaction with another protein or a membrane. As discussed above, D1045K may interact with the activation loop. These observations support the hypothesis that mutations that increase the positive charge on a surface patch of the helical domain or interact with the activation loop have the potential of increasing the activity of p110α.  Fig. 7. Fig. 7. Mutations targeted to the p110 surface. (A) Mutations targeted to the surface of p110α and involving an increase in positive charge are weakly oncogenic (E579K and D1046K). RCAS and wild-type p110α are shown as negative controls, H1047R ... Go to: DISCUSSION In frequency of occurrence, the hot spot mutants in p110α differ from the rare mutants by at least one order of magnitude (Fig. 1). Their biological and biochemical activities are also significantly elevated above those of the rare mutants: their EOTs place the hot spot mutants in a distinct class above rare mutants. The differences between oncogenic activities of mutants in cell culture are even more pronounced than the EOTs suggest; not only do hot spot mutants induce higher numbers of transformed cell foci, but also individual foci are larger in size and density, suggesting more rapid cell proliferation. The same kind of differences can be observed between the three activity-defined categories of rare mutants: foci induced by the strong mutants are significantly larger and denser than those induced by weak mutants that have a distinctly lower EOT (Fig. 2). The hot spot mutants also consistently show the highest enzymatic activities and strongest effects on Akt. The data suggest a rough correlation between frequency of mutant occurrence in cancer and the extent of mutation-induced gain of function. The selective advantage for cellular replication mediated by a gain of function in PI3K could translate into this correlation between frequency of occurrence and PI3K activity, and the superior activity of the hot spot mutants may account for their higher frequency of occurrence in cancer. However, the fact that most of the rare mutations also induce a significant gain of function suggests these too contribute to the oncogenic process by providing a selective growth advantage to incipient tumor cells.  A study of rare mutants reveals several features commonly correlated with PI3K oncogenicity: enhanced lipid kinase activity, constitutive activation of Akt and TOR-mediated signaling, and high sensitivity of the oncogenic effects to rapamycin. The latter documents the importance of TOR signaling in the transformation process. In clinical settings, rapamycin has been far less effective (24, 25). However, recent studies with the human cancer cell lines that show enhanced PI3K signaling demonstrate that combined inhibition of PI3K and of TOR has a synergistic effect on tumor cell growth, whereas single inhibition of these targets is ineffective (26).  Mapping of the p110α mutations on the structural model of the protein suggests three groups of oncogenic mutants that are defined by their location on distinct functional domains and their differential effect on the activities of p110α. The two mutants in the C2 domain increase basic positive surface charge of that domain and may therefore mediate improved recruitment of p110α to the cell membrane, making lipid kinase activity independent of signals transmitted through the regulatory subunit, p85. Five of the six gain-of-function mutations mapping to the helical domain are clustered on an exposed surface patch of the protein. We speculate that they modify the interaction with another protein or with a lipid-containing membrane. The third group of mutations, located in the kinase domain, cluster close to the hinge region of the activation loop. These mutations may induce a gain of function by changing the position and mobility of the activation loop. This region could also serve as a target for the development of structure-based mutant-specific small molecule inhibitors. Our structure-guided interpretation of mutant effects is in substantial agreement with previous studies that considered the effects of mutant positions and the nature of the substituting amino acids on the function of p110α (14, 23). The possibility that some of the gain-of-function mutations enhance the thermal stability of the protein was also suggested previously and is supported by our observation that some of the transforming p110α mutants are expressed at significantly higher levels that the wild-type protein (23) (M.G. and P.K.V., unpublished work). The existence of more than one molecular mechanism for the mutation-induced gain of function in p110α is further supported by unpublished experiments with p110α constructs carrying double mutations, either in the same or different functional domains of the protein. The gain of function for mutations located in the same domain is not additive, whereas the gains of function resulting from mutations in different domains have an additive effect (L. Zhao and P.K.V. unpublished data). The arbitrarily introduced mutations that show no detectable phenotype map either to the interior of the protein (P217K and G912R) or on an exposed surface facing a different direction from the surfaces containing the gain-of-function mutations (E116K and D1017G). The map positions of these nonfunctional mutations are in accord with our proposed interpretation of the mechanisms governing the mutation-induced gain of function in p110α.  Collectively, the nature of the amino acid substitutions that induce a gain of function in the helical or C2 domain suggests that exposure at the surface of p110α and positive charge may be the two most important and perhaps more generally applicable requirements for activating the oncogenic potential of p110α. For mutations in the kinase domain, interaction with the activation loops appears to be a mechanism that could lock the enzyme in the “on” position. The cellular transforming ability of two mutants that were engineered to meet the two criteria of either surface location and positive charge or proximity to the activation loop supports this suggestion. The failure of these mutants to induce constitutive signaling through Akt remains unexplained.  Our observations on the rare cancer-derived mutants of p110α focus attention on the molecular mechanisms for the mutant-induced gain of function.\n"
     ]
    }
   ],
   "source": [
    "print('Longest text:')\n",
    "print('')\n",
    "print(training_text['Text'][train_word_counts.idxmax()])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Shortest text:\n",
      "\n",
      "null\n"
     ]
    }
   ],
   "source": [
    "print('Shortest text:')\n",
    "print('')\n",
    "print(training_text['Text'][train_word_counts.idxmin()])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Empty text\n",
    "Empty documents were removed"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style>\n",
       "    .dataframe thead tr:only-child th {\n",
       "        text-align: right;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: left;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>Text</th>\n",
       "      <th>Gene</th>\n",
       "      <th>Variation</th>\n",
       "      <th>Class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>3316.000000</td>\n",
       "      <td>3316</td>\n",
       "      <td>3316</td>\n",
       "      <td>3316</td>\n",
       "      <td>3316.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>unique</th>\n",
       "      <td>NaN</td>\n",
       "      <td>1920</td>\n",
       "      <td>262</td>\n",
       "      <td>2993</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>top</th>\n",
       "      <td>NaN</td>\n",
       "      <td>The PTEN (phosphatase and tensin homolog) phosphatase is unique in mammals in terms of its tumor suppressor activity, exerted by dephosphorylation...</td>\n",
       "      <td>BRCA1</td>\n",
       "      <td>Truncating Mutations</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>freq</th>\n",
       "      <td>NaN</td>\n",
       "      <td>53</td>\n",
       "      <td>264</td>\n",
       "      <td>92</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>1660.034077</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4.366104</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>959.287860</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.309241</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>0.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>828.750000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>1661.500000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>2490.250000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>3320.000000</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>9.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                 ID  \\\n",
       "count   3316.000000   \n",
       "unique          NaN   \n",
       "top             NaN   \n",
       "freq            NaN   \n",
       "mean    1660.034077   \n",
       "std      959.287860   \n",
       "min        0.000000   \n",
       "25%      828.750000   \n",
       "50%     1661.500000   \n",
       "75%     2490.250000   \n",
       "max     3320.000000   \n",
       "\n",
       "                                                                                                                                                         Text  \\\n",
       "count                                                                                                                                                    3316   \n",
       "unique                                                                                                                                                   1920   \n",
       "top     The PTEN (phosphatase and tensin homolog) phosphatase is unique in mammals in terms of its tumor suppressor activity, exerted by dephosphorylation...   \n",
       "freq                                                                                                                                                       53   \n",
       "mean                                                                                                                                                      NaN   \n",
       "std                                                                                                                                                       NaN   \n",
       "min                                                                                                                                                       NaN   \n",
       "25%                                                                                                                                                       NaN   \n",
       "50%                                                                                                                                                       NaN   \n",
       "75%                                                                                                                                                       NaN   \n",
       "max                                                                                                                                                       NaN   \n",
       "\n",
       "         Gene             Variation        Class  \n",
       "count    3316                  3316  3316.000000  \n",
       "unique    262                  2993          NaN  \n",
       "top     BRCA1  Truncating Mutations          NaN  \n",
       "freq      264                    92          NaN  \n",
       "mean      NaN                   NaN     4.366104  \n",
       "std       NaN                   NaN     2.309241  \n",
       "min       NaN                   NaN     1.000000  \n",
       "25%       NaN                   NaN     2.000000  \n",
       "50%       NaN                   NaN     4.000000  \n",
       "75%       NaN                   NaN     7.000000  \n",
       "max       NaN                   NaN     9.000000  "
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "training_data = pd.merge(training_text, training_variants, on='ID')\n",
    "training_data = training_data[training_data['Text'].apply(len) > 50]\n",
    "training_data.describe(include='all')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Text features\n",
    "I did some counts of words present in the dataset just to have a feel of what kind of features I have."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "CountVectorizer(analyzer='word', binary=False, decode_error='strict',\n",
       "        dtype=<class 'numpy.int64'>, encoding='utf-8', input='content',\n",
       "        lowercase=True, max_df=1.0, max_features=None, min_df=1,\n",
       "        ngram_range=(1, 1), preprocessor=None, stop_words=None,\n",
       "        strip_accents=None, token_pattern='(?u)\\\\b\\\\w\\\\w+\\\\b',\n",
       "        tokenizer=None, vocabulary=None)"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vectorizer = CountVectorizer()\n",
    "vectorizer.fit(training_data['Text'].values)    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Random words and their counts:\n",
      "('regulation21', 123187)\n",
      "('tgagatctttttiii', 140459)\n",
      "('d17s1322', 47190)\n",
      "('boudewijn', 33299)\n",
      "('nph3', 104006)\n",
      "('crebbp', 44867)\n",
      "('wordeman', 152418)\n",
      "('nitiss', 102292)\n",
      "('hsc7e132', 75579)\n",
      "('500000', 13139)\n",
      "('treatable', 144028)\n",
      "('dan', 48350)\n",
      "('endorsed', 56662)\n",
      "('iodophenols', 80985)\n",
      "('1o', 5944)\n",
      "('ifthey', 77636)\n",
      "('proactively', 116333)\n",
      "('magoh', 91847)\n",
      "('untidy', 147686)\n",
      "('23g', 7453)\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print('Random words and their counts:')\n",
    "for element in list(islice(vectorizer.vocabulary_.items(), 20)):\n",
    "    print(element)\n",
    "print('')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Vocabulary size: 155732\n"
     ]
    }
   ],
   "source": [
    "print('Vocabulary size:', len(vectorizer.vocabulary_))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Conclusion:\n",
    "The vocabulary has too many tokens, and the dataset has very few training examples in comparison, this will make it difficult for the classifier, thus, I'll have to limit the number of tokens in some way.\n",
    "\n",
    "I tried to group words per class to find good features that'd help the classifier but didn't find any. It seems that classes don't have special words for them only.\n",
    "\n",
    "A more thorough investigation could reveal such features (composed words or similar Genes ..etc)."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We can see from the examples above that the documents are very technical and specific to the field of study. I can tell because I didn't understand one bit :)\n",
    "\n",
    "I think using a pretrained Word Vector model (like W2V, Glove ...etc.) for representing words might not be very benefical for two main reasons:\n",
    "1. The technical words were probably not seen in the Word Vector model training set (or at least not seen enough)\n",
    "2. Due to (1) a lot of interesting features (words) will be replaced by unkown (UNK feature) which will decrease the quality of the document representation\n",
    "\n",
    "However, retraining these vectors will most probably produce a better representation, but more data will be needed."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Vectorizing text data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Finding a good representation for text data is crucial in Text Classification tasks. I have spent a lot of time testing different choices to represent data including:\n",
    "- Leaving stop words / Removing stop words\n",
    "- Text preprocessing\n",
    "- Stemming\n",
    "- Size of vocabulary\n",
    "- Words to be included in the vocabulary\n",
    "- Tokenization\n",
    "\n",
    "Most of the work I had done is not included in this document for the sake of brievety."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## BOW and TF-IDF\n",
    "First I constructed bag of words (BOW) and TF-IDF vectors. \n",
    "I tried to reduce the number of words by using stemming, excude stop words, limit vocabulary size due to the number of examples in the dataset and to speedup training too."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "RANDOM_STATE = 7878\n",
    "VECTORS_PATH = path.join(DATA_PATH, 'vectors')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "# used a stemmer to reduce tokens\n",
    "stemmer = SnowballStemmer(\"english\", ignore_stopwords=True)\n",
    "class StemmedCountVectorizer(CountVectorizer):\n",
    "    def build_analyzer(self):\n",
    "        analyzer = super(StemmedCountVectorizer, self).build_analyzer()\n",
    "        return lambda doc: ([stemmer.stem(w) for w in analyzer(doc)])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Training target\n",
    "y = training_data['Class'].values"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### BOW vectors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training BOW shape: (3316, 5681)\n",
      "Targets shape: (3316,)\n"
     ]
    }
   ],
   "source": [
    "TRAIN_BOW_90K = path.join(VECTORS_PATH, 'train_bow_90k.npz')\n",
    "vectorizer = StemmedCountVectorizer(tokenizer=nltk.word_tokenize, stop_words='english', \n",
    "                             max_df=0.8, max_features=90000, binary=False, min_df=0.03)\n",
    "if path.exists(TRAIN_BOW_90K):\n",
    "    X_bow = load_npz(TRAIN_BOW_90K)\n",
    "else:\n",
    "    X_bow = vectorizer.fit_transform(training_data['Text'].values)\n",
    "    save_npz(TRAIN_BOW_90K, X_bow)\n",
    "    \n",
    "print('Training BOW shape:', X_bow.shape)\n",
    "print('Targets shape:', y.shape)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### TF-IDF vectors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "tfidf_transformer = TfidfTransformer()\n",
    "X_tfidf = tfidf_transformer.fit_transform(X_bow)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Bigram BOW vectors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Training bigram BOW shape: (3316, 24539)\n",
      "Targets shape: (3316,)\n"
     ]
    }
   ],
   "source": [
    "TRAIN_BIGRAM_BOW_90K = path.join(VECTORS_PATH, 'train_bigram_bow_90k.npz')\n",
    "bigram_vectorizer = StemmedCountVectorizer(tokenizer=nltk.word_tokenize, stop_words='english', ngram_range=(1, 2),\n",
    "                             max_df=0.8, max_features=90000, binary=False, min_df=0.03)\n",
    "if path.exists(TRAIN_BIGRAM_BOW_90K):\n",
    "    X_bigram_bow = load_npz(TRAIN_BIGRAM_BOW_90K)\n",
    "else:\n",
    "    X_bigram_bow = bigram_vectorizer.fit_transform(training_data['Text'].values)\n",
    "    save_npz(TRAIN_BIGRAM_BOW_90K, X_bigram_bow)\n",
    "    \n",
    "print('Training bigram BOW shape:', X_bigram_bow.shape)\n",
    "print('Targets shape:', y.shape)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Bigram TF-IDF vectors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "bigram_tfidf_transformer = TfidfTransformer()\n",
    "X_bigram_tfidf = bigram_tfidf_transformer.fit_transform(X_bigram_bow)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Visualisation\n",
    "I visualised the vectors to have a feel about how good the representations are at seperating classes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "5302"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA3kAAAJOCAYAAAAK+M50AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fc77b0a25c0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "tsne = TSNE(n_components=2)\n",
    "bow_2d = tsne.fit_transform(X_bow.todense())\n",
    "plt.figure(figsize=(15, 10))\n",
    "plt.title('BOW vectors (TSNE)')\n",
    "plt.scatter(bow_2d[:,0], bow_2d[:,1], c=y)\n",
    "del bow_2d\n",
    "gc.collect()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2633"
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA3IAAAJOCAYAAADyGDWDAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\niIiIiIg0M0rkREREREREmpn/B8TKC/tfyjUbAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fc762ef1c18>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "tfidf_2d = tsne.fit_transform(X_tfidf.todense())\n",
    "plt.figure(figsize=(15, 10))\n",
    "plt.scatter(tfidf_2d[:,0], tfidf_2d[:,1], c=y)\n",
    "plt.title('TF-IDF vectors')\n",
    "del tfidf_2d\n",
    "gc.collect()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "5832"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA3MAAAJOCAYAAAAd2l69AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz\nAAALEgAACxIB0t1+/AAAADl0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uIDIuMS4wLCBo\ndHRwOi8vbWF0cGxvdGxpYi5vcmcvpW3flQAAIABJREFUeJzs3XecVNXdx/HPuVN2Z3th6U2qgkpx\nRUBFiQ27orHE2JJoYqLGRKOPJnliooktakw0MdY81iRYULGLAooigtI7SO8s23fqPc8fsyxbZmGB\nXXYHvu/Xa8Q599xzf3fQmfnNacZai4iIiIiIiCQXp7UDEBERERERkT2nZE5ERERERCQJKZkTERER\nERFJQkrmREREREREkpCSORERERERkSSkZE5ERERERCQJKZkTERHZD4wxKcaYBcaYTm0glrONMf9p\n7ThERGTfKJkTEZFdMsasNMZUGWPKjTHbjTFvG2O61asz0hjzsTGmzBhTYox5yxgzoNbxxcaYi2s9\nP9YYYxOUlRljvPvpvu40xrywP65V7VpgirV2gzHm3erXs9wYEzHGhGs9f7w6vjuMMd9Wl62tnXwZ\nYyYZY4K1/x6MMScbY1bWel77723H41EAa+1bwEBjzJH77e5FRKTZKZkTEZGmONtamwF0AjYBf9tx\nwBgzAvgAeAPoDBwCzAamGmN6VVebAoyq1d4oYFGCsi+stdGWuonmtBdJ50+A5wGstadbazOqX9MX\ngft3PLfW/sQYcyVwOXBydZ1CYGK99iqA3+7mmmfXajfDWnt9rWMvE08wRUQkSSmZExGRJrPWBoFX\ngAG1iu8HnrPWPmKtLbPWFllrfwNMA+6srlM/mTseuC9B2ZT61zTGdK7uYcqrVTbEGLPVGOOrfv4D\nY8zC6p7D940xPWrVHWiM+dAYU2SM2VTd4zUGuAO4uLrHanata71ZXXeZMeaaWu3caYx5xRjzgjGm\nFLjKGDPMGDPDGFNa3fZDiV43Y0x3oBfw5S5f4J2OBt631i4HsNZutNY+Ua/OX4FLjTG9m9hmfZOA\nM/fyXBERaQOUzImISJMZY9KAi4knajuejwTGJaj+X+CU6n+fQnxYX54xxiHe0/QfIKdW2bEkSOas\nteuBL4ALahV/D3jFWhsxxpxLPDEbCxQAnxLvdcIYkwl8BLxHvNewDzDRWvse8CfgP9U9VoOq2/03\nsLa67oXAn4wx36l13XOJJ7M5xHvUHgEesdZmAb2r7zmRI4AVe9DrOA24whjzK2NMoTHGk6DOOuBJ\n4PdNbLO+hUBPY0zWXp4vIiKtTMmciIg0xXhjTDFQQjxBe6C6PI/4Z8mGBOdsANoBWGtXAauJ974N\nApZaa6uAqbXK/DTec/UScCmAMcYAl1SXQXz44j3W2oXVydKfgMHVvXNnARuttQ9aa4PVPYcJr1E9\n/+xY4LbqurOAp4AralX7wlo73lrrVscfAfoYY9pZa8uttdMaiT8HKGvkWAPW2heAG4DTgMnAZmPM\nbQmq3gOcbYwZ2EhT440xxbUe19Q6tiOenKbGJSIibYuSORERaYrzrLU5QCpwPTDZGNMR2A64xOfS\n1dcJ2Frr+Y6hlqOI954BfFarbLq1NtTI9V8FRlSvBDmq+po72ugBPLIjYQGKAAN0AboBy5t4j52B\nImtt7aRrVXU7O6ypd84PgX7AImPMV8aYsxppezuQ2cQ4ALDWvmitPZl4svUT4C5jzGn16mwBHgX+\n0Egz51lrc2o9nqx1bEc8xXsSl4iItB1K5kREpMmstTFr7WtADDjOWltBfAjkdxNUv4i6i3bsSOaO\nZ2ci9mmtsgZDLGtddzvxRVYuJj7E8t/WWlt9eA3w43pJS8Ba+3n1sV6JW8XWe74eyKsemrlDd+LD\nGROeY61daq29FGhPfA7gK8aY9ATXmgMcsjcrdVprI9bacdVtHJ6gygPAaOCoPWz6MGCltbZ0T2MS\nEZG2QcmciIg0mYk7F8glPucK4H+AK40xNxpjMo0xucaYu4ER1J3PNQUYQjx5m1pdNpf46pej2UUy\nV+0l4kMeL2TnEEuAx4Hbdww1NMZkG2N2JJcTgE7GmJtMfJ+3TGPMMdXHNhGfM+YAWGvXAJ8D9xhj\nUquX7f8h0Oj2BcaY7xtjCqy1Ljt7uNz69ay1a4FlwLDd3OOOdq8yxpxZHa9jjDkdGEiCYajW2mLg\nQeDWprRdywnAu3t4joiItCFK5kREpCneMsaUA6XAH4ErrbXzAay1nxGf2zWW+Dy5VcSTtuOstUt3\nNGCtXQJsIT6Hrbi6zAWmA1nEE6ldeRPoW33+7Frtvk68V+zf1atMzgNOrz5WRnyO39nARmAp8cQR\ndi7ass0Y83X1v18K9CTeS/c68Dtr7Ue7iGkMML/6tXkEuKR6Ll0i/yS+3UBTlBJf1GU18STxfuC6\n6tc6kUeI95bW91a9feZer3Xs0uqYREQkSZmdo1RERESkpRhjUoBvgJOstYkWjNmfsZwNXG6tvag1\n4xARkX2jZE5ERERERCQJaZiliIiIiIhIElIyJyIiIiIikoSUzImIiIiIiCShPd7vpiW1a9fO9uzZ\ns7XDEBERERERaRUzZ87caq0taErdNpXM9ezZkxkzZrR2GCIiIiIiIq3CGLOqqXU1zFJERERERCQJ\nKZkTERERERFJQkrmREREREREkpCSORERERERkSSkZE5ERERERCQJKZkTERERERFJQkrmRERERERE\nkpCSORERERERkSSkZE5ERERERCQJKZkTERERERFJQkrmREREREREkpCSORERERERkSSkZE5ERERE\nRCQJKZkTERERERFJQkrmREREREREkpCSORERERERkSSkZE5ERERERCQJKZkTERERERFJQkrmRERE\nREREkpC3tQMQERFpSSXBIK8vWsDyoiKO7NiRs/r2J9XrJRSLkuLxYoxp7RBFRET2ipI5ERE5YFhr\n+Wz1Kt5asgifx8OwLl25c9JEQrEYwWiU1xcv4E9TJuE4hpJQiJyUVG4aPpLvHzm4tUMXERHZY8Za\n29ox1CgsLLQzZsxo7TBERCQJWWv51Yfv8d6ypVRGI+zob9vdp5zXccj2p5Dq83FWv/5cV3gMWSkp\nLR2uiIhIQsaYmdbawqbU1Zw5ERFJatZapq9by/XvvsWbSxZRGY3Ey9l9IgcQdV22BatYV1bKs7O+\n5sL/vkQ4FmvRmEVERJqDhlmKiEjSstZyx8QPeXPJIqqqk7i9FnUJTNpAeMYsrrrvGy792Zmccc3J\neLye5glWRESkmSmZExGRNmfJ1s3c8NJ41q8tB6BP71z+edl3aZ+RUafejA3reGPpAkLeELgOuAbY\niwVNrMW/rpLAkhJ8ayvYQgX//NXzTHt7Jne/dbsWSRERkTZJwyxFRKRNKQlW8d2HX2T9qnKIGYgZ\nli3dzhkPPo3runXqPjpvCm77Enz5QTz5VXt/UWMI98hg05V9KTmuA9ZAVSTC7MkLWDhtyT7ekYiI\nSMtQz5yIiLQpD0+ajBux1Olhs4ZQRYwXvp7JFYVHAzC/eAMzK5Zjqn+WdKt8+3xtm+Jh63k92HpW\nN/B58JaFeWnqV9w9ov8+ty0iItLc1DMnIiJtyty1G+M9cvW58PXqdTVPn100jdA2H6F1aYTWpWHL\nfezVEMv6PAZSveAxRHNSeMW/hU9Xr9z3dkVERJqZkjkREWlTenfIAyfBOpQOHNqxAIDSUIi3v1lJ\nrNJbPVeuGT/O6s2PC+Py8BefN1/7IiIizUTJnIiItCk3jx4NHrB1NhawePyGHxxzDADjFswlPn2u\nduLVDL1yjey9urq0eN/bFhERaWZK5kREpE3pkJHJE9eNJbOdN57QGUtep1T+e9Nl+D3xqd4z1q8j\nEnN301JjmrL7XF198/L38loiIiItRwugiIhImzOiR0++uP1GKsIhjHFI89Vd3KR3bh6GvUnLdqi3\nwMqOska2IBjZrfteX0lERKSlqGdORETarHR/SoNEDmBMn757lsjVDJ+sO3SzKfweDwVp6XtyNRER\nkf1CyZyIiCSdgNdHqreJg0tcWy9vM7Ue9csbMsDx3XvuaYgiIiItTsMsRURkv6sMh/nl+y8yLbQW\n4xjO6HY4vzvqLPxO0z6WeuTkkur1EoxG6x7Y0QNXe7ikAUJASuPDKHflR0ML6ZKVtcfniYiItDT1\nzImIyH5VUVbJ8P/+kcmRVYQ8LkET47U1sxj99kO4btMWNfE6DnedeDKBOr1ztrrDrV7CZgykJChv\ngs4Zmdw84rg9Pk9ERGR/UDInIiL71a1PPUskzdTrPTMURSoZt+qbJrdzZr/+vHTBxYzo3hVPiouT\nEW688l4kcqleL78/8aQ9Pk9ERGR/UTInIiL71fTQ2kaPvbtq3h61NbBde77fYzCHhdoR2OTDCe5r\ndHG9cnN59PSzOalX7+ZpUEREpAVozpyIiOxXnrLGh1Lm+QJNamN7VRWPfTWNVyfOJVYZw7oAXjI8\nhkiGpSpn7/agC3h9XHDYAP4w+uS9Ol9ERGR/UjInIiL71bn04TnWJTx2y+DTdnt+RTjMOf9+gS1b\nyvFWWIzdOYQyFrP4ygyeXB9VREn1+ghHI0Rs49sQeB2HdJ+P3nn5XH7kYM7pd+ie35SIiEgrUDIn\nIiL71Y23XcbUX/6B5aen7twNwMKNnY+jc3r2bs9/ZeF8iqoqoV4it4Pf6+HWo0/kzKMOxec4/HbS\nRF5ftIAUj4dwLEb//HasLS2lIhLGGMPFA4/gjuNOwOfxNPOdioiItCwlcyIisl+lZ6XxxuN/ZOpb\nM3hj1Syy87P4+blnkZ2V2aTzp61dQ1U0is8xWCym3v5wjnHIDKQQqN5s/J6TTuXmEcexYnsR3bOz\n6ZiRiWstRVVVZPr9pDR1vzoREZE2Rp9gIiKy33m8HkadfwyjOGaPz+2elY3PcYhmuPjKTL0NweML\nV4467JA6Ze3S0miXllbz3DGmznMREZFkpNUsRUQkqVx25CC8joP1QSjPYk38YRzITkvlH9ecT8Dv\na+0wRUREWpx65kREJKl0z87hybPP55YP3qXEGySa6dIrJZcbh4/gpIF9NPdNREQOGkrmRESkRU2b\nsZQHn/qA0sowg/t24nc3n09aWso+tTmyW3em/uBa1pSWEPD5KEhLb6ZoRUREkoexu1iueX8rLCy0\nM2bMaO0wRESkmfz5sbd5/ZOFYOMLV1oDOJbX/34t7dvtfuVKERGRg40xZqa1trApdTVnTkREWkQ4\nHOW1SQswducOBMYCMcONv3up2a5jrWXj9jK2lJY3W5siIiLJQMMsRURknxSVV/Loe58zce4yUrxe\nLhxxBFefWMhrE75MuA+cAdZsaZ7Ea/6aTdz24jts3F6GBfp0zOeno4axaUMJo47pS8cC9f6JiMiB\nS8mciIjstQ3bS7nwwRcoD4Zxq4ftP/HRdOas2sApnbo0fmLDHG+PFVdU8cN/vEJFKFxTtmDNZm54\n7i0y17r89dlJdOmQzUt/+wEeLYoiIiIHIA2zFBGRvfLV8rWcec+zlFaFahI5gGAkwocbl/OLRZNx\nvQ22gcMaOLxHu32+/lszFxJz3bqFBqwD0eot5NZtKuEXf3h1n68lIiLSFimZExGRPRKMRJk0fwXX\nPz2eSMxtcDySZYmkA15D0YB4cuVW7+1tAZ8f/nr39/c5jvXbSwlGogmPuZ6dXX9fz1u9z9cSERFp\nizTMUkREmuzfU2dx3xuTcV1bpzeuNl+pwVsOOBBNh40jLGkbIK/c4bqTj+HSC45tlliG9OzMa9Pm\nURmONDjmCbWdlZpFRERaipI5ERFpkv+bNJM/vzWlSXUd14ALvhLwBA2VXS05vvRmS+QARh/emy75\n2azasp1wNBYvdC3eEHjCuz5XRETkQKBhliIisltlVSH+8vZnTapraq1uYjA4YXCC0Dc3r1lj8nk8\nPH/9xVwxaigZPh9OxJJSbEnb5DZYXyWaYDioiIhIstvnnjljTH/gP7WKegH/C+QA1wBbqsvvsNa+\ns6/XExGR/e/rb9fhOPHeth2ssVgPELOQ5WI7hMGA2eLDFHl3JnUWPCH4zcnfafa40lP9tI+mkL46\niieUOGFrn5+J16PfLkVE5MCzz8mctXYxMBjAGOMB1gGvA1cDD1tr/7yv1xARkdYV8PvwmHhyZrFE\nsi2RrPgxT04IT0YE4xBfTTIvitnmxVkSwGAwxnDdMcPoXZDfIrH9560ZBEOJF0Lx+zxcd/moFrmu\niIhIa2vuOXMnAcuttauMaYZNhEREpE0YekgXAik+qiJRIpnViZwDxuviyaxO5HbwgM2PQlYMp8xH\nbnqAn540fI+uVxkOc+d/PmTS/BUAnDiwF3defAppfn+DumUVoUbbueP6MZx83GF7dG0REZFk0dzj\nTi4BXq71/HpjzBxjzDPGmNxEJxhjrjXGzDDGzNiyZUuiKiIi0sq8Hod/XHM+joFINjWfHk5q4h4x\nHDD5MQ7r0p7nbrgYv7fpvx26rstpdz/Du7OWUBWJUhWJ8u6sJZx219O49feVAw7v3zlhOz265CmR\nExGRA1qzJXPGGD9wDjCuuugfQG/iQzA3AA8mOs9a+4S1ttBaW1hQUNBc4YiItHlFVZVMWLKIiSuW\nE4o2khTtRiga5eW5s7nqjVf55fvv8PWG9c0c5U4DunZg1IBedT45rE08CsPnOPxo1DD+/Yvv0b1d\nzh5d599TZ1NcUdWgvLgyyMtTZzcov+ay4zAeU7M5uQW8Xoebrz15j64rIiKSbJpzmOXpwNfW2k0A\nO/4EMMY8CUxoxmuJiCS1/5v9Nfd+NgWv48GY+KqPT59zPoWduySsH4nGeGvmQt79ZjEZqX6+O+JI\njurdhQvHvcyK7UVURaMY4L3lS7l15PFcNXhoi8R95QlH8d74ZcR88edupRdyGg5zdIzDd/sctVfX\n+KR6aGXCY/OWc9nxQ+qU/fq1DyntaEgpsXhCEPNBeQ5sdRsffikiInIgaM5k7lJqDbE0xnSy1m6o\nfno+MK8ZryUikrTmb97EfVM/JRSLEYrFasp/+OZrTP/RdaTUG5IYicX4wT/GsXj9FqrC8R68qYtX\nMujILjWJHMR7pILRKPdN/ZSxhw0kKyWl2WMv7N2VqwcM5anFXxNfrNIQ2ZqKr10QE4sX+fwe7jnq\nPDqnZTfaztptJbw/ewmhcJQTBvZiYLcONccKstIbPa9dVjorNhUR8HvplJvFmq3FrNhcBD5DVTtP\nnboPjJ/EqUf23cc7FhERabuaJZkzxqQDpwA/rlV8vzFmMPHvFyvrHRMROehsLy3nvx9M4+PS9YQT\nDKu0FqasWskpvfvUKZ84ZxmL12+tSeQAqsJRJq9ZSTTV1m8GnzHc+84nFJcGOaxze35wfCHpqQ0X\nDtlbd5w+Gqcsxv8tnk0k1eIt8pA5PQ2TFsPn9/DGndfRLjOj0fPf+Go+d70yEddaYq7l2UkzOP+Y\ngdx+3miMMdxw+kjemrkw4blTF6/k43nLibkuvTvkM6Br48Pzt5VX7vO9ioiItGXNksxZayuA/Hpl\nlzdH2yIiB4KHnp/AYxsXYCy4XgPehlOWXRNjYekGBlV1oH0gs6Z80vwVVIUjDep7rCFKvWQuBu7a\nKG+uWIixMGXutzz90Vf89xeX0a9ju2a7n5+fM4p5t61hw5YSQqEoxhj8lanccNWJu0zktpdXcdcr\nEwlFd/ZIBiNRxk+fz5hB/RnaqwudcrP43YUnc9er8YQPwDEGxzEUVwRrzlu4bjML121u9Fp5GWnN\ncKciIiJtV3NvTSAiclCIxGKMX7yQ1xbOx+d4uHjgEZzRtx+JtmX5ZsEKHtu0EJviqZ96VbN4csJE\nMyI8t/Yznl49hVEd+vDA0WNJ9fjITk88XDK13MGmG8LuzsTIv91A9XBHAGMhGnW59ulXmfTr5hsg\nEUj189T93+edj+cxZfoy8nLSGHv6EA7vl3hlyR0+W/QtHscBYnXKg5Eo736zmIHdOvDH1z7mza8W\n4FqLz+PhtEF9yc9M48XPZu1RjLeec8Ke3paIiEhSUTInIrKHXGu56rVX+HrTBkLVidTXG9YzedW3\n3H/KmAb1//72x1hPg+L4uEpj8GZEcNIjGAMV0TAAn25axh9nv8ddQ8+mpDLxQh7RSpebRx7HQ19M\nxefxYK3FVkYx1E0oDbC1qJL/PPQmaYEUjht7DLkd9myFyURSU3yMPX0IY08fsvvK1RzHgQQLYBri\nPW93vPQuH85ZVpP0RmIxJny9iB4FOURjDbclSMTncbjl7FGcOrhfk+NKFtZaijYW40vxkpWXufsT\nRETkgNbc+8yJiBzw7n7gRaatXFWTyAFURiNMWLqYxdu2NqhfEgqBkyCDiVpytkfx+oN1N90GQm6U\n11fNIhiL8vG85Y3GclyH7nz5o5/wyJgzefbcCyBBz2Cc5dnfvsw/b3mO7/f6GZPHfdGUW212xx/W\nE9dt2D/p93o4/tBD+Gju8oS9l6u3FJPqTZQRN2znzduu5HvHNz3BTBYLpi3h6v43cnmvn3FJ52u5\n5Tt3snV9UWuHJSIirUjJnIjIHvjs9S95a/ocrK/h26e1lmlrV9c8rwxFWLphK6MP7Y+JNOxVMhby\nn1kc/5cEYtblwc8/JRKNJTwOsGl7OVkpqYzu2YvCzl1o3yEDWy8dslisGyFWFSVUFSZcFeb+qx6l\nbHt5U2+72WQFUvnT98aQ4vOS6vPi93pI8Xq54oSjyM1IbfxEA1npAfy7SOgM0DUvm675+97r2NZs\nXV/E/5x6F+uWbSQSihAJR5n76UJuGX1nwo3URUTk4KBhliIie2Dcg29hA0GIueDUTSwcY8hJDWCt\n5fEPp/HMxzNwHEOwKkwgGqOqG9jU+DkmFKPj/DJYU0bKggqCQzMb9N7ZCLw4dzYDOuazeH3DHj8D\nDO/Xo07ZX79/Dpf+9SVs2MbXEjZgPZCyrGTHUwA8Hocv3/6ak78/qplemaY75ci+DD2kCxPnLiUY\niXHCgEPoUZBLWVUIGplV6BiHP116Gl8tW8P7s5cS8PuIxmKs2VZMzAW/18Hn9fDQlWft35vZS9Za\nrLX8+us3eWvtXGLWJd3j51dHnErvzHweWfAJXsfD/xx+Gv1zOvDuUxOJRuqugOrGXIo2bGfulIUM\nOnFgK92JiIi0JiVzIiJ7oHhzCZlbtrH9tK4N0o6qcASsZfz0+TzzyQyCO758OwZjfGTNLCGS5WKi\nLmP7HUbpynLmAdnPbSI0IB3rd8BrIGYxEUva+GLCJ+ZywznHcuM/36xZ2XGHy0cNIdVf9218YIf2\n5AfS2Oit7nWz4Akaop3zCPXOI3V50Y5i3CbOQWsJ+ZlpXDRyUJ2yzEAKpw/uz9vfLG5QvyArnWF9\nunFM3+5cf/qxQDwhmrN6I7NXbqB9VjqjD+9Niq9tf6ytKNvK72e9zYytq+I9prWOVcTC3DlrQp36\n533yOCd17E/XpZuJhBJtZ2HZtGpLC0ctIiJtVdv+1BMRaWMKTxvMpic+pOMzS9h0RV9s9WhLE3Fx\n07zc/vGHdN+eQTBc74u3z0O0YzYdH5uOcS0rDinl4lvPY95ni/CtC9Hhl8soO68d4X5peNeGyBy/\nlZjjpeoEy9E9uzHh9qv5w7gPmbdmEznpqdww5ljOGHpog/je+HQ2xauK8HsdCMWwGX7wO1i/h8oj\nOtQkc240xrAz2t68snsuO51IzOXDOUuxxHs7C7LSefq6CxusFGqMYVCPTgzq0al1gt1D20IVXDLp\nKcqiiRe0aczEjYs565Tu+CekEC6pe651Lf0KezdnmCIikkSUzImI7IHv3TGWSS9/RmxxCT3vmEE0\ny0csx0/x8R2pOLqAmOuypawi4bmu17Dm5sOJtktlVWmYk3ulkdM5m+1ri/FuiZD75IaauhYIntyF\ny48cTEkwyKPfTGO+bxu5AzK4ZujRnH5o/wbtvzjhc+79eBpkpcQXQkmrHmpZGYY0P/g9eH0eHK+H\nGx79ITkF2S30Ku09YwwPXnkW5cEQs1duICstlcO7dUi45cOeeGjcJF74fBYR4wIGDHTLz+bPV5zF\ngK7tmyf4XbDW8vtZEyjfw0RuhwmZq+HpPmS8v52cJ9cDkJLmp/C0wfQc2K05QxURkSRirE08P6E1\nFBYW2hkzZrR2GCIijVq9aB03DL+dyvIguPFhctbnsO7GgYS7pQOQPy9MMCOlzsqSrtdS1cnGFzsx\nJr4tAXB5QV8+v/olbMStmc9mAes1nP3RjWzYWsb4+QuwHoimAQ4EvF6uGDSE246tO99t0E0P4jqm\n7oqW1mIqI/izAhzvzeCY7DxOuGgEnQ7p0HIvUhvz0LhJPPv5Nw2X/KqeRPjEtWMZ0b8HoUiUbzcX\nkZuRRofsxjc+3xt/W/AJjy/5tMFQ2T1mocvL2+kyK8qZPz6VC246E08TVvkUEZHkYYyZaa0tbEpd\n9cyJiOyBv//8GarKqmrW6TDEh1gWvPIt635xOB3eXI1/djGhS47Aeg04DlhLKLdWIgc1f76waQlT\nVvyNn5/5e4rnbgYg69B87n3tfxj7/OsQtPhsvCfJXwTB9paq1Cj/mvU11w49mtxAAIB1m4oaJnLV\n17FpPg7t2p77fnohfu/B97b/wuezEq/dXP1S3fz8BG4643genDAFgyEaizHkkC78+YozyU7bxQqb\nTVQeCfH00s/3PZEDMLD98va88+9b8XsOvr9LERGpS1sTiIjsgTlTFpDoO3nK6nJylpWTOmsbxSd1\noLJjlKr2MaJOiMD0NVhPLOEecNYx/O+lD/HC5w/xUWwcH8XG8dr8x7nto08haDHWYDDxP60hdbMB\nC36Pt86edrtb+ONfP7vooEzkgOqhlY0rqwrzwJuTqQxFqAiFCUVjzFyxlpv/b8Iuz2uq5WVb8DnN\n13tWGYtw0/RxzdaeiIgkLyVzIiJ7IDU9cU+N4/NQuNqw9ucDKRtWgJvpw033kPnFGjJnrMepbLgS\n4Q7rvlnNy396rU7Z4nVbMDbxPDEnCBE3RseMnUMB2+VlkRKzNMg0raWT8eH1HLxv905s9/PtgvWW\n/Y/EXL5ZuZ6N28v2+fodA1mE3cb3Ctwbn29ewbdl25q1TRERST4H76e7iMheOPPaU0gJ+OuU+VN9\nnHH1dyjqloob8IA3/tbqKQ4qbA4PAAAgAElEQVSTOX0LTtglZ/IGTKjeF3pr8W2uIlYR4YPnJtU7\n1ngMBhjUviMTnpnEWf1/ypjuP+KWax/l4e+djnGrE7rqhzdmeenXV+77jSex7AoDbiMvqLX4Gkl0\nfR4P28or9/n6HQJZDG93yD63U5vP8bCsbHOztikiIslHyZyIyB644s7vcvSYIfhTfaRnp5ES8HPk\nCQP4yYNXEhuYj/XvHE6XsrYCW53YZU/eSOZXWzARN95LF3VxyiJ0/ss8IL7EfG3d2mdjTeIE5Kie\nnfG9vJTxt/+b0NItxNaWMOtfn3LXeX9myp3XctnA/hTm5nHjyKF888jNtMvLaqFXIzn0zs4jsM1i\norUSXTf+yEhN4aLhRyRM6Fxr6dUhr1lieODosc3Szg4RN0bPjPxmbVNERJLPwTmBQkRkL/n8Pn73\n6i1sWLGJVQvW0rVfJ7r26wxA4YBezJk5E+uJD+uL5vjjPWXE1z4peGUlue+tJdwhQCQ/hezp8Tlv\nvhQf3/necXWu8/p1V1D4h7/hhO3OXjoDHTpl8tuBI/n5m69jYjuTPRN1cYsq+Pufx3PH3Ze38KuQ\nXL4/dhj3PPYe/rXR+GbpfsBnGNqvK4/95mK2llbwzqwllAVDRKs3Ug/4vfz8jGMJ+H3NEkOWP5Vs\nX4CSSFWztNcvqwN9s1p+SwUREWnb1DMnIrIXOvXqwPCzjqpJ5ACuGDSUQMrOIZjhLmlEClJrNhYH\n8JZHSV1dga96yGUgI5Wu/Tpx2W8urNN+WqqP2b+/gSGHdcGkG3yZXm4673gm3nwNH779FSToSTIR\nl5kfzG7mO01+Jx17KD+4aCSpKT7SA34C1sOpg/vx0K/ivWXtstJ59Zbvc8nIQRzSPo9j+nTj4SvP\n5rLjm3dT9dO6HNYs7TgYHh524e4riojIAU89cyIizaRbdjbPnDuWWz96j43l5VhrybhlBGUPT8O/\nvhKMwU1xyDqjHzefPIpNKzfT/+g+HHPm0IR7hfl8Pp7/4cUNyjt2STz0zxrIbL9zSGU4GmXJ+q1k\nBlLoUZDbfDeahL533jAuOH0I6zaVkJ+bTnZmoM7xgqwMbjvvxBaN4Yyuh/PWmrlUxSJ73YbP8TCy\noBdd0nOaMTIREUlW2jRcRKSZWWvZWllJqtdLZkoKAOMmfMaKlRv42Q/PIiMQ2E0LuxaORDmj4Coo\nDVF7nUbX65DzyxN55Z6fMGHmIv742scAxFyXQ9rn8tcfnEvHnMx9urbsPWstN3/1KpM2LtnjhM7v\neDAYjsrvzl+O+S6Zvn3f/05ERNqmPdk0XMmciEgSeuylj3jlxudwSkPgxDcVLzmlD87Ajtx27gnc\nO35SneX2PY6hR0Eu4391BSbBfneyf1hrmbxpKe+snUc4FmPGtlVsC1UA8VVK638ij+k8gDuOHMOG\nqlIKUjPolJa932MWEZH9a0+SOQ2zFBFJQht9Lpt+NAjvtio8lS7RgnTwOPhdl3HT5hKO1t0GIeZa\nNmwvY+G6zQzo2qGVohZjDCd27MeJHfvVlLmuSxQXv+Nl4vpF/PvbGQS8Pq7rP4rDcjoBUBBQj6qI\niDSkZE5EJMnc/fbHvP7lfBwMkYIAlTnxFRpNzMWpMIQiUdwEoy48jqGovHlWU5Tm4zgO/ur1yE7q\nfCgndT60lSMSEZFkoWRORCSJzFq7nn9/MhtjIeaHUHtq1iW2DpRnx2jXMYM120oI1RpmCRCJxji8\n24HbK7clWM6Tiz/js83LaJeawdV9RjK6U7/dnygiIpKklMyJiCSRJyZPr5lYFcm2UG/6mzUwrWgt\nXTLT2FJaWTPcMuD3cfXoQnLS923xlbZqa7Cc8yb+g9JIkKh1+bZ8G/O2r+f6Q0/kB/1GtnZ4IiIi\nLULJnIhIEqkMRYhncya++XWCtUxcC3+55hw+mbWCiXOXkZOeyuWjhnLCgF77Odr9566p71AUrKyz\ne2pVLMIjCz7h4l6FpHv9jZ8sIiKSpJTMiYgkkfMLD2fGgrVgwUTBJngXt1h65OZy3anDue7U4fs/\nyBZQFKpgdtFacvxpDMrrilNrRc5/TfiSiZsWQ4Lt98KRKG/OmcOlQ5u0KJiIiEhSUTInIpJEzj3y\nMJ7qNp1v1xThK4GQnzq9UQGvl0sOP5KAz9dqMTa3vy+czD+XfIrf8eJaS25KGs8cezndM/JwXZen\nXvgMZ6QhlkvDnkoDT775pZI5ERE5IDm7ryIiIm3JGzdczi0XjOKQdnl0Jp0sXwpexyHN5+PKQUO4\n47gTWjvEZvPZpmU8tXQqYTdGeTREZSzMhsoSfvzFS1hrWbR6MzZqCSz0QazeyTGg3MPWknBrhC4i\nItLi1DMnIpJkHMfhqhFHcdWIo4D4RtQVkQgBrxePk7y/0YWiUV6cO5tXF87HMYaLBhzOp2ULqIpF\n6tRzsWyqKmVJ6WbyMtPAgm+zh/TpfiqOCmMNGAe8Wx3syjQ8rXQ/IiIiLU3JnIhIkjPGkOFP7gU+\nXGu58o1XmbNpI8FofEuFe6dOwR8Amw2m3vBJj3EoiwTp364D2e3T2VpeQVmmj9gaH04YvFUW71ZD\nNAB9sxJMphM5gEXcCJ9snsTUrV/gMR56BPvw9l/mULbcYvyW3sPzeeD3N5KaktzvGyKiZE5ERNqA\nqWtWMW/zpppEzrM9RMa7y0hbVEJWupfSM9pRNSYL48SzOtdaDs/tDMCvbx7Dla+9Ss5SSNke328P\nDKWHgE2LsmbxZpZ+u5m+h7RvpbsT2X9c63Lfoj+zqmI1YRsfYrw0tAIzIgU7Ow8LLP14G1dn/A9D\nLuyC13gYVTCKo3KHYOr/aiIibV7yjscREZEDxox166iMxIdTekrDdHtgLpkztuItjeDfUEXe8+vI\nfHILDoZUj4/fDjqDVE98kZfH58wgZyn4t4Ox4MTij6wVQFqU8uOC/P35ya14dyL7z5ziuayuXFOT\nyAE4KeA/IoS3WwSMJefHxXhPKGF+6QJml8zliRVP8a+Vz7Vi1CKyt5TMiYhIqytITyfgjQ8WyZ68\nEROOYdydx52wS9bHWzgl0JcXRl3NeT0G1RxbvnErKdvBsXXbdFxIW+ol2t5lbcn23cbw3rMf870e\nP+HsrMv5xajfsmrh2ma5N5H9aUHZIkJuqEG5MeAfVkne77bgHxDGSdl5LOSG+HzrF6yvWr8fIxWR\n5qBkTkREWt3Z/Q7FY+IfSYFlpThR27CS1+Hokg4MzOlUp/iQQE710MqGPCHAhb6Hdtjl9R+76Rke\n/OE/2LJmG8HyIPM+W8Q1R/ySFXNW7sXdiLSeNRVrEh/wQsaYSrxdYgm//cWs5etNs1s2OBFpdkrm\nRESk1WWnpvLc+RfSKSOTaEEqNtHUnZilb98uDYrvPOtkSJD7WSzRzvEevlsvPaXRa4eDYcb/7d2G\n57uW+654dE9uQ6TVLSxblPiAiffO7XjUFw3G+Nf9H/PSPz9p2QBFpFkpmRMRkTZhcMdOfHb1NVz3\nm4ux3rofT67XkNI3n2FD+zc4r29BARecPxRbaw8Ci8X6IXhYlN8eeQY5GWmNXnfmR3MTJoMAqxZo\nqKUkF9vYf8y7O89C+XQf/31mCl98srCZoxKRlqLVLEUOYuNXzeL+uR9QFg3RKZDFnwsv4Mj8rjXH\nv544l3ee+ohQRYjRlxzLCReNxOPVrl3ScowxXHHOiVQ9Vs5/f/UyVEYx1pJxVBcef+O3jZ538/e+\nw8j+PfnXa1+wanMRtrOlz/Ht+clRx3NEbsPevNo6dM9v9Jgv1bfX9yLSliTqjbMWcMFWOBQ/mgth\nhyARXntuKiNGH7bfYxSRPWes3btfcFpCYWGhnTFjRmuHIXLAW1G2lT/OfpfPt6xocOwfwy/lxE79\neObXL/H6X98hWBGfSJ+ansKAkf350zt34PEooZOWF43FWLBkDQX5WXRq37J7xZ2ffxXl2ysalH/3\n5rO59oErWvTaIs3pvoV/ZkFZ03rWrIXSf2cQ/DiD2mObu/cq4InxP2+pEEVkN4wxM621hU2pq2GW\nIgeRqOty05fjOO+jvydM5ABumfEqm1dv4dWHJ9QkcgDBihALvljCV+/O2l/hJpXiLSVs31QMQEU4\nTFX1Mvuy97weD0ce1rPFEzmAR6fdQyAjtU7ZkScMUCInSee2w24hdUU+boXBhsBGILzUR9U0P7GS\nnV/7rIXYVofgxMw6iZzX5+GYEw5tjdBFZC9omKVIkgpGI2yrqqIgLR1/E3vKnls+jUkblxDZxZyK\nikiYcc9+iONp+FtPsDzI529+xfCzjtrruA8UJcEg7y1fysYN2/jmvg/Z/OkKQh1S2XZ5Pyo6pGCM\nYUhOe86ryKVn5/YcPWYwXp/ectuqLn078Wbp88x4fxarF61jxDmFdDpk1ytgirQ10ZjLw898wLyJ\neVCZSUZFJabEQNhhx8RQX/8QKYVBegzN5Qx3LH9NfZNwKIq1Fp/fS1ZOGhdedVzr3oiINJm+WYgk\nmZjrcv/UT3l+7iwM4BiHG4cN50dDCzGJJkXU8vKKrwi50d1e49m5c+nsNGzL4/WQlZext6EfMKas\nWsl1b7+BwVBVFYLTssnM6kz50e1xUz3xn7yt5astG5hVvJJ+ty0mEEjhocm/p2u/zjXtWGuZsWId\nXy5ZTU56KmOG9KddZnor3pkUnjaYwtMGt3YYInssGIly9WP/ZcHKjbhdUiDmxz8zhj8cJf5uHv9n\nZHEqkcWpzH/REjh2Dvc++QPGv/A5mzcWU3hcX865ZDiZ2Y0vGCQibYuSOZEk85cvP+eFubMIRqN1\nynIDAS4ccPguzy2LBHfduAUqDMFu+YQiKxsc9vg8nHb16L2I+sCwqriYOydNZPLqlTsLffEezNKR\nHTFYqJ0EewzRdC9Fnf2kLSrm2kE3c/sLP+f4C4YTc11uevYtvly2hqpwBL/Xw1/fmcpfrj6Hkf17\n7N8bO4C99fj7PHnnfyj1QIY1/OiOCznv+tNbO6ykF4nEWLWuiOzMVAryM1s7HAFe+vQblm7ciuuJ\nvwc5ERd/2Y5ELrEZU5cybFR/bn/g4v0TpIg0OyVzIkkk5ro8O+trqqJ1e9eqolEe/WoaFxw2cJe9\nc4dktmNWUSNLrVsgBmZWGngN7iWHkjVhFdFw/FqxaIyb/vljuvXf9cqAB6ptlZWc958XKQ01khB7\nDdYkmIbsGCL5qUAJkVCUey//G+XFFUQHd+bLZaupqn59w9EYAL96/m0m/f7H+LTIzD77z/3jeWjC\nZ1RePBATc9nmcbj7g6kUF5dz1W++29rhJaXtJRXc89j7TPvmW4wxeHNDZOQZunbK4YLvHMN3Dh/S\n2iEetCZ8vYhQJFbz3IlarGGXyRzAK//3GedcOrxlgxORFqNkTiSJBKNRQtHEwyTXbtnOad6L6dS7\nA9fefznHnjesQZ2r+ozgF9PHNZwx5wLrfXhXBoD4PkUjhh/G7574DXM/XUg4GOGI4w8lkBFo3htK\nIvdNnUJpKNj4bENjIOaSNr+YvPfW4i0KEe6cRtFpXUhZt3OVxHAwzKO3/IsOfzynJpGrLeZa5q7a\nyNBeB2fS3Jwe/c8nVI3sBl6nZt+6UM8c/jH1a65CydyeCIWjPPTkR7z98byastSuZYQ2prFtm2Hb\nkjLmTP2QN074ikd+em0rRnrw8tWb5xxN89Re16RRoapwC0UkIvuDVrMUaYNKKoOM+2IOT3/8FQvW\nbqopT/P5KEhPPKfKt7Ycay3rl23knu8/wpfvfN2gzimdD6N/dgc8tXuQXCBk8KyKr+RnjYWUKH+4\n9iI8Xg+DRx/OsNOHHNSJ3CcrV/DaogVYwFRFIeo2rBSKkfXZJjo8v4yU9ZV4gjECK8ro9ORiUlaW\n161aEWLBpk0N26jm7Gbuo+yetZaywR2w/no9nD4Plf3aUVkVSnyiJPTbB9/k3U/mA+CkxAgcUkZo\nQxrGY8k5Zhsdv7uGvBM2M2f2ZqYunreb1qQlXDj8CDxuvZ+bjNntFuLaT04kualnTqSNmb5sDdc/\n/QZgCUddHv9gGqcO6svdl5yGMYbfHn8itzz9KpGAB9fv4N0eJpphaPfm6po2QpVhnv31SxxzxtA6\nbTvG8EDhBfx90SQ+3/wtFkuPSDYLFpeAAeu4+HwRXv/p1fv5rtu2P06ZBJURsqdtJuej9VT2y2br\npb2wDvEeOQtpC4tpN34Vpt43Jyfa8KuU9RjK0kMEQr46w6IA/F4PR/To2HI3c5AwxuA2tuG3gVAs\nRmsv8TDpq3k89v5kiiMhTu7Vh59fMobUFH8rR9XQuo3FzJyzGte65B6/hZyjiyiZmUt4WwpdL1+J\nk+Li+Cy2RwVZRxbz3BfvcGz/Xc/fleY39pjDefKZ91mfFf8BI3VbGOPaXQ6zDKT5ufZWzSEVSWZK\n5kTakEg0xk3/eouq8M49ymKuy4dzljF6YG9OPrIvT74+maqO/ngSYSAcSMFEIdIuQPHY3uBasl9Z\nzrrldXt+isNV/PzL/zK7aC0+x0PUutw04DuM7TKE+QM3kZsRoF+ndrtdEfNgtHrNJro9MBenMooT\ntWR9s430+dtxoi5YCHVLp2xQHo39BO76DNbnwVMZxfVB2Zn5xHqV0zm1BxvWlxFzXbweDwb4y1Vn\n43E0aKI5dIw5bHDrLUoDBFzISW/dnua7n3mdZ4uWYdMNeAwrNi/iv39cyJTbbyQ90LZ6wVet24bX\n6+DrW0pOYRGOz+L4LHnHbsUTiGGqOz+NB4zHUtFjOa7r4ui/492KRqP8a/XzrKhYwZFZh3NJj71f\niMTjOPz61OO4YeJ7BLtkkVoUa/Q9KTXg46Szh/DDX55KWlpq4koikhSUzIm0IbNWrsetP0wGqApH\nGP/VfPq3z2OWr5Q6U9odg78qRvmoPvFiDxRffCRVsao6bfxi+ji+2baaiHVrtid46P3JPLL6S1K8\nXmKupVNuJv+8Ziwdc7U6XW0dP9iIpyKCqdWJ5gnvHGqZurqClDUVCc6Mi+alsPGqfnS9bw7hggAV\np+dhHPAcFua5sRfz5dLVZKcHOPmIPmQGUlryVg4q/7jzSi649zliMRc8DrgWx8L9157bqj9abC8t\n59mipXWGgNoUD8XEuPe5Cdz147Y1n69Hl3wiEZf2w7bh+OPvT+n9ysDYmkSuNiclxrdbN9C7veZ9\n7srS0qXcvejemufrqtbz7qYP+POR91KQWrBXbR5/wTGc8uGXjA9EqOzkJW828aH0tQTS/Nx05/mc\nMOaIfYheRNoK/Wwm0obsam5DNBLjuw88R9o6h7Q1hsBaQ8omQ+p68BR7MdZg3J2PkCfAm7Pic1c+\nXbuC6VtWErE7P9VNsYfYSh+RqEt5MExVOMLKzdv56dPjW/guk0/2wpI6iVxCFkJd03D9dd9WXb9D\n0endiOamEOqTRcqmKtr/z3JMyGVNcBuHdW3PVaMLOX/YQCVyzax3x3a8/b8/5PxhA+melcl3Bvbi\npZsv48TD+7RqXG98MgOTYNqlTfHw4doV+z+g3ejSMYejB/XAk7ZzwR5vZhTja/wdKytV+yXuzp8W\n3Zew/I65/7vXbTqOw4NP3MSfhhxPRkEqwXZe3FoJt9fnIb99FiNPSp55clXhCK9Om8vbXy/EdRP8\njyNykFPPnEgbMrhnJxJ1GAT8XhYuXE2512KqlyczLpigxeBgG0kD735/Imsi5Tz6zefYfEvtdU/M\nej/GrXsx11pWb93O7z+YiD/g5aRevTm6c5eDfuhlfk4m67Y23vMG8U5R63PYckFPorkpRHP8pH5b\nhvUYKgbng7UUndyZLo+X4pTHCHxWTPbZh+yfGziIdcnL5g/fG9PaYdSR2diwNteSQtvckuKuW87m\nyjcnYdPKa95HPCku1lLnPctGwb+9HQVZOa0TaJKojFTiNvK+Hbb7vrrkxScN5+KThlN2bRXj/+9z\nPhj/NbGYywmnHcFlPxmNz5ccX/+e+PBL/vbe5zXP73jpfe793hhOH3poK0Yl0raoZ06kDfF7vTx4\nxVmk+rykeONzqAJ+H8N7d6PIYzH1prLveF6/HAAL4WiUR6dPIxRM8GtmOHGCFozGeGnOHJ76ZgZX\nv/EaN3/wLtbubj20A9s5PxuD17/rLz+uxxDsmUn5Me0J9ssm2j5A+bACKgqrh0sZQ7B3JqHOaTgh\nS2BZiKv7jtgP0Utbc+53jsYTcaHekGoTdbl8SNvcp83v83JD4VXxhZKqw67504VY0MENG9ztafxh\n5M2tFmeyaI6ErSky0wNc/tOTeP6DX/HSxNv48a1nkJHVtuZkNmbu6o11EjmI/+B464vvUlLZyH6f\nIgchJXMibczI/j1479c/5BdnHc91pw7niR+P5crhg/aqrUqPSzQWAwzhTQFiFR52jFKxedH4NgQN\nWCLe+G/GVdEIH6xYxqerV+3t7RwQzr1+DP2P7l3z3Jq6Q2It8V65klEd6p5Yv0fTcag4PBfXbzji\niN5c1qvhXoBy4PN6PDx24ul4q2I4wfjDRFxGhrP40diTWju8Ro3sMYRfdruF9Ko83IghWuZl89ud\nWPV4H7a914WqCQN44jsP0jl37+Z7HUxy/I33XCb8ce4g9Nd3pjZ67J8fTtuPkYi0bcnRzy5ykMnP\nTKN7j1z+9OlkHl46jXYpTVttrGa4pQNuRpRoWq0hW1EP0aJU8Fi8eVU4/vhiEHUYCOfaOj/zVEYi\nvLVkIaN69Nyne0pmHo+HP064nYs6XUM4GGHTZb1J2VhJ1uebcUIuVX2y2Hp+D2K5u/l7shYTc8kI\nBLjv9p8c9MNXD2YnHzuIWUP78/yEKWwrreC8UYUM6NuttcParcGdD+MfnR8AYPqslYxLmUlxhypG\nFfZl7JjBpAXa3tYKbdXpHU/j3Y3vNyj/fo/LWiGatmdbeeND27eU7nrYu8jBRMmcSBv0xZrV/HjC\nGwSj8QUHNlZVklEZwqalNuztqWax4LPYQIyoFyKZiebeGIgZopvTCaw3GAxej0PXvGyys1KZHdpM\n1OPWPwOf0zbn8exP6dnp/O+4m7nr4ocJVLpsHdONorN67FEbxoUjY5n89tNbyMrXiqEHu7RAKj/+\n7qmtHcZeGza4J8MG92ztMJrVUx99yTcr1/PLs0bRu2N+i17rku4X0SejD0+veJYqt4oMTzrX97mO\nQ7M1Hwxg9MDeLN2wLeGxMzVnTqSGaUtzYQoLC+2MGTNaOwyRVjf2Py8xa9OGBuXpC4OQkhrfN2vH\n/lnV/wtH0yBUYJs2eDoG6WvjFVN9Xj7+3bV4vA7DnvoHlZFInaoBr5fnzr+QozppmXGA8uIKPhz/\nBXeVLqDScQm7u1vmEvzVe8j9ZsQoLhs6dLf1pWXs+LxTj6jsUFxRxcrN21m4fjN/eu2TOscCXi/T\n77uhlSKTcDTKCf/7T8pDdecXdm+Xzdu3/6CVohLZP4wxM621hU2qq2ROpO0Z9PjfKAvvfoJ85nJL\n6lZworB1MMTSaLTnrjYTsaSvBBxD58/W8MSLv6L7oV2Ysmol1739BsYYXDc+aPOaoYX8csSx+3pL\nB5zSUJDn58xi0spvWV1SQmkoiAEirkvMWtJ8Pqy1nNKrD8d178Honr3IT0tr7bAPSuuXb+SvP32S\nbz6eh8frcMJFI/nZIz8gI0fL5x+sXNdy7/hPePXLefi9HsqDid9vu+Vnk+r3snxjER7HMHpgb+65\nbAx+rwY27Q8VwRC/H/cRkxd8i8fjcE7hAG49Z5Q2pJcDnpI5kSR3zsvPM2/L5gblKdU9PMFYvDco\nsNmSvQScGES9sGUY2JrvGIaE8+gjLhlzS8icsZ3U5UV4wlG69u/C0/MfxhhDaSjIhyuWUxmJcEKP\nnnTP1hLjTTF/8ybmb9lM16xs+uTlsa2qikNyckj1+lo7tINaeXEFV/a7gbKicmz16pE+v5ceA7vx\n9xn3qZfuIPWvSTN47L0vCEaiu69cT9e8LN799Q9bICoRkbg9Seb004ZIG3TziONIrfXLrwlDarlD\nx0Uh2n+0AX/E4jUGf5cUsrMCeL0O3ijkLSC+1GJ1IufU/6Jq48Mwsz9ZS9qCzTihKNbC5lVbWL98\nIwBZ/8/efYdHUX0NHP/ObE0nIYRACBA6RKqIFJUiCIpKsXdFVBSx9/IC9p9iw97B3lGkCQhK7723\nkJAA6T3bZua+fywkhN1AGkmA+3keH8mUO2dTdufMvfdcm52r2sdzS6cuMpGrgPiohlwb35HesU2J\nCgqmfWQDmcjVAfO+/hdXkas4kQPwuDWSdx9iy5IdtRiZVJu+WbS+UokcQHJWHqv2HKjmiCRJkipH\nJnOSVAf1bR7HW5dcSkxICNYMhcDDKqZ0g0yhktU4kug3t9BywgamdhzIj2+PYuiAjoSE2CiM0Wg4\ndRdxj68k7rGVRH69C7XgmDlwigKKQtpNLUtdT1EVNHflbmwkqS7btykJV5GfIXSG4MCOlJoPSKoT\n8h1VW6fs3637qikSSZKkqpHJnCTVUUNateHZLn0J9Vi8RU5UFWEzI+xmsq9ohyfbwaePfU1YSACP\n3zOIH94bRcMPNhO0OQtVE6iaIHhDFjHvbgX9mOHUqoJW344WVlJCPLheELHtZIET6czTqmtz7IE2\n3x0KNO3QpOYDkk6JfIcLt1b+B1Jdmjeu0vVaNoyo0vmSJEnVRc7glaQ67NcVm3H46TETVhNawyD2\nbthfvG3NjHWoRRrKMSsLKLrAnOcmcHsOrrhwLLkKqg6GRUWLCCDQJVBNKs98/5CcUC6dkQbe0pdv\nX/gVt8uDoXv/OCw2M007NCG+d9tajk6qqjV7kxn/8zwOZOQgAJOqcG6LJrx43SAaR4QBkJGSyV8f\nzWXvhv206dGKK+4ZxONX9uW6t7/DoxsnvkAZCssomCJJklTT5N2bJNVhHr2MsvcChKoQ1iC0eFPy\n9hRUl++NieIxsCYXYctUMHkUFENBdSnkDm1H77GDmLr7PTpe2P5UvQRJqlVBoYG8v+o1elzWDbPV\njD3IxqBb+/HG/PGy+BnBl6IAACAASURBVMlp7quFa7jjw19IOpLIAeiGYNWeAwx++UuW7tjPvk2J\n3Bn/ML+8OZ2Vs9bx02vTGNXhIQIKPHx010jfecXl9N6cZTjcnpMfKEmSdIrJnjlJqsOu7N6Bbclp\nvhP1DUFwnofrX722eJPL4fZWrzy+QK3VhGINQBElNy0KCsKkMj8rnWejw0/dC5CkOqBhswa8+OeT\ntR2GVI2+/m8tb81YfMJj7v1sGj3XZFKU5yje5nZ68Lg0PnroK16e+Qyv3jiE8T/PQ1UVily+yVmg\n1UKRn6TNbFLZeziTc5pGV/3FSJIkVYFM5iSpDrvyvA7M3rCTTYmHvU+BNR1FQIMF+7nmkcsZNnYI\nAAlbkpj+4RzfRA5oGB1BaqyfhE1VyLIINI+G2SLfCiRJOn28M3PJSY8RwNpIleNntwkhWL9gMwCX\ndWtHv/iWrN2XTKHTza8rN7Np/yECbBZuuagba/elsGTHfp+2PZpO/ZDqWzfSMAymvTuLJdNWEtYg\nlNtfuJ7m8bHV1r4kSWcueQcnSXWYxWTi07uvYunO/azYnUSIxUKvRtG0+18MtoCSog7TJs9Cc/sO\nyVRNKg98cjd3zfjHX56HKd+FosqhZpIknT6cbq3cc908MaF+tx99/9yXmsm25DSaRIRxQbvmDOla\neh5lp2YHWLM3udToCItJpXPzxjQK9992Rbmdbm5qfi85aXnF25ZOW8Xdb9zCNY9eWS3XkCTpzFVt\nyZyiKPuBfEAHNCFEd0VRIoCfgObAfuBaIUR2dV1Tks4GqqpwYfs4LmwfV+YxhxPSios7HCsgyAYe\ngw6KjW0eJ8JiKt6neHR6moMxmUw+50mSJNVVVnP5p/srZhMWmwXPMUMorXYLl9w5gPs+n8byXUmY\nFAWTqhITEcrn915NRHBJj1uPVrE8Obwfb0z/DwUFj67TLS6GSbcOrbbX8/64L0slckd9+sQ3DBs7\nBKvd6ucsSZIkr+ougNJfCNHlmBXLnwL+EUK0Bv458rUkSdWs28Ud/X7gu10arbvF8dnE24lJd6N4\ndNAMVIeHuB05vPbWXbUQrSRJUuWpqkpIOROcHq1j6dC7DbZAK4GhAdgCrHQZ0JFFjU0s3r4fTTdw\naTpFbg/70rJ4/se5Pm1c3bMji18Yw9T7r2X2M6P4bMxVhAXaq+31LPptuf8dAuZ981+1XUeSpDPT\nqR5mOQzod+TfU4F/ATkLXZKq2dB7BvHHB3PITctF83iHW9qDbFw2+mIijhQ4mfX902xaup0dmxJp\n3a4JXfufI6v5naGyU3M4tC+VmNaNCIusnqFgtSW7qIhbp37P/sQ80CEyIpAPbx1J+5io2g6t1szZ\nsJPxP82jyO1BAS7qEMf7dw6v7bBq1NjBvXjtzxMnOjaziYGdWhE36HwaOAXJOw/SLD6Wne4ipk+d\n4XO8bgiW7UqkyOUh0GbBrWl8MGc5f2/cRZDNyt0Dz6dtlwbV/lpO9D6sypETkiSdhCKEv5k0lWhI\nURKAbLxzjj8RQnyqKEqOEKLekf0KkH3062POuxu4G6Bp06bnJiYmVks8knS2yU7L5YdXf2f59DUE\nhwcx8sGhDLz5IpmwnUU8bg+TRn3Ikt9XFg8ta9YhlsP70/C4NDr168BjX9xLeFS9kzdWB7g0jR6T\n3kHPVFEM7++xQKCoCrOfuoMm9U+P11GdFm7ewwNT/vLZrgB927fgvdHDaj6oWuBwe7j2re9Iycr1\nO3/ObjHj8mjFc4WtJhMfjB5OzzZNGfb6VPalZvltV1UUFr0wBpvZzMAXPyO3yFlq/2Vd2vK/Wy6r\n1tfy3rgvmP7BHJ/tiqIww/EdVqulWq8nSVLdpyjK2mNGOp742GpM5mKEECmKokQB84BxwPRjkzdF\nUbKFEGXWQe/evbtYs2ZNtcQjSZJ0tvnksa/566O/vctUlMFiM/NjyqeERoTUYGSV89qi+Xw7fVOp\nZTXAm9D1bB/L56OvqaXIal5qYjo/vjaN7w8kUtS6PpygcNHMp++gaeSZn+gWOF38sGQDf2/cTVZB\nEYVON3aLmT7tm/PXmu0+x6uKwspX7ufSV74gI7/Ib5v1Au0sfvFe/vfHv3y7eL3fY2Y9M4rY+mHV\n9jo0TePWlveTfiCz1PaHPrmboXcNqrbrSJJ0+qhIMldtwyyFEClH/p+mKMo0oAeQqihKIyHEIUVR\nGgFp1XU9SZIkqYQQghmfzD1hIgfgcWl88MCXPP3tgzUUWeUt2r/XO7P7uEKtCgrbUs6ej5OUPYcY\ne95TOAtduG7oeMJEDmDE61NZ+3rd//lWVbDdxl0Dz+eugeeX2n7HBz/7Pd4Qgqn/raVXm2b8tdY3\n2QN4akQ/AOZu3FXmdX9dvomHL7+wckH7YTab+T7xY+Z+/R+LfllGvagwbpt4HQ2a1K+2a0iSdOaq\nlgIoiqIEKYoScvTfwCXAFmA6cNuRw24D/qyO60mSJEmlGbqBs9B10uO0EAsLt+xkb9LhGoiqahqH\nhYKfCvQCQWRY9a3xVddNef5HHPkOdE3HlOeEk4yocZezbP+ZKi23oMx9yZm5PDG8H1az71y0+CZR\nDO3WHgC7texn3SHHLAtTnS65tS8v/fU0j31xn0zkTjOabrBiVxLzN+0mu8Bx8hMkqRpVV89cQ2Da\nkbk5ZuB7IcQcRVFWAz8rinInkAhcW03XkyRJko5h8nNzeiyhKqTd0ILCLvVBM7jkl29om2dh2rNj\nsdXROTlPXziQKzd/BTnm0kMtVZg4/JLaC6wSnvxmBrM27C7+uln9esx45o5ynbvx360YhjeBC15z\nkKzYMDhmmRF0A0zVXZz69NWzTTOSlm/yu++Szq2pF2hn7nOjmfDLPFbuTsJmNnNdn87cP6R38XG3\n9e3Oi7/947eNPIcTt6ZhNcules8WHo+Hu9/9jC0HDxNgNvPaLdfQu6M38d91KIO7P/kNp9u7FqFH\n1xk7uBejBpxXmyFLZ5FqmzNXHeScOUmSatOmPYmk5+TTr2v70279PUeBgytDby1zf+blseReFI2w\nHrPWoFvnQq0eU566uyZCrJRvNqzmf38vgHQLCFDsgrGDezPmol61HVq5jfviD/7dluCzPdBqZuWr\n4056/t2dHyVhc1Lx10VtI8nvH4cwqaAq2PZn44oJhQBvUq4qsHHSw9UW/+mmwOmi7/hPcGulx+c2\niQhl9rN3lrudMZ/+ztKd/ouyBVjN/P3caMKDAqoUq1R3/bl3K/P37yZCtfDz7NW4GwQiLCqKxwAh\nuCywPu/cN4pBL35Oel5hqXPtFjMf3z2Cc1s0qaXopdNdrcyZkyRJOl2t2raXx0e+hmVfLkKBl4Is\nDHx1JM/ec1Vth1ZuAcEnvqnMvaBhqUQOQFhNLNWyT2VYVXZLl/O4sdO5LNi3C7Oi0jeuFap6evVC\n+UvkAIrcGnl5LkJDTzxs77onhvP2PZ/gKvIOow3cmUHArgz0UBuqUwMBWVd1QLN7P9Lfvv3K6n0B\np5lgu42/nx3FU9/NZl3CIUyqwpAubRl/9cAKtfPx3SPZkZLKtW99z/GPvR1ujSe/ncWnp9F7RF2Q\nVHSA1VlrEAh6RJxH08DY2g7Jh1PT6P/DJ6TmOEBA4O4M3M0iit8/hc37/znZ6SzZuocil+88ZZdH\n4+dlm2QyJ9UImcxJknRW03Wdxwe9gCW1CMXwlnhXc9wsePBnOsfHcfkF3Wo7xHJr3rEp+4/pwTmq\nSbvG7LWZMOW5CVmWhu1gEc6mweT3ikK31/0eSJOqMqhVu9oO45T4atEqHjxJMY0BN17Awb2H+fbF\nXzB0b1qhCDDnepM7oYBuM2NJyWPseR0Z0LHVKY/bnwJPAQvS/mVv4V5iAmK4OKo/9W21M/crMjSY\nz++terXT7EKnTyJ31Jq9yVVu/2zyZ8pfzDg0E83QcK3T+PqbX7FnBHLhoJ5c9+RwomIjaztEAJ5c\nNONIIucd2u0JCfR5EAZg2E3cN3sKAS4FISJQlJKHTALIc5x8DrMkVYfT6/GmJElSNfvo57mYM50o\nx9WMUHSD91/9qXaCqqSP171ObLvGpba16tacr7a9S9i2PGJf2Uj4/BSCN2UR8fcBmr6ygYi9ZReL\nkE69Xm2anvQYRVG45f+u4d1lr2ANsPruF9Bwynoaz9xD80a1s5h6hiuDpzY/y/SDM9iQs4m/D8/l\n6c3Ps6/Af6/k6cJ6guHWcg3P8slOzeHHj35n6lM/kTQsi+ReuaTfV4hjuYfs3bnM/Gwe93R5jNTE\n9NoOFYB5u/cVJ3LomvcJX1msKkXdzZi00usWBljNDO7c5tQFKUnHkMmcJElntd27UxB+bsoUHZwH\n82ohosozmUx8ue1dZjq/47NNbzLT+R0frXkDgIY/7UN16qiat59B9QjUIo1Gv/v25EnVy24pexBM\njzbNyt1Ou/Na8ebCCcR18n+Oy+Gix9CuFY6vOvx04FcKtEI8wgOAJnRchosvE6bUSjzVpVuLGCxl\nFJe5sF3zmg3mNPT3lIXcHHcfXz3yE/nfuTAOCY7v6tQ9BkV5Dr554ZfaCfI4xjHx2W35WHQnilv3\nOU51auixZoRdRT9HQT3yORJgtdC6USRDu52Zowmkukcmc5IkndWGXtIDxU8pd8OiEn1e+W+06xKr\n1Urzc5pitXp7cVwOF3qey+cBsyLAeTi/5gM8yyyZ6L/AzNSxFR8G2K5Ha668dzAWm28FUluAlY0L\nt1a4zeqwOXcLws+AxAOOZJKLUmohouqhKApv3nq5z99OvSA7r9w0pFZiOl2kJ2cyeeznuJ0eDJf/\n5TLEkf80YTB/7soaja8s5zdtzNGMU0Sb0bpZsaYVobh0MASKS0dxaljthShH1nw0wkyMPP8cLu7Y\niv+7+mKm3HctlpNUGJak6iLnzEmSdFa7pGcn/nd+Y4zVh1Dd3hsOw6RgBJl5ZfyoWo6uepgsJ7ip\nkCPFTjmbzcbmNx9m6fYEPpq7gv4dW3LngB6Vbu/g3kN4XB6f7bpmkLq/doaqqSf4RZq49SVe6fQi\nDWx1Y05URfU/pyWLXryXj/5ezsHsPPq2b8HI8+PLXYgn35PP7MN/syF7I8GWYIZEX0K38NrpQa1J\ni39bcdI1EeHIW5ABWkoRT9z8Oq9/+8Qpj+1E3u5/JRcmf4LD5e2NUywK4nyBfXcuShpgEejtzBgh\nJUOeQzJg/NiKFdiRpOoikzlJks56sxdOYtRD73Dgt02oLh3LeY154937aBFTO/OPqpvZbCY6LorD\nCWk++5p1qHvV5M5UfdrH0ad9XJXbaXteawKC7TgKnKW2m61mWp/bosrtV4ZJKX07IY50uSgquIWb\nxzc+xYjGwxja+FLM6ul361Ev0M7TI/pX+LxCrZDnt0wkX8tHExo4IaFwP5c3uoxhMVecgkjrDt2j\nYxwZ9SDw/9xIOe7/635YDd/WQHAnEBEQyNpR45i8fjFf7fkX7AqKqmC09Z2vCqC4DB5uN6Bmg5Sk\nY5x+76iSJEnVzGo28+37j8H7tR1J9UspzOHH/WvICdb8799ziJ8nTefax87ucvbV5bcD05h1eA6a\n0DApJgY3vITrml5drdfoPaw7U8fX59C+VLQjCxVb7RZadGpGxwvbV+u1yqtQL1lnS89VUYMNlGM6\nhA0hmHbwT7bn7+CJdo+iKlWf5ZHvyefDPR+zs8C7GHuHkHbc12oMgebAKrX71YI1fLt4HS5Np2+H\nFjw9oh/B9hMvH+HP1B8W8nPWHCK65qCaS3qo3Iabvw7OZGDDAQSZg6oUa13W68ruTPm/H8Gj42lp\nx3zAheo+SU9dHVn62G4288R5/dEy8vjGsd67UVGKexqtmTq6TSEsV+WRjpdwVb8+tRitdLaTi4ZL\nkiSdIYQQrMzYz/SkTQC0Do1i8rYFWOekE/JJSvHTb3dzGwWDIvC0DMAwKzR69yBTF7xO45bRtRf8\nGeCXA78x49Asn+2Doi7m5uY3Vuu1CnIKmTr+J/77ZTkmk8qgW/ty47NXYQ+seNJRHR7Z8DiZ7iy0\nwyZMETqKn04MIcCmWnmg9Vg61juHrIw8du5PpFmzaBo3aFCh62mGxn3rHsBllC7/HmAK4MOukyu9\nFuGoD39m9d7Sc/wCrRYWTrybQKv/nhl/3v3oL77YvpNWgxMJaVDksz/AFMC4VvcRH9ahUnGeLr55\n4Rd++t8fZA4Oxd3ISr2vD4PHQHH776kTwHyjbhRCOWrKskW8s2MB7kCBtUjhwbb9uaNP39oOSzrD\nVWTRcJnMSZIklUNuRh5mi4mgsLr7JP2ljbP5PXE9Dt07n0rBe3MUNW4XloNuFCD3ugYUXBmJOLq+\nnC5AgUcPdGT0Q3IB5KoYtfpudOGn6h0qX/X4rBYiqjmL0hfzTeL3ZHxnJ3h4PmqA772FEN7OjSGR\ng9n0cQ4b5ieCRSA8Ck36BvLOaw8RbCvf39cfKdOZlvKn3303Nb2BS6IrPn9p18F0rnrT/xi/G/p0\n5pmR5RtKJ4Tg3HtexxNipXnPA4TH5nJ8R6RVtTK+w3M0CYypcJxHaZrGpFcfoP556wiop3FofT26\nNXuMiy+rW4VZ9m7cz2d//830mBSEVcWc5iby+X2YcvRSCZ0AApuGMn3/F7UVqiTVGRVJ5mQ1S0mS\npBPYsyGBuzs/yvVN7uHqhqN5bMAEMlIyazssHztzU/ktcV1xIgclI5Y8ze0ogB5mIn94g5JEDsCk\ngAI/Ntxbo/GeifwlcgAGBobhv5rfmeKiBhdyTZOr0FNNOFfaEcfVZxEaGDkqFsXCmm9T2LAgEaEp\nCIcKmkLK4kIef/3tcl9va+62Mvdtytlcqdfw+8otZe5bsKV8fx95mfnc2+NJPMHeaqNpu+pjGKX7\noFRUGtmjq5TIAbw26Rrihq+gfmsXgQ104i7OJDX6WZYuXFSldqtby87NefGx0QQK78werbGNwx+2\nwQhRi6tZCsAcbuO33R/XZqiSdFqSyZwkSVIZcjPyeLTfeBI2J6G5NTS3xubF23n4wv9D1/3fuNeW\nRYd34ykjYci/ugGGXcHdNhBF8zMaQ1FIDXD5bpcqRC3jI1VBqfSwv9PJJdEDaRLamIJfQ9BSzBhO\nBcMNhkNBTzcBAkVR2DkzC+EuneAIt0rirCIyXBnlulakrf4J9lWuamZkaNm9gqEB5Ru++trNk0nY\nmOgtYw8UZQWStLoxmltF96gYmkKLoDgeafNQpWI8ate2nbS5IhFLYMnfs2oCS4DBf2tfr1Lbp4JF\nNfHdhaMI2eHyjgYwq+Q81hxTyxAuHjeAD7dMYk7mt1gsvktuSJJ0Ymf+p4skSVIlfTf1b9K7huAJ\nLenJMnSD3Mx81s3bVIuR+QowWzCXUVRCi7Xh7BoCTqPMiSp2k7yJqqoLI/0XQegZUfllCE43T//f\nTQi3StZL9cmZHE7BL6HkfhZG0dwg6jUI4qHW49Ac/qd3GA6FbHdOua5zTWzZQ4KvajKiUrHffGE3\nlDJWWLjnkp4nPT8vK58NC7dgaAZBa1LA403ospPC2fxnO3bPbUbcxn48H/8M9axhlYrxqKWL/kZ3\n+wZrskL9tpnsOVy+pLgmtW3WhEWPTmBS3gXctbAx4+v35/c17/H0u/fSpsPpuaanJNUFMpmTJEk6\nToHbTadPJzPJksjhEXEkvdCdxAmdONoXZ2g6qYl162ZpcEy83+0KgKKQ9Wgs+SMagCbAED4H3d3m\nglMe45luVIvb6V2/J8qRjFkBeoSfx90tRtduYDUotnFD3vv1Huq3CsKzx4pzSSAtmzXhjVfvZ3LX\nt4kP60BES7vfcy3NNRoHNC7XdSKsEdzX8h5Mx5TMNCtmHmo9jhBLcLnaEEKwvzCRLblbKdSKsFvN\nvHnr5ajHZXQjzotncOc2J23Pke9ENXlvq4JWpxC05iCKW/cmdQ6DPqamTBxzU7liO5nWbc7BZPVN\nig0dclPs3Pb+zxQ4615vuz3QxtBRA3nkg7sZdt+QOj0HWZJOF7IAiiRJ0nE6fzqZfKcbjpuebz2Y\nT+zr27AF2nhz4QTanteqtkL0a17Kdp5YOw2TogICXQhe6zaMmXs2MT9tJ8JyzOs5ZuGn8yObM+XC\n22oj5DOSYRg4DCcBqv2sGF5ZUSvXbGXCmO8RGmAooAoUMwx7vT1jBtxcobaEEOwp2IeqQMvgluU+\nL8OVwaSdb5PlzkZVVDRDY0SMdx08TTP4fdUW8hxOhp/XgcjQ8iWHhmFwY9MxZB7MLolPVSDYyqXX\n9eHRT+6t0Gs7mXe/uYhG5xZgtpXcx3kcCj++25vk+m15fFhfru3VqVqvKUlSzahIARS5zpwkSdIx\ncpxOP4kcgIK7cQjWACvxvdvWuUQOYFBMe5ZEtWBp2j5A0CeqJUEWGwNj2vPqpr/5Zd9aFLwFObpH\nxdE2NIpRrfvQIKB8N6tS+aiqSpBatbXOzmTnd4/ntW9u5f2PppG2N4/gOJVrR/Xlyq4Vr0CpKAqt\nQ8qfxIE3AXxz57ukOtMwKJln+sfB6TQPakZ8WAeu7V3xJEhVVR79/F4mXj0Jj0vD0A1sVjNBAXZu\nn3B9hds7meG9p/Lz/DtpdmEOGODKV5n/dTx7QluCRyM5M7farylJUt0je+YkSZKOMWfvLu6bOZ2y\nJpe9kNuMa58YjtV2+s0xK/S4SHPmEx0QRoD59Iv/ZIQQOAud2AJtskesAtKS0vn1rb8wDLjm0ctp\n2CyqtkM6pZKLkpm47WXchttnX5d6nXm4zQNVan//1gNMmzyLg3sO02VAPFeMGUxo/ZAqtVmWNXuT\nefj9bzAV5ZMVEI4weZ/RB9osvHT9YAZ1an1KritJ0qkle+YkSZIqqVlIGP4TOQCFm5+/pibDqVZB\nFhtxltpZVPpUm/7hHKaO/5nC3EICQwO5Zfw1DL//UpSyKlqcRXRd5/XHp5CTXcAjL91Ew5iSao8f\nPzqV396eUfz1n+/PZvi4Sxn77qjaCPWUSE1Mx1HgJLZdY0wmE4V6Uam5dsfK9+RX+XrN42N5+JN7\nqtxOeZzbIobmLeLYnpyG0Lyzei0mleiwEPrFt6iRGCRJql0ymZMkSTpGuwZRBFstFLh958xd2a5t\nbYVVJW5dx6KqZ2xiM/uLf/j0iW9xFXkLPuRnFfDl099jsZq5/J5Lajm62vXO898xJSkBPcyOEgyz\nX/6S+IRCfpg9kT0bEkolckf98d5sBt1yEW26172hxBWRdiCDCSPfIHHrAVSzCZvdyuNTxtJlcLzP\nmoB6roq2NgjsUSRYDhPXJrqWoq4YRVH4bMzVfDZ/JX+u3oYhBJd2acuYS3piMflPWCVJOrPIYZaS\nJEnHScnL4/IfvibXVVINrl/zZnx55dW1GFXF/bVrB68tWcThgnzC7Hbu634+d3Y997RK6gzDYN38\nzSTvOkjz+Fg694v3if+GpveQkZzlc25Eo3B+Svm0pkKtc7Iycuj/9EcYwVY4dtipR+eeqFgyNxxg\nye8r/Z7be9h5TJz2RA1FWv2EENze9gEOJ6Rh6CXz4myBNj5e9zq76+3m+6QfcRtunOts5H0eDgJU\nw4TZYmLwiHO596mhp9XfiiRJZw45zFKSJKkKYkJDWXf3WLamp5HtdNC5YTShNv/l1Ouq+fv28OT8\nv3FqGuAt7PL2iqXowuCec0+Pdc9y0nN5pO94MlIy0T06JrOJmDaNmLRgAgmbEpnxyTwKcgrJTMn2\ne37W4Wzyc4vIzS4iqnE9rNaz6yPv8bs+QMQcl8gBqArfL1xHX1tomec6C2u3rL1Dd7AycxUZrkxa\nBLegS71OqGWso+jPmrkbSUvKKJXIAWhujekf/c19b99BbEAMs/bPY84XKYgj0+d0DHTdYM60NQSd\n66Fnr3jaBLeWSZ0kSXXW2fXJJp2VijQ3qqLIRZGlClEUhXOiGtZ2GJX25vKlxYncUQ5N48PVqxjd\ntTumOlwgRPPoZGfm88HYzzi49zC65+iQOA+JWw/w1CUvkrDlAG6HixMNLgkIC+LGi1/HZFZRFLh9\n3CCG3dirRl5DRRmGwYIZ69i77QA9Lz6HzudVvXBFZkERYPXdYVLxBJoZOmoga+Zs8HvuZaMvrvL1\nKyu5KJmXt/8PTWi4DTc21UZDexTPtn8Ku+nkD1XcLg9v3fURmlvz2adrOqmJ6QC0CmlFt8MuFpp/\nx+Eqnby6nR7+/GMpSyPm0dAexVPtniDILCuUSpJU98hkTjojvbhqLj9u2YTLo6MG6FiCdXo3jOPl\nc4cRZT81VcUkqS5JzvNfltyheSj0eAi11b1CKEIIfvt6Kd99vBBDN3AVuTAiwiG1ZIF2j0tjx6o9\nJ21LNZvQwsMx3BqeI70uX74zlwbRYfQe0OFUvYRKSUlM566eT+POyEdRFH557geiusYxZenLVepN\nHHlFT97Yu8tnu+LWaexWuWDE+bTqFseedQml9rfs3Jy+1/au9HWravK2DynSi4qnrLoMF4cch5lx\ncBZXx4486fmLf11BfmaB331Wu4XugzqX2lbWdBNDGLgMFwcdB/km8VvGtLy7Yi9EkiSpBtTdR7OS\nVEmXTfuMr1ZuwlEAhsuMlmvFmWpjyeG93PTfl+jCOHkj0mklzZHPvvwMXLrG2owk1mQk4jH0k594\nBourF+53e4DZTLDVT29NHTDvz3V888E/OApduJweUFWU+uEoDeqXOs7UEEIftRF0o7e3PfheG6GP\n2jBFK6CAGqRgahOGERRU6jyX08MPn/1XY6+nvB4Y8hLutDwU3QBNRzEEaRv2M/Heqs33u/WBKwje\nkQ7uY/4WNB0138XHX3rL73+05nXGvX8nTdvH0LRdDPdPHsWHa/9XpetWxZS3fuCw87BPQVmP8LAs\nc0W52lj8xypcDt9lBwACQwMYeGvf4q+79mqJ28+xik0Q0NMBgCZ0VmetLTPpkyRJqk2yZ046o+zI\nSmXHgVxK3QkIBaGpaIVmDppyeXrxLFYnpKIZBle2bce93c+vsze3p6tFW3ZS4HQxuGs8plNUUc0Q\ngh25h3lh4yy2BeSbcwAAIABJREFU5xxCAdyGjk01oyoKujA4L7I5Axu344rYTgSaz66fcZPQULak\np/ls9+g6ah2d//P9p/96k7hjKKoKkeGI9EwA6n8eiDW+5HcqdFzJsLugq70/Y+EERdXw7M8k5/1w\nhKPkuWVmal61xFqYV4SiKASGBFSpncz0PHJ3H0I5LlFQdIM1v65AfH5vleZrLZrxIjeOeJm9IQrC\nYiL8YAGfTL6PRjENio+58r4hXHnfkEq173a62bx4O0JAp4vaY7VX/u8sP6eQH16eRsM//S9ir5S5\nZEhpW7ceAkXh+DG4iknl/vdGExBU8jsTGGTDSD6EaOQdUq2YFTAJ7L0cWNqVJHm60BGIcsdwMtvz\ndvD+7g8p0AtRUOgQ2p5HWz90yt4vJUk6c8lkTjqjfLltlTePO/4BqlAwHGaMEI2/ErbiyvX+6n+x\nfi3/JOzjr+tvlmWcq2je8k38+t8q5psyEdYj38vFcxnXsjMPXzmoWq81O3krL22cRba7yOdH7TRK\n5sksSdvLivQE3t76D7/2v5smQf57q043s/dv5+vta4iwB/JizyFEBAT5HLMoKdHvuU5dZ1t6Kh0a\n1L35gNkZ/ofGKaoKikK9+wOwxps5NrcRQvgkO8qR/MrSwk3o7bnkfhR+pB2F+K5Nyx1PcmE2k7cv\nZEV6AhHWIO5q04fOzvq8ftsH7F67FwG079mGJ6feT3Tzyi20XZBXVOY+3e0h/o8XaBESydOdhtAn\nqmWF27dYLPwyY0KlYjuZtfM28sI1bxZ/LYTguR8focelXSvV3vQP52BkCzx7DSxtVBRTyc9VuODC\nxn3KPPfAzhQ+eexrNv67FadL80nkABSziQtG+Cn+k1+AkV+IEhaC/VIbgZe7sTYv6c1UUGjkbEx6\nUiYNmzXwPb+c3n9pOrN+XY3SxEX95zO9aaECAsHWvG08vPFxJnd7q9LtS5J0dpLDLKUzxq7MDFYm\nJ5exV6CYBAhvz8RRbl0nJS+Xefv21kyQZ6BNuxI4Z8xz3LPsb+abssAA295875Nxk8J7CRtZvXNf\ntV1v4aFdPLFmGll+Ejl/NGGQ63Fy6bz3WZORVG1x1AZd1+n1/WTGTp/Jyj2pzN6SQPfPP+LDzUt9\njnXrZQ8zPZjvP2mqbUfX9hKGgZGeib47AX3PfiwFBQwdM5CgGywc30l1ol4rxQK2Tk6wGqiqgs1m\nJq5RMHOn/kte1okXhz5UlMvIhZ8y88AW0p0F7MxL5bl1f3HjK2+wY9VuNI+O7tHZtnQHD/Z5DrfL\nc8L2yhIbF4Up2Leoh1DA3ToMAezNz+D+FT+yPvNApa5xKuRl5jN+xBsU5TmK/3PkO5l41Rtkp+ZU\nqk2he/+is//PgZErMAoFwiMwigRiH1zW+FK/52WkZDKu5zOsmrXeW4VT073vP8f+Z7fR4Px48vOc\nzPxlFb9/s5Tk/RmkOA7SpF8jFKEjMnNwzUvDFOLBcHhjMRwCPddgx5j9jGr/IK/f8T76Cf62yjJ+\n3DfM+HkVhiGod8+R6qvH/ermarmsypTLM0mSVDEymZPOCH/v3c2Q76ZyIK0AVIFP15wCpmAPAjCc\npTukCz0e1h8+WGOxnmlufPtLilqHgUVF2EyIADPupkFYD5QkDM/PmlMt11pwcAf3r/gRTVT8ZkoT\nBrcs/oo3N887bee+PL50BqmZRxYzFyX/TfpvGQ6t9LyfNhH1/bahABc0bXbqg62Eux4dgtVmxkg4\ngEjLBJcbnC70w+nsi9mDUCv+c1MUiGoaSqtWDXDv2McPE3/ivXFfcEPsGBb+5JsEH/X57qU4NDfG\nMe8lTsNDxpBQdFvJXbhhCBwFDpb9sarCsQGoqsq9749GmFTEkWaFqiBsZrLvKukFcuoak7cvrNQ1\nToX/flmO7xAIbxXI+857slJtXnmfd4F3/YBB6vACcl51kPexi6zHiui3awBW1X9F4t/emYnL4Sr9\nd33k30rzJqht4giIb0XHnq25dfAbfPrGbL56dy73XD2Zh154E/cD+Sj1FZQA0FMFadcUkPeek8Lp\nbvI/dJJ6VT4FOxy4nR4W/bKcP9+v2PuZruus/G9n8demSMPnocRRH+/9lCKt7N5aSZKk48lkTqo1\nQgg2ZaXwY8IalqTuqVJhkkf/nn3kXyqYDDAJUEr+M4W5UG0Gig5opYdT2s1mmoSUvd6SVLa//l1D\nUatQsJR+KykeZgmgKGR4nFW+Vr7HyaNrfit1c10ZX+9bxfQDm6ocT22Ys2sPxXf8xxIK721YXGrT\npEsu9Tu75/bO3bCb6+YI+/iuzbj11p6oHk+pYXIel4fsczNOcGbZTGYTr71xO3tnrcCTX4Sz0IWz\nwInb4WbSqA/L7EVak5GI5u89ySPQYkpXAnUVuTm8P71S8QEMv/ki3lz2Ei0HdSaodTTOixtzeHJr\ntCalf0578yt/jepWmFuE5vb/UCUjOYsJV71e4TZD64dy4zNHqlW6wTlfo/A7N+GZEdz+wvVlnrd9\nxS6/sSiBgsCeDuyhAbTvFMuyBdtxuzRcTg8et47uNiiYb8eTZ6Hhr8GEPRVA0C0W1EiFot895L7i\npPAXD+KYjmxXkZs/35/tc60TOZBQ+ndXuP2OAvXuQ7A0Y3mF2j8VXB6NtNwCNF0WDJOkuq5ufqJL\nZzyXrnHPsu/YlJ2CQGBSVMKtgXx30SiiAiq2dEC+y0mRdswQJ7cZMFCDXag2gWrXUVSICaxH7gEL\nHsWJccwnqVlVGdaufTW9srPLqi17UHQDYfF9LmQEHnl7EYIu4VWfn/Xf4d34jEuqBLeh8dmuJQxr\n2vnkB9cxuhCU9T3I85ReJ6tdZAPm3zKKZxbMZUtaKvXsATx0fm+u6hBfA5FWXtaBdAzNz415JZ+3\nhFpC+e+X5T6LR4P3O7nk95Vcce9gn31NgsLZnZfm++jAomDKKj2k0hZgpWWX5pUL8IjO57XmkznP\n4dI1es18HUP3HbbZKqRy8/JOhe6XdObriT+j+/lZASz7YzWGYaBWcD3DO166gQuuOp9vJv5MQU4R\ng27py5BRA8ocTpuTnktGcpbffUKD0JEeBsZ1oHl6e3Zt8zMCw6PgXBGAtZWHwMEWxEAzpgg3ee+W\nvWh6UUHFHk41jA4r9XXhjGCCry491PnoR5KhGCQ5am84rW4YvD1jMT8t24QArGYT4y7tzQ19utRa\nTJIknZhM5qRa8cnOxWzISsZ1pFiF0BQKCvN5cPkv/DBgVIXaspj8/RqrGAV2RIHg55uvp3FgGFH2\nEBJzcnhwzgx2ZGagAE1Cw3hn8GXUs1etIt3ZatSI/nz//VTfHZqBKduFKc+NyaHz0sSK/Uz9KdLc\nOP3c4FZGUkF2tbRT07o1acjKPal+e+fu73yBz7a48HB+uOq6mgit2kQ2icAWYPUpLa/vE5hbVzyZ\nv7hhf3LcRX6TOcMQeFy+C0sDjG7dh2Vpe3HqJfutqomgBA+2Aji61WKzENO6EecO6lTh2Pyxmczc\n1qonU/eswHHM77vdZGFc+37Vco3q0KprHB16tmHjv1v97hfCO6+uXoMwv/tPpHXXFrzwx1MnPU4I\nwWP9J5Cekum70wK2biaUWMEqlhGrt/XfHSbgaAesMCBzXzip1EO/EQK2pRG4ORVFLznPZFbpObRb\nhV5PQLCdehGB5GR5h08W/R2CJc6N7dxjfsd1bxVWW6iV5oHlL9JTVf8eWsHnCV+gmrzfBN1jZufq\nNrg83iTc5dF466/FhAcFMKRL2xqLS5Kk8pPDLKUqE0KQ7SrCoZX/Rvu3xPW4DA1hgDvNjvtQIO50\nOyu3ZDH8x28wjPIP7bCbzUQH+S9l3TGqEV0imhQvFN6sXj3+uP5mFt9xF//eNpp5t9xBfFTdq+p3\nuoiLaUj01nwU1zFP53WB6jGI/DOJmI930uKHREa3fIC/p1Rtvo/b8H/TXRma0MmvhqGfNe3jAVdj\nth0ZPgyA998D2sUSHXh6DhUWegZGwacYuf+HcExnwA09UU2lP5oUBdyfKViVipW9N2FiaPSl9Lqi\nOxa773wrRYGeV5zr99yu9WN5tdtwIqyB2E0WrKqJAdFt+fOuR7lizCXUaxBKeMMwrhw7mLf+m1jh\nHqgTeaB9f8a17099WxAqCm1Co/io1w10rR9bbdeoDhP/fKLMfYqiEBgaeEqvv2nRNtKSMjA0388L\nc2uV8Fe918/X8jm3T2t0f72zVkFAD+97wb7lsSRvbIRLDUZrGEzBBc3Ivioexez92VoDrITWD+G2\nEwz5LMtXMx4hJKzkoWHux/VJGxNF3tRQsiaFk/54FKZAFZtqo3dkrwq3Xxl78xL5MukzVJNRXCfG\nZNFoP3QbUPK9cno0Pp5bvjX+JEmqeUpdKgTQvXt3sWaNrOR0Olmeto/n1/9FmjMfBRjUuD0Tu15B\n0EnW9Ooz8w2y3EV4MuwYDhPHDx27Pr4jr1x8id9zc51Oft+xlR0Z6XSMimZY2/ZkOYq49PuvcWol\nN/xhNhv/3TaaULtvpTipeo188HW2m4rQQyzYDxTS+N809P25pY6xBVh5d9nLtOzcvFLX+GznEt7a\n9k81RAsmFJYMfZx61tOvR9ahuXls8V8sS0oi0GrmkfMu4qpWp9+QUQDh3ojIvg2EDrhACQQ1mh27\nX+PlGz8hNyMfhCCqWQPG//ooRjOdP1P+IiEvgRyj5Pfr6MfYsSPxTIqJu+JG0SuyJwAfPzqFGZ/M\nx+10owAWu4XrnhzOLc9fc8IYdWFw2JFHmCWAYIvthMeejR4bMJ6N/27z2d7v+j48+/1Dp/Tas7/4\nhw8f+spbwfI4AZdbCH/O+/fdyB7Na51e5p8ZG3h34h8YhkDXDMxWFf38IvKaB1GQGYTu9v0sslvM\nDHDaMO1Kp1PfeC6762JCIyo2FeBYv329lM8mHTfnzmoQdnM+PS9rzS3NbiTSFlnp9ivijmUPoJsK\nfYqxCAGGAfsWNSM/zftag+1Wlr88tkbikiQJFEVZK4ToXq5jZTInVcRXu5exIj2B3lEt6RXVguv+\n/bzU0DeraqJRQBguQ6NQc9O7QQseO2egz/peE9bP4NeE9RQlB+BvDpDVZGLH2IfQDYNlB5I4mJ9H\np4bR2C0Wrvrpe5y6hlPTCDCbCbJY+eP6m4gOCubHrZvZkpZK79imXN6m3an+dkh+rPtnMxNGvoEj\n31Fqu2pSGXr3QB744K5KtbsiPYGxy3+kSHef/OCTaBkcyYxB8sakNgkhEBmDQC9ZLiJDV9nqtpJn\nqNgVKxFZN9Ik4gYatfDtPc9x5vDU0okUBeYhNNBzVMzhBkJTUMwwLPZyRjYdVmqu1bYVu/jv52WY\nzCr9r7+A1t1a1Mhrratcuov9RYkEmQKJCYip1OLkQggmXj2JpX+s8nYUKwp9Rvbgme8exGL1X32y\nuuxcs5fH+o/3TebsEPqAjeCRNqyqhftbjaVzvY4ApB7M5p9Z60nITsLW3sp3/6aiGaLUkwDFpBPV\nOovACAdF2XYGRffjyct951VW1r9zNvHRqzPJyynCZjdzzR0XcdOY/tXWfnndvHw0JpP/e0BxpCj0\n+l86ACrntWzCl/ed+MGHJEnVpyLJnJwzJ5VLckE2Q+a/d6QAAyxK3eN3bW63oZNYWDIZfd7B7axI\nT2DGwPuItJcMhXywwwAWHNhFEf6HU2qGwaH8fK777UeyHU4M4a1haDebyXU5i6/r0DRcus6Lixby\n0dBh3Njx9OyhOJMUZBf4LdFh6AY5qbl+9pTP+ZHNaV8vmrWZVV8r7ulOQ6rchlRFxiHQU4u/zNRV\nljvt6Ed+ewqFB2f4FOqHuQDfUvf17PUw3o8jbW9a8TY1TEetp2PND6LThz18kpMOPdvQoWebU/N6\nTiNCCL7Y9xVLMpchECgoNLBF8mS7xyrcK6QoChN+exyXw0VaUgYR0fUICvNdxP5UaNu9JW3Pa8X2\nFbtwO70PFVWzijnURMPLw4kJjuGqJiNoF1oy18sRlsfirr9jCIPtSxqiiRCO75pSFIhun4bJKghr\nlM9O0x8kF8XTJLBJmbH8k7qA75N+QhPe0SGtglryTLsnMZlMPsf2G9KJfkOqZ45llQgTQmh+l0lQ\nFO/ne4PWWeTvj+bhyy+s8fAkSSofOWdOKlOBx8Xviev5fNdShi34uDiRO6o8fboGggLNyV3LvuWD\n7f+R6sgDINwWyKxLx5b5JDgmJJQH58zkUH4+hR43Ds3bE5fjdPpc1xCCf/fvr/gLlE6Jjhe2x+Px\nnd9mD7LRe3iPSrerKApf9LmFZkERVQmP1iEN6NOwZZXakKqDhWPfRba6rcWJ3FE6CttyfkSUsWxJ\nZFTpeYJGrgkt0YpWKAiv738erQQf7vmYxZlLEUe+/wJBmiudV7e/Uek1GG0BNmLbxlQqkSvMLeTQ\nvlR0TUcIga7pLPxxKf83/H+8ctO7bFi4pcxzX575NCMeuIx6DUIJCguk//UX8PX6D/jwgvd4tsNT\npRI5IQSTd39Ake7AabgoyPA/MgQBmtv7rFs1CzTcPLdlAt8n/YjmZ+7u0vTlfJ34XXEiB7CncC+P\nbfIWcdm74xCvPvcDY15+ked+fYMF+xf7baemjWg87KTHNIuxM2XsNXRsGl0DEUmSVBmyZ07ya3N2\nCqOWfIMuDFy6VqW1vXQh2JGbyr78DL7YvZSPe99Ij8jmBFtsjOnWg4/W+i622ygomFWHUsp9DYtJ\nPpeoK8Ib1uPGp0fw0+t/Fg9/sgVaadahCX2vrdrEfpvJzNs9ruGmRV/i1D0V+q1UUYiwBfFez4oX\nL5Cqn2JqgDC3A20LYJBn+P8b1hB4jHysJt+qiNfccSFb1yficpYM9TZbTJxzbnMiG56eBWGqQgjB\nrq0pZKXn0+acJtRvUHpuV7Y7m0k73ibZ6f+9NcudRWJREs2DamZReWeRizdHf8TSaatwNw4hs08s\nWmQgiscgeMMhApcloQhYPn01Ix++nDv8FB6xBdgY/drNjH7t5pNeL8VxkAKtZEkAa6AHj8N3KKgQ\nCmZbSVEnby+VYMHhf3HpLu6Iu63U8V8nfuv3elmeLOYsWsYnr80i+JFUsBo47DAlaSczs2YysdNz\nBJtr76HDVc0vY23WJpI9uwGfDkoUBSYMuI1mQTKRk6S6TM6Zk4oZQvDz/rV8vWcFiQVZVV6cuSwN\n7SEsHPJwca/ctB3beHP5ErIdDlpH1OdAXi7ZzvJXGrSaTFwX35GJ/S4G4Pc/FvPtO9Mpyi6kw5CO\nPPnUjTQMr3h5bKlq1s3fxF8fz6Ugp5B+1/Zm0K19sdorVo2wLDtyD/PutoVsyU7Bqpo56Djx8E2z\nojKufT/uaN0bi+o77EmqHUJLRmTdCEYeC4oM8oTvz8aM4PIWa1AV/88eZ/+6ms/enIMQAk0z6Nwj\njqf/dx1BIWdX4aPMtDyeuWcKqQdzUE0KbqcHq92Co9CF2WJixM29SRy4ksSipOIeueMpKDzW9mHO\nCauZtQhfuv4tlk9fQ2GwhczrO4LlmJ+/RydgazphC/cB3iUgpuyaTFSs7zBQIQSbF29nx8rdRMbU\n54KRPfy+1xwoSubFba/gMrwPmXIPBpOwrCmGXvIgQTEZhMfm0Px8P2vSARbFwuSubxFoLqnUeduq\nO8t8jZ459REt8rC09KAc++utK/SLvog74m4t89yakl2Uw0NbHkWUnjpIi6A4xsc/V3uBSdJZTBZA\nkSrlhQ0z+SNpY6m1jU4Fm2Ji2sX3EhdS32fftB3beHTubD9neZkVlRCbDZeuIYR3rkfbyEi+Hn41\nQVYrzz/xKcve/QfFY6AAhlVFNAzkhw3vyISuDhFCkFiYhQmVhgEhWP2uFVh+PyWs5c0t8yjQXNhN\nFgY3bs++gkySCrNoHRrFwx0urnNl3SUvITRwLyEl4zHWOrVSQy1NCFrZY4mP+euEbbjdGgcTMwkN\nDyQisvKVBk9nD9/yCTu3JGPoZX+mm2I9RI7PKHO/gsIH3SYTZD61SwqAdw2665vcg8flIfuyNrha\nR8DxyztoBlGfrkZ16diD7Nz/3igG3166UIjb5eGJgRPZvnJ38RIFJrOJCdMep+fQ0stOGMLg4Q2P\nk+PJKd6WsbceKRsbIQwFISC8aS5Nux9ELaMwiF21Mz7+ORoHNCredufqe0oNsSz1Ot+JJGRcRulE\n7oggUxAfnju5zO9RTcpz5/F5wlfsyN+BWbEwIKofI2OGV+uSG5IklZ8sgCJVWLqzgN8S1+M29JMf\nXEUuobO/INNvMjd37+4yz1OAmNBQpl17I7uyMknIzqJN/Ui6RDdCURR2b97Psnfmo2olH8Kq28BI\nLeLl/33P5NfuPRUvR6oAIQTf7VvFW1vm4zhmzkgjeyivdx9J9waVG951Xdy5XBfnf70wqW5TFDPY\n+tE4ehbawUvZ6tZwo2ACWllDaRv960nbsFrNNG999q4XmX44lz3bD50wkQPQD5jRcsBcz//+fg0u\nqpFEDiA7NQez1YTH5UFrEOSbyAGKbqCH2lHTC1FVhaAw39h+fesvti3bVWqunzPCzkNv/MDl+ZmM\n6NOJ+FjvMEFVUbm/1b1M2vkWumHgwUNkyxzqx+XgdlgwW3VMlhOvcWpgUN9aet7u4IaDmHnY9yGk\nRbHg2Wcrc4J5ZaqHniqh1lAeaftgbYchSVIlyEcuEuAdtmZVay63f3rtH363Nw4ue55L+8gGzL7p\nVuoFBNAjpgnXndOJro0aF38gvjj2Y4TJ98NRdRtsn725egKXKk0IwRNrfuflTXNKJXIAh5x53LJk\nCvNSttdSdFJtU01RNI9dy5CYz7gs6l6Gxv5Mh9hFmExnxtpuDreHlbuT2Jx0uNJFRspsu8iFqZzz\nhgun+b7Hqqhc2ehybq/EkL892w+y8t8d6HrFHgQ2atGwOMkxpxd4FzY7jjCpmPK8Q+4VVaHHpV19\njpnx8dxS38/8XrFkXnsOhV0b89Pqrdz+wS+8O3NJ8f7WIa14s8vrtA1tg+lId5migi3IU5zIWVUr\nvSLOx3xcd5pVtTI0egiKprJ5TQK7tqZgGAbXNr2a7mHdSh1rV+1M6vw/zu/VDm23zbuU4jFUQ6VX\n/fPL+d2S6pIDO1N46fq3ubHZGB668DlWz1lf2yFJZznZMycB0DggDK0GeuWOyvU4yHIWEWEv/aT1\nwfN7MWXjOr8PMt8ePBS72f+6Rbqmk7LlgN+S+EIBe/jptzj0mWZjdgozk8uuSgfw6OrfWB39FLYq\nDruUTl8mew9M9spXPa0LDM82yHkG9F2A4K+t8bw0rxdmkxVDKIQF2PnorhG0jPYdnVAZMc0isdrM\nOB0nW4NRwXLMkp9mzIRYQnjpnAkEWypWiGPbxiQev+NzdK0kCRs88lwenjCiXOdb7VZuf+l6vnrm\nB4JXpeBqEVH68bJHJ2hnJsE2K+ZgEy/NeMbvPDiPq2RagBYRQOG5jUvNvXN6NL5ZvJ6h57ajVbR3\nvp1FsbCrYDf68RkW3sXmR8QM49LowQwpGsyPST+TUJhAiCWUyxtdirohguv+71UURUEIQXBoAC+8\nfwvj2o5F13X2FO6lgb0BEVbvN/qRF0cy4blcDkevhwADzAITZpqENuaqJmV/rwwhWJ62j225h2gS\nGM7FjdpWeTi6VDWJ6dn8tmAdf06ehWl7GqYcJ+kHMpl49STuf+9OhtwxoLZDlM5Scs6cBMBhRx6D\n/n4XrYwS4KfCf0MeJirA9ynx3L27uX/2DLQjT2pVRWFC3wHc3KlLmW3pms6lATdQ2DwY1aFjO1SE\ncuRX27Co3Pb9GG69quYXZZVKPLvuT35P3HDS497tcQ2XxHSogYiks5lLd2EIA5NqZmPORnI9ebQJ\naU3TwKrNrTTc6yHreo52O+1Ki+Dm70bi0koeRClAZGgQ854fjama5iSt+HcHrz7xEx63hmGU/bn+\n9n83syBzIVnuHLrU68SAqP4VHlqp6zqXdxuPv9uHhyYMZ8jIck3zAGDpH6v44bVp7Csq5HDPGDzB\nFhRFoVuzRoxu3pKgYDsdL2yP2eI/kXnn3k+Y+cl8AAq6N6agd1M4rpfSpCrcP6Q3oy/2PiQ47DjM\n/219obgQyrEiLOG83XWS32sl789g7LXv43KWHlkQFh7Id/OfxGwpu7hS8oF0VhxajRqp0bp+C+JD\nO6Aq/n/2hZqbWxdNYX9BJi7Dg81kIchs5YeL7iQmqIwxstIpNWXhGt6fswy3R0MYAoQgZHESQRsO\nARAcHsSvqV9gMssCW1L1kHPmpAp7a+t8jBpM5AJMFr+JHMAlLVuz474HWZqchEfX6dcs7qSTsP+f\nvfMOj6po+/A9Z8/WdJIQeu+CVBEBFRARsbxYUbCA2LChvmJvr70XwIZgRSkiIiKCdKRKEaSHTijp\nPdl6znx/bEiy7G5II+TTva+L62LPnHNmtmR3fvM883u2Z6Rx7NWeOESRAHRoxH+3D+uBPCIubhYS\ncrWAVHteuc7LchWe4ZGE+DeTbE/h9d1v+ZhgGIVXaAkh6BrdhXtb3hV0on1acp6i9CapWVs74NZ8\nJ3gSKHS62LDvKL3aNKlcP6fQq187Pvz+Xn6Zto4TRzPZuuGgT9QM4M7/Xkb7mHa0j2lXpb5mfb0q\noJADmPL+Qh8xt2D2RubP2oCqGrh+ZF96D/BdqOkztCd9qlB/8p53bmfp96uw5zkQmgRdwinzaYOi\nYCw1yY4xxQT9vWtoaxC0rwWzN+Jx+1/ndmlsXrePnhe2DXCVl0aN47m+8ZDTPBsvH+1azr681OI9\n7IUeFw7NzZOb5vDtRSPLdY8Q1cehtCwmLlyL06N57T6LtnPkXdgU84FM1FwnhQVO9iUeo22H6vl7\nDhGiIoTEXAgAVibvpeakHDzcvmxxpSgKFzZpVq575Tmd3PrTD9gtgpO/4prZQMqdben+/TEmTw9Z\nK9cGesY3Z1Xq/tOe1yO2Zmpchfj3oes6z2x/3s950C2LUvUk/JW9hVXpa7govm/lOtEO+jzMLLSi\ny8DCMMdqxUdVAAAgAElEQVRe/hIs5aFZqwQefK6kEPTSeVuY/e0aEhpGM+6167BYqmf/4b4dgW37\nAQoLSqJdY66bwMG9KcWPX3r4e3r1b8eLH56+Jlx5sYZZmH5sEq8P/5D1q3eS19f/+0MABofOax/N\no13rBvxnYBcG1O3HsrQVuPSS1FSTYmJoQ/9C2kt37eTJjT9h3uQgLIDJjC4ludnVtwg1N+lvPzMy\nXUq2ZCaR4yggO89Fw5gIVPWfO4XTpY5Ld2FWzGfNKCY1J58vlm5gwZZEXO5AbqUSZ6s6qJtPoGka\nD0ybzy/P34klSBQ5RIgzRegTFwIAi8FEjrt6JxZlMfXgBm5rXbUC0gA/LfuT7//cjMPsAgWEGxQ3\n6EZvXaJWLw/h1s9nk5ydR4uEOjx65YWc1ypkUX82uLl5DybsWoa7jL2ZjW0xtIyMr8FRhTgTOOwu\nVi/ZSVpyDm07NqLL+S1qhXPf4tQlQS3kT+LSXSxLXV55MYcFsBc/urjVYVYdbIrd7bvf163pdG/e\nsJJ9lI8BV3ZhwJXB09Mrf9/O/LFoR8C2eg29aYALZm/0EXInWbdsN3u2H6Vtx0YV7lfXJUL4u0Da\nwq28PPdJAOZu3MlLPywuzubQdB3bMSffPvEzuoDlbg+T4uYxefr92OrbWJi8iEKtkPqW+tzS9GZa\nhbf0ufebv//KV/kbIAy0dgrW3RrKKdV7NI9O3DkWUhwpJFiq7qoabPuLR9fp8/xnCM37/OPCbSx6\nbvT/C1Fn1+zkunOJNcWilmG2pkud6UdmsjR1OR7pIdoYxS1Nh9OjTs26FSdn53H9u1MpcLrwaEGW\nuhUFV6wV59D2eGJtCIeDWWu3cctF/kY9IUKcSWr/N0CIGuGmFj34bPdKHHrZE53qIruKqXQpWTnc\neOE41L05ZPevj2dQQ8zpBgyl9KhmlvycsxMly/t4e1IK902ew8d3Dg0JurNAuNHMl31uY9TqbwIK\nuiijle8uGnUWRhYYj9vD8hlrWDZ9NdYwM0PuvpRul3Q628Oq1Wiazorf/mbia7+gaxKXy43JZKRF\n23q8PmkUZktgA6Oa4lDB4XKddzrBVyZht0PBp8UPB7fbx/ebOnEgIwZH0b45q0nl9n49iIsMq3w/\nZ5EL+nfAFm6mMN9/z9lTb90EwPxZG4JeP2fqGp5448Zy97dxfxL3fv4TTrf3e8OsqnxyV+Dv8at7\ndKBvu2as3HkQCcz+bjUp21ORWblwIhWp6WjAPb2eY/au9xna8Gp0qQdNq/0qb6M3tCcEhe0hYq3A\nlCKLBZ3JYsDWr5CPMycgMyVxpjjGtnmAelUQdUMadWTGwU24Sxu0SCBPKRZyAOn5hVz6yhSWvXhP\npfs603h0D18fmsrajLUowoBAMLT+VeQe0EjKOUa7uq0Z0uPiYvH9+q63SMwvKVGU5c7m0/2f86hq\no0Nk+xob96TF6ylwOPGUsf8UAc5zEkoqreuSD+ev4vKubYmNqJkSHyFCQKg0QYgiRrfuzUX1WmNW\nVAyV3StSAc6JCr4voTzccuPLqInZKG6dsB1Z1J12iLpfbCNq0QHUTAdCCq+wy/X9Ina4Pbw/z2tT\n7Xa5mffZIh656DmeGPQyK2etrXbL8BC+dI9rwsYrn+KuNn1pbIuhjtFGx+j6PN95CMsvf4R4a+0o\n+KxpGk8NfpUPx0ziz/mbWfHDWl4Y+iZfPj/9bA+t1rJn+1FGXPImbz/zI4X5Thx2F7omcdhd7Nt1\nnFlf/3G2h0i7yOB7mk5iUoz0ie1d6T5E+FgwXVr82GjQ+Wr4HB7r/yc9mqkM6NiSD0Zezf2XVT0z\n4WwyffkTtO5Q8j0eFm7h9c9H0qq995ixDDMQo6n868iZeYWM+nhWsZADcHo83PHJLLLy7AGvqRNu\nY2jPcxh6XgeS1x1F5BUijyaDRwPpNa9wJaXzxm0TAIIKubS8XBCyZLJuEKSMMpB1mYKjKXTu04zI\nu7MwXZeBU3fi0l2ccJzg9V1vBXTKLC8PdehPk/A62FSve6fNYAKPwJDo78qcnleIx1Mzi7CVYerh\n71mbsQ639ODUnTh0B9OP/sCvYjZ/R69npuM7Rs8by/xDvzNp/xQfIXcSt3Qz7cjMGt3XvzbxSNlC\nDigKE/sccmsa36zYdAZHFiKEPyE3yxA+HMrPYPKe1fx45MzWTfnrqmewVDI1RNM0BtmGoxRtRJfg\nTbHUvWUIpKqQdf05uOtFIJGIUwoW2MxG1rw8hnED/kfipgM4C72ry5YwMwNGXMgjn9beVc4QVWfu\njBV888ZsEHDH0zcw5Hr/dLo/Zq/nrdsn4ijwTT02Wox8nTiB+EbVYyn/T8HldDN8wJvk5wVP1a7X\nKIav5v+3Bkflj67rjNn8IA498DjNiplG1oY82f5xTErVooi6lgWudaCEg4gHtRGKUjH7///PrFm6\nk5ce/j5g25RfHqZh07hy3ef+KXNYufNgwLaL2jXno7uGBr1WSsllPZ5H7k2C/AK/dqNZ5fsjnxId\nHxXw+rzCQnoueMtvwl50c17p2Zn5J37Dc4pwsygW7mt1L52jKx/J9+g6y5L3sCs7mUZh0Tw/cRlC\nD5yqvPi5O0mIrh0LYaVx6S7u2/RQyZ7UIOhu8BwwYWpbdmmNaGMUY1s/SIvw5tU5zIDcMn46Ww+f\nqNS1revFMntcxWs2hghRmoq4WYYicyF8aBYey0tdryRM9a/nUx2EG0wsuPSBSgs5AE1KRCmXNoFX\nyIF3EVVx60QsPVDU5v/jVy86gvXzNrP3r4PFQg7AUeBk8TcrSNpzrNJjC1G7ub7bWMbfPJHsrcfJ\n3nKc9278kGE9H/U7b90vG/2EHIBBNbBlWdm18v6p7Ejezeg/xnDb+tHcvn40D6x8DLvL+xptWLUX\n7XSr2LVg3VBRFN7u/AZNrSWOc9HGaC6pO4BL617CPS3v5JkOT1ZZyAEohhiEpT84FkPmDZDaHT39\nP0jXVp/z9OwX0JM7oCe3QU/uip7zP6T9Z6SeU+UxnE16D+hAr/7+rpnX3da73EIOIPF4WvC2E75t\nS6et4rZW9zPYdBOj2o9l7dyNRLWIAVdgkWA0G0k/lhn0/hE2G8Ij8P/wSgxCJ82Z5ifkvK2SHHfV\n3j9VUbi0QXse6tCfa5t2DSrkAOJqaUpfoad82ykUI6gNyxZ8ANnuHF7f/Rb57vyqDu203DHgvEob\nmcRF/nsWbULUDkJiLoQfiqLw+6VjiTNX736OMNXEy92vpml41aIaJlXF3SyizLmhMaUApPRbULUY\nVR4Y3JuNi7biyPefrAsh+HvFziqNL0TtZOYXv5O95bhX/Jf6l7ExibnTlvmcGxkXgUH1/3pUhCAs\nqnZOnM4ELt3FnrxE9qTv5a3Db+M2ubx/UwJyzVmM2fggAPm5dqQePAXKZFYZcFX1G3FUhkhjBC91\neoGve07h655T+LDru9zWbAS3NBtO95huGET11YmS2WPBPhtwAhI8u5CZt6C7vYtNevoIcEwDTqbJ\nFYD9O2TOM8jUC9Hti6ptLGeDFz+8hfHTxtB/yLkMGtqNKb88zF2Plc+e/yRt6gc3RGpVv0QULvp2\nBe/d9QknDqSieTSO7jnOayM+4PoBHSCI2NHcGg1b1Suz/zFt2hT9T5b6B13rZWAz2DAr/g6hutRp\nE96qzPtWlPOD7PNuHh+DwVA7a5tFGiMxG8rpoFrO2ahLd/Hwlsf4K+v0NUurwoCOLbl/8AVYjCrh\nFhPmctaPs5hURvarWbOWECFCYi5EQOpYbPz3nIHeXP1qQgJx5upZsRr1/q1IsxJU0ElVIcxs5Kbe\nnQm3mFAVhTrhVp6+tj+XntuamLqRqAH2bSiqgcjY2peuEqLqfPfOnKBtX77+o8/jwaP6ByxSbFAV\nelxWO0TJmebTfZ9z18YxvLbrTV7d/wYS32wzIUA36Mze8Sude7YIWqjaZFZp2iqBG0ddWDMDryVI\nTxI41+AVcqWO40RLH8yfhzoh3cFMQlyAA3L+i9SzzvRQzyhtzmnIE2/cyKMvXVuhiNxJXrrx0qBt\nLw8bVPz/KU99h7PQNwLnLHSxcPxvvPvrEyinfN+bbWaGPTEUa7j/PrTS1Is10b1eEglheYQZnTQI\nz+G8BkkYVTexpljqmuOL6xQCmBUTvWJ7Us9atkisKJPHXO8n6Do0qsvcJ0dWaz/ViSIUhjcZhkkp\nNY/wbln0QXrAc7T8UTC3dPPx/s9Ic6ZX00gDM7JfD1b8714m33sd854axSWdWgQ8z2RQCDObsBhV\nHh7Sl95tQ+V1QtQsITfLEEEZ3Ogc3t+5FKfmRislmwRgEAqeIJuRPzjvep7c/DMOrSRtQkEQawqj\nW2z1FNQceXV/mv5RlxeufwdTUj6i1I+DrgpklwTmPDGSetERPDG0Hw6XB5vZWGxpPej2/sx462c8\np2TfqKrC+Vd0q5YxhqhllJEGKE+pHdW0Q2Me/uxuPrj3c2+EToLJauLVX5/CZD67jow1wY9JP7E2\nc13x47KqCvycPZtrz7mCq2/uxbwZ63HYvX/3qtFAXN1Ixjx5Bedd2KbYre5fg3YYhAmkr5jzfn9C\nV7O/E6QfQoBjEdjK7/xYEdy6xob0wzg1N+fFNSPc6I2ibEw/zPhdy9ifm06LiFge7NCfnnHNqqXP\n1MxsHnnta47tykK1Gbh5+AWMvmZg0PNjI8P4/J5reWDKz96izYBJNTBh1NXFbqCaRyPjeGDRe+xQ\nGtnJOYxf8yrTXv2RbSt3EZMQxbDHhzLw1otOO942Ea2xGc00jc72Oa4KlbaRbRiYMICFyYtYn/kn\nJsXMJQn96R3bK+C9ko9lcc81H+J0lBiWjBjTn1vHXHLacYBX0P1/o09cbyKNkfx87BfSnRnEEU9i\nzl6kAYRZojsEslCgNqiYiYsuNValreaaRv51AasTm9nIOY29wvyDkf8hOTubG96bRoHDRe82jZl4\n57UczcghM7+QVvXisP0Lfh9C1D5CBighyiTFnsvLW39jRXIiihD0q9eGC+JboAqFl7fOx3XKfoFO\nMQ2Y2e8ulp3Yw9Obf8alaWhSp0VEHBN6DaOhLbpax5eXV8C1fR5D352BVBXvXrpWMcxa/TYxMZFl\nXrv+1028fut4pC6RuiQsOoyX5z5Bqy5nfnN1iJrni/Fz+f7hb/12UUpg9Kd3cPPdl/tdY8+3s33V\nbkxWEx37tqu16UzVzV0bx/gUUy4LKaG5uzUv9nmCTWv28dusDTgcbvoPOZd+g89FLcPV8J+M1JKR\naZdyamTuJLosdrwvAzMi4nFE2K3VOrbEjHSeWLKArSnJCCFRzE7UcDfnbTJz04jLeCZpoc9inMWg\nMv78YVyYULXUwaSUNG67cQLGPB3FU2RYpUDjy+sz5bX72bx2H9M+X07qiRzO6dKEW8YMoEGTkrR8\nrajel8HgvzBwY/07yUoptU9NCDAZweUufpEvGzOYxyaUr/yJR/eQ78knTA3jjd1vc6TwCC7d+5qY\nFBPtItryaJuxFaqfeHnnZ/2iUgBPv3MjFw06t9z3qSi6rjNnwm8s/HIpRouJYY//hwuvDSw4a4LM\n3Bymrv6J44XJmI0qB2N3ISqhgQbU7c/tzaqvAH2IELWJihighMRciEqT6Sjkub/msi7tIEbFwLBm\n3RnboX/xCrxH19mfl0aYaqJRWMwZHcu6NTv4Y9kWzu/TkYv6dS73dR63hz0b9mM0q7Tq2vzfFz34\nl3FV63uw7/c1PLC1iWXu7k+DXPHvZOSfdyLL6VgiJaDBN72nnNlBBUDXdez5Dqzhllrzt6tn3g+u\nJXiXCcLwirnA5g6nF3RmRNxvCLXiBbaDcSA1jcu/+wa3QfdutJACJAirB2OYnbqvHSb9maZIi+/r\n2SIijl8H3l+lvofe8xaFf+aihmuoTdzoWQY8R41oRrjnv5fx7QdLcTq8r5WiCCxWE+OnjaFRs9On\nZ86btIhPH/26xNTKZPI3PlEE939yL0PvGhD0PrrUmX10Dr+nLEaXOqqicmX9KwDJmoy1KChcHH8R\n/eteXGbx61P5ftJyvpm4OGCbLczE7LXPl/teFUHXdUa1G8vxfck+x3sPPY//zX78jPRZUd7Y9Q67\n8nZV6BqzYua+lvfQJab8v/chQvx/oiJiLpRmGaLS1LHY+OiCm4K2q4pC26jKF06tCL16n0Ov3udU\n+DrVqHJO79PXngrxz+CXvZ/x2Ts/MveThQghGHr/YO585JqzPaxaR6QxMqAbn5T+wkMURVdqihlv\nzWHm23PJzcwrMRkUcP4V3XhpzhNnVdTpyT2A3FJHgrvueSTsdam0MXlQ4JSIsQKYIPzeahVyAPe9\n8xWe5jrGOCfC4H0BdYcBT6YZlz2C9KFNsKzKxj6wjs91B/PSkVJWKBJ1KjmJecTdmIP1okKkWyAM\nEs8JlYyJsXz+4yKEoyR1X9e9NQq/+WgxT78d/HfmJFfe7d1b982LM8lKywN3AAGtS75/46cyxdwv\nx39lYcqi4si0W3Pz8/G53Np0BK91ermCz7iEP1fuDtpWWFi+KHhl+GnCb35CDmDNnA3s23KwVmSi\nDGtyPa/terPc2QAmxUTzsGacW4XSDyFC/JOoHUuZIUKECFFD3PPYdfy6fxKvTXmIBIuN5IMpZ3tI\ntY7bmozwOxYsiUNKMDosZ3hEXl656T0mP/kduRmlhByAhPXzNvPMFa/VyDgCoRfOw1fIlULEAiVG\nG5oEhxTs81hY6GiEHj0Jwh6F6PFgvRVsIxGx01DC76vWMaYmpXPYVIixrgNFlcU1jxWLhjHe6+7r\niIvAo/s7EMaYbFUScgBh5xdi6WNHGEGxSYQZ1EYeYu7IQrj892DrumTHX4d9jv0yZxXXDXqSoQPG\n8eXk+T5tV959KTOPf87YSfeAEnis+Zl5QcenS53fkhf6iQqX7mLu8XnlfZoB6doreIqqxXLm9lkt\n/GJp0LY54+cHbatJmoc145E2D1HfUh8AkzARroZjUkxYFAtWxcLgeoM4N6oj7SPacWvT4Yxr+2jQ\nYu8hQvzbCEXmQlSJA0fS2LUvmbqxkXTv1AQlyA9oiBC1hdQjadzTdRz5WSVFhM/p2473V7xU5cnq\nP4Uesd1pfLwxSfak4mNCgCcHDJElj08KvHHnjD3jY8pOz2XFzLVlnrNx4VYcdgcWa82ISx8KPgne\nJrMQ0e+j5X+B03OQI24X+9xG4qwX0CX+KYzGhmDp5z3XMviMDfHEgRTUKA33KeUXhABUHWHUkW4D\nBa1iMVFSusVqMHJnm75V7j/+Uie6xXdVQKhgau3CkK2jBVhfjo0v2fs88oaXSJq7HaFJkDB19dfM\n/moRv6x63+ea3pd35cNAhkdCoJktPH3vV7zwwQjMp4goj/Tg1JzkZ5rZv7IpmtMIQhLXIhPjeRlV\neOZw+wMDmTZpecC2B569ukr3LgtjGYYcZls5ywbUAB0i2/PGua+gSQ0FBSEEx+0nsGt2mtqaVCil\nNUSIfxuhZY0QlcKj6Tz91hzueuI7PpiylGfe+pmbHphMakbwVc8QIWoDD5z/tI+QA9ixajcTH/ri\nLI2odvJwmweIMkYW19GyKBYa1I2njdYe4QGpgclu5dlWT9Muvs1p7lZ11v1Svv3Ui75acYZHEgRR\nlrmTEWG5HDXuB8LqbaRd461c2WIjfRpMJMzYsMaG2KR9IwwOZ9A9ekL1CiBpNGA1GLEYVGwGE3e0\n7s3IViWGGZmuLD7dP4l7Nz3Ag5sfYdbRn3Drpy/6HF0nsMg2qAYuGNQWk/mU8gEWI8PuvBjw7otO\n+nk7ilsidBASFLdO4YbjTP50rs91depFc/71vX2jcwIwGKBODNs3HeKrCf41/IzCCFmxJC5q5RVy\nCJCC9P2x7PyxGV+/OINXb36fORN/ozDPftrneyqf/zzWzxDomlv7MPCqrhW+V3kZ9nhwt8ebnhx6\nxvqtLAZhKF5Ua2CtT8vwFqcVcunODJakLGVnTkmNWLtm56uD33L3xvsYveEePkicQIazaoI8RIja\nSsgAJUSlmD53I59PW4XTVWInbFAEHds24KNXbj6LIwsRIjjHDyRze6sHA7aZrCZ+LfiuhkdUu3Hp\nLv7M3EiyPZnGtsZ0j+l61lbIt63axaMXnd4kYtDIfoz7ovxGHR7Nw8adO7GYzXRpU/n9s7onDdL7\nBG60jkaJeqLS965ORr7+Lutb5oHRV9FJHVzJNtAU6kSYWHP7fWQ6C6hjsmEylLznhZ5Cntz2LHnu\nPHS8qZFCGshNsbJ3RTMUIbiiWzteuekyv0yNrw99y4rUP9DwdUGONkbxRrvX+fDFn1m9ZAdqUYHm\n2x8cyNARvQG4c/hrHPxxK4rbNx1TCrD1acLcle/6PdevXp/Dd6/9BB4PRIShxNVBqN7nYgs3M3vN\nc37X9HxqPHaXh1N3MQqnh4Zf/oXH7sZsMxMRE8bHG98kJiGwiN+8di8/T1uPUVW4cfTFtDmnRLR7\nPB48Hg2LpWYiY89f8yZrf/adW936wg3c9sKZKXlRFVIcKRwuOEK2Owe7ZifOHMd5dbr71qorQkrJ\nW3veZWduiXmKRbHwUKsH+ObIVNIcacWfNYEgQo3grc6vYcLEhqyNRKgRnBPdocaeW4gQFSFkgBLi\njDPn9y0+Qg5A0yU79yaTnVtIdKTtLI0sRIjgpB/NDNrmcZ0+svBvw6SY6BvX+2wPA4BOfdtjNKu4\nncHrUQlFENewTtD2U/l52TImPbcI3QlIgSlO8MIHI+jWrn2Fx6eo8ejWm8A+/ZRBNal2IffGT8uY\nufZv3JpOhMXEY1dfzLXndyzXte8/ci+DfvmAPN3DyS1HUgfdroImMAiYfPn1mBQD9az+5V1Wpa/G\nrtmLhRyAFBq2uAKsUQ7sORZ+2bSLXLuDiaN9Iz//aXA1m7L+otBTiFu6UVBQFZU7mo/CajXz5Js3\nkpdrJzsjn4SGMaQcy+Ktp35g97ajnMjKOFVfFaOogZOMbnviamZM30SgReuTrpmnYndpBOvIHmnC\naHfjLHTicXn48tlpPPr5GL/znrzrC7asP1D8eNXinVx2bXceedFrtqSqKqpac9Ovl356gn1/HeCn\nCb9htpi46cmh1G0SX2P9lybfnY9RMWI2+ApZj+7h0/2T2JL9Nx7pKXbTNQsT047M4LkOT5Fg8TVU\nm5k0y0fIATh0B28lvuPXr0Ti0B28v2c8e/ITi48LBGNbP0DXmC7V9RRDhKhxQmIuRKVwubSAx4UA\ntztwW4gQZ5v2vVojhAg4uavXvGacVwEKnS7yHC7iI8JC+0wrwDtLX2Rsn2eDtpvMRgaPCu5UWJrE\nw4f5dNxipKtECDhPSJ6761t+XPwCFnPFoyZK1EvoYY9CzpMg8yDiCRRz9dYPe+ybeSzcurf4cZ7D\nxQszF2EQgv/0PL2jb4wljPlXjeXNrb+z4OhOPLpEz1ORBSZ6N2rC//oNoGWd2KDX788/ENh1UAqs\n0V4xB7By50Hy7E4irCWvY7Qpitc6vcTy1BXszN1FvLkug+oNpKG1QfE5EZFWIiKtHExM5pHbJuFy\nuNF1iRuDt5bDqd2qgptGl+wzdGpOfj7+C6vSV6NJjbj2CaTvsvsY+Agh6HJ+i9O+Vj79KALhKPlt\n0zwaa+duhM99z1v5+3YfIXeShbM3MXREb5q3rrnvmdK06tqiQhHr6kRKyeyjPzE/eSEe6UEg6BTV\nkXta3km4Gg7A/BML2Jr9N27pK7Kd0oXL42bSgSk81+Hp4vstSF7I/OQFFRqHS3f5CDnwirwP9k7g\n8+6fYDL4R/9ChPj/QEjMhagU/S5ow08LtuD2+Aq3+NgI4uqEn6VRhQhRNkaTkWsfHsKP7//q2yDg\n8a/O/ESn0OnmpR8Ws2jbXgQQYTXz7HUDuKRT6zPed23C4/Yw/Y05bF68jYSmcYx69WbqNj59LbEO\nF7Rl0Kh+/P7lcr82W6SVp6aOpX6L8k2Wv5nxK/JUA0Up0J3w0+Kl3HyFfxH58qCo0RB7ZuoWOlwe\nHyFXmrd/WVEuMQcQbwnnnfOv5Z3zryUpJweHx0PLOnVQymEA1MDaAKMw+k26AZz5JZNhCRzLzKFd\nw7o+54Sr4VzZ4AqubHBFmf1M+WAhTrurWIQZMVHQNh7TnjQf9524QW24acQl3j6l5IXf3mbfikx0\nKbH0cGG46Sji9TqomorbpWE0qZjMKmOeuDJgv52b1mfr4RO+BzUdNdOOmuPwOWyy+U/+50xdHfQ5\nzfpyJeNeu6HM5/1PwK27SSo8SmLeXvbkJ3K08CipzrTidonk75xtvLX7XV7q+AIAS1KX4QrwmTp5\n/sGCQ9g1O1aDleVpK5h97OdqHfO0IzO5vXmoAHmI/5+ExFyISjHy+l6s2rCPzOxCHE43JqMBg0Hh\nubFDQo6AIWo19747kiYdGvPNCzPIyyqgSbuGPPr5vbTuVrGV+srw5HfzWb3nMK6iRRBnXiFPfreA\nyWPC6dy0/hnvvzaQk5HHLc3vw5HvnRhv+wMWT13Js9Mf4eIbT5/SOW7K/XTt35GpL88iL7OAtj1a\ncu2jV9ClX0dUY/l/0jJS88ET4LtKl6SmZZX7PjXJgdTgBg65J4tlV5DGUVF+x3Rdx2l3YbGZ/b7P\nL46/iPknFviIOV3zCrmCDKvPufVj/NM0PbqHRSlLWJ62ArfuoWedHlzd4Epsqm9q/q6tSX7lMMJE\nDHrHCBq2DkfTNa4e1YcrLivZp/jhh7PYOtWOdHvHUbjchq1/IfVfzabFX+fhTlJp1aEBrS+PYYZj\nKjnbczg3+lwGJ1xKuNG7CDn1oZvo9fRECpwlz08pcBP7q29Ex2w1Fde2833t/A6VtNUij4LqQkrJ\n31nHWHx8JwcL92JnFxp2yvNMj9mPcbjgME3Dmpa7xpzb7WHm/tm4DP7nB6qDWV5OOE6c/qQQIWop\nITEXolJERlj59v2RLFq1m607k2hYL4YrL+kUisqF+H/BkNGXMGT0JTXaZ2pOvo+QO4nT7WHKkg2M\nv8GN4A4AACAASURBVOPM2ZPXJl696f1iIVeaN24dz0U3XFCuxaCBt1zMwFsurtI4epzfmkMrNiKd\npxiBSEGfntWbGlldNKrjL7xOYq6AkA2GlJKZb//M96/Pxp7nQDEoRMVGcMktFzHs8f8QFRdJtCmK\nZzo8yZQDX3Kk0Cu4co6Hc2RjA0rvNevVqjFRNn/3yon7PmFH7s7iyfuilCVsyd7Kyx1fxKiU2OhH\nxYRRkOf/ObEYzAx+qy2L05ayiNks2DyL/nUv5kL9EhZP3YZ0lXo/XYLCpTYsvTJoeqOJW5oOZ1Hy\nEiYfnVTc/3H7cValreKVjv8rFnTrXnuAZdv38/i3v+LwaEhV4FEFRpMBq8mIpul0v6wzNzzm/zf7\nn+G92P13kt9xgOtuv/D0b0IRTo+H3elpRFksNIuOKfd1NYmUkmc2z2XBsR3YNRcRJidtYh0YyumT\nrktJmjOdpmFN6RTVkQ2ZG9ADyECBoEVYc5w5OmNu+RD9+YKAuxqrso58QWyv058UIkQtpcqlCYQQ\njYUQy4QQO4UQO4QQY4uOvyiEOCaE2FL0b0jVhxuiNmE2G7nykk488+AQRt5wQUjIhQhRBjuSUtAD\n7fkBkjKya35AZ4m/V+4MeNzj1tixZk+NjWPE1UOw1hNgLHlPhEnSuHc4PTqUz0ykpom0WejQqG7A\ntlH9ulf5/tPfnMO3L82iMMeO1CWaWyMzOZvZH/zKvd3GkZ9dgFNzsiJ1JcmOFEBS1xJHF9t54PEK\nMQH069Ccj+4ciqb5LlwcLjjiI+TAW9st05XFn5m+bos33nGhXx04k0Wl00NRLE5bikt34dCduKWb\n5Wkr+XbnDP/C9kKCBp6tYSSYE3BqTmYeneXTv1t6yPPkszDFt1TB+PmrcRQtvEibiYxbu5AxtD3m\nazrx8YY3+N/sxwNGgvsP6Uz7zo0DHD+XVu3KF33/ced2enz+MbfOmcWQ77/h6ulTScnPL9e1Ncmq\n1P1FQs4NCBLC81BExaKPTWxNABjW+HrC1DBveYhSGIWRCDWCu1qMZsp7C0hLzkFLNgS6FeCNzvml\nTxchghjbmIWJi+uWX2iHCFHbqI7InAf4r5RysxAiAtgkhDj5rfi+lNLfVihEiBA1SoHDyf9emsSW\n6ZtAgvW8eHK2pUKhRszApnz70XOEW85CoeV/CUnp2Tw9bQGeADlYAujWvOZqjZ1tylo8Vww1l6Jt\nMZv5ctoTfDB5GlsWHcFgElx8bUfGDL++xsZQGb59cBijPvqBv48kA95oxHU9O3Hf4MApqod3HeXA\n1kOce3EHYusHd/rUNI0Zb87BGSBdU/No5KbnM+ez+fx12UbSXenFbSnOVJTYZUx+agydIzuTm5bL\n+Ps+5+oxI5ASul/amYc/u5u6jeM4UHCQQPl3Tt1JYl4ifeIuKD522TXdSUvOYdZXq1AUgdPhJjzc\nyt71Kag2HWMpveTSXRyssxODkoCGjqG+m8hbczC2coMGeqqRrjFdSCpMwiD817A90sPW7L+5rpHX\nbbLQ5WJfyikprULgbhjJbqB+m7JF2fvf3sPqJTuZN2M9qmrghjsu5Nwezcu8BsDucjL2x+9ZvSUL\nJHhsIFXJ3hMpDNj7GR9dfzH92pfLqbxG+CVpW5GQ82IyaBWKjnWK6khdi9dVM9YcyxvnvsqylBXs\nzd+HUTESb46jia0JPep0w6SYWL1kJ5pHJ29GJNEPZiECzGClEzzHVIzNPIhTNJ9RMXJ7k1uYcXQW\nuZ5cAJpam/Bsh6cq/NxDhKhNVFnMSSlPACeK/p8nhNgF/HtmJiFC1HJ0XefGPmNx7shEuCSuBCP6\nrEOoeCfWeV8mcvXskcw6Npk6tlB0tTpJzs5j2uqt/LJhJ/mOQA6AXgPuuqrRv+0fSpcBHdm4cKvf\ncdWk0v786ik+vmf/UV56ZBLJaw9iCDdxyZiBjHtsGIriO5GPCo/ghYfvhoerpdsawaSqfDf2Zgpd\nLjJyC6kfHYkawJo/Pzufu7s8RtqRElHS6cL2vLPsRb/XAcBR4MRRxr47l8PFmsx1FLpy/Np0dL47\nPI0uHc/l4T7PknY0A83jXbjYtGgrD/Z6mm/2TaCOqQ6KUPwEnVEYiTeXWOUfOZDK9s2HadmuPp/O\nfpBxIyejaTqZ6XmwSoV1sUTekYO1R0kaptvgAiERERp1nspAWKS39IICakMPT297jgRLAq4gxc2j\njSX14pKz8oK+DgBZBQ4Sosr+ruxzSQf6XFKxGmbXfPwxx45KFOlVRMY8iTeeJJCFkgemrOT2AQcY\nN6R21IdTTlmayXFYsBldnM6gVyC4MK4PI5vf5nM8XA3nqobBjXFE0Y1dOyzkfhVF5B05+GlzTZD1\ndixRY7IxtXWiFK1RmhUTnaI60ie+N33rBqkHGSLE/1Oqdc+cEKIZ0BVYD/QBHhBC3AZsxBu989tV\nLoS4G7gboEmTJtU5nBAhQgAz5y7DuSsL4ZLoJjCmuH1+ggWg5GjcOvIFfp3pX3g3ROXYczyN2yfO\nwOXRcWtBynUUufJNXrCOe4ZeVLMDPEs8O+MRRjS9j4KcwpKDAp6b8Ui1mCcdSkrhvu5PIPJdKDrI\nDAe/Pz+HxL8PMWVq5Vbg1+w5zLcrN5OVb6ffOS0YfmEXIq1nN5JtM5mwxQW3Un/ogmd8hBzAtj92\n8d6dn/LYF/f53y/CSnhUGDnpuQHvJxSB6K4X1/86lUx3JmvnbSQnIxet1L5QXdOx59lZOWsdA27p\ni0214XQ5fe6jCAWrwcr69D9ZPuEgq+fvQgiBYhDomo6mSTwnS97oAlyCvG+isHRxFEdn6lvqcfsL\n1/DJ2q8RqvSZ5EskTt3JkcIjAVPtTIqJwfUHFT9uFBt8byJAnXBrwOMZ9i2sT3kch5YGCKJN7elb\n/xNMqr8RzKks3LOZE8d1kCUDLz1WgQAJXy8/yiODPAHr1Ek9G/RsMDRCBApbVTNDm3bm9+M7i6Nz\nKQURxIfloyq6j6AzYCDCGME9Le8k2hhNPUuCV9RXkH6Xn8vCnzbhcWs41tmQbkHkqJzixQHpFGSP\nrwMeQc5HMVh6FWK90E5803CGtbuWC2J7lfkdszfxKOuTN9KsUQP6tuhZ4fGFCHG2qPKeuZMIIcKB\nH4GHpZS5wCdAS6AL3shdwFmilHKSlLKHlLJHfPzZKWIZIsQ/mfV/bAWXd5Vciw08+ROAfcmxGhzV\nP5+XZi2hwOkOLuROIgTOGkwvPNuERYYxO+NL7n3vdnpc1oUr7r6UH5In0/s/1TN5evN/30KhG1Eq\no1Vx6Rye+ReHklIqfL+vlm9k7JdzWbX7EDuOpvD5kj+58b3vOJB9lB05O3FqlXORPJPkZ+eTtOd4\nwLYl360MeFwIwejXh2MOYLcPYLIYadk8eKqgRbFwfG8KLrt/5Mue7+DonuMYhIFn2j9Bi7DmqELF\nKIxEqhF4dA8zk2Yxad8X7Bi4CNrm43S4sRe4cDo8JUKuFEqsG3euoXiPVIQSTY9BLWh/QwyijHJh\nEolAoAoDVoMVs2JmWKPr6RBZUijepKr0ah14cXlgp1YYDf57tvJdx1hx/I4iIeftKdu1k4VJ5TM2\nWntgX6Ayev7osDLRN7It9Xz0rAfQU/ugpV+BO6UzqRnP4NHt5eq7spwf14wbmnXDrKgYhYKUCjvT\nEnBr3ve2ma0pV9Yfwrh2j/J+l7fpENmeBtb6lRJyAHeMHUTj5nFYbSZU1YDcHkH6ownkfBRD9gd1\nSB9XF0+KAWw66OBYYyP7oxgKZCHdYroG7bcg38GYic/zctYL/G7+hUlpnzFy7V3syNoV8PwQIWob\n1bJ0I4Qw4hVy30kpZwNIKVNKtX8OzKuOvkKECHF60o5mMP3NOfy9fAe5HgeoAlwSf4cALxKQAVK1\nQlQOTdfZdqScVtdSYivDzrwq/J2SzJ/HjhJrtTGoZSvCTCaWJu7jk7V/YtfcXNOhA6N6dg+Ydncm\nURSF6x6+kuseDlzrqyocXLMPxROouLTCyj/+ptlwfzv5YOQ7nEz8bQ3OUpEml0fjRE42Y36eQL32\n3r1jF9TpxT0t76xyZHFV2hq+OvgNbtxFqWh9Gd1iZIXvk5Xinwp5Eo8n+OLC5aMvwRpu4YtnppF8\nKBUkGC1GTBYjD396D03a12f7ru1o0v8eV9W/gqwYA1IV3p30pbCGW2jeySuO4sxxPH/OM+S4c0ix\np/Lm7nfQ0PBoGq4dZhwbIlEiNbDo4Aj8uVRiNOo8kYViKXqfBezO28ODGx9DVU//HigoXFZvEN1i\nutLY2gizwb9A/Of3XsfDX85lyfb9J7tgSLe2vDEisJfb3+lvEmhDoFvPISnvdxpHDPK/qBQNYqKR\n8miZe0rB20WdsDDfQzn/RTr/QODxZloA0a4f2HRkPp2tYZiM7SHiYRRj+eoQlhchBE+dO5gbmnVn\nVco+bKqJC+o2po45jDA17PQ3qCBhERY+mnk/m9fu59DeFI4cSGXpr1tx7fYaGUWOzsbS3YHUvZ/B\nvBmRODZasK+2sO/c/XSKCmxs9NqnUyi48JjPfj9d0Xkr8V2mnPcpqhIyfg9Ru6nyJ1R4f72mALuk\nlO+VOl6/aD8dwDXA9qr2FSJEiNOTeiSNe7s9jj3P7rOiLQE1NfB+EYB6w9rVwOj+HShCYDIYfERA\nMaWLIRWJ61dGll1AuaJous5DC+ax/NBBPLrEaFB4ccUSukfVZ3nK4WIXkp3rVvDh78v58errad3l\n9AYN/x+IaBhN1p4M/Ez1NEmLFiXGFYUOFx8tXMuuY6m0aRDHQ4P7YLP4hnR2JKVgVP3fR11TyDke\nUSzm1mauo64lnmsbDa30uBclL2Hqke+LH0skK9P/4Jj9GM+f80yF7tWwdX0URQR0T7WEW3hl2HvU\na1GXK+8ZRL1mvu6Y/Yb1od8w756itKMZ5Gfl06R9IwyqNxo1sumtfHX4WzSpFa8NuY42ZOVeybJ9\newizGVFdGqKob4NqQLcaeStxN199dIw7+vfgog4tiDJGsSJ1JRLpLW/weTSurWakU/G6UJahaqwD\nChCq73NTDBJd0/GUo5abqqg0sDagVXjLgO1SSg4UHOSqIeGMumYgnaLOOW00KceVGLQt3bHhtGLu\n1m4XM372dqQmg7ouSiTCLOnStOS7Wmpp4FyNOEVBG4Amqp3dDhfnyhWQsRLddjdK5H/LHEdlaBUZ\nT6vImsmsUhSFHn1a06NPa/74fTsrF27D49aIHJWNuYsDYQSBBDNEjMhBzzbg2O+NwgbC5fJwsOnf\nfpNhbwa8ZHHKUp8U3BAhaiPVsdzQB7gV2CaE2FJ07GngZiFEF7xzyEPAPdXQV4gQIU7Dty/PojC3\nsNiAAIrmRQJc8Rbyz4shZp5v1Mjd1sa08c/X7ED/wQghuKpHB+Zu3OlTV86kGnDbXcVRUOHUuH9g\nTwaeXzGjhNPx0+6dLD90ELvHO8Fz6xp4YLnjsG9yvRDkR8Ltj09kxoRHady25r2rXA4XKSdySGgY\ng8lU9Z+ku56+gTdXvoVwl3z+pUFgbBZN317elfl9JzK4/r1v0YoEx4b9R5m2aiszHhlOu4Yl4iYm\n3IYWsAq0xGjxnTwvSP69SmLu+yPTAx7fX3AAh8eBRS3/Hj1FUbjx8f8w/Y05fm2aS2PFD2tRTQZ+\nnriAV355is79Akds4hvFEt8o1ufYRXUvhKz6PPfLTFyaRn6aDaTCDrxixjmsExErD2FJTPemb7eO\nJffipniyc0nKzmXTgWN0aVafiaOH4tRd6Oi495hwbjGDq+jDKYVPkEu4nOiqsXghxNDEE9DJUNcF\niuH0Yk4RCj1iugVsc+lu3tvzAQcKDiCRKBgIV8N5psOT1DEFr/cWbmyKXQucxhtjPn2pC6vJTPee\nDdmw6RiKqyTiiKRY2EoFGkZEUOBwEXZy4UFPQwoVIX0NloQAqyI57lI5F7f3RoVfIK2XIYy1p/RG\nodvNh+vXMGf3TnQJV7Rpy6O9+hBp9o+Wnsr5/dqBABGmY+nqFXKlUcwQdkUehv3RtAgLvFjldnlQ\nIvSgLpxprrTADSFC1CKqw81yFYHX0OZX9d4hQoSoOH8t2eYj5IpRBMfv64AWYSSnVz3qLD2KYtfI\n7RHPm8Ouq/ZxuF1u1szZwN7NB2jYuj79hvXGGsQ44J/IuKsvJikjm62HTqAqCm5dp1frxrx3+5WY\nApgXVCczdmwrFnInUdygB5ofKYKszjF8/9psnvj6wTM6rtJ4PB7G3jmZjY407PVVjDkavWwJfDTx\nrqDX5LvzmXdiPn+mbwSHgZ7GXtzQ7UoMpfYwDerfnf0TRjBr3HRweiNElo4JfDz3ueJzxkyeXSzk\nTqJLyX2T57D0hbuLj7WuF0uj2GgOpGT4nC8MkrptfM1FStcuqww6wXNt12VsoF9CxepgjX5tBPWb\nJ/Dlc9PIzy7AbDXjKHTidnqj8x6Xhsel8eZtE/ju8CcVShGdMG8dmScC/y1Li0ruoFbkDmoFlOiR\n0mw5dILhH07j3fv68nvKYnL/MoMrSP+6G3koCV0DbBakppHlaYDZ40I5NTqn+Au5WFMdPFLDqTmQ\nQJgaxkOt78diCCyO5x3/lX35+3HLk1kMblwuJ5P2T+bJ9uMCjxE4N24cS47e4HfcICw0Cb8q6HWl\neeXSwVyZ/i35Ra6i0gDCAwYH6AqY0yE9y8H431bz1DX9vRepzQMWVtMlpGsGfHf3uZH2X8+amHM6\n3EyfuZiVi7ZhizRxw/B+vJu0nT0Z6biK9hZP3/43a5KOMH/4bahF6d9OzcnuvEQE0C6yHaai4vIm\nk8p5fduyZttfSI9AGP3ff0OsztP97wwaWQ0Lt6AejUSPyfYTdALoVef8anv+IUKcKUKJwCFC/MOI\nSYgm5ZD/amJ2nwS0SCMIgR5uJv3qohQjj847c3/nqt5dK9XfH5t28OTUnyhQIEoKJtwzgmbxsTx0\nwTNknsjCnu/AEmZm8lPf8eHqV2nUunyFc/+/YzMbmXzv9exPzuBQWhYt68XSLD74yn51opUj1awY\nCXh0dq/fd8bGc5LtOTv4/sgMjtuPk/ZeXfaeG4NmtiKNAjTJAj2HWx7+hKkfjPG71q7ZeX7H/8h0\nZCEVCSrMd/zCbx//wVvXPUNCg5LXdszdVzN61BC2bDtA3bhImjWp53Ov5OzABZjTcgvQdb14D6EQ\ngk/uuoYHpszhUGoWBkVg9zho1DWZ8PhCn2tjSlnbVzdNwioXMR1y10CG3DUQgFtb3u/rIFpEbmYe\nyYdSqd88wa/N7dFYumM/R9KyiXIL6qlWWrSux4HUzHKPIdgnMTUnnyOHJBfUOZ8F1r+9eYGnZiUb\nJMbGaTj2ad62vAIEkLtIULedQCglrpWaR+AqMGKN8hXVue48nuvwNCARQqGxtVGZwnVl2qpSQs6L\njiQxfy92zR40XS/K3IrzE95lY+pzaNL7OlsN9bmoweRy70ltHBXF77eM5O01fzB/XyIOtwepgq6C\nOV2gIHBpGr9u3l0s5oSwIsLHouW9jaHI9UeX3m2LB9wqzdXgqfU1idPhYuSwN8k+5kC6vBL/tXU/\nkNXNhqtTibB2aRon8nJZcnA/l7VszZasrXy8/7OiAg3ez9MDrcbQKdorSC8b2o0/lm4LGFKQGnSp\n15EOjVqVObYHu93Nh/a3kKpvBnw9YwKtI8q+NkSI2kBIzIUI8Q9j2OP/4Y1bJ/gU/9VVQeaVjQmY\nS6Iq5FXSke/tb37m6+37QLUhdEGGQTL8ix+56JiLlMNpeFze6JCjwImz0MXboyby4apXK9zP33uO\n8OyUeZyw22lktfLJuOHUiz9zk+fqpGW9WFrWiz39idXIde3PYU96mk90LmBUDkBKolecwGmXzPts\nEZeM6HtGIqh78hL5cO9EXLoL3QPHosPwWAWcdPI0CKQB/ozLQ9M0n2gbwIrUP8h25nqFXBHCLJHd\nsnjhmS/59MtHfc43GVV6dqt63bqEqHB+ePQWDqZmklPgYHHhLLYV+FXZYVTz26vUT31LPU44kv2O\nCwQtwltU6d4AFlvgD4Cu6QHbkrPzuGX8dPLy7djWZ2LK9SCK9oLGx5k41s6MwaKjexSkXnEDHYfb\nQ+LxdO4ffDsthv/J27/Pw1OUUXBSbAlVojZ2c2rQMvyXQxySDWnQOwNLNwXpkOQtUbBd5PSmaJb6\nmnNLN+8njmd0i5F0iGx/2gikJj1ltJXtTNswfAANwwfg0vNRUFGVipevSAgP551Bl/Nq/0vp+cwE\nNF0ipO+YT90LqYSPxi0iyct5GRMu0jWFRLdKhCJpYSz9fMwIa2ADlzPN9z8uJPuYHXkylRYBboja\naCejtQndUvIZKnC72Z6awvmN6/LR/k/9ot7j933E+53fJtwYTo++bahXrw45PxUQfm0+itn72kgN\nrEYLw9vcwPqVe0g5nkWr9g1of25jv89A925teebQs0zc/Rm5kekYMNC7zgXc0ca3Dl6IELWVkH1d\niBD/MPpecz63vnCDzw+WvV00MpjvtaZzTlzlNq9/s2MXaAKhF02+dAEewaq6WrGQO4mUkj1/7see\nXzG77K9+WsmIz2Zx0OPAYVLY53Fw6etf8OO8dZUa87+BGzp0pGu9BtiM3nQks0HFZjYyok0n78RY\nk97lex3C/84hfEs6aUkZfPbY14xqN5aME/5ipar8ePSnkkmZHQqamkqEXCk0m8K6xEN+x3fk7kQT\n/hNt6RakKckcT8rwawtG/eiIgMfjo8KCRlGa161Dl+YN+G+HB7mq/hVYFDMKCrGmWMa1eZRzozuV\nu/9AvNLhf1gUf1H1Yodnq3Tfk6jmwGu3jds1JCbBf2HkxZmLSMstwLQ1G2O2B6EBHonL6cESn02n\nIYl0unoPna/dRePuxxBK4DTRYNLJajLSKDYKIQSNtQRi83PRdySi79yLnnoCQ30HUQ9mYhto4JRc\nQRSnhvXHI2T/t4Dk/nmkXJ5PwXu5ZD1cGLAOXpY7iwmJH/PIlnEcswcu2XCSWE8Lb0pnKaSEaCWO\ncLXsQuEnMSnhlRJypTEbVbo2bYjhlGmaqihc2rm1//lhNxBTfwv2mG8h4lF6Wqycb3GWqvdmhLBR\nCGPVPqeVZeWSbaWEXAlSAWuK79+1zWikcWQUf2b+iQySZfBn1sbi/38+Zyx9wy7E/lUd3AeNKPkm\nukZ2ZWz8ozx53VTe/vgbpu6cwYvffchjD36Ky+kfrWzbrDkTBr/B170n80Xvz7iz3cgad/kNEaKy\nhCJzIUL8Axk27j+s/3UT21Z66+ToJsWboiIl1r35mE+4kIrA3tSCu66Zd+6+qcJ9HE/PQnpMfs5r\nAoFusAW9TlTwB/LdFRtAESVRxaJC2y8uXs01Q3qGfnCLKHS6+WzxeuZt3IkEBndpy20Du7A1LZl4\nWxhXtWlHrM3GvT3PY+x7Uzl44ARhq49jPlZQfA9HgXdP1aRx3/DU1LHVOr7j9lKmO2GgeKRfVh14\nAyuxEf625vHmOG+q3aklvhQgz4ijsPx71j69+xque2cqnlLmJoqAHi0acuens+jStAE39e1MXIBx\nCCG4vvG1XN/42nL3Vx5UVeWzHh+zJzeRpSnLaBPZhksS+lfLvXOz8tm3+WDANi1ADTe3prFu7xF0\nXceW7PJxBlWbuYi4K7M4AgIQ2ywbg1Hj0Dr/2mxtG8Sz53iaj8QSgMWoMqhzG9KOZvDIRc9jzyta\n5JESmZ0LWQWY24UBBsJHmij4yoV0ey8Ou8VE+M0mlEiBZ79OzvsOXJs1tOMa7t06pvb+deCc0onT\n7eS9PR/wTuc3g0bo5vzkpN1AI6rFg8Eo0TwCqQvWLo6E7gEvOWO8PGwQI8ZPx+F2Y3d5sJmNxIbb\neOSKvgHPF0Ih3noe8dbzkFGjka514FwBIgphvRShnr2UQXOU6nUplaf+XuATlRN4F5+uaN2WRWkH\n8QSIlGq6hl0rWRQ0mlT++8p1gO/e73GjJ+O88jDWLg6EUSI9kMYmJs4K49ERoahbiH8OITEXIsQ/\nlGGPDyVx4wGchU5se3JAEUQvz8DdJA53Q+/UyugWdDumkhATVeH7W4zGwO4GAEJiNBuLzRYAFINC\np4vaB033CsSOxKO+Qq74/gIU+O33zVwxuEeFx/5PQ9cloz/5gcQT6cXumTNWb2Xd3iPMfGQEqqFk\nstQwLoZZrz1IYV4hQ2NG+r19mkdn3S+bqn2M9S31yMvPA0BRIPKEnUxbmHe/XHHnElu6RrtG9fyu\nH5hwCctOrEQvJQGlB7QMA8oJK01b1vW7RkqJR+oYFd/JfYuEWNa8eh+f/r6OHUdTiLCqrNhxmIVb\nEtElbD5wjOlrtjLt4ZtpHFsStbIXODCZjcU2/XaXm1y7k7gIG4oQ/Dl/M79+vhhnoYtLRlzIgOF9\nUY0V+5ltG9mGtpFVTw8tzcYFW4K2Hd/vn9pZjMTv7zvs8nw/owlFlUQ3yiNidxLmdWmg83/snXd4\nFFXbh+8p29IrIRB6770ISAepKiggimJHVBAUfW2IfhbsYsNeQXoVBBREem8htFACKYT0ns22mfn+\nWAjZ7CYkgKKwtxfXZaacc2ZndvY85yk/ihqHYe5QnZfv6E2wrw8vzFnN4cRUEARa147k9VH98THo\nmPP5apf3BAA2sMUo2E8r6OpIBDxgxNRNh/VPBV1nEX0TCcHgfG50DSRCPvAhc3whSoKAkCZAE8ok\n31FAvDkBa64Pe04lEeRronfzepj0OrIKClBsMkfWNCC4Ri4+oUVY8/VkxQeh2Cp3H4uUIpafXcGO\nzF2Igki3sC4MqTYIvViOonkpaoQFsealh1hzIJYz6Vk0qR7hFC2X3Y3V0giCgGC4CQw3VWrcfxfD\n7+rKR5tX4Vp0U0P202jaOoro1DQAmleJ4P1+A/DV62kW0JTfzq3Cpro+H5IolakZd4HCfAsnteP4\ntbIULzw4xeQ1DtTchE29q1L3wouXfzNeY86Ll+uUToPact+rI/l52nwkSSZ8eRKFbWtCKXHwZoiQ\nXwAAIABJREFUGIeDI0cTaNrEfVW9PEIC/RAFC6pmdPHOaYKG3mGmTosaJB5Lxm61ozPq8Qvy4dkf\nnqhUH0ajrtz9qRk5lWrvemXHiQTiUrNcZBBsisLZzFw2HY2jd3P3FXm9UY8oiSilY8oA+SpIBJTm\njqhhfHB8RnGoZaMxCUQvrYc5Uu8M/RRAV6jyw/2evcTVTJE8VvtRZh79Gk2ngqjhiNdj/j6c51+/\ns9jAAmdlyu+Ob+XbE1spOplDlY2FNBPDGX5XX7oN64gkSxh1Mg3a5nMoZCN/Lq3tkvdlV1TyzBY+\nWrmFD8cOIXrDYWaM/5pzp1KQZIk+9/Ygr0dtVkbHgiBg1Ml0PmUmdsV+LIXO/NMj22NZN2sj039/\n2S3/75+mSo2wMvcZfd3DAXWSRMf6Ndh5IhF7gIQ+7+IzIldV8FQYULBqBCacw5Ht9KT47jlLlXNm\nmn8YgSRL/PLUaIpsdqc2nWRnY/pmFsYeI3rHcbeQbABBBkeCiq6O87PTNZDQNfD8OQoG8H/IQN5L\ndhBBK3LqjAmiu/dN0ATeW7SDXUfTUDUNWRJ5c/F6vnlsOJHBzjBKTRXJig8mK/7yChYpmsIbR6aT\nYkkt9iwtO7OCX3f+yUtNnqdB04oXtPEx6Bje6d8jJXC59OvYha2PHGDXN8kgaqCB6K/x5Ie3MLB1\nTwpsNlRNK5Yk2Jy+hbnx8ylyKGRbfNA0gSBjEX46HZ1DO1HTp0a5/amqiqFT4UVheZedEJt3vLiI\nihcv/3W8xpwXL9cxI6fcypBx/Tgdk8Dbs9dwwEPOkaBpzF2xndcracwBvDdsIFN+XYemSMV6SIJo\nZ9b4+2n6QRT71x/i1IEzRNatQuch7SrtpahXMwJB0dAk3L1zGgzs61kr6kbjSFIqVof7vTXb7Lw4\nbibt7Dqe+OQhmna+6PGRdTKdB7djx297XULt9EYd/cb2uOpjbBzQiCfrP86chHmkWFIIMvrx7tPt\nsCVUZU30MRpFVmHCoO7lGj6dItvTIrA5y3/fxJGdSVQLimDINx2pUcc153PmsY18f2Ibwh9phH+b\nDA6NI+o5Tv5xjF8/r887a6eyPvMvliev4NT+UDTVfdKvAduPx3P6UAIvDXkL6/kwTsWhsubHv7Bu\nCMI6pBEAjvQCDiw6gFBCEsRSaOXorhPsWrWfm4ZeW+9xs66NMPmbLoYyluDOp4d4POe1kf2cIX6t\nNORtThF2QQVHvB6pqgOh9G2SNJTTF59BUdEgy8z2FXvoNsxZ3t2k15Fnz+eVmNcoVAqwqXby61lh\nO1AqSlZzgK5OxUKoBVFAV19GZ4CM5wrRtRbxHaXH0EVG1Lve2/R4P5KOpWGxO8d6YQFkwve/svrF\nB8vsQ/ZgGJbFgZxo0q0ZLiGCgh6U8CKefmUGUx66lx4DW1a4vesBQRB4bdwTnLjjNOt2bMfXz8TQ\nm3oRbHB6vv30F71k0TkH+Tn+F1IKJeKyqxVvP5MTQt+oMB6ofekQSf9AH3x8DChY3PZJOqlcUXov\nXv5reI05L16uc3z8TTTr0gjjso1gdy/JrgkCNg86RRXhli5tuLltUx5//3vOZGfTLKIKMyaNRXe+\n8EbbPi1o2+fKEu7fu6MvU5b9WSwYzPmE+O5+wURWDbmitq8XqocEYtDJmN3C1RSkXCvHjyQyqevL\n6E16ajWN4qHpd1OnUwMe++xBko4nk5aQgaqqCIJA/bZ1uP//Kp9DWRFaBbWgVVALNE27mLMUCbd1\nalXhNnx8jIwe1h+Ged5vUxV+OLEdS4GFyG+TLwowA7ZCG8f3nuKvuVtZ0XwVNtVGTlIgZc3sfPQ6\nFry3HLvF9XPV7Aq6uCzEfCuqvwF9Ym5JbediLAVWdq3ad1WNOU3TOHAmma3H4vE3GRjYphFVAssv\nzCEIAh9vfYMJN72ItfBi5drOt7Zn9Auec/8igwNY/eKDrIs5SWz3ZHJi0tGyrdQKDGKXvAardrEd\nSZHIX2hBK6V8UFRg4fC22GJjDmB58q/kOfKKK0P63KGjYIHVmQ934VbpwdBBRq5ZQY+mClWEcHKU\nJDRNw7ZfwXa4iLAvfZFri4g+AiIisighnm1IkS3PrYlCq405W/ajkwTsirs354FeFb+HcQWnsaru\nFYIFWUNX2857Ly++4Yy5CzQIq0ODIZ4FvC+w/OwKzA4HcVlVUEsVgPkzKZ2dtY/RObycWNrzjGx7\nK3OyZiMYXO+nXi/T2L9R5Qfvxcu/FK8x58XLDcKY27qyc8FqNNF9gnTQnO86wa4EPkYDP77srgvm\niYy8QuZsOcDeuLPUCA1kZJcWtKxVrdxzbuneiuYNo3h4+mxSHDZMCkzo25nRd1ZORPl6pnfzeryz\nfAMWmwP1QvU3VUNQVIzHMwCnEWA1Wzl0Lo2H5vwGq00IosDNz/Tif9VqkJuQSZ2WtWjcsf5lPQeV\n4e9sP9dWhKKpGI6az1fLdJ3IWQqtbFiwjbzG7hP60ozo0pKDK5e6lYIH0CQRKddpzKlG2aM9KOsk\nAsI8V868HJbsiOGNJeuxK87FF1EQ+GzNNt4dM4hezeuVe26d5jVZnvMT+9YeJP1sFu36tSSiZvlV\nbA06mcFtGzO4bWMYdXH7AHM7FiYtIjb/BP6yP/WTG/DbT3+5n++jp0pN1xDP/dkHXEr8S6Ei4d/7\nkveRDfteFc2g4nO7Dv9HnOF2siDTwK8+JwtOYi9DNkAv6xkUOoBT8g8XN9og49FCTH1kqtweQq8B\n3ehVpQfP79gMuN97AYHEzFwcZVT91ckVny6FGcLQC3psrgliaHYBJVPC4aHojJeLZNqyyC7yLI+i\nIvDTqQ0VMuZuadqDM8dPsit7FwoqEhKSLDKhwePoxPJD+L14+S/hNea8eLlB6NG1GXUWrifObgVJ\ndHq4NA0xx0qWr4G9cWdpXy/qb+v/bFYuoz6ag9lqw66o7Dt9luV7jlA7PJiPH7iVuhFle9mqVw1l\n9cdXt7ri9UKBxcrZrDxmPjyMt5as51BCCopDQU4vJGjNCcQSoX+aKJA1rCnoJOf9VzQ2Hz1NRl4h\nvzw1+hpexdUjWO+DTpSwGcoO0dMEgcJPqlJ4XCNCl0tudROFUSaXUN4QPxMP9+7IF50OERcdj+Jw\nnYALioojxDnhtNYJBg9heJIsccv9V16RMj2vgEe/WsLJFFf5BVXTsNgd/O+X1Wx8bRwmffkTVEmS\n6DCgzRWPJ8qnOpMbXvw+2hrbWWfahqXA6lJKXpIk+tztuuhi9CC6LdeUqDLDn49av0+ePY/v4n4g\nznwaERFREIkrPE2EsSpp1jQETSgW9VbRUFUT8bnh/Op7lqaD8/EtzCdmpx9ZqTo0BfLOhSEnNGfv\nBn/qdLYztF0Tjp1No6hUnp4siXSqX4NV+45RWMrD7WPQlft+Kk3n0I4sSFyE1W4rzi/UFNCsAtbo\nK5MsuBGo61uH4zknyhSct6llawGWRBAEHmv0MIPMtxCTewgfyUSHkPYVlpjw4uW/gteY8+LlBqJJ\nh/rEbY1Byi4CQUBQNXyiU9BvOsOv+Toavz4GvyD3cuxXgxm/bSHPbHH7gT6Tns0d78/i2du6c1eX\nVteV1EB2ag6/fbMOk5+RoY/1R2+8etXTVFXjo982M3fLAWRJwq4oDG3XhNeH9uSxNs+i5rnnitjD\nfUAA04Fz+O5NRrQ6sEUFcrKXldjkdBpVuzy9wX8TsijyeOPufOr4C00vQKk0Mb1JT8ypLOw6PWgC\nggUCTxQhW1Ry6/ngl+7AJ09hdP9mFOSYGTHlVtbN3kRRftGFCF8kgw5zkzA0H6fxJMgi5lGtiFx1\nAsXqAAE0VWPK949TrZ57Zc7KoKgqYz9bQGJmbtkHaRp7TiVxc5Pyw9f+LvQGHR9t+j9eH/UhSbHJ\nIAiEVQ/hpbmTCAh19Uz2j+jDLwnzXISgRUQa+NUnQOePXbWTWJQEgIpafFyaNY2nG0wix55NNVMk\nO9MymB7zOxbFTj1TNi9HvYvxHQXRqiBLGgu/DOeT032xVfUn02LmxMETbDl2hpE3taBlrUhi4lMw\n2+zoZQlREHjv3kG0rxfFjN+2YrXnF8tWyKJAkI+J3s3K93yWxCSZeKnJ8zy/5nXECKdhaE/UkfdN\nEDgE/AK8Bl153BF1O3uyphPvob6VKGgMq1G5sOWaPjUuWTDFi5f/MkJZgozXgvbt22t79uy59IFe\nvHi5LOZtPcCHKzZTZHcgZZoxHU3HeCwdOd+GzqgjMMyf51Y/z9z9R0nLLaB38/qMubkNYiWS/8vi\n5qlfkGN2NzBKEurvwx8vP4S+EiFN/1Y+fvxrVn65tvhvQYBnvnv8qnhqAH7euI9PV28tLuQATu2u\n0d1aoy6LYcO8rcVFOy6Q07cuuowiTIdSiz12mgDoJSaseJbb+v7DQlp/E5qmsTh+PzNXrkJ46RCi\nAnpBRnOo1O7ciDM5DtTSeVESGIOMOAocOKwO9HoZSRZ5+5sHMUoaX02ZRcyWo/gF+nDH5CEE9m7I\nN+t3k5pbQMuakUwY1JV6VYI5uuMENoudZl0aYjBVXIajLLbFxjP5pxXu+ZAlMOlkZjxwK10a1bri\n/q6UjLOZKA6VKjXDPIbTqprKT2dmsSVjG7Igo6ERbgjnucZPE6gLZNW5NSxOWuqmL2YQ9dxdczQ9\nq3THrip0XfUe+XYroLG2zTKqGswuzlGrVebZFQPYeNp1Eq+XJZY9ex8JGTlsPxFPqJ8vQ9o1JjzA\n6a3JyC9k+tK/+OvQKQB6NqvHi8N6ERZQ+UWuhLg0Hrt3BpoKWqFzkUoQBb5bMYlqNUIr3V5pFmw7\nyEe/babAYsOgk7i/Z3ueHNDlitv9N5BkTmLi7q+IzRZRz2vTiYJGi5AA5nSbfF0t+nnx4glBEPZq\nmlahlQuvMefFyw1EocVKr9e+doYYqZrzHxqBv5/EdDwTUZbIbxVBfvfaxecEmIz8MfUhfA1X5lUa\n+Nb3JJXnXTjPre2b8uboW66or2vNrjX7eWnQW+47BFiS+SP+V8H72ee1r0nLK3TbbtLr2PZ/j/HL\nm4tZ9ulqCnPMxZ6igjZV8T2YilDKkNFEgf4P9ea5rx674nH927Db7OxbF0NhrplWPZvx4hOziD+Z\n5vFYQRAo/ZtYrUYI362c/LfnEQKcy87jy7U72XE8gVB/Hx7q3YHMAjPvLd/oYrSXxqST2fLG+Aov\ngmiaRlpCBqIkEh515UbFpUiIS+OT13/lxOEk9AYdg0d0YNBDbUi0JRKiC6G2b63iz3dx0lJ+TV7p\n1oYsyIyocQcDqvYnqTCbW//8giLFTnPfTL5rug4/2f3z2XCyFk8tHeSyzaTX8cLtPRn2D5X7t9vt\nvDPnW87kJVIvsBZTRj9YXCDqSpi75QBvLXXPU7yzU3Omjex3xe3/W1h/bj+z4jZjV1WG12rP7VFd\nvIaclxuCyhhz3m+EFy83EIcSU4tDxRAFp+acLJHbvz6qXkJ1KBhOZbmck1dk4blZq9za2nTkND9u\n2ENiBbXextzcBp106VfOuoMnKtTev5mfX13geYcG899eelX6KMvLabE70ASBsa+OYmnmj/zumM+D\nb47GN9AHv2NZaCXugSPQQNawJqRO6MwvJjPT5v9BgcW9Ct8/TUZ+IXO3HOCHv/ZwMiXjitrS6XV0\nGtSW3qO7ERoZTJWosrXDPC1uZqTlkZF66UWIc6dTmf/uMjYt2o6qVr46bEpOPnd+MJvluw6TnJ1H\nTEIKL8xZzclzGW6qHKX5+MFbK2zIHd97ivsbTeTBppO4v+EExrWeQmLs2UqPt6KcOZHK+Ds/49De\nM1gtDvJzi5j37SZeHTuPNoGtqeNX28VQbhnYAoMHMWdREGh5Xig6WO+Dcv5emSQHWhnVSP0M7t5M\nUQC/q+AxrQiZ1kwej57IiSZ7sHdK5VjjXTwZ/RQ5tivXx5zx2xaP2xdtj+H04YQrbv/fQu/INvzQ\ndSKzb57E8JrdvIacFy8e8H4rvHi5gVi1P9bjCr+gathqOfV+VIP7pHDb8fji/49Pz6bTC5/xxHfL\n+GDFZgZN/4ExH8+95AR2dNfW3Na+6SXlfbQy097/OxTmuHvMLpCbnn9V+mhWI8Lj9pphQehKCGgL\ngsBd/xvG4ozvaf/G7QjnKyGqBonM0S2x1QwEUUCVBFbuPcYjXy72aNT8U6w7eIIBb37PBys388nq\nrdw1Yy7v/brxqrRdYLGyXcpFK/XLp5XzUNodCt/+tZujSZ69eQDP9fs/7qv3JN8+/wuvj/yQoX5j\nOL4vrlJj+379bsw2e7GRAlBkc7Bk5yGaRkVg8GCshQf4sm7qI9zUsGLhlXlZ+Tzb+zWST6ZgK7Jh\ns9g5HZPA091fwVYijNOm2onOieFATjRW5cqM+5nTV6A43N8NccdT2bPVuXCjaQpxuUtZevp2tiQ/\nikmwIJUSsjNJJtKs6QD46gwMqdEcoyRzsCAUSbj4mRUW6ti/rwonTlbhj9iGlEYURLpXMLcwKy+X\ntKzMSx9YBm8fe98lNxDAolp559j7l93mBcy2MsJuBXhx5AfX9DvsxYuXf5b/fmKKFy9eKoxw/l9Z\nP/OqLGJuG+m+vUS57ns+mes2kYiOT+HBN3/mx6n3l9m3KApMG9mPB/t04OOVW/i9DA9cj6Z1L3EV\n/35uvqMzc6d79sANeqT3VenjuVt78OAXC7HaFVTN6Zsw6GReGu45Jy+3yMofKefwqRmIPiGXoqZV\n0GQRSqx02xSFU6lZRMefo3Xt8iUj/g4KLFZemLMGa4kFB4eiMmvjPuZt3Ift/AS1ik7PkpcfItDf\nc/nysliy8xDZOhWhlT9BxwqRLCoIUBhpwJRiRSpVMV4DbL4i8/YeZkn0MR7u05Fx/Tq5HPPTtPns\n/zPGZZvNYufp7q+wsmB2hce261QSDsXd6JEliacGdWPLsdMs3XUYm91B27rVmTT45kpVWARYP2cL\niuJ6kZqmYbXY2P7rHnqMuImY3EN8duKL4kUXFY1xdR+mXUjbSvV1gdhDZXv9tqw9TIduDdmRMoWz\nhZsRBYVAGboE5HLKEkFs0cV3Ua49j89PfsnoGqPoHdGTaa0GIyCwIjGGN0/fxNQ621i5pD6zf2qG\nLGuoqoQpOBDfxiKCn4ymOfPlPn/4dgy68qc+Ow9H89abs7Ee1YMGutp27pvYmxG9B1T4ulVVJc3q\neQEg2XKuwu2UhSyJHp8XgLzETM4cTqRO85pX3I8XL17+/Xg9c1683EAMadcEo97DREYS8T1XgKV1\nVSyNwtx2t67jnFQtW7+X3EIP4X0C7M3Oov3IacQeinffX4IaoUG8P3YIL9/hbtQEmIy8Nuq/n+8x\nZtoI/ILd8+Ka3tSQJp2vjlht85pVmfPUaPq3akDNsCB6NqvHj0+MKNNLE5eaheBQyRnUEGvtIOwR\nvk6JAg+cTs3yuP0CDkXlj+jjvDBnNe8u38Cxs2nM2rSPW9/5iUFvfc8nq7ZSaLGV24YntsbGI3ko\ntqOB05ATBBAE0uw2ur/yRaXaNhda+WHBFmyKgjVMT2rXIM71DCa5Vwh5DXywhegQRQGdXkZnkFEl\nAcUgkNXSv1gC4Jt1O93Cipd9ttpjf1azlQN/Harw+CKDPOvR2RWF6iEBTBjYlfXTHmXLG4/zyYO3\nVdqQA0hLyHArigNgtzrIPJtFgb2AT058jkW1UHT+n1W18sXJr8iyZVe6PwA//7IrN4aE+5NljSbF\nvB1RuGhk6kSV+qZUQuQCl+Ntqo0FSYtwqA70kswbbW9l26ApPNnmA46cnskvs1phs0n4Visksm0q\nmpBKi3h4b8wgPn3oNtZPe5QWNcuvLmq2WPi/p+ZiPaIHRQBVwH5ax/cvbSI2/vRlfQZ/B3d2ag6l\nvW+ahi4pF1kQsRVV/vvnxYuX/yZez5wXLzcQ7epWZ8RNLVmw7SCKqiKKIpqq8kjLZox66WG2J53j\nf7+4Tk6NOpnpowdy4uRZpv66waOeFgCCgDUygPte+pady1+/5FhGdWlF5wY1+WT1VtJzC+nVrB5j\ne7a9LnIi9Hod889+zZdP/8SmxTvQGXTc/uQARj13+1Xtp37VMN67d3CFjg016FFT8ghbfQKxwIYj\nyAT1FY8GXd2qZRfFsCsKj361hMOJqRTZ7IiCwKxN+12O+WnjXv46fIoFk+9xCfm8FJqmUYZms4sG\nHIKAisZH89Yx+a6+FWr7m/dXY003Q3WD8xkWBDT5fJsqGDWRUQ91p2vfZnw9fxMbTidQFCK7PO8a\nsPFIHGO6X/RSlTdpTkuseIjeg707sOdUkksYtF6S6Fi/BlUCK6eLpWkah7Yc4695WxBEgT5330zT\nmxrRrEsjVvoZKSpwXZCRdRKNO9Vnd/Zej+3ZcTAnfh5PNhhfqXEAjBnfm4//b7nbdlESGDCsHelF\nS8lNUjm6IITCFJmobmbqDShA0qmE6fLJcvhhj9NhjTEgGDWkTgqZtkwijM4wY1+dAV+dgW8WnAWd\njeFv7iQwshBNFRBllcR9kVSXR1CnXsU8ze/O+g41TwS1xPOmCWh2jfd+/Ilvp71aoXZEUcRX8qFQ\nMbvt85evXEj+pTv6ELP/FIfNFw1e3dk8ghcdQQz2pV7r2lfchxcvXv4beI05L15uIARB4NlbezC8\nY3M2Hz2NyaCjb4sGhPr7ADCoSiBt61RnxqotJGTk0KVRLe7r0ZYAk5EBL34DPgLlVmOQRcy1g0g6\nk0pUbc85XSWpFR7MB/cNuVqX969Cb9QzceYjTJz5yLUeCgCWszkELzqMYFcRAN9DqZg7VEeThOJQ\nS70sUb9qKC3L8V6s3h9bbMiBU7i6NDaHQnJWHn/GnGRAm4p7IltXq4KtnKqNpVkXc7LCxtz636Lx\nERQKqhlcw4xVjXA/H777/l6iajt19hp0q8NacyqUCmMTBcHNOG3YoT6HNh/12GfX2ztU+Fo61Iti\n6h19eGf5BuyKiqKqdG1Ui7furnho3wVmTvqBNd+vx2q2AgK//7CBYRMGcv/rd1G9QSQJR5OwWZz3\nz2DS06xLI5p0bkh8yhkcZQgy787ew1nzWar7VK/UWAbc0Z4TR5NZtXB38TZJEnl2+p1UjQphz9Ii\n5t9TA1UB1S5y6nc/DnwTzNC5yVg1mdwfA7DsMoFdAAkKlkHMm0lEDHB9v+RmF9JzQjTBNfKRdBfv\ncI22KSRY5lOHyRUa79nkdDTFww6bSE5qkYcdZfNE/fG8G/uB2/YJl2EUe+Knl8byVPdXOJ2SiSM1\nH70gIvno+d9PE5AvEUrqxYuX6wfvt92LlxuQelVDqVeG96VqsD9v3zPQbXuKqIBQsZLaSfFpFTLm\nvPxznNh3GtF+0TgRrQqhcw+S16su9lpBGAw6BrdtzLO39ii3DP+a/bHFhlx5mG129sQlVdiY+3zS\n9yz7ZDU+LaqQ36de+YsG54kKrriHw+FQkB0qIQfyyGnmh6oT0QQw5DiY/9oYwgIuer8GtG7EV2t3\nUtqs0YC+LRq4bHvuxye4v+FE1FKG36BH+uIb4FPh8QHc2qEpg9o2JikrlyAfI0G+lcsJBDi5/zSr\nv/uzRDilhtVsZcknq+g3ticfbvo/Fr7/K3/+shlJlhjwYG+GTRyIIAg0D2zGgsRFZbY9P3ERTzd6\nqlLjEQSBiVNv46HJt7Djr2OYfPW079oAvUGHoij8MG4vDkuJCqtmkZzTOg7PDiChaSSW3Sawnd9/\n/oZ8+spKutzcHB/fi1Upb+pTF6F1uoshByAbFMzSWqigMdewfi0SRQ/5vAaVqrUCK3XtzQKb8n7L\nt/klfh5JRWep6RPF3TXvIszoHsp+ORhMBj7d+gZbluxi9+/7CY0MYdDDfYis6333evFyI+E15rx4\n8VIhjA6Nwgt5S+UgFdho37XJPzQqLxXFUmBBEFzTbORcKyHLjtL//p48+/0TFWrHp4J6g3pZonpI\nxSa/W5buZNknzvBe35g0bLWCsNYNgbKkLM5fxAdPDK9Q+wBtOtdj77aTGLMcRGzOQTGKiBq0b1vX\nxZADqBEWxP9u78nbyzacz+ETUFWV10f1L/ZiXyCyTgSzTn3GR+O+5sj2WPyC/Rgz9U4GPnh5hW5k\nSaR2eNnyCZdi52/7sFvdvWuqorJz5V5GTLmV+6aN5L5pI92OqeETRZghtLhqZGkyreWHjTpUB9sz\nd7Atcwc6QUfPKj1oE9QKQRDw9TPSZ2hrl+PPHErEbnEfq2IVObKyClH2RmR46NNuc7Bx9UEG3nnR\n89n/jpasS/Zc3knRKu5RmzzqXjbOfxFHkgyO88+fpCH6qrz08MNlnmdVrGzN2M6RvCOEGkLpXaUn\nEcYIwo3hTGo0ocL9VxadXkevu7rS666uf1sfnsi2ZbPs7K8czI3BV/JlQOQtdA296R/RY/TixYsr\nXmPOi5dLkJqZzxcL19OheR0Gd2t5rYdzzXisVwc+2H3AdeMFy0AQnCFpqkY/QwByBTWvvPxzNO3S\nCIOPAUuha6l5vVFHz1EVnwiOuKkFm47EUXSJcEhRELi1fdMKtfnjK/Nc/g5adYKCTlGYW1dFMOrO\nP16uk3R/owEfQ8X1wp58cSgT7/4Sq8WO1WLHFwm9UebJl4cWH+NQVGZt2sf8bdEU2ez0bVGfZlER\nBPoa6dG0bpmesio1w5m++qUKj+XvRG/UIUmim6dQlETyQ/NZmbyKFoHNqOXruVDO8Gq38eXpbz3u\naxZU9v2Mzj7I16e/o9BRWCwvciw/lm5hXbmv9j0ezzGY9C6VcktSK6QeNf1qcRL3YjyqqvHjp+vo\nP6wd0nmDP8g/Aj9DFGbFVWNNQKKqb/cyx10aWZaZ+fUkprz5Mfl7ABVMze387+kxRIZW8XhOocPM\na4dfJ9ueg021ISGxPm0DE+s/QYugf0ac/J8kz57P1EOvUegoREUli2x+OjOLRHMio2uOcjk2Pa+A\nhdtjiEvNomWtqgzr2Bz/f0jnz4uXGwXh36RF0r59e23Pnj3XehhevBTTe9irCGuOgar3QihzAAAg\nAElEQVQhqBrW2sG8s+hZurSqf62Hdk14cur3bCzIobhuuV3BPz4Pi4+MscDGA3068MjkKy/ycTQh\njXd+XktuvoVeHRvwxO1dkaSKF9K4HtA0DYvZisGkdykKoygKn/++g9UHjuFrMPDS8F60qXPpPCZN\n03hx0FvEbD56PpfKOZlu0K4uH2x4rVKFZz7/fTvfr9+NzeEpucjJV+OG0aVh7Qq1N7LaI2SneBZS\n7j6xPwukAo/7nhl6M/f3bF9muxnWDLZkbKPAUUDLwBbUFury54poTsQmom9fhKGxnep+kXQP74ZR\n8OO+T+cTm5xenAcoiSIhfiaWPzf2b5mAnkrJ5KPfNrPvdDLBviYe6NWeOzo1vyLvRlpCOg80meRS\nmEUIgIil/oi+F9sNkP15r+XbGGX3apMT9k0mz5Hnsk0n6PiszccYZefnkFqUil2zE+UTxZKkZfx2\nbjUOzd3A1wk63mjxGlWN7qF/mqbxULPJJMUmu+iiGX0NPPXFo4Q1qM7Lj/+Mw+7+nBl9dLz8/mja\nd7uoJZdpOcCW5MdRNQcadiTBgCz60TtqDibZsyF2NViYuIQ1Kb+7XX+AHMDHbT5AFP77RZ1KsiRp\nGavOrcZe6np1go4PW79HgM4Z/nw0KY0HZi7ArqjYHApGnYyvUc/8yfcQUcmiPl683GgIgrBX07Sy\nf+BKHus15rx48czIiZ+S9eUWhBKCt5okYK0ZyOZT31zDkV1bLBYbcxdvpnrVEPr3aXPV2/9o4UYW\nzT9fLEEDBBD9Jf746glM+oqF+P1d5KTnErPpKL6BPrTq2QypnEqNiqKwY8Veti3fjV+wLwMe7F1h\n3afNi3fwxdM/knUuG4PJwPDJQ7j3lTtxODS6vjLTTfj99g5Nef2uW4r/LioooiDHTEhkkIsR7LA7\nWPnVWtZ89yeqqtF/bE9ufWIAekPFciFLkppbwJKdh/ji9+0ugW2SAPfc3IZnb+tZ4bbeGfsZ62Z5\nFgZvMmMkf8UnedzXMDKUxVPu87hvX/Z+vjj1Naqm4NAUDKKBBn71GVfvYd448jY59hysqhWdICMK\nEmm7GnPqlAejQSczcWBX7u1xeTprZZGQkcPID2djttqLPz9ZFGlXrzrP39aTIqOV1KJ8mgVFEulT\nuVytdb9s4qNHvkKSnUZEwGIdUoBwcRHmPEbRQNvgNvSq0pO6vnU4mBtDnj2fFoHNmRM/jwO50Who\nNPCtz/j6j1KomJl54kuSLBe144Tz/6l41jzTC3rurjWKXlV6etyfdDyZZ3q9SlGBBU1VURWV3qNq\nM/mztmDoyviRC4k/6a7XZjDqePTZgQwe0dFlu9meTFzeQvJtZwgztqFWwDD00pVXjyyP/0W/SIo1\n1X2MooFXm02lmsldu/O/zBtH3uZEgXteoUkyMaH+4zQLdHpwR3wwm2PJriG7kiAwoE0jj3nZXrx4\nuYjXmPPi5SrQve4j6M/klJ7/oEkC9yyawAO33XxNxnU9U2Sz0eeeTxBLzQs1AZp3rMFXz43yfOI/\nwLx3ljLrtYXI53X69EY9766dSp0W7uFqikPhxcFvcWT7cSwFFkRJRNZJ3PfqyEvKE+xdG820Ye+6\n6IEZfAzcPmEg0Q382HA4zuN5W157DKMkMmPc12xcuB1RFDD6Gnn8kwfofVe3K7jy8jl+LoM3F//J\n4aRUgn19eKBXO0Z3bV0p71JeVj53VX/ULderSacGREzpy7xt0R7Pa1mzKr88Ndptu021M2HfJCyq\nawl+g2igkX9DjuQddfOiWPN0xL3tj6CAtW4IStBFj1XfFvX56P6hXC0SU7K4e9RbyDFOA6CoaTiF\n7arDeeNLEIFIO/r6CnZN5baaLXm19RDESn6mu1bvJ87/FFurbin3WAkJDRW1hFneMaQDj9cbV3wf\ns2zZPH/gRaxUTr/MKBp5qO79dAwpu7Kn4lDYu/Yg6Wd206TZl1SNsiCIoNMLnD47nGcel7CVejYM\nRh3v//gIDZpenrj9iXMZfLp6KwfjU4gI8uPRvp3o0+LyIi6mHfo/zpjd9TV1go53Wr5FqKHymoD/\nZr4+9R3bMrcXh9NeQC/qea3ZK1QzRVJosdF16hcoqruR72/Us+3NiuXoevFyo1IZY+768v178XIV\nEfOsboYcgCaJ7Dpw6h8fz43AD6t2I3hYXxI0OHTwrPuOv5HU+HR+//Evti7bxb4/DzL79cXYLHbM\neUWY84rIScvl+QFvoiju3pxNi3ZwZFsslvN6XqqiYrPY+fb5X3iwyVPEH/XsaQL4adoCN2Fnq9nK\nsk9Xs/XYmTLPm7FqC++O/YxNi7Zjt9qxFtnIzcjjw4e/4OCmI5f3IVSAhpFh/PTkKPa8PZG1Ux/m\n7m5tKh0mGBDiz+zTM+k4uC0GXwP+IX6MfnEYM7a+wcN9yjYCHunT0eP2UwWnPH53raqVo3nHPIYD\n6g02go4l4r8lnrCf9+Ozy3mPJFGk1hUUJCmNxWJnTNtnMGxPQM6xIOdY8Nt1lpDFh4tzUDUV1HMy\n5kwFm+pgZWIMi87sq1Q/xiAD29tsYVfkzkseq6C4GHIAu7J2s/LcRc3JdSl/YuPSVUxLIwoCrYNa\nlXuMJEu07lmfHv1nULthAUYfBwajA1G0U6vqEjp1KUIuoYdoMMg0b1e72JDTNA2b1U5FF6dPpmRw\nzyfz2HAkjswCM0eS0nj+l9XML2PR4FL0jeiNQXSNGhARifKpft0ZcgADIvujE129+bIgUcunZrEX\nUpZEF0lS+WwevtsTMEWfQ+/x2+nFi5fLxVulwAvg/DGMz81BQKBmYKC3IhVgjwpAzilCKL2wqGo8\nPLLntRjSdUNaQjqHtx0npGoQLbo3+dcJhX/z/GyWfbIKUZIQRQGbxYbDQ35YUUERR7Ydp8XNrtU7\nN8zf6lZo5AKJsck802MacxK+QG90Dxs9F5dSxqg0ypur2gss7FuxF7vVdcJtNduYO30JLbtXrBjJ\ntSKkajBvrnjBbXtEkD9PDerKx6u2umwf2LohPZvX89iWJEgeaho6EQXRU8FDEEAoUhEU507/nUnY\n6gYjRQYyqsvVK3z0zKs/IWeaERwXByE4VOT0QvSJedhqng+pVEFI06EFKRQpdr7cu55dD61AlEUG\nPtiHHiNvKvd780fKWuILE7BrlTfALrDq3GqGVhsEwBnzGTdPzKUwikaebfQMevHS4dFbFn1Kh87u\nXhxRtDPxGRuh1bqz+Y9DyHqZgcPbccf93dA0jSWztjLvm40U5lsICvXjoUn96TO0/PDvT1ZtxWKz\nu1yNxe7gjcXrSUjP4anBXdFXoohT17AunCw4xdaM7UiC0+gM0Pkzof7jFW7jv0RNnxo8Ue8xvj/z\nI0WKBVVTaRrQhHH1Llb7PJuVS0SgP2czcwhYfRzjySy089adtjOJNR3aMOD2m67VJXjxcl3hNea8\nEJOWypOrVpBhLkQDqvr58fmgW2kSFn6th3ZNGf38MJY+8A3YlGJvkSqLWLvVol2T2td0bP9VNE3j\n0wnfseb79cUr7QEh/ry3fhqRdSJ4YFAHZv+y3c07pwnQrMXlhVNVlj1/RPPr52vOiyrbi/u31AtA\nNUkYT+UjmZ2eHUEQMOe7lz2/EIpZFjarje0r9tJjhPtkpm7LWuxbF+O2XZIlujWuxYYjpz22OaJp\nQ2IMspsxB3Auzj3n6L/Ew306Mqxjc37YsIciq50xN7ehTkTZHo/6fvXQiTqPYZYdQzqwM2sXNvWi\n91NzaNiOKajZJR48RcXneCafv/oAkcEBHvtRNBU0SDiZhqXITr0mkegvce9P7D6FYHc3WgSHii4l\n/6IxV4r07FyiN8QCcHT7cXau2sfzP5dd8n5rxvYrMuTA6clUFJXjh84iWSuneSchcm+te6jrV+eS\nxx6NTmTryh106Oy+T5TAnJ3FY/8bzGP/G+yyb/HPW/j58z+xFjmvMys9n09e/xWDUU+3fs089pWf\nU8DmPbFoJs95ovO2RZOcnVepsFpREHmgzliGVBtMXEEcgbpAGvo3uG4Kn2Tmm/lw5WbWHzqJJIoM\nadeEiQO7MKP1B2TaMjFJJvzkiwVNfj8Qy8vz/sCuKBiOZ2I4lY2gaMULJZpD5d0HZzLg9pvYfSqJ\nBduiyS+yckvrRgxp2xhdObnIXrx4ccdrzN3g5Fkt3LNkAQW2ixObMzk53L14PlsfHIePrvKFEa4X\nnryrDzaHwuK3l2FIzEXx1ePTuwF/zn7xWg/tP8tfc7ew9qcN2C127BbnBMxaaOXVYe/x1YH3Men1\nDL+jLUsXnQ8pu1AAxU/i48kV1xS7En77+g8Xr5q1qolz45ugGs57dGSRkN8SCdpwDoddoXm3xm5t\nBIV5nvxfwGFzkJnsXnId4P7XR3N4W6xLqKXRx8CYqXdy272D6TZtJkU21zDBOzs1p1HL2igOD54N\nSfQ4xsqgKAqrFu5h65+HURSVBk2r0f/2dtSu/8+JE4f6+zBlaMVKzIuCyOSGE3kv9kM0TUPRnF7V\nbmFduLvmXRQqhRzKPQyAalexZtjJmepulA/v0IzWHiqFns7P5NUDKzkQe4bwX+zoCkSMsg4BmPTa\n7XTv36LMsflHBJCjE90MOk0WUfxKeLBE0MLPG2N2FcOO3OJdlkIrWxbv4OTTQ6jf2rOxdDWiK8Kp\nwph+72IpsmN6IBW5VYW03AEQBYnGAQ0vfSAwc/oKknYFI8vunr+iQpEiWy+37aqqMvfrjcWG3AWs\nFjs/fba2TGPu2d6vITT2hzKMOZtDYdPR0yRn5VEtpPzvcWnCDWGEG66OIHhlKXSYWZPyO7uz9mAQ\njfSL6E3XsC5X/BxY7A5GfzyHtNzC4vy3hdsPEh2fzJyJowk3uC76Wu0Opi1YV1ykKfDAOcRS7yVB\nA7HAxjMzFrIpNQXL+ffZnlNJzPhxDUHzDxIY7M+IKUMZMq5/pa/hdFoW22Lj8TcZ6N28Hn5GrxSC\nl+sbrzF3g7PyeKzHBGWHqrLm5HGGN/H8g3ij8PSY/jw9pv+1HsZ1w/LP17iFH6qqxtkT50g+lUK1\nelWZcldvBndpzvSf/iAv30KPDg2YOLzbPyZNYCks4bER4Nz4Jij+OkomgGQNisI/xcL4SSPwDfBx\na+PMkcRy+5BkiaY3eZ7oNunUgLd/n8rXz/5MXHQ8IZFB3PPynfQf2xNBENj48iNM+/JXdqenExLk\nx6t396dFTWeeypipdzD79cXF0gOCKGD0NXD3i5dvCCfEpTHpnq8wl7hvMXvOsGz2drr0bsoL744s\nt6rntaKeX10+bv0B+3MOUOgw0zSgCZGmqgA81eBJEs1JxBWeRs6XeavfpyhmV0PCaNIzdKy7EZFr\nK+LuTd+gaDlErtHQsmQ0TaXI6vx8Pnh5CbXqRVCrnudS+G++MZYnlkZfWKcAzkd9SiJKo3AEQBM1\nhHA7WpCCrAhouQ4CFrtWBVQVlei/DpdpzHUPu5nFSUuxaa75l1WNVekf0Ze5CfORz4ej2lU7Cq5h\nxAICce9DfoZTFsK3jrXChpxB1NM97GbCKmDYaJrGyaPJqHI4n78cxeNvJCHLGqIE1iKRQ7tD6DBi\njNt5NovD5ZksSWqyZ5mLooIiTh04g29uMDmDG4LO83OrlyXOpGdX2pgrC4fq4J0dMzjOMRA1jGY/\nHq8/jlY1r07os1Wx8trh18m0ZRXng/4cP5uTBae4v47naq8V5Y/o4+QWWlzmCTaHwqmULPbEnaVD\nvSiX4w8luoaJCx5kJQAUHx1/Jp1FKRE7bnUoWCUNpYoP5thUvpoyi+RTqYx7r2LXoGka7yzfyKId\nMaBpiAU2/i+jECHAQIikY/zQbtw+uFNFL92Ll/8MXmPuBmLXzmMcij5N+06NaNmqLgBphQUUOdyL\nAdizzGz8eC2xBeto3rUxfe/tjsmvcmE2XryUpijf4nG7KIkuRl6TmlX4ear7BO6foPfobhzachRL\noRVLHX9Ug+RiyAFoOpHqL/ZkyJh+HttIjE0us32dQaZVz2Y07tigzGOad23MJ9vectses/koLw1x\nbvdVNCyqyq48mRZvOUWZ7/rfMCJqVWHeO0vJTsmh+c1NePCN0VSrV/WS1+0Jh13hmfu+8ThpVlWN\nHRuPsWzOdu647++rlnklGCQDnUNdJ2+aplGQV0S4vgo1wqMgHMa9l8dXU35GdSioqobOIHPbkwNp\n2M49J+/T2DnUDz2JpoLwlIaSLpPzcQhqttMwsNsdrFq4m/HPD3Y7F6Bx3WoMnTmWZc/ORc51fh8c\nQSYGTx9JlfpVKbTaqF8rhD3WOBIKszEdMXPs+Q048lwnxZJeJiC07JL7fSN6E5N7iBMFJ3GoDnSi\njCTITKg/niifKG4K7cT2zF3oBZkuYTexJuUP1qT8gUW1UMunBs2SbuLnhM1wvnqlZhagHIUEAQFf\n2Zcapij6RPSifXC7sg8ueZ4gYPI1YNbgj01NOTrQl74js/D1U9j+ZyhPfPYVouQ+VTGYdAQE+ZCT\n6a5BWKOO5xSB9CSnN9x4OpuAv06T17uuU0ujlJVqcyjUCg+q0PgrwlNb/0e+Pqe4myLfAj5I/oAX\npZdoXL3uFbe/LWM72fYcl8I+VtXGloytDKk2qEJGdVkcSUrFbHMP11VUlePJ6W7GnEmvcylEY2kY\nhpyVWBxieQFbVABGvUxh6bBwWcRSOwhTbAZWs5Xln6/h7heH4x98aV26bbHxLNl5CKvdgZhnRTNI\naJF+IIkkqxqv/L6ZhLMZTHzU83fTi5f/Kl5j7gYgKyuf+7u/iPl4GkgCcxwqhhBf6jeoTlDLSPxr\nauT7XPwx0ycWUP2zoxxH4IjVwbblu5kzfQkzd79DcMTV+4HzcuNx852dOXvy3Pl8tIvoDDpqNY0q\n46x/ll6ju/L7j39xfM8pCo0SHquOCAIpotnj+YpDKVMAG+Dhd8Zw63inJpymaSz7bDUL3/+VvMwC\nGneqz2Pvj6V+G3dvi81qZ+ptb7sZxMs+XU37/q1p1dPpRe91V1d63dW1opdbLnu3ncBs9uz9AKex\n99uC3f9aY640h/ad4aNpS0k96xS+79yzMZNfHcat42+hXb+WbFy4HYfNQdfbO1KvVW2382Pzj3Oy\naCeiqDlrQcsgRDoIeiqLrFfDAAFV0chMz3M7tySTHhjIpAcGsnztHgRR5NY+7hp2/WkEQFbdbO6b\ntIHSS26iKNB1mOdqngCyKDOl0WROFJzkZMEpgnRBtAtug0EycDj3CDNOfFqcN/hT/GzG13uET9t+\nVHz+ypidLmG75j988RuVj2h0/z4YRQP+On+mNX0Zf13lNd2GjurEsl+2Yw0OJEltzo+/WNCb9Ix4\nrC9RDdzDXMFpBD4wsR8zp6/EWuJ9YjDIPDjJczRFeI1QRElEVVR8DqehS8olc0xr0InFBp1BJ9Ot\ncW2qh1RO268kObY85iXM44w5gQDB38WQc47d6Y2defAbPqk+/bL7ucChvCMuOaAXkASZUwVxV2TM\n1QkPwaSX3UK7ZUmkZpj7fKBJ9SoE+ZooOl9gxlIrCNOBc4gWO6ICmgiIIi36tuBACW1CwaYQsD4O\n4/EMKGH46Q06EmOTadr50iG7S3cdpui84SnlW7H7Og05AEQBTZT4/sBhHncMQP4XRhN48XK5XB/Z\nuV7KZcKIdzDHpiI4VASrgqBoWNMLOLItlh3fbCL8ld2ErTmHUORc+a06Jw7RquA4r+tjKbSSnZLL\nDy/PvZaX4eU64I7JQ4ioXQWDz8XcIA0QQn1IPOMuunstkHUy76ydyvOzJlK3UQSa3sNrUtCoFuLr\n8fyjO46X2bZfsC/DJw5G1jnX0b59fjbfvTCH9MRMrGYr0X8dZnL3V0g45i7DEL3hMJrqPpG2FFpZ\n/d2fFby6ypGVUeC58mMJbB4KrvwbSU7M5KXxP3E2PhOHQ8FhV9ix4RhTn/gZgOr1I7n7heHcN22k\niyGXn1fEqkW7WfD9JpYcX4FWOhxRAilMQa7ufF8aTTo6dm9UoTHd1q+9R0OuJCFVg3lt6bP4Bfvi\nE2DC5G8kOCKQ6Wtexse//GgJQRBo6N+AQZED6BLWGYNkwOww817shy6Tf7tm55OTM8myXczjbNXR\n1WNUtNmHos0mNDvoNT06QaaqIYJ+Vfpwf52xTG/xxmUZcgD3Pt6Hm/s3R6eX8QvwQR8cQK/hHbnn\nMfcw15LcMqwdk18bRrWaoej1MnUaVmXqjHto18Wz19vka2To+P7FhpUu10roghh0yfkIgK9Bz11d\nWvLumMsXtD5VEMekA0+zPWsn5yzniDV7fh8IAuSaMi67n5IkmBM8bldRCdJf2QLs4HaNMciyizEq\niwKhfj50aeSusSkIAjMfvp0QvY6w7/cSNucgUqEdQQFVFjC1qs7T857isw/GYdBd9CcELTuK8XiG\ns1BKifZsFhtValbMGHWUkIlxBBsvGnIlUHUSx0/8szI3Xrz83Xg9c9cpeXlm7h44DXNMMmKBzU3V\n5cLfquJcGQv4PR7/v5LgybbI6RZKZ9EpDoVty/fw9Dd/98ivb1RV5dfVu1mx8QBGnY6H7uxB2zae\ny6tfj/j4m/hs13SG1xhXnDMkADknUnmk3XMsSfwK/wDPRtI/iSRJdLmtAytIQ8o+gJJvOG/UCCBo\nCLJKc1/3nChN03hn7Gce2xQlkVsfv6X478I8M8s+XYPN4rqibrPY+OWNxbwwe6LLdofNPRy65Dl/\nB83b1nIKWHtOewGgW99/Jq82zZLOr8krMUkmRkQNRy9dutx9SZb9sh2HzfVCHHaFU8fOsX/HSWbN\nXE9c7Dn8AkyMf34IXfs0JXp3HNOenIWmOY8Nei4D2dPXVQXBT0VvlImsEUrPAWUXQLkc2vVrxcKU\nbzm26ySZ57KRJJGAkEuHnXli6dnlZUoMLExczLh6jwDOUMU+Q1vz12/RWIrsgID91zAiUiIY+/rN\nhBnDqGq8OgVwZJ3ElDfu4KHJt3AuKYtqNUIJKmOxpDQ9B7ak58CKS0c8PuMBQqsFM+/tZZjziqhm\n8uH9B26j/S2tL3f4Lnx8/FPXz1fAs16pBjqL0cOeiqNqGnNPryPVku6ez6g5Q18b+F2eEPoF/IwG\nZk28i2nz1xIdn4yAQNfGtXh1RD+kMqQx6lUNxe/THVjMrlqtgkNDn5DLoOFdAPh63HDGf7MUS1I2\n+tQCt1BMwGnIaRqbFm0nOCKIZl0blSnJMbhdE7YdT6DIZke0Kiju6cxoQHh45b2uU+58lwNLdhf/\nXa15FN/ufge9oXLvIS9e/g68xtx1REZyFhvmbaUwz8wPP6xFOpeP5KG6XWkEcL7hrArqtwfLXIjX\nl1H9C+Dw9lhmvbaQwlwzve/uxm1PDPjXaYdda1RVZcRTn3FCsKFJItg0Nv+4jJF/1eLlp++8pmPL\nzy4gZtNRjH5GWvVo+rcWtPht+Q4cZtcFBkEDzWLnyw+X8eyr9/xtfVeWANWEzgpiaBGKWQZNRDQ4\n0ClQT+8+kU1PyiTrXLbHtnR6mTFTL97nc3GpyHoJW6k0QlVROb7HXZS+Vc9mKB6KCRh9DfS668rD\nHLMLikjJyadmWBC+5/XvatQJp+eAlqxbcaDM8+4eV7735Gow/ei7HMuPLf77j9S13Fl9OEOrVzz3\nJTEuHUXxIAkgCrzw6I/Ff1uK7Lw+eQ5DRnZkw5qY84aMk6J9evxq2BD0rm9JQQe1fGrR68nWDB7R\nEb3h6lcBVhWVeW8vZf/6Q8g6CYddoVWPpkxbPAWDqeLV+lItZctUpFlci6xMnHob7bo0YM3iPdht\nDvoMbU3vwa1dBLyvJsGhfgSHXtpItal2NE3FIFW+SqEoiox+fjijn7/61XEtioVch+cQW01zrwQ6\nJHjIZfdV5LDzwJafOV14ivqhAnJpPRcBJLP+qsgj1A4P5qcnRzpz0QThktIBDocDaylD7gJ5JXIc\nG1ULZ93UR5j99RoWzD+EtcA9p9puczC2wQRkvYymaQSE+vPen04pm9L0aV6fVY2PsfVYPA5znrM6\nbMln1aFS0yYSHlY5Y258/1c5se6wy/UkH0rijuqPsiLjx0q1VRaaplFkc2DUyYiip0/Oi5ey8Rpz\n1wlbl+1i+j0fo6oaRXoB2Wz3uMrliDKi6nXIiYWIpUpjC4BQaMca4Yf+XD6UCOnSm/TUG9SSRTti\n6NaoNlWDL4bTfPXszyz6YEXx38d2nmDhe7/yc9xnyJUQXr3embtos9OQK/5xEdCABfHx3H82najq\n10bXb/nnq/n62VlObTQNLIF6CpuGo8girUND+eirJzBexdLO0XtOgocKqoJd5eieuKvWz9WgX8uG\nLPn2EOYAC2JVGwgKQoqMIctE9zvd89r0Rp3HUEhwTkoWvv8ro567HVXTUAQRmwfjTBCgZhP3PCEf\nfxOTvh7HjEe/QjkfJmj0M9Kmd/Nyc6cuhc3h4MVvVrB99mYMCbk4/A30HdeHqROHIwgCT78+HEES\nWbtsn9u5L380moAgD8vfV5F1qX+6GHIXWHR2CT2r9MBfVzEP1f+zd57hUZVbG773npbeSQNCD71I\nB6lSBSmCIkqxgCgoCoqAekDUo6AIWEGkKqg0FQHpHemdEFpogSSQ3ifT9t7fj0mGTGYmBfCofLmv\nix/s+s5kZs/7vGutZ9VvWoWzJ2IxF4lwGvTOo5obVh1B52b//Mrb44F7Rz2aAAVFbf0Ma0UtT9QY\nQI/vnZvhlJariWlsj4oBoFujWlQLtu+jt/jdnzm5IwqTwYwpv4vC6d3RLJi0nFe/HFHq+9Tzqcvp\nzDNO99XxsU8PFQSBdl3r33X0VVZk9qccYE/yPiRFpl1QWzpWaI9avLvfhQxTBguvLeFc1nkURaG6\nVzVGVHuecPewu7re/aakpuq28lsZGmW35PHuPYo9vjgWxeznQuZtZNSIRYVc/r1Mt++vKCicFlkc\nhlznRlfOEEWBR7o0YaW03GGfoBJJSslCMZhtddaGXCNT+33CgjOznV5r9vDHOAAF/4QAACAASURB\nVHYljj3RV9iz8QTXBRlBllFEkVCDwg8fl/67AmAymR2EHFjnS3lpuRzZdJKWjxbfpL4kfj18li82\n/kmm3oCnTstL3VoxrEPT+9JepJz/HwiKs+L+v4nmzZsrx44d+7uH8a8jL9fAoNCRNjdAY5gXmhS9\ng1gzhnujScpFkGSHpswFyGqRtAH18Nt+BXeDhEoUkSwSuRW9MTxeH1kUkBWF0d1bM7JLS9IT0xkU\nNsrptQZP6s+I6f+cKMvfzcCxX3JJY3FYnhVMEsNq1+KtV/v9z8d08dgVxrf7j22Cm9sgmOxO1ay1\nBqKAYJLQJmSx+4e38fK8P26mixZs5udXlzj22dKIPDyuJ+9/8vx9uc/9QFEUPlizgz9OnMdgsqAS\nBVQqFW/2ac/TDztPyxrfYQrnDl6ypTAXIPiDZxM3wn3qcuu2hKwoGPNMyOlZyPG3bTM9rbuW2Xs+\noHZz5+m3cTG32PbDbnIzcmnTtwUPdWlYqii4RZK5lZ6Fr6cbPu530rumLlzP/nE/IxgtCFL+dFQt\n0vW9x5n87mDbcZfPJ/DZf9aQlJBJxSqBvD3zKcIrB5Z4X4A5G/bx05+nMFkkKvh48t6TXWlft+Rm\n0gCvHh9HtpTtdF+rgJaMqflSqa6TkZbLqP5fkJOVh5wvuHVuGjvzjKJotGoH8Se4ydR61oMKnUS8\nNd609WhHpEdkqdMCC3Nq11m+n7aSy2dvku2jIefhCCxh3qhVKsZ0b80Lj7SwHdvPd7jTBvU6Dx0b\nchwnwq6QZZnRJ8Y6NFTXCGrmNvsKrXh/0sYURWHGhZlczrlic1nUilpqeFZnYp03yxwxkhWZiWfe\nJsWYaieaPER3ZjX5FA/1X7uoUFrGHH+NXCnX6b7eXn0II5wW1Zvg5nZv73O3LV8Qp7caLdXwT8bP\nLc+uRExRIGzzQ3zy3qvIiszh1CNsS9yJWlDRK6wnTfwb39P9Sxyf+KTLfdvk1Q7b3hvwKce2nMaU\nl++emr9dUQnInlqQFdQ51n06Dy3fnphJpcjwEseRlJzB4aOXqFk9jLp1Kpf5dUQdj2F8i3ecp8oC\nfV7uxutznc+BSsPGExd4b9U2W18+AHetmrGPPsywDsXX0yZm5nDldiqVAn2dmtGU8+9GEITjiqI0\nL82x5WGTB4DTu6IRVSLmYE+yOlsnSP6/nrM7RtapXOakF0ZxU2MJ9yZleBOaqz0ZWLsm/z14lFxf\nHUiSrXZm/rbDtImswrFFu11ea9vyPf8KMXcyJo4v1+4jJVtPm8gqvDawPV5lSFsqLSpRwK65VCH+\nLmetWSPn2iarkk5FdudqUGgsilaFKdyH10d9xaIfJ96Xew59rgs/T1mBkqJHyJ9UK4L1XqPffPy+\n3ON+IQgCU5/oQr/m9dgeFYNOo6Z307pUDwlwec67P4/jzU7vkXQjBUt+5E3bVIX/p+6YzrhzZXkO\nmArNuny9ERQFJf42aDX4NqxBraauhU6lWmE8/+HTZXodvx05y8x1e7FIMpIs06VBDd5/qjtqUWTX\nvG3oDGaEfO0pAFhktn30O2PGPIZPviV4zbrhfPvLay7v4YpxS9ezI+qy7f+JmTmMWbiW+aMGODVQ\nKErRPmmFyTIX7xpZGL8AT75aMZqlX27j2P4Y3D109H26FQtnb3F5jsdLiegamDBfU5M53x85XY1O\ncGNgjX5UdQthxqRV7Li2FgWoHhnKpBlPUrFK6cwa9q89wvShX9iaw6vTwTc+i/QB9TBW9GHuloN0\na1SLyvmTNGOec1dRo96IQW/AzaN09VeiKDKrySd8eekbYnIuAwrVPKsxttaY+ybk9BY9H0R/xC2j\nfc8xk2ziau41orPO0dC3QZmuGZV5lixTlkP0Sy/n8WPsz7xYo2wRF4Dk9DQMJiOVQ+5fZK91QEt2\nJO9y2C4g4Omvo33Y3UfRC1P4XbiaHkSEbxoVPHNtO81HPRjc41FkRea/56ZzJfdO1sPFmEs09m3I\nG7XH3ZexOKPdgFbs+/UwYH2mFPz09Xqxq9Pj/7NiPMs/XMNvX21Cn5Vn+5kUJAUhy4jsqbVdQ6VS\nOV3YcEZwBT/69HJ8z7PMWeRJBirogopdWIioUbxgrFKv7AJx1Mc/cOhWEor6jtNmYfJMFuZvO8zQ\n9g85jc5JsszUlVv548QFZNn6jfDzcGPuyP6EB/ji46FD8z/qy1rOP4NyMfcAIIgCZm8taf3roGit\nVuqyhwYh807OusXfHXWq3qmYK7xFzDOju5yKsVYQaUFuqJtVgivnoYhjndFiYf3xc1QuJu3if9Xk\nuYBMvYENx89zIyWDJlXD6dqwZom5/Ys3HmbOtgPWoi1BIPZ4FL+diGbLtJEE3Gcjjme6t2Tqln0o\nYpExCTD0ifb39V6lIScjh2tnbqCIAtltK6N/KNzac6kIilZFVLbzOrC7QafR8PWfHzHhmVkYTsaB\nDOraFZi6dCyhwf+81UVBEGhSLZwm1UpeBQYIqhjIkotfMqrxBGKjb+I9VofXk1oErYB+p5e9kMu/\nPn4+CL7eCKJIHmpOHrri0pGvJM7HJ3E45gbt61ShRmgFDlyM5eNfd9mt/O44ewVJ2cLUJ7qiuZpm\nE3J2WGQ+eGIWn+14767GAZBjMNoJucK88f0G9n3wconf0bretTnlIi2wR6hzC3pXhIT7M2nGILtt\nezZHEXOuaF9ABQRwa2wVWpoaFoKmJ5P1diWaN69Fs4dr8tyjs8nNzrOlzsWcS+CNZxewbMuEEmvm\nFEVh3vilNiEH+WnuFhnvvddJe7oRsqKwI+oyz3W2LszWa1ubqL3nHS8mwO/fbeOpcX1K/T54qb14\np96kUh9fVn688TOJRufutEbZyPmsC2UWc0mGZIwuhP2fqQcYUe35Utdpx95OYPKE70iPNoMAugow\n9oM+dG3VukxjckaLwObsS9nvsAihFTXU8S6dy2lp6Fu5EYtjDmCULSgIxGYGciPTHw/RRNVdRgY3\nfZyHWtfgaNoxOyFXwOnMKKIzz1Hf9/40Li+MRZKpNLoDmXlpeO2LRaU3I3lp8e9Vn5dnDUeySA51\n2ZsX72TD/G3kORFpAiCYLFiC3NGk5CGqRKo3KnkhqCiKovDjocP8kbkKjW8WgiDipfFgVI0RNPZz\nblrk6+eJV0QAOTfS7NZhFUDQiPQe5VycuuLRN78iTjGDVlUwKKfHZeUZMUsSWielKt/vPs6G4xeQ\nC52boTfwzJcr0KpVqEWRoR2a8kqPNuX1d/9PKHeoeABo0rk+6Q2DUfIn4oJJQjBL9gYTLnL5FUD2\n1dhcBQVJwW/zZQSTRIiPF2ZJdvqsURQwmiX6vdrT5bgee+neakjKwsWEZHp+tIg5f/zJT3+eYtqq\nbQyctZysPNe5+yazhS8KhJwCKAqKCAZFotvr3/LIc1+wdk/UfRtj/96taOnhAxYZLLL1b2SWGPNQ\nwzIXZN8PNi3aCUBmtxrom4SBWnRIAQWstZNGiYyU0kdBSqJOzYpsODKb1enf83PaYjaf+4a2Levc\nt+v/3YiiSIOHayO6izYhByBnOBcugiAg5E9EJUkm/kZqme+ZnpNH67e/ZtDsH5m1fh/9Zy6n2cQv\nmbf1oJ2QA2tT5N3RV5FkGZWX8yi0ICtE779A5j383U9ec908PddootuHC7GUYNL0Uo1RCE7C2f4a\nPx66D6liM5eOROfmKL58X75j0y8I1hYE7T+rwLufDWbf1mgsZovds1FRFEwGM/t3nHO4VlHMRjPJ\nN53b0muSc/PvKSAUmoh1G97J+cUUmPf57yW+j6UhRa/nl/PRrL1wjkxD6eueCjDLZrbd3sH+lIPI\nLn5zNIIGP03Zn3cRnsVHQE5nni7VdWRZ5rXn5pJ+1gySABYB4y2BWa+u53Kcc4v/slDHuza1fSLt\nopw6UUd93/pU9yxdanFpeDGyHZE+wXiorfdRCQoqASIDswkZJlG/v7UGe2fSbts5ihHMN9RIGdZn\nzcZbm+/beAo4cDGWDlPn8fnG/RjqVCDlxeYkvt6GlBHNiAnS8Gj9sfTzHc7ccUsw5/eE2/L9LuZP\nWEZWSnbBOopzNGp0HlreWDja1t6lLMxcv4d12ctR+2YiqBQQJXKkbL6K+YaEPNfPqp8vfIV7qI91\nmpD/T9CpmHtwOhpt6c2OUtKzrUKuaNNBZygK01ZtJykzx2HXsr0n7YRcYUwWCb3JzLK9x5m//XCp\nx1bOv5tyMfcAoHPXEdyqOqhEhDwzQd+fRNQXafCZnOsQyi9AzLSPuimigOe5JLy2xLD+xcXoNl1E\nlW6/Wuau1dCjcSRevp68+Okwh2vWaFyFwZP/dylzk3/cRI7BhDF/0qo3mYlLzWD+NtcPs72nryLq\nZbzjZHxuWP/p0iQQwOIpYMo2M/OrLew6HnPfxrlwxigWD+9DrwqhDKgcwR9vPcvLz999Efy9oHPX\nInloMEQG2Tt+FUWScT+bxA9TV973Mfh7uVPB9+4s1v/pPPFGH3TeGruZiaamCZcFq/mIokj1yNAy\n32/ArGXkmuy/yyZJ4tT1W06PV6tE0nPyGDDuMWS1/U+BIlqfA2qtmswU5/VqBciyzJFNJ1n2/mo2\nL9lFXs6dZ0W1YtJRAVJz9Hy3s/gJh4fana+bfE5tr0hUqNAIGjoEtWNOk8+KPa+0uLlp+f3Ie7z2\nXj8aNa9Kte7eBM29jVuzIlEgAa6IlxAEgaRb6XYulwWYjBZSbpcsfjU6DW6eztMiJU9twe3o2vCO\nrXy1BpURdY4TWAWwaFV8v/d4ifctjp/PnqH9ku94b/cOpuzaTpvF89l82XXPxKLIiswnFz5j5c3V\nxRqBiIJI68CyR8AivWo5FfUFpBhLtwCyef9+TKkyyPbXUiRYvHy9i7NKjyAIjKs1liERT1PTqwa1\nvGoyrMozjK055r4aWrirNazoNJKZzftT1TeXCN80GofGo9HmkSPlMOfSl2SaM1FjfbbnbvMgeXwI\n6Z8GkjI5mPQ5/pj0974AUJikzBxeX7KObFetUlQiufWDMeaZ2LhgO1+MtvY6WjZtNUa98zTiAgRZ\noeujTfnmyAzaD2jl8rjr0TeZMfwrXnpoArNGzCXuklWkZeTm8fvZw2i9DBRNjjHLFrbedt2r091N\ny/qERaxKWsDrS8cw78SnbMtbQa2m1V2e44w120v/HVWAjScv8NScH8nOM5KTkYsh/z3KMRT/XoE1\nVXPJrqO2+uByHmzK0ywfEJrVr0rsobN4HIlD1JsdnZckkGvqkK8bESQZLIotGueArOC1L5ZoJRZZ\nknETBbTnk8h4qiGmCp64aTV0a1STVrWsK6WDJvSl06C2LPtgNdnpOTw6ogutehVfuHs/Sc3WE5uc\n4bDdLMlsPnWJt/p2dHrel6v24JGq3JlbK6DLBkGRMXuKtm1ffL+Tzs3uLuXNGS2aRdKiWeR9u97d\n0nNkF2Z/tApBku/k7hdGVqyfhcNxaG9lkxxX9mjRvx1Jkjiw9ih7Vh/E3VPHoyO7UK9N6VKlKkWG\nM/3XKcxM/gwlzDpp8uqXjemsDsWItVCwCBqtiio1g6n/UNlSiFKycknJcm66AHdqVhzGGOjLy2/0\n58BP+7l1+gaKSrCaoAggWmRUKpHwGq57iRn0RiZ0fo8b5+PJyzHg5qnju7d+YM7eD6hSrzKVAnwJ\n9/chId21wNl04gJjurcp9vV5ae9PWuDNa8msX3EYN3cNIZUC+P3HA6QlZxNZvxIvjOtOr4EtWJ/w\nB2vinIsYvaTHIluIrF8Jdw8teUWcMDU6NbXql5yOKwgCA8Y/xurP1tlNYhWNiLFNZbRqFW/27UDF\ngDsRrNotaiJ4alGMFvt0L7VIXuMwjly+yYhChill4VpGOh/u3YVRkqy10fm8sXUTLStWIsC9ZHOR\nUxlnuKG/iVlxbSijFtS8Efk6PnfRXFwQBBr5NnTpxHkxK4ZuoSWnvMXevO18h0Xgdqzj78jdoBbV\ndAruQKfgDvfleq4QBQF3TSYRPjkYZPsJvqzIHEg5RO/wRzm6L4ac37ztUrxNF3UkznOD+9g7dv2x\n8y4jRvkDRs53iDXmmdj185+MmjmMlIQ01+dg/V7UebIl/1n4arHHRR+4yKTuH2I2mpElmetnb7J7\n1UFm7Z5Gtr8Ody8JRXbyNBQUkoyuW3YUEBDkR5/hnVEUhZ/+PMn3u0+QqTfwULVwJvTpQI3Q4g2h\nmkRWgoOOrsCA9fe2yIK7JCvkXUvh+frjyI1PBwRa9GxCw67VOHq95MbneSYLz36zkvmjBuKh05CS\nnMnlK7eoWy8CX59/hmFQOfeHcjH3gPBcp+b8cfwCuqvpNnGiiILNYAJAuGIgp0UontHJqLJc/+AK\n+ek6BWt2iqwgyArVjyfR7KMBdGlYk2bVK9qtMgZHBPHmwtH3/XWVBrVKxPlUFTQq18HnxLhMNI7P\ndLQ5oOQ7EQpAWqr+Po30n4VWq2HstMFMO+sklVSW0SRk47fxEqpc62flXuzv/43IssyUvp8Qtfc8\nhlwDgiCwa+UBhk4ZyOBJpYs6129bm3eyJzLzwmwsigV1mETwlAxy1nnhFhtIYJAP7h46LkXHo1aL\ndHmsCc+N7VbmFfwsF+YYBWjUKiySbJtouWnUjO3Z1mY1PmvtZF5qPAF9ttXpUcDqkjh6znPFpjOt\n+GQt16Ju2NmGG/VGPn7mC+afskbOVr0xhJ4fLSLHxWq9x/+o6e70iSvZs9l52vSJg5eJPhXLnGUv\n8WjNHqyJ+9XpcSIiuVIuLTvUJrxyIDeuJdsMhLQ6NdVqhdC4ZelW64dOGYhRb2TdN5utf28R6j3d\nhoZD2tC1YS279i9gFTMN3u7FiffXIRitrriCJJPTqhKmCF8qBdx9qvaGSxewOGsXAmy7cpmnGpTc\nlPtc5jmMsvPPoYiIm0rHtPpTCXELvutx9g/v61LMXdNfK9U1mjeuy++yY99EQatQr2npzCxMsgmV\noEIl/P0mE1mWbCyKY4sTs2Im05xJHZ86CNtDwVTk+2cRuHYymfTUnFL19isNqTl6TBbHsRQgmCTc\nLt1JL1Zr1aTEpVEpMozY6DjHE1QiHnVD6fdqT14Y9WiJ9//q1YV2iyOyJGPINTBv/FIm/v4WOak6\nwlRO5gqyivo+pa8d/Gz9XlYdOGNLX99/4Tonr8Wz+s2hVA601n3H3Erh6JU4Ajzd6dSgBm4aNa0b\n10RlkpC0Kvv0SkVBzMhDDrAXWGK2Ec8VZ8gs5Px8dPNJglPSUbUNQ3LynS1K9M1EZq3bQ8yifSTs\nvJB/X4X6T7dmzuLXy/sBPyCUi7kHhIggP5a88iRv/nQaS4a11kERBRBAUYkIkoyhThD6llXwPOO8\nVkMBEHFuhgBkxSQxqX+nv2T894Kvhxv1K4dwJva23aqgTqPm8Zau+yOpLC53IeZrXQXwC3hwV7AG\nvtidE8ssrD923i46J1gUfLddsQk5/xBfuj/b6W8a5d/DoQ3Hidp3ztbyQ1EUjHojP0xbTfdnOxEQ\n6l+q60R61+LDhtPYensbtwy3qRVek649H8FH43PfxlqSLfWi0U+wYv9pjl2JI9jXi5FdWvJIgzut\nD4IrB7EgahYrP/mdkzujCK5Sgafe6kfjTsX3F9u+bI9NyBWgKHDzYgJpt9MJCPXH18ONjW8/T4f3\n5ju9xotd/vpFgv07zrkUcgWYDBaWfbOD974YQrgujASjY3qqVtTgqfJEJYp89v1IVi7cw44NpxFE\ngW59H2LQCx1KLcRVKhWjPh3Gs+8PIiMpC/9QvxKNUya/2JtH4uNRx2cjGi2Ywr1R3K01z2N7PVyq\n+zrDaJGcTgxlRbFG61zwZ/IBNt/eioxEoDYQFSok7I8XEXk4qA3PRAy+5/YBIe4hiIjIOI41SFc6\nF9EW9RsQ0tSNpJMGFFP+30pUUHnBiMH9iz33UOoRFl9bahOtld0r83adt/DU3F+zrLJQxzvS6sZY\nRKPoRB31fOoC4J7jRTqO0S+1WkVmeu59E3OtIyP45VAUepOTxWKThDpFj/uFO/MPySwRWi2YUZ8O\n54MnPsOYd0dw6jy0vLX4FToOaluqe0uSxNXTsU73nT8cQ5i/Dw9Vqs6Na0n4V01Fpba+YbIEPhoP\nOgU7z+ApSqbewMr9pzEWEq0KYDBbWLzzGFMGduHdFZvZfuYyigJqlYDqlx0sGv0EdSoGs+qtYQya\nucwq6PIR0h2FHIDHmdsOpnUWs0RaVDxz3h/M16eiiLmVYnP5dLakbZZkNn+2AfeTt2wL9QDRPx/i\no/AApnz8bKledzn/bMrF3ANEvUohvPnRML4Y/R2GXCOiRSatVySKjw6LnxuKu3WiYAr3xu1yqmPp\njijw5alPmdx2Cnk5jsXvHj73p8/YX8EnQ3ox/OuV5BiMWCQZURRpFBHK851dt+iQNNb0U2dTL3WB\n0BPgtWGd/ooh/2P4YEhPgr09+X7HUcwqAV1yLl47r6LLMaH20PJw/5a8uXD0/7sVvP2/HcGQ4xhp\nUGtUnNgeRdeh1hSq3MxcYs/FkXYrHb9gX+q2iXRwcg11C2F41aF/2VjVKpGBLevzy5Foh30Rgb40\nqRpOk6rFp/8FVQzklS9fsNtWUG/hyhGtOOFSeJ+/lwfvPt6Zj36zt2zv3bQ2XRuVPoU5O89IQnoW\n4f4+eJehfciKBbtLPEZRFC5FW1OXhlUbwpxLX2KS70wutaKWx8J72xpeu3voeO617jz3mnNHTUVR\nOJZ+nA0JG8k0Z1LbO5IBlfoT4maftqpz16EES3y/51cSL+TQICKSnj1a4ebuGLEM8vHiq5H9ePOH\nPzDmt71w06j5/Pk++BXTmiDLlMXKuNVcz4mlskclBkcMwk97ZwGgW/UaLDl1nDyL4wpX56rOI40z\nzs/kfPYF2//jXRhIuKvcGV51GFqx9EYRrvBUe9AmsBVH0o7ZpXNqRS39KpbezXP+1xP59NsfOPr7\ndWSzQtXW/kyeMBR/b9cLLJeyY5h3xX5B4mbeTSZH/Yevms4p+4u5T1TxrEITv8aczjiNMf/zqhW1\nVPOsSgNf62LMQ61rkphwDKlo70tBoGKV0vWKLA3talelfuUQom7ctjNd0snguS8WzdlEW7aQzkPH\ngNd74eHtTstHH2LabxNZ9PaPxF1KIKx6CM//92na9ClViy3AWmvs5qlzOnfx8rUKpVnDezNttZZj\nJ48SVCsZjVamkW9jRjd4Bs9SLjTEJqejUavsxBxYUyIPnb3Khqph7Ii6Ynv9xvy3YezidWz9zwgi\nq4Ry6uu32H/qMmdibiB4uTFvxxGc9XxWpeXZZVcVIAgCQmouv0wYhiTLmCWZ6BuJPDd3leOAZQW3\nIkIOQDDL7J2/A8rF3ANBuZh7wOgypD2XT1xl3bytaN3UWC6nkdqthrVlQT45bSPQXU8Hs2wnZHo8\n25F6DarS5+Xu/P7NZvtVMnctfV/5e4w6SkN4gA+b3n2BP89fJyE9iwYRoTSKCC12stmyWTVOHLhm\nt5ylCGDyAG0uqDxUjBneka4t75+d9D8RlSjyev+OvN6/I9ejb5J2K52aX1bDJ7DsdS1/B+kZubwz\n+hsub44CWaF61/p89O0Ygircm0Oop58Hokp0bP4tgNpDw4d7dvLTiVNoD9+mwq/XQVIQBQGNTsOI\n6c/Q75We/9P2HNOe6o6Hm5bl+07aXBZb1qzEotGum/e6IiUrl//+soPd564BCg/XrsqUJ7rgqdXi\nrlXb+iJ2G96RlZ+stYvOCYJARN2K+IfYRwsHt2vCY83r8sPeE+iNZp5q25jKgcX/ja4mprLz7BVE\nQeBKYipbTl1CrVJhkSQGtm7IxH4dUZVikcFQTGPwwnj7ufPco7NITEhHEIPwaS6jezYRX09veof1\nontI8TVZBr2Rd3t/TNTe8yiKguABvhPd8Oip5XDaUU5nnuHDBtOooKtgO2dd7B8smrgH01U1ikVg\nv/oKS2fu4PPvR1O1pmO9Ysd6NTg24zUu30pFFKF6SPGT8as5V/ng3Mc2U5I4QzyH0o7wdt2J1Pa2\n1u42Dg3jiXr1WXPuHAaLGQEBrVrFmOYtqezr+Dc6n3XRTsgVRidqERBRUPBSezEucqyDkJMUiQMp\nB9mfchBREOlYoT0tApqXqpH489WeRS1qOJByEAA3lRtDIgbbolClwU2nY+rrL8LrpT6F5dd/cro9\ny5LF+awL1PX5+9x4R9cYxYHUQ+xO2ousSDwc1IaOFTrY3s/BL3Zk79Yo9LlGpPxJvc5Nw6gJj6K5\nC1dIV4iiwPxRA1h7NJp1x86hUat4olVDejapzdXT15n/1g9cOHIZ3yBvBr3Vjz4v31kIad69Mc27\n3707rSAIzucuHlr6v9YbsKZ0fzq0N3mm7uiNZrzUKr79YBXP9p+AKIj0eL4zz00eUGyEPNzfx3kq\nqaKQfCGej6+tJa+CozDM1Bu4mJBMnYrWNOOHm9Tk4SY1URSFDacuEptSpF5TkpF8dU5b00pmC9Ub\nVwWsv98qUaRZjYo0r16R41fj7SJ0gkV22V9YcbJYWc6/E8HZasDfRfPmzZVjx4793cN4IEi7nc6l\nY1fxD/Vl2o9biJYN1vyn/D/3C6GVObZwD8lxqbh56hg0sR9D3hkIgNlk5rMX5rLv18NodRrMRjOd\nnnqYNxa87NAb5t/OiI9+IvpsAiqz1cFP5admx9djEEU1amemIOX8o7BIEo/VHIMlLt32g6WoBNTB\n3qy/Nh+N9u4nKlfPxPJam3fsJgYAnr4eeM7ryeFb8ahv66n4eTSi2THtK7J5db48+PE9CbqkrBR+\nP7kNf3cfHm/2vxGHZkmi74yl3M7IxuLCCS3A0531k59FJ4i81eV9rp+9iVFvROehQ+OmYc7eD4mo\nU/GexjF3y0EW7zqGRZJRFJmiQ3HTqBnZpSUvdXPtbFfAzwt28/1X24s9RqNVYTY5TtLC+6jweSKX\ndHM6vhofHq/Yj87BnRyOUxSFodXHkBTrmMYeMNsdt7YaRETaVXiYEdWe7Mq5IQAAIABJREFUA+BW\n3m3GzZpB5lqPIv0HFcKrBrJ43RslvraSeP3kG2SYMx22e6m9+KbpF3bjP34rgT9iLqIRRfrWrkuD\nYOfmN1/HzOVounNnvuoe1RhWdQhqUU1l90oOC2qKojD70udczL5kiyTpRB3N/ZsyqsbIUr8uk2xC\nb9Hjo/EplQi8V14+/ip5kvNG1Y9X7E//MkQG/w5SErNYvWQfJw9dpkKoL08+354mrWqUfOI/kOw8\nIxtPXiAuNZOGEaF0blADjUqFxWxh1oh57Fl9EK2bBpPRTLdhHXlt7kiHZ6ckSTzVcBwZl5NsUStF\nLVKxYWWWHptZ7ELwmz9sYNuZGPu2TWaJgDVnsfi6kdUz0sHMRDBJhG2MYeDAdowq4gC+99xVJnz9\nCya9CcnfHUSBwCUn0GQ4bw/SvEdjpm/6j8P2q4lpDPvPAoR919Ak6zFX8CC3ZUX8fr+AOtuxZllb\nswJ/XJrr8nWW8/ciCMJxRVFKFZ4uj8w9oASE+tP6sWYA/Ny8JoePXmLdjuP4eXkwYsgjBPh7w7tP\nOT1Xo9Xw9vLXGXUrnYTLt6kUGeawyv6gsOjdZ/7uIZRzD/y0bCeWhEy7lUdBUrCk5PLDgi2MeKV3\nma9pNJhRa1RUb1SFl2c/y7zxS1Hni0JRFHlh6YuMv3QAWSvicyAJwYmQA7h07Cpfv7qI1+eNuqvX\nNuW3z4gNOo+CAAZYu/V3RlR9ns51i3d+vFf2nrtGWm6eSyEHkJabR7cPF3J4+lg+//O/nNp5lgtH\nLlOhciDtB7bGzaP0KZDOuJiQzJJdx2ytRgBQFDSxGahyTchuGkwVPFm290SpxNxTIzqwYeVhUpOK\ntFkQQKNR4entjk6nJjHBfnVc10KPuWcm6fmBvUxzFj/dsLboKCroov684FTIAWTONuDWVoOMzMWs\nO06Zx9KPk/unm0MjeRBISsjgdnw6oRVLV5vpCmdCDiDHkoMsy7b0aUEQaB5ekebhJYvwwj3UiqJT\n6aju5bqf2rms81zMjrEJObA2Ej+afpye+h5EeJTOhEQratFq/zfmOQAhumCu653XZNX1/vvdiUsi\nKMSH0ZPL/jz8pxFzK4XnvlmFySJhMFvw0GoI8/dm2djBeLvrmPTDWEbNHMatq4mE1wzFz0WGxuof\nd5NxJcku/VCwyMSfvcmfm07Qvpd1/uQs1Xx4t2ZsuRqDkGE9V5VtxGfHVbS3c1Gn5CEduEFuuyKO\nxJKMdD2N1Z+t49LxK3y2YxoASTeSWfHsfPyjYpEUBUWjwvBYHYQQb4QsI0qR57DWXcuUNW/amqyb\nTWa6DOmAm5eOH95biXuy9RknAKqMPHRX08lpVQnvw3F3RCuAWuTVOc/dxV+gnH8i5WLu/wmtWkTS\nqkXZfnACw/wJDLu3icSDjqIoXI5NJjMrjzo1QvHyvLdJbDll4+T+C3ZW6gUIZolT+89DGcTc9vUn\n+ebj9eTlmhAEaP5wJFM+f4aOg9pyaudZdB46HurSgNFvfYMSJuG3OwGfQ0nFdL6CjYt2MPrz50s0\ntijKqiMbiA06j6ADIT+crmglFt1YzMO1mqFV/3WT2GtJaRhNxbgD5aM3WThxNZ6m1SvStGsjmnZ1\n7nh482I8895YStzFW0Q2r8HLs58lKLz4/nNbT1+yT2WSFbz3XCOnbQQWCsydBHLi063pjCWYjoii\nyPeb32TFgr3sWH8SrU7DwOfa0blXI/Q5Rrx93enf6gOH87wez0Es8pU2ySZ+i//dQcydP3jR5f2l\npDsTsgpFjTpcGdIJOK2j+SfQN/wx9qcedLqvT3jx37noLOeul7Iicy7rfKnF3P+aYVWH8OG5jx22\n+2p8qe3zYKfi/5N4+6fNdu69epOZm6mZfLvtkK0NkX+IH1o3DYvf/ZldK/ajKAodn2zLiOnP4O1v\nNXvZsek4OFuIs8hs++ModdrV5sM1O9h73uqS2qFuNf4zsAvBvl7cyM5ECFFT4dMDCLKCYJJsvwOi\nRcbzzG3kzjXIM1vAIiEo4Lfxks2n4PSuaBJjk6hQOYgJj7xPYmwysmQtexHMMj7rLjBlzQRmPP05\nRr3Rluqv89Axbv4o5oz8loPrj9ucO2+c+wlJkq3O44VeiqBYBarb5TRyBzXA72gClqQcfKpX4NVP\nhvFI14fu29+lnL+XcjFXTjl3SVJqNm9+uIZbSVmoVAJmi8zIwW15pt//Lwv/v5OK1YOJUqugSHqc\nohEJr+66P1pRDu+5yGfv/nLnfAWO/nmJ8UPn882qV2g/8E6T4+tbogkI0eFzKNllLYLtOrJCfMwt\nqjWIKPVYADZd2QFV7bcJIgjuCiuPbGBY2wFlul5ZqBUWhE6rRm8suc7swMVYmlZ3HcnZ//tRpj3+\nqe3/t64msnfNQb4+MoPIYhruCkXaQ+suJJPTujJKkabZkpeWxT/tRB2Tgk+AN50GP4x/sPOVeLVa\nzdDRjzB09CN22339rdf09nV3iNypApw7OWaas5AV2S69r3oj170BxQrWV2M1Uell297cvxnL2m4n\na70IZvvoXGCw9z1H5cAaUUp00kMrQBtw16ZGoe6h9A7tyR+3N9ttbxvYhvq+xVu8e6u90Qgah350\nKkGFl/r+uCr+FdT0qsGrNcaw6PoSW7plNY+qTKzz5t88sv8/pOfkcTXR0ZXTZJHYdPKiTcxJksS4\n9lOIu3QLS/7C1Jaluzi9J5qFUbNRqVW4BXihqEUHYxDUKjyCfRjyxQqSsnKQ8iNje89dY0j8z2x8\n+wVq+gdYv/9Gi6ORHCAYJT4b3pvJr3+HkpmH+/lkmzN0AfvXHkVb3Z/UxAyHumxFkjmzM4p5xz9h\n+YdriN5/kZCqFXjmnQH4Bvnw+UvzMRbqcWkxu3acBdAk5aCv5Mfc2a9QLbj4hbRy/p2Ui7lyyikj\neSYzt9KzmDZjPbHxabY0DIDFKw9Qq2owLfKLk8spPTsSd7H65hryZIN10hvWq0SHuhdf6cPmj9eh\nmKU7/RUBVCIvvVG8zXhh5k5f73T7lQu3SIxPJ6TQpFp7Mxefq5mIlpKjJoqs4Feh7C0ILCoTorPy\nOAVSc4pvsHuvtKtTlWAfL+LTMjFLxfcxKtzewBkzhn7psE2RFT544jOWX3Vdq9G9SSSLdxyxmdxr\nUvSYajiZhGhUzF+9G9/1F9C6aVkwaTnVG0UAAu0GtKLvmB54eJfswpuVoSc4zM9BzEkpKtShjhMl\nf42fQ51Ws+6N8QnyJisl2+H4oDe98FJ58kyVp+2MMsLcQ3nm2S4sPrUPczwoRgFBq6BRa/jPzCHF\nRhz//O0w88YvJf12BgFh/rzy5fO06ePYNHxSnQlMOvOunXhSC2om1Z7g+g0pBYMinuSR4M5svL0Z\nSZHoEdqNcPeSG6a3CWzNr/FrHfs2I9DM/58dKWgR2IwWgc2wyBZEQfyf1OqVcwdrqqPz525hI6Rj\nW06TGJtsE3IAFpOF1Pg0/lx7hIc6N2Doyz14Z/FeFMsdgxEFQJLZvfEYSW0qIanufP8kRSErz8iO\ns5fp2aQ2jUJCuRXgjibVsY7SEuhOh3rVqXIxnZQ4x+e15KHiW/cEUtcexM9ioeinSDJLJMWmULFm\nGJO+H2u3b93cLWWO2CtuaiLDg8qF3ANMuZgrp5xSoigK87cdZsHq3ZhVAoqbBlUgeKSCmD/nNRgt\nrPrjRLmYKyNbbm/jpxsrbP83ySZ+jV+L3qLn6SrOazsBfH08+HjnVKY+OQtLXAYIoA71YerP4wkI\nKL0bp0MtVSHOn7lhJ+Yata/Hsa2nS3VdTz8Pp/WmFtmCWTHjJro5nbBXVkdw03jJIcVPUCs8Vrt4\nR8V7RSWKLBv7FDPX7WXr6UtYJNlpQ2lfDx31KruOfmalZWPIdV7An3g9udgxRIYF0Qw3DplzQBDs\neiAWRcqf35nyjWouHr0CwLWoWLYs3cXcY5/g7unatj85MZPne812urotbAtBMzzZwQb/iUoDHY4V\nRZEFUbOZ1O0Drp+9aT3WXcuoOUNp+2wLArT+TptM96/2GC1/as5v23Zw+1w29SNq8ViftngV0wpm\n3bwtfPXKQtv/E2OTmdrvU95YOJpHX7CPPAbqAvmu2Vy2Jm7ncs5lqnlWo0doN1uLhXshyC2ozC03\n/LS+vF7rVb65/C2yYv1caUUNr0eOxV31z21/U5j78d6VU3Zc9pRVq+jf4k5E+OrpWLvIVQF5OQbe\n+WA52buqoNFbqPt0CxJ+P4WYbbKmY0gKgqyQKSjW50rR841mrienA7Co7wCG7owlc8FxBElGUKxu\n2IpK5JFx1mf08GlPMXvkPIfrpAyPxGjKQankjp+TBTM3T53TtHWLxcLS91ZgyiudOy9YTV38u9Th\n6xdKv7hZzr+PcjfLcsopJWsORfHRd+ux+OVPDAWBAjsr7zgZMX8uWKdmKAs/+et6ij2IvHh0NCbF\n8cdXRGRxi+9K1Yj55o1kZEWhSpXgMt//6UdmkJ6S43Tfog3jqBhxp84pPSmDQaEvlnxRASb/8Bpd\nhrS3bTLJZn6K/Zk/Uw4gIxGgDeS5qsNs/aAKSM1J5/WdkxH8LYg6UGRQzBB4qzKfD5pW4q2T41I5\nu+881ZtUpUrdSqQb9ayNOsrJJYfJPZxIlWrhPPFmH+q1Ll0d7fxth5m75aBtAlWlgh+/vjEcrda1\nu6Y+J49+PsOd7hMEga2Sk55Ihdiz+iAzxi8iM8wTMctAVvdadi1WwOoQ57P9Cu4XnRuP6Dy0jJg+\nhMfH9nK6H2DiiEWcOXrNySBh3dFpROWeYdXNX0g2JhGoDWRgxcdpHVS86YrJYEKS5GJF5L3Q23OI\nTbwWxs3TjfXZy+76utejb3J862ncvd1pP7CVrb6oNORm5rJ/7VH0WXk07daoRDdTi2zhau41REGk\nume18ihXOaUiLjWT4V+vRG80YbLIaFQitStWYMFLA9Hlt1nYs+oAs16cR162/WKSrBHJeqQ6hnrB\ntt/ufpUr46WIHJ61iZxbVrMgQ40AMnvUdEjr9tBp+GhwD7vemPMXrmfFJ+shLQ8C3Bk8qQ8vjbyT\nUfLVqwtZN2+LLaDoHuLNxXcaYs5fyAhaeRXv4ymIJuv/NToNwZUD+fbUZw5GUn19hzm8puJQaVQ8\n8mxH3pw36n/aJqec+0O5m2U55fwFfLfpoFXIFRYW+YJOHyTglaig1aho3+Lfaff8d2GSzU6FHICM\nTLYlBx9NyVG2yhEVSjzGFc+/1o3ZU39z2B4eEWAn5AD8g/0YPLk/q2etR3JRqyB4wFPv9rMTcgDz\nryzgdMYZW6Qn2ZjMFzFf85+6b1PF805dXaCXP593ms7Mrd8SL9xEZVHTLqQNowYV774qyzLj20/h\n3ME7jonu3SoS94wffuMvIuZKCGaFGydvcGTTScbNH0XXIR2Kf3OAl7q1KpVrZGE8vNwJCPMj7VaG\nw77aLUv+jjTu2Zj0jTXI9bdOaASDBSwAAqgEBLOMJi4Tt0vOhRyAUW/i8B8nihVz50/fcL5DgSN7\nLtCuW1Oa+TctcbyF0bqVzqAmNVvPl5v2s+vsFWtPrtYNGPFIC7Rq1z/Nsiw7FXKAy0hoSSiKwtdj\nF7F5yS4USUalUTFv/BLe/22iS2ObwpzadZYp/T5BACSLBJMFer/YldFznnO5EKMW1UR6l75h/NHL\nN/nl0Fn0JjOPPlSbbo1qoVbdmwDcens76xLWkycZCNGF8EK156jp7bqWs6zIssyxLac5svE43oHe\ndB/eibAy1PKW40ilQF+2vDuCPeeuEp+eRf1KIfh7uvPfX3ZwISGZehWDGfpwEzx9PDDqTbZ6NEXA\n6hQZmd+XMf9z+fv1G1RZdMIukqe7lo6oNyOpRMjPClCrRAK9POhY3/7z8dJIe/FWmJSENBq0q0vz\nno0xm2TCqwfjXbMCHb9fSEEOecqgahiqeeO77zYas8KQET15ckJfByF3NSq2WCE3aGI/dv60j9SE\ndIIjgug7ugePjuxSpgWZcv69lEfmyimnlDQbNQOTl9ZezBUgKwTfFgn092TxzOHlrpZlYGfibr6P\ndR1NWNR8/n1Ja1oyZQVrZq/DZDDj6ePBi58OpfeL3Wz7l83dwYoFe5Dyf/xr1Anjs6UjcXdis68o\nCr9+/gc/Tf/VrkZKF6ah0uwgTNUMCAIE60IYVX0E1byqkmHKYMLpSZgVe6dIAYEWAc15pebL9/wa\nP37mc3at2H9nnBqBhMV18FmZhNfmVIQiJpWevh6sTlyIRls2t83ScvNiPC81eQtzITMVTz8Pfrj8\nNT4lpMF2mPot6bmF6lEUa/vcNr5+6Nx1RHp6s2XySoy5rhvfCqJA12EdmLjkVZfH9G/1AQYX4uiT\nRS/QuMX9m9wXRm800+/TpaRk67EUuNWpVbSoWZl5Lz5e7LndROeN4AUBtkqryzSO08djeG/OGm7m\nGVCn5uJx6jbqLOt76uHjzurERcW6sRoNJvo+NJ5Mfx1inhn3iymIBgtunjre++Wte2oEXcA3Ww6y\ndNcxDKb8AidFQTBY6OXvx4yP7q71x9Jry9iVvNth+7t1JxF5H1oNSBaJKX1nEPXnBQw5BtQaFaJa\nxaTvX6XDE39te5EHEUVRkBXFrjYO4EzsLUZ+uwaTRUKSFVSCgFolUsfLh4yfjmG6nIwAmCp68tAY\nFcGVzBy9UZFLyUEFFyZ47mFbZKwA2U1NVseqGGsFovPQ0bVRTd7q25EAL8eG4M7Guvjdn/j18z9Q\naVQICOg8dczcPpWIupXosHQh8dlZdueoBYEBdeszo2sPp9dcMOkHVs10XtsNsE0u2/e+nH8+5ZG5\ncsr5CwgL9CPWqHe+U1F44am29O/eGM977LH1/40jaUdd7qvkXum+CLk5L89n43d3mkbnZur5/KXv\nkCwyfUdbfzyHjenC0y92IjkxEx9fDzy9XafICYLAwPGPMXD8Y4C1PkwUBf57YzqJhiRkZFAgwZDA\njAuf8kmjj0kxpaIWNZilO4rKHCORt9vMUe0ZYl+No0rdSvf0OveusbeLN9bzBAXcTmQ7CDmwRg7i\nLpXdbbO0VK5dkQ25y/n9m81cPnmNxp0a0H14xxLP23n2sr2QA9siiibcn69e7I8sy2QfuMKB349h\nMVusEaEia5NaNw3NezThk+FfIckyj7/6KHWLpJY+8lhjNq52/Axqdeq/TMgB/HHiPOm5BpuQAzBa\nJA7H3OBiQjK1w11Hmuu3rU30AcdWCI071XdytGt2bT/FuN+2IQdoQOOGqZIPeQ1D8V8TjTbRmnZ8\nenc0LXo0cXq+RZJ5fvbP3OpWzVrXaJHJaVcF/7XnIT6LLUt33bOYu52RzeKdR62tKgrW0QQBxU3N\nHzlZ5Iz7kq8/f61M1zTJJqdCDmDB1SXMbDz9nsYMsHvlAaL2nceQv9hgMUtglpj5/De07NX0nnsx\n/pNRFIVLt1LINZioXznElv54N+QYjEz/bRebTl5EkhUaVw3jvSe6UiPUGmH76Ned5BUyOpEUBcki\ncTojHXrVwE2oRfe6eiZ1XY4AqFUSsiKy/VJ1pmx8xPrIKOpoCYgGCyH7bjD44WYM/c8TxY4xI8fA\na0vWciMlg9rhFRgaGsHarzZhMpjBYF3IysvJ493HprPsyjfM6NqdUevXYpIkJEVBp1LjpdUyrnVb\nl/do2buZSzFXmjKEch5sysVcOeWUkk9feZynZi4DlWgfnVMUmvj6M6R/eUuCu6E404PhEUPu+fqy\nLLNp4Q6n+xZOXm4TcwBqjYqwSiU7ft2+nsTKT9YSfeAiFWuFMXhSf5TaEummdKuQK4SkSOxJ3kvX\nkC5Y5DuTjqzvDOT+aEKxQK6Qwpilk3j2/acYNKHvXb5SkIpOSvI/prKPGhIco08Ws4R3wF+bhiOK\nokOa4+2MbI5cvomnTku7OlUdJnuHY266vN75hCTbdd/5cRwXj13h9K6zyLLC1qW7SL6ZiqgWkWWF\nOi1rMv2ZL2zn7vrpT9oNaMV7a+44Ob76bh/OnojlxpU79v2iSuCjec86vf+5uEQ2nryIJMv0aByJ\noMDV5HS6NazFteQ0Vu4/TVqunq4Na9G7aR2XE9mT1+Ltm6LnY5ZktkfFFCvmPt0+lZeaTCDu0i3b\ntoi6lfho07suz3HG+8s2IQdooSDaoRZRgKyuNQj60WryU9Q2vTDrjp3jYnoGiia/HkejQgEyekdS\nYcExJCevr6wcjrmRH40pktIsCKBWsT/RMY23JGKyL7vcl2J0nbZbGjKychnzzTKiz16DPhVxv5yF\n18lUWxsTUSVy9s8L9yRys/Kb159IP4GASMuA5gyOGISn2vOexn4/iE1OZ8zCtSRn5aISBGRFYeoT\nXejdrG6Zr6UoCi/N/5Xz8ck2Z91T1xIY+tUKNkx+ngAvd87fSMT9zG08ztxGkBTyagehb17RVl9r\nwsL4Tivw0hU2DZHpUusqeyMj2HGoos3AzHZfALWIV/uaPPNO8W1gtp6+xJs//GH7/4FLNzh09BJB\nZnuXSkWBrJRsYk5c5eFmNVj/9DCWnjrBtYx0WleszDMNG+Pv7vq3sHGH+qg0Kqep/Y8MaVfsGMt5\n8CkXc+WUU0rqVQrhtc4t+XL3UQo/pb2NCks+dW70UE7JdAnpTHRWNEbZXmwEagOI9Cl9TY0rkuNS\nUWTn6eRlKSYvIO5SAq+0nIxRb0KySFw/e5Ojm0/x5NpHURyNKzErFm4ZEvFUe/JIcCd2Je8hNyaP\nnB9NkJ8hqKBgsphYMHEZeTl5DJv65F31APMJ9CYrtVDaZ3QuCJDdNwjNtZuIxjvvg6gWqdc6ssQG\n3sUxe9UG1n60AVVcLlKYOz0n9uCd4Y5Oj4X5etMBluw+hkoUEQUBURSYP2oADSNCbcfUr+zaxKZK\nkP2bXLt5DWo3t9bgPTWxHzfOx5GToUelUTG21dsO5//562GObztNs27WybQoinz322tEnbjO3s1R\nhFUOoO/TrVA7qVv7dtshFu2wRolkRWH53pO2fVNXbrU2/c2fwB67EsfP+0+xfOxgB0EnyzIJp29a\nIwJOnDrP3XTsC1cYrZuWJRe+5ObFeM4fukT9dnWoWCOs2HOKoigKaT6aO0KuEJYgDxS1iCzJxUb7\n1h6NxuTE6VRRi4hVAnjkmfZOzioZo9HMqh93k5GWTUCTyhQXd7AElV3ABOtcC+V7yQQwGE20+eIr\njD5qaBYEapGcJoGkdw2n0pxoRKM1eqzR3f09zLKZ96M/It2UjpQvcPenHuRKzlX+2/D9v9VIRpYV\nRn67hsTMHApX8ExbvZ2aYUHFLlA441xcIjG3UzFLdwSMApgtEr8cjmJU11YEbIpBdTUNMX8hy/NY\nPG6X00gd0ghUIvVDk9CqHRcVPLQWBjQ4z8nx6favQSWQ1yCE7PZVSNFpkBXrz73RbGH53pOsO3YO\nQYD+LeszpN1DTCgk5GzX8NKS3b4Kvjuu2m0XRIG8HOtvTnX/AD7oXDZn4hXx3zI04hWMhju/lY06\n1GXyD2WLTJfz4FEu5soppwy82L8Dzz/WlulLN3H9VhrDe7WmY7Paf/ew/lFkZeiZ/+lGjh+MwcvH\njaGju9Cpp2sThQa+9ekV2pMNtzaiEqyPJJ1Kx5u1x5cqfSTHYGTd0fNE3bxFzZAgHm9V366uwT/U\nicLKR60t+yNw0ds/kZdjsAlERVEw6o1smbYXzzmO49WJWmp51QRgcMQgKugq8P2SFflmHo4s/2AN\n+389wndnZpV5bOPmj+KDJ+6cJ5gVAubcJPPtaugHmvBck4iiFlBJArWb1mDKqjfKfI8Cpi5cwf4x\nv6HNt+VWpRvYMXIVKamZzB7/gtNzjl6+yQ97j1tT5gpFWsYs/I1d771kM7R4rGld/rtmJ3lOIjuT\n+ndyOSZBEKhSrzJgrR90xaqZv9vEXAENm1alYdOqLs+5mZrBwu1HMFpcN+hVwNYDKs9k4XpSOuuO\nnePJNvaf/3njl5Kw/E+EpxuiqIQ7kX5FAUFArSpd2lTl2hXJCEnnm5tzSThyC1+NL33De/NIcOcS\nvzuCICBaZCRnjqSygk6rZtIPY4tNB8xOddHSQxCo3zqStv0c+96VxI7tJ5nef6Yt9U1BwTS6NQ7N\nuPIRy2DTXkAFtwr4aXzJMGc67OsS3LnM1yvg6xVbrEJOEEBtff8VNxWWQB3pXcII3BiHWqemwcN1\nSriSa46nnyDbkm0TcmCN/qeaUonKjKaxX8O7vva9cvxaPNl5RopaMZgsEisPnGbqE2UTL9eTM5wK\neaNF4mJ8MldOX0d7LR2lUEaCKCmQZcDtchqG2kGoRNe+EJE+HniIKgxYELAKOcVDQ07bytYos6Kg\noNhE6vn4ZFs0/ZvNB9l99orzrncqEUPtIAcxp8gKdVvd/QKlX5AfG/Q/kpOTR9LVRCLqVXK66FTO\n/z/KPwXllFNG1Go1U1y4V/1/JzM9l6HdPsVssk40MlJzmDFxFYcPRjPp/addnte/Uj86h3TiYvYl\nPFWe1PWpU6oV5sTMHAbP+ZEcgwmD2YJOrWLhziMsG/sUNUOtBe5arYYG7etwdt8Fh/P7vNzN7v+S\nJJVo4Xx6T7TTSF/G8WwecmvOJUOMzZ1ThQpPtScPB1kND0RBpFtoF1IqZfG9uBJJci4Mrp29wfbl\ne+g6tOT6ssK0H9Ca6Zve5ctXF5J8MxXvAC/efOVpmvduyaYm0aS/nkXlRB0tateiUq2yRXKKsuf9\nzWgLTaIEQLDInJi+G1yIuTWHouzqWwowW2SOX42jVS1r7Z4oivw2cTjPf7OaWxlWweCmUfPBU92o\nU7F0rSfMTu5TgLOeciWx99w1F+2KXWMwW9h6OsZOzGWmZLFxwXYUg5mA1dFk9qiJJcCaXqXKMKAJ\n9aFro9IZcJzLPM/nMV9hyTfVyTBnsOLmaoyyiV5hPUs8v4W3L4cN2XfSJAEsMuHZEt9f/JKgioEu\nz83JyCV97RloFwFFBKGXu47Plr1S6uiy3mhiwY4jrD92nuS4VNy1c7CZAAAgAElEQVSahOJ1JB7R\nIiMAPmvOkjagHhQWvgAmicBbWS6vWxzT6k9hytn3ybbcEaQNfRowOGLQXV0P4I+rlyDQUX4oGhU5\nTYOI2J/Gh+smo1LfvU38TX0cRtnR9McoG9ga9zaJWWrq+o+msrdzIw2AbNNNDiUv43JOLHqlEm0r\ndOf/2DvrwCiu9m1fM7MaNyQECRbcixQpboUCbanRQgWo89agRoW2aA1q1FtokWI1oBS3osXdEwjE\nPVkd+/7Y2LKb4H37+95cfyWjZ3ZnZ859zvPcT/uIttc8q5drc4Af+aXpOhn5ZeSbl0O9qpFe9eSK\nsBgNNKlRlb/W7EPTdZ8zirKGKTEXZ4MoDiVXRtP8SUIrUfVGMmVFI956/hsyLmThrB2OvWU0usWA\nKAi0qRODUZLYciyBE0kZXmHRTlnhUGJqmW3XxZJzipKI0Wzg2S8f8+t0++XiDSSkZDBqUBfq1ry0\n22lQkJWg5rGX3O5ictLz+OrNRRzdcYKY+tE8NvFeatSr6rXNjsTTvL1rOYqm8USjrgxp3OqKz1PB\nP0+FmKugggquG9Mn/FzYiS52KgBg/S+HePg/mVSOLLtzGGoMpV3ElY3kv//7RrILHKiFL3yXouJW\nVN5csJq5z5SIx/fWvsnY7hM4vOV4cbO63dOJJ2c8gq7rTBvxCevm/4Wu6YiSyMDHejPm01H+2xkV\nTH6W/5p0T9Z9nLXZ69iQvgm35qZNeGvurD4Ei+RtptJlaAfmTFxcZmkDgD++XnvFYg7gpr4t+eHk\npz7Lh9dtD9exaoYx2X/nzJDhoMDlJMjsayBjd/ufRRHAJ38sJiKUVa+Pwu721JMKC/A9nqqqvL5g\nNav2n0DTddrVr8n0BwdgNZm47Yk+/PXzDr/nG/hYb7/Ly8NokBCv0GhAwFPouDTnjl7AaDbidsoY\n021EzdmPZpZA1dGiAqj2Uh/6tbi0mHOpLj46+WmxkCvCrbn5PWkpfav29lukvDQfv/0Qd439nLOK\niqjp6AJUFgws+uRJQgLLL+C9c8Vegs9kU1AjBFetMI/QUnUEXaeXIQjpMssGqJrGQzMXcTol0zNj\nG2zG3iYGd60wIucfRACMF/Ko/3cyidUDcEaHgAYIEBKfycpf3r6s81xMuCmcT1vPIMGWQJIjhaYh\njQkxhVzVsYqINFo4qzv8Oh5rAQZ+uvDVNRufRFujMYtmH0EnohEgFVAg57InfQKKZsdOA87Y4okw\nRXBTeGvMkpljWd9xOGsmGhqRokCU8Dcrzh9kT3aPa3bUbRlbzSsksgiryUC3xlduJtSgWiVaxEaz\nNz6pcDYfREHAbDRwZ4emTN14BF0QfMScJgkQZiXIYkJId/L+5I68On4zgqBjMmk4nQZcaiPCqwyi\nWRcDX6x9m3tnzEN3uNDdMlaTAbPBwIS7Pc+JvQlJfp9dqp8QY6Bwht3zp8FkYOBjvRnwaG9im9Tw\n2mzZpgO8smS157cDLJsxl+qCgRUfXP+wybU//cXUEZ+BqoKuc35fPDuWbGPCry/TaYBHsN3325fs\nU1M8OwjwyrHf+ODIGjYPHXfd21PB9aVCzFVQQQXXjT07TuNvZBbgxyV/8MKjw6/r+dYdPlks5IrQ\ngUOJqbhkpThXyWAwMGPzRBw2B2nnMomuWwVToR3/lAc+Yv38Ejt/TdX4feZKDEaJJ6Y/7HPOu8YO\nZuaz3+OyezpTqlEga3AtXDUCafvqNBoaQ1g0dUq5M3zV60czaur9fP7crDLz+cwBl65Vpioqu7ae\nIj05hwbNqlO/cfmFmi+F0+lG0TSC/Aini9EsBiS7bwdHN0lYJP+vlv4tG7DjZCKOizpGiqbRpo5/\nJ88Ak4myPopuE74ix16S97jlWAKdXvucnZOfpnXP5jTr0oiDm4967VO3ZSzd7ulU/P+xA4nM/nQN\nCSdTqVYzkhFP9aRFO9+OZ8+m9Xj3t43+G1IGZqOBezp5h3NWia3kVaoB8ORSCQINW9Rm+lN3YbyM\nmZsfz87FqfnP+VQ0FZtiI8RYvjixWsws+/RZDp9IZPehBJo1rEGrxrGXPDd47j1Bh7Blx5GrBuGu\nHoLoULCeyiRq5OWH0205fpazadnFnXUADCJqRADumqGYz+V6QuBsCn8vfJujRxNYvW4PfXu3pUFc\njTKPe7nEBsYSGxh7zccBmHD3bQxasdB3ha5TLyD4ujhYtg1vw8LExciaXGy2JKBhFhWqGD1how7Z\nwdz4OQiCgE01kK6GMe/cTzxT9z6OZn+JIKhIAILn2dMs8BTrc0M4UxBPnaDaV922qJBAHup2Ez9u\n2l08A28xGqgRGcaA1lcXWvrpyCF8/McWft15GLeicHNcLV4a0o3QAAsZmoJuEtEL78ViBIGBI3vQ\ns2NTZr36O7uOVWbkg7fSrcc5QkNd7NtbhdT0Bnz/h6G43UtffoiV+05w5HwqdatEMqBNQ4Isnu+r\ncmgQVpPBJ6rAZDDQr2k9lu056nnxFJbNAAhdehyTxcjtzwxg1BT/Rl7FQq6U+D+vK4z7aBHvPeO/\n/MjVcHp/AlNHfQVKqfbrOqg6k4bN4I/c2ew6n+ARcl6vb4EM0cYHW1fyQseyZ3or+O9TIeYqqKCC\n64ZYTrkyV+CVh9mUx8a0jaiCjL/HWJGxxsVYA61e9v+qqrLhp61+j//bzJV+xVz/kT1IOp3CLx8t\nR7eIJD5SH7mKFd3s6YDvd6m0fmoCWz55jTXJxyiQnXSsXJc6wd7Fx28fcyu1mlTnpV7v+D3/sPHl\nG4mkJmUz9sFvKChwejrWgkCzNrG8/tF9HMg8xJqDW5DzoGvVTnTp2LLckLeExEyembCQzBwbAAFW\nE28/fxsdWpfdsTPdGov86+li4wEAzSBCj7LzOPq0iOPXvw+zLz4JR6Hbm9Eg8dqdPQm8zELbRfy8\n/aCXkCtCVjXeWbKWt+7pwwcb3mL1jxv5ecZyNFVj8FP96D+qZ3E+2aHdCYx/YjauQvvw7MwC3nj6\nR16edhc3d2/sddzI4AAm3duX8T+tRBKEMmcZzUYJoyQhKypP9b2ZtnW9RWrlGlG07tWcPWsOeKzL\ni/azGnlh2oPlFgwvIr4gns0ZW8pcLwkSAdKl62EV0SSuBk2uUBi169/Kc98BppQCTCme2WpLoJlu\nd3tbrNudbj5btY2TyRk0qV6Fx3p3wFKYr3o4MdXvZ6kbROSqQZjP5aIbRW6+w+MW3KhRLI0axV5R\nW/8pmsbV5J6NNVlg9y5Eb5R1Fj3l+yy5GsySmTcbj+f7hB84nHsEHZUqxjxaBJ1DFMAhW9ltq02B\nZkDTBU+9S0M2qbKVr+N/5OZg389a0wWiDJkczTt6TWIOYEz/jrSIjWb+X/vId7jo2zKOoR2aXXV5\nAovRwIuDu/LiYN8oBceOBLJvb0zoylMYsuwgCKhWI3l96lFPCmDPkgPEH/c4vmZnW/llSUl+uyDk\noMgqhsIQY6vJyJB2TRjSzmP4c+LkOSbPnk+O7KRTnQZ+3ycGSeT1oT0Z2eMmxnz7GxfSc5BynUSv\nOIVQ4KZF96aMmOA/bPeTn9b4hg0XsvpkQrmficvhYsOCrRzdfpLqDaLpM6IbIZFl1+388e1F4PRf\nj1POt5N6PoMJf5dRw04X+Hb3bsSsAJ7u1/GyBpoq+OepEHMVVFDBdSOyt86FxUVDlEXoIMEtvUsS\n85McSaxL20C2O4cWYc1pE96KQzmHSc3NoF3UTVQNvXRe1MLEn4msHUj6yUh0rZRQETU6NqqF8RK5\nb+CpN6f7yckAUGUVTdN8RJAgCIyacj/3vjSEO8d/hFzFUCzkAHSzREH9EDpPfQepRUDhzOEa7qzV\nitda9Pcypmjdozl3jR3Eovd/9zpHv0e606xzI/Jz7fyxZBfnTqXRumNduvZtXtz5mPj8fDLScr3M\nBg7ujmfMtMk4u52HEB0C4JS+n0WvxfHhm8/5Lf6sKBoPjZ2NUkqU2R1uxk5awoKZo4ip4t9A5tc5\nb9G//ziETUnokoigaihtK/P7Iv/iFDydnyHGME7+vhapTjiiUyHoeCbVul+56+GCbQfKXLf+8Bne\nwvNd9RnRjT4juvnd7qv3VxQLuSJcTpkv313hI+YA+raMo0NcTTYdOYNLVvhz3wl2nkpEB4IsJibd\n14/QADN5dhet68T4hFgWMf6n5/jk6W9YP38LuqZRqUYUz37xKHWa1/K7va7rXHAkYVNtxAbU4vPT\nX5d57QB1gmpfMsSyCEVWcTrcBAZbvO5NXdf57e/DzNu8j3ynm25N6jCqZzsigz0iMTQqhDGfjeKT\np79FU1RUVcNkMdF7RFeadSmxoT92IY17ps8rzn3aduIcszbs5uexw6ldJYJq4cEEmIw+gk5QVKQ8\nF7pRxFQjnDHjyh7cyHM4Sc+1US0iBKupnBGlf4Apo+/m5QIbT323gEzZyZ3NmzGyV+frWgss0hzJ\n2AbPoekaq8/dhU0pMdo46YwhWzWhFTnG6JAiW6lryueU24BTk7CI3jNMAmAQRAIN16dMyS2NanNL\no2sThZdDlFPHkGEn8+6miE4ZQdFQg0xE7cjgh+nrUGTNx4yliIAgC1JhCZMtxxM4diGd6pGh9GxW\nly9m/coXAQegCehGkRPyEayBCjEBdcjI99S/jA4L5sMHBxJgNlIvOooVr40E4OSeM1zon0ztZjWL\nzZj8kZCc5X+FIKD5EY5F5KTn8nS7V8jNzMdZ4MRsNTHn7cVM3/xOmfVCT+9L8Csai9i79hBKkOY/\nqMZj0cvcv/ZxNj2bGQ9ffemcCm4cQlkdmet2AkHoB3wESMA3uq5PLWvbm266Sd+1a9cNbU8FFVRw\n43h452gypoUinywVTiRC2DNZ/PjgxxhFI39n7uKr+G9RNAUNDaNgRNZkL3OJwMQopvR4jSObj5F8\nJpW6LWNp0a2JV4fooZ2jUBU4tbkW9syA4pAhc6CbGaP607HapRO3VVWlv/k+v6GOBpOBFc75XsvO\nHbvA4S3HiKgaxk19W9LyPxOwNfQVO4JLJeBEFsqtJXlHVsnIjHZ3cUtVXzeztHPpLHjvdzRFZejz\ntxFTP5pjBxN54cGvvWrHhUYE8u3SZ9m67ggfvv6L32uSohSipqZ7LdMKRAYk3M+9j3Tz2X7erzuZ\n+eMmv8e6pV09Jr80xO+6Ig6dTWTVjv10b9OEVnXL78CdP5nMYy3H4na4ccUEo1QOxJhUAAI89Mod\nPPT0wMvu9I7+YjHby6hHFxMRwp/jR17yGLfd9GaxWU9pBEHg911vIhlE/srYwvq0jWi6RqeojvSo\n3O26FLIHcLtk3A43gaEBZV53piuLD0/MIM2VjiRIqLqKW/OtGVgak2hiYPStDI4p26gppSCVD1d/\nwwU1ESXJgGFHFZ54+A4692pCTpaNR975kVOaHb3QldEgioQHWfll3AgvkZp8JpX1C7bgsrvoOKgt\nDdrW8zpP9wlf+jW/qB4RworxI7G7ZPpO/IZcu7P4GSAAoqJRe0cyXQa144nnB2O1+IYoyqrKxMXr\nWLbnKEZJRNV0Hu5+E0/06fA/U0j5QsFadqW9hqo7kVWBlTktUP1YfwaJMk7dQu/wo5gE75xfVRfY\nlNuaqS0+JtBw+TO6/23WzNnEjCe+Ii/KijMuElQN67FMrOFVyxUvZouRe0d35bbhN/PQZ4tIzMzB\n6VawGA1YjRLptZPQwrx/44JTpdOxUN74z0gEBKpHhl5T24+dSeauT+f7tlPXCZcFNn3ynN/9Pnz0\nC1bN3uCTb12/TR1m/j3N7z6v3TaFHeuPgsOJj7q1mHljztPkN7bywpFffNujgnQoACHfgNkg8cuL\nI6gRWbZDdAXXD0EQduu6ftPlbHtDZ+YEQZCAz4DewHngb0EQftd1/ciNPG8FFVTwz5KRmkdacg4G\nwUDES9koFyQc262IYSrWrg7MRiNG0YiiKXybMMurMyrrMgjeg4J55jTuq/8YRkVCcSkYTAZqNIrh\n/XUTsAZ6OpKBUgAF2IjrnoA9y4Ij14I5yE1glJ1mlepxOUiSRO8Rt7Bqlm8u1J3PDSz+W9M03nv4\nMzYt3o4oCoiiiCXIgjSgsv9aYbqOftHEiEOV+fnsPr9irnLNSoz5xFt8vPbEbJ8i4LlZNiaPXcCh\nPQllXpPuz1NF0lm9e6tfMXcyId1nWRFnL5QxelyKprVq0LTW5YXorZu7GVVWcdYOQypwYz2YVhym\nOXfsHBIPJfLGl0/idslsX7qLjPNZNGhXj8Y3x/l0zl+/sycDps7ye57nBlxeEd3wyCDSkn3t6QMC\nTRgMEpP3fsbfp8+ByUVIlQKSnMnsyt7Nyw3HXZbzn8PhwmotO0/KZDb6nS0tQtd1PjgxnWRHik8x\n+vJwa27+SP6TgdVu9TtDd8GRxGsH3kKtomAwgBQjo7c6y/Qv5hAUMprpU3/nZE2t2F4fPHmNeXYn\ni7YdYFTPdsXLo+tUYdgr/gsrK4pWpovh+SyPC2WA2cjsp+/h5bkrOJWSCejERVdi6gP9ia0UXu51\nfrh0M3/sPYa70PgIYNb6XVQODWJohxtj0a9oCoIgXPbM540mJqgnimbnUNbHyGpumY6rqi5QyVyZ\nxmFxnM5dhKa7PaU0EDnlrM2YuJf+Twk5gB7DOrN79X42L95OSJod0SBBaDCYjbj9uNmKkoDJZGDI\nAx25Z+QtvL90E/GpWbgLTVvsbhlXQSZ6Qz+OpBaJXdb06yZkGtaJpoomkSoWPrAFwSO0dJ1Px5Sd\nL7fll51+jbPOHDiLLc9OYIjvd/jA60PZsWI8mE3gKnz3CoAkIagqnYa0QxRF3j20hlQxn+K3sQZC\nqhEh3yMVjAaJ+NSsCjH3L+RGh1m2A07pun4GQBCEn4DBQIWYq6CC/w9wOWWmvrSQXVtOYjIZMN5p\nxNJRwRCjEnynZ/TXIBjoGNUBgLP2c2WGNZYmZ6IDJVdF0TyhV7JbIf7AOWa/uYDH338QgLtq3Mn3\nCT8AEBDhJCDCkz9VP7Aewcay8wcuZth7w3HpOpvn/IWmahiMEnc8N9AraX3V7I1sXrIDt6NEhDoK\nnFSODyE/LsSnAyVo4O5o5OLunqxdniV+yoVsCvL8m1vs23Eas6UMASCApa3//UTdv/ho0SiG1ReZ\nhBTR6CLb6mvFYXOiqRru6qEEbU/0yrcTZI3N32/k4PDuvD30A1wON4pLRjJKNOoQx6Tlr2AsFUJX\ns1I4I7q24oeNe73O0bVxbfq29OTG6FoWuHeCEASm9giCsXB5Hrj/5p6HqvPVdLtXqKXZYuT24Z14\nbfFSlu50IYiekF/RoFG/ewIJnL1kPa8Xe7/N3rUHi/+v17oOn+6YfMmyF6VxKi5+vvDLFQu5IhRd\nwaE4CDL6hs7NPTMfVVQo0qOCBIKkY7k7k6/fX0Gy3YagWTw18ErhUlS2nzznJeauB3WqRLDw+fvJ\nLvCEsIUHle+kCaCoGou3H8R5kQuqQ1b4dt3f113MJTtS+C5+FqcKTiMIAq3CWvJQ7PAretbcKGqF\n3EbN4IGoupN9+x4mSQmg9PCYhEaMsYAEZxr7CxozIOY7kmzryXHnE27pxJ1hnf+rxcavFlEUeWn2\nGO55cQgHNx0hrHIodtHIF9OWw0WT16IkcOvQdjw6rj+mwnzN5XuOFQu5InS97Bm96z3Xu2bGM/zn\n/Z/YmJCIJgqE6xIfP3UnzcvJXzX4qwtZSI7dhVsUfH4/DdvV553fX+bNwdPQTEaQJNA0cLoYN6uk\nhMiGoS/wyfa1fHNoB7IDxMwSIQeefORalxhgqeC/w40WczFA6TiY80D70hsIgvAo8ChAzZr+430r\nqKCCG0eKI4Xj+SepE1SbGgH+HQXLYuaUpezeehLZrSC7FYSfgpBiZMyxGgaDBOhUt1bnvpr3AGCR\nLJfsmGpOHfdelYs3k10yq2ZtoFWPZtRsGEO3Ol2xKTZ+vvBbsT275YSVE28l8laL9xn+xl1l5iAB\nnEnN4vnZyziflYNQRSByQh+mDx9A05q+Ambp5yuL3SuL0HUd89Zk6jSM4ExNCsNXBARZJSCvALmB\nt6GHVTIyqGbZxdNL43Z5rkeMUrC0dSCYdFwHLCjxJk9dpTJCiMxWA4F9/MyEuAX63ex/tmpQ7+bM\n/GEj9otyx0RB4MkRV14aoTw6DW7L0i9XYUwtQJR97wNNgKkjPiY3Pa9Y9MtuhcNbjvHzjOXc86J3\nyOe4Qd14rHd7Plq+BaesMKZfR6qGexwcNdt3kP8hCEY83TAjRHyHLh+CvIkgGOnXHfLT6rNgfqPi\nWlSDh3WgascaTJ+/HF0T0QubqSkipzfVpMmAkxzLO1ammHtt0BQvIQdwas8Znmr3Ml/sfu+yPqcN\naZv4PmF2uduYBCNuveyC2WbRTEAZMy0nbafw13eXKqukZWQh6oCfvB0BqB5x+eFlBoNIZFAAmQW+\n92S1cF+nzcsRcUU4ZRlFLXUPqRqGNBuCqpPuLLvG4NVgU2y8c2QSdtWBjg467M3eR5IjmUnN3vpX\nCCFBEDAIVvpV6cL8pJ2oCLh1CbOgYhUVsmUjCiqbMjZTPSCG7pWf/m83+bpgy7Oz7MvVnDmQQL2W\nsdz18u1o/sLmDQZuu7d9sZAD34hDANUYiODOQb/oVhScKm2dl1fj8kr4eOy9V7R934e6s2T6Mi/z\nJFESoXYEg6b/iK7rxFWrxLsP3ErNqJIZtA63tmaFaz7LvlzF1t93EVUtgofeuZeoahFexx/ToSdD\nG7RlyHs/YC/lums2SLStW71CzP1LuaE5c4IgDAX66bo+qvD/4UB7Xdf9PkUqcuYqqOCfw6E6ePvw\nZJKcScXLIkzhTGj8BqGXUW/J7Va4s+NEP8WZdaq0szJ6SneirdHUCaxdLD50XeeVg6+R4kz1dIr8\noNl1UnrnQxmTWIGhAcgumbb9WzF+/rNIRonta3cx+Y6PcNvcnhI/goDJauLdNW/QuINvzS6XrND7\nnW/IsTnQVc0T4iIKBJpN/Dn+EcIuqrE1uvnzJBzyzc+yBFn4eOsk9AgTE775hSCrmXefHsa2rHhe\n3P0zqq4jaypWyUjnynWZ0f7uy6pVpus6dzzxAsEP5EJR9E2BgHO/lcCNtcjJtOFyeHfkjUaJ16bf\nx1/Bq9lv2w+Cjq4KCDpUWtWcqROexFiGo1xWjo0XJi7hZHwaAFUrhTD5pcHE1S67gK2u6+w8lcjv\nu46gajq3tm5Il4axZQpNVdM4dC6FHyYuYtuukwQcTPW2E8dT1sCg66h+hF5UTATzE7/0We5WFJbt\nPsbqAycJDbBwb6cWtKiWhp71IOAos/2lkZUwcsTlhEeGYTIbGf3FErafPOeznSipNOmdyEPNBtKn\nqv9adb3FskOk/pR/uuTsXIFSwFN7nil3G5No5PaYITQObsSa1LVsy9rhVW/OJJq4p8Zd9KrSw+/+\nz+4dS7ac7bNcd0OVWR04eTCZc82tyEGS53cRZaN6q2QCwpwEGYK4LeZW+lXtc1l5aYcTUxn20Xyv\n4s+SKLD4+eHUiy677uSl0HWdvpO+JTk7HynLgWY1eAo1F/6Wjcn59B7YlikP9L/s4uVlMe/4IlZl\nrUKXvO9Li2jm2bj/0Cjk6mz3bxRn83aw9Nx08hU3RlHjlDMYByWDS9GWqkxtPum/2MLrw6l98TzV\n9mW0UqJelESe/u5pvvl0HaIoous6mqIxemw/bru3g9f+U35Zz6JtB71q44mCQFWDTGLzfM+z1ygi\nyBpBx11sfOVtrOZrLy9xLbidbl7pP4kTu04X10W1GSFjaFO0IFPxNYQHWln1+khyU3J4pOGzOAsH\nIwVBYOSUYT4DYxdz9HwaE39ex8GzyZiNBga3bczYQV2xXKUraQVXzpXkzN1oMXczMEHX9b6F/78C\noOv6FH/bV4i5Cir455h8ZBrHC074LK9srsx7Lfz+RL3Iz3NwX7cpXi6IRQQGWViy9TW/+6U6U5l6\n7H3sime03qW5CmebPOt1HTJG25APq5SZAAKYrCaGjOnP6KkP8EjjZ0k8dsFnm0Yd6vPx1sk+y//c\nd5y3vvgN4/LjmJLyQBBw1g3H1a8Bzw7tzv1dvM1T5k1ewtyJS7xGQwHCq4Ty04Wv/HYWz+VlMPfY\nVjSDRO8aTWgbVeuyTRmSM9N56ejLIEL+omAcmwNAExADNTr0r0/vm29myosLEARQZE9oaJ/BrXny\nVY+ByMms0/y5dzNKLnSt1ZFWretfd0OId3/bwOLtB4trL1lNRno1q8ek+/r6nGv/2WSe+e53nLIM\nCKgpuYTO2Y9Q6t7RAWt4IK48O7rq+8WrwSZmnfqUmqVGht2KwohPFnImLROHW0EQwGww8J8eWdzf\nfB7l3kClEYIQQj9AsHQH4IGP57P/bIrPZqJBpXH3JL7s+RYhZYTXlSfmFqV+Q1il8me25p9bwIrk\nVdjXBGBfEYSWLyJFKwTfk4e5iRujYCTcFMbbTd/EKnkGHY7kHeWncwtJciQTbgpjSLVBdIhoT8Kh\nRMIrhxAR7T36viJ5JQsTlqBJJZ1Y3Q3unYFMGfgqn05aytETSaQ2tCDFKsT1jkcylHyWJtFEnyq9\nuKtG+eUziihwuvhkxVZOJmfQqHplnup3MwGmKytF4Y8Nh0/zzHe/gU1GCzB6mzfIKoZMO43b1Wfu\nM/dd9TnmLvuD3078gbWz78CASTAxrNa9dK98fWewrwfZ7mzG7X/Fk5N8ESHGED5pNf2/0CqPCC/I\nsWENsmC4RmFwT8yjZCX7DkpEVY/k26Mf8ffmE8iywk0d6xMW6RtunO9wMfyTBSRn52F3ywSYjFhM\nBuaMuRdXbj6TZ/1EtuygZ/0mPPHQkCsKk/aHrus43DIWo9FvqYMrOc6xnac4vS+Bk44C5qck4rgo\njy5QFLm/Wk1+f2Ge32NM+GUcnQZfOlxa0zzv5v8VQ6F/E/8aAxTgb6C+IAi1gQvAvcCwG3zOCiqo\n4BLYFTsnCk76XZfmSiPVmUYVS/khJVsKNhP56YViow8lVeBHt5oAACAASURBVCTrnSgEt4GmbXzD\nG8/azjLv3AJO55/22C+jFXcKjU4rK1L+RJHckGrl1sd6sG7CGmSnjNPmvz6O2+Hmj6/W8MjE+zh/\n3FfIAZzcE+93+YULmQT8sBfBqXjyIHQdy+lsDPP2kdSzNQWyi9P56VS1hlDFGsLtzwxg48JtJJ1J\nxVngxGgyIBokXp7zjF8hN3PlHLabNoJBB1knY+PfNBn4EoGWywsjW753HZgE8n8KxrHNCrLnHFqu\nxLYlZxjcqxuz/xzL5tWHcNrd3NQ5jjpxJeGh9SPqUr9n3cs618WoqsruVQdIiU+jXqtYGnXwNR85\nk5rJwm0HcJXqQDjcMit2H2VQ8zg6NC0pum1zunnsy5+xuUolsYRbEfvWI3j1aU+tXR2CIoOYsfoN\nnmj9IspFeSyaJGBvVIlRMxex8o3Rxe1ZtvtYsZADz0CAU1b4aG0Qt8UZCbGU7/pYjK6BXuLw169l\nQ44nZfjkYwmCwPj2j5Yp5DwbUaaGDI64tPV7gVKAbVkgthVB4PZ872qSkZzPwqn0XB5DuvenZ5Ue\nxUIOoHFII95u+mbx/3PeWcTbb9+HViiKI2PC+WTbZCpV99Q67Fu1N2nONDakbUZz6eiSjuVCOC/3\nfZracVWZ9MWD/DhzLat/24t0SzKS5H1Bbs3NqtQ1DKo2ELPkPVOxdtk+5n25nsy0POo0iGbkc31p\n0qoWr9ze/ZLXfqV0bFALY5YTd9BFQg7AKIEOB86lkJydR7SfsM5LkVuQz9wPNhHQVUBzgnhRpQlB\nEKhhjbmGK7hxhBnDCDYGk+X2NjESEWkW0vQfaYNTVvhz73H2JiRRKyqMyucL+PHleeRlFSAZRAY+\n2pvR7w5HuoraZZqm+RVyABnnMwkINNO1X/l5k8FWM4tfeIBNR+M5fiGNmMhQejev7ylvERXGd++M\nu+J2+SMxI4epv25gx8lzyKpKgMnEqF7teKT7TVclkgRBoFH7+jRqX5+P/vgLR2KC13rj+VwCfzvG\nMn1bmcd4/+HP6JR1aTF3LaKzgn+OGyrmdF1XBEF4GliJpzTBd7quH76R56ygggoujUN1UN6sRa6c\nW66Y+zFhHmvS1oKhJCncUEWj0vtp2F6OZdTz/by2T3IkM+noNFxaoTDTS9qxLm0DzcOaMTbsFT6b\ntJQzx5NZYzlN72dup0akmeQzqSz+cKnf5jpsTkRJxBATiEN2I6XKXknqIWV0nh1/n0VQNK9tBU1H\nyndzvOA0XVZswSBIyJpK+0q1+bDdUD7dOYXNS3awd80BKtWMot8jPahcI8rn2Iu3rGB7wAYEc0mD\nM6smMn7ZVGYMfavMz7Q0oiChOQUcWwNA8X6Z6jLM/XI97347kkEXhQ1djC3fyS9zt7J1zRECgy0M\nHnYznXo1LrMDkRifxos93sSWVYAqq4iSSP02dZiyYjzmUq6MW46f9Ztvoug6b4yfzfJFrxWblaw9\ndMqv6Y3SuAr3PDWQOExUiQylwU11EQSB6DpVOHc6BR2PPb1mFFHDLNjbVkdzuDiUmEqzwrzGNQdP\nFgu50hgliX0XqnJLXd9QSf8oYCr5LIfe3Iylu48Qn5aNS3MSFZtDYKSTnnVbEhtcfl5pt7s7smGB\nbyH6Jp0aFI/s52bk4bS5qFwzyue76BjWkZ//PF0s5IpxixiW12Dg/QPKPf/GRduY/eZCr2WZF7IZ\n3Xwsv2bNAkAURB6sPZw7qg8h2ZlClDmKiE4lM54Wq4nRL/Rn9Av9eX7fi2S6fWelRASy3NlEW0sG\nEX6du5XvP1pdbChzZN85Xn1sFtO+eYSGza+sKPnlkJiRi6DpZT/KCg1cdp5MZHBhMejLxaW6GLf1\nNaImFqArAoLZo/mL0+MUgRph1akbdHWDJjcaQRB4JPZBPj71WXEZGINgwCJZuLN6+SF214Mcm4P7\nZswjs8CBwy0TeCGPoJ+PFM/GK25Y9tVq3G6F/3w66oa3pywMkkiPpnXp0fTGfI8r9x3nlXl/IpcK\nBS1wufli5TYE4JEeba/p+E1rVPWu0yirhP96FFEuPzu9IMeOPd9BQPDl56lW8O/lhge/6rr+B/DH\njT5PBRVUcPmEm8IxCibcuu/MhYhIzYCyO147M3d5hNxFCAIIFhjzY09q1K7ktW5p0jJkzb9Zg6zL\n7M8+wPoJyTjOe5Y5HW5W/baHJm1iCQg0Y4kIwZmZ53O+Bp3iuG/jt5ybXgdNVhHzFSI+Oo/5iB1L\ngJm7xg7C5ZKZ/8NakhIz6NanNR07N8adlOsV4leEs2MIO81JhS9ej0jYnn6G8bt/Y0b7u+hxX2d6\n3Fe+7f0fGX8iRHv3LgUTZEWfJysvl4iQSxtIDGrTkzXrViNIOrriK7ySEy9dMsBpdzPmvs9JT81F\nLjRUOXH4AssW1qBJq1o0b1ubZm1i2ZOzjzWp6ziblc75+Rk40/K8Us2O7zzF3IlLeGRSSVBFgMno\nle8m2txIOU7UIBPOTBtbftlJt3s6AZBjc3rlpBThVlRsqkrXAW28lt81dhBvLt2AkO9CzHMhVwvG\nVScCRAFJEsmxlTQuxGrxOxGm6TpB5suclcMKQY8jSCX3rMXoCbVasnsnK5yzQFTADAfVv3hx/w5e\nbzzeS8SUZvz859A0nU2LSkbFW/Voyrtr3iQ7LZfJw2ZweMsxRFEkJDKYsd89SeteJcY4ld3VEHTR\nrz6xJ2ksmbmSTT/vpHmXhox80zek85uX5/htly3Hxu41+2nTq0XxsmBj8CXdGKtZo8l0Z/osV3WN\ncFOJwYKqqPw4c53fIuyzPlnN1K8f4eDZZH7eeZiEtCwCLSb6tWrArS0bXvXof3iQFWeYxSPoLkZW\nEdye33iDmEq+6y/Bu8c/wBlSgCCCYPQcX9dAkwGXgHQuhBeHv/CvDj9rFtaUNxuP58+U1aQ4U2kY\nHEefqr0IMV75LOWV8tnKbaTmFhSLGPOWsz7PXJfdzcrv1jN66v1Yr8D8BjxOllHVI8k473tvVq7p\nO8h2o9i0eBvbl+2mZsMY7nh+ICaTEU3TyEnLRQoy8/qC1V5CrginovLNur95qNtN1zT71bVxHapH\nhpKQno1bUTHHZ5dbY6807z30GW8uGXvV567g30NFJmMFFfwPIgoiI2If4Jv473zW3RrdH4tk8bOX\nh0XnF5d9YAHOSqeBjl6L421ny3Wx1GTQq7jgfMnsj8ulsGfrKU8Selg4ZBcUhsN5CnqbLEaO3Gsh\nKScJTdTBLKKaTWSMj6XGiwkMGtaLWp3qM6Dyw+BSQNdZN3Upke1qM2xYdyyBZp8QzoJBkciidzvd\nmsr6lOMUyC6CjJdOflcCnP4trDWBpKy0yxJzUWHh9Avpxzz+9lknCAJxTS4d2rXy191kpuUVCznw\ndKz37TjDvh1nWDJ7CzUeU3E1T8OlucEIYXfrqB0DSX/EVmzt7XbKrJy13kvM9Wpen0mL14KmE7L6\nNNbj6eiSiKBq6AIc3Hy0WMy1q1cdSRR9OjRWk5EO9X0djPs+3J0lu4+w0+BCN3qHX8mKSpMaldic\n/hfbM3ci1TRiPCjiLmWYIgDBFp2WMb45byUYQAwDU2ewDkU1NkG4yCU0uWAtu7VvwBpE0fyzjIys\nyHwXP4vxjV/2Oaot34ksq7y+4HlY4L1O13Ve6v02545dKK4TlX4+kzeGvMsXe9+jev1oAMIiAzEZ\nTDjdvmI0JymTL8Z8C4LAkfUH+Wnab3y65R0atCop1p6TnuezXxGn9531EnNFnLWdY1nyctyqTPfK\n3WgZXiIuh8QM4nj+Ca/akCbRRPdKXb2eEzlZNj9mSIXnPZ7CfZNncWrnaVSzATkmGASBjUfimbRk\nHbOeupsG1a5ccIUFWBGNEuKFXJRKgR4HTkkEt4oh14kcHUSlkEAaxly5C+GpgtM+jp+CBLpLIOOl\nKoyc1M0nxPTfSPWA6oyq8/A/ft41B056/ealXP/h8qJBJCct74rFHMCUFeN5vNVYr3qckkFi8orx\nV97gK8Rhc3BvrSexZ5WEZ3//xk/0HNaFtXM3oxU+C02tq+HoXMuvO6zd5cYpKwSUU2vyUhgkkR+e\nvoev1u7kjz1HEUx5iKKIWpaDWCl2/LGHghwbQWGBV33+Cv4dVIi5Cir4H6VLpU6EGUP58ew8stxZ\nBBuCuLPGHXSO6ljufhku35HQ0sQF+xbFjrFGk+JMKdvBEg0lpQzHOR0EqwWxXixk5RAaYKDjgJY0\nGt2G8Ykr0RTvY0oWA71/H8boVn3pXeVByHd5iavMrafZ1zGOgJAA3E652AnNaDYiRPjvnImCSK7s\nuCwxF5wXTn5wuq/1uwZ1oy8/1GxEr9txHzXzy6xtqHLJNZotBh54wr9LYWl2bTnpM0tSGrfFQW6D\nNIRSGku0CFBNxNrbiGN5yb7KRcn1oQEWnmjSmG+//APLiQwEVUconH0TgLNHzxdvazubi+m8AzlI\nQA2QQBAwGyRa146hbd3qzNqwi9kbdpNrd9G0RhVeGtKVT2Y8ztB3fyA5Jx+5METTYjTwWJ92fJH4\nGWcKziDrntmyKk0jSToQjdXoKdsQbDHzxciuiMIXZVy5BJaBEPw6R3K+5/SFZ9F0NxYpkmZR46ge\n1IuzeUvZnfYOmVJjfKpLCXCy4BSKpmAQPa/QI/vP8cXU5Zw+nuwJFa0ewbjJQ71E94ndZ0g+k+pT\n8FdxK/z+2Z88OcPT4TYaDQx9sDOLvt/s/f3pOlpyenFhYQBcLp7p9hZ/5s4q3iy2SXWO7Tjl98pv\n6uMr5OYmzGdV2pri//fl7qdeYF1eb/IqAPWC6vJs/THMOTuPJGcyAVIAfav2YVA173DP4LCAMmep\nHA4Hzjf/IEQSQdfRLQay7myCGm6lwOlm2Efz2TrxScxXaIihaCq6rqNUC0HMdSLludAFQBRQqgZT\no1IY8569vmn6gkWndvdQ7ujV87oe9/83jBeZhciVAxEL3D4DXQIQGRPB1RDbpAa/5sxmzjtLOLU3\nnrjWdXjgjaGYLNdurnMpHur6GrasAq/rURWN1T9sLP5f0MG8P4VgRSW/h28YZ1igFavp6rrhGUlZ\nHNl6nLqtYompG81zAzrz3IDOZCZnM7zOU5ch5UAyiORnFVSIuf8PqBBzFVTwP0yzsKa8G+br9lge\nEaYIMtwZftcZBAM3R7b3WX5btYEcyD3kNbpfeh9zfjDpKSbKy+MTTEaoWok8YN3OC6yWMlF6+M72\nKWikKAVs23oIPd3ut/Pw14+bmL/rA7544Qd2LN+NZJDoNfwWztQPYWXKUbSL2hFgMFHVenmhSQ83\ne4CPU2agm/RiQae7BFoV3IzVXPaMpz9GPt2f2rHRzP96I9kZ+TRoVoNHnu1D7bhLF/OOqhKKKAp+\nay4BGOu6PblARu/1YoCApaOhWMwZjBJd7vD9Th9+oAeLRn+D7uf4x3d68uTOJ6Tz+pM/EKTpBAG6\nQaCghplgg4kZbw3kw2WbWbjtQLHRyN6EJB6euYj5zwxj0bgRLN5+gDUHTxEWYGVY55ZIUWl8eTre\nI+QKqRSXSXhsNjdLt9GxShtaxlZDFAWU7GE48xdiNSolUUdCJYhaiSgFsSdlGgn5P4PouScdahq7\n017HKARzKOsjkGREQcePsSaCLiAKIhmpeUz4zxxOHUvyunUT49N5adS3fLv0OSKiPGGM6YkZnnpQ\nF6EqKkmnvGcR73+8O4FBZhZ8u4ncbBs1alcifsN+sF1Ur00HtcBGdkYu4VGeGd9nv3yMx1uN8/kp\n1W5W06fuYroz3UvIFXHKdppN6Zu5pVIXAJqENmZK84lousavO48wf+F+Fgo/Mbxra/q38tjym0wG\nBg3rwO/ztnuJUKNRwnnqnJfg12U34b8cJePhViAIuBWVj1dsYdwgjyvknjUH+OrFH0k8doHImAge\nnHAPPe/v4tNOk8FAjagwzmXkoIVa0EJLfl8takYz55krq+FVGotoxqn5ziYZVCMz333xqo/7v8Id\n7Zvyzbq/cRX+tgs61sR8LhdKzaJZAsw88MZdmK5hZsoSYGHUlPuvub1XQkpOPpl7z/l9t1yMqGgE\nHEqjoHMseqmC30ZJ5LkBna84TFfTNJ7r8jpHtpU4UVerV4XP97xHQJCVyOhwHnz7Hn58ayFup4yu\n6UgG0Wv2sgiT1UTlWv9cSGoFN44KMVdBBRVcEXdWH8L3CT/4CDOTYGRKs4l+X06xgbV4tv4Yfjg7\nlxRnYcdVB13RyV/nJPpYPZJMdpyOsmeSitCBjGgD+QESiuLyWCuVwioZaV+pNp8P+Kbsg2Q5iIqJ\n5LWfnvNafN6WzZbMM9gVN4ruMUgxS0beaH4rkuCpWXQw9xAb0zfhUt20j2zLzZEdimdoAG6Ka8qD\nqY/ww/L5yPXsmMMD6BXai/sHDPZpRpp9P0czv8WtJxFlaUVc+MMEGqsVrxcEgZ63taLnba189r0U\ng+5tz7pl+8qcndPy/c+E6oqOklmoBEwSUTGRPDzRY+2uKio7lu/h4F9HqVwzClEUUP2IOZfdxY7l\ne/js3T9QVa34nhAUnZB4J2aLytbNx1iwdT8uxXsM2SWrfLVmB9MeuJURXdswomtJTt3XZ1b7tVo3\nmDQOS6t5qvZtAHyzdiffrauM3T2aMKubZ7qdZnC79hDwMKIocmDPcU5ZF2IweXdwVN3J0ezPcas5\nANQwZZLgqoRGyWelyzpxhjgEBF57cjZnT6f5HYNQZI2VP+/mvke7ARDXpo7fMESz1USL7t7mHIIg\ncPvwTtw+vFPxst6Gu31PAqBDbkZ+sZir2zyW6ZveYdqIT0hNSEcyiHS5swMv/TDGZ9c/klf6Pyaw\nKmVNsZgr4p7p8zh2Ib34/xfnrOCXHYf56nFPiYKH/9Mbo0HilzlbcbsVwiICscp2zuYWeB1HAES7\nG0O6DaWyx6Row+HTjBvUlb3rDvLG4Gm4HJ7nS/LpVKY/9iX2fDu3Pd7Xp52v3t6dZ2ctxSUrHtMc\nQcBslHj59m5lXtvl8GDsA3x55luf5Q/HDb+m4/6vMLJHW/YmJLH3zAV0QKoehmF0BxoeySFhXwIR\nVcO479U76D3831fWoSzSzqVjz3dyQrZfdtUTAF0UsDgUnGYJXfdENrwxtCd9WvjWQL0Uk4fN8BJy\nAEmnUnnhljf4fM97ANwzbjAtuzVh5az1OG0umt/SmC/GzsZlc6HIKoLgEXJPfzzymsstVPDvoELM\nVVBBBVdEx6ib0XSdxed/JlvOJlgM5vbqg+hZtfzQvyahjZnWfBJ5+fmMavAcuXn5aC4NVNht3E2l\n+jFENY/m/NFsBKuOGKiiZhp83BwLalrIrx0AsoCQaUCPVIoFnUmUqGQJYmD1Znx/Js1vO3RALONF\nXD0wnF97PM63J7fyd0YCNQLDGRXXmZYRHgfDhYmLWZO2rljIHsw7xJyz83mxwQvUDa6DqqrMeOwr\n1s7bjMlsRHErNOpQk9t/7ePdBl1n9ravsUZ8hSSpiCLkueNJLPiTHtXnEGTyLe1wMTani08W/ord\n4WT0nQOoEeU9wlo7ripjJ93JjAm/oqkaDru3+JZPmMApgkX1GlLWEUk/XwlaKdx/bzceGTMQk8WE\n0+7i+a5vcP54Eo4CJ2arCb2MNEgdmHz/RzhsTjAaEWOrIxhLRt9lt8KZpEyMBslHzGm6zuHzqRzN\nOwZA/aB6xWI5yFC2tb9TdWJTbczfcISv1+4odrnMtJmYvKoZwVG30Ku5iNsl895b3zNwkv8RcZt8\nAUm0omgFNApMJkcNJFexFl+YfEHiqSGPE38ihZTzWX5nJouu8cLZkhnsyjUr0fP+LqxcfxhXRBC4\nFcznMwm2mrh11KVD9kSrBc3mpwi6yUhsQ2+HzaadGvLj6c8ueUytnGCsix1Il+0+6iXkith28hy7\nTp/nprrVEUWREU/34v4neuByylgDTDzUugyDBUFAcJecXyi8Cb99ZW6xkCvCZXcx6/UFDHi0t08p\nkE4NY/n2iaF8uXoH8WlZNKpemcd7d6B+9LXNOHSM6kioMZQfzs4jy5VFhDmc+2sOo3nY1dv6H8w9\nxNKk5WS5s2kYHMfgmNuINEVyIOcgyc4Uqlmr0Sy0CaJPjPb/PQ6eSCTCaCIsyIrVaGRIuyaM6Noa\n6RoLuP83iD90jhe6vUl+YX5ceaUUdHxn6ERZY/yD/ZCNEu3r16BGZJi/XS+LzUt2+F1+al8Cr9w6\nif3rD2OyGOn3SHcee39EsQtxmz4tWPjub+zfeJiqsZW5+8XBNO307yp2X8HVUyHmKqiggiumc6WO\ndK7UEU3XrrjjsWXhThz5TjR7iRJQZJWc9DQqPVNAFcHTCdfsAtmfhKPEm5BEEdXt6VwWxFrB4Hld\niiesaFXd6NEyogGGN23Po3FdsBqMWIMsuF3+Z6WCw0tEgaZpbF17lLXL9iGKAn2GtGb8Lf18ZhjT\nXRmsTl3rMzPk1JxMPjaNKc0msmnmdtb/9BeyU0YunBE7vPUYMx7/ilfnPlO8z5zNexDCZmE0lurM\nChqyZuNQ1id0qPp+uZ/hZ78uZcmDcxEUHQTY8uxyGrzWiZnjn/HarkvvptzcrRHxJ1NIiE/ns4m/\ng+YRGgajRN1tHbDffoosdya6LqCoGrmH6tC0ZwMen9aBFrWii4+1+MOlnD18HrfT09Eu6nALgoAo\nCaiKVhLWqYMjv1B4uNxoZy8g1Yst+cx1nY7t6vH5kQM+1yYA+ebzTJnzAa6jMsZoA2NHjqFllRZ0\nrXQLf6asAkB1iDjOBSIaNay1bBiMBoyY+G793z7lCpyywqd/bqVX8/rs3noKR5bF78C6rkF4QCMi\nLS05lv014KRzyAlylACynQHE/xDKK8PfJcQUzMnMFL9hk0VYrCaatC65ZllWOV05DLl1HVRVA13H\nVbcqtw+/hcDQS+esPDZtGJ//53vvnDlBoO8j5Q+i2HJtfP7cLNYv2Ioqq7Tp05wxn46iamxl+lft\nx4b0TX7361nF+7iLtvl+V0XM3byXm+qWCEpJEgkI9HQim/ZrzoXD533dY3UduUrJ77BfywYAnDuW\n5Pcc9nwH9jyH3/ye5rWi+WzU9bfbbxLahGnNJ12XY21I28Tcc/OLB4IyXZn8nbWbQEMgNqUAWVMw\nikYiTOGMb/xyuQMX/2bWrN/Pq/P+xBHo6V5KNhVrrsDXu9JZ/ud+fnhrOAH/QE7b9ULTNJ686SWU\nUs8UVVGLXXQvJ9RSEAX6tGpwVSYvPu3x44xZxO5V+9E1Hdkls/TzVSQcSmTqytcBqFQ9kqc+fuSa\nz1/Bv5P/e0MkFVRQwT+G3e7kh8/W8MnE3zlx6LzP+qsZQY4/dM5vIXChrk7RRIF8xkjWlEiUMybQ\nwVJNwGiS0AHNVPK6FBCQUswY9gYh7giky7lIQkyevJlX5z3j82Itevm+85sn50XXdaa+tJD3X1vM\ntvVH2bL2CFNeXMDH7/zm076jeUfLzG9QdIWVqav45ZMVuC6eAXMpbF6yvVgEAczfsgmL2c9nIOhk\nOHb7PUcRqbk5/PzAHKR8FdGhIdo1RJfO8Xe28MtfvkViz2Rk8/qqjYzbsIGznUOxDIrl7ie78d73\no3jspVtRdAVBEJFEEaNBZMygtnw++nYvIQewds5mr2sowmCS6HLnzdRvXZuQSmU4dbrc6C43mhHy\n2wgUPGjlD/Uo3ZrXwXKR6YUgaRiXnCFlXA5ZX9hIm5zLS40ncfzIKapZo+kWdQu5u8M4+1l90v6I\nJuW3GBI+jaOhvT2youMsw1ExNTGbeV+tZ+3Sfchu2LuwHrLTe4RdVw00iniCuLCHqSE9gOIwoilg\nznVxfpqBs1+ZyTjvKQsR1yTGxxim+BoECA0PoPutJa6Qqzcf5UR8aonDnyCgAl8u2IrdUXYZBUVz\nkGrfTteHq/LW7+MIrBqBYLVgjgrj6c9HM3Zm2TW6dF1nXK+3WTfvL9wON6qisuvPfTzd/hVsuTaq\nWqvQNeoWn/1qWmvQo0o3r2UXG1qUxmQse91jrwxFD7eiGTzPCl0AzSCS172Op7A3HnObonpbVWP9\nu1qarSaswRYUTWF1ylrePPQ2Ew5PZH3qBlT9cuwe/js4VAcrklfyfcJsr9B0DQ2n5iTTnYlTc6Gi\n4tScJDmTmXDoHY7nnSDFmeq3RuO/lfizKTz/82ocwUaPq6gkogYbsFeVEDRIPp3NXc/7hq7+m1n2\nxSovIVcaf2VR/GEJNJc5SHGllGdWUjpKwO2UOfTXMeIPXW6tzQr+L1MxM1dBBRX4Zf3y/Ux7dVHx\n22r5wp00aVWT92eNvqbaSnWax2IJtOC0OQFQ2lhR6luQnDqIAmqWSPYHEeiuEqFoT9QIsJoRBAGD\nXUUJ9H10SdkOptz/EYtSv8FoMtKmdwu6DO3A5sXbi7cRgG73dqJxB88swJF959i56bhXrp7TIbNu\n2X4G3dvBy2gkQCp/9uScLRF7nt3/Sl3H5XAXu6yl5ij+yxcAZim8jDUe3vtuod8ehKDqfDfzZ27v\nfHPxsqwCOw9+uoCCYhGmczw3G4dRp0FIXaYffh+75m1lv/D8YmoH1qJecD3v45eh22W3wqipw6hS\nqzIDao72v5EgoBlUUp4woAYL6CaF2ae2IwVK9GzdjM17z+KUZSpHmDEmHkLZVUBRCUTdDrpDZ+L9\nH/Lj3pncrPdl9sYMdLVE/OvA6m/yKfjsU7QIFQK8DRUCzzoIPe1g7l/r0XUdTdPZ/2tdHLlmWt11\nCjlPZcf0ythOVGJvs1/pNfwWZjy2A3t+TYyBOnKBgOfucTPp3un8GD+T8Mqh3DOqKwu/24TT7kbP\nyELPygVdJ7ZNXd6cORyLtWQGYu2WYzhLlYmQzC4ChXyEHHjyhXd56v+xd57xUVVrF/+fMi2T3kkg\nlBB6r1IVUESwey2g2Dv2du3XdrFcvYpdLFgQOyIWVER67xB6SUgjvU879f0wIclkJhAV232z+PEh\nZ5+y58yZffbaz/OsNe1sBvdsSOHLzSphyfq3cfSd/K1iiAAAIABJREFUiyTKSJKA1MPBuwdfJtrW\nfHpUSV4ZFUWVpHVvy/5NB8ndUxBQq2cYJj6Xj59mL+OsaadxZafLGJkwnG8KvkM1VE5MGM0J8UOC\nznvl2MGs3Z8b8prXjA0WyDmCyEgnzyx7lFtvm4mwrwQjzIK7b3J9rZzTauHjO6bUy7Nf/vhFTJ/y\nQsCiiC3MxoX/PBtBFHhm93McdGXVE6N8Tz5bqrZxW8bNf7rnm2mazH/1ez5+ah4VxVW075mKME3D\n06s2dMimGZQopUzf/TRWwUK0NYabM248qvfnXwUzZv2AKQqBPmeCgCGZ6HaQvVBZ7GLltoOM6NPp\nz+voL0B2ZuhnHiAmOZrY1FgObc/BHmYjKiGS/H2Hg/bTVZ24lKOP6y3FLa9dw/TJL7RoX0EUOLQj\nl469gi1gWvG/hVYy14pWtCIIPp/CM42I3BHs2JzDZ7NWcMGVwcpyLcVJFw5n1oMf4bOrlL3YAa/d\nn45VDlSU6aQsrQ0yyjZ10HWDSRcMYeGmvey1G5hSo31Uncil2Zimye61++k9qjsAD396JwW1h5l1\n3xykJJG0S9ogiiJZrmw6OjuwceU+vCEEQnTdYNOaAwFkrndU87UyIiIdnR2oHC6wbUchyDKm24NZ\nWAKGQUzHNmxae5AuvdrSpm0sKTEJZB7oQM/0Q1jkOoU/E/K9MRRVdWLeoQdJpStX9D6TNtGB0a7q\nqloIUacl6OCr8gZsm7duB2qTmjRF0NlhKeWWnz+kS5damgZcVENlUfHiIDLXsVcauSFWlwVBoOBA\nEVqEjaq0SGyHqxCbSkAKoEyKxIgRMOsKFjXTQMNgffheVv/7dgzT5Pui73ll0JJ6j7t6mFC8q4zK\nkiq+XZSJESIQ43H5WLlhP+GRgVEfyasTtd8NBugBD7TAviXt2LMgEeNgTp2HYTVluZvY8MOWunQm\noY7IBXSFZZ+t5qxpE7j4ujGkd01m+uUv4ikth7qoW/7mAzxw6uPM3PZcfc2KM6zB1sJq92Lb58ZQ\nJdAFCvM9PLzuI258djxnnHQiP87bxAezPuSMJ5cgygYmKpoJmu5mRcH1TOywEFEIJKy1lS4ev+C/\nZK7YhWyV0TWDIaf1xzRCGBa7fezfkl3/d5eIDKZ1vp4fChcy//DXLCj8njGJJzE6YWR99H141/ac\n1q8LC7YEii9cMqofndvEBX8hjTCwa3sWf/0YH63cwjcbd1NcXUtceBhnDe7B5JH92JFTxCOLF+JV\nNSb068J5L0zls7cW4ttTTLjVwrhbJzDx5gnsrN5Flis7IMKlGAq7qndxwHWQzuHB8u9N8ehnP/H5\nmu31f4fbrCy4/yqiw3+Z0mwozJk+l4+e/BKf2x91P7glB+EmiHs5DGvvXz7dUkyVYl8xT+56hhf6\nPfuX97XLKasEa+hVH0NuiGM9+fHPfN27459OvluCoacP5OvXfwzZ1ntUd7+nZB0yV+zi3glPBCxE\nWGwy/cb2Ij7l19kvNMWYC0dgd9p55ea3KS0oJyImnO4nZLDuu01BipVelw9b2F/7mWnF8UErmWvF\n74Zqj5cPlm5i0fb9RITZuXhkP07pk/G3GMD/v+P7LzbSXHbP/I9Wt5jMaYbG9qpMqtQqOod3pm1Y\nKvYwGy+vfZILVz2Lx2LFbJTtXaMI1OaFIenBz4gginTv047r7p7INedNZ6NVRYtxIJd7CF+Vgy2v\nGjPCjlzn26MYKq/tf4PtVZmYl5popsau4kwEBBYVL2Z80sk4I5OxWCRUJZAdyLKIM7zhJWiYBm8e\nfLvZlCeraMVcksD2Q5kIzjD/yrTNihgdCZpGbUQYMx79Ck3TGT2+N3dNGc29cyqwWlQy0vLRdYk9\nShKHfImYQgXYYJdWyM0r13NLp9sY3b1hFfvCc8bx5JNrgvpg2AVOmDQgYNv+wrIAgRETE2+iiSmC\nLighv2MTk2q1Jmh7ZJ3EflPIFomcXfloadHoQ9thZBYhuBUEzcQUwJREoi4cgPvkMAxXedDxtZqP\nHFcFHSPi6BHZ3Z+HFyL0aJpw3n8+QC3TQ9ot6JqOapiE7ShBVAxqhrfDCLfhPOSqG3MCjxFEyOie\nQummPZTUmdEfwdHqUjRFw1PrJ81eVWPG98twF5QjNDpGVTTKC6tY8skqTr18DABnj+/Lqo0H8fpU\nHJ4adJ9c91kBQ8BU4K3pPzJ24FBe/vd8+l+UhSgF98MwNYrcq2njDEyPnD5lBtuX7URVNJS6BYq1\n324MmQZmD7OR3rdDw2cyNB7fOZ1Cb1F9TeicnI/YVbObG9Kvrd/vmamTuHrcEN5buglJFLhq7GDa\nJ7Qs4mCRpSB1UoBXf1jNrMUb8GkapgnfbdqNKArYx3bCO6odpSZ8WFPMe4+9Sc9uDujuC4oSa4bO\n3pp9xyRzby5aG0DkAGp9CmMefZ3N/7mtRZ+jOSg+lY+fnldP5I7A9EH1Gz7iX/710y3d1FlfsfGY\nHqB/Nvp1SGFfbi5IweO3pDQ8icUeF+v25zI0468fMRo6cQBxKTGUFVQEbBclgRuevzxgW6+R3bnj\nzet5+eZ3UH0quqYzZOIA7nn3puPap2GnD2TY6Q2/o8JDJayevyHkvivmrmXYGYOO6/Vb8ddDK5n7\nGyC3tJKZP61lU1YB7eKiuGrcEAantz32gX8i3D6FM596l7LaBvW1HTmF7Mgt4vbTf31UpxV/DFy1\n3mbbFF/o+oGmOOwpZPrup1F0BcM0QDAZGDOAaztdjSPJRpHVimkGzspMBKpTZRL3Cai+JhElRaPC\nYqDpBpdOGUvh5S8H1d45wu10Heyf0H2W+znbqzKDBEtMTBRD4YfChdx20p2IL4sQQtVv5MkNcvEb\nKjayrWp7SFn8bhFdubjdZK6/eqb/E4SZmAoIel26kdWK4tPq79vyhZl06ZXKjCv+wUsL2rB8fT6d\nO2q4Ou3HbOTgLcom9mgPj/30EQsy7sVSp6A2rm9fZlzQEdfnWQg+EwEwbAJG9wgevmYqy3/M5INX\nF1FT7SGmYyxhUQJuwT+RMqxgSoAA1TVhCCFkPa2ilUGxDROF/bUHWFu2jvJ2pVjDLCjuwHsgyRLt\nuqXSPikORRZxTe2HY3sRtqxy9HAbysBUJpx3Aqvl3UHXAlB1nepaL0RAJ2dH0s9ux75Zh+rTLMHf\nXzXaTqmuIltMwgS/IW9jmLJEzcAkooorse8rw77Pb25vpMRjxMcFFYibmJRkZOH6sbxFhS9Smojj\nZBnZIdH21CQA3l60jkNbD+EgOIvO6/KSuWJ3PZkb0DuNCSO6MW/RNow8qYHINYKvGJYv24YsS9gj\nFcSQb2gTtUlqbEVRJVsWZwZZHyheFVESESWxnqCKooDNaeOUqQ1kcEPFRop9JQHPt89Q2FS+ifyU\nAlIdDXYZXVIS+Pdkv0VAaX4Z7zwwhwNbsuk6pDNnXD+emKSWK/UVlFfz9s/rUQIWHEA3TFy+hgfA\nrfj7lbnbRZyaQkq/wAixRZSJtBzbB/LV74NrSgE0w+TnbfsZ26dzyPaWoLKoslllU+1g84sDLYFq\nqFQplb/pHH8EbrnqNL548HUMUWxItTRMZB9Iiv83p1sFPKLBuv15fwsyB/D+/pd59Lxn2bhwK4Zh\n0q5rCg99emfIaNvYyaM48fzhFB0qISI2PEBs6/eCz+3DFmYNqtcG2L585+9+/Vb8+Wglc39xZJdU\ncNHzc/AqKrppklNaycaD+Tx6wSlMHNB83cTOvCIKyqsZ1qU9zj9BOeqe2d8FEDkAn6bz/tJNTB09\ngPjIY6u3teLPw4RzBvL+y4tCtg0b271F53hx38vUqDWYR2bKJmys2MyK0pV0ieiCGWIyC1DTX6DT\nRgfVmtuv+geYIrjjZJ78aQUvLl/LOzeez9iLR/HTB8v8nlWyiCiKPPbVvfXS5UtLloUkX0dgmAbZ\n8j7ue+ZCnr730wYvNFHgof9OJjyyQXlsRckqfCEMhB2SnbNSz6B0uxdLHzcRU6oRIw0wwL0sjNrP\nIqFJlNHnVfn64zW8Ofk2PrjZb2q8rGQ5b+8/EOSZJ1kMnElVbDl0OGABZ/4HTzP9lI9ZNGsphkej\n19l9efK2a3jjqW/47rOGFdqK0lqiRVBHxaBaxQDJK12XyM5JpEO7YkTR9PNO0Uq0Gcu8u3bw352L\niZ5Sg2V4LYaoYwwzUS3B99PnUYhLiSEuIoxzhvTkq/U7cQ9Mwd03Gcmt4IhwcMno/nSsimD6tu/x\n6I3OYfhVS6984QuuHDuYaacO45lnHuPq9fdyyGnBFxeGtdyDbUcxVRP8nkxaGGg2kH1+QmcCCOCN\nFlCcUVRN6ELM137iaArgixYJOdpIIA6sQo1UoCLUDg0IO89C1M12kP3Px3va++TkHGLe+lp8TguO\nEI+yxW4hJT0pYFt4rYYzuwYh3MQMtV4iQnhYGAA5G5LoOKwQq6OpdYPG3JdLWP71E4iyyLjT+zJm\nbDdkq4QaQr3V0A2/6qYAoiQyaHxfpr14FfO27eXdJRuodHnpMbIUEoOfbwSBfTX7A8jcERzcdojb\nRz+E6lNRfRqbF2fy8dPz6HrWAM69bRIjh3Q7ZhbGqr2HEH9BpoaqmRTvj6ZNn4KA6JwoiAyOGdj8\ngXXQmiFbAN9v3fubyFx0YjPiP4Dc/rdpzVlES1Da818R0dHhXN6+M7P37EcNF8EEa42JrdI/jqtO\nAU+8iM0iE3sclB3/KFjtVv797f0t3l+SJVLSk4+943FCTGJUyGwF8FuitOJ/H61k7i+OF79biUdR\nMRrlQ3lVjafmLeHUfl2CPFsOlVQwecZH1HgaXsxJUeGcd0JvLhjWh7iIsN+9z4ZhsHRnVsg2zTDY\nnlPImF7Hrm1oxZ+H2IRIJpw7kO/nBiorhoXbuOGeicc8vshbRKlS1kDk6qAYCj8XLWFE/HBi7Crl\nXguBMQ2TdgkOXv74Rt59cSHLf96BS9OobWujtr0DfAoeReW2d7/my9ev49xbJ7F18Q4i48I54YxB\n2OvqA0zTxGc0rxAI/lovWZA44aRufLzkPrZvzEaUBHoP7IClqcJiMxNO0/QrapY5ioi6phKhUXmC\nY5QbwWZS815wpKKp55tTDr24Yeig+2RkMfj69196EfdfelH93xVltQFErr7vBqTnmuT3tCLJEkWS\nB63OIK6gMI5al4O2yRVkxEcyVO7HR9M246spQG6nIgyuRK8bYoQwsHSSUDY3IReGybVnPsHba57m\n/nPG0i4umtmPf4a59CBC3QTjhlmbufu9mzgttSff5G1HUQz8pm0Cwk4Hiqbz7uINDO+SRlSYg+xT\nu+JVVDTDROsAtQNSGlb6BQF3kojsBovLABGUCBE1Ucfo5EUbLeM5oysRnxUTtrQa2xXhiGU+jAXW\nRpFIgfCzq5Hb6DinWql6xhtYpycIxLWNpaqoCjlJJOoWG4Kt4TtQDIXFxUuRIrqgtIvCcFgQNF9A\ntFCSJSY0sQ1QfBqCZiAlaBhuAZRG47ds0H5UJENGdEMQBbLXJtFzUhQJ6VVY7Hrdd2lj14+dWfFZ\nVn19zLefrmPHxmyEoyjLGrqB1W7honvPYerD5/PCN8v5cMUWvKo/kldQpJAcJyBKgb9XEZFoa2iS\nMuOGmbirGxbsVK+KCWz/ZC3bP1mLY0A7Plv9TJBaaWM4rBbEEM/2UWFIREoxKIJfbChCDueWjGkt\nqieTmjG5Bzi5728jS1a7lXNvncjcGd8FpFrKdomoaxyg+xeljkjqNh1ShLp/BoFRPKtoJSM8nS7h\nGb+6b6qiMvuxz5n/2g/4XD7adE7m5peuot+YX++Z1xxuv/tssm+YycbsSn9trwAoGq4kES3OX5co\nCnBa/67H/dr/XxEZF8Gw0wey5puN9SnW4BcOuujec/7EnrXij4L0yCOP/Nl9qMfMmTMfufbaa4+9\n4/8jPDlvMe4Qq62mZmDdkMfrt8xiwVs/YRgmnft14LQn32mkXOeHy6ewKSufuWszOaVPBlFhv73Q\n+2jILatizootzbZfMro/SdGh62+OBpdXYXNWPtUeL/ERztbau98ZJ5zUnfRubcjLLsVqt3Dq2QN5\n4tVLsTmOHemtVCpZVrIipGR4kcdDmqMXfWOjWVp4qK4OzT+NkQV45YTJdEpow/CxPfiqJp+D0TpK\njKV+9mMCbp/Kaf26ktY+ka6DO9OhVxpyo0mjIAhsr8ykQm0+5CIJEpd1mEqYHIYsS6SkxdGmbSxS\nCO8wi2Bha+W2oM9jFa1c0n4KX1XPpUgpCRRxk0FO0XAvdoLa0CBbRMZO6sfgUV3qtyXY4vm+cCE6\ngWlypiFQntmRuyedfMwIxg9zN7Bh5b6QbYJX56eP7ubKMYNIDg9nRe4hDNNPtUXDQQwdmXnyjcyd\nvonc/X5jaMdoN9buSkAEpPIpL03mmv40z0oPM9VSUuMisW0uYNObSzEb15D5VJZ/vpo7Lz6PHgnp\nrNmcj1kgI2bbEerYom4aCILAgs17yCour9d4MQVCzHwFDKuA5hTRwkSENj60bl6w+SePZpiEr284\nUVdYSO1SibObB8dIN1Ksga27QuTF1dh6+8dJS4aIUS2i7tDhyOJYZDjVPdviPq0j8miBiM5KkNO8\nYRqkxSSQly3jSo9BrPXhTY/F1z4ayW5l1OhevHLrO7z78CdsXbKDLoPSSWgby8pFO1GKwNJJxaiW\nEKz+Psf2tDLjv7fiFl2k9ohiy+Icsle3x11mR7LohJFOePlFfPVfKVCdUjfxRtUy8IxOHN5YiK6G\nTunTNYOa8lrGXn4Sd7z/LT614Ry+WisJGWU0Xhs0DVC8An3McaTFB9bF6brOC9fPDEpPFRr9Vw9X\ns72yggmnDQ7ZH4DUmEjeW7Kxwa6hBUiNi2L2hXfTP6YfJyWM5h9tzyXa2rLUTt3Q2XAwP2Tb1FED\nSI755e+lxug7pieiKLBvcxaKVyWlczJ3vz2NK86/hG5RXcgQu9DG04H+Sb3Z596HJEgICFhEmVOS\nxnFn19sYk3ASsdYYKtUqoiyRTGxzKlPSLkISm7d/OBp0XefmE+5n6WerUbwqhm5QVVLNog+X06lP\ne9K6pf6mzxwKp50+kHFD0okWBHp2S2ZnuA/TacEiS4Tbbcy44kw6J/82U/dWBGLopIHk7T1M/r5C\nrHYLdqedG56/jBP/MezYB7fiL4lHH3308COPPDKzJfu2Rub+wli/P4+ymhBS54ZJ+GdbmVuxrt64\nN+eu9/nx85W4+oZ+qemGSY3Hx7PzlzHjyjN/z24fkyz2TmtZ+oGq6yzcuo+lOw9SUuNia/ZhrLKE\nphuE262kxUcTbrdxzpCejOvduZXc/Q4YNqY7w8a0LK2yMVIcKdglOz7Dh14uouyxIToMpO4+irx2\nrlv1Id+fcjOzRiXy8u7vyHe56RKZwF09z6VjeENKl1cNXZ8nCkKzbUdwaYdLmL7raTRDQ29UE2ep\nUwG8rMMlxNn8KnyGbw3UvgpmDdhPh7Ar6tM1AQbG9GdQzEDWV2xAN3Rk0V94dkvGNGRRpshbHFq6\nXxewJoCeL6FpOja7hcioMKZcNyZgN4to4f4ed/PYtv+gNioWK9zcnv9edEFQBD4UIqKaT1uy2RqU\nD8/v2ZvuCYl8uH0rZW434zqlc3bX7thkmay9hfWiKKYm+IlbozmkYAEz1G0XBUzT5PHPF5HyzT50\nLZjE65rBB49/zrhnLsRabkP1NYmcCga1YgkbDhS3yLup/tKyjqVXDYraJDJjESl0R5ESVYMggBxj\nII1xB/FCTIHwqXbCTnPgWSnh3RgBPiu616DGImCNdqAblUGqn4ZhUlnjJT4iiRLTpHpStzozbwHH\nV7tY9uVazDofum1Ld3DriAd4a8fzDB/bnVU/78S3X0CMNLDGmkycNJTJV4zlxX2vkOXKRnZIxD1r\n0i9/FBmW0xkwLJ2E5Ghee+obvJ49DZ2wGsTcUoGlo0qWXIqzjRXtTdC3qiGV8MNjnOSVVyGLIo2T\nKlWPhQPL29PxhDxEi4GAia/WysGVadzu+4ZPbp9Cp6QGxUpRFJEtcsi0zsbYNnsVvHhDs+1Ou5UX\nrzyTW2fNR0BAMwy8qoYoCAHZKOAniDaLzAPnjkUURNqF/fK68WkTRpBXVs03m4LrN6+dOZd5d19K\nSuyxa++agyiKTL7vXCbfdy66riM1emj6RfeFaKBOy2hUynDWV2xA0X30je5L2zA/qXJIDk5rcyqn\ntTn1V/ejMdZ9t5kDW7ODthu6wYs3vcnwswb/Lu/O9p2SufIG/7v+WsNkV34xhmnSo21ii8azVvwy\n2MNsPDDnNmorXVSX1ZCYFh+wwNmK/220ftN/UeSXVXHla5+FbHPmVmMr8+BrJEThc/vYv2ofclI3\ntOTQq4uGabJ63+9vIBkVZiclJpKCiuqgtlHdOrToxbEt+zD/nLOAkqraADW+I4XyXlWjtI7ortuf\ny5CMdjxx4anE/I3y8P+XIQoiN6Rfy0NPv0HtgjAEya9sKEgQd0sVCWm53LbxeT4Yfj/vDu/d7HlO\n69+VmQvXBjwDAHarhfSko8uhd3C259+9H+WHwoUccuWQ4mhDsj0Jp+ykX3TfesEEo+ox8MxuOLB2\nB7jfxYhfjFinQCEIAtemX8WprpPJrN6JUwpjcOyg+vTIjs6OlPhKg9JKbWEWXnrlFn78fAv5h8ro\nO6Qjp5w1AGcIGfSO4R14e9hLLDm0mcy8fNJs7Tnl6u4trnkdNb4Xzz08F6OpLQBw5pQTAH/6aa4n\nD2eYzhNjxyEJgQylbYd4SgqrAPBusBN+ZqCqpWOiBddXGoLWcA1TEvB0TwBBQNUNilKdRO4K3cfc\n3fkMzUhD0wO/z9gOFbQbcJgqy37MDelghIhCGH4fwlDwqJaQ2w0TNEPEUqcKKQh1qbF1pzH97gNI\nMQZyHFg66YSfV0HZo/EoUf7vqDI/gnYDgi0ZTENg+1YB0+VqIB6CgFTuQc6twmwkE26a/ujk16/+\nwN3TJ7N19c+sWPApdlsF407OoX2XIp7cu40Drlx0dFRdBQts7bSMMRl9SYjyL9K165iAzW7BV5dK\nFXFhNXK6gmABHRXHIAnbQAeFU8E8qNJITwe708Y5t0wkOToCVQ8m27XF4Wyf3xV7pA9DF1Fc/udO\nEnRmL9/Mw/84uX5fQRA4+ZLR/DR7WbOETgBMXwgPiSYYmpHGkkevZ/WeQ6i6Trv4aL7ZsIvskgo6\nJMZQUFbN3sJSOibGcO3JQ+nTxMz+l2LKqP4syjyAR/GR3L2UuPQKBNGkOi+aD9es5+6J437T+Y9A\nOorJOkC0NYpTko7PtY6GjQu3NSvMUnG4Cp9HqU9P/70gigI92yUde8dW/GaERzuPaizeiv9NtJK5\nvyhueOvLZtuch2sxQikKGibWgppmyRyAw/rHfOUf3nIh5/znAyrdDVX+GclxvHjFWUc9zqdq3PT2\nPDYcyDtqsXpjeFWNZTuzGPvYTM4a1IMHzxuHHCJVrhV/LHy7LHh+jADNqPeNMwHXy5EkPFeMKeXx\nr8yn+HfvBwOiYI1xyaj+fL9lD3ll1XgUFYskIYkCT06ZgIbKmpK17KreQ6ItgRMTRxFrDVQXS7Al\ncEn7Kc320dCKAolcfUMRuF6AiLsCNrd3tqe9s33Q7mennsGWyq0BIilW0cqk5AmktU3m6jsm1G9f\n8Pl63n1pIbXVXqLjnNzwz0mMPMVfuyIKImM7DGRsh2OLOTSF1Wbhof9O4fHb5wQUw/ca0J6LrxtD\njjuXGXtfokarRUBAFmWuT78mwD/v4uvHsHNLDj6vilEqU/1hJJEXVyOJEharTNzNMuJOkZp95fUO\nAlqCk5oTO/pvm2liS2o+spE0NZan9v+b/udVUJJvpXBbEqZFI21gAaJsoqIQ17GCkv2xmEajZ0LT\nEV0qRlToqL8VAy8ilkITe7aB7hTwdBUQbCCJwSl87go7FoeKZNX9/PBIOZ4FxDCDsJPKcX1QQtR+\nCU/vZLLXpdJhSD6iINYps0JBZiLeKjtNlVDlCg+mKARFxlSfxr5NWWCU0if9LvpMc9W3lbo3k+U2\n0ZtobiqGwveFP9IzqgcAYyb15b2Xf0LxaZimgWOYhyZ2c4gCxD5mo+R6HbHW31eLJHP2LRMZcfYQ\nBEHg9AHd+XJ9ZghrCgFvdeA9PiK81RQ3vHA5BQcL2bV6b0CdzhGYQOLA4N/KEbw1fS5zn/4S1a0Q\nnhTFHTOvZ8xEv7VG99TEZo97ZcEqPli+CUXT6d42kRcuO4OEqJYrBuaXVyEKkD46h/AEF5Lsvwmx\nnUrZqc1DMUZjFUMvDvwdEZPY/O/RYpOx2v93PmsrglFZVsuapbsxDZMhJ3YjLuG3pRK34q+JVjL3\nO+FwRTU/bd+PrhuM7d2ZtPiWyzWDv+6sOdRaBSJlEZoYRFqsMilt4th/lBXsPypPPT4ynOWP38CG\nA3nsyitieNcOpCcfPZIC8NqPa9iUVdBiItcYmm7wzabdJEWHc8P41jzxPxsLPt+A7gtRC6MKqPus\nWLsqFPgOce3GGxmffDLntT0nKFIUZrPy8W1T+GHrPlbvOURKTATnDu1NVKTEA9v/RZVahc/wISAw\nr2A+kiDRMawDV3e6gjaOFqzgu+c03+aZH0TmmkOKI4UHe9zHJzmfcsCVRaQcwaQ2ExmdMDJgvzlv\nLOb9VxpUQsuKa3jizo+54/FzGX/WgKan/cUYNqY7c1c9xHefr6estJqTT+9Pxy7JKIbK07v/Q63W\nQCAw4Nk9z3NSwmimpF2ETbLRa0AHHnjuIl5/6lsO51VgboymU0w/hlyVQmSUk37RfdDXy5x9+0vU\n5lagxTpQk/yrwAJgk2XOPXkA33+yLSjVMvJaOzVnllNeN/GPTvUS08aNw5eAS274vaf0KcJbY6Om\n2AleAxMBa0ENjp3FVI3vDE0XakxoG1lO5TsxOHb7/0b0/zdu9CA2EmI0TdC8Ert/7IwjxkOXMQeD\nauEEC9h6+bDl+u+VLasSd04bqo0h6JFFuFRi0mthAAAgAElEQVQf1QURKO7QEVM93oZjuIhoE/Ct\n1zHK/ee32GQyBnQkb9tLJMR6sDYKhlTrAjIGapCBAlQoDXWfznA7z39wHc//60t2b8sJ+QY3XCZV\n/3Qh+PziN6YAolUkvU97BEFg05r9uBcewlHjwZ1irytyaz5bwiZLDOncLmi7w2nn2UWPkL0jl8cu\nfp6cbbn++0edxocs8tSHdwQdB/DQpS+yevby+v1rCip47PQn+eend3DyUWp8Js+YQ2ZOUf3f2w4V\nMu6xN1n48DUktZDQdU9NRI6oDSByAKIEiArrytf/5f3cfglOufREZj/xBZoSvAB81s2nNbuQ1oq/\nPxZ9s4UZj85DEAUw4bWnv+X6eyYy8fwhf3bXWnGcITRngvtnYNCgQeaGDaGND/9O+Gz1Np6etwTT\n9PuqiILA9eNP4OpxLf8BjXrotYCoVmMIHpXEtzciNCl0N60yntP6gyiiOcAdLwaZd0bYrax84sa/\nbH3ZyIdeo6qZz91SWGWJdU/e1JqX/yfjoWnvs3753qDtgt0g6rpKbL0Do1gj4oZxecdLW3Tuj3M+\nZWHRIrSQBVx+OZWnev+bZMfRU3uM2legdkboRjEVMXFxi/rTUkwa8HC9CmFjhDltzF390DGP3/Dj\nFua/8gOyTWbK/efSuV/HFl13ffkG3jo4C68R/NsSEckI78z9Pf5Zv60gp4x7rnqb2moPoiiiqjr/\nuGwEl918CgCVLg+3zprPBl8WRjsFZBN8AtZdFsYXJDJ5yhBeuvFN8vcXApDWvy3mKy60JgIvIiLh\ncjjVWnBKtqEKuLcKVL/ug0wPhgjFNw9rtFBlIkgmHYbmYc9Tqf4gCpTAcU2I0ol7phhJAsNjUv26\nD9dXOmgmWu8I0l4x/BOdJvCt0yi7paFe2ZQEzvvwet7dsjOkINUROOPcpI/ORtAMBNNEkKH6LR+u\nDxTCIh1Mm3EFout+xp5bFng9Q+TW/BPwmYGLGbIgc2ryKZzf9jyKDpUgSiKJ7fwLcj6vyn8OPMc+\nV6DoTfU7XmrfVQLVOQFnVBg3vH0zrz71bX2apgGYFigdHI3mDJ0WGB1m5+t7LyfaefQU9jnPzeeT\nZ+bhcyt0HJ7BI+/dQlJysKG4oqhMsgdHy03AFu3k2/J3Q54/t7SCiU+GbuuRmsCz55zK4bxy2qcn\nkpRydCPzafNfojp+K6IcPP85KeFErmhmHNJ1nTxvHlGW6GZVPv+KWPvtRh47/7mACOrYySO45/2b\nj5kO2oq/JrJ35PL2fR+yc/UeohOjuOjecxh0al90zSCuTQzlpbVcMfG5IF9Yq03mjS9voU3bYI+8\nVvy1IAjCRtM0W+T43hqZO84oqqrl6XlLgmp83li4ljE901sUnQJ45PyTue29b0K2mQ4L5ef2IPa7\nfTgMf0RKkUSUoV0Q6giM7AFnsYGrTeBAXetV0AwDy58wgO/OL2bB5j0YpsmpfbvQq4kQyvz1O38z\nkQN/Xd2sxRt+EXluxfHHiRN6s31DFl5PE9NuAywZgTNNxVBYUbqK89v9A6d8bPuM9eUbmiVy4F9E\neSvrHR7scd/RTxQ2tXkyF3Zxs4cdch1ifcVGJCSGxg0mJYQPV1PUVntCEjkAtyuEx1cT3Dn2X2xb\n0mAAu/zzNZx546nc/PLVGKbBzupdHKg9SLQ1miGxg3BIDZPvGq0WI4SyKICBQbY7m70V+4n2xhMV\nE8ZD096nrLiGxot9X85eRbe+aQwd3ZVop4MTx7dj47Y9cETO3m6i9vSxcU8OwofQ5cwRDE+KZNL5\nQ1Djapm++xk0XQu6tmEaWARLkCegaDFx9jMIe1Gm7EYRZV/TibdAQkYpkck1VH0UE0TkAPRaic1z\nO+FLlLEdqiVmdQ5mbyu+nuHEd/T4zd2bZG4aHhPXV4HPpyRLzPnv1ygZcZAQFhDJsogiQl4lapKD\n9FHZyFYDrP7+AURcaSONdtxxzzQe/cez9B5kZ9ipAg5nw+exiQb/iM7js8p0lLrnWhZknLKTriXd\nuPKUWynOLQPTJCU9mQc/vYP23dtyecepPLrzCZQ6Gw7TBO9iLYjIAZiGyeuPfYnPaOi7CJgqRBxw\nU9EndPqVT9Nb9L6YcueZTLnz2OJam5fvPqLOHwABUCpdIY7w462fQy/0CppJ8fwDTPvoFWSLX+mz\nTf84Rl7Ti/P6DcdpDU7NvXrkiby0bwc6gc+cVbCQZA+d4vlO1nssLVlW/7dNtPHvno+S4Pjr+3gN\nnTSQr6reJ3PlHlxVLvqN7YXzD7ApasXvg9w9+dwy7H68Li+mCdVltfznilcQAMkqk5SWwPDLTw55\nrGEYLP8xkwuuHP3HdroVvytaydxxxuLMAyFTVlRd58et+7ihhWRuXJ8Mzhvaky/W7gjZrqZEot82\nkpcvnMSt/5lLdZUSEG0TAEkBUTExrA3bU2Oj/hQi98bCtby1aB2KpmNi8vHKrUwe0Y87zhgFwOas\nfB7/IrRJ9a/B7OWbf1cy59P8syWb/Mcbsv9dcNKEPvw4bxN7d+TjdddJu0smkZdUI9qDV8QlQaJM\nKWsRmbOIx77vh1zHFvsRxUiMiPug5snABrk3gvOqkMd8kvMZPxX/jGqoCAh8e3gB/2h7LhPajD/q\ntexhzdemHMtr6+c5ywOI3BHMf/UHJk47hY/MOeS4c/EZPmyijY8OfcLd3e4iPbwDAF0jugQdewSm\nCVXf2bnr2w8QTBHTNNE1naZZG16PyvyP1pA2OIqfin5mxq796E18yTBBKNTZVuH3mZRkkW8+Wcft\nT52JFtE8+bZLdkzdDCLogiwgyBB1p53Sa9zIZW60hIbi/uLd8SguCxHe0GTYFMCwyxg2GU/nKLzT\nepI6IxNzgAgnhCHaQ5AHAcTowO9D92lYNxUQu7kAI9xGxTnd0aPsSKKAM78G2xc7sY2QEc4JJg6S\nQ6TvI93o0LEd+fsOU5ITw5TbipEtKpa6x9jrFhgZ1Y75W4ZSbtuGxaERK3biXHEk90+aHhBRObQz\nlztOfJg5h16jjSMZWZBR6tibIIAYEfpZ0jQd0TDRrSKeJBuGRcBWpmKt0rBVNB9t9Cgqn63ZxuUn\ntWiB+Jhom36UaPlRap3jI0KLOkTtrsVaqaIY1EchstcXs6N8Ff/N2MQDk4dxft8RAcf0jelFjC2S\ncqUiwNdNEiVGxgfuC/D94R8DiByAz/Dxz8wHeGdwi5TDWwSv7sWte4i2RCEexTfw10C2yPQ7qedx\nPWcrfn+UldTw7WfryNpTSNfebTntvEHMfvxzvC5fQM2rafjltwyvSt7eAr58aQFmXHD0zTDMAGuT\nVvxvoJXMHWeYphlSEpq6lMtfgkcuGM8jF4zn9CdncahJAbpVlpg4sDvte7SjVhBDpk2agKg32ELZ\nLTJ3n/nHr8bklFby5k+BioReVeOjlVuYNLAbXVMSmLV44zGl5n8Jqly/PcIXCi9uncfbG7ZT43Ig\nCCZRkR5mnHwho1JbDVCbQrZIPDnzCtYs2c2axbtQHD4O9N6ImuwJub9u6iTYWlbTOTbxJD7L+6I+\nIhEKdqllfoqi8woM2wRw1VkTOC5AtIWumVm8Zh2ffrwGYiyEnaIgyiaGafB53lwGxw6stzoIBVmW\n6dIrlb2ZwT5Xw08++iTrixnfNtv2n/teRHvAhWqqmCbsr7BT5Ipgae67tHPG8mCf0xidnMGQuMGs\nLl0bYNMA4FnmoHZ+GKai01TMoykqYw/z8I5H8Wo6qpFC0/hKxFoDqVHGpK4Z6JrBq48sYOTMvmyr\n2RYUgavVa7EIFrpGdGFHdTBhBbD0kNBiHUQsyaLi7O6Ysn/MM4GKvChcbTzEF3gQmwwhpiTgi6tb\nvBIFTItAxfi2JM7ajzsjGX24gCQGE1J1d2AEVQCEuqiqUOkh5stdlF7Wj/bxsXhfWI2hG4iigaAH\nx5xMTLy6fzyKSYqm/HAFN03I4LJ7ChlxWhU+r8jir1J4xzKYkupqDLM9GCYFC/aSeWANNFEnNU2/\nQffKL9eRcnqiX5ClEZwXWlF3ejAbDYGiKJCSnkxWkoPink7/m0iE2vYObKUK6RUSRQTZxtVj+a5s\nLj9pECXeUrZUbSXVnkKPqF9uWQKQ2iERW3QYvkp3wJ0ygb4T+mMYBvNf/YEvnv+G2koXfU/qydVP\nXcKN44cy86e1gSczTMIKlQCzdgDRgLBDPqo7OHlizhpO6tyLBGdDWqQoiDzQ415eP/AWB2r3AwJJ\n9kSu7XQ1kZbgCOXc/HkhP4tu6qwv28DguN9GdH26j3ez32dd+QYEBBySg6ntpzAkrnmPvlb87+Pg\n3kLuuuxNVFVHVTQ2rtrHF++tQNuXHbTY1hRqWSViTHR9ttYRWCwyw8f2+D273Yo/Aa1k7jhjTK90\nnv16WdB2WZYY3zcD8Ie531m8gZ+27SMqzM60U4fTp0PzYg2vXXMOU1/6BI+q4vGpOGwW2sVFcWOd\nyEeXzols3ZgbMm2lW6dk8qqraB8fw7QJwxjWpXl1sd8Ct0+h2uMjMTKcrzfu5LUf1lDt8dG/Ywo9\n2iaGnCSoms7izAN0TUmgsLImxB6/Hhb5+NfLfZezgpdX7kHTHICAaQpUVTu4/tsvWH/FHYRZfl8z\n9r8jJElkxLgejBjnf3mY5mS2V2Xy4r5XAib1VtHKyYljA1IDj4ZxSWPYV7OPLZVbUczQUYXx0acw\nZ/oX/DR7OaIkctqVYzjrptNCeu+IchuIerzZ6xmGwU0XvsrBPYWAHbDjmhtB9K3l2Hr5CeWWyq2M\nSxp71H4/+85V3HTRa+QcLKnf1qNfGvc/c8FRj2tOWhwgv7qAWNMfzTxUFU2pOxzD9D//ua4Kbl33\nGe+MmMpVHa+gc3hn3s+eHRCNcH8bgRkiRbEprA4JZVIOiqEgCCAJBlqTGi9npoEYgg+qisZ443Qc\ncXZWla4OuD6AaqrsrdqHqEoY1hAedbpE2eTumIKAY2cxvhQnako4ul1AizRxp9oIP6RiL9UQNTBF\n///DY52BYlCiiK+dE0Ex0b90oQyVsaHVm2UbXhN1h+43EG8GgglirQ+5xE1yr2RqBkVTsqEc30Yt\nSFkS/Ol4Q2P9k/KL7jubN+7+gKoyePGf7Xjxn+2whlkZeN1YqizueosDx/YiLAcrgojcEbjdXp7+\n4Acu7DIyaNy3j5ZxXmjF/ZGK3W7HNExi20Tzr3l3c+YrHwcsKpoy+OKtDJvQF0tlCVuyD4e8XkJU\nGNN3Ps2e2oYaWIdo59FeD5NkDx1p27pkB+88MIec3fmkZrTh8scuYtD4vgC8teVZrux5O6rLVy+Y\nEt8lhWfm3c1rt7/L92//jNftj7au+mo9W37OZOa25/jXP8bx6OcNGRyCGZyuWd/W6N69t24Jd40J\nVFKOtcZyf/d7cGkudFOvtyoJhaMtGu2p2fOryZxpmmyr2s6Hhz6iVClDr0uFVjWVN7PeIdoaTZeI\njF917lb8/fHiY18FpOArPg1V0TEcTqASMVkm4vpwbP3BqBCo+VDFt7C2bmcVs7gMEuPqs8UE0+SM\nyUPp2KVlXr+t+PuglcwdRyzdeZBn5y+r90KTRAFBEJBEkavHDaZzcjxeRWP8E29R4WqITqzam8N1\npwxl8oh+LN5xAN0wOLFHJ5Kj/SuE7eKj+f7Bq/hp2z4KKqrplprIiK7t6wU+7r1yPFO2vIOpN0QF\nTQG6dE9m1l3Ny7IfD3gUlUc//YmF2/f5V8oNA0VvmKgt25XF8t1ZIVM7RVHAIvu3D+vanv2Fpah6\n6JqiX4pfo4Z5LDy15kcMI4LG0wfTFPEpMncum8Nr46487tf8X4MgCPSJ7s193e/ho5xPyHJlEy6H\nc1qbUzk16ZQWn0cSJKZl3ECBp4CN5Zv4quCbAHI4NGoIP0xeRlZmDkpdzd6shz5mw4/bmP7d/SEj\n2Yqu8X3+TtaVZpMSFsU/2g8g0eH/Db79/I91RA7qv3/TpPKlWBJeK0SQBUTh2OnLVruVmfNupfhw\nJft3H6ZHn3ZExx1bhe/MG0/luateC9nmmOhnELohUOIKx2yiiOjVVV7ZtYS3Rk5lTOKJdInI4J2s\ndzlYm+X/zdYcu992h4XEfg6wloDhnxukRlaRWx1dTxwBjGYyST1uhfuuepdxk/qRMj6VPHKD9ql6\nywNhJvZzZURHw/djKPitCupsVbw9EonNy8I+sBw5HMoqIykuiSBvgpPIvTrOfJW43uXsDk9GCw9+\nxVlKvf409AqNnSVtSYmoJB4XgkvHPV+h9oPQE3dTACwyKBoIAmnd8lB75eD4r0CyO4LKZzxUPe8l\n8nYHggUEEQxNJNaSyoCY/gD8YPVSfUI7HGtyEFQD0yLiGZ6Gr38y3s0NRClseyFiM/WVAKYkUhJp\n4fW5e+h1diDxFASBiMvt9E7vwZiMk0jukEi3IZ2ZuzYTURahST23KQvs9dUwffIETn/q3SCzbpss\nkdrnMBtqA8WMPIaXx3b8m1cGvhjUvw0/buWRc57B5/Hfyz3r9vPIuc9w/4e3MfyswbRJS2BBzWyW\nLdzE9z+vp+P4zpxxwmBqK1x8O/OnAO860zDxuRU+f+5rbnzhCs4c2JMZ3y2nsKqWy8cM5JWcz8ne\nXxRwfRPwxVrqjodqb/OZGke8Io+GcNlJjVYbsm1I7K+Lnrk0F/dtf4gqNbRytWIofFPwHXd0vfVX\nnb8Vf29oqs6ezLyg7aZpIoQ7kbpEkfAKCA4DQQaSIOZBkZq0KFxv+58ps7Qcs8aFEB0OCBhVNQhe\nH7puoPhUfB6VqFjnX1YQrxUtRyuZO05YsTubu97/NiBVUBAEBnZMoaTaxduL1vPlmkzS28QFELkj\neGPhWt5dvAFRFDBNeOarpdw+aSSXjPbLldstMqcPDJ3WkpYcw6xnp/LIqwvIyS5FtkicOrYn91wW\nugD2eOK+Od+zfFdWPYENBdMkpEmtqhu8+dM6iqpquHT0AOat20G1x4t2HAhdWtzxVxpzeQQMI1TE\nTyCrsizE9j8Ol739KRv25iEY/gl1j/REZl92IXb5r+khlB7e6djiJC1AiiOFlNQUzkg9nd3Veyj2\nFTMgpj+Z3+/h+10r6okcgM+tkLliF7vW7qPHCYE1ZLWqj4uWvsVhdzVuXcEqSry1dyW3pp/C5txi\n9nyyLsTVBdBNlK02bAMMBsT0a3G/E9tEk9im5XYlE64Yy7yXFnBgS3ZQm7JVxz5ERpHkelPsptiS\nm4NhGIiiSKojhYd63I9qqIiCyNXJMzicWx7yuhFRDnoN6MCQ0V3pN74tD+1+pL4tKbwWUTDJr4lC\n1SUiaq307JVCXmlBvVpiY3hcCj98uRHHegH7/YGlxaZpUvWxB9NrEh1rxzHW4hcnsYJnqc7hyobo\nT2zXKtpe6EOUvAgiREe5SI0pY9eyjuhOG8YIjchRtcTurKKkKhrT2kBWBUUn5sd8DKuAZ1AEmi5y\nqCSerD2JpD25FVEJvnkmoHVLRevcxh/l03TkPblEDVPQMUHy16nFPODg8FMWDv+URmznSiSLQVV+\nJLtLIlgg7iEjJYE1+3LQB7Shpl8ygqJhWmUEScDlU7FZZHx17w+hmYgc+P3U1eQI1NQIVJ9B4YYO\npA4+hKIomJKJ6QXfJo0NT2aS27OKjnefwrwvFoQcg+vvi+BfNJx711SumzmXkmoXomggiSbTTk9k\nlXdFyONqdRf57nxSw1IB8LoV5sxczKcPzUb3BJJin1vhjbveY/hZfvKzrjSbO7w/wHAwatby8o9r\nOMfWFavdEmRErqkaO1btAcBqlbj77JPq227511ncf+0sfIqGqZt1UVmBqi51JE2AM3v/NtuPKzte\nwYx9LwVtd0pOukQ2X496NDy16z/NErkjKPYV/6pzt+LvD1ESkCUR1Qj9uw2fakdwePxE7sgxNoiY\nCu45Iqanbh7l82EWNUT3vvxoHYt/3kNluQsBiE+K5LZHz6Hv4E6/46dpxe+NVjL3G1FcVcvGg/m8\n9N3KoJovTTdYu79hZaWgsoaCo6QTNlXAfOG7lQzJaEdGcvwxV04y0hL58KnLfsUn+PUorXEdk8gd\ngYiALIuIoohXUesTfVw+hS9WZ7L9UCGf3XEx7/y8no9WbuG3BNbsFplbJo489o6/EE6HTlWNjmE0\njWSYZMT6J5uHK6p5et4S9h4uJT05jn+edRJtfwdi2Rinz3iX7NxyRNP/jIg+k927ihnzwpusuvOG\n/zerbt0iu9INf+1i5opdeGqDV+M1VWfnqj1BZO6tvSvJdVWg1L04FUNHqxJ57NAyTBPSNZ3m4lei\ny8KVHS8iyvL7fs8vrp7OWVFT0ZTA35vrU4Xo8U4iukqhi54MEyFHY+3SPQwb07AgZBEtrFy0k9Ki\n5ieUHrfCHY+dQ0SUP40z1ZFKjjunPk0ywemibYTG5R0uZXj8CZimycvTv2bhvE3+RZwmhfaqqiMW\nytj2hiF0bZD+F3UR022CCZWPeql+2YfcVkTLM9ArgFvrnm1Zp13/w/WS8qpHpqogAlODhLgqygri\nkCw6pgkZvYtglU6JEocpCki1KvFfZGPLqUWPs1B7ciyYAmqZHWIFSm7pSOKMLAQ18CZq3VLRMtpA\nXRYBkojetz2u3MOEd28YzwW7QOz1URQuDSN/S2MRH50XvlvBlWMGodcNbBFtXCR0LkOyGFTkRlJa\nE49NllA0DdMET9d4wtflBZE6U4DaYWm4B6TUs+H8g3ZuaXc+73z7Hrpdx7taQ1mvY1glNvePY+Oa\nzKNWazusFs4e7K/ZTE1w8vxN4azN+hS3TyA5vgybbEMt7UZzCY1lSjmpYakYhsHdV75F9v5i9GZq\nlgsOFGEYBqppMG31x7i0QMI3z7cHx7BofBGd0KNsiB4Va1YF0WvyaNc1tGJsj75pvPr5TcybvYqv\nl26ixi5S2zYMwyYgSgYD+4QzqG1gquJP8zfz/quLqK3y0LlHCrc9cjYp7Zqvdx0Q04+rOlzO+4dm\no9aJ9LSzt+Xhng80e8zRUKlUkesJjro0hohIl6MIF7XifxuiKHLihD4s/WEbapMxH0HA1kMNIHL1\nMEDuE4m6tjK4TRTRECgtaihsPpxXwcPTPuCVT6fRtsMf40PciuOPVjL3G/DSglW8u2QDsiQe1Xvo\n18Knapz37GzsFpnzh/Xm9kmj6tMS/woorqrFIkktInNOu5Wv772cF75dwbcbd6M0WiVWdJ2DReUc\nKq3k3nPGEBlm562f16O24LxNERVm56HzxjK2V/ovPvZYuHXIKO7/bguG0SByIAgGNpvKs6Mms/Fg\nHle88ln9xCm3rIqlOw4y87pzOeF3qlUsd7nIzi1HMBsrmQqYpkllmZe1ubmckJb2u1z7r4z4tnHY\nwqz43IGTRYtVJj41WOFrQf6OeiIHYGoCenWDYqa7jUR4rh5iOivwwtUPkhTZcnny1XsOsWDLHgZ0\nSOHsob1afJzVZuGsaRP45o2FAZ/LZrFxuf1yErvF8O/cH9isVWI2UrAVNIhYpLKoeEsAmQOYNePH\n4IlCY5gmsqVhzLklYxpP7f4P1WoVIKCZGiPjRzAsbqj/WoLAzQ+cyfmXj+KlJ75i48r9Qac0dJNe\ntYPYL65BEiQUXcVda0WP8SGV+0mAUWailNXVDyU3pKE649yYhr/KqvRANLmbUhDq1C9Mwx8prS0N\nQ5RMRBG6jiyls1JCzXwd5ScfSqVEzYmpuEbHI+TKaEjg9J/P0yOKimvaEP1WAWLd7TXBH5FrMu6a\npkT5ioQAMgegyB6MKA1BFcAtItQ9MYWVtVTX1YAl9ygmqXtJvWF1WJwb01PDrJ4PMP2LJWzOKkAd\n1gZbcTFqgQ/TA4JVwESg/KweqG2cxHy+A2uB/9qmLLJ0n5fKbzwBogienokYNumoRM5ukTmlT2dO\n6J7CjL0vs7VqG6apYhOT6B+bgywZ6KaHCNFHtRG6JrhbpH8BZdPqA+Rll/oJvCyDFixoFRkfgSiK\nrDq8L2S/fLqGMjER6YAdRBEjwoYW48AIs9D3pJ48NfVFFK/CmItGMuKcIfWG1ynt4rjxvjO49p6J\nvLN+Ed9s3IUsCVwwtD8XNFGyfP2Zb5k3e3X939vWZ3HVGS/w+uc30b5z80qboxNHMTpx1FHuZstR\nrVX7x+lmvh0BAZtk5YyUicfleq34e+KG+yZx8GARWXsK0U0DwQRDFv6PvfMOj6Lc/vhnZnZmS5JN\nbxBICL0XadIVUOwoYkURxa7X3q71qijYOza8166IvdOUItJ7D5AQQkjvW2dn5vfHhiSb3aUJyP3d\n/fDk4dmp78zOvPue95zzPYheA61CxNQyeB/BZKBLiWCqC3wHBRDahh4L+FSNbz7+k1sePOcYXUmE\nY03EmDtC/tiax4cLV+H1aYdkzByUUIV36nGrPmb+uYHyWifTJpw4nXtWcjyafmghkZcO6UVCtA2r\nIgcYcvvRdJ3thaX0a5vBtSP7syG/iOU79hzyvVUkiWS7ja/uuRKb+diUCxiXdTp5gyr4cHVOvZol\nxNldvH36lZhNCnf+54egn2YDuPvDn1j8xI3HpE0Lt+8OuVxAQNQM5m7e8T9pzJ162RD+/eCnAcsE\nAWSL3BDm1RSzFNgV6h6JBmUGoHh4NFGfVoMW+JpedPXQQzbkXB6VkY+/Q229jP7Xyzfx2Bdz+eqe\nK8lOPbQCrtdOuwLNp/PTu/MQAJNi4qonL2HEeL/65m3JIvd+9hll/Q00Gyj7DBJ+1VGKQDkpuLsv\n3lsZ9lySJNKzfzZWm7lhWaI5gWd6PEVO3Q7yHfksrVjB4rI/WFm5irPTz+S0NH9od1rLeIaM7Mqm\n1fm4m4XbmWSJU7udzO29L2FB3jr+9ekCaipNKCOqiP9uK/h0/z0WQJcFakZkYWAgIKD5RBDAUyez\nZ3ULDF0MfOcEA80lsW9dCmk9ShBFA0kRiDlPxjtAYeviDhiiCbH+skXBwCPo2FKdWBNcOIfHYHwk\nYXjrDXeTBFIYqf/awPtZUmdntzsWoxPPUAkAACAASURBVLPT/5C4RaTNNgSPSLI9ih5Z6SgWjbQu\npYhNSjpIJgMhykWJlMN/br4IVdN4eutU8sZZqftdxLPah5QqYD8rirrl0cQ+twrJoTY+hz6dFd+v\n8ocnNglv9baKxZDDT/4JwPs3X0SXVqk8uXkquY7cegEOEZduZllNNsPjthIjeegVk8vC6uAw/9Ep\nI1Hqy4Ts2NIYXiskJ2AUlQbE/JptZi594Hx/23SNkG5kAf+opKkCnywhlzt5/bb3GiYxVvyylj4f\n9eCxr+4JiDwwSRLXDTyN6waGLhPidXsDDLn9GLrBsw/O4rXPbw57v44maZZUREEMUiLdT9/4PlzY\nahzJ5hO/hl2EY0eF283qNjremBhMDg01WkKzSETnOlF+iUbuUIlobiJopIJ3mwI1MlKntui1Doza\nOgSLGeLsDZMfzdE0nYLc0oBlzloXcz74nS3LcsjsnMGYa0YSn3Jso08iHDkRY+4I+eyPdbiOZq2O\ng0TCeVQfc9bncEdVbYMwyqGi6zpen45FObpft82sMHlkf2bMX37AezGgXStuGeMfbGanJGCRTUEh\nqZIkkpkcD4Bskph+7flsKyzl7TnLmL9pJyZRQNONAIEUkyQiCgJpsTGc3qs9E0f0PWaG3H7u6nUp\nd/TUG+p5Na0FVBEiFxKg2ulG0/UGwZqjSa+MtLB64oYIGbH/nZ2vS3MhIBxyeYHm2BNieGbuIzx5\nyYtUFldhGJDeJoWHv7gLxRL8jFycdRLPbZqLW6sfDDfTOtctIrsujyVpmYvEYoPs9GQm/mM0fQcf\nutLchFc/azDk9qMZBhe98DErp916SMeQTBI3v3w1k6deTk15HfGpsQHqnL0GZJNwn4hlceB5LFaZ\n08YG5w2lZcSzJ7cs5LnSWyVw95QLg5YLgkC8HM/T+c80hFt6dA8f539KTu0Obm5/AwDDz+jBf16d\ng8ejNqhxSiaR+MQY+gxqhySJzF1SSm2Vv/3ezDgqLuxK9NI9SOVO1PZmai5NQU2SEPN94JKoQ8aH\nQFVBmOfaAPsOJ8ZSE1Wt47GOcKEnQs1GEyXV6RjNlEwVi0rXfnmYbKq/vpxgUHurGceU+hBQn+YX\nPAnxzCjJjfe41mMlvyYWQxAaf1WtOloXJwm7FYaPUthkmk9G10p0TQgw5gAMUePn3YtIVjtgiXWy\nx1WAJulYR8pYR/rzXiVBYEQ/gxVNDTka5xy87sDlUrUbND1s7baYcjevX/ACQycPIK93Hj4C+2QN\nkZ2uFHpF7yHe5OLitFhW1iZS4CrAJkVxfsvzGN7EU5XaIg6zRcbl9CIkxIGuY5RWgGGgWGQufeB8\nxt1+NgADk9vgCzUR6AOhPDDPV6p2Y1tfjKdJyKnb4WH1vA2snruek0b3DHl9oVi1dGfYdbk5xWHX\nHW0UUeGijHF8tmcmerMO/Oa2N0RKEkQA4O25y3B5fegxJtSYxr6rLttG9O9uaj+2E3NJDYggSAae\nzQrV7zTmYosxURCmPmNTZMVEt75ZDZ/LCiu4ud/9OGucuB0eFIvMZ9O+4cWFT5Dd49hEGUX4a0SM\nuSPA6/OxueD4dfz7UTWdcc9/yIwbLqRTy5SDbu9RfVz75izW1MtNy5LIzWMGcc2pR++H4rpR/clI\njOW9+Ssor3PSoUUyNtlEbmklKbHR3HHmELq0agxdOeukTrz2yxK8Pq1BNc0kiiTHRHFyh0APUscW\nyTw/8WyKq+v4Y2seVkXGpsh8uWwD5XVOTu3ajosH9yDaYuZ4IgriIUvo70c4mLV+hGQlJ6DEmPDW\n+gLOYQh+YYYJ/Xsfk/MeK/Id+UzZMg237g+3ExGZlHXlEYU3dezXjg92vMa+XcVIJonUzPCz3Jdk\n92Vl+W5+L9ruD3+KgupmmiC6IlIyzEabzkm8Ouqqw27P9n2hjSaPz8fe8mpaHkZupdlqJjkj+LlX\nzDKPvnI5j976EQL+GVeAsy8eQK8BwaHHV99+OlPvmxkgWGIySZx32UAm3zUmbL7ljNx/B5UXAFhe\nuYIrvJdhV+zYosy8+NH1vPyvb9mw0q+c2W9IB257dCxSvYGxp7w6QLBFTY+h8nx/GQutkxMjyQdo\n6N0aJ0pySlJJ9OoYRoi2Cf4/2anj22qmdqv/Hhl1tejnBv/cZQ/JR4nyBjiCYkZJaMtMuOf6EAB5\nQz5q7zYBoZaCSSdxRKM4RbUrCb15e0QQbDoZw/PJE7zsKtNJaGtCC6FSqeuwIbeCCbM+o1tPUNoH\nG2A+w0eVoxDLUBMxkxSkZBHvBo3atzz4djc3CSBqfTHqSS1RmyviGAZ4NZTvt7C90kXelj0owyXs\njzY3WAXqNP9kiiRY6Jd8KWe2Dv/bMXhkF9565ifcbhUwUE6OATEa874o/vPTvUTHNuYRxipWHuxx\nBk9t+BlV19AMA6sk49nnQ6hoZnDvrsIQ/EGJTXHXufnz+5WHZcwlp4QvPyAfxmRnXlkBiiTTIv4A\nBdAPwunpp5FiSWFWwVdUeCtpYUlnYtYEWkf970VSRAjNmrx9QeqyAOgGmk3CvcSGe5kVKcWHXif6\nlYmNA9TrqEcxm/B6/JM3oihgjVI4+6IBDevfvf9jqkurG/oqr1vF61Z5fvJ0Xl8+9ahdX4SjR8SY\nOwIe+WwO5XXOg294DKhxerj2rS+Z/+h1IeX+m3LJS5+wo6hRZVHVdF76cTGJ0TbG9j9wkeJDRRAE\nzurTibP6dGL+xp3c99FPeFQfBpBbUsHkN2cx664raJHg/xGNtpj5+LZLefTz2azOLUQQBIZ2bsOj\n40eF9VylxkZzQZPcouFdT0zVpeyUBHaVBKsCtkqMRRSPjTEHMP+eaxnxzNv46vwhqYYIhgz/uWY8\npjCz8iciHs3DI5seD8gj0dGZkfcf0ixpdLAffr0lQfAXSz4YkiDyYv/xbK8pYX1FATVeN6+oC6kp\nluo16eu3i/MgykenfEZTiqvrDsuYOxA9+2Xz8dx7+fO3LTgdHvoOak+L1qHFHU4+pTP3TBnHjJdm\nU1RQSVKqnStvHsno8w6s/rfTsSvsuhWVqxiZegoAm6QSFo4to2qMhIhAVkuJmPjGQX3f7JZsytuH\nEeo5rZAg3keA8owG2gIDx7xyhNPiMZr1gaIoYCkNLi0gmC0IqhZwHiXKi9XuoXm3I1oFoscruOf6\nBzumgnIEn4bevTV6ooKS7CFheAnWjEYDs1ZVgWDvnSjqeA0DCzp6HZTcn0DiE2WIsTpNnPoYukDR\n9jjcqo+tO1Q6tlFpVmECwScQGx9D3eNVDaUbLMMFzANNlE5yoO7REZo8mlKli07rKygZ0ooqhwuf\nrmMWRITl+USt2Ivo8l+f16mizlexTpSQsxrvp4hOsuxhU05bZi8ZQq3rD2IsK/nHmYMZf3KPoGtV\nzDIvfHgdT772HjVnbQfZ/x7LYi3btO2cRKDa6/g2feid2Ipv8tfi8HkYld6Z6UvmsE6tgybhoYYk\nhhybSrJEdNzBvQ5NadelJVExZhy1nqB1Z447+CTnTxvn80ne54gJ/nun7zZze/8b6Ns2+H4cCr3j\ne9H7MFRwI/xv0Soxlt2lwaHwoiyh6PXTG5qAtq/Rm221KWiagfcA0VLnXTqQxXM34XB46DekAxNv\nGUVcQuO7tPT7lSEnnXauzcXlcGONitTUPdGIGHOHSXmtkzkbchpUyf4yhkGDnvghqg6qPp1lOXsY\n0ikr7DZFVTUBhlxTXvxx0VEz5vaj6TqPzZwTED5pGFDr9nLJS58w++HJWOpDnFonxfHvmy/C6/Mh\nCEJIo7SgvJqlOflEmxWGd83GqpyYEvtNefeGcZw99T84vY1eDots4r2bgkPVjiZxUVbW/us2theV\n8uO6rXRrkcYpXdr+VxlyAN8X/hhWEODt3Bk81/PYzwh2sKfQwZ6CV/MxfdtClBZODI+EYYBo1rDK\nMme36n5Exw4VXryfHpnpAPw7Zwmf7FyOSZS4ufOIIz5XVLSFUef4vbILinJ4Z+1S2sekcEmbk4Ly\nJoaM7saQ0YcuxAJgEc1hCyknKn7DcXlpHv9YNtO/UBLQgflF27lg/lt8N8qfQ9rRIfjrrYlCUP8n\nliiIFhE5W8PlVTEMA2WJSuJbOYg+HV9iFM7e6Q1hhIKmE7O2CLnSwDBbAwwAk9WMbVcNjvZxDYaC\nX/WySWJk03PbxYCcSVNVFYNOa0v+sJ0NhZ2bEmtx4PXZ8OiB369hQJTsv09V0xMw3CKVLyQQd1sl\nYrQOOiDBnrUtcFX5vf11VTJV+2zYE2sQLP6rMDQDvc6gOKoQUW4ibiMJYDaImWymbKoP0REoxOVa\nlc/t44bQ6YyerCko5qXr38K2KVjuXhQl9I0CZNUfFwGLZCO2YiTT55Q23Igqp5vHZ82jos7F9aMH\nBB3Hnmah7oLtSE2sSh2Vl3Ne5+XezxKvBJbjaGdP5u5uo6nwVrCtNof77h/C3ff+wj7Dh+GPe0WI\nUbBaFNzN1GlNJonRVw4PasPBePHDG7j10jfwNClb0rV3JpPvOv2A++WW7+bTik+QUhqfFzHTw4sb\nX+Odli9jsxxetEaECAfj2pH9WbmzIOB3w2ySGNG1LWWbt1LkDDT0zBaZq247jX5DOnDNuS81hLc3\np0e/bK65c0zY88rm0OMtQRCQTiARvgiNRIy5w2RfZQ2K6dAUHA+KQeMA5jDk4zVdo84VPLPYlM0F\n4evTVDvDF1A9UvLLqnB5Qyt6VjpcfL1sI5cOCZyBVEyhH78Xf1jEx4vWNBRc5wuYfu1YercJId10\nApEcG82fU27i6xWbWZO7l56Z6Ywb0C1s0vHRpkNaMh3S/nsT5nNqg5UP91PpDS/UcSxQJBNP9TmP\ne1d9hU/U8Rk6NkmmnT2FCzKPLHT1yYtP4+6PfgpafkH/rpgkkWE/PU+pp7Ew8T0rv+LDHcv4/JTJ\nR3Q+t8/H6XNeocTdqLg4deOvzBpxLR1iw4eHaZrGTQ++ydZPViA4fci905jy0g3079quYZsz08/g\nsz0zg/ZVBJle8X4vxb/W/hjy+Dm1JeTVlpMVk0j1zlKSPlpH6WXdMWyBni0RgeHRHXn+rLPp8+BL\noArEfrUZoX7G2P5HPtacctwdEsEAy/Yy5FInmklC7Ng2oE81fDpmt4y3uA4tzoJulXEXivXKmIGY\nBBPEa1hOMeHdqGFKF4meZKZwUD4tzS3IdwUXPB+YnMRyLYZiV63foDMAw19YXRLryyjkKIB/Fr38\n/mRMWSqCxUDdJVPTJwaapELv+iODtjVriDpfQbAIeJb6cMzykPBCVIAxB36DTulpwhQiZ7eu0sFb\nd3+A/KBM/nkdMMUoGKKA0GyQp5gUTuk0lJ3mHJyaix6x3RiXcT5nPvZp0DEB3py9NKQx93n+r+iG\nEaQZYxgGn+/+mRvaXxq0fOaeWcwpnotUr7Pe8UaFZ1NuYNXyEk7qmkmPDq3ZsGgLD587tUGtU1M1\nbn/7elq2Sw/ZvgPROjuZb5c9yrIFW8nfVcrgUV0OWJag4Zr//AAhPvC+CSYQ43XemfcZt5016bDb\nEiHCgeiT3ZIpl57O01//Rq3LgwGM6d2Rh8aNpKBfb+6b/B6aT8frVVEUmS69WnPW+P6YZImsdqnk\nbi8KPqgAPftlHfC8Z1xzKl++9ENAnVaTLNH/zD4oYQy9CH8vEWPuMGmdHIc3zOz6YXOEkXduVTuo\n+l2P1uFDyxKibWHXHSkxFvMBi33/snZbkDEXij+37+bTP9YG1dy7Zca3/P6v6w8aWvp3I4oi4wZ0\nY9xhSM5H8NPJ3pGtddtCrosxxVDg3EuyOQmzdPg5krvqdrGpZgtto7LpEhusyheK0S0783XsDXyZ\nt5pSt4Nhae0Y3aIzsnhkz+DpvTsSF2Xhn5/+SlmtE5sic+sZg7lsaC9e3/x7gCG3n/VVe/mzJJeT\nU9oc9vluXz4zwJADUHWNKxe9z9Kz7w2739nnPYh3bi6K1/8+G7/v5r5Bj/DK6ml0b9sKgDPST2d7\nbQ6rq9Y07CcLMg90vr/h815niDpH9SwrzSUrJpHWnVsShYD29RYqxnfze+hMIvg0rGaFe84bjiJK\nCF7/hIipzBnQbcolDuQSR+DBdQM8XqjPpZVSfEiJGr4qUDMaB+2CSaFodjotxhQgmBptP93QMcVJ\nJDwV2E96dA/xShwlnlI8mo9aFWwmDVE0KHDvZlDLLCzeHnywfh2GV0DcJ5N8arhaYgK+PL/x2nzu\nXAAs+1zUfeql7t1G76cQRUBoZlMy4tKptnnweX1B4VFuhweP00vUz9upOrsjUSsLA4w5A7BGW5h8\n0cSgWXdnmAk6n67jdHuxNROGyasrbigVEXBNgkG+IzjPfF3VeuaV/IZq+Brqt7l1N++XvsdzY6c2\n5Gx2H9qZL4rfZe1vm/B5ffQc0RVbzF/zhA0Y3okBwzsd8vaVWhVCmHFsYfXxz6E/3miGhqqrmEXz\n/0zt0hOB03p2YFT39pTXOYi2mBuilNp1bsGHs+9h8dxNVJTW0q13Jl37ZDZ8N/c+fSE3Xfh6QLkS\ngAuuHBxSBKwpEx6+kG0rdrJpyVYE0R/mnJqVzJ3v3HBMrjHCXydizB2EorwSSvLLyOraCntiDHar\nha6tUhtERf4OJFFg4ZZcOrQI74VJskfTvVUaG/YEz8zcd96Io96mJHsUHVokhfUI2q2HFmP91bKN\nIZUxNd1g1c69DOwQSQ7//8q5Lc/mu8IfQgprVKqVPLjxEQQEhiQN4qqsKzGJB+++vLqXB9Y/RJm3\nMeQ4xhTNU92fxC4fXBU2KzqRu7qNPrwLOQADOmQy79HrgpZ/lrcy7D6vbJ7HySmH751bXBJaua9a\ndbHPWU26LThHb9XWXXhn70L0NQ4ABA1El4+HH57BN5881rD8tg63UOmtZEXFKpLMSfRplvuTaI6i\n0BW6IHmPBL+X/eRz+xKbZMe7p5ykD9bg65iBKMvIIrz54a20TvKH5SXF2CirdaLFWZCcB6vp6Q9Z\nFyw6sTdXorT1YvgEYhUDeZeHgjXpiCpE79PxFMagDjCjJHkaJtf0+n+hMEsWOtvOY8b2pXRJ3ttg\nuOjo7HLsQiCPmB1dcNSnVO9cmEW7YXkggKmNF99Ov3cuoK2igBTnF86URQ3DJxKzy4fYqR1GeSVG\nqf/ZNRzgWwS20TKqEXgPMtNac+OKG/j+jdn89M5cfN7m4Z4GcokDQ5GoOq8zsT9vR1A1lG4ipm5m\nbrx/gj9ksxmiIIQWYICQ6sjZUW3Jc60KVoM1BLJswQI880rm49GDo0yq1WryHLtpE53VsExWZPqd\n/vfll7WyZpDjqUJoNpckiAbdWnb8exp1hLi8biqdVbSIO3A+sUtzMa/oN34pnk2tzz8xFCfHMbnN\nJLrHRSYsjxeiKJBsjw5abosyc1qY/OY27dN459vbePmJb9ixeR/2OCsTbxnFqWcd/B1SLArTZj/M\njrW57Fq3mxZtU+k6uFPEiD+B+e9KqjmOOGtd3D/mSa7pcjuPnDeNSzKu582738cwjIb8lr8LTTfY\nW1Fz0O0+vPViTunaFrH+BbQpMo+NH8XpvTock3a9MXkscog8Lati4pLBB1cc8/l8LNqSF3KdACHr\n0x0Kmwv3cvZzb3HyIy9x5VsfUO0MXUIgwt+LJEhM6zEFmxTec2xgsLhsCR/nhw7/as4L214OMOQA\nan11TNlyYilyHVDt9Ah/QMMNwgFq1dCh1t/NWYFhCn6HRZ9B5apgL1O8Es9paaOCDDmAe7uHrvWV\naomhc5y/DzXJJl5ZMoWuo3ujtM7C5jJhqQWpGu6+5K2GMKEPb7kYgLqTW6GHaN9+BAHiUuMw223Y\nJ1ajtPUiKCDaDEQTJGZXktS2AnO1DgYoKW7kOG9Yj1dTFEHBpLfmgx0rscpOzCZf0FdjoJPavbDh\ns6PcxvrvOpG3LIPagWZ0cb8mY30cJnD7PcuZfPIqBrTMJ3qXi6RFlcgODcEkISQnILTwh8SabQpX\ntLqcZCUpqG1rqtayOmYVt756DTEJwYO+pjfI2zqW8hv7ED8zkcSXo0i4QeZTx2fcv/4hqtVqSj2l\nbKnZSrVazchuwQYYQK+s9JDh4xdljaDSbUNrEr6q6QK1XjNx5uBJOpcW+jlUDZWXcl6hyBU4Gan5\nNNavzGXN0p14PQcz6sGtuXk/70OuW3kTV6+4jimbp1LsPjIv2i1DJmF4RIwml6F7Qcszc/nQ847o\nmMebSkcVk2bfxPVrbub+bQ9y5Z/XMHXByyG3rVFreGD9w3yx98sGQw6gSq3ixZxXyHXkHadWRzhS\nMrKSeHbGZL7+82He//nuQzLkmtKuVxtOmziCbkM6Rwy5E5yIMReGF659k/ULNuF1qziqnagelR/f\nmsPP785jaOc2mOXDcGqGkIYWvEbw8kPEpsj0yT54/pgkibxy9bmse+52Njx/B8uevoVxA49MUOFQ\nSIyJ4su7ryAx2oZFNmEzyygmiatG9GVwM7EWXTeYuWQd5z/7AWdMeY/nv19Iv3++jsMTWlTBp+v0\nzc447Da9Pu93Ln7+c3bvc1DnMFizvYwhD09nc+HeI7nECMeYFEsK17SZhBJCGXA/BgYLSxfj0Q6c\nNwqwpXZryOVF7iJ8+lGsE/kXuaLdwLDrrm0/hJyakvpCy4dOm+jQeUAmQaRdTGivfsf2LRG04H7J\nEMCUFtpIWLo9nxe+X8iv67YHLD+9ZRfu6TYaUxNLqV1MMt+NvClgO9lqZts+h98SazJgcDm9THvg\nCwAykuJY+K/raXdyB+rO7IAea/bXhTOJCBJgBsEGSrzC07P/ySOvX4Kljweh2WMkmQxadK7ELij+\nsgNx3tAlDkLQ2taK+YWFuDSVBGv4CSFbcmBoq6GJVO+1U1GSyL5T4qlpY4VkgREjd/Php99z+sg8\nrjt5NV32FRO904XkbeIVFUXE+Fg6DOzAo7PuJvYMG/s8wdEWXt3Lr0Vz0AyN0VcMR7E0iQcUBMSU\nRMxd25OyvIboXU7Su5ZgTfYiKQZIOm7dQ6mnlAc3PMoD6x/m5ZzXuHPtvXQfXknvrMDJy/bpicy4\nMbSok0kwiFZUCmpiqXKZqXab2VtrxyypLKn4I2j7gYn9UZp/SfVUqzVM2/ZcQ2HtTWt2c8kpU3ns\n1o944o5PuHj40yz9PfT7DX5v5LPbXmBB6SI8ugfN0Nhel8N96x9kXdX6sPuFI94Wx6M9H8S8Nw69\nTkCrFInJS+XV8546annR6zbncN/8fzF56Y38Y9Ud/Lzv16Ny3P3cvvQ+tFhPw6smSLDZsp73VgZP\njn2z9zuq1dCedc3Q+Lrg26PatggRIhw5kTDLELjqXCz5djmqJ3Cw53Z4+OKF73lv8ktkJNjZWRws\nQx8SA7/hJgqgGwgGRJXqeG3gs4gIhgEGaFa/etfBSI6N4vSehy/Tfjxok5LAvEevZfWuvVQ73fRq\n04KkEEUrH/rsV+asz2lQaXr/91Xhal8jAI9dNBrbESTevvnT6iZH2f+/wdXTv2DpE7cf9vEiHHvK\nvGXogha2GPp+6nyOA+bPubQDe2C9uveQQjUPBV3XWfr7VjwelaGju2IKI+4Tjms7DGZm7goKnIGD\nJ7vJwh0rvsAk+qX97+t+OhdmHZoAy8sDxnPevDeDihI/1PPMsIPPy8YM4a0WM5AL6hCa2I6GSeTK\nuy8I2Nbp9XLO1PcpqW7M9XvUPJuv77mS9Hh/KZKr2w/i6vaDKHfXYRg+llQs4p3cN0mzpDEq9RRS\nLaks+HUDvhAy2AD5u0qprnQQGx9FXJSVVy89C/Hyc0hMiWFPVQFP5EzBsdONd52GmCggD5R5pGQ6\nD3a/BVOuhM8INtjjY02075nNvD+24SmxIIgHn1QzCSYGJw1iQcFaADxa+O83055GvtXcoHis+jQQ\nwOvTMCSBmo5WajUr5181j/j4xgmJHTvi0fXg78UWY+HmNybSpVdr7lh7T1jFV5/hw625mfDIhaxf\nuJndm/bg9aoIma0wFAXNEDC5dOJ3e0jMrEQ0NQuFRG/wwKia3+u1pPxPLht/Pi9GncvyHXuYt2EH\nC7fkMvih6ZzarR33jR0ekIPtMzRsskZmXBVezZ9/F2vxP9Oh1E+HJQ9jcekSdjvzg0JbDQycPhc5\ndTtoJWby0E3v43IEHuPpez/n3e9uIzktUCUTYJcjlz3OPUHqowYGL29/jZd7P0/MIYRaN6Vdchbv\njH/+sPY5EEWuIj7c/Qmbq7dS84GdqMsqIcpvaFX5vHy2Zyaba7ZwV8e//lu1umA9RnSwNxlgQe18\nxqlnstuRT6I5kZbWFqyuXBs23Bgg3xksBBQhQoS/h4gxFwJXnTtsaFNtRR2CIHD2SZ159Zcl6Acr\nUWAYxBToeKIEdLOB6AVLnQE6KA6w1Oj1qpb+Qs91aSKGcmCDbsYNF4ZVgjwRkESRfu1ahV2fX1bF\n7HXbA0RODjacOq3H4RuvS3bsV0dsfj8FHM6jXysswtEh09YaSTDhCyEBvx9FlIlTDlyXbUVF+Dw0\nCQmb6egIAf00azmvPP5dw+dp933BhZOGMvmOA0udN2fO6bfzze61vJuzBLneeNtR6/fI7ffKTVn/\nM62i4hiQfHBBlHb2FH4bcztPrf+VdRUFtLDFcn+P0+kef2Cv/qtzHuPWc6dg2lEFooCuiPR7aAwT\nzxkWsN2tM74NMOQAHB6Via/NZPbDgTl+SysX8cWeLxsMkQ3VG/m9dAF3driNyrJg4ZcGDANRElmx\neDtT75uJs75vTs+Ip9f9dnyKhtxWQm7bKNyhyeVc++MsBvSwU6EGT7h5dZXaYX+Q4JUoXxGLY0c0\nUW3rEJXwvZCAQLfYrgxKqeXr3Wspqoumlb0qZEWZSR0u54l/ZbNiRwFen4+TsltyxWufs0UtR40y\nGiIsJ/88lnlXzkEUygCR7Oxa8nLj0Zt1TapXI71VAoZhUOENP4FolaxYJStilMgrS6aw7vdN/P7D\nGuYv2IHX2/gu6T4dQTQwDNBKGBrcngAAIABJREFURTBAitODcsH898rL7KK5jO4xiumzl7KnvKpB\n6OqXNVv5beU2htVGc9YF/Rh+RneiTDbSLekUuApQpMZziogh66kposxDXR7g8c1T2O3MD3nf63x1\nLJi/Hp8a3B9oms78H9dx8TXBJQoKXYVoRuh+XkdnaflyRqeNDLn+eFCtVvOvzVNwaS6cSy1IXR3Q\nRIhn///rqzdQ6i4l2fLXlIpX79sYcrkggGHRuerWx/HtVpBbqbS/IBYl/cCTpy2sf2+6yf9nqqsc\nPPvPL9mzq4TW2cnc/fSFxMYeXk3FCP9bnLgWwd9IfGocsUl2ygoCc21EUaDPKH+Y4qge7XlzzrKg\nukKhcCQJ6PX1grABIkguA9nTxMyo/4GPKtWpa1k/MAkxUujcMpnUuMObTTzR2JBfhCT5FesOBQO4\n9q0vmXHjhWELi4dCPkBuTYQTl04xHWllyyDPsTukZ0VE5OJW45GEA6tKVnrDqyn2iDuyIr/7Wb97\nH89+t5CteUXEzy8Nilef9e9FnHRyO3oPDJ1zFI6xmb0Ym9mLIlcNY2a/GhRa6dZU3t2+hB2/7qKi\nqo5Jk04jOiq8ql+K1c5LA8YfVht6tMtkwea3WbMtjz3F5Ywe0B2rOTgUbsXO0KHK+6pqA5QOF5cu\nYdaerwI8SgYGXt3LO7veY0Lv65BMYsgita3bplBSWMXDN33QuNAwKMyvoPi+ChKf0YMUBg1dwJCc\ndFVGskz7Fp/uC/AweHQPHkqIP0UgpqOD/E8y0AZUkDygFsmiozVRVgS/Sueo1FNJsSRzY8dhzNm7\nhTofbClLoWNiCSL1IWsIXJRxIR1j2vPKz38wa4k/lO+Cgd1J7RTLxtwy/wHru/RSxcxq33sMSK0C\nvYLxN2awaPHHAfXPzBaZIaO6Ep/oD3GNl+OoVEM/12fZz2D+x4vZu6OIvI278bp9yC1TAgy5/bg2\nKVh7e5CSG++LWiQipwV/B07NyeKteRRX1wYoFuuA29BYnl/Ijse/YcXi7dz79HgmZ09i6pZn8Rk+\nfIYPRVSwSTbGZ4wL2W6TaGJk6ql8tPuTIO+dz/ARVRHPm9M+QA1xHT5Vo6bKGfK46Za0sF5MA4PV\nlatRDZVWtgy62rsgHkri5FHkt+IFqLqKgYFrgZW4WyrDpscuLlvC+Rl/LS9vSOv+LMybF7TcMEAr\nF3EttYAuoBaKrF/tov1TgF2AMJ7rCZmXhlwe4a+xdvlO7p/874bPxYVVXDz0aZ56+yr6DGx3gD0j\n/C8TMeZCIAgCt795HU9c9Dxet4qhG5gUCUuUhUlP+juwrOR4rhvVn+m/LsXXfCo18GDoVgKMMq8d\nFEDxNKtZA4gqCJpBQxpHfXimLIqYFROPXxxaVOC/iZTYAyToh2FLQQmLt+YxvEv2Ie/TL2v/tvWu\nzwYM7NGRR/9ERRAE7u14F98V/sDC0sU4fU40NAQE4pU4JrS+jD4JBw81bBfdFrNoDlLLkwWZ0amn\nHnH7thSUcM30WbhVH7YCd1i38qtPfst7P9x5ROcod9chi1JwEWqfwPxVe5mv7gPD4OXXtnNamZ03\nnr3+iM5zIHp3zKJ3x6yw65tLXjfFpfoajLlv9n4bNlyrRq0hs3c8nXu2YtPq/IBjyorEY69M4Kl7\nPgu5r+Yy8KyxYukfGE4rigbVdSZ8rgQe7fIgvxTNYXttDiWekiCDUmpRwzOvXkbfpJOQRIEHNz7K\nPlegUrEgwNC4U9hZVE56vJ1vR97IjJwlLC3dhd3owZkZmbSOjqGLvTMm0cSpj71FaW2jgfHu78tx\nZhhBAQJeTWP6yuUMHOvPP8tsB1Pfvpo3nv6eHVsKsdrMnH1xf668eVTDPhdknM+Huz8OMHoEBLIK\n2/DaiPfRNT3Ag6WkJiIkJwU+oqKOtY9/JrGp8WBK1VFLReQmBp6AQOeYTuTsKcMTQmXYMImo0RLu\nYhd/zN3MrklFZHfIYlqPKfxespBC9z7aR7djSPIgrFL4SYeTEwcyp2gexZ7ihmtTRIWz089k+j2/\nhBU7sVgV+g4OLejVNrotqeYUCt2hlac3125lc+1WFEEh1ZLKg13uO2Abjza5ztwGVVJDE9CdAkKU\nEdKgS1AOXIroUOiU2g5prQUtzt1wjv2vW81HsbBftMYQMLwCBYuqsZwBpmbtEQWBG9teTwtri7/c\npgjBPHzThyGXP3brR3y34rHj25gI/zVERrRhGHBmH15a/CQzn/2OvTn76D6sMxfecTZJLRtFBa4b\nNYCEKBtTvp5/wBprQb2zKOC1g6XKCK1hZxjILrBUGKhRAlgFLji1O9eOGUBSTBQ7isqocrjpkpGC\nLcSM+YnOSW1akhQTxV61uiGvBPwlF7QwYatOr8qf23cfljEH8M/xg3nqiz9oPuL+/PYJh93uCMcP\ns2RmfKtxjG8Vejb/UOhi70xmVCZ5jly8un/QpIgKbaKy6GI/tFpzoXhj9p946nM9JY+OEObVr650\nhF5xCGTHJAeFiBkGeIutfjUSWQD8yoi/ptXyySe/cdllpxzx+Y6ElNjooDBLAMUkkRjTGMJaoYYv\n+G5gYJEsPP32JH74fBnff7oMj8dH/6EduP6eM7HYFPJ3lobe2SdgVJkCAhg0TaCs3I5oWOmemkqG\nLYPJ2ZN4d9e/KfaEVjH8pfQXBqb2Y1vtdso8ZUGGp+rTuHrWS1TvSEfTDS7o1YnRHbK5ffAIrJbA\n2MRPF68NMOQADIng+aR68qsDcyQ792zFq5/dhGEYCIJQL9LT2HcNSx4CwJcFX1OlVhEvxzNMH8p7\nl8/E6w42eLylFUgJ8dCkPqf1VGeQIbcfQQ7sJyVB4uLW49nkqcWsmHA2M6oEn47s8BuPhmGwYWUu\n2R3SiFPiGJtxbvAJwqCIMg93eYCFpYtZXrGSKJONUamn0kZsy9tbnwqrFdazfxt6DQj9myAIAg91\nfoCHNz1G+QHCU72Gl33uQmbumcXErCsOuc1/lda2TDZWb8Zn+LAMcuH4NRr7hECVasMASRAZmjT4\nL53L61GZ8eKvVH6bhHJlCZZeXr/8nVug+kM76ubG0kGaWaB0jJnalDiMlRAd5aJD233YrB6cLgVj\ny0AG9O/3l9oTITSGYaCGmDQB8Hp8Df1ChAjNiRhzB6Bdrzb88+PbDrjNBQO68dGiNeSXVaIeyKBr\njhDKXwS6DDEF9bWLZDD7BDrFJPHA+FMpqqpl3HMfkl9WhUkS8Wk6d5499JCKcZ9IiKLAjBsv5O4P\nfmTL3hJEQSDWZuGpy8ZQUlXDw5/PwdfMqFNMEolHUOz80oEDOLVLZ+78+Cv2VTjo0zaVqReOPWyB\nigj/ffg9fHcyu3gui0v9SnrDkocwKnXkX/pB3Lq3tGF47Y0zYUgEiIXsp2O3w1df3Y/VJHNbl1N4\nafNvuOvFKAyX5J89b9Z2Q4TXf1t8RMbcrvV53DniURz1oWrJGQm8vfkloqMP7qF4ZsIZTHr9iyDH\n5CPjAvOQ0i1pFLhCh2R2iulIlMmfC3L+hMGcP2Ewe8qqKKmpwyvoWIC4hCiK9oZWuZ04aDwfub7C\nZKnGp4kUFsVTUpRG56QkBmU01qQ8kMelvL50Rak7tNFoiDpytAtHnRu5xMEnrvV8umQdgm5wfptM\nHrvrooZtP168Nmh/IUwkvigI9G0R2ruxtXgHb+x9gxrNP7iPMcVwR/t/0DYmm2HJQxiWPATd0BEF\nkTfu+DdqOJl+3UDblY+9e3tU3W88x7QMnQslCCA06xaF+r9hXdoQZ7PiVX2NfbNuIPgMrCX+70Yy\nidjjjjwPVRBMlDhiWF0UjyBAqslJq2Q9bNGOqBgLj7x0+QHf5Sg5iud6TmNR6R98u/d7ytXykNv5\nDI2l5cuPqzE3MmUEc4rn4NN82IY6qXwhAfcyM5YBjZEEEiL3dLzzL6ll/vD5Mt565ifUeo+te3oi\nNfhDeKe8OZF/bn0P6icwDKDgjGi8SWKDymudw8q6TVn07bUDq6KSW1iAqvqQD0fRO0KECMeUyNv4\nFxFFgfdvuYip3/zG7HU5qD7toGIe+9EVEFQarDpBhBsvH8bnP62iQHGji35v1XaLgxU7C3j669/Y\nVVzu917V/3a/8MMi2qUn0a/tkQ8c/w7S4mL46B+XUFbjwKWqZCTEIggCbtXH098soMYVGBonCgLn\n9ut6ROdKtdv5+MarjkKrI/y3IYsyZ6WfwVnpZxy1Y2Ymx1FU5Vf98yTIqDEm5BofYrO5nLufPHKv\nIsDEdifTOiqRGTl/UOquo3ang2LBwJCbDV4lAaf58I3T8uJKru91T8Cy0oIKLoibyGzfzIPuf1J2\nBt/eO5Gnvp7P9sIyWiTYuX/sCHpmBRool7S6iJdzXg3IQwNIVBK5vu21DZ+rnW5u+/d3bNxTjCyJ\nqD6NSaf0Y8KNp/D8w18FeWdi46M485RBDFf78dryP/l221YUxcNpJ9WQai9gbvF8RqacgiiKnJI8\nnNnFc0JeR3q9kEPrqNYhc6w0n4Cj3Iap1IGaEgUmsaFK3Fe788n8ZD6TLvOH7Soh6mwKhoBcZeCL\npyF8PtrmIcaqc0WvQA/xji2FTHtkJp47N4DYaLfX+mp5YstTvN7n5Qbjd3+Ol9vhOaAQl6T5GD2s\nDafd2Yl87/vkVe5jvjc4bM8wwKgTIbqJWIphsKJiFWe3OJOP/3EJT8yax4Itu9A0HXO5StwWR4Nn\nWpRETj7lyDzehmFww5KPWVtRgEtTEQ2dt+p2MtPyOeY2dvSdasA1yoqJMy/s68+9PgiiIDI8ZSiV\naiVf7w0vp2+EEUs5VsQpcTzU+QHez/uInLodpNxTS9s9PYj+MwVXdhl9undiZOawv2TILfx1A+88\n/0uDIdcUj1vl4zd/47zLBjLrvT8wvALuFAlvrERgzJCArgsUFceRkVBB/NYaLh0xlcdenUC3PllH\n3LYIwQiCgGI24fUEzwCZLaaIVy5CWIQD5T0cb/r27WusXBlege6/gZx9ZVz28qcNkvsHxDCQ3KCo\nMLRHNo9cPQbZJDHq8XeodQcaM2aTCUEg5HFP7daWlycdekjLic6WghJufe9bal0eBEFAEgWeveIs\nBnXM/LubFiECq3YVcMPbXze+i7pBTL6bqN3+GmHJabE89dZEWrVJOarn/WLmAu4vWIHRLIlFUHV6\n5wjMevPuwzreDb3vZue63SHXXXjn2Vz/3MQjbmtzNlZvYuaeL9nn2keMHM3o1FGMSTstYHByw9tf\nsXzHnoAIB6ti4vGLTqNoUT4z/70QQ/ebWy0zE3nhg+uJbeIJ+j73Z2aVzGowxwQgRo7hxV7PIosy\nz219kQ01gYp+siBzZ8fbGsJun9v2AltrtjfmMumguk1s/roNOjKEEFWKq1VZ9Pa9ACzcvIubZ4Q2\nGCaceRILS7ZjS1uPzebGLMro+BicNIiJWVdQU+ni6rNeQDytFNuZjpBhkKckj+CqNoHeoxW/rOHx\n8c/jdoSuu2i2Kjy98lJ2maegGR7A4Oft3fEk+D10glCfO6X6b1pTQRkRkbEtz+W8luc0LNN1g9VL\ndzDtvpn4fDqGYRAdbeHRVy6nfRe/Uuov+2Yzp3guquFjYGJ/LmgxFrNkDjsYXVqay81/foZT82JC\no2tyESZJR5IM1FKJqmmJmDxmdNWfv56ZncK0d6/GYjv0NIOtNdt4YfvLQTm0+69zUNLJXJt99SEf\n72iiGzoCwlEfrF93/suBYcqigWAzMBwCGAJKosDbP9zCR88u4rfv11HVQaboJCuGEvycJydW07F1\nIaV3pmB4RKxRZj6dd99hfQcRDs6Glbncc/WMoOXP/nsy3U/KOv4NivC3IQjCKsMw+h7SthFj7uiz\nNreQp77+ja17S4i2mBnZvS3F1XVs31dGlcMVkBcmSyJtUhKYddcEBEHg+1VbeHLWPJzewLAZWRIR\nBSFAzn8/PTPT+egflxzz6zqeGIbB1r2lqJpGl4xUTIcwAxvh+FHsKmF5+TKGJw/Hbrb/3c057izY\nvIupX/9OYWUNFtnEZUN6cfOYQcf8Oe13wxNUtLc2eOcEn4Fc7eO36yeT3iLpsI51huVSfGHyM5Ja\nxvPpnrcPegxN05j25g+s3JJHeqKdR/8xjpTE8M+Druusmr2OdYs244itI/p0My1TWtDV0pvznv4k\nZKh6SrLIuReI9IzqRUp5a5JT4khOCyxL4XC6uGn9LQTJihr+0Nprsieh6iof7v6YP8r+BMAmWbms\n9SWcnNRYsF3VVb4r/JEFpQtRdZXyPVHkrEhAL/Jh2BQMJVhBVXaorH7z3obP10yfxfIdgTW4+rfN\nYMZN43lx+ytsrN4YUHZDERUubnUhFT/JfPTGfGw3FKN084Y05tpHteOhrg8EXqJh8OTFL7L85zW4\nHe7GdplNiJLIbdOvg+EvU6vmAlDjs7DJ2ZJSTwwGIroGermAlGAEFVmXBZl/dXuEltYWaJqOo9ZN\nVLQZySSh+TRyNhcimSTadkpr8CA9uelpchw7aI5FtNAzrge943rSI64HUU1Kg7y+dQGvb/kdA8iy\nVpIUV0tTh5Sugmt1HJfaz6dd5xb06NfmoIbP9vIy3lm7nDKXk7EdunB2u068nPMqW2q24N1vrPvA\nqDKRmGDniZMeOey6cyc64wY9gaPOb8DbxjiIOqsOwWRg6ODdpqDulEkbBy/1eQ53jY/Fm3dy95r5\nuLXAfkEUNTLTS7EvVnHN8wuYWaPM3PHYWIad3v1vuLL/39TVuHjhka/Iyykmq30qdz5+AdH24yfO\nE+HE4HCMuUiY5TGgV5sWzLzz8pDJqrklFfzri7msyS1EFAVGdm/HQ+Mac3gq6pyoWrDBpmo6UoiC\n4maTxPAuB6859d+GIAh0zji6no0If50aTw23rruj4fOswm8QEPhP/3f/xlYdf4Z3yWZ4l2zcqg9F\nkhBDvJvHgj9fe4AJ/3iF9bEedFkgfa/GO/dPPGxDDsAabaG2InSNN1ddaC9PU0rKazjjrldRY8wY\nJoEdFeWMevhNHj9/JGNHnxS0vdft5d7Rj7Nz3W7cdW5/XbPHIfVVO0bW92hkEWyNQZXTzeqq7Wyq\n2UJWVCb3ptwVtM37C7/CiA+hMSLA0rIVXJM9CVmUubrNVUzIvAynz4ldtiMKIh/M+JVPfl2OBpwz\noCs3334e4zLGArDIlsudS3/AHe1FCKVarBu0khR0Q2dLzVbqfA6ev2YUe4pcvPjDYgzD4I6zh9Ij\nMx2X5mJj9aag+on+Wm7zSN/dD6/Hh2mXgtItdI5gVnRwdIJTc3Lu26PpvaILW2fuwmI1k90zk6QW\niXQf2gmv4uH9HVVIQixRoptF1R3xIUL9MyuKIKaFntSNk+Oo9FSy/MtcPpr+G163imw2cfE1w7jo\n6mF06hFYT3R7bU5IQw7ArbtZVrGclRWrkESJa9tcQ/9E/zglyRyFWZJxayoJdgfNIwtFGaz9qhja\nvSspUfEhj9+Ud9es4OnFC+vVUQUW5Obx4opFzL7kJpZVLGNB6SJ2rClGz6hDiNao0Cq48+Mnyd7W\nm8ysVMaM60tC0uEbdhV1Tr5atpGcfWV0a5XGef27YLdaDr7jUaZarcYwDNp2Smf9yjysoxxEnVOL\nWK/XY9QJyO1VzN28OHRYWr6MYclDOXNQdz4r3saKwgI8DeMQA1E3sHwl4NrQqERt6DrOMN7gCH+N\naLuVR166/O9uRoT/IiKeub8JVdMQBSGobtrmgmImvjYzKJzSpsic07cz367Y3LDObJJItkcx884J\nxFhDVHyNEOEoM3H5NSGXy5h4t/9bx7k1Ef4Kv3/+B1MufSnkOkEU+Nn9KZIpfC2/c254kTxFA7nJ\nNrqBXOVm9b//GbT9zOe+44NHP8fjCjRUpDSB5C+j2fBdZzRvcwUOnaTsSlr39cvLm0UzV7eZyMDE\nAQGbPfTWK+T3WhfSm2XSZGac/GbIaxg/YSpbE0yw36Oq6aTsczLvi0catlmbV8hbc5ax/vdN1CRa\nGq9X0xE0g+euGsyP4he4Nf/AVjM0zkg/nXEZ5wecq8pbxd3r7gvKHQSwm+yckz+BN57+EbfHTcrr\nxQEFpMEfCvhGn1ewmhpn6H8s/Jmv936LSTChoxMrx3JPxztJqS8wPbtoDp/vmQVGfdsQ6vOhDn3y\nQdJN1M6MoXZuo1FitshMvHUUF1wRqLL47q73WFT2xyEdVxZknu81jVg5lhqvm1N/fRGHz0uv5L0o\nSvCEpq7DiOQRXNP2wCIlVW4Xfd95g6A0QsFgYr8ePDrwND5a8C2zxe8RzE1KVXjBtdSK57MkJFnk\nmRnXNISNHgo7i8qZ8OpneH0aXp+GRTZhM8t8dvtlpMcfn+iFYncxb+x4q0FwKI54dj0lEX1LMWKM\ngbrbRPV7cWhF/vdM6ezBPqma7q06cl+nu6lVa/mzbAVfrd/Dn3nVOFUPsYKDuJk+TM1EaWXFxIzv\nbyclPe64XFuECP9rHI5nLhK79jchS1LIAthdMlIZ3qUNVqVxUGORTXRrncY/zz+VNyaP5dRubemR\nmcb1owdGDLkIx5xddbl8sedLPtsZXhRDxcfULc9S5A4t/x7hxGPExYPDCkiIonjQ8X6+7gk05ABE\nAdVuZuWGXUHbz/1wQZAhB6BXGWh7dFqdVIgg6eyX4hdEHZOik9a1MefHo3tYWbE66Bjd5O4h6/0Z\nBnQUuoRs/+9z1rA1UfZfgyj4/2SJknQb01/9rmG7XlktmH7t+fzx8UPc1Ksb9hoV2amS6RV5d+I5\n/Cp9TZVajVt349bdqIbKr0WzWV+1IeB8sXIsdjm2eTMQEekZ153hY3oQmxCFSTRR9kgyvhLJn8tm\n+MVinuj2aIMh59VVPt8zi1kFX6EaKi7dhUf3UOop5fntL2EYBrsdu/mi4Ct/8W4kfEgY/hLnIe9H\nODTRh2VsFZgab7DHrfL5uwuCtt0vznKorKhYBYBdsTBj8BWkWe2UVseiaYFt1HWoc1hYWrkE/SBC\nJXNyd6CHfBgEvtm6GYB51XMDDDkAQQHrQBeq4MXl8PLcg18e8nVUeCuY+J93qXN78NanQrhVH1UO\nN898F3yfjgWqrvLk5qnsduY3FGwvM0qxP1CEGGOgVYtUPpuItlcGTQBNwLvZTOWzCex1FrKsfDl3\nrruHL/Z+gZqwhD69NzCo/1a6nLQHW2s3mPffdwOTWWT8pCERQy5ChBOESJjlCci0CWfy/cotfLVs\nI5quc27fLlwwoBuiKNCvXSv6tWt18INEiHAU+DDvExaWLULV1ZBKf03ZWruNJzZP4ZkeUwPyYSIE\nU1FUSc7qXBJbxNO2Z9bfplJ22qRTmP3+72hN1O4kk8SAs/ogSeG9cgfDCBGSKIYxHA38Sr4JrWsw\nR+VSvC0Rr0MhJqWOlI7lyJZAL41u6Ki6iiw2KnWMGdufr6b8hOWiwHpiQp3E7cNvCHne/3z2O0SF\neKYlke8Xr+fGW4NFpW68egw3Xj2m4XNuXR61W4NDVT26l/klv9EjrjGfSBAErmlzFS/lvIpP96Gj\nIwsyFsnCBRljMSsyr3xyAx++Po/F8zYjvZrI6eNOYvykYSj1k3s+VeOPJev5XP4Ap6k26J00MKj0\nVrLHVcDC0sWoeqiSBcFF7/bX6mtas6/5LqYWPnz5jfe8utKJrusBaotnpZ/JL0WzQxwgGB09oPh5\nz4QM5p9+O+sqCnh83VRsVk9DSz1eE1aLF1U3GkoyhMMQwvVTBhr+Z0mzecLUeAUhysDwwN78cmqq\nnIdUbuH+tY9QXZZN8/uqGwaLt+QddP+jwZqqtXh1b9h+2rXIitHc4akL6JUSpZurecMXOrJCECHu\n5ko8ayy4l1uQzALnXTiYK0eNCrl9hAgRjj8RY+4ERBJFxvbvytj+RybFHyHC0WBH7Q4Wli0KGHAd\nCAMDl+bm8/yZTGxzBZJw5MbA/1cMw+Ctu97nu+mzUcwm3IKBt0UclDnAItP7koE8P23ScWvPdc9c\nwZal2ynOK0X1qMgWmdgkO7dNv/ag+7YwTBT4NDAFhlmaaj3069kuaPsxV5/Ku/d/hMfZLMwySUBq\n5R+cRyW6yB5UcMDzbqzZyC2rb+fyzEsbimjHJUTx1OQ7eGbap1T3yUOM0Ugqb8lDl93I539s4P/Y\nO+/wKKouDr93tqb3hBBSIPReBEVABcSCfHb9UBAVC/beFQVRFHtXVKygIgqCWBCx0atK7wQICek9\n22bmfn8sKZvdTYGA4Levjw/ZOzP33pmd3Z1zzzm/s2z7PlpGhXP78AFEBrvDBc0mA0L6KCUjJaZG\nysE7dIdfw6JCtdXs53TxzMdz+XHfLqSeQnhECcH9SqhQg+kQ2hMp3dEVEVEh3PbY+dz2mLchuXdX\nLg9cNw1xfg7mU8r8+tcUoVChVmDX7X4e7H0fKTXQKwWGMO9jhEGil3meZ4ukKC/Z/HBTGFenXsXH\nez/1M7ta80ShZ2R3z3GEoGdMMv0S01ibswuXasRg1AgJcgvCtAxqiVGp/7HlP+mdePjnhd6FxgWc\n1sZdezC0OJry0DzqvnXSJdCLaxqNdT3PPlhb+Cd23YYQsro2W20sTazHtvL3rWz5ez89+rWh1ynp\njT6uwFFYrcLqC+2gEVze96oEpF7/YpJQwNrHjrWPHbNi5pIewxo9rwABAhx9AsZcgAABfLKqaG2j\nDbkqNKmxJH8ZW8u2Mb7zI/86dbgjZdGMxXz33s+4HC4cmoYMtqBsz0Vo7sCwv1/6kfNW7OC73ycf\n9hiTZ//KrBXrUTWdiCALk/57FoO7eRtXAKGRIUz96wXW/vQ3GRv3k9Q+kZOH9643V66K9yeN5T8P\nv4MaakaaFHDpCCl54ILTfe4/YtwwVn3/JxsWb8bhcIJZIgyC6GeC/XomQ5QQNDQcuqPaMHEcuic/\n3TuDFtYE2oe1A6Btp5a8+9G9lBZXYjAqaAqc/fQ0yu019/Cs5et5/brzOb1zOnffej6Xv/eV96C6\n5LpLT/Nq/mPBBj56bSE5394fAAAgAElEQVQlxZV06NqK28efT5uWrX2G/ZmFmR7hvXht5XJ+3b2L\nXX9lUBFrRsa5f3LzHdFY5xnRB5nIKc9g9B8fMv/MWzD4MQyllEy4fTqlRRXEdq/wKu5dG01qtAlp\njUN3sLpwrZcUv4KCjuechXArO9rXWAk+1eYWp6ka2wXOnWb0opp7wmI1ccN95+CLIQlncGpMf37O\nXURmZSb7KveTZc/2MCzNipkz44fQMsh30fQrU0eyu+IZXLoDHbdsv0kxMSZ1tP8TP0SQycRDpw/g\nmd+W1DoJCIuCx/u553xtt1G8nvMq0iyrDTrpgLIvw0EXGAwK3U9qTXCI+0LYNBtlrnKizVFexmRG\nRYbbe9WqlOLMcKRe8x4KReeCvr7DfOtSXFDODRe8SlmpexHgi/d/Jyo2lPfn3UVIaMMiKm1CW2MU\nRjQv95sbazsdx58S6ajzWZNgiPVfSklBwaKYq3bltrY3E2oK9bt/gAABjj0BAZQAAQL4ZOa+Wfx4\ncIHv/JMGMGCgX0xfbkpv2MPz/8QtfR9kx1p3PpmjTSzmvYWIOnL8UhE8tfJpTunTrsn9j31rFqt3\neXu2XhpzHsN6tD+8SdeDzeFk0mtz+HtnJvGRoUy8/RJSWvlX1pRSsnn5dua8+zPr9+5G9pRE9ldQ\n00rRqRXqiYGTovswLv16Fuct5ZO9030+pPaJ6s0d7W71OdaNU79m+fZ9Xu1mo4G1U+4A4KEHpvGd\nvQikRCCQiqBPucJH0+72OGbayz8y68MlHm1CEUydfQf7w3fyUcYnqLoLHYlFsRBviee3NS0oqLQj\n95TgSghCWjwNZOHUsJpL0ZNNhBjNvNzvMgYl+Da6M3bkcNfod7DbXMQ+n4MhynfemFmYuTJ1JIPj\nT0eXOq/veItNpZtx6I5qg6hvVB/WFK7DIb2VCO3rLDi3WAi9pMwdcmiQOHeZKXk7CmlTsFhNJLeO\n45rbzuSkgY2/n6SUbC/fwYqClYDg1JhTaBfm+1yryLHn8F32D+wpzyApuCUjEofTKriVxz7FzhKM\nwuDTuNhQmMULa34jp7KMoWnp9ImN4uNd32DTSwk3RDM8fACLdi6iLLwQvchA5fww9O3uhYWY+HCe\n++A6QqMtfLjnY1YVrsEgDBiEwuXJlzE4vmbBYlvZdiZvmYLqVNjxW2scpWa381MKYuPhuzvvxNoI\n79z1F7xC5p58r/aO3VvxynTfocK1kVLy7Nbn2Va23adH1uAw4niyDcUFFWjqofvHpGPu6CTqziKv\n/cEtOHRr25sAgQA6hnfEXCu8+ViTkVnAtz+vZ2/+QQoTt6K3ycJiMtMurC3tQtvSPaIbrUPT/rH5\nBQjQnARKEwQIEOCI6R97Cj/nLsLpM++mfjQ01hSuhaNgzO0szqbMaaNHbJpXmNeRMOXpGXy2eT22\n1mGYChz0LDUzY8b4ZusfoLyoovpvQ4XTy5ADQFH4cNrCJhtz5TanT0MOYPzMn46KMRdkMTP5/v82\nen8hBBs2H2T15nwc9iBYBGWLJdF3Gwlup1S/nwnWeK5OG83KglVM3/uZX29DobPQZzvA6p2+r4VT\n1di0P4cuyQk8+9x13LA9k5dfm4dL0xg39mx69/W8Tk6nylcfLfHqR+qS5x+exeszbyE1OJlfc3+n\nxFVCr6ieLN3uJL/yL5yahtWpeRly1dcjS4dkcOkaGeUFfo05p1NFHLo2tqVBhJxV4VUTLsIYzp3t\nbyc9tA3gDre8vd0trC/ewOqiNVgVK4PiBqLqLtYUrfMSjJEuUHON2H8PxbYkGGNLFb1U8fDIIeHR\nF0aS2Cra5zz9IYSgQ1h7OoQ1/h5MsCYwtvU1Prftqchg6q73yHO4jZ82Ia2JM3ZhR1kBg+K6cH5K\nX7pFt+Tjs64E4MudC5m2/x0Ui06QAna9gq8qZ3J9/3EMSXI/K+3udZCdW7JIaBlJtz7u75Z3dr3H\nmsK11YIiAJ/t+4JocxQ9DoWIdghrT7Q5mkIK6ThsFxUFQTjKLARF2nll0CONMuR0XfdpyAFs3VB/\n2HEVQgju63A3M/Z+wa95v3lsMysm+iX1ZdCHg5n43HuUrBEIk8R6WgUh51b47M+smDkl5mS6R3T7\nx3J6a7Nw8RaefWsBLlVF10GYgjHHJZN0xT42lGxkQ8lG5md/zynRJzO29dXHxZwDBDhWBIy5AAEC\n+CQlOJkLWl7ANwfm1puLcazYWpjJNd9+Tl6pOyzMbJSMH9yfKzoMOuK+J034iI+CcpAnxYFBoMYH\nscKpceZ5D/Dzd881w+zd9D//JOa9tQDVqSJNBh9SFACS+MSGa2nVZeGGHX63VTia/v7p5e+DbS4o\nMRDxFIqxVcMHNYDT4eKL937HYa81H6eg6LkY0i5uyTm3dKOFNYF2oW3JtB3ggz0f+733TMJI9wj/\nBYvrE+zRahnR6e1b8cYbt/jd98/lO73zrw6xe/tBAFoFt+KqtJq6UE//9AnOQ3W6pARcOpjqLDzo\nwCEnh1Ex0CE8we8c0ju0qFYerZgfhrmtC2OaC6FITAYTkUERPNb5IaLM7vumML+M8lIbSSkx9Izq\nQc+oHtV9SSmJMkVy0FFHedYIhq0RGA0KLpdE3evtgdFUnR++Ws3Yu872O9ejTamrlGe3PI9drymQ\nvrVsBxu03WzIbcF3+/bw7KZ5/DD0YSLMbvGSrw7MISio5j03KBKB5J3t06uNuTbtW9CmfYvqfSrV\nSlYXrqk24qpw6k6+zfqu2pgDmNL9aV7Z9jqby7YQGmsjOdHCTel3kBTcuNIGqtN/mGNTAiNMiolr\nWl9F3+g+fJwxnTxHLkbFxOC407m01cU8uOERzKOLiPMTrWrAQIgxhNPjBtErqmf1wsA/TXFZBZPe\nmI+u1nxbSpcBZ56V0g0RRPQqBtzvzfKCFfSN7kPXiC78kL2AhbmLsKk2OoV3ZGTK5bSw+v+cBQhw\nohIw5gIECOCXES3P5ZSYvszZP5clhcu8thsx0i2yK38Xr/fIw1FQ6B3Vq9nmoekal3/9GRU2gURB\nSrA7YfzCFXSOTqJH3JE9dHy5bzuye1R1IWUAaTaQMSCawuJyoiObJ0fkiocv4o9ZyyktLMcldXd9\ns1qGhQSk2cij91/a5L47JPoPb2zKIrWuOSGvH1DpbtCA/CHoIbejhN3e5HlVsTRzNTN3z8Z6VynO\nGaHotZQRpZTsX1rOaU8MrG5blPOLX0NOQSHEGMqwhKF+x+vdOsmnp9JkUOieltjoecfE+c/7NJp9\ne9xigmpqwalxVoT0YVpKidbZhEkx0Do0hr6x3gXBqzAYDTz4zGU8de/naJpO0QvRhHSC2J5mbrz+\nAnrFdkcRCiVFFUy+fyYb12Wg6+6Kcqec0ZG7JlxUrcoohCDOGutlzAkEA55IwDwnje9mrUZ1eXtD\nVVUjL6fU7zyPBYvzlnp5ahUBRkUnzOykxBFEsR2uXvIa3wx5iBJHGVard0ipooDZ6q1EWkWZWoZB\nGLyMOYCCWh7hdQX7eHf7EvaXW+kdcwHjOgykVSMKm9fGbDVjDTJht3nf7+FRTVcG7hLRmed6TMah\nOTApJhShsLV0G5W1RHk8xhcmrIYgTonpx0VJFxB8nKkR3/HFi0jFAnh+3qRLoXxreLUxB+CSLhbl\n/MrqwrWsKFxZnff9V/HfbC3bxuRuTxJtbppnOUCA451AnbkAAQLUS6wllhvaXseo5JGHMifcRBmj\neLP3q1ydNppIcwRWxS0WYFUsRJujGJU6stnm8M2uVdgc4lCdrBqkhJdX/3xYfaqazmeL/+Ki5z+h\nsku0++muDtKs8MX0w+vfF5FxEby34SWuevwy+nVMwdArBWlQkEaD+98QC1e9dyNWa9PzUjonJ2D2\nI/8/uEvjVfEoHke1IVebitfdht5hcNvSB5h64B2KLbmY29iJHZ9P2G2eIZKJyZ4PWPtt/sPL2oW2\nZVLXCdUCO7/nLuauP+/jxjU3M2nTZA5UZvPimPM86nVW8cyV5zZp7m07JxEc6ruW59kX9vHZPrZX\nH4KM7rG1SAumbBvCriHsGopdw1DuItxYQWhoEJek9uLjgQ2HhfUd1J6pc+7gsmsHcdaFfbjj2pG8\ned9j9InrWa2o+fitn7J+9W40VUfqEl2XLPtlCzde+CplJe73VErJ5tKt3gMIyfrSDYx7YDgXXtnf\n7zyqREGaCyllg7XjapPjyPVr5JsNbsNLorCrzH2+VoPFp8okgK77fwSKMcf4VCoVCNqFusNhF2Ru\n5rql0/n94A52l+czZ9+fXPTLVPaUFTT6fKq4a+JFPtvvf6rpCztVWAyW6nMoV32HUwJ0iejC671f\nZlTqFcedIbc3Pxt7dK5fD6Vi9r53dpbvYlnBcg8BL4nEpTtZcHDh0ZpqgAD/GAHPXIAAARrFWYnD\nOCvRW5LaipXnuj/D2qJ1ZNmySQpKok9UrwYlxJvC3tIC8FE/SkqF7HL/Dyn18cD071m8ZQ92lwqJ\nfh6khaBv3w6H1b8/QiNDGPnghYx88EIAdu/N5Z2pPxATF8m9t5+H0Xj41+3r+67iohc+Ra3l7UuL\ni+TVa72l7v3iWuF/W+VUaMA7t754A19nziHHkUsLawKxWhKlxgIv72BQDwcVqS70vSYsVhOjbhrs\nsT3Y4P+hslN4J8IPGXKf7JnOorxfq7ftrNjFoxvH82SXJ1gy6Wbe/2U1K7fvo2V0BHcNH0BCZI2n\nrcJVyQcZH5JtO0j7sPZclXKlz/p6L39yI7df8TZOR42XpkO3JG56cLjP+Q1Oa8Md/frzysrlmA0K\nanokbUMjOD8smZjQEP5zRh/MJt8Ge5m9kpe//5JSm42rTzubbsk1XucWSVFcfZvv+l77dueyZ8dB\nnyGhJcWVzP18BaNvGgLgsShTl02lmzn/lt7MmbGsRiijFn+u2On32MaSby/gw92fsaV8Exoud2F0\nZwKjEq+gT1v/obMA7cPasaJgpZdKJ0CFq8bQ1A8ZcBajGZctElNQMYpSc3E0TWBW/YfcGRUjl7W6\nmC/2z6o2CgQCiWRl4Sp2/LmLZQeisGs1hqUmJZWqk1c3/8IrJ1/WuItxiDPO6U6LlpG8/ex3ZO0v\nJKVNHLc++h/atG+8F9kfBY5Csu3ZPtWJzYqZ3lE9j3iMo8W23H2Y4xwoVh3N5Vn0Xph0wnt6i7dU\napVYDBZUzdOrqkqNX3J/I84Sy+D4MwLlc/7FrCv6i1n7v6JULSU9JJ2r00YTY4n5p6d11AioWQYI\n8A+wv6SEmZvWc6CkFOuWIrI/WAMunVNGn8rQG4aQnhCHEkjgrmZd7i4unzkbXXqulCuKzhU9U5k0\n8PIm9bcjO58rX/3cbcgBarDEESM9YhWEUyPk70LWf/rsEc//WLNk6x427c/hvN6daBUT0aRj9YMd\nAT+ekuBxKOH3+j12XeGfvL37XY+HRs0uUCzSy5iTEpy7LRg/SOOmB89j4JmedTV/yP6RL/bP8hrD\nIAxc33osp8aegl11MG6d73y35KBWPNVtot+5/lX0Fy/veN2r/fluzxAfFO/zmD9+2kjmnjwGDutK\nSps4v31XUeZwsCkvl9jgYNpGN/wg8e4v85j+4WZkVW6QLkgboPHpHQ83eOyfK3Yx8c7pPkP1ADp2\nT+aV6eMAeHPnO6wpXOtdogCB1WBF1VXK1hooeScS6tQgs1hNzF31RIPz8ceKrF28kfEcwqBWRzXr\nOpSUBVNZamHI9l48/NCVfj2VTt3FYxsep8BZgHoo3FLTBWVOC9sLqt43SYxVZ8m5TwKwvzyHe9ZM\nwmKxI6VACElFWRCTUu6ma8f6Q7T/LPqLb7O+I9t+EJtmq87FdGoG/j7YEunDMI42h7D0vPsA2FW+\nm2X5y9HROTm6Hx3C2h9TcY5FOb/w+b4vAXfZitrvuVkxk2htwWOdH/lHVSrrI6soj4e2PISzyELW\nFyk1nw1NEHFSIdGn5zUpjBzc5905rBN3d7ij+Scc4B9nduY3zM361qNNQfB010m0DD7yxZFjRUDN\nMkCA4xRd6ny0+Vem/PYXug6aBKFpGM6PxliusjhkPy989gmx4aE8N+wcTktN+6enfFzQOz6dLkkW\nNmU5qkOjhNCxmiX3nOTbO1If6/dme7w2Vgp0g8QVSXXNt+DNRcx8eFxzTP+YM7BjawZ2bH14Bxu6\ngfa3720h9V+Pz/fP9F799+FRrSKuVTiv/XS/z4fbAbGnMufA3Oq6clVYFAt9DuVjbi3b4rfvLFu2\n320Ar+5402f7pC2TmZw+mQXfrGPn5izadkrk7Iv6EBYRzGlnda23Tyklj8z7ju9X7EB3SsxhCrcM\nP4Xr+p1S73Hg9shN/3AzemWdOmZL4dX2s7jznPo9PW07Jfr0pFURGx9e/bema16GHLhD0WyaO6/K\n0lUl9JJSymd5LgaktT18AYlSh53xq6aR0EJDaGDfYEHLNmJsqRLexcbO3Yl8HJRJp3mrueiCfj77\nMCsmnujyGN8c+JbVhauxaS52lho4WOY+P4GOIiSTetWEJyaHJnDqb0NZkLsMJV1H32SENSbuFx/w\n5qxb6/V+9YzsQdfwLtz99/0eojoGUfv6SYyKjqYrSAQx1hAAvs6cw48Hf8Klu5BIluYvZ0Bsf0Yn\nj+KvlbvYmbWPpM6R9OvYDbNSR570EJqq8dXHS5g/cxW6pjP0/F5cdcsQTI1Qycxz5DN905cUz7fi\nWGtFmCHk4lKCejlpE5bGgNhTOS1u4HFryAG0jIojtLAV5XGZpN2yg8qMEHS7gaDkSozh9QjH1INT\nd7KlbAu7yncfNyIvAZoHVVeZlzXfq11HMnX3e0zs+vg/MKujT8CYCxDgGOHSXUzY+DS/bXFhsQZR\nXmEFBNJiQE0IRk0AhEACuZUVjJ07mwcGDOKG3icFZJaBry+8lUnLZzNv6x5cmqRPq0gmn3YJUdam\ni5PER4RiUDyvqblMIbhSkKIbubpfdy6+d7Cfo//lRL8Pef2BOg9K1stQDP6vtZSSXEeeV7vuNKCY\nfZcWuKjV+X7v7TBjGFcYr+aznbOglQ1hhFBjCHe2uw2LwR1OF2327+2qL8w331Hg05gBKFXLGDvi\nZZx2FYfDxersdXyjzKRV10j6xPXinBZnVefq1eW2mXP4Y23GIW+WwFkmeWXWMswmA1f16ut3PgAv\nzZ9Z43WohdQEPy3d1KAxFxYRzKXXDOSL93/3CrU0W01cPGYAAEXOYtYWr6u3LwBhlgSfbvMw5ixW\nE9ffc/hKlnO3bSYkpBTKBPnPxCLLFaTTLZMvInSCL3VQqITxyrrlfo05gBBjCKNSR1bn5S7J3cKU\nDXMocNhICg5nYo+RdI5Krt6/stLOgtlrAQt67VriEl549GvemnWb1xia1Jid+Q0Lcxb5DOk0KJLo\noAp0CamRJRgV9z2eXxFC2/AoMisz+SF7gUd+n0N3sDhvKT9N2EXRZhdSStAFwf0+5+6JFzEwfoDH\nGFJK7rjybXZtPVjd9tVXv/LrnsU8OnEU7cPb+8zrq2Jx5jJynop0l5fQ3PdW6bRIHN0c9JvclzMT\nhvg99nhi8uD7uePvuxBGSUj64YXV10WTOjvLdwWMueOcYmcxm0q3kBzUipSQ5Ab331K61a+ScUbl\nXq5bPY42Ia25MnUkrUPSmnm2/xwBYy5AgGOAQ3Pw2MYnyLHnkZbizlipqLSwcWsqmmbwKTeoI3l+\n2WL2l5YwabDvPJn/J4yKgYkDLmPigIb3bYj+7VMJtVqwOVX0Wk++JoOR9x69hviI5lGv/KdYnLeU\nGXs/x6bbUFA4ObofN7a5rlF1+RRDBHrcX1A2Hhx/gAiH8PEo1oH1HieEINwYTqnqqXZoCtPQnQJM\nnj+wwa5IhrQ+1WdfmRn5PHH7p+TnlqIokSAiuOaxMzj/3EEexl9KSDLBhmAqNW/BltqFneui6fVL\nwZeX2ZG6JGhoOcEXl6NYJNmqjR8P5rEkfxlPd53oVaja7nTVMuRqdafD6z8ua9CYK7H5EJ0BkALV\n0bjFnDG3nUlcYiTvPv8DdpsTo8mA0Wjg5ofOo3PPFAC+3P9Vo/oCEBZJmw4tyMkqJjU9nrF3nUXX\n3mmNPr4u6wt2U2GzoM+2oBcaqq+VdAhkgSBoETBIkB3RNI/LwPhODBzaye/2dUv95/nt25Xrs/3T\njBksrSOiUZe0yEKE8BDBJTakgkJ9Pe/tLvb5UOnSXNiTC9HXhVOV/1Wx2sybM2aRfGMyqSEp1fuu\nXbazliEnCb2ojOCzKpAuwfNbXiHSGs4DHe8jweo7LHjpgi3oZUq1IQeAU8Gx3sqeXdlwgkScRYaE\n0q6iL9uD1lQLnkjZNJXeuhiFkUhT00LQAxw7dF3nhW0vsalW9EWEKYKnukwg3Bzu97hwk/9tAKpU\n2V6+g2e2TGFCl/G0DGrZbHP+JwmoWQYIcAyYuX9WdYFbm81CSWkIFrNKm9SDuPOTfK8kaVLy5aaN\nZJaWHLvJ/h9gNCh8dOvldEyKw2w0YDUZSYwMY+qNFx0VQ2598Qae3PQ0j6wfz7dZ36HrjVfvayqr\nClfz/p4PsOnucDkdneWFK5iy9flG96EYzCiRU1ASlqPEL2jQkKviPy3P8woXMytmrk6/kr7mARhV\nCybVyrDg4bwz8EWffWiazoPXf0DWvkIcNhe2Cge2cicfTPiVzAzvwspPdH4Mq2L1aOsU1oErUvwX\nM08ISvArAqJXuguCY9YJO2TIVaFKlXK1nB9zvBXxMotLfH6KBQJbqW/PZG2uGnSm50N31fEmnfQO\njXvoFEIw/NK+fLPycT76/h5e/vRGvvzjYc6+qEZ1sz7xk7q0C2vLW7Nu4+ulj/HSJzcekSEH0Cra\nQE5OBM6/rV5GL5ogaKf7OllMRn7I/pHHNz7J01ueZWXBKo4kv79Fkv9SAWYfyrEVaiVL8pfVa8iB\nu7JIHQc/inCHq+6t3OfTayZ1kM46BzkVyn6x8Evurx7NP32ztvpvSw8HQUMrESZQgiWq4qLAWcjL\n21/ze20KNznB4UORU5FU7jqxoj0eHXoDAzgbWRyE5lRwqQq6DrqE8nIrCk0TMzEqBno1Y/mcAM3L\n9H2feRhyACWuEiZsnlTvcakhKQQpQfXuA+DSVeZlfXdEczyeCHjmAgQ4BizNX47dYWDDllQcTiNC\ngK4LWsS7V3Z9SWebTU403YBLg98y9jC6+/GrOHYi0iomgpl3jyKnpBynS6VVTMRRCWd9f/eHLM6v\nie36KnM2Cw8u4qWezzWr4mcV0/d+7rN9a/l2ytVyQo1Hz+s4LGEoqlT5Nms+Tt2FWTFzYcv/MLTF\nYM5MFMDYBvv4e/VuKiscSCkRFh1LXzvGJBf6ATPzZy/n5ns9lTlbBCUw9aQ32ViymSxbFn2iejVK\ntezatKv5IOMjr/byN9xeDlOyitS8i7qrUmV98XoubeUpJd8yMsKvmWQNa3jdtFdaB1JOVdm33Hgo\n3FIgTDqWeDvPXHFzg8fXpUWraFr4aL88+VKWFnjXjKyNAQNGxchVqaO8ttkcdu6f8QwFQe46dZGV\nsTw/6mFCD+WJ1ceI9J58tHYjUvdvUgqhk9KqgtmZ3+A8FKK4t2Iv28q2MybNT7XrBmjbOYnQcCvl\npXavbeeP9M5nLHAWYBAGvyUQGoMRI9JXyQVdYF/t/bApHVDsKvZoCw6tWaQIGlKBYvU02iSSAmcB\nWfZsknx4GFqmxJBtPAB1w3cFtE/xX9fweERRFG4aeCkd9/Rm7LdzAPe9Am5V4/atc0hOLGvQADcJ\nEzGWGG5ve8txnSv4/84feYt9thc4CylyFhFl9r9A80inB5m4+SmfNSKr0NHJqNh7xPM8Xjgiz5wQ\n4nkhxFYhxHohxBwhROSh9jQhhE0I8deh/99pnukGCHBiokqVTduSsdlN6LoBTTMgpcLBXP/FS4UC\nvbruxmDQ2JB70O9+AY6MhIhQkmMjj4ohV+Ao8DDkqihRS5h94JtmHw+gzFXmd9vu8j1HZcwqhBAM\nTzyHN3u/xqu9XuTN3q9yduJZTbq2JYUVICVKtErM5DzCRpYQMqySkJElrDnpRwqdRei6zk9z1/Ha\npLn8+r1brKVrRGc6hncg03aAYmfDnuzT4wfxbLenSA9pTYQxgm4RXXmz56uc0eNkTGYDepmCMPr2\nePh6kAg2m+jboyUodY5RJNef6T//qzYz7nqEi65OJbxTBSFtKug2zMTXz95NRLD/wuVNJdIcwYBY\n7/BWi7AwLH4oHcLaMyRhMJO7PekR8gegqipjZ95NSbtMzOkuzOkuyttnc8OX9+F0NVyDMD20NVf2\nD4cOOrKOMI4UUJFmJCnSQIuWB6oNOQCH7uSPvCXkOfJQdZ1tJTnsr/CWpPdFZkY+zz74JWaLCaWO\nG+2kAe245g7vcitxllivwuSHw/VtxmJWzFgVCxbFgkmYUL+JQ8+vs4hj0gk52UXPSM8FuytuqAkV\nVoJ934sKSrVoTV3GjhqBl/q+kJjCBeedNqjJ53M88OCiBdV/S6kgDykcb98Tz0lBZ5MaXL+Rmh7a\nhme7PUWr4KSjOs8AR4Zaz+evwFH/Zz8lJJn3+rzNjW2u5+yEYRh8eG0FwucCyInKkS4LLwQellKq\nQogpwMPAg4e27ZJSBlwJAQIAsWpbbHaou37i/iHy9SMtiQyvwGxWaRFfhEs7emF5AY4eP+f86nfb\n8oIVXJ58+AWB/RFksFLhI4cMIDm4VbOP5wtFKIftAezSKxVV1QkfXYISqlc/jCpWiSadfLDtE5bc\nUIK90m08fD9rNW+8PIdOL0COK8ftUdFdnBF3OqNTr6jXkEwMSuTxLo95tN1437lk7Mhhz/aDaAfM\nGJKdiFq/lGbFzDktzvLZ33tXXM7tljksXrMXqYIhGMac1Ytx/XznBvrinuH/5Z6mC7Q2iRvbXMeQ\nuNOZvvdzbJqNQbEDGZHU8KAvzfsAY2snSq264YoFjK2dPDt3Ko9fWn8NQoB7Ot5Gm8d/5KPblqNW\n6EiHAhaJCIIz7/OazUIAACAASURBVEwkMVmwvMDbg6YIhem7f+WTHVtx6RoSQZzVwgcDxtImzLfC\nZmZGPreOfBOHzVX9NWsyGxg4rAvX330OMfG+82uCDEEMTRjML7m/1evpSQ5qxUF7jk8PnkExEGGK\n4NWeL7K+ZAO6lHSP6Mp27SCP//4JqqqBJhAWHUO0TpsRIQyI9SzWntAyijG3DuWTNxdhX2PFmORC\n1BG9FAJSgz2N7irSW6Vwz2sjeH38fJxFgISItkaeeekGn/UUTwQKbb4NVxBsP2DmxbMe59ENj5Np\nO+Bzr53lu7DrdoIMDYfiBfjniDJHUegs9GoXCNJCfN/vtVEUhQGx/RkQ259KzcbKglU4Zc1n2SiM\npAWnMH7jBMpcZXQO78zFrS4g1hLbrOdxrGi2OnNCiIuAS6WUo4QQacB8KWX9Os51CNSZC/Bv5Ytl\nSxm/bima7v0DajK50DRDteQ+SAwGnd7ddmO1uigrD+aSuOsZ1a3HsZ10gCNmTuZcvsma53NbvCWO\n53t417CzaTY+yZhBniOP/jEnM7SJinMLcxYxfe9nXu1J1pZM7l5/vsHRRtd1thccIMRkJTnSf522\nd577jmWDZnt7FQBUQc5NngGEkfcUYOngpPYCrFkxMyZ1FIPiGpfvVxspJds3HWD7ngyWt/iZXA5i\nEAYkkpEplzMk/owGj3doKhaD8V+lRDvm3buhW6nX+yI10NaHMmPcq43uy+lUWfrzJnbuOkBEspkz\nzzqJ6OBIZu6fxYLshWh4rsxrajB/5sZUFwM/NDIhJsHK4eMx+BD3ufeOaWz8fY9XdYygUAuzfn8E\no8m/QaNLnQUHF/Jt1ndUaN4KihbFwpi00aQGp/BJxnS2l+/wsY+ZZ7o9TYzFMwLj4IEiPp7xPVv2\n7iasi+Ts8/oxrNXgapXWuuQdLOGbLxezttvPqCF2XLhQEBgVE9e3vpaTY+r3/EopyTiQRZDFQou4\nE/NhtYreU9+k2OFt7AO8MOwcLu7UhX2V+xm/cYLPfYzCyEs9nyMiIH5yXLOpZDPPbfPOqz4r/ky6\nawPYsS+bs/v3IMRq9XG0J6qu8lXm7OrFGeOuSEIizFTEFVYvxCgIrIYgnu72JNH1hHAeS5pSZ645\njblvgZlSyumHjLlNwHagFHhMSukzAFYIcSNwI0BKSkqfvXv/PTGsAQJUUWF30OPN19FNdR/sdJJb\n5hMWZmf/gVicTiMR4ZWktMojyOpCSqgoi+ST054hxOy7DlGA45dKtZKb1/n2VoxOvZJhCUM92v7I\nXcK0jA892gwYeKfPG5gNjX//v94/h/nZ31fL77cJbs3DnR/wW8vqWPDtplVM+vJ37JXuh+7YOHj7\n2v/SIc7bW6jrOtetHocuvD3SukOQd2uNMSdCNeKez0X4SH9pqHB4Y8lz5FHqKiM5uJXHNdQ0jR8O\nLqBMLWN44jlEmBv/gJhbUs4L837HoWrcce4A0ls0nOdXl/yDRdw7aDxZu3IQiqDLgI48v+hxjMaj\nkw5/3XsP4OxY4OGZA9AdYNgSwUc3vnTEY+TYc3hs4wQPj5hAkFkSw4HyIOpmMSpCZ1LvYVyc4mm0\nSyk557QnECXe95AwK3zwzV0ktvIf5l6FLnWe2PQkWbbs6hwcBYVIcyRTuj+NWTGzvngDb+58B7vu\naWQYhZERicO5qNUFjT39enHqTpbmL+fv4vVEmSMZEj/4mHnbjxfmbtvM3Qt+8Go3CsH22++pfj11\n13ssL1jppSiaYIlnSvfJ/6pFlhOFX9fv4MWPf6E4p5ygSAs3/HcAlw/yLUJT5CzmqU3PkO+qEb3S\nKwzsfa8tei1137YdI/no6RsaNf7sxT/z7l2/IIySuBdzvbzcBgwMTRjMqNQrmn5yR4FmLRouhPgZ\nfOZRPyqlnHton0dxFyWacWhbNpAipSwQQvQBvhFCdJFSltbtREr5LvAuuD1zjZl0gAAnGiFWCze0\n6sa7mRuQinTLoB3SVg4OchAZXk50ZDngKbcsMHBf99EBQ+44R1VVZh6YRYGjkItbXUSrYHcsfrAx\nmFEpVzBjn6coSfvQdl6GHOBlyAFoaIzfOJEpPZ5u9HwuSb6Ii5IuoFwtJ9gYfERCK3MPzOfHgwtQ\ndZVOER25Of3GJocobc3bz2OfLEZXa+aRlysZ8+bnLB1/D8Y6IV+KotA35iTWFK718NAYhIHKVZ6f\nBSVIHhLU8P75qPSTS9RU4ixxxFk8PYm/5PzGx3s/rX79Y85PdA/vyr0d726wvye/+plZyzfU9LVx\nF/3aJjPt5saH3ZYXl3NFyxurX0tdsnHxFi6MuJr5FTPqOdI/Bw8UgZQkJEX5fNgdd9poXs99De/Q\ncEHbjkns2JxFUmoMwSG+PUyNIcGawK3pN/Hu7mlo0l3cPMYcTX5ZGOBd700Au8q8Q+qKnTZcYRKz\nj/RJXdcJjwxu1HwUofBIpwf5Yt8sVhasREOnd1Qvrkj+b7VhX+wqQfqoW6hKlQJnQaPGaQxmxczg\n+NPrLbvxb+eCDp3ZXVjMG6uXV9+F4WYz3185xmO//yZfxqbSLdg0m9sbI4wYhIHr24wNGHL/AN+v\n2czTU74H3f2ZtdnsvPraIvJLKrhlRM1CjKqrfJwxncX5S7wMcV0XKFYXuqPm+2Xn1mImTP2aCeMu\nqXd8l8vFu3f8CprAmKwiVYEwe/avobG1bNuRn+w/QIO/8FLKegtcCSGuAUYAQ+UhN5+U0sGhb10p\n5VohxC6gPRCIoQzwf8uD/z2b7iuSePTtz7GHKdjbhINRYduuZIIOOIiMKCcpsRCzSUVKgdEguDL1\nMvrHB+STj2d+yl7IjP1fVL9eW7yOWHMsL/acAsBZLc7klOh+zMueT6VayZD4M2gb1tarnx+yFni1\nVXHQ0XQBHEVR6q3HUx+FzkJe3vYa+2z7Pdr/Ll7PLWvv4K0+rzXJoHvzt5/xEvaTArtN8M2mFVza\n3bt44FWpV7Kvch9FziJUqWEQBuItcWz+XlC7oLmWb0DaBVg8f5gNGOgV5T80Oc+ez+s73qLYVUSH\nsPaMa31Doz1ads3uYchVsb50I4tyfqk3NHZ3ToGHIVfFqp37mb9mMyNO6tyoOTx09lM+2x02J3Pf\n/IELbj23Uf0A7Nl+kMn3f0FOlltNMbZFOMOeSmWVXEG5Wk56SBuuSLkcV7aCmmPAmFBL5lN3vwfb\nYrby4HXTUFWNS68eyFW3uhcrluQt4a+SDcRZYrmw5flYjQ2HRfWM6sHrvV9mX8V+LAYzidZEJq7/\njD1l29GlZzilLgV9Y30UfpaCkkEGYr5SUWqltOlGEN2thIQ2PI8qggxBXNt6DNe2HuNze9vQdI96\nlVUIBJGmyEaP0xBSSnZuySI/p5S2nVpSUFzEk/fPoDjbRnCkiTseP5/TTvv3/17c3f9U7u5/KkU2\nGyFmM2Yf+X+R5kie7fYUf+QtYWvZNlpYExiaMIS4EzQn6mhxoPIAb+2cygF7FopQ6BXRk5vb3tjs\nSssvTVtE3UALocNnM1dw0/BTq2ugzsr8mhU+PKoAhhCVFhcdIPMjz8/7okV7mDCu/vGnfPwh7nVB\ngVZs8CtuFW/xH/5/PHNE75YQ4hzgAeB0KWVlrfY4oFBKqQkh2gDtgN1HNNMAAf4FnHtKV9pZruf+\noRMpahfC/svSAIlNM2Ozx5CXG0NYiIv0uDBeOXM0cUGBuP7jGVVVPQy5KvKd+by3axo3pF8HQLg5\nnNGpV9bb156Ko6s02ViKnSXc/df9frfr6Ly1cyr3drir0X0eyC9D6r7Fk/cWeNeOAwgzhTG52yQ2\nlW4m23aQpKCWdArvyJoJO3j81lqGlBSUfhRB3J1l6If+MwkTIcZgzm85wmff8w98z6wDX1e/XlW0\nhlVFa3ih2xTighp+2Jvhp/wDwOzMufUac09//Yvfba//sKzRxtzOvzL8bpvzWuONOXulk/vHTqO8\ntMaLWXpSBj+UbkYcMpC3lG3lqY1TKJyYQMhkFSSo2e7HB2OiiilVRa8UVFa4PWdff7KUmFYh/JDy\nBWVqeXW/Px78ifs63E3XiC4NzssgDLQOTat+fXuHEczb9yJ2VUceEpJShE5qmOS0+D5ex7/9/XIc\nsWaKhulELdJBgtDA3llh7ANNy0NtiBbWBGItsWTbsz3aJZJvs78j3hrHaXFHph5ZXFDOw+M+Int/\nIYoicDhcaGqV11pQnutk8m1fsemmvdx8y4VHNNaJQlRQ/QtKwcZgzkk8i3MSfQsW/b9T5CzisY1P\noB8ynDSpsaZ4LQ+uf7R6MbK5sBU4fJcjsUum7/yaMe0vQ5c6v+b+7iFUUhuhgCnaiTHciVpaFaEh\nMEbauWn+eN445wm/C3LZmTUecr3QgHO7GXMHp0d4vlkxMzyx8YtgxxNHanq/AViAhYfc1iuklDcB\npwFPCiFcuCsi3ySl9JalCRDg/5C2vVrzeeZUls5Zxb6cfArahRKaGEFKRCSqrtEmKpqu8b7V2QIc\nX3y07xO/25YVrKg25hrDsIQzWVm02uc25ciqyDSJV7a/1uA+W0q3NqnP3ukt2bVnL7pW5zykYECb\nDn6PU4RCt4iudIuo0dLqN6gD7829k3emfMe+3Xm0bp/ATQ+ehx5j56ecn8lz5NE5rBNDEs4gxOi7\n9lltQ6424zdN4J2T3mjwfAqd/qWxG6pzVe7wv92u+q+LVBeT2Yjm8i3fHRHX+FIGS37e5FZWPISw\n6gQPrfDKJ7HtlzgqVcx7TJjauDAl18xVqmD/s8bT5bC7+LJsJtQy5MBt3Lyy/XXe79v0akUx1gi+\nPON6Hv3rU3YUV2IQkpMTYni6xw0+i3PPXrURdCvlnXTKe6kYi0ALA2OZlTGd+vsY4fCZe+Bb8h2+\nFyUAPsmYccTG3OQHZrJvVy6al7KxqPWvZO47a/5vjLkAR8anGTOqDbna5Dvz2Vyyhc4RnZptLGFR\noNJH/qpB8nvRzwx3DCbcFFH9/amr4NM5KEGYas1ZkQSlVFIZl8O4BY8y7TzfRuiFI07jxdnfV78u\neSeK8GtLsHR357mGB4UxJnU06aE+vPwnAEdkzEkpvWOF3O1fA75/LQMECIA12MLQUSdmnZ8ANeQ7\n/OfD6D5yaOqjXXhbzIrZpzEwJs27ePPRom5opS8EgvzKSl5cvoTM0hL6J6dwY+++GH0oCgLcPugc\n5i19G3sF1XWhFINOWqqRU1I7NnmOya3jePqda7zax7a+usFjV+Sv8rvNpjcux25YwhA2lm7yua1N\naOt6j71qUC8e/tx3SO1Z3ds1anyAKx+9hA8e8VYtBXjsi4bz9qooyCvFaa+JQzTEaT7zSaRFQ9N0\nSj+MJPrhfKTRXS5CtwtkuaD8K08DUqaX+VyJd0kXe8ozPLxujaVtWAozBz2KqqsIITD4lDs9pCbq\nUhEIjBtDkFYN3SJRMhRQFZRmzJmSUrIgZ2G9BcZd0sX0vZ8xKqX+Uhn+KC6sYMtf++ox5Gq/luzJ\nyKJ12r+nhlaAo8POCv8Bc38W/9WsxtwZQzvw2w+bQK35jRBGnfBeRSgGhQ0lmxgcfzrxljgycwsw\nhvteqNJdCq6CqpUmiTDohPUsQghwxeZTaq8k3BpMRsVefsv9gwqtgj5RvRjc+2TeSJuPI0MBBNKu\nUPJ2JCJEZ8Lnl9E3tafPRaEThRN35gECBAjwD+MvjA8g0tj0ENlXe75InNkzzG9k8uUMbkAKvzkx\niobX+GKUFE5+/21mbtrA0v37eGHZEnpOfYPc4lIO7M3HVukpVBERFMqcu6+lT/dQLMEqweEqI05r\nyZfjbmlwrEJnYaOKgDcWXT/yYtA9o3oS4ef9vS395nqPHXFSZ+LCvcU3LEYDD114RqPncMVDF9G2\nV5pX+4W3n0tcq8bnBXXsnozZUhNrpBX6zicxJmiEtDCh55nIfzie8q/CqFwUTNmMcPIfi0eW1RhW\nQgiE4t9oqc/waQxGxejXkAOo0CoIjaukSqhF2A0oJUaESxAR3zyiOFWoUsWueapYasXu3MLaeaK/\n5f7Bb3m/H9YY9koHiqHxj2tBDYQfBggA1CvBn2RNbNaxnhxzLsknGxFGHWHWEEadsK7FxJye6y4L\ncEgi96q0UT5L0kgJukuQO79qkUJWr2VkfdKa3O8TkTpszNzJL7m/8fSWZ/kt73dWFa7mgz0fM2Xb\ni3zx1ROkjAhGWHUwSoLa6zz96WhOTut9QhtycORhlgECBAjwj/HlguW888lCzGYDr068lg4px3Y1\nunNEJ0INIZT7qEN1f4d7m9xfsDGYF3pOQdfduV/NnYTeGM5ucSbzsr6rd59FG+sE50iJdWUpY95/\nHqvJhK7pnHPxSYy7/1wMRvcvc1JkLB+OaSBLvRbL81bw7p5p1R5OBYU7291Kz6ieTT0lD06O6cfU\njPd9bjPXjS2sh5d7PM/bu99jXdE6dHSSrEnc2/FOwswNhzj+8sQ4Js/+lbmrN6FLyemdWzN55LlN\nLuT89trnOZiRy1t3fUhIRDB3Tr0BayPqLtWm+0mtad81iW3r9+NwqMgKBefaYCwn2cFUY42YFTO3\nvngxb9z5E2XFlbA6CLtLo+fJrVlvzMCpuUupKAaBxWom1ZzKXjXDazwDBtqF+gzqaTZMwkRqnxy2\n/JyK1AVSVxCKjlAknfqVN9xBU8ZSTMRaYshz5KMVKhS/HYW63wSKRAmShF9fjKWTE5d08enuz5m3\n6Sf6hPXhsl7/wdLIciPxLSMJCbPisDdkBEtA0CLh+KiTFeD4ZmTy5Tyz9TmvdqMwclrcac06lqIo\nvHzzlTxyykRsJWAMVVEs7u8XiVv0CKBbRFcUs+6h6q07BSV/RlG6LqpWrpwEKZAu93dm+ZZwlGCV\nNje34LGtb3ksGDl0B3srMlhX+ifvTn4UJjfrqR0XNFudueYgUDQ8QIAAjeXUSx+nLCkcoR36DpPQ\nwWBg1mv31H/gUeDFrS+zoXQTEkmYIYwHOtxDSmjKMZ+HP3KK81mzZwNJUQn0TGtYYGPCxknsqczw\nu31fZgx7M2vyOiO22IlbaUOplfJlsZq4cFR/rr2z6eIDebY87tvwkM9tb/V6nRBT42Tl/fHZ3pks\nyPnJq318p4d9Ko3+23E6VeZ9tpwFc9YhpeTMC7vjPCObxYVLUHWVWEsMY9JG0y2iK7qus3HdXory\ny+ncM5m4FpFs/nsfX077g6x9BXTqmcLI608nKF7hvr8f8vLC3dB6LAPjvNVLm5tXt7/OmuwtZG+P\npLLISnC0jaT2ZVze9jzOa9m8Igd/Fv3Fq9veJO/RGLQCA+i1nkTNOnHP56KE1DxrSYfAUhrKG8Om\nYDE3rozD2mU7ePKuz1Bdmo9wyxr6nd6WJ1+/5nBPJcD/GT8d/JnP982sXjQLNgTzSKcHj1r9wsV5\nS/g4Y3q1Z10Ad7a/nU7hNeH2o3+6FSXCXm3Q5f8aR8maaPAjolWFYtJ59e2zmLrrPWy6d2H5XpE9\nuau977qvxyP/SNHw5iBgzAUIEKAxXPPwW6ytqASTpydDOFQ+v+u/dGl7/BhS/yRSSibOf5nd0Zvc\neVAKmEqDear/YyRGx9d7bLYtmw/2fMz28h1e2zRdsO7vdOwO9ypp6y+KMZV7/5YEBZv5etlj1bLT\njeWpzc+yw8e40Hw/yNtLd/D2rncpV8tpaU3kng53Nqno9/8DutRx6S4shsOrG+fQHMw5MJdNpVuI\nNcdwefKlJAb5Klvb/JSr5Ty/9WWy7dkoCFSp0TuqF+PSr683RPNwsGk2bvj8fgpeC0faPe91JUYl\ndnKeV+iYtAtOKR3MLSManw+7f08e8z5fwaY/97J7m+9yJfPWPI45UJc0QBPQdZ2MygyCDSG0CDr6\n4msVaiWbSzdjFEa6RHTBrJg8ts/f9BtflrsVi4WA7K9aUbmr4YgHAbwz7Txe2/kGdh/G3ICY/tyY\nfn2znMOxoFmLhgcIECDA8cbm7QchxXf9prsmfszCT8cf4xkdn3zy+xx2R25GmGoUwFxRFTyx5Fne\nPf+leo9NDEqkTWgbn8YcEqIiy8nOiQbAYPO9KOiwu3A5NSzWphlzefY8v9sO2ptec88X7cPb8XKv\n55ulr38rilAO25ADsBgsjEy5vBln1HhCjaFM7DqevRV7yXPkkxycTIK1/gWMw2VPRQaUmHxuM6e7\ncG4xU7EgFC3XgCnVRegF5RiTVNbu+RNovDGX3DqOWx/5DwCvTvyGH76uWfwWAh55YWTAkAvQZBRF\noc0xVHEMMQbTN9q/jTKiyxkUri7lp4r5KEEalkQblRkhUFcNuQ7paXF0jGiPWTF7GXNmxcwZ8ac3\ny/yPRwLGXIAAAU44dEUBHwILUgicfuTa/x/5veQ3RKKnoSWMYI8pYW9uFqnx9ecYWg0WDBjQ8Lym\nFoPRo8yAI8ZAUK73dY9PjMRsafrPTFpoCn8VF/vclh6a3uT+Avz/khqSSmpI6lEdI8QQgqm1C6l5\nh/+qOQaK34oCp/vz4ig04NhoIer+AowVh/8IducTF3Lzw8P5ed7fRMWE0H9w4+oTBghwIjCm7/mM\n4XwAdrTex3VrP0O3C5BVv/tVv2sCIQRms4G7rxuKQRi4r8NdPLftJTRdReKun3dBy/NpH9Z4teAT\njYAxFyBAgBOOSKuBHKcG5jqxS4rgkhGn/DOTOg7RTH5qmmmC/JLCBo25U2P6813WD2jS01AzKAoz\nR9zJW6vWkllaQqcbwln14kqcDrcIBrhz5m5+6LzDkmK/sfUN3PKn71DKq1NHN6qP7KJSpi5cyYod\n+4gNC2HskL4M6Xp0DEFbuQ2nw4XL7iKmZfRhnXMAbwrzyigtqSSt7ZGHfrk0Fy+teJstciMA6bI9\n955yK8GmI1d+TAlOJqFVBMX9bNhWW6sNNwwSPdMCWq0FFSnACeVfh3PuZUdWnsZsNjP80r5H1EeA\nAMcCp8vJ53N+oqS0nEtGDCWpRVyjj20Xn8LzTw1n8odzKdphRph0UrqZaEEyB/aX0y41njGXnEJ6\nqrvP1JBUXu35IltKt2LTbXQM60C4KfxondpxQSBnLkCAAE1Gl5Jp69bw4d/rKHM46JfUikcGnk56\ndMwxGT+3qJhzbnkNNTYYaTaALkHTCcksYcXsScdkDicC93/5NDlJuxF1IsBkhcL7A9/EbPIdkuV0\nuPj9xw2sXbYDvVsxu9qvw6gYD1Wxgjva3UqXCE9PwM4tWUx/+xd2bc0mKTWG0TcNoWuftMOe+57y\nPUzZ+mJ17bcQQwiPdX6IlkENK5YeLC7j0henU253oOkaLbvnEpNWTKjFyvkpZzO8xTlNzuPzxbpF\nG3hh7Jvk7XfXGxSKICjUyrVPXcGFtx25yEaWLZtXt79GkbOElOBkbmt3M5Fm3+HFTWHP/hxUVadd\n6+aVH28uMnbmcMeVb+O01yjqXHrNQK6/55zD7vP632/Faa0RVZASDE4j75/6VpNVRH2R78jn+S2v\nsG9RBeW/WNAdgu4DUln/bRaa6i1Yohhh7soJmEyBNfUA/27mL1zMW09+j7QLECA1Qdf/JPDChDsO\nq79v1v3Ixy/9in2LEWGRpJ4dwjMP3EFkUMN5dScSAQGUAAECHFUe/WUh32zdjE11P2wJIMRs5odR\nV5MUdmxWwHKLivnvra9RquoIXZKWGM5Xrze9HMC/mYysLMZvnIAI1hBmkBqgCs6wn83YYZf5PMZW\n6eCuUVPJySrGbnNiNCoYQgUjnzmJjp2T6RLRGbNyfOflTJ79C7NWbEDVVLr+ZzumIBUh3A/wQkBq\nUApPdnviiMb4Ysocpj3su2g3QJ+zejD5+0cO22icf+AHZh34yqv9iU6P0ibs8PJbFi7ZwMPvzcMR\n5S5fYCpx8NjlZ3Lxuf0Oq7+jxfCe49F172eTB569lCHDm16aYs6G75lT+TV1HaZSwuliCNf1a3ze\nWn1IKdlvy6RCrSAtJBWTbuaSAU/5LCnQMjmaD7479sq7AQIcS+wOJxcPfQK91F2suxqTZOyEwVz+\nnzOb1N/K3X8y4cpZSFutkEuTJK6PmU/fPbLv9OONphhzJ3aVvAABAhxz8isrmb1lU7UhB25vjV1V\neX/tsVuMiY+K5NfPHmftlxNY89XEgCEH5Dny+XDPxzy2YQJv73wXJVLjmR6TSMvqirI/lLC9Lbg2\n5AZGn34xV7w8g273vky3e1+m76OvM3v1JgC+mb6c7MxC7DZ3iKaq6jiKNeY8vIHu4d2Pe0MOYOXO\n/aiaTly7gmpDDqj+d69tH4tyfj3s/nes2820R/wbcgBrf/qbue8sPOwxfBlyAE9tefaw+ispreS+\n6d/jiLaCQQGDgivSyoT5v/Hn1r38940ZnPHUVB6c+QNqrc/2sWbO/9g77/AoyrUP3zOzPZveQ0Lv\nvYo0aSKCoNjLsSD2rseu5xzFz65YUey9d0UQRXpHeg2dJKT3bJKtM/P9sRAIu5tsOmVuL68rmfLO\nM2R29v29T/tipV8hByrvvDC3XmOuylsbcN+mss31GtMfgiDQ2pJCt7CumCUzOr3EhEsGYTRVd40b\nTXquuOnULcagoXGEj7/5DdUpUE3IAXjgpx+X1Hm8Tz6di+o6NncOcAvkr3exc/+Bhhl7EqP59zU0\nNOrEvqJC9JKEUz6SR+WdeHkUhY252S1n2GmMo9LFzO++ZmPUCqRYGQTIqMxgffEG7ut8N09ddl+1\n4898bCYVzqPeArvDzX+//5MnFs3njLUCLqfvZN7t8pC2N5f2XU7M0LxjSYwIZX9uEZGtSwMe83na\nl4DK2PgxdR7/86e+hyCCWr545icuvH18ncffUZoacN/xxWiC5cnXf0TVi3Csp1AUUCWRa2f9gKrz\nTo7mrN3J3DU7uT+2DYs+WkRluYMhkwZw3VNXEJ3Y9M2od25K50jz6+oIVLgr6zWmVbQG3GcmpF5j\nBsuN943H5XAz/7eN6HQiqqpy+Q0jGXdB/ya9robGiUBRsc33owygCrgq6v4uK9htB4/vgIJOZfee\ndLq1b1cPQcGZ6AAAIABJREFUK09+NM+choZGnfju4Bwq3A5AJTkxnzMH7mL44J0M7LOH2HBbS5t3\n2uFxy9x351tsbr8MXYKMIIEgekMq3aqbTw5+xrHh9PM27aom5AAEBAQZnE6Z9a3tfq8jywom84nv\nlQO4YcwgTHodsjtwLpSKytfp31HuKa/z+Hs2BrcCbCutpD6pDGXuwCK0vmTkFaP6C/nUSyAJHPtf\n2Lw9fPHkd2Tty6Ukt5S/Pl3CbQMeorykotHtOp5h43r4n5noFcwjKlDUwA2zAzGtd+Awymu6XFHn\n8eqCTi9x9/8u4JvFj/DG17fx7ZLHuPLmUVqRHI3TgovOG4XqR3xhUOjWP6XO4yV3jAbJzzvVI9Cz\nY8d6WHhqoIk5DQ2NoHlr60/kSv8QZq6kTXIerZML0OsUBAHMZjfO8HXsKNvZ0maeVqxYsIOiDmkI\nkm8LAlWBAmchdvmoQPt9vf+/j4CA5BQoa61DH1I9LEwQBRKTo0hq3TwFbhrKoI4pPH7RGMr2tKrx\nOEmQ6vW8hkUG9vQcixBRvybkNfVgEvwuc9dO/65tEPyFLx5JJDyMVOrAvKcQwX1UNMkemcrSSuZ+\nsKBe164LI8f3wtjTBYZjRJugIhgg7Bwnh+yZdR4zOTqR8cIkVMV7u6rq/WwMc4+iV0qXRrQ+MCFW\nEyntYn1CLjU0TmW6dWpHm1Ghhz/Ph98/BgV9rMLDd11b5/Fuu+EihONjCnUqyb0i6dCh5vf9qYwm\n5jQ0NIJmRclCJAliM10kJxYhHS8gJJXPDnzZQtadnmxauw8h3uVTsRIAxTv5L86u4JM3/uK5h75F\nn+MAP94iFRVFByDQfVRHDAYdZosBc4iR6NhQnnijcYpENBdTzujBn/c9wJmhNZd/N4p1b4p9wR3j\nEfz0OayG2ciZUwbXywMjiRIDIvyH4d3W/uY6jwfw8K2TkMqc4DkmtMlPlUVdXgWq5Ds1cNpdbFm6\no87X3VWcwaqcHbjl4PPw+jxgxTqpHDFSRrAoGAc6iP5vAbpwEOspZv91xoW82+8tJjCZccpE3ukz\nk1uGX1OvsTQ0NILn3VceYcrdAwnpDqb2Mr0nJ/LZN48TZq17iHPntm34v/evJrKD0bvIo4eB49vx\n5tv1q4x5qqDlzGloaASNqHPgzDeiFOkRRP/hY3nOvGa26sTFo3iYmz2PVNsu4o3xXJwyBasuOK9O\nsMQlhCMfMKJ0deJTm0SENpndueOut/F4FDxuGaNZj9Q/BI9FrO7lEcATqiKo8H9PXUHRHaVs35RO\nZIyVPoPaI/mZ4J/o6CWJ27tPZVhxf17fM9Mn30wURLqHdavzuOOuG8Xv7/3Nvo0H/BfrMBqIH9qb\nu/93QX1N5+7Od7AgdyFfp3+HW3UTKoVyX+e76VDPSpaSJHFVRDzf7tmHu3UEqgCGQ2U420d6C6Ic\nFp1yqNGv2NfpJZI7B58vubckkye3vIxgsKGqAup+kXGRU5jarfaWDaOTRpE96RtCJlZ/l1h1EbQy\n13/13Ww0ceXgKfU+X0NDo37ceu1F3HrtRY0y1sC+3fj65//iccuIktAobWZOdjQxp6GhETSSaqA8\n3VKtkNTx6MSG92w6mdlvO8BTO5/2qY+xnR0syl/MA13uo2d4j0a73jlTBvDdFYtgjA1VpyIc/l5T\nXRBuCmf3W04c9qM5ck67m4RNNrIHWpENkrfvjwjOaBVVgtHRbTDoJRKSo0hIjmo0O1uSPpG9uTj5\nQn7O/AVJkAABQRD4d+d70It1D3vTG/S8tvxpFnyxlA8f+4rS/LKj+0JM3Pj6DUy+ZniDe4iNjR9T\nrwItgTjnoiEsnbQYR8Xeqm32zjGUTuyEioqAgDveghxhRl/iQHYfFb86g44L7giuz5uiKPxv6/NI\nxkq8DkwVUPi75Ec6ZacwLLFnjeefFTucTSWb2Vm2E48ioxN1SILI3Z3u0HLNNDQ0AO8Ck4YXrc+c\nhoZG0Mzc9RELV26lYEEcbW7fi3j8XFWFITFncmuHm1rEvhOB69beUON+o2jgvYGzGvWaW9Yd4Pnn\nvkQdl4OumwPRIzIsdijnhk3grsve8dvnSoqVkW9xYgjxYAlz4rAbsBeb+fniJ7HoLI1qnz/emLuC\n9xccLRkfZjYw55EbiLCamuyaJa5SdpTtxCQZ6RneE0M9hJw/inKKWfnrOlp1SqDfmF6NMmZToKoq\nz1z5KmvmbMBR4UQQwGgx0n/aSJbGKZRVOumYGM0Lk8fw/h0fs+HvrQgCxCbH8MBHt9NrRHBezL/S\n1/FZ5rtIUvUwTlUFq7sDbw9/LChb91XsZ5dtN+H6cAZG9sckNd2zoaGhoXEioTUN19DQaBLK3Dbu\nW/sIe95qjbV7CdFj8qoEnapCiGThhT7PEqYPbVlDW4h39rzHquI1tR73Yu9niTfFN+q1FUUh40AB\nBqOOxMMetcK8MqZOfAW3yzdfyXRmJeE3+lZNvLjVhZzfalKj2nY8P6zawvQffItpSKLAppfubdJr\nn+4oisKaORtY+PVy9AYd46eOps8o/57iirJKnJVOIuMj6uQR+3jnHywo/glJ56fypCOGT896ob7m\n+5BamsOr2xey35ZPn8hk7ug2knahMY02vkbDqSh3MPf7taxZspvouFCm/Gso3frUvZKhhsbpRF3E\nnBZmqaFxGpCeWcS6LWnYxCLMnWzEWCMYHDWIEF3dEpDD9KH8X//HeXXqZ6z9Ihx3mYHIAcXorDKD\n4/pzfZ/LTlshB7CrfHdQxzXFGpooirTpEFdtW3RcGO27JLBne2a13C7JCNZL/LeRWJC3iMlJ5zVZ\nOJvb7fYr5ABkReWPjalM6Ne1TmNm2rP4Ov1bdtl2Y5bMnBN/NhMTz0UUtFyK4xFFkSGTBzJkcu1z\nhJAwCyFhdffSjkjszcLSH322y7JAR3Mnv+coisK3B9czJ2MbYQYTd3UbRbeImnP0FmSlctea71AP\nBzUfqizhr6wdfD3qRnrUcq5G07MyPZ2bZv+E/XATekNbmeQ/D7J6cSq3PzqJ8RcOaGELNTRODTTP\nnIbGKUyeI48nZv3E9tXl3gmPoIIHzHnlSA6ZXkNa88CjlxOXEFHnsd2yh137clEU6N4xAZ1Oi1+f\nteddVhevrfEYg2jg/UYOs6yJ/JwSHpz2IaVF3h5hsqzQd3Qb0i5Z7vd4EZF3BszEKNW9ymMw9Hng\nVfzVDDnCyO7tmHlD8EUqcuy5PLH9KRyKo2qbQTQwJHow09pNbYClGg3h7pUvUSTsrgq1VBQB2aPn\ntf7PEWep/r7xKArj/nydHEdZte23dTmLu7uPDniNfr8+g0Px9Tp3Do3j17Nva4S70KgrK/NXsaFk\nE0n6tjzw247qrS9UFcEDHT4twWIx8N2SRzEYtVYNGhr+0DxzGhoa7Lbt4Yk/36IcA2GDBCp2h+Eu\n9E7QKyOthBwoY8uSdK7f8CIPfzWJs1KG1ml8vaSjZ+cTq6+LoipsKN7IqsI16AQdZ8UOp0d492a7\n/m2dbmH12prF3F0db28ma7zEJkTw0e/3sXXdQQryyujaK5lWbWK4c8NmbB5f75xe1NerKEgw/LB6\nS41CDmBE17ZBjVXuKefjA5+xrni9zz6X4mJFwSouTr6QcH39er2drJRU2HHLMjGhIS1aLOS1M+/n\n7e2/sKp4KaroJl7qwP19rvERcgAztv/tI+QAZu1aytSOQwgz+ObKpZUX+RVyAHtsWkXdpqao0kau\nrYSOMYnoJR3lrnLu3Xw/btX7N1HVdZw5UGTdpo54PIenmoKAqlMp6WnEegD278qha28t3FJDo6Fo\nYk5D4xTl9d0z0SWVE5ns/T1yaCHFy2MoWRMDooA7yojO5ga7h7e/+o7Y26LoFla38LYTCVVVmbn3\nbbaV7sCpOAHYWLKRMXGjuaL1Zc1mxxPd/sP0nU9X2xahi6BPZG8uSb6oRcJQRVGkzxnVS9pfknwR\nX6Z/jUtxVW0ziAbOiT+7ycITv162qcb9AnD5sL61jqOqKi+kvkymPSvgMXpRT5Y9u1Yx51Jc/Hzo\nN1LLUokzxXFJ8kXEmk6+nKucEhuPfPkHW9KyEQSBxMhQnrtqAr1aJzRoXFVVcatu9IK+TuJQFEXu\n7HURd1J7OfLfM7YG3PfJ3mWMTkok2hhFkjmparvNbQ/aFo3Go9RezrTPPmLPXjeCAJJO5drxXUgL\nW1Il5MDrjNNJCn16HGD95uqhtfZ4HfJeF9Ywc3Obr6FxSqKJOQ2NU5B95fsol8urVZsURJWokfm4\nCgxU7g3FFWHCFWlCsnsw7HHya+ZvJ7WY21G2s5qQA3AqLv7OXcjouFHEm+JqOLvxaB/ajk/P+BDw\n5ofp9SdmGNHI2BGUe8r5Let3vC3DVUbHjuSi5Kbrw9U1OZ7dOYUB9//+6PVBjbOvfB+5jjxkVQ54\njEfxEGeMrXGcYlcxD25+pGoSur/yAKuL1nBHx1s5I2pQULbUFZfi4qeMX1hbtA5JlBgafSYjYkZh\n0Zmx6I5vFBgciqJy/dvfk11chnzY9ZmWX8KN7/zAnEeuJyas7s15VVVlQe5Cfs76jUpPBSE6Kxcn\nX8jouJHVjnPIbuZl7mBnSTYdQmM5L6UXIXW8j0ASUUBlScFv7LCryKpMa0sK93W+G6vOSsewOITD\nDRWOs5wQgxOn7GyyUOHjUVQVjyJjkGqfUtlKK/nm/SUsX7ADk0nPpCsGc96lg06aXlnXfvQhBw56\nUBXR23BCho/n7KbDWU5Cj3vFCgKYTW5AAY7en6lYJrltDMltT75FEw2NExFNzGlonIJsK90RcF/C\nhZnkzk6iYpfXYyGbddhsEeQ5C5rLvCZhc8mWakLuWLaVbm82MXcsJ6qQAxAEgUlJExmfMI4Sdwlh\nurAmn/w+c+V4flvn/9m86IyetI4JLncz15kfUAAA6AU9vcJ7Em2MrnGcN/e8Xc2bcIR3933QJGKu\n3FPOvRsfwK16W0WoKvyc+Rs/HprNroJE+kR24dkBFxBnqpv39vttS3FHHcRqkijLtqIq3omzR1b4\nae02bj57cJ1tXZS/hG8P/VDlubV5bHyV/g06QWJE7HAA8h3lXL74A0pdlVTKbsySntd3LOSbUTeS\nEhIZ9LUubtuPd3Yt89kuCioWYyX2w5r9QMVB3t33Afd3uReTpKdTZCW7iy0clYMqAipdooqriqI0\nJbKq8MaORXyxfy0Oj5tWIRE83nsCIxP8F3lxVLq464pZFOSV4Tncw++DGfNI3ZzBg89e0uT2NpS0\n4rwqIXcsiiySsyOW0Lg0v+eJIigK3gdegb5lVqbPuqYZLNbQOD04OZaCNDQ06oRb8e0rBt6VUkGC\n2PE53mIo4A259JhoF9K2+QxsAiw6C6KfV5ooiJglLZwnEHpRT6wxttm8GC/9a4LPto4J0Uy/fFzQ\nY6RYklECTNYlQWJ4zFBu63hzreMcqDjod7tH9ZBekRG0PcHy3r4Pq4QcHP48Cl7R0i4yj9X5+7lm\n6ScoQRYmy7fnc+u6O5lT+RkJvbNoO/gQvc7fhTnCG4Lo8sjszs2pl62/ZP5aLQQXDoekZv5a9fsL\nW/8k32GjUvbek112U+Ky89ian3nlpllcHDuNy1vdzCf//RqXo/pYx3JX11G0s1YX3iIKnaLzDzcd\n9yKrMttLd1Dh8RbzuaRdH3rEFBJmsGOU3MSH2OiXkE238LbN0pPuuS3z+GzfGio9LhRUMiqKuXft\nd2ws9P/sLPh9EyVF5VVCDsDpcLPoz008sfgFFuQu8vk3P5E4WJyLKPp/Nl2V/r2xiiKgKCKooEfk\nlcFn896P9xATH9aUpp7QOO1OVs1ex77NB1vaFI1TBM0zp6FxCtI1rAuzs+cE3C9IKoZoJ66CoxOe\nC1tdUO/ruRQXNreNcH04Op9O4k1Ptj2HFQWrUPDT1wroF9mnmS3yxeNRWLJ6N+tK1rE9YgnoFVCg\nvdSVJ894sKXNazbO7d+Vc/t3Zd6GVHbnFHDjqMFYLHXzYLa2pNAltBOpZburxJGISIguhOd7PY1V\nb22wnZLQ+M/xjrKdfrcLAhh1HiTRTaGznFX5+xkW16HGscrcZTy67b+4VTeCCJKoAiqqCh1GpLFt\ndhdESWWvfiWpZV3pGtYlaDtVVaXU7VuQBKDYVVL188LsXXjU6p85BZV1RenkfZGK4vSKlu9nzGbH\n6j28OP9/fscURZG54+7kz8wd/JK+iXC9mVKWU+nH0y4js9u2h36Rfbm41YXsLEsl2lyIQ3FiEo0Y\nxBBuan9D0PdaXyrcTn44uBHncUVYHLKHmanzeWPw5VgkCwcr0sh15hKhj+CPpStw2H0X2lRRYefW\ndLKsB1mSv5T/dH+s0RraNyZ9E9uhqn584oJKUoL/asZj4kfwzq1XIgFmQ/3CiE8GilxF/Jkzn73l\n+0k2J3FuwngSzb75qjPv+pBf357HkbUoa2QIb65+luROST7HamgEiybmNDROQbqHdcMoGHGq/sMO\nEUF2Hv3ytVqNJFvqXplSVmW+Sf+OxflLAZAEkQtbTWF8QvBelobiUTw8m/oCNrf/vmkexcMDmx5m\nctIkzk08p9nsOpbf/97Ki+/8hRjuIPm6g4iSgiCAKsJ+NZU7lj3EWyNebBHbWopz+3fl3Aacf0+n\nu/g1czZL8pfhVlz0iejN5a0vrZOQ6xLamZ22VJ/tBtFAK0vj9ykTBIHaov9kVSGzoqTmg4D5uQur\nefmOXgMkvYIlqhKPU0dociHv7/+Ql/u8EHQBE0EQiDZEU+jyzW+MMx3NQ5QCFcpRQXbLVcGPLoeb\nHat2s2vdProMDCxSx7fqzvhW3uqzHx0oY2n+Mr/hku/v/5A3+r2KRWfh6Z7T2VSyhfTKdGKNsQyK\nGoBBbHrRkOewIYkix64fGSUP7SMLcOsyuHPDqsMLWyog4FJceMbpYE00OH3/3aRIBZfiItuRw+rC\n1ZwVO6LJ76GuhJutjBsaz/yVuSjykXtQkSSFp86/GJ3Fzsu7X632N1tSsBSr3splKRe3jNHNQLY9\nh+k7nsaluJBVmf3l+1lZuJoHu/ybzqFHQ27nfriAX9+aV+3c8uIKbh/4ML+Vft7cZmucQmhiTkPj\nFEQURO7odCuv756JTPUiEaoMzmwTsu3oyu/0+ybX6zo/ZPzE4vyl1UKDfjj0E2G6UIbEnFk/42tB\nVVWW5C/lr9y/qfTYaWVOwik7A+bIyMiUyxV8nfEtGfZD3NR+WpPYFYi8QhvPz/oTgJjhBYgGhSNz\n4CNza5uhkBJnGRHG0zf0qK7oRT2XpFzEJSm1V0sMxF2d7uD+zQ9hl49WRhQQuLfTXQ2ybWX+Zn4/\ntJokczQ3d7oAg+T9rA2OGsSyghU+x6sqOD06XLIOsyTQNbz2CpS7bTU1qFeJbF1KdNtSRJ3Xy1bk\nKibaGBX0PVyecikfHPjIp9rp5SlHK8Oel9yTn9I24T6mEI2ggHFdGYKPk1zlz69X8H9vf4G7bz76\ncIGhiWdw09lX+G2FMTnxPJbnr/B5f4FX8G4r3U7fyD6Igkj/yL70j6y9CmpjkmAOrxYOqytV6NEu\nB0nvXahRUH1CJqUEDyGTbFT8eEyFVVFFDFfQd/Ie61JcrCvaUKuYKygpBgFiwoPPTWwMXp5yNTOj\n5/L10h3YKyElSc9/L5hM36T2fJX2jd/38JzsuUxMHI9V13CP+YnI1+nf4pAdVfeu4BXmL6W+gl7U\nE2OM5sJWF/D59O/8nm+3OVg3fzMDx7V8BInGyYkm5jQ0TlH6RPTm6Z7Tee/AB9Vyg1RFoHRtNPoQ\nhR5tU7j/prNpl1Jz1T9/eBQPf+ct9JtX82vW700m5j5P+5JlBSuqrlviLgm62MHyghVc0/oqTLqm\nz6c5wvtfHW3ObU6pJJAz46+DS7isS/1E9elGenEWT/71Gg6pFNUpMTh5CPeOrHtBhRCdhbf7vcGC\n/EVsL91OnCmOKUnnY9FZ6mWXLMucv/gpDpQdEepZvL97M2+eeSFnxfVnattr2Va6g2J3MeAVcQCy\nKrC3KAajqKN3ZCt6RdYecpVoSiDVtsvvPkmvEt+lqOp3FRVjHb1Vg6MHoRMlfsj4iXxnAXGmOC5L\nvpi+x4QsP9BzHFuKM0krL8KjyuhFCWOlQOhnBT4STFVh/oFVRNzhQszVQ4TCKtMSUpduZcZZz1QT\ndE7ZyZt73w4YNg1UE+AtgVmnZ1rHIXy8dxXiOgdJORWI7dSAn2/wPhMh4yqxL7SiVAigCOjbuAm/\ntZhjnaY1iZ5Ne3fyxvZZeGK9eYP6PCv3972L7m07Ntat1cqdIyZy54iJPttXFa4JeM7C3MWc32pS\nU5rVYqTadvn9DnKpLlyyi4rKCt7e9y6uQXY45H+M9J2HNDGnUW80MaehcQqTZEnkyR7/xea2sa54\nAzvLUlFUhb4P9GZw9BkNag7tVJwBC62UuI+GiaVVpJHnzCfFkkKCKb5e1yp2FfN52ldsKt7s62ms\nY9W6nbZU+jXjKn5hcUXVz54KHbow/42Ou0bWnCOl4WVPQRrT1z+N2EpBbwBV9rBBXswtX6fy7pXP\n+BzvlJ2IghjwWRdFkXHxYxkXP7bBtj22+T0O2kBFrBJqLlngvrU/sX5Sf3Sijtf6vczawn/4O28h\nTtlDqd3K2nw7oTo9F7bux21dzwoqHPKchHEsL1jpN9Sy2v0h0snasV55hAMi+zMgsn/A/Va9kR9H\n38yagoPsLs2lrTWanlIs19vvpvKY4ySdhBsI7SOR/3A8ggiq7BUyyk3FrDourHBh3iKy7VmBve2q\nh25h3ep8P43Nnd1GYXHo+e7JeejGyQiG2t9Fgg5iXsxDKZDAoCKF+wrWSk+lnzOhtNzGK+mvQPxR\n7747vpzn977IrITXCTG1bKEnsYbntiVyqZsLs2QOWEn5CC7FheUeA2Vr3JDl+x0wbMoZTWWexmnA\nqfvp0tDQqCJUH8rouJE+PaJqQ1EV/ilax+L8pciqzPCYYQyLGYLD4+TuTf8OONlqa2lDhaeSl3e9\nQqY9EwERWZXpE9Gb2zrcXKcvdpfiYvr2Zyh1l9a4Ui8c7jpVG3HG5m1RMGpIJ9YerlpWsiaauIlZ\niMdM+lQVkAV6x3VvVrvqi6IobNm/C1EU6dm2U7P2xzpQcZDpf89ATFEQDmszQQIkqEzMJaskn6QI\nr5c5rSKNDw58THrlIW9BD4eFWF1/Hu01iQ5hdfdEB8Pi7EMo6vEeMAG7W2Jh9j+MSfS2OzgjehBn\nRDes9UGSOZF/d7mHD/Z9TLG7GAUFqxRCiiWZveX7kQQJFZVoQxS3dqi9smd9EQSBM2PbcWZsu6pt\nry79P166/i0ObEsHoP+YXmxWiqmYbQCXWPUpdR/QU/ZhBKtbr60Sc7vK9vJ9xo/IAT7rekHPBa0m\nE2GouRl8cyAIAinpZsx6A540PapbQJCCEHQCSLGBeyRuK9tGhaeSkOM8xF+t+A3M1b1/ggSqQeH7\nlXOZOqZl89JGxY7kl6zf/O4bEzu6ma1pPsbFj+HHQ7/U+P0EIBhVEn+0UH7AgO2qo62A+ozuQXzr\npnknaZweaGJOQ0MjIB/s/4h1xRuqVh0PVhxkTeFacipz8PjpzwWgQ8elKRfz8YFPSa/MqHbclpKt\nzMn+gwta1R5OuLlkK3/lzCfLkU2Zp6xWIdfF2hmn6vUWhuqs7PQTghamC6WVpXmrhk0a24sPvllB\nUUklFbvCKA53ETm8AFQQ9N6+S090+2+z2lQfcrOKeX3Gj2zZuQddKzeWsyvR7xK4pc1NDO0e2HvT\nGDhlJy/vepWDlWmoVrlKyFVDhPeWf8eTk+6gxFXCsztfxKE4AO/kOcxUSYl7DVcsyeG3sbeTaGl8\nMeBR/HsmBAGKAlSHbAjdw7oxo+8LlHnKMIrGqnL8uY48DlakEW2IpIO1Q9CFT46l0u3i1U1LWJ63\nlxhDKA/2HUPv2OA+O+17t2HW+hepKK1A1EmYQ0xMOPMxcB0n/GUB9wEDUqnXo7SxeBOv7Xkz4Lgi\nIte3u45hMUPqfD9NhiCAAK6dBuRsCVp5OBLRqqpQj396JEFHibvER8zlVOYiRPoRi3qV7JL6taBo\nTC5Imsw/RevIdGRV23516ysx6Zqn9UlLMDFxAgvyFlPkKqrxuCPPgrWdC8/zcfB0GZNuHcfNL17b\nDFZqnMpoYk5DQ8Mv6ZUZ/FO8vlpOnFNxsad8b40hJf0i+9LaksKGko3IavXVZ5fqYmHeolrF3O9Z\nc/ktazbOIHsu6UU917W7miTz0cnmq7veYFPp5qrfrTor03v6L43elIiiyHezbmbGe/NZvGo3zi2J\nJBn6kDCinL5xPRjdemiz21RX0vfncc9V72B3OEHR48nS4dhoIuKuYt4xz6JH61cQjWCXHcQYoxFr\nShyqI2kVaby//yMy7ZkoqKhu/yXQBVElyuItBrEwb7HPYoMogEnnQRIr+WzfGh7u1fiVTTuFm9lS\n6EI9rt+hiMrEpGGNfj3weofC9dWFabwpjnhT/T3QRY5Kxsx5HScuEOGAM4/Ll+7j/q7jubFH8Lmw\nIeEhVT+bBBN2fD/PgqTST+9dDHhn33s1jhdnimVodNPk4taXwWd1YebTv4EqUPRSNCGTyjEPsYMI\nokWBekSyKyjEGHwb3neO6sABxw4E03GCzi3QJdZ/o/LmRBRFnu39f2wq3sTSghVYpRAuTL6ASEPz\nFmlpbkRBZFDkAObnLqjVOweHF5eGO/miTKtgqdE4aGJOQ0PDL6mH8+uOp7bcgPTyTDyqBzVA4+Pa\nBFqFp5JfMn+rNRcIQCfoCNWFckO7qdWEHMB9Xe6mzG1jW+l2EkwJtLe2rXW8psJk0PH4nRN4/E7f\nhtknAx/MmIe90gVHis0rArgESt+NwNjXwe1rp2McbkMyiJglE9PaTaVvRMOT+Wdn/c5vWXOqF9lx\nCyhOEI9Z6Fdl8OTpuP18b6XFLHuWX8+xCkiSky3FmQ22zR8vD7yRyQvexCWDooqAiiioXNmhI5Zm\nLLoA4G78AAAgAElEQVTTUB5e+WuVkIPDHgUBXkn9i6ndzkBXj9DaCRcP5KfPV/q0ZtChY3jvAQA4\nani3mAUz93S6q15exqYkPDKEe56YwuvTfwHAOTsCx+/hmM6xYZ3iv12KQTCQaEpAFEQy7IeqPasG\n0cDEhHMxSr6erEuHTmD+X3+iSM4q77TqAqnUzPkTxzT+zdWTvpF96dvM1UVbmrHxo1mUvyTopu9C\ngObrGhr1QRNzGhqnKKqqsqV0K0vyl+FR3AyLGcqgqIFBe01CdFYkQfKZFOsFHe4AIZaqCttz7Fyz\n52c6dkkg21k93EZAoHd4rxqve7DiIDpRh1sOLOYkJKKNUTzU5X5ijDEBJ3hh+lCGNlFVzdOJLesP\n+t2ulos4lofg/EdB/DuSqMcKcFlcvLX3HZ7o/jjJluR6XzPfmc+vmb/7iHp9Ww+uXXr07d2oHm+I\nm1Iqck6rieh03q+0jtaObCzZgue4cwXA5THSOaxp8iaTLfHMP+d+pm/+jC3F+YQb9NzRZTzjk06g\nsMAgWFN8APy8JlRU5mfsYkKbuhcfuez6s1g0Zwu2Mjset9djbzTpueXBCRiMtbuvHu/+KEnmxu/9\n1xiMndSXPoPas/zv7bhdHox9nMxRfsYRwEnjUl080f0/SJJEWkUa32R8z/7y/YTqQzkvcSKjYs/y\ne55Bb+DlYc/w8oJ3yIo4ACokl3WgzYEeXPrsc7gcbpJaR3H//11E196tm/CONY4n3hTPfZ3v5rnt\nryBKNXvnVBVcthOvKbzGyYsm5jQ0TlE+T/uK5QUrqjxpqbbdLMhdxLkJ59A7ole1IiT/t3gGe8Sd\noFMxlFu4p/dtDIjtx+dpX/iMKwgi1yZfzWcZ1fcdccTtS4tB8eQiGJKITC5EVj3esuWCHpNk5PKU\nS2q0O0wfhqIGLg4gCRIDI/tzTZt/EaoPDfafQ6OerF22C5dkB/yFN3pFtOoUkQsEKn63EnqZDY/i\n4a/cv5nWbmq9r7u5ZGvAfYYubuRSASHfQhtrBx4bfwsW41HP14jY4czJ/oMyt7vKmSgrUOY0Iitm\npnZsOnEVY4zkzTPuabLxmwMJkUBLKVZd/RpyR0RbmfXjXfz02XLWrdhDdFwYl1w3nD5ntK86po25\nNWn2dJ9zdYKOlJBW9bpucxETH8aUf3mfK5fi4o+Nv9Z4/PLClYyMG0GbkDY83PWB4K8TEcnzFz9a\n9fv0e77g50Wrq37POFDAvVe/x+tf3UqXnvVfTNGoO93DutFKGc4hliH5FMLxNo8HFUGA8XG1R55o\naASLJuY0NE5BsuxZLM1fVs2r4VSc7Crfza693mbDw6OHclOHG7hl3r+xR5ZWJWe7wit56eAMHhEe\n5sEu9/P6njdxyt7QEVEQub3jLfQK7wkCfJb+RZWIU1VI3dsKl8sAKGzPcvH1sAfZ7djAIXsmnawd\nGRV3Vq2NY1MsycQZ48i0Z1XLPzCIBh7qcj8d61nQQaPuFBXYeP7NTzGfXUHFHKtvAYtj8Qg4/jER\nepkNBYU8R36Drq0TdN5S536ikURELFEm/jf8MRLNvg22Q3QWnuzxX75O/451xRtxySr5FVZChI58\nNPx82liDb559OjIhqSc/Z62v5p1TVdCrOoYltgt8Yi1ERIUw7d7xTLt3vN/9/+n+KPdsup9K+Whp\nfgGB/3V7rN7XbAnssh2Bmt9RahC5VbVRVlLJqkWpfve9+sTPvPPjXQ2+hkbdeHzgZVy/ci0msxPp\ncCilgHJk2QurZKevNZ1ovUqJcxcRxi4taa7GKYIm5jQ0TjFUVWV21txac86WF67EKodVE3LgzY9R\ngdc2v81757zGa31ncKDiIJn2LAocBaRXZpBgSmBswmjGJoxmyg+z2FtcSKW9eo8jvSji8Ri4NKXu\n5bLv73Ivr+1+kyx7FuLhEutXt7mKTqHN1xhXA5bO24rYyoVpTAVKkYR9hQUEFdyHk6iOQzjmG6Wj\ntWF98wZE9uPL9K98r4HA+IRxTEqcWGPvtGhjFHd2uhUARVXxKDIGSfvKC4anBk9kze8HyfIUVolp\nEYGZZ15eYysKj+Kh1F1KpD6yXi0rDJKBWQPeZEvJVlYWrqZDSAfGJZw4uWDBoKgKz+58gQq5osbj\nRkQPb/C11q/cG3DfoYMFAfdpNB2hRjOvD3qah1fOwm7MwGpw0C00k3amfMRjXpkqRgodmzQxp9Eo\naN9sGhqnGF+lf8PaorVBHTsv/y+/bwFBAIe53PszAqsKVrOkYBluxY0kiPx86Femtr2G4bHDOKtV\nL1Jz18Fxzbw9ikK3mPrlJkUaIpne83/kOnIp91SQYknB0IAG5xr1o6LcgStbwIxA2DVlWC8ox5Mj\nUfxaFN7ChMfMTvQKphFHPSqi4L/qZLCE6kO5pf3NvLv//Sovh6Iq/KvNFYyOG1WnsURBOKWEnKIq\nbC7ZwtbS7YTpQxkRM4xoo2/1w/qiE0UWnH8nC9L3MC9jB0mWcG7pORSL3n+IpUfx8HzqS+wp94oL\nAYFRsSOZ2u6ael2/d0QvekfUnFt7orKzLJUSV2mNx5yfOAlJCv7z8Wf2fDLt2VyRcgkW/dF2Bclt\nYwKeY7bULxxWo+G0skbyxTleb/Lu4k/YUfwOynERBiISJknrLafROJw6324aGhqUuEoPl2UPnHN2\nLKroP9RHVUHweFfW95TvZUnBsqoqXd6xZT45+Dl9I/pwfd8BfL9jG8UOBy7Ze12zTscDQ0dg0TdM\ngMWb4olv0AgaDaHfkI58/0kISlkpgl5GDFMwhClE3FtEyUvRIKre/wUwdHIRcs5Rb0R6pW/uU10Z\nGNWfbmEz2FSyGeVw0/kwfViDxz2Z8SgeXtw1g4MVaTgVJzpBx5zsP7iz4230iejdqNca27oTY1vX\nXvL+2Z0vsK9if9XvKiqL8hcTpgvlopQpjWrTiU6eM99vFeAjDIocwMUpFwY11qKcJXyS/lnV70sK\nlpBgjOeFPs8C0Kl7EmGRFsqKK33OveLGkXW0XKMpaB06iZ3Fx7fcEBAFI4khI1rEJo1Tj8ZrBqSh\nodHipFWmo6+LB0sE1X20eMmxnGH2VoFcXbjGb7llSRDZXLqVSLOZOVddy439BtA1JpYRrdvyzqQL\nuL5v0zaS1mh6uvVO4cyR3al8PRHnDiOqx9sGICLWwtuLbua8m/sRflkFUQ8VEnlfcVWYpU6QSDT5\n5rLVhxCdhWExQxgRO/y0F3IAy/KXc6DiYFVhI4/qwaW4eGvPuzjcwZVFb0wcHkc1IXcsf+T82czW\ntDytLSkBG4W3tbTh5g43BTWO2+2uJuSOkOPM5d2971f9PvPb24mICql2zLjz+3HxdQ0P49RoOCZd\nDMMSZ2KS4pAEM5JgJFTflpGtPkQUtGgTjcZB88xpaJxCRBoifBp114QggOLAmxdzTFRObGkSd5wz\nDfAWPREQUH0qUQiIh8PfoswWHhg6ggeGBl5p3Gvby8/ps8lz5NE1ogvnJ08i1hg4TCgYFEXBXunC\nbDHUK0fnWNyKjCgISI3Y8LqpyEwrYPXiVCSdxPCzexAT3zQiRxAEHnruElYt6snfv21ETVUYc15v\nRpzTG0EQuPPW1hRs30GG/RDyMY+HJOgYGz86qGvIisKCA/uQRJGRbdrVq4fZ6cTKwtV+F1fsNjsX\nXHEfd/77FiYPC+yhO+I1aqzG7nnOwIVuXGrzikuPx4PT4SHE2nI9/dqHtKNdSDv2le+vylsWEQnT\nh/JYt4eDDhd/78AHAfetLFrNlg3bEIAzowfz8YJ7yT9oIyujiN5ntMViOXl6Gp4OxJj7M6HNPGzu\nA4iCHqs+paVN0jjFEAI19m0JBg4cqK5bt66lzdDQOKl5YttTZFQeQj4mh02HjjhTLFmObL/nGEQD\n4wznUuqwcWH3icQcU+1vX/l+nk99yWcCaRANvNZ3BiE6y/HD+bAyew3vHfgARVQQRFA9oBf1PNN3\nOgmm+gVSvvK/n5j/60ZU1VvqedjY7jz28hV1FnVp5UX8b+Ns1hWkIQgCYxI782TfSUQZQ2o/uQX4\n6t1FfPPBEhRFRTycUX/Xf85n3AUt4wkt95Tz4f5P2Fy6BUVVqkS/XtAxMWFCjWF2X27ZxBNLFqIc\n/h6SBIEXzx7Phd16NIvtJyMvps5ge9kOn+1KhUrB3ZU4SkKYufJZeqTEo6gK6ZUZ7CxLJc+Rx/6K\nA2TYD6GoCt3DunF9u2uJNTYsb8ejeLhh3S1+91kkC7MGvNmg8YPB5fLw8LQP2bklAwBJErny5lFc\nfVvLFE9xKS5+zZzN0vzleFQPAyL7cWnKxYTrw2s9N8eRy5rCtfyVPZ9ypeYiKuCt+ppoSuCpnk80\nmkDX0NBoeQRBWK+q6sCgjtXEnIbGqUWZ28asfe+y27YHURAxiSZuaDeVvpF9+DztSxblLqkm9ADC\ndGG83m9GwMnAjxk/80fOn6ioiIioqNzc/kbOiK79PaOoCjcuvQPZXF0Mqgp0VLvwvyEP1fke33p2\nNrO/WeOzfcQ5PXj85SuDHsfmdnDOX29Q5nKgHBYhOkGkdUgUs8++3Vsa/wRi/+4c7vvXOzidxzVy\n10t89teDREbX3PahKfkp4xd+zZ7ts3183DiuanuFz/a9hYWc8+UnPtsFYNn1N5EUemKGVGbkFfPw\nZ3OxOVxcN2oAlwxv3Dy12vinaB3v7/8Q53GLK3KeQu4F5UhddLR6KRl9fCVOxVWtvcexCAhYdVZe\n6vMcZsns95hgeWvPO6wt/sdn+/Vtr2NUnP8G2I3JbZe8yYHduT7b73x8MpMuH9zk128sFuYt5qu0\nb1BUxecdXRMm0cjtHW9t9JxJDQ2NlqMuYk5bxtHQOMUI04fycNcHeLXvSzzd80le7zeDvpF9ALgg\naTKh+lD0h2P1RUQMooEb2k+tcVX34pQLebrnk1yacjFXtL6MV/q+GJSQA8gsysUj+YZbCSLsd+6r\nxx3C3B98J44Ay+dvr9M4s9O34JQ9VUIOwKMq5DrKWJXvPw+oJVk6bytut+8kz+2WefnxH2jJxbk5\nOX/43T4/b4Hf7S+uXOZ3uwq8sWZVY5nVqPz38z+Z+PwnbM3K42BRCdN/WsCZj8xsVhsGRg5gSPSZ\n4BZQ7CpKhYpSplD4QCW6tiKxs8y4o4uwK46AQg68RUpciovVBb6LInXljk63cnbcGKTDFUxNoonr\n2lzTLEKuMK/Mr5AD+HTm301+/caixFXKV2nf4FbddRJyAE7FRXplRhNZpqGhcaKj5cxpaJyihOnD\nfApGhOnDeLbXUyzKW8yOsp3EGmMZF382yZZWtY6XYE7gXD8NmmvDVar4a0kGgGoTWVmwmkV5i3Gr\nboZEn8nouFG15pXInsBVOJ12F0ZzcGW599ryscu+/fhkRSGtvIhhcQ3rldbY1CTW1q/cy6czFzD1\nrrOb0aKjeFSP3+0KCi7FhUGs/jfJLrcFHKumfS1Fsa2cXzbu8HmWK1xu7nr3F968pemrNqqqyvKC\nFeyy7UFSJVyHPDhXuhFTJMJnWBFCBASjSrDRdk7FSaY9q1Fsu6btv7im7b8aZays9EJ2bEonKjaU\nPme0R5IC39D+XTkB91XYHI1iT3OwpXSLNxKgHusxRtHQ4PzjpsajeMh25BCqs7LLtodfs36j2FVC\n25A2XJZyCe1C2ra0iRoaJy2amNPQOM0I0YUwKek8JiWd1yzXS0mOwznXjKGvnWPn84pTwCqF8MnB\nT6tCxjLtWawuXMN/uj9atcrvD51ewuPHQyWKQtBCDqB7RCIWSU/lcYJOFEQ6h9WvR15TMuKcnvz8\nxUpcTv/C6YePl7aImHM63DjXm1HsYOjqQoqp/rc5XsgBnN2uA9vz8/yON6FD5yaxsyH876tAXh6V\nZbsPNIsNv2T+xtyced78VQPoO4joOxpRERAFqvJHg8UoGmkd0rrpDK4jiqLw6hM/s2TeVkTJW17J\nGmrmxY9vIDE5yu85nXsGXogKjzox8179ISISaNVLPBxEFWuMxeaxYZftVbmpAgImycSAyBOnerBT\ndrKycDU7SncSY4rGKlmZnf07iqrikt1e2wWv/TvKdvLszhf4T7dHaBPSpoUt19A4OdHEnIaGRpOy\nz7EP0aXDtcOIsYcT1S0g6FTsq00YRtrwKEeFiUtxkWnPYkPxRgZFBQ7jvHzaCL58d7HP9nMvCi70\n8wgTk3syc+dinIoH+bDXyyBKtA+NYUB0001yC3LL+PaDxWxZf5CUtrFcOm0EXXom13pex25JTLlq\nCN997D9E0eNRsFc6MVuMjW1yQFK3ZPD4rZ/glCPxKDIoApaxFYRe4vWu9Y/o5/e8mwcM4sON6yk/\nrpx+tNnCpT16NrnddaXSGaAyoyCgKCrlJRVYI5pOPDhkB3Nz/sClHF14EA4XwDkiAeoi5EREzJKZ\nwVGDGtHKhvH37E0s/WtbtcUKu93FIzd+zOjzehMTF8aoCb2xhh3N8QuPDKFX/7Zs3XDQZ7xbHpro\ns02WZYptZYSHWtFLJ05p+L6Rffjk4Oc+2w2igUe6PESSJQGzZCbPkc/7+z9kb8U+BKCTtRM3tp9W\nt5Y0TUiFp5Lp2/+PEncJTsWFiFg93PfwM6p6VORsBTFKwO5w8FLOTGZOeqlljNbQOMnRCqBoaGg0\nOi6nG0VWMVkMfH7wS/7OW4hzm5HKJWYEFYQImYgpDsRQxW8rhVGxI7m+3bU1XuPztxfw3YdLcbtl\ndDqR868cws0PTqh2jKIouBwejGY9lRVOpk6Yga3UXrX/mtvGMO76Qby49S8WZu9CJ4pMTunNv3uc\nTYgueA9fXdi/O4e7rni7WqioXi/xyIuXMWxs7VUcXYqL8/s9FTAc67d/nsBgbNyJXUlRBT9+uoy1\ny3YTEWXl4uuGccaILsgemSvHvEBZSfWmxYJBIfyOYgYN7cJ9ne4OWGG01OHgwfnzWJ6ehiDA+A6d\neGbMOMwNbDbf2JRU2NmZkcvN7/3s6zxRVYwZpXRYmc2s9S8QlRDZJDakVaTxbOqLOOSGhw7qBT39\nIvpwVZsriDQ0jb314e4rZ7F7e2bA/UaTHkkn8tx7U5FlFZNZT/vOiSiKwvMPf8/y+dtQFBWzxcDN\nD05kwsXVF3dmfvQ9cz/YhGIHwagy8IpWPHH3LZR7yvn4wGfsKt+NRbJwftJ5jIpr/qbbawv/4b39\nHyIIQlVI9QWtJjE5aZLPsU7Z22fQKDXfwk0wfJ/xI/Ny/goYdn2EI/d37L3GZrdlxpT/NbmNGhon\nA1o1Sw0NjRahpLCcV574ifUr94IKHbol0vMRM6scK3yKMegFHSBU9WI6gk7QMTnxPKYkn19vO2RZ\n4fO3FvDLV6twOd3ExIVTkFuKovi+7+58fBKTLj+z3teqK5ePeo7SIt+S42ERFr5Z/EitrRXm5yzg\n7cfnYf/HQHVlodK9Xxte+fTmRrW3tLiC2y6ZSVlJZVVoq9GkZ8g1bdENLuOf79MpW6JHdVS3e/i4\nHvxnRvCVRU9E8svKeeiLP9h8MAtBEPB45Ko2CgiCN0lTUYl9azWSDK27tWLG4ulExNZegr6ulLlt\n3LfpgVonyeA1S8X7dAgCROgj6BzaicFRZ9Avsk+NIcwtyc1TXid9f+C+df4wmfU8Pes6evZvW+Nx\nn3w9h29nrER1Hf3MCAaV3tOiyR+Y6lN0ZGj0EG7pcGOdbGkMytw21hdvwKN46BvZu8GtI5qDVYVr\n+C1zNqXuUtyKJ6j+gt6QYMFn25u9XifcEtpUpmponDRo1Sw1NDSaHUVRuH/qB6xfsRfZoyDLCnu2\nZzJ/+v4Ak0fBu6p8nL7yOGV6in0aZMv7L//Bz1+sxFHpQpFV8rJL/Ao5gLefn9Oga9WF9P15foUc\nQHmZnYLcslrHWFu0jtBpRejauQ7nnaggqujiFK56uvHLsP/y5UpspZXVchSdDjdLPt3NZsdmjOcX\nE/NcHoY+diLuLiLmxVwi7i3EFloIQFZGIe++NJcn7/6Cn79YSUX5yVGUQlVVpr39Axv3Z+KWFVwe\nGQXQuRWEchc43BhTC6qEHED6zkzuGPQI9orGv8cwfSj9I/tVVaI9amf142RFINtm5WBxZFXY5bCY\nIdzR8VYGRvU/YYUcwFnn9sJgrFv2h8Pu5qFpH+Jy+hYyOpaf319dTcgBqC6BvTkH/VaPXFm4ijJ3\n8xfiCdOHMjpuJOMSxp4UQu6P7D/56MAnZDmyqZArg24Uf7yQO8K365rvfayhcaqg5cxpaGg0CpvX\nHqAovwxZPuqBU1VwpUt0ze5PauIGREFEQMC+T6T0nXgqjTYi7rQjhileUeeBsg8jeUuax6uf+29E\nXBuOShdzf/gnYJGQ41Hk5otOyM0s8bpL/FxSVVVCrKZaxwjRmRH0EP14Ee4MHZ5DeqRYD9ZOItFR\nje8RWr9iL26Xn1LpkoonQ4ehkxv0EHG7994EEcQIF/k9tvLDgr/49NEVeNwyYoyL7WHr+enOv3nz\nlfuJOFycIrswnzkLl6PXSVxw9mgiQr2r8m63my3F+2kfnkSksflX6jccyCSnxFaVS3kEURCJ+2QT\nisd/+fiyQhuLvl7BxBvHNrpNN7W/gc8PfsGqwtV4PDKeIhnXPhnjID0KAqKgUmgzU5BjpnunAsCb\ncxVtiG50W/zx5749PPz3n5Q5nRhEkRv6DeDBYcG3J7jommEs/XMbeVklOOzBiQIARVH54ZPlXHXL\n6IDHOIsV/BUYMXRzBjznn6J/GBvfMo3HTwbciptfMn/1FuRpJJLC4httLA2N0wVNzGloaDSY/JwS\ndmxKqybkjuB0utFviuOVCS+ypXQbGZtK+PSZlYAD0FP4WCxSkgdBD54MHSgC+4zZ5OeUEptQd3FS\nVGirNVSxpYiOCw2Y69aqdTQhobWLubFxY9hRthOn4kKf4kGf4hWt4YYY2loavxpcdFwY+MljUmW8\nIhx8SuELordVwcdPLUJ2QMxL+YgRR268jPtS7+PNga/w0Te/M/f1rXidRSrfPLuGaU+PYq5hJQ59\nJjqdjKoKlNtC+XjkU80q6lbsSsPh9l0QcOkFQrrGU7EzB8XP8+6ocLJ9ZWqTiDmDqOeG9tdzTdt/\n8dWrP/L9f2fjcrgRwuzQx4jdYETKKqHT9aXoung9eJIgcWZ00zfO/nnnDu6ff7TXoEtRmLX+H3YX\nFvD++RcFNYYlxMjMb29n6bytbFi9l8J8Gzs3pQe1MJOZVlDj/pBEHRWHfAW46gr8rojQnzj5hCci\nRa6iGjspGAUjTjWwWD4WVVVRnQKTBgcW5BoaGv45MWc8GhoaJwVZ6QXcMPlVrp/4Kt98sNTvpMtk\nNtC5RzJh+jDalnfmm8fWHneEgJylx5OmB8W7ci5KIpUVwU0CjicmLqz2g46h7+D29bpOfdiwai+i\n6D+8aNKVweXt9YroybkJ49ELOkyiCZNoIlIfwb873xswdKkhXHztMIym4wqSSCr6ZA+6+MDNjZUi\nCblcJPI/hYgR3pL5R/6XJZn7Nz3M3Ne3gltAdQjoUjyEXl3CD64f8ZjTMRhkRBEkScUaauP6pf9p\n9HuriYVb9/rdLgDnP3s5Ce38t64wmPQkd0psQsu83rbJV52LeLj/mloG6jIn5oU2zLlurENN6AU9\nCaYEHu36ICE6S5PaA/D4wvl+ty84eACXHHwTbINBx9nn9+OhZy/l6bevpXu/NpjM3sInkhT4+R48\nqluN40779zgEfXXpIRhU2oT6ryKrE3T0i2hYuPepTpg+DEX13/OzfUg7rm57JUKgJqPHo8LUmJsa\n0ToNjdMHzTOnoXEaUl5mpzDfRmJyZL0rH+7adoh7r34XNUAuGoAkiYSGmenaK5lbLnyD7ENFQa2y\nG406ktvWrwmuwajn8hvP4pv3l+B0HM2jESVQjptTRkSF8Mys6+p1nfpQmG/zm7un00vBTnkAuCh5\nCmPiRrOnfA9WnZUuoZ0Rg+0UXUd6DmjLbY9O4t0X5wLgdLnQtXURfntxjecJBm/orL6N7FMyXxDA\noTpAksGtwzLRhvW8ctD7evngsKCzVrCvNJMO4bU3uG8M0gtK/G5XgQvH9OOanYO5pv2dFGYWVvub\n6vQ6zp3W9KF50YmRPDv3cZ696jXKSypQFZWE9vE88cP9WNtZUFSVaKP/3mxNgUMO/LlelnaQse07\n1HlMvV7Hc+9OZfvGNFK3HCIk1Mhbz8zG46kuICKjrZx1Ts3tLM47ezjqiyqfvDGfiiwZYxxMvmUA\n0yZfyCu7X2dL6daqYyVB4tGuD56wHv4TBbNkZnjMUFYUrKqWK2cQDVySfBHlngoMgiEo71wHawfG\ndm++QlQaGqcSmpjT0DiNcLk8PDTtA1K3HPJuEGD0hN48/PxldRrH7fbwyE0f+RVyggAGow6dXsfQ\n0d2Yevc47v3XuxTkl9Uo/I6eq+e+6RchSfWfSF1x40jCI0P49oMllBRV0KFrIjfdP4HOPZJYMHsz\naftzOWt8r6B6uzUmfQa1Z96P67BXVs8xkSSx1mp8xxNhCK+xF19jcu6FAxhzXh/S9+VhCBX5sOR9\nsh3lqKqCKIiYJBMVnspqlUnFUBV9h5pzaUSrAkYZ6+RyhCDWFFblbGs2MRcdaiGnpNxne4jRQJjZ\nhCAIzFzzLC9cO5MtS3cAYDyrA7YzUxj10ickRYZxz8RhnNuvS5PZ2GtEN75Mm0XGriwMRj2J7U/M\nfKOOUfUXlYIg0LN/26rPx4ChnXjmgW/YsyMLUYCBIzrz2AvBvb8mjR3BpLEjfLbf3+Ve8h0FrC5a\nQ4whmsFRZ2hCLkiubnMVkqBjacEyFFUhRGfhypQr6BHenVWFa7zRArWkJRtFA2cnaOGVGhr1RWtN\noKFxGvHva99jx6Z0n+1Trh7KrX4a7AZizdJdPPP/7N13fBXF2sDx3+6enp5AQkLovVdpNkCsWK6K\niqioWLBj96K+dq5dufbuVVEsqKgggiJKUXqVTigJIQnp7fTdef84EBLOSSEkgZD5+rmfS7bMzhV2\nwTcAACAASURBVCbhsM/OzPPcN73SUbbh5/bi389fAcCapSk8dc/nuEqrXyQ/dEQ3rr1zFOmedN5N\nexdiAu2r+208PehRWiXU7/S1+qbrBvdf9z47t2aWjRpa7WYGndqFR14ae4x7V3NCCLaVbCfdtY9E\nWwu6hHfmu/SZzM36FSFEWVCnF6qo4QYhEygK2H9HPNY+XiKuKUC1hzimHL+u8kqv50kIr7/Rppxi\nJ1d9/CXZRSVEWWzk5ZbiUwSqHxShYDebuOGMQUw8s+IatNIiJz+v2coLcxZXWGdnM5t4+oqz6jWg\nO15c9d3X/L03LWi7zWRi022TjkGPpIbkN/y4dBd21c5feX+zOn8tkaZIFucsCZkt1KJYEATKEwyM\n6c9N7W+ot9kFktQYHUlpAjkyJ0lNhNvlDRnIAcz6atkRBXPOYnel67NUTaHfkI5lXxfkllT7ZhYC\ntcvWLkth5/YM/HdtRYsxyqbnGfFuHt76f3wc9w4mU+P92NI0lec/mMCsr5czf9ZaTCaN88acxKgL\n+1U4bsOqXaz5K4XLbzoFm636pCgNTVEUukR0pktE57JtY1pdwgVJo/nv9jfYWBQYqdKijEDNs3Kl\n2Q46OW4oK4Zms784h0pTfB6g6wqekph6DeSmL1/DMzMWoBiBrmQTGJU7+HipWwWXDenNTWcMCjo3\nLNLBewtXBSVMcfv8/PfnJU0imPv0oks57ZMPySg5lM7frKrMveq6Or9WbnYRj976Cel78oiKdjDm\nulO4cNyQelkzKtWMSTVhxco9a++nyF+xpIOGBgoYwsCsmhkcO4jeUT0p9hfTJaIzyY6GnSEhSSea\nxvtUJEnSESkqcFa6r3wNscPpfp0dmzNQNYUOXRNRVZXeg9pXWrctOjac4ef2Lvu6W9/W+EK0r2kq\nEdF2igtd6H6jbKTK5fJi/jCa2Afyyo5VFMAqeHPeZ0w67/rqbvW4ZrGaueSak7nkmpOD9m1YtYsH\nrv+w7Osv3v8Du8PC90sfa8gu1ppVswZtO/z52qSYOD/xPC5OvogbpxrM+P1XZqszODyYEwIMQ8Hr\nM2HxNWfGmU/XY8/h6R8WoOpUmrBB9Qh+25HCA+rpQfuEEGQWhK5Jti+/+tqBJwJN01gy4WZ25Oby\n49bNDGjZktPbtKvz63w4dS7ffLSo7OvsrELefn42v/64mje+ur3OryfV3HspHwYFcgGCi1pciF/x\n0ze6Dx3CGy7plCQ1BTKYk6QmIi4+EkUJLjIMYHNYQp6zZmkKzz74VSAYEwJHuJXHpl5Fl57JjL3p\ndL764M+yqZaKAjEJ4fQd04Jbrp6KQ3VwwdjBDBjWKeRaOc2kEhZuoyD3sCLaAnwpFowSBTW84nk7\nnKEzDDZmm9al8tyDX5GzvyhkzTuX08u157zIJ788cAx6d+QGxw1ie8mOoNpTFtXCG/2mVgj4VFXl\n8lFnM7CkMy9vm4rfCPwu6ULn6rZXMjw+OHCqDznFTlR35YEcBPalZ4ROiqIoCglR4WQVBq+xS4xp\n+Bp5x1LHuDjuHXZKvbRdWFBSIZArb8fmDP5esJmhI6rOainVn7UF60Ju1zHoFNmR7lHyZyNJ9UEG\nc5LURGiayjmXDGTOt8HrUq+/68ygbfm5JTwxaRoe16GkFi6nl8k3f8wXvz3EVRNH0GtAW+bMWIGz\n1IOn7342zs7i9zcOvpktYOoTM4ltHh40OgOB4K+0xB26swoIb/DUuyRLUk1vt1FY9scWHr9rWrXH\nZe0rbIDe1I2T44ayKHsxqc40PIYHFRWTauK6tuNDjtwBtA9vx2v9XmFr8TY8uocuEZ1xNEA6/YP8\nomYF5gmdhR2AgR2Smb16S9D207vLUYi68u4LcyrdJ4CfZ6yQwdwxJKqYKl3jv2OSJB0xGcxJUhMy\n6fF/ERFt5/vP/sbn9WN3WLjurjO5aNzQoGN/n7U25EiRMARLft/EGef3pffAdvQe2I4/9v/JB7OW\n49sRCYeNbuRlB49WQGBaVsduSaxdtjNomqcapaNEH3pyFgLwwz3n3HDkN30ce27yN8e6C3XOpJr4\nd9cHWJW/hjX5a4g0R3Ja81NJdlSdhVJTNLpHHpsH8RaRkRjWwFTKykbnBALVGjpBg2EY/LJ2a8h9\n0xev5aQOyYzq3anO+ttUOYsrefkDoMBf4WlkOAtJdEQ1XKeqsbVoK5+nfkmeN4/WjtaMb3M1LezH\nZ9bRo9Utoisbiv4J2q6g0DOyxzHokSQ1DTKYk6QmZsKks5kw6exqjyvIK8XnDX6b6vfpFOVXXH+3\nYP9Cin4PPeoCoKhK0FRLt9uHI9xGZHQYzhIXbpcPk1nDZFIZNb4nyzy/IWwHzinWmNT6LmyW4y8Z\nyNFw1bIw+vHOpJoYHHcSg+NOOtZdqbHbzxzCWz8vBQSKoZSNMigc+LMCk84NXucIsGVfNnola0gF\n8NSM+Yzo2QHtBEl3vyY3lSfX/syO4v1Emu2cn9yTbYVZFPu9XNNhEP9q07derjtu4giW/hk6aEaF\n/T39TPz7C34849Yjbtvr9bNi0TaKCpz0GtC21nUuy/s9awGf7Dk08r6xaBP/3vAI/9f94RNy3dgt\nHW/i3rUP4jEqfq5d13a8LPUgSfVIBnOS1ATkevKYnvol6wo2oCgKLe1JDIkbzLC4IUSYQ6/p6Tu4\nPT99tQz3YTXRVE2l90kVExvowo9iqnyKjaoqCKiQNMXQDRb+EijU271fa5rFR5LUKpbzLhtEfGI0\ndzCWnIJ8LGYzkWHhtbzzE0PHbon4fTomc6gc/1JduH3EMPq3T+SGOdNRXCrCJFBKVIRLg3A/Xbs2\n44ZTQwenUY6qXzK4fX725hbSpnlMfXS9Qf2SvpF7l88om1CX73Xy2c7lZfsnr/6Blzb+xuLz7q/z\na3fumUzHrons2JKBoFwOVAWyL1Xxh8Pe0nx2FGXTMbJ5jdvdsDGFxyd+juEXCCOQ0GbUhf2489EL\na50hUwjBtD3Tg7cjeDvlXV7q83yN29J1HZfXTbg9rFZ9aSjhpnDe6v8aP6bPYn3hP8RaY7gs+RIS\n7Y27pIwkHe+OKphTFOUJ4CYg+8Cmh4UQPx/YNxm4AdCBu4QQc4/mWpIk1Y7T7+SJjU9T7C8KPPgI\n2Fm6i52lu/gi9Uta21sxscNNQdPg+g3pQLferdi0NrUs06TNbmbI8G506JrIrtLdvP3tl2z5shB/\nroraLDjQUOwGYaNLSDhLxVOqUzTHQtE8G4dPxdy0JpXnP5xAn5Mqvq1uFt34H36r0rF7Ejs27av2\nuPTUXK4+6wVe/OhGWrWr+UOqdGQiI62EtVQp8QdGFsq/nvA4Kh9FbRkbRZTDSqEz9DG6YRBhr3zk\nurEo8Xm4f/m31VYayfWU8tCK73j+pEvqvA9vfH07X3+0kLfn/IooFXhaqxSepiDsgZEfTVEp8IbO\n3Os3/OxzZxCmhRFnjUUIwZepXzPt9rXoRSrlP5d+n7WOfoM7cOpZPWvVzyxPVsj6agDZnpwatVFQ\nUsDtNz/I/u/zwQvmDhpjX7mI8edfWas+NQSTauKSVv/iklb/OtZdkaQmoy5G5l4VQrxUfoOiKN2B\nsUAPIAn4TVGUzkKIyvOfS5JULxbnLMFtuCt9AEt1pfHM5md5vvcUosyH1pqoqsrTb47n1x9X8+uP\nazBpGudcOoDh5/ZmZ8kuHvlgKvnTwsAbCOKMNAuBx98DVzIJYh/JQYvTKVGBCFATFTDbwBfUDb54\n94+gYO5E98qnN3LlyBcoLTq0FkhRFcbdPJxvP1mM+0DyGVepF7fTxxOTpnH75PNJbBVHYnL91Vxr\nqtqGx+EzQpTRQKFPTNW1sP532xWMeeWzoOmWJk1lYPuWxIY3XEKX+vLchrnoNSkaCfy4dwMCeKEe\nArrLJ5xG/skKb29ZiMeoOBVcFwbdo4NHgmakfcfsjDkYB7LYJNoSGRl/Or+sXIRRGrzW1+3y8vOM\nFbUO5uyqvdJ9KjWbcjjhX3dRvMQFB94R+HboTLv8O1osSOCswSNr1S9Jkk489TWJ+SLgSyGERwix\nC9gBBFdalSSp3u0s3R2UJv5wPt3HH/sXBm03mTXOvfQkXvnkZl746AZGju5LUb6Tp2ZPpWCGA7yH\nf4QooCg44iyEDfahRhso5kN7dV+5YO8w7kpGNU5kFouFbxc/ypR3r2Pk6D7cNvl85qx9mhWLt5UF\ncgcJIUjfncvDEz/h+vNe4ZqzXqQwv7SSlqXaCDNbua7TUOzaoV9aBbCZzNzc5dQqz+2YGMeq5+7k\nlK5tURUFu8WEzWyiR3ICz199Xj33vP65/X6+3bPmiM75ae8GZuxeXS/9uar9IBLsEVjVwDtpBbBp\nZh7seRYOU8VSK79mzeenjNllgRxAhjuDL1O/wev1Hx7HlTk4I6E2oixRRJkiQ+7rFVV9gLhq62qK\nFx8K5A4SPvjw+c9r3S9Jkk48dTEyd4eiKOOBlcB9Qoh8oCWwtNwxew9sC6Ioys3AzQCtW7eug+5I\nklResj0Js2LGJyp/MPHjJ825N/Bnn87fCzazZlkKzRMiOfOiATRLiMQQBguzF/PGnfOwXudElFay\njk2As8CLrVSg2ioGbpaeHvgm9APOqAv71e4GTwADhnZkwNCOZV8frN1XlezMQm6//E2m/fpgfXat\nyZnUbQTJ9mg+2L6EfK+T/nGtua/HKNqEVz8Sqmkab990MQWlLrbuyyY+Kpx28SfGCOpXu4JLmtTE\nu1sXMaZt/zruDYSbrXw7YiJf717F7xlbaW4L55oOg+kfF3iOSHWmsbZgHWbFzMz0H0K2oaNjbqOH\nfK1tsZkYObrPUfXx0e6TeeSfxyu8TGtmiePOTrdVe+7aTRtQLCAOfw+nQ8m20NNIJUlqmqoN5hRF\n+Q1oEWLXI8DbwNMEXrU/DbwMTDiSDggh3gPeAxg4cGDN5m9IklRjpzU/jVkZc/DplQdzFsVC+/B2\nuF1eHpjwIWk7s3G7vJgtGl99uJAnXruav+N+Y1nGKuhjxShVQBOgV/JKW1dwb7YQ6QWl3EtyU7xO\n2EgnpfMcIA6d2yI5htGXy8H7g0ae15tp7yyoNqjLySpiX1ouSa3iGqhnJz5FURjTrj9j2tU+AIkO\nszO404n1crLI76rVecW++htxDzdbmdBpGBM6Dauw/Ys9X7Ig+0/8hh9VUauscaaaFKJuLKDgnejA\n55muoFgFHbomctbFA46qf/G2eN4b8BbLcpezx5lK76hedIvqWqNzB/UZyJfeWcE7TBDVs2knhJIk\nqaJqgzkhxKiaNKQoyvvAwU+edKBVud3JB7ZJktTAIs0RPNptMh/u+pidpbtCHmPRLJzW/BR++mwZ\ne3Zk4jN7UawKPg/40Hnylfcx9SvF0l8gPAr5zzYHQ4AiKgRlFXgVhBFI7H6Q0CFxDJzZfzQ/TV+O\n7tc56+IBXHHDaTJ1dTkXjhvKn3P/IT01Nyib6OHSd8tgTqp/Y9r0560twVOxqzO0ebvqD6pD24q3\nsyD7z7LRMENUUekdcGgOtD4eTE/n4Fpsh2IzF48awZXnnYNmOvrssYqiMKTZYIYw+IjO69W+B7Hn\nRJA/txhRLh5WLHDbw0f0zlySpBOcIkTtB8MURUkUQmQc+PM9wGAhxFhFUXoAXxBYJ5cEzAc6VZcA\nZeDAgWLlytpN5ZAkqXJFvmKW562g2FeMQ7OzqmANu0p2YwiD3tG9GNfmCppbmzPx7ucoOWMnWqwO\nCnj+sVL0cRTCrYIqwDiQDFwPBF5qMz9GrnYoP/hBmkBVFUytfURMyEeLCbSnZjl48dzHaG4Pzsjo\ncnp478U5/D57HV6vD3t3nVbXKVzS91xOj696vdKJyO/T+ev3TaxZlsKief9QUhS6YPK3fz1KWPiJ\nVX9POj7d8feXzM+spM5bCJqisvCc+4i1NVzyl093T+P3/X+U1QmsSo+I7kzseCPzMn9jc9EWEmzx\nnNPiLNqEtWmAnlbP5XVx9wOT2T1tH0apwN7bwk2vXM0Fp5x7rLsmSVI9UxRllRBiYI2OPcpg7jOg\nL4FHud3AxHLB3SMEplz6gbuFEHOqa08Gc5JU9zYU/sNr298EAX7hw6Sa6R/Tj4ntb0RVAkHZuhU7\n+eLruWRcuArFWm4kzQ/+VDN5/6mkgK4iiLwtn+IPoxE64FPBYqCGCUyqRrvEZLZv3ospVjD4lK7c\nde+lREQFP9gJIbjv2vfZvjEdn08va1txCJpN2U//lr25p8tddf2taTTWLk/h3zd+HLT9tLN78vCL\nY49Bj6SmSAjB8F9eYb+7pNpjTYrKb2fdRYIjqtpj69Jnuz9n/v4F1QZzQ2OHcHP7G+SMAEmSjktH\nEswdVQIUIcQ1VeybAkw5mvYlSTo6PsPHmzveqbAA32t4WZO/ltX5axgYO4Bff1jNG1N+wnxhDg6t\n4gOQYgItyY+plQ9/mvnw5kEolEyPIuqWfHy7zeiZJrQkP551VrwpGiVhLmavfjrQVhXFd7dv2kfK\n1oxDgdyBtoVP4FrsYO0569jrTA+qhddU9B3Ugec+uJ5XH/+e7IxCrDYzl4w/mWtuO+NYd01qQhRF\n4YOTr2H8ok9w+j14Q5RxMCkqJlXjlZPGNHggBzA0bjALcxZXm8F3QvtrZSAnSdIJoS6yWUqSdJza\nVrwdQoy+ewwPi3KWEKFG8r+sj3Hc40VrrqOE+kQwQIvTDwVzVoPIq4swt/NSMiMSz1obBVPjUKN0\nFIvAvdTOwSmXmfvycZZ6qp0GmJqyP3Sw51XxpQauuzB7EePaNN1RqL6DOvDJnPuPdTekJq5TZDx/\nnHMP8zO2sCBjKytzUinyuUiwR5HsiKZrdAJj2vSndQ2yf9aHjhEdOTPhDOZl/lZlBl/DMOqvOJMk\nSVIDksGcJJ3AqhoNy/fk8+K2l9F6+zCpIWO+QBsmgS+t3EeFoWDt5UYNF0TdlE/ph81RUyIoLgzO\ndqeqKhZr9R8zrdo3J+SUb4uBuXXggSzcFFZtO5Ik1T+rZuK85J6cl1y7gtr17fJWYzil2TCe2jgF\nlxG81tSiWLCZ5DpTAJ9fZ/rcJaTszqRfr3ZceMoAOWIpSY2M/BsrSSewzuGdoJKAbo8rFR8+Diyb\nC3mY8IN7tQ0jXwOTALMg8ppC1PBA4KVYod1tKuNuHo7VVnEapsVqYuTo3pjN1QdznXu0pH3nFmjm\ncp1QBIoZ7KcEaiqNjB9ZgzuWJOlEVOgrJM+TV+Pjk+xJ3N/lPpQQFcF14efVba/h0QNpIr26F12v\nMj/bCSklPYsLznqKaY/P4+8P1/PWvT9w4SX/oaBY1rGTpMbkqBKg1DWZAEWS6t67Ke/zV+7SWp/v\nS9XwrLejmAW2gS60uOBU3+OSx7L9Yxdzv1+NxaLh8+n0G9KByS9cgc1uCdFqsIPZLOfNWonuE1i6\neoi4qghTgs6N7a7n1Oan1PoeJElqnHYV7+LZLS/iKZeff2jsEG7peFONzs/15PL69rfY5dwdtC9M\nC8OpO8uSpdhUK0/0+D8S7Yl10vfj3cXjnsO5qQSl3Ee6YYJ25yTz7n9uOXYdkySp4bJZ1jUZzElS\n3dpTmsozm5+tNhnA0bKoFm7tMJH2ohN7d2UTnxRNfGJ0rdvLcu/nz+yFODQHo+JHyilRUpOzM2sf\n+/Jz6de2I2E2+7HuzjFR4ivhjjV3h8xMeU7CWVzZ5ooatfPYP0+yx5lao2MVFP436IMj6mdjVOx0\nMWbYlAqB3EFGmMK8v59u+E5JklSmwbJZSpJ0fFuWtxyfUXkSgCOhoKApGn7hD9rnNbzM2jebx3o8\nQnTs0a9tS7DFc3mrMUfdjnT827x3P7PXbEE3DM7u3Zm+7ZKOdZeOqazCfG75z4fk7DJQDtSsHj2m\nHQ9detmx7dgxsHD/4kpLDMzL+q3GwVyhr6jG1xQIfkqfxQUtz6/xOY2Rr6pppfrx85JfkqTqyWBO\nkqQasSgWBsb0Z0ne3yH35/sKGrhHUmP33m/LeP+35Xj9OgLBjKUbuHhQDx6++MRZH5ntzmHq9tdJ\nd6UD0DasDfd2mkSkJTLk8bf850OydxpgqIHajcCsb3bRIXEhY4ad1lDdPi6ke/ZVus8gxJBSJbpG\ndGZp3vIaH7+leBsX1Pjoxik2IhxTKwv+Pd4KqwqFCs0Gxh2zfkmSdORkAhRJOoENjj0JsxqiPlwV\nBkT3D7ndL/xsK9lR6Xkdwzoc0XWkpkfXdV6Z9RNjpr7Oze99wHu/LcHt82MIgRDg9vr5ftlGNqZl\nHuuu1gm338O/NzzMXtdexIH/dpXu5r71D+E3gke4t2fuJWdXIJArT/hUPp9Z82DkRNE9vGul+7SD\nw5Y1cEnyxWhH8LjTO+r4zNJZ1yZPuQJhB+PAPxGGBYhUeeb/rjqm/ZIk6cjIYE6STmBtwtpwbouz\nMStmtAP/VadHVDesijVou45Onq/ybHInNxt6VH2VThwu3cWe0j0U+YrLthWUltDvPy/x5tYtrMbD\n/OJ8CuJ0rOaKJS08fj/zN6Q0dJfrxff7ZuIXwdPZvIaXuZm/Bm3fl5tDZTFKSWHTy7Y4qNlJ2JTQ\n62UvTKp6GuT3e3/k9lWTuGP13azLX8c9ne9CrcEjj4rK2Yln1aq/jc0pvbvw8ex7OemaHiSMjGfE\nrQP4es6/aZ8Yf6y7JknSEZDTLCXpBHdJ8r8YEjeINflr0RSNk2IH8t/tb4RMCBBhCqdPdG+mp34d\nsq0wLYxif3HQOhYTJjpHdKqX/kuNhxCC79JnMidjLiZFwyf8DIjpz43tJ3Dj+x9TGqYhTIFJXUJV\nEIagJFzDnH+oDU1VsdagnEVd8nr9fPPRItJ2ZTPw5E6MurBfnbS7sXBTpfu2Fm9jNOdW2Na/fWeE\nmBd8sGrQoVtEnfSpMTGrZl7p9yL/2fQce92BaaoKCucnjuZfLS+s9LzbVt5JqXEovf7naV8SY4rm\n6Z6P8+3emaSU7iTWEkun8I78vv/3soA70hTBkz0fO6o+f7JrGn/mLEQXOuFaOLd2uJme0T2Oqs36\n1LJZLFPuvvJYd0OSpKMggzlJagKS7Ekk2Q8llriz0+08tXEKJf6SsrUnEVoET/d8nBhLDJ0iOrKt\neFuFUQWLauHilhcyPe3rCtkxLaqF4c1Pw2FyNNwNSUG8Xh+LVmwn3GFjUN92VRaMry8LsxfzS+Y8\nfMKHTwQS76zOX8Pne77gH6cLEX7YsJOq4HNo2Ivc+PXACIymqpzbr0uD9Xnrhr3cM/5djANJH/6Y\ns553X/yZT+beh8NR+yyqQgj2u/dXuj/R3iJoW4TdwTn/as0vM1MRvgOjSKpAswruHxscvGwr2s+n\nO5aypySPIc3bMa79ScRYT6y/h2EmB1N6P1Xj479J+75CIHdQvr+AHcW7mNT5jgrbr2oz9qj7eNAz\nG59le+mhqeglegkvbnuFezpNom9M7zq7jiRJUnkymJOkJqi5tRmv9n2RtQXryPHm0i6sLZ3DO5UF\nAHd0vJU3drzN9uIdaIqGQHB58qWMTBhBK0crPk+dzp7SVMJMYZzd4kxGJ55bzRWl+vTJd0t49Y9l\nZUutrB8qvDbhQob2P7p1jLowSC3JI8xsJd5W/cjQ7Iw5QWUwfMLHkpy/UZS2UMk0X6vZhFkzoxsG\nD154Oq2b1b6sxZGaPPHjskDuoOJCF09N+oLn3p9Q63bTXHsxqij9c3HSRSG333npaDKsr7FloR+9\nxEREOzd3jx1NxxbJFY5bmLmdScu/wWsE1hxuyE9n+q4VfDdiIvH20D8rIQQ5WUXYHBYiIk/Mcgfz\ns+aH3C4EfL93JsMTTj2q9veU7mFp3gpsqpWR8cOJMAe+1yXekgqBXHnvpLzHOwPfOKrrSpIkVUYG\nc5LURJlUEwNjB4TcF2YK46Gu95PnzaPIV0ySPRGLGij+3SmiI0/0+L+G7KpUhXWbUnl54TKE+dBI\nnFsR3PbxDyztcSdW65ElwDno94ytPLr6Rzy6D78w6B3TkpdOugSfKMam2YgxxfD2J9/y95KNmK0m\nxl42iuLI4pBtCQRdw8ys94uyaZaBHQKL2+CRi8/HbwhO7daWZhFHX9qipjL25uEs8YTct37lrqNq\n22/40VQtZGmQJGtiyNqJQgie2/IizpaZtLzy0Kj4l3mf0qdlZ+KssQAYQvDo6h9x64fa9hh+dK/B\nG1v+4Kl+wbkY1y5L4eX/+47C/FKEIeh9UjsefPYyomIa7vvdEKoaj87eXcL0VX8w9qbTy15cFfoK\n2V6cQoQ5nE7hHVGV0OvqhBC8vv1NVhWsKdv2XfpMrm49jjNbnMFfuUsrva7LcOE1fFiOMBmVJElS\nTchgTpKkSsVaYom1xB7rbkhVeGPGQsThT7Cqgq4Kpv20jBvGnHLEbW4rzOK+FTNw64cyLq7JTeP8\n+S/RNyEXXdfJezsC90YLeBVQ/UxdNotWT5ggIbi9SFMEz157AyNfexeXQ0OYQPGDIgT/d/pQLhjY\n/Yj7WBe87sprMFYxqFYjbcJah8y4aFEtjEwYEfKclJIUcjw56FRMdqILnQX7/2BMq0sAyHAVUux3\nB53vFwYLM7cHbU/fk8Pjd07DU+5+1y7fycO3/I83vrztmEzJrS+jWpzBj/tmhdxX8l04X27/kxYt\nYxgxug/f7v2eORm/YFJMCAThpnAe7Ho/CbbgBCAr8lZWCOQO+mznF5g2xZBd7EW0gMq+lavzVzMk\nbvBR3ZskSVIoMpulJElSI5Zd4gQ1xBOkAhm5NS+WXN5nKcvxGocFFAicfpV8j4HzHw33Jgt41cCF\nDAV8CvvesWBRLKjlxkcsqoXxba8mPiqa1ZPv5dq27ejpNzMiPIrfr7uWcScf3bS3o9GmYwJmc+ip\nn207hohKj4CmaNza8WYsqgWTEnhvalWttHG0Znh86Hpx2d5clBBjS37hJ9OdVfZ1mMmKXkm0GWG2\nsaMkhVRnGuLAMT9OX4bfd9jP02+QvjuHHZszanV/x6tLky8mXAsHEQjID/7Pt1PDu8GO84OujwAA\nIABJREFUx+3jq48WsjZ/HXMz5+ETflyGG7fhIdebx6vb/lv2fSvv54xfgrb50kxk3x/Py5NnMuPZ\nlejZlT9S5XorzwQsSZJ0NOTInCRJUiN2cpc27NywEaEFBwFnDelWqzbTnfkh13spgM/Q8C+3gif4\nwVXfr9FiRQ9an2MnpWQXCbZ4LkgaTcfwwNo9i8nMY5deWqs+1Zd7n76E5//9TYVtmknlsanjjrrt\nXlE9eb73FBZn/0W+r4CeUd3pF923bCqfEIL1hRtYmrsMVVHpFtENPUQpA4tioXNEx7Kvoy12TmrW\nmqXZuzDK/ZisqoZq2smLW15GF14sio+RsW52pAxA14OLbKuqSnZmAZ26JwXta8zeHPBfvt7yAz9s\nnY3QoWRmBN61h9YIFuSW8GvWfDyHre8UCPK8eaS70kl2VFyj6BUVR3GFAQVTYxElKn4M/Hgxvo8g\n6sbCoPISVtVK+7B2dXuTkiRJB8hgTpIkqRG7fdxwvn1wE6UIOBDQKbqgozWCQX1q9wA5LL4Da3LT\ncB9W2NoQCg6zF5fZAorg8PmdigLhRiQ3tR9fu5s5Bkac14eO3ZJ4/5U5ZKTl07N/G264+2zC6yhB\nSKwlljNbnMGSnL/ZULCRIl8xw+KGYFEtvLvzA1bnr8FjBNbtrchbSZQ5ilxvboXyH1bNyqnND02X\ndekuwu2bCDNrlPpMKAR+NjGOAqLs+bgPxG0+oTE310pS51WY1nbCf9jyQJ9Pp2O3EyuQO2hM5wv4\n7pZNFOSVVtiuqAq9BrTFqe8MeZ6qqLj04Cmsw+IG883e78q+9qWYER6F8qv0PCvt+M8txZzohwPL\n48yKmVaOZLpGNFyGVkmSmhYZzEmSJDViDruVOc/czBPvzmZZWjqaonJh7y7cf33tCx9f3nYA01KW\no3tL8BmByEBVDOIdJVg0A05x4V5mD6yXK0/ADeMqr/91vGrVrjlPvV4/AWiWez9PbZqC1/DiNbxY\nc63MTP+Ba9pcXSGQA/AYXjzenKA2/IcF1dPXfE/aJ17iU8z4O3gxneYhMtmFWTt89E3BECqxI7Kx\nzGqF8DvKRuisNjPDz+1FfGLDZQ5tSKqqctvk83n5/74rWyuoago2m4Vr7zyTDdaVpDnTykpoHCQE\ntA1rE9TeuS3O4des+RT4CgPHHf67DyAU8p+PI+y8ElpeaMakaZzS7GRGJ517Qq1LlCTp+KKEmht+\nrAwcOFCsXLnyWHdDkiSpycvzlPL+tiXMz9hChMmKxZKK3ZKDTiCwKPkxnNKfw0EVoAQG6i64oz+3\nXTfmGPf8+PL85hfZXLy1wkibikqCNZ4MT2aN2rCoFsa1voIR8cNZtXkTj147LRBMGAe+8WZB9K0F\nWHsFZ+bU0OkdlkYLt2D3j5exfnERjjArF101lNGXnYSqBqZ8GkJgCIFJbdxL6bMzC/jm48VsWLWb\npFaxDBjWkb8WbCZzbz49+rdh7I2nk5gci0f38OTGZ8j25uA1vKiomFQT17cdz7BmQ0O27dN9fLP3\nW/7OXYbhgZ23hyH8wceZLRr3PnkJI0b3qee7lSTpRKUoyiohxMAaHSuDOUmSJKk6pf5S5mTMZVX+\nauyanTNbjIJddr6f/ScOh5WJ4y8mMaH5se7mccUQBhNW3FwhkDtIRUVVFPwh1siFck6Ls7my9eWM\nn/A0+1e5g6a4qnF+4p7N5vBYTMVgZPQmIk0apyW9T4ytBwAF3sLAdE0tiuc2zGPW3g34DYNeMS15\nst/5dIk6ugQwx0LG3jzuuOItPC4vfn9gBFJRoFlCFBdfM4wLxg7GbD40IclreFmS/RdrC9cTbY7m\njIQRtHa0qvH1Jt/8MWuWpgRttzssPPTc5QwZ3jVon9fwUeIvIdIUgUmVk6MkSQrtSII5+UkiSZIk\nVSvMFMaYVpeUpccHIA6GDux9RO1M2/IHU/9eRmGpSpjN4MaBvbij73l13Nvjh6qoIZOamBQTQhFQ\ng2AukECjLQA5m1wggkfPjAINvUiFcIFqCgSPGjqtrbmEazph5jZEW7tT6CvkzR3vkFKyE03RcOs6\nu/Jj8RqBunfr8vdy9cKPmT3q9kqLjx+vPn3jN1ylHoxyWWGEgOzMQj55/VeW/bmF596fUDbl0aJa\nGJEwnBEJw2t1vZvuP5dJ497B5604PKdqKv2HHUpYk+0s5YPVK1hdsgBHdAYmVcGsmbm45UWc3eLM\nWl1bkiTpoMY9n0KSJElqNKZt+YMnfltBXrEJ3VApcpqYungjzy2beay7VqWs9HzeeWE27704h9z9\nNS/3oCoqA2L6B9WbMykmTmk+jBvaXo9ZMWNTbdhVGxbFQqKtBWbFXO5YjWhzFANi+ge+Dq9k7ZUC\nW/9sR/q6BPxFGjFKCf3C0ukTlkWcrT+nJL4NwEtbX2V78Q78wo/H8KAoftpEZ2M3Hcrs6DX8TN+1\nosb3ebxYu3xnhUCuPI/bz/b9u3luxVQeWv8I/932OjtLjq4wfPvOLbj1ofOwWE04wqw4wqxERNmZ\n8va1WCyBd+XZpaWc9/kn/Jb9C9aodFB1/Phx6S6m7fyKa6e/Qk5RyVH1Q5Kkpk2OzEmSJEkN4tW/\nl2EYFf/ZMQyVT1Zv48GTjLL1W8eaEIK536/i648WkZWeh64fChC++2wJV9x4KtffdXaN2rq2zdXs\ndaaT583DwEBBIcmWyOWtxmDX7PSN6c3Gws1oikr3yEApiZnpP7Ik9y90YTAodiCXJl9cNiVv+JXd\n+PXtTQjvoe+VUMEZb8PrtpO9w072jmaYNIW+53fhvJMHY9ViAdhTmkqWOwuDiolSFEWQEFbM7sI4\nALyGztbCLBqbqJgw8nNCB0bmzh7C781ji9gHbsh0Z7KhcCOTOt1Br+ieNb7GjuIUvk6bQbYnmzZh\nrRl7/uV8fvZDrF+xC6vNTJ9B7SpM5Xxr5TJKXCV0TchGPaxkgWoSeGO2c/7t7/D5y9fTIT6uVvct\nSVLTJoM5SZIkqUEUloYO1rw+lWKfmyiro4F7FNq0t39nxieL8bh8Ifd/9cEizji/P63bV79GMNwc\nzpReT7KleCsZrkySHS3pHN6pbKqfXbMzMLZ/hXOuaH0ZV7S+LGR7d18/jvS019n4034Uk0D4FDyx\nFgq6hlU4TlM1TusyqCyQAyjwFaAeXgSNQM15q+nQVEGraqJXTMtq7+14c9n1p/L60z/gPuznplgN\nYu7JA43ylQTwCR+f7pnGi9HP1aj9XzN/Y1rq9LKv8wryWVuwnge63MvJZ3QPec6fKdvo1WpPUO25\ng0zhPlQ33Pnmt/z85M016ockSVJ5MpiTJEmSGoTDalDiCg7oNE0QbrYdgx4Fczu9zPjf4rJ09pX5\n4r0FPDBlDCsWbWP3jixato5jyIiumM0mhBDofgOTOfAErx4YdTs48nYkXC4Pn337MysXbycmPozx\nV5/Ly09MYv+kPNZv20a75JbMWruHaYvW4PEHAjKrycQ1p/WnfULFkZ62YW3wG8H3ZRgKhZ7A919F\nwaqZuKLdgCPu67E2cnQf0nfn8M3/FuHzHlqLaDvZCaZAMpTD7fdk4/K5sJurrivo1t18kfpV0HaB\n4K0d7/BG//+GLD8Q6dmHtbkn5LUBPFk2VAPydtZ8+q4kSVJ5MpiTJEmSGsSE/j144+/NGMahgE5V\nDUZ3S0Q7TqZYZuzNQ9Oq70tJoYtbLn2dnMxCPG4fVruZ8JfsDBvRjXk/rMbt8pLcthm3Tb6AfkM6\nlJ2n+3XSU3MJj7QT26zqBCNFJaVce9lzuHMMhEchVS3k/p8/5Ponh3P56DMZNXgIAJNatmJU7478\nvGYrAOf160KPVi2C2osyRzEyYQQL9v+J1wiskdMUDZNmwe1thlUVDI1vz797nU2sNSzo/OOdoiiM\nv2MUl153Cn/N38Rnb82nMN+JrYe/0mAK4J2d73NPl7uqbHt7yY6QWUkBSnUnud5cmlmbBe0zRxWi\nWoLPEwdy3+T+GR/YUMnInSRJUnVkMCdJkiQ1iLsHnE+J18e0tdvx+VU0VXBet0ReHj7uWHetTLOE\nSHy+6jNM+v06GWl5+A8c6yr14nJ6+emrZWVJONJ25fDEXdN44aMb6NIzmQVz1vHmlFnofh2/36Bn\n/zZMfuEKIqNDTy/97/vTce03wHcgEjEUhBf+9/Qf/OvM4VgshxKl9GjVoiyAK/AW8Pv+P9CFTv/o\nvsRZD43QXdnqCto42jAv81ecupN+0X05P2k0kebGlbmyKmHhNs68qD+jLuzHvtRcfi6ezRLnokqD\nsbWF6yj2FhNhqfx7YFWtVV7TUsl+xW9CGKAc/n5AQO6CBDzpDgwVkjrGkp6RT8vEmCqvI0mSdDhZ\nZ06SJElqULphUOhxEmmxY9KOvyGJlx6ZwcJ5/+D1hKgIfYCiBEZXqqMoMPj0roy98XQeuvGjCtM3\nTWaNzj1a8sqnoddKXXLBozj3hGjTZjD57Us5bUDwVMjF2X/xv92foqCUBS+Xtbq0SafAz3Lv59F/\nHi8bjQwl2ZbEQ90eINIcGXK/IQxuXXUnbsMdtK+VPZlnej0Z8rzX533D8rC5qOaKvyx+p8autzqh\nGAreCNBc4EwC0VzjjD6dmThoEN2aybqNktRUHUmdueNjXoskSZLUZGiqSqw9/LgM5AAmPfEvzvrX\nACxWU2BEJcQUvZq+BxUC9qTs59tPluD1VFyv5vfp7Ni8j/Q9OawvWM+P6T+R7cou26/ZK/kn2lBw\nhAWvMSzwFvC/3Z/iEz68wotP+PAJH9+kfUuGK7NmHT4BJdjiubvTnVUes9e9jyc3TsEXYk0hBNY9\nTu72ICal4oSmcC2M+7vcQ6m/lA93fszElbdz08pbeSflPYp8Rdx51mWYtrfG8CkYHgXdo+Iv1ciY\n0RpFV0CAyQ05A6GkNZSGGfy4bQuXfv0FC3bvrLPvgSRJJy45MidJkiQdlT+2bmbyr99RFOND9UI3\noznTrp2IxdS4Z/L7fH72peVxx+VvBRWGrilFVTj5jO5kZxaydcPeoP1h7RQiH8msUC4gydqCZ/tM\n4d1vvmHm82sR3nLRpCKwJsHMn58JSrgxP2sBX6Z+jVdUHIHS0Lio5QVc1PKCWt3DieJ/Oz9lQc6f\nle63qlaubzueoc2GlG0zhMGcjLn8kjUPp99JG0drekR2x6k76R7ZnT5RvdhWso0Pdn5Mga8A/cDP\nUUMjxhLDc72fwayaWZe6nc/+/gW72crCL4vQy83kLegMzgQCaUXLSQgLY8mEiahVLfiTJOmEdCQj\nc437X1pJkqTjnEf3MGPv9/yV+zdev46xsSPO7VaSWzbj4evOJyas6ix6x7v1e9O4feVXGImAqmA4\nYIMvm6GfPctzZ4/h9BadsRxeYKuRMJtNRMeEUdlLT82kYrGYcDm92B0WhADDMCpMz7RYTIybOIKF\nczewc2tGhSyLAI4H9x1W9Q32eTJ5fftb3HbpRNauSWHXL8UoJgEoaGGCx167KmTmRAMj5LowgYEu\nql8HeKK7rv14VhWsocgfOnOkx/CQ6kxjKIeCuempX/FH9sKyKZoppTtJc+3l4a4PMTdzHq/teCNk\nWzo6Jf5iVuWvZnDsIPaadlDScSs7V9jR9XjKD/e6YwkK5AAK3R4ySoppGRF66qckSRLIYE6SJKne\nCCF4bstLpDpTcbn87H0uGVtmDhiQq6Vz2afrufeNKzjvpJoXLT6e3P7dZyxbsx2jl1rxYdSs4IzS\nuW/ZDGJsDj4/bQLJYY0zsUNUTBhdeiazeX0ahn4o7LLazFw1cThJrZuxa3smyW2aMXRkV2Z/vYJv\nP11CUYGTTt2TmPjAebTv3ILYZhH88u1KSorc+P2BwMrU3otSyb/Cq/JXo6kab//n36y9aTOLlq2h\nefMY/nX6GdhMlqDjc4pLWbbUS3pRFPYYJ44YF9qBdVom1URrRytm7/sZs2pmYOxAYi2N8+dxtJ7u\n+ThPb/oPOd7coH0W1UKi/VAWUKffyYL9f+ITFade+gwfU7e9RoG/sMpruQ0Pac69FHgLmbnvR7yG\nF09BcJIV1Q9GiPwpPl0nwhL8s5YkSSpPTrOUJEmqJ1uLt/Hy1ql4DA87Pkki7C+BWm6ARADe5iYW\nzH/iWHWx1k6+43HC/tLZP07D06Hq5dd9Y5KZPvyGBupZ3cvOLOSB6z+gML8UIQTCgP7DOvLIS2PL\nasnVRF5OMV++/yd//rKBogIn1lNKiBxfVGna/MldH6RrZJdq231n3lI++OsPOo/ciWoyUFWBEIH1\nWFazRmtHa9JcaeiGgXogreKEdtcyrNnQGvf9RPLEP8+wy7kraLuCwrsD3sSqBSKrPaV7eHbzC7hC\nJD2pjBCQuT+anLxIusTk031zb9Zs2ora3oX9VCfeIivpn7Wl/MhcaQso6ghCK/eLoAtaKuEsuvuW\n2t6mJEmNmEyAIkmSdBxIdaZhiMBojnWdUiGQg8DjnDnXz/Jtuxu8b0fjru+nEfaXjuoHc44AveqX\nghsK9lHgdTVQ7+pe8xZRfDT7Hv5v6jhu/ff5TP18Io//96ojCuQAYptFMPHB8zAMAyEE7uVVF0p/\nZdt/KfIVV3nMos27eGvu37Q/eQ8mq45mEigqqJpA0QS9onqR5tqL1/Cho5clRflo1yeU+EuOqP8n\nAkMYIQM5CBQAn5/1e9nXcdY4/Ec4PVVRwGTScaVYyX0ynGVf78a5xkzJj+HkPNocs9WHJd4N5abD\nOjLBsQ8wBIo/8PfJXAIT2vSpzS1KktTEyGBOkiSpnsRb49GUwAO/cvjCqIMUcLkrT5l+PFq5YDvK\ngWfcyGVG2Z9DMeUKHMv8LPx5Pc5ST8N0sAq6Xru1Y6qq0n9IR86+eADtOgcX5K6pgtySQ+UJPBre\nraZKM2MawmBp7tIq23vjl78wO7zYIrxBI3yKAmsL1oXM0KgqKusKNtTmFk5o36X/wOaiLQCEm8IZ\nGjcEi1rzqY6GAbl5kSQscqH6wO878BffpyJKVYpnRNDy2t1YWzo5GNApQNROSFgKsRuh+SpouVHj\n2osG1/HdSZJ0IpLBnCRJUj3pFdWDSHMEKirubmCEGMjxh6uc2rNjw3euloQQaMWibGDBnAvxn+uY\n8gQY4lDOfiGI/sVP4lt+YubpfPzcXK4643k2rAw9KlLffv95LaP7P8bofo9zTu9HuXjIU+zekVXn\n1/km9VsmLL+Za5ffwA0rbmZm+k8V9odHVkx4U/BSc3w7Qgd0PuGj0Bc6WcdBqTkFKKoIWT4BKk+K\n0lTzI6qKSoSp8uLgPuFjbuavZV9f1+4azkoYha2aouEQ+NX3eE3kZkVgzQvx0kAoeDdYUVVodVkm\nWrgO6qGfjeYTWAugXXQ0n782AVWVj2iSJFVPflJIktRk7cnfyyPvT2XcpEe468Vn2ZZRt3WdVEXl\nkW6T6RXVk9bjsvFFqugHEl4YGuhmGDv5rEbz0CaE4JXHviN8fcXgwLbbYPiGnYy3LSXWXIJJ8WPb\nKYhYKVD9oPjA5fTicnp5ctLn+Hy1S/NfWzu3ZvDCv2eg+w8Nj7qcXm699PVaj9SF8uHOj5mV+TM6\ngTb9Quf79Jl8sefLsmOsNjNnXzwAq81ctq34y2gIMThrVa10i+xa5TWbRYThKTETIl4rY1bMQdt0\nYdAnulc1d3RiuqX9TVXuLyoXQGuKxmWtLuWdAW8yueuD2NXKp8YKAXvS4jEUpdJoWbFAW0dbHuh9\nJ1+9MpFTT2tFVJSV5MRoJk04gz+/vpcv37iRxPioWt2bJElNj8xmKUlSk/PH/oV8vGEauW9GocXp\n6PtN5C0uYtI3H3DzayO4eMiZdXataEsU93aZhK+Tj8LBTp75cA5b1+0lLiGChydeQK+2SXV2rfq2\nZmkKi+ZtRPhEhWfVfpftoO8lKZhtOh3FfjYWJrJ2ZmdcPgeHP9UahmDDyt30H9pwo5EvPvxNyO1C\nwEevzuOm+8+tk+sszFkccvu8rN8Y12Zs2dcTHzgPIWDezFX4fTr+PWY8621YenlQbYGoTHgU2sa2\npXtktyqveeMZJ/F/X80lf28kMa2Ck6m0sCbQL6Yv8/f/jt/Q0Q5UQb++3bWEm8KP6n4bq57RPXis\n28M8tfk/QfvMipm+0cFr1RRFoW1Ym7I6cqEIoZKbHwmaQklbM+G7fRWmV1usJi4bdyrX9DyjbNuz\nd44N0ZIkSVLNyWBOkqQmZWPhJj7e/QneLDOx9+Yh9MBbdD1Xo+DlGD58aj4X/1x3wdxBZtVMs/Ao\npk5qvA9vf/6yHrfrsILUFr0skAPQFEHv6H1kmBPZQ1hwIwr4fA1b8yxzX0Gl+zauTa2Ta3j1ytc9\nHj7N0WTWuOORC7jx3rOZeMlrZKUXUPheNLahLuynOEEFY1UEl918VVn2ycpcMKA7P67axLbUIhwx\nLiwOH4oaCKEVRWFS5ztJsidySrOTWVuwDrNq5qTYAcRaYuvithutDhEduKb1OL7aO6OshpxZMRNt\niWJUwsiQ59g0G1ckj6lwzkFWxUqEZxgWJRevotPqss5E/ZBD1p48VFXF79cZMKwjY286vd7vTZKk\npkUGc5IkNSkHp7yZWvlQLKAcTEKQ4Cfq5kLyX43lu62zuLjz6JCFmeuKEIIdJSlsL9lBjDmaAbH9\njyjRwrGgaRqKolQooh0R7wykwT9Mp9PTSV/XDL+74j8zut+gz8B29d7X8hJbxrBzW+j1cT36tTmi\ntnI8Oez3ZJNkSyTaEo0QgjxvHjat6syUodjsFtp0SCArvQCEgvsvB+6/HEAgecnu07Lo2DkJRVFI\nycvjs0XLKTJ8jOrZhbM6dMSkqqiqwvs3j+G3f3rxXepsPLadmDRB9+iu3NDuOiLNgYLTyY6WJDta\nHnEfT2SjWpxBsiOZeVm/UegrpF90H0bGj8BhclR5TktHS+Zm/kqeN58WtgT6x/Sjf0w/LKqZl04/\n8HmiKIhxgh2b95GxN592nRJo1a55Q92aJElNiAzmJElqUnJ9eQAcns9AMYG5gxcl3GBW5mwKzDlM\naH9dvfTBb/iZuv11thVvx2/4MasmpqV+weSuDx3XD9yjLurH/FlrD2VjBJx5NjQteOpZ20GZNOvZ\nhswNseBRQAOzycx9T1+CzdGwQeuDz13OLZe8HrRdURQm3F2zUViv4eWtHe/wT+EmTKoJv+Gnc3gn\nNs7JIvt7DaNQpdkLKlqMEbReqqW18qm0V940nHXLd1b4nkJgCuib//mJfWl5uFpozHhpAarHAAGr\nE1fz4RXtmX7NOCyahqoqnNW7K2f1rnp9nRSsa2SXGtXyK69bZNdK1zKWfwGkKAqdurekU/fj9++0\nJEmNX+NYdS9JklRHkmyJle8UYOniQbd7+St3KZmuzHrpw29Zv7O1eBsew4OOjtvwUOIv5Y0db9XL\n9epK9z6tuWT8yVisJixWEza7GcVwEOE7HU2pGB0bqkL07flE35GPY1Qp4eeXcunb3Tjt7IZPutG2\nYwKTn7+8Ql24sHAr735/J5pWs1pxX+z5kn8KN+ETPly6C5/w8U/BJopz3RiFGqCQM7kZepFSIRlJ\ntCmKp3s+UWm73fq04uGXxhIWETyy53b5+ObjRXw3ZT4mp4Gqg2qAdZ+P/E92MGOjLC0gSZLU1MmR\nOUmSmpTxba/i8Y1PIwRBySIMp0rE5YFMdqqisKV4Gy3sta8pForP5+ObtB/wh0hfmOvJZb87m3jb\n8Tsd69o7RnHmRf1YuXg7VpuZYWd0JyzCxIacV9ld/D268OEyNNaXtCRfD8fazYu1W+BelWbHrp7e\n6ef25vRze9fqXEMYLM75C5+oOHqmaOA43YXzp8BURnSNnPtakNg/jPHPD6NnZHea26v/WQ4+rQsd\nuiSyPkTZBiFEUB0/BUFY21Jm7fkac0wKpzU/hQRbQq3uTZIkSWrcZDAnSVKT0jasLbd3uIW3Ut4t\nS0whDswSVCMNDuabUFDL1hvVlT/3rebDtDcD7YdajqcoGFVkyzteJLWK48Ir4yps69P8QXo1u4cM\nVyqPb3wBn6hYfsCqWukTXbtg6ljzCx2/CF1OQbUH/7xyNrkZkXBkiS7iE6NQVAVhVEyWYhgVM4ei\nCWLuzcPUxodqE8zJmMu8rN+4qd0NDIobeETXlCRJkho/Oc1SkqQmZ1DcSbw94HXGtR5L98huaKoa\nyABY7hPRrJrpHdWzTq/7QWpgGmVleVWiTJEkWOPr9JoNSVXMtHR0YET8cKzlFiVaVQsdwtvTO6px\n1jWzqGaS7MHr3oQB3m3B6/8Sk2OO+BoXXTUMi8UECLQWfkwtfWgmhZjYcMrnl7ENcWFq6y0rYaCj\n4zW8fLDrI7yGL3TjkiRJ0glLjsxJktQk2TU7Z7c4k7NbnMn6gg28k/I+utARGESao7i7052Y1Lr7\niNxdtA9FESEDOSHArtm4veOt9ZpBs6GMaz2WHpHd+SN7IV7Dy7C4IQyJG1xtmv3j2XVtr+HFra/g\nN/wYGGho+A2d4u8jKhynWRRuuLti3brli7Yy5b7peNyB0b0OXVrw3+m3YDId+v3q1D2J66acyne+\nr1AidBCg+k0My+nDd8+sLTvONtgVlLwHAtOCU0pSqi0yLkmSJJ1YZDAnSVKT1zu6F6/3f5XU0jTM\nqomW9pZ1HlQV+9xV7n+57/MnTBFnRVHoG9OHvjHBxZcbq84RnXiqx+PMyZzLXude2oe3Z2jsID4+\nfzZrp2fiL1CJSbRz54MXM/i0Q9kR/1m9m8du/6xCWylbMxlz8hRmLnu8bJvX8PJr7ExU/dB0ToGP\nJZZfUCKaI4oPJGrxhv69FALMivwnXZIkqamRn/ySJEmApmi0C29bb+33imsPOwhKvCIEGIZ6wgRy\nJ7JEewsmtLu2wrZnbrkLbqn8nCcnfR5yu9vl44v3FjD2xtNRVZU1+WvRRXAxdYHAPsSF89fA74dz\noQNz10PTLMvaM9x8lTaDa9peRWtHqyO8M0mSJKmxarxzXiRJkhqZ3rZTgUAAV/7pngCKAAAV9UlE\nQVT/r0y6tpIzpMauuNBV6b5pb/3OI7d8gt+nU+grCplkRbGAGn0oyYp3vRXXQjvCp6Ae9k/4tpL/\nb+/O4+Mq6z2Of35ntuxpmqRbutuFymILsRVZpQhFARW4LPrCjauiKCgqi3rvZXEDwYV73XC5F8Gy\nagW5VwRUNhVKWyqFtnTf0tomXdI02yznuX/MNJ00E9q0TWZO+32/Xnll5jnPnPzm9eQ5M79znvM8\ny/n64m/R2NnYYz+dqU6WtSynoX3jQbwbEREpNLoyJyLSzzrbO/nN9/+Xxb96hURpBP+KJJHjIEQZ\nXzrq6vRVOzkshUIeqVTuGUp937F44TqeeuwVpsyamL6nsPsFN8Iugr8yew06I/FYDe854e08WT2n\nxz6TfpInNj3J5WM/1FX2zJZnuW/t/Rjp2VKHxobwxcmfpzpW3eP1IiISLErmREQO0sa2Zh5ePZ+1\nO7dSu9E4ITmEE886nvKqMnzf57ozb2HFwjXE29PrrMWWRJk8fQJ3/Pmmw2LCE+ndey+ZzmOzX+x1\ne2dHgqceXcA5F36S4yqP5dXmRcT99P+JlwrRvsZILSnBLH3VbtiowVxxzdlUvN3nzysipPzObvtL\nkWJ165qu58t3LueeNfd1W/KioWMjty29g9uO+6b+/0REAk7JnIjIQZjbuIYr/z6beCpJCofFfe7f\nnqRuws+49vv/yqAhlaxatK4rkQPobI+zbP4qXn1uMW877eg8Ri+9adzQxI2zvsHaxRsAGDK6hpt/\ndx0Tpo7r034+c8O5vLDhRbbP9XEdBvRMnrY1tfDhs++gvb2D8ZdNIPKOFhqakiydGya+Okx5cYKi\ndgiHPWqHVNJyzHr+Z/nveixiDuDhMSrrnrkHNjySc+3CLZ2NrGtbx5jSMX16PyIiUlh0z5yIyAFq\naW/jE8/eS3sqQWr3AuRFHonqMFtnVfD9T/2Ul594hY5dPWeyTHTEWfL3ZQMdsuyHZCLJxyZf05XI\nAWxZ18RV9dfT3NTcp33tjO8k8uFN1HxvM1bWM6kyz2javJMtm3bQsqODRT/dwZ9+VswLr1WxuayM\n7ccUsf68crZOjZFM+qz03uC3Gx7NmcgBRLww5ww/u+t5Q9uGnPUcTvfPiYgcBpTMiYgcgOcXLmL6\n47cT9/bMQGjr44Qfb8fN92grrqB5fBFb1jVRVNpzYbBoUZTqusEDGbLsp8d+9ASdWVdSd/N9x91f\nvjfHK3r3fNNfAfAiUHX1dqzYh5gPIQdRH+d8kok9/0Ptgzy2TAiRCpGe9tQzXMTYNrWYeIVH0Vkt\nxF3P2ABqojWMKK7jh8t/zCMb5rAruYuIF+k1tupoTZ/ei4iIFB4NsxQROQCfWfAQDAp1rTPgrUvQ\n0VmJO9og7BEfXkL75Crm/20boXCox+vD0TAnXzBjoMOW/fDaC2/0uu2Nl1f2aV+loeKux5HxCWq+\ns4XOBUX4LR7EUux6pBI69gy93DU6gst1mtWD1nFhvMqeyxfs1hzfQVO8CYB17ev5/cbHGVlcx85k\nS4+6EYvwlrK+DRkVEZHCoytzIiJ9lEwmSWYlcgD+xjAu6kE4c1gNebhYiGVTSrjjLzcxctJwYsVR\nokURRk+p485nbqa4tKiXvyD5NOH43pOcMUf3bQ23k2tPxrCuZSi8IkfxO9spPr2V+PzibokcgPmu\nx4yWABZylJ+7i3HF47Ac990BJOi5tMGG9gZChAjZnhMKYQvzifFXEPZ0PldEJOh0JBcR6aOk3/Pe\np3htCXg9v2QnhhRjlRF+ueQHbF7biJkxdEztQIQpB+iia8/j3psfJhnvnhyZGZ+8/fI+7Svshfnc\nhE/z/Vd/jMv8e1jY0fpEGfElu5N5BxhEfYYObqZoRBvNrSW07Come8KU2rqdVNaMwGvxci4w3psU\nKWbWnE5DxyZqYtWcNfRMTXwiInKYUDInItJHRdEoXouPX+7tGWbZmSIV7Tmc0pI+NbVVmBnDxg4Z\n6FDlAERjEX7yyne4/t23sHXjdgBKK0v42oPXHlAifsLgE6j6+QmsSa7CSnwSy6L4O7P/V4zwyARV\nX96KFzYGRx0pH5pbSli6vA7ne0wcv5FoNMGSlqVMLp/I4p1L+xaEedw45bo+xy4iIoVNyZyIyAH4\n+tiz+ErT04ADM6LbW+iIDcJlJ3TxFBWLtlFZVpq3OOXAjJkykgc23E1nR5xkPElpRckB7cc5x9zn\nl9GyrY1EQ6xruOVetaj8zHas2IGXrhAKwaCKVo4+ah0lRQkikfSVOM+M6YOns3LXKjr93BOh5NLQ\n1sA/5q/i708vIRwJcca5Uxk/adgBvScRESkcSuZERA7AB047mWkbJ3D1w/fwz3Arw4aXs27RNlqO\nrcYSPi7iUbK8mTm3fj7focpBiBVFiRVFD/j1d936GH+cMw8/lTOLAyA0NIVX6WN73cXueVBZvmdZ\ni7CFmDF4OifVnMjjG/+PzsxkJ/viHMz94T95Ye5/48cdZsbvH3iJy6+ayUUfOfmA3peIiBQGJXMi\nIgdo7IhhPHbN9d3KnvjTSzz65EucPuMYLvniGXmKTArBulVb+ONv5+H7vSdyAHiulylNwDBClp7A\npDZWw6WjLyHqRakrGt41c+W+JFZEaH+pCOKZtRCdo7Mjwa/+82lOn3UcNUMr+vCuRESkkCiZExE5\nhGbNnMGsmVpyQGDu88t6TeRCYY9QyIOQI7UNvHgYF+u+EHjEIpxUfSJ1JSOoK65jSsVReJnLd563\n/5NRdy4ogkTPdNFCxsvPv8E5F729D+9KREQKiZI5ERGRfhCJ9JwQZzcvZFT/eyPxjSEY0kmonB4L\nCyRcgmHFwzhr2Lu7la/ZtZb1bQ19CMSlJ8XcK680MyJRfQ0QEQkyrTMnIiLSD2aeN7XXbaFJHfhD\nOwhPayVclySZY404gAfWP8QzW57tev7sluf4j8W37PcQS4DiGR2QI690vuMdpx+13/sREZHCo2RO\nRESkH5SVF3P5VT3vmwxHQwy+tG2/9/Pg+kfwnU9jZyP3rL2vz3GE65KUX9hCKGIUFUcoLokSK4pw\n4+2XUFZR3Of9iYhI4TioZM7MHjSzhZmfNWa2MFM+1szas7b95NCEKyIiEhwf+tQZ3PbzjzPpmDqq\nh5Qz87ypfPW+9xMZ3nPh+d7E/Ti7krv4W9OL+G7fr4tYmGsmfJYxJaMJWYiqSBUfumgWM049itKy\nGGMmDOGu+z+tq3IiIoeBgxos75y7ZPdjM7sTaM7avNI51/sYExERkSPA26aP567Zn+567jufX78S\nocPv6PU1zof4kijxxTEi5UbbyCSrdq3G7X3jWw7fOvbr1BbVcvzgaQC8+vJqrr/4l7jMZCxbG3dx\n5QV3ceuPPkz9SZMO8t2JiEg+HZJhlmZmwMXA/YdifyIiIocrzzyunngVMS+G7bUogd9qxFeH2X5n\nFc0/qqLtj6W0PFrGJ87/AfP+umyf+456UQbHBnc9d85x67WzuxK5PeXwjS8+gMu9irmIiATEobpn\n7hRgs3NueVbZODN7xcyeNbNTenuhmX3SzOaZ2bzGxsZDFI6IiEjhmlQ+ke9NvYNRJaOA9JW4nbMr\naPzSULbfXkPijRiu0wMMP+FIdKbYdncFLvc8KV0mlL2FkO2Z7WRbYwstze0567a3x1m/Wp+7IiJB\nts9kzsyeNrPXcvy8L6vaZXS/KrcJGO2cmwZcC8w2s5yrkjrn7nbO1Tvn6mtraw/mvYiIiARGabiE\nD2YWAW/9QyntLxSn14NLGORaRtyHxOrIm+5zRcsK1rdt6Hq+r6UHQiHNgyYiEmT7PIo75850zh2T\n4+dRADMLAxcAD2a9ptM5tzXzeD6wEtDAfBERkSxTKo7igrr30/50GcT3I7HaR5WkS/J84wtdzysG\nlTB8VFXOuhWVJYwYXd2XcEVEpMAcilNyZwJLnXNdpwLNrNYsPc7DzMYDE4FVh+BviYiIHFbOGX42\n1r7v+cgs6oiMS7xpHR9HW6r7sgffuvvjxIq6X9ELhz2+dfdHSd/yLiIiQXVQs1lmXErPiU9OBW4x\nswTgA1c657Ydgr8lIiJy2Jn41jqWvro+xxYHMYcZDPrsdizrFKyHh0/3pQpiXoz6qhO6lQ2rq2LO\ni//G4w/N5fUFa5kwZQTnX/aOHgmeiIgEjxXSTFb19fVu3rx5+Q5DRERkQL2xaAPXXfELEvEkvu/A\nHISh+JRWIuOSxKZ14BXt+bwOW5i3VhzF0pZlJPwEDkfMizG5fBJfmHQ1nuleOBGRoDKz+c65+v2p\neyiuzImIiMhBmHzsSH4w+0oe+Pmz/PWVhXh1nZS+dxeRUbmnrwxbmJlDzuD8EefxXOPzdPgdTB/8\ndk6oOl6JnIjIEUTJnIiISAEYO2EoN3z7Ym5+fRmrWjf3Ws/DozxSzrGDjiFkISaWTxjAKEVEpJDo\n9J2IiEgBOX/EuUS9aLey7MXFK8LlvHfYLC34LSIiSuZEREQKybSqqXxw9KWUhEqIelHChCkPl3dt\n35Fs5t61s/nmkttI+G8+u6WIiBzeNMxSREQkT7bHt+NwDI4O7lb+riGncWrtyeyI7+C+tbNZsGNh\nt+0pUqxuXcOzW57jzGEzBzJkEREpIErmREREBtjSnW/wvWV30eF3AFDkxfjcxKs4pvLorjohCxEL\nxfhH86Kc+/DxuXfdbDZ3NPKhsZcOSNwiIlJYlMyJiIgMgIa2Br637C4a4009tnX4nXxn6XdxrRBt\nLueiURcwq/5UmhM7CVmIlEv1ut8ntzzFmNLRnFz7zv4MX0RECpDumRMREelnrck2vvbaTWxpbSKx\nIUTO3MzAyiBR18Lsjl8x5+9PURur7Tb5SW9+2/C7Qx+0iIgUPCVzIiIi/ezh9Y/Q/mqExi8MpXN+\n8T7rW9Tx6NbfEfUiXFj3fiIWedP6rcnWQxWqiIgEiJI5ERGRfrZk/Up2/GQQrsMjsSqKS+z7aptf\nk76f7uzhZ3H6kFPftO7YkjGHJE4REQkWJXMiIiL9bOeLIfDTj+OLo6Q2h3D7WlUgaxm5BdsX9lrN\nMD427sMHH6SIiASOkjkREZF+Zm1hSGauxjlj++3VtP25hFSzh9+Z+zWe57G5YzMA2+Lbet33LUf/\nB8OKhx3qkEVEJACUzImIiPSzsfXVWGzPpTbX6bHr4Uqabqgl1Zh7YulYKEKnHwegJlqds051tJrR\npaMOfcAiIhIISuZERET62cWnn03R0Qks5neVWcyn6B3tREYmc74m7EUYWVwHwL+MupCoF+22PepF\nuWjkB/ovaBERKXhaZ05ERKSfjS0by+e+/R5+9ps5tP4tioWg6KQ2YlN7jrEMESLkhfjE+I/jWfqc\n64zq6QA8vP43NMW3UhOt5sKRF3BizYwBfR8iIlJYzDm371oDpL6+3s2bNy/fYYiIiPSLtmQbz2x5\nrmtduIRLYBgRizBz6BlsjW+lOjqYdw05jaFFQ/McrYiI5IOZzXfO1e9PXV2ZExERGSAl4RLeM2IW\n76w5kb82/Y2m+FamVEzm+EHTCHv6SBYRkb7RJ4eIiMgAGxSt5L0jzsl3GCIiEnCaAEVERERERCSA\nlMyJiIiIiIgEkJI5ERERERGRAFIyJyIiIiIiEkBK5kRERERERAJIyZyIiIiIiEgAKZkTEREREREJ\nICVzIiIiIiIiAaRkTkREREREJICUzImIiIiIiASQkjkREREREZEAUjInIiIiIiISQErmRERERERE\nAkjJnIiIiIiISAApmRMREREREQkgJXMiIiIiIiIBpGROREREREQkgJTMiYiIiIiIBJCSORERERER\nkQBSMiciIiIiIhJA5pzLdwxdzKwRWJvvOI4gNUBTvoOQPlGbBY/aLHjUZsGjNgsetVkwqd0Gxhjn\nXO3+VCyoZE4GlpnNc87V5zsO2X9qs+BRmwWP2ix41GbBozYLJrVb4dEwSxERERERkQBSMiciIiIi\nIhJASuaObHfnOwDpM7VZ8KjNgkdtFjxqs+BRmwWT2q3A6J45ERERERGRANKVORERERERkQBSMici\nIiIiIhJASuaOQGb2oJktzPysMbOFmfKxZtaete0n+Y5V0szsJjNryGqb92Rtu9HMVpjZG2Z2dj7j\nlD3M7DtmttTMXjWzOWY2KFOuflbAzGxWpi+tMLMb8h2P9GRmo8zsL2a22MxeN7NrMuW9Hicl/zLf\nNxZl2mZepmywmT1lZsszv6vyHaekmdnkrL600Mx2mtnn1c8Kj+6ZO8KZ2Z1As3PuFjMbCzzunDsm\nv1HJ3szsJmCXc+6OvcrfCtwPTAdGAE8Dk5xzqQEPUroxs7OAPzvnkmZ2G4Bz7nr1s8JlZiFgGfBu\nYAPwMnCZc25xXgOTbsxsODDcObfAzMqB+cD7gYvJcZyUwmBma4B651xTVtntwDbn3LczJ0+qnHPX\n5ytGyS1zbGwAZgAfQ/2soOjK3BHMzIz0h9/9+Y5FDtj7gAecc53OudXACtKJneSZc+5J51wy8/RF\nYGQ+45H9Mh1Y4Zxb5ZyLAw+Q7mNSQJxzm5xzCzKPW4AlQF1+o5ID9D7gnszje0gn5VJ4ZgIrnXNr\n8x2I9KRk7sh2CrDZObc8q2ycmb1iZs+a2Sn5Ckxy+mxmyN4vs4ai1AHrs+psQF9qCtHHgT9kPVc/\nK0zqTwGTudI9DXgpU5TrOCmFwQFPmtl8M/tkpmyoc25T5vE/gaH5CU324VK6n/hXPysgSuYOU2b2\ntJm9luMn+yzzZXTvnJuA0c65acC1wGwzqxjIuI9k+2izHwNvAaaSbqc78xqsAPvXz8zsq0AS+HWm\nSP1M5BAwszLgN8DnnXM70XGy0J3snDseOAe4ysxOzd7o0vf96N6fAmNmUeB84OFMkfpZgQnnOwDp\nH865M99su5mFgQuAE7Je0wl0Zh7PN7OVwCRgXj+GKhn7arPdzOxnwOOZpw3AqKzNIzNlMgD2o599\nFDgXmJn5oqJ+VtjUnwLCzCKkE7lfO+d+C+Cc25y1Pfs4KQXAOdeQ+b3FzOaQHta82cyGO+c2Ze6F\n3JLXICWXc4AFu/uX+lnh0ZW5I9eZwFLn3IbdBWZWm7nJFTMbD0wEVuUpPsmS+ZDb7QPAa5nHjwGX\nmlnMzMaRbrO5Ax2f9GRms4DrgPOdc21Z5epnhetlYKKZjcucjb6UdB+TApK53/sXwBLn3Hezyns7\nTkqemVlpZrIazKwUOIt0+zwGfCRT7SPAo/mJUN5Et1Fc6meFR1fmjlx7j38GOBW4xcwSgA9c6Zzb\nNuCRSS63m9lU0kNQ1gCfAnDOvW5mDwGLSQ/lu0ozWRaM/wJiwFPp75686Jy7EvWzgpWZefSzwB+B\nEPBL59zreQ5LejoJuBxYZJmldYCvAJflOk5KQRgKzMkcC8PAbOfcE2b2MvCQmV0BrCU9KZsUiEzi\n/W6696Wc30ckf7Q0gYiIiIiISABpmKWIiIiIiEgAKZkTEREREREJICVzIiIiIiIiAaRkTkRERERE\nJICUzImIiIiIiASQkjkREREREZEAUjInIiIiIiISQP8P7zC9EZriFYgAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f7c3cf8c630>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "bigram_bow_2d = tsne.fit_transform(X_bigram_bow.todense())\n",
    "plt.figure(figsize=(15, 10))\n",
    "plt.title('Bigram BOW vectors (TSNE)')\n",
    "plt.scatter(bigram_bow_2d[:,0], bigram_bow_2d[:,1], c=y)\n",
    "del bigram_bow_2d\n",
    "gc.collect()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "4055"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA3kAAAJOCAYAAAAK+M50AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nAECAEPIAAAAAIEAIeQAAAAAQIP8fjEfJFT6cwUEAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f7c45d06588>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "bigram_tfidf_2d = tsne.fit_transform(X_bigram_tfidf.todense())\n",
    "plt.figure(figsize=(15, 10))\n",
    "plt.title('Bigram TF-IDF vectors (TSNE)')\n",
    "plt.scatter(bigram_tfidf_2d[:,0], bigram_tfidf_2d[:,1], c=y)\n",
    "del bigram_tfidf_2d\n",
    "gc.collect()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Note: \n",
    "Both BOW and TF-IDF vectors don't seem to have well defined clusters, this doesn't look promising but we'll see after training."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Doc2Vev\n",
    "I trained some Doc2Vec models of different sizes and settings (with / without stopwords) using the script **doc2vec.py**."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "STOPWORDS = False\n",
    "def clean(text):\n",
    "    # TODO: optimize this\n",
    "    n = []\n",
    "    stopw = stopwords.words('english')\n",
    "    for txt in text.strip().lower().split():\n",
    "        txt = re.sub('http[s]?://(?:[a-zA-Z]|[0-9]|[$-_@.&+]|[!*\\(\\),]|(?:%[0-9a-fA-F][0-9a-fA-F]))+', '', txt)\n",
    "        txt = re.sub('[\\W_]', '', txt)\n",
    "        txt = re.sub(' [0-9]+ ', ' ', txt)\n",
    "        txt = ' '.join(txt.split())\n",
    "        txt = re.sub('^[0-9]+ ', ' ', txt)\n",
    "        txt = ' '.join(txt.split())\n",
    "        if re.match('^[0-9]+$', txt):\n",
    "            continue\n",
    "        if STOPWORDS and txt in stopw:\n",
    "            continue\n",
    "        if txt:\n",
    "            n.append(txt)\n",
    "    return ' '.join(n)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Run this script to generate the vectors:\n",
    "`python3 vectorize.py  --vectorizer doc2vec --size 1000 --filename 'data/vectors/doc2vec500' --stop_words None`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "doc2vec_model = Doc2Vec.load('data/vectors/doc2vec500')\n",
    "cleaned_text = training_data['Text'].apply(clean)\n",
    "STOPWORDS = True\n",
    "cleaned_text_sw = training_data['Text'].apply(clean)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "Xdoc2vec = []\n",
    "for doc in cleaned_text:\n",
    "    Xdoc2vec.append(doc2vec_model.infer_vector(list(filter(None, doc.split()))))\n",
    "Xdoc2vec = np.array(Xdoc2vec)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "200"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA3MAAAJOCAYAAAAd2l69AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fd4462db4a8>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "doc2vec_2d = tsne.fit_transform(Xdoc2vec)\n",
    "plt.figure(figsize=(15, 10))\n",
    "plt.title('Doc2Vec 500dim (TSNE)')\n",
    "plt.scatter(doc2vec_2d[:,0], doc2vec_2d[:,1], c=y)\n",
    "del doc2vec_2d\n",
    "gc.collect()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Run this script to generate the vectors:\n",
    "`python3 vectorize.py  --vectorizer doc2vec --size 1000 --filename 'data/vectors/doc2vec500' --stop_words english`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "doc2vec_model_1k = Doc2Vec.load('data/vectors/doc2vec')\n",
    "Xdoc2vec_1k = []\n",
    "for doc in cleaned_text:\n",
    "    Xdoc2vec_1k.append(doc2vec_model_1k.infer_vector(list(filter(None, doc.split()))))\n",
    "Xdoc2vec_1k = np.array(Xdoc2vec_1k)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "5"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA3kAAAJOCAYAAAAK+M50AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nSZIkqY78f8dyeoRJY43lAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fd444670f98>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "doc2vec_2d = tsne.fit_transform(Xdoc2vec_1k)\n",
    "plt.figure(figsize=(15, 10))\n",
    "plt.title('Doc2Vec 1k dim (TSNE)')\n",
    "plt.scatter(doc2vec_2d[:,0], doc2vec_2d[:,1], c=y)\n",
    "del doc2vec_2d\n",
    "gc.collect()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": [
    "doc2vec_model_1k_sw = Doc2Vec.load('data/vectors/doc2vecstopwords')\n",
    "Xdoc2vec_1k_sw = []\n",
    "for doc in cleaned_text_sw:\n",
    "    Xdoc2vec_1k_sw.append(doc2vec_model_1k_sw.infer_vector(list(filter(None, doc.split()))))\n",
    "Xdoc2vec_1k_sw = np.array(Xdoc2vec_1k_sw)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2695"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA3MAAAJOCAYAAAAd2l69AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fd4438c1208>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "doc2vec_2d = tsne.fit_transform(Xdoc2vec_1k_sw)\n",
    "plt.figure(figsize=(15, 10))\n",
    "plt.title('Doc2Vec 1k dim without stop words(TSNE)')\n",
    "plt.scatter(doc2vec_2d[:,0], doc2vec_2d[:,1], c=y)\n",
    "del doc2vec_2d\n",
    "gc.collect()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Doc2Vec vectors don't seem to be doing better than BOW/TF-IDF vectors. Training will tell."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Note:\n",
    "I will skip the test set exploration because it was the same as the training set (plus some comparisons between the two sets)."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Training"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [],
   "source": [
    "def show_prediction_result(classifier, X, y):\n",
    "    probas = classifier.predict_proba(X)\n",
    "    indices = np.argmax(probas, axis=1)\n",
    "    classes = np.unique(y)\n",
    "    predictions = classes[indices]\n",
    "    print('Log loss: {}'.format(log_loss(y, probas)))\n",
    "    print(classification_report(y, predictions))\n",
    "    plot_confusion_matrix(y, predictions)\n",
    "    \n",
    "def evaluate(classifier, X, y, X_test=None, y_test=None):\n",
    "    classifier.fit(X, y)\n",
    "    show_prediction_result(classifier, X, y)\n",
    "    if X_test is not None:\n",
    "        print('')\n",
    "        print('Test set:')\n",
    "        show_prediction_result(classifier, X_test, y_test)\n",
    "    return classifier\n",
    "        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "test_variants = pd.read_csv(TEST_VARIANTS_PATH)\n",
    "test_text = pd.read_csv(TEST_TEXT_PATH, sep=\"\\|\\|\", engine=\"python\", skiprows=1, names=[\"ID\", \"Text\"])\n",
    "test_y_data = pd.read_csv('data/stage1_solution_filtered.csv')\n",
    "test_data = pd.merge(test_text, test_variants, on='ID')\n",
    "test = test_data.loc[test_data['ID'].isin(test_y_data['ID'].values)]\n",
    "yt = np.argmax(test_y_data.values[:, 1:], axis=1) + 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Test bigram BOW shape: (368, 24539)\n",
      "Targets shape: (3316,)\n"
     ]
    }
   ],
   "source": [
    "# Bigram BOW\n",
    "TEST_BIGRAM_BOW_90K = path.join(VECTORS_PATH, 'test_bigram_bow_90k.npz')\n",
    "if path.exists(TEST_BIGRAM_BOW_90K):\n",
    "    Xtest_bigram_bow = load_npz(TEST_BIGRAM_BOW_90K)\n",
    "else:\n",
    "    Xtest_bigram_bow = bigram_vectorizer.transform(test['Text'].values)\n",
    "    save_npz(TEST_BIGRAM_BOW_90K, Xtest_bigram_bow)\n",
    "    \n",
    "print('Test bigram BOW shape:', Xtest_bigram_bow.shape)\n",
    "print('Targets shape:', y.shape)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [],
   "source": [
    "Xtest_bigram_tfidf = TfidfTransformer().fit_transform(Xtest_bigram_bow)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Logistic Regression"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "After testing different representations (word count, TF-IDF, word count + bigram, TF-IDF + bigram) TF-IDF with bigrams performed best.\n",
    "\n",
    "Logistic Regression was having trouble with documents of class 8 and 3 in all our tests. This may be due to the scewed number of examples per class, however class 9 was not affected by this. This might be because it's easier to classify."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "lr_param_grid = {'C': [0.001, 0.01, 0.1, 1, 10, 100], 'penalty': ['l2', 'l1'], 'class_weight': [None, 'balanced']}\n",
    "lr_clf = GridSearchCV(LogisticRegression(), lr_param_grid, cv=2, scoring='neg_log_loss', verbose=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Logistic Regression - Bigram TF-IDF\n",
      "Fitting 2 folds for each of 24 candidates, totalling 48 fits\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Parallel(n_jobs=1)]: Done  48 out of  48 | elapsed:  9.8min finished\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Log loss: 0.9504546004449558\n",
      "             precision    recall  f1-score   support\n",
      "\n",
      "          1       0.66      0.73      0.69       566\n",
      "          2       0.81      0.46      0.59       452\n",
      "          3       0.00      0.00      0.00        89\n",
      "          4       0.78      0.74      0.76       686\n",
      "          5       0.50      0.35      0.41       242\n",
      "          6       0.81      0.58      0.67       273\n",
      "          7       0.66      0.95      0.78       952\n",
      "          8       0.00      0.00      0.00        19\n",
      "          9       0.93      0.68      0.78        37\n",
      "\n",
      "avg / total       0.68      0.70      0.67      3316\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/usr/local/lib/python3.5/dist-packages/sklearn/metrics/classification.py:1135: UndefinedMetricWarning: Precision and F-score are ill-defined and being set to 0.0 in labels with no predicted samples.\n",
      "  'precision', 'predicted', average, warn_for)\n",
      "/usr/local/lib/python3.5/dist-packages/sklearn/utils/deprecation.py:75: DeprecationWarning: Function plot_confusion_matrix is deprecated; This will be removed in v0.4.0. Please use scikitplot.metrics.plot_confusion_matrix instead.\n",
      "  warnings.warn(msg, category=DeprecationWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Best Params:\n",
      "{'penalty': 'l2', 'class_weight': None, 'C': 1}\n",
      "\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAATgAAAEWCAYAAADy2YssAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nTxf5dYPPd10YAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fea379010b8>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print('Logistic Regression - Bigram TF-IDF')\n",
    "lr_clf = evaluate(lr_clf, X_bigram_tfidf, y)\n",
    "print('Best Params:')\n",
    "print(lr_clf.best_params_)\n",
    "print('')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Log loss: 1.0497543689101787\n",
      "             precision    recall  f1-score   support\n",
      "\n",
      "          1       0.65      0.54      0.59        94\n",
      "          2       0.67      0.30      0.42        46\n",
      "          3       0.33      0.57      0.42         7\n",
      "          4       0.60      0.62      0.61        65\n",
      "          5       0.61      0.80      0.69        25\n",
      "          6       0.67      0.55      0.60        22\n",
      "          7       0.67      0.88      0.76       101\n",
      "          8       0.00      0.00      0.00         2\n",
      "          9       1.00      1.00      1.00         6\n",
      "\n",
      "avg / total       0.64      0.64      0.63       368\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/usr/local/lib/python3.5/dist-packages/sklearn/metrics/classification.py:1135: UndefinedMetricWarning: Precision and F-score are ill-defined and being set to 0.0 in labels with no predicted samples.\n",
      "  'precision', 'predicted', average, warn_for)\n",
      "/usr/local/lib/python3.5/dist-packages/sklearn/utils/deprecation.py:75: DeprecationWarning: Function plot_confusion_matrix is deprecated; This will be removed in v0.4.0. Please use scikitplot.metrics.plot_confusion_matrix instead.\n",
      "  warnings.warn(msg, category=DeprecationWarning)\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAATIAAAEWCAYAAADl+xvlAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\njwUywzACz/8DPB/hSKUbyvEAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fea38f7cf98>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "show_prediction_result(lr_clf, Xtest_bigram_tfidf, yt)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Logistic Regression performance with Doc2Vec was similar to Bigram TF-IDF.\n",
    "1k dimensions vectors without stop words removal performed best.\n",
    "Trying a 10k as in [Dai et al.](https://arxiv.org/abs/1507.07998) vectors would probably improve performance (wasn't tested due to training time). Training on a bigger dataset would too."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [],
   "source": [
    "STOPWORDS = False\n",
    "test_clean = test['Text'].apply(clean)\n",
    "STOPWORDS = True\n",
    "test_clean_sw = test['Text'].apply(clean)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [],
   "source": [
    "Xtdoc2vec_1k = []\n",
    "for doc in test_clean:\n",
    "    Xtdoc2vec_1k.append(doc2vec_model_1k.infer_vector(list(filter(None, doc.split()))))\n",
    "Xtdoc2vec_1k = np.array(Xtdoc2vec_1k)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Logistic Regression - Word2Vec 500\n",
      "Fitting 2 folds for each of 24 candidates, totalling 48 fits\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Parallel(n_jobs=1)]: Done  48 out of  48 | elapsed:  4.4min finished\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Log loss: 0.7615879415357669\n",
      "             precision    recall  f1-score   support\n",
      "\n",
      "          1       0.77      0.78      0.78       566\n",
      "          2       0.89      0.64      0.75       452\n",
      "          3       0.87      0.15      0.25        89\n",
      "          4       0.82      0.84      0.83       686\n",
      "          5       0.59      0.57      0.58       242\n",
      "          6       0.81      0.77      0.79       273\n",
      "          7       0.77      0.95      0.85       952\n",
      "          8       1.00      0.11      0.19        19\n",
      "          9       0.93      0.73      0.82        37\n",
      "\n",
      "avg / total       0.79      0.78      0.77      3316\n",
      "\n",
      "\n",
      "Test set:\n",
      "Log loss: 1.0477106393895972\n",
      "             precision    recall  f1-score   support\n",
      "\n",
      "          1       0.68      0.62      0.65        94\n",
      "          2       0.46      0.28      0.35        46\n",
      "          3       0.00      0.00      0.00         7\n",
      "          4       0.57      0.66      0.61        65\n",
      "          5       0.59      0.68      0.63        25\n",
      "          6       0.65      0.59      0.62        22\n",
      "          7       0.69      0.86      0.77       101\n",
      "          8       0.00      0.00      0.00         2\n",
      "          9       1.00      0.50      0.67         6\n",
      "\n",
      "avg / total       0.62      0.64      0.62       368\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/usr/local/lib/python3.5/dist-packages/sklearn/metrics/classification.py:1135: UndefinedMetricWarning: Precision and F-score are ill-defined and being set to 0.0 in labels with no predicted samples.\n",
      "  'precision', 'predicted', average, warn_for)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Best Params:\n",
      "{'class_weight': None, 'C': 0.001, 'penalty': 'l2'}\n",
      "\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAATgAAAEWCAYAAADy2YssAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nIcv/A5rHpoUMURTAAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fd4438c14a8>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAATIAAAEWCAYAAADl+xvlAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fd41eb2c240>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print('Logistic Regression - Doc2Vec 1k')\n",
    "lr_clf = evaluate(lr_clf, Xdoc2vec_1k, y, Xtdoc2vec_1k, yt)\n",
    "print('Best Params:')\n",
    "print(lr_clf.best_params_)\n",
    "print('')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Fixing imbalanced classes.\n",
    "After some tests, undersampling with Cluster Centroids and over sampling with SMOTE worked best."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(2690, 24539)"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ratios = {\n",
    "    7: 600,\n",
    "    4: 500,\n",
    "    1: 480,\n",
    "    2: 450\n",
    "}\n",
    "ros = RandomUnderSampler(random_state=RANDOM_STATE, ratio=ratios)\n",
    "X_CC, y_CC = ros.fit_sample(X_bigram_tfidf, y)\n",
    "X_CC.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(3780, 24539)"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ratios = {\n",
    "    6: 400,\n",
    "    5: 400,\n",
    "    3: 350,\n",
    "    9: 300,\n",
    "    8: 300\n",
    "}\n",
    "ros = SMOTE(random_state=RANDOM_STATE, ratio=ratios)\n",
    "X_smote, y_smote = ros.fit_sample(X_CC, y_CC)\n",
    "X_smote.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Logistic Regression - Bigram TF-IDF (balanced)\n",
      "Fitting 2 folds for each of 24 candidates, totalling 48 fits\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Parallel(n_jobs=1)]: Done  48 out of  48 | elapsed: 10.5min finished\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Log loss: 0.49706536552379527\n",
      "             precision    recall  f1-score   support\n",
      "\n",
      "          1       0.85      0.76      0.80       480\n",
      "          2       0.88      0.81      0.85       450\n",
      "          3       0.81      0.88      0.84       350\n",
      "          4       0.86      0.82      0.84       500\n",
      "          5       0.69      0.77      0.73       400\n",
      "          6       0.85      0.90      0.87       400\n",
      "          7       0.87      0.86      0.87       600\n",
      "          8       0.99      0.99      0.99       300\n",
      "          9       0.96      1.00      0.98       300\n",
      "\n",
      "avg / total       0.86      0.85      0.85      3780\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/usr/local/lib/python3.5/dist-packages/sklearn/utils/deprecation.py:75: DeprecationWarning: Function plot_confusion_matrix is deprecated; This will be removed in v0.4.0. Please use scikitplot.metrics.plot_confusion_matrix instead.\n",
      "  warnings.warn(msg, category=DeprecationWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Best Params:\n",
      "{'penalty': 'l2', 'class_weight': None, 'C': 10}\n",
      "\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAATgAAAEWCAYAAADy2YssAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n0lgywSVJ0lgywSVJ0lgywSVJ0lj+D/LEqwxg+fTLAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fea3817f278>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print('Logistic Regression - Bigram TF-IDF (balanced)')\n",
    "lr_clf_balanced = evaluate(lr_clf, X_smote, y_smote)\n",
    "print('Best Params:')\n",
    "print(lr_clf_balanced.best_params_)\n",
    "print('')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Log loss: 1.0497543689101787\n",
      "             precision    recall  f1-score   support\n",
      "\n",
      "          1       0.65      0.54      0.59        94\n",
      "          2       0.67      0.30      0.42        46\n",
      "          3       0.33      0.57      0.42         7\n",
      "          4       0.60      0.62      0.61        65\n",
      "          5       0.61      0.80      0.69        25\n",
      "          6       0.67      0.55      0.60        22\n",
      "          7       0.67      0.88      0.76       101\n",
      "          8       0.00      0.00      0.00         2\n",
      "          9       1.00      1.00      1.00         6\n",
      "\n",
      "avg / total       0.64      0.64      0.63       368\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/usr/local/lib/python3.5/dist-packages/sklearn/metrics/classification.py:1135: UndefinedMetricWarning: Precision and F-score are ill-defined and being set to 0.0 in labels with no predicted samples.\n",
      "  'precision', 'predicted', average, warn_for)\n",
      "/usr/local/lib/python3.5/dist-packages/sklearn/utils/deprecation.py:75: DeprecationWarning: Function plot_confusion_matrix is deprecated; This will be removed in v0.4.0. Please use scikitplot.metrics.plot_confusion_matrix instead.\n",
      "  warnings.warn(msg, category=DeprecationWarning)\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAATIAAAEWCAYAAADl+xvlAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\njwUywzACz/8DPB/hSKUbyvEAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fea5dea1710>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "show_prediction_result(lr_clf_balanced, Xtest_bigram_tfidf, yt)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### MLP and LSTM\n",
    "After some hyperparameter search, the following models performed best.\n",
    "\n",
    "- MLP with Bigram TF-IDF\n",
    "- LSTM with Bigram TF-IDF"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Train on 3316 samples, validate on 368 samples\n",
      "Epoch 1/50\n",
      "3316/3316 [==============================] - 12s - loss: 1.4756 - acc: 0.4943 - val_loss: 1.0356 - val_acc: 0.6060\n",
      "Epoch 2/50\n",
      "3316/3316 [==============================] - 11s - loss: 0.9096 - acc: 0.6743 - val_loss: 0.9756 - val_acc: 0.6332\n",
      "Epoch 3/50\n",
      "3316/3316 [==============================] - 11s - loss: 0.6737 - acc: 0.7521 - val_loss: 0.9232 - val_acc: 0.6440\n",
      "Epoch 4/50\n",
      "3316/3316 [==============================] - 14s - loss: 0.5509 - acc: 0.7868 - val_loss: 0.8914 - val_acc: 0.6739\n",
      "Epoch 5/50\n",
      "3316/3316 [==============================] - 14s - loss: 0.4806 - acc: 0.8094 - val_loss: 0.9526 - val_acc: 0.6250\n",
      "Epoch 6/50\n",
      "3316/3316 [==============================] - 14s - loss: 0.4598 - acc: 0.8127 - val_loss: 0.9198 - val_acc: 0.6793\n",
      "Epoch 7/50\n",
      "3316/3316 [==============================] - 12s - loss: 0.4330 - acc: 0.8266 - val_loss: 0.9718 - val_acc: 0.6739\n",
      "Epoch 8/50\n",
      "3316/3316 [==============================] - 12s - loss: 0.4112 - acc: 0.8272 - val_loss: 0.9856 - val_acc: 0.6658\n",
      "Epoch 9/50\n",
      "3316/3316 [==============================] - 12s - loss: 0.3881 - acc: 0.8393 - val_loss: 0.9754 - val_acc: 0.6685\n",
      "Epoch 10/50\n",
      "3316/3316 [==============================] - 12s - loss: 0.3796 - acc: 0.8426 - val_loss: 1.0006 - val_acc: 0.6413\n",
      "Epoch 11/50\n",
      "3316/3316 [==============================] - 12s - loss: 0.3771 - acc: 0.8453 - val_loss: 1.0210 - val_acc: 0.6603\n",
      "Epoch 12/50\n",
      "3316/3316 [==============================] - 12s - loss: 0.3524 - acc: 0.8540 - val_loss: 1.0542 - val_acc: 0.6685\n",
      "Epoch 13/50\n",
      "3316/3316 [==============================] - 12s - loss: 0.3584 - acc: 0.8465 - val_loss: 1.0798 - val_acc: 0.6522\n",
      "Test loss: 1.07984153084\n",
      "Test accuracy: 0.652173913043\n"
     ]
    }
   ],
   "source": [
    "import keras\n",
    "from keras.models import Sequential\n",
    "from keras.layers import Dense, Dropout\n",
    "from keras.callbacks import EarlyStopping\n",
    "batch_size = 128\n",
    "num_classes = 9\n",
    "epochs = 50\n",
    "\n",
    "x_train = X_bigram_tfidf.todense()\n",
    "x_test = Xtest_bigram_tfidf.todense()\n",
    "y_train = keras.utils.to_categorical(y - 1, num_classes)\n",
    "y_test = keras.utils.to_categorical(yt - 1, num_classes)\n",
    "\n",
    "model = Sequential()\n",
    "model.add(Dense(512, activation='relu', input_shape=(24539,)))\n",
    "model.add(Dropout(0.2))\n",
    "model.add(Dense(512, activation='tanh'))\n",
    "model.add(Dropout(0.2))\n",
    "model.add(Dense(num_classes, activation='softmax'))\n",
    "\n",
    "model.compile(loss='categorical_crossentropy',\n",
    "              optimizer='adam',\n",
    "              metrics=['accuracy'])\n",
    "\n",
    "history = model.fit(x_train, y_train,\n",
    "                    batch_size=batch_size,\n",
    "                    epochs=epochs,\n",
    "                    verbose=1,\n",
    "                    validation_data=(x_test, y_test),\n",
    "                   callbacks=[EarlyStopping(patience=8)])\n",
    "score = model.evaluate(x_test, y_test, verbose=0)\n",
    "print('Test loss:', score[0])\n",
    "print('Test accuracy:', score[1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Train on 3316 samples, validate on 368 samples\n",
      "Epoch 1/50\n",
      "3316/3316 [==============================] - 35s - loss: 1.8150 - acc: 0.3797 - val_loss: 1.4631 - val_acc: 0.4918\n",
      "Epoch 2/50\n",
      "3316/3316 [==============================] - 26s - loss: 1.3088 - acc: 0.5811 - val_loss: 1.1387 - val_acc: 0.6168\n",
      "Epoch 3/50\n",
      "3316/3316 [==============================] - 33s - loss: 1.0586 - acc: 0.6475 - val_loss: 1.0136 - val_acc: 0.6223\n",
      "Epoch 4/50\n",
      "3316/3316 [==============================] - 31s - loss: 0.8949 - acc: 0.6936 - val_loss: 0.9565 - val_acc: 0.6413\n",
      "Epoch 5/50\n",
      "3316/3316 [==============================] - 31s - loss: 0.7781 - acc: 0.7337 - val_loss: 0.9181 - val_acc: 0.6359\n",
      "Epoch 6/50\n",
      "3316/3316 [==============================] - 31s - loss: 0.6870 - acc: 0.7569 - val_loss: 0.8902 - val_acc: 0.6332\n",
      "Epoch 7/50\n",
      "3316/3316 [==============================] - 31s - loss: 0.6122 - acc: 0.7820 - val_loss: 0.8728 - val_acc: 0.6549\n",
      "Epoch 8/50\n",
      "3316/3316 [==============================] - 31s - loss: 0.5615 - acc: 0.7955 - val_loss: 0.8549 - val_acc: 0.6712\n",
      "Epoch 9/50\n",
      "3316/3316 [==============================] - 32s - loss: 0.5235 - acc: 0.8076 - val_loss: 0.8605 - val_acc: 0.6766\n",
      "Epoch 10/50\n",
      "3316/3316 [==============================] - 33s - loss: 0.4966 - acc: 0.8112 - val_loss: 0.8648 - val_acc: 0.6902\n",
      "Epoch 11/50\n",
      "3316/3316 [==============================] - 32s - loss: 0.4666 - acc: 0.8224 - val_loss: 0.8633 - val_acc: 0.6739\n",
      "Epoch 12/50\n",
      "3316/3316 [==============================] - 32s - loss: 0.4530 - acc: 0.8236 - val_loss: 0.8910 - val_acc: 0.6739\n",
      "Epoch 13/50\n",
      "3316/3316 [==============================] - 32s - loss: 0.4355 - acc: 0.8245 - val_loss: 0.8965 - val_acc: 0.6739\n",
      "Epoch 14/50\n",
      "3316/3316 [==============================] - 31s - loss: 0.4236 - acc: 0.8278 - val_loss: 0.9092 - val_acc: 0.6929\n",
      "Epoch 15/50\n",
      "3316/3316 [==============================] - 31s - loss: 0.4077 - acc: 0.8353 - val_loss: 0.9162 - val_acc: 0.6712\n",
      "Epoch 16/50\n",
      "3316/3316 [==============================] - 34s - loss: 0.4005 - acc: 0.8350 - val_loss: 0.9212 - val_acc: 0.6848\n",
      "Epoch 17/50\n",
      "3316/3316 [==============================] - 32s - loss: 0.3934 - acc: 0.8402 - val_loss: 0.9303 - val_acc: 0.6929\n",
      "Test loss: 0.930335418038\n",
      "Test accuracy: 0.692934782609\n"
     ]
    }
   ],
   "source": [
    "from keras.layers import LSTM\n",
    "\n",
    "batch_size = 64\n",
    "num_classes = 9\n",
    "epochs = 50\n",
    "hidden = 128\n",
    "\n",
    "x_train = np.array(X_bigram_tfidf.todense()).reshape((-1, 1, 24539))\n",
    "x_test = np.array(Xtest_bigram_tfidf.todense()).reshape((-1, 1, 24539))\n",
    "y_train = keras.utils.to_categorical(y - 1, num_classes)\n",
    "y_test = keras.utils.to_categorical(yt - 1, num_classes)\n",
    "\n",
    "model = Sequential()\n",
    "\n",
    "model.add(LSTM(hidden, dropout=0.3, recurrent_dropout=0.3, input_shape=(1, 24539)))\n",
    "model.add(Dense(num_classes, activation='softmax'))\n",
    "\n",
    "model.compile(loss='categorical_crossentropy',\n",
    "              optimizer='adam',\n",
    "              metrics=['accuracy'])\n",
    "\n",
    "history = model.fit(x_train, y_train,\n",
    "                    batch_size=batch_size,\n",
    "                    epochs=epochs,\n",
    "                    verbose=1,\n",
    "                    validation_data=(x_test, y_test),\n",
    "                    callbacks=[EarlyStopping(patience=8)])\n",
    "score = model.evaluate(x_test, y_test, verbose=0)\n",
    "print('Test loss:', score[0])\n",
    "print('Test accuracy:', score[1])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### MLP / LSTM with word index vectors\n",
    "I had built another model with word index vectors as input, you can find it at `mlp-lstm` notebook.\n",
    "It didn't perform well but more hyperparameter search was necessary."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Other classifiers\n",
    "#### SVM\n",
    "I have tested SVM using Grid Search for the following parameters: kernel, C, class_weight. SVM was very slow to calculate.\n",
    "\n",
    "#### Multinomial Naive Bayes\n",
    "Very fast but had the lowest results. However, this model performed better than Logistic Regression in classifying documents of class 2 which other models failed to classify, this means bagging would improve performance.\n",
    "\n",
    "#### Random Forest and XGBoost\n",
    "Their performance was very similar to SVM\n",
    "\n",
    "All these models performed slightly worse than Logistic Regression. A more thorough hyperparameter search could improve the results."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Other things I've tried\n",
    "For the sake of simplicity, I chose not to include the following in this document.\n",
    "- Added Variation and Gene to the text and pushed their counts up in the BOW to be one of the most common words (high weight). The improvement wasn't noticeable;\n",
    "- Binary BOW performed worse than occurences count;\n",
    "- Reduced BOW and TF-IDF using SVD;\n",
    "- Trigrams didn't seem to do any good;\n",
    "- Concatenated DOC2VEC vectors with very small BOW vectors, I was hoping that the BOW vectors would capture some features that DOC2VEC would've missed and that an MLP would be able to use them.`"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Conclusion and perspectives\n",
    "The problem is rather difficult, we couldn't achieve better than 64% accuracy in all our tests. There are some more ideas that I would've liked to try including:\n",
    "\n",
    "- Adding more data will probably improve accuracy;\n",
    "- Understanding the clinical evidence more would help design better features, we could construct a vocabulary of each class and give stronger weights to these words. It will help make a better preprocessing will help minimize noise, deleting paragraphs with no interesting features. More investigation on what features are most releavant will help too (using Random Forests);\n",
    "- Bagging would probably help too;\n",
    "- Testing a CNN model similar to [Yoon Kim](https://arxiv.org/abs/1408.5882) or [Johnson and Zhang](https://arxiv.org/abs/1412.1058) would improve the performance, however more data will be needed for training the embeddings. An LSTM model is also worthwile similar to [Johnson and Zhang](https://arxiv.org/abs/1602.02373) or [Miyato et al.](https://arxiv.org/abs/1605.07725);\n",
    "- Trying a different document representation could improve our model too, like [Skip-thought vectors](https://arxiv.org/abs/1506.06726], however they're very slow to compute, the training takes about a week!\n",
    "- Spend more time in parameter search, try [hyperopt](https://github.com/hyperopt/hyperopt);\n",
    "- Optimize the code.\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Thank you for taking the time to assess my work. Please feel free to contact me on my email hanifi.yazid@gmail.com if you need more information."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.5.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
